[{"Date":"Jan. 2, 2016 at 12:01 a.m. ET","Headline":"Higher Yields or Growing Payouts?","Summary":""},{"Date":"Dec. 19, 2015 at 12:01 a.m. ET","Headline":"S&P 500 Dividend Payments Stay Strong, but Likely to Falter in 2016","Summary":"By"},{"Date":"Jan. 10, 2016 at 8:33 p.m. ET","Headline":"Drugmakers jack up prices despite government pressure","Summary":""},{"Date":"Jan. 11, 2016 at 12:53 p.m. ET","Headline":"Getting prescription drugs is now as easy as ordering takeout","Summary":""},{"Date":"Jan. 19, 2016 at 3:41 p.m. ET","Headline":"How to emerge from a \u2018death spiral\u2019 in stocks","Summary":""},{"Date":"Jan. 22, 2016 at 5:56 a.m. ET","Headline":"4 Cheap Stocks With 3% Yields and Earnings Power","Summary":""},{"Date":"Jan. 21, 2016 at 12:01 a.m. ET","Headline":"Five Pharma Picks for Another Volatile Year","Summary":""},{"Date":"Jan. 25, 2016 at 4:10 p.m. ET","Headline":"Inversions like Johnson Controls-Tyco to hit corporate tax collection, CBO says","Summary":""},{"Date":"Jan. 26, 2016 at 12:01 a.m. ET","Headline":"7 Quality Income Stocks Sporting Yields Up to 8%","Summary":""},{"Date":"Jan. 30, 2016 at 12:01 a.m. ET","Headline":"Apple\u2019s Tim Cook Is Smarter Than You Think","Summary":""},{"Date":"Jan. 31, 2016 at 3:31 p.m. ET","Headline":"Alphabet, Exxon results to mark midpoint of ugly earnings season","Summary":""},{"Date":"Feb. 2, 2016 at 4:45 p.m. ET","Headline":"Dow logs nearly 300-point loss as oil sinks below $30","Summary":"Pfizer Inc.  reported on Tuesday fourth-quarter earnings of $613 million, or 10 cents per share, compared with $1.228 billion, or 19 cents per share the same period a year ago. The latest results include three months of le..."},{"Date":"Feb. 2, 2016 at 1:08 p.m. ET","Headline":"Recession risks warn of \u2018severe\u2019 drop in the stock market","Summary":"Pfizer Inc.  reported on Tuesday fourth-quarter earnings of $613 million, or 10 cents per share, compared with $1.228 billion, or 19 cents per share the same period a year ago. The latest results include three months of le..."},{"Date":"Feb. 2, 2016 at 7:19 a.m. ET","Headline":"Pfizer beats profit expectations, but provides downbeat outlook","Summary":"Pfizer Inc.  reported on Tuesday fourth-quarter earnings of $613 million, or 10 cents per share, compared with $1.228 billion, or 19 cents per share the same period a year ago. The latest results include three months of le..."},{"Date":"Feb. 5, 2016 at 2:31 a.m. ET","Headline":"Apple could offer investors shelter in a recessionary storm","Summary":""},{"Date":"Feb. 4, 2016 at 12:01 a.m. ET","Headline":"Today\u2019s Top 5 Stock Picks: Solid Profits, Discounted","Summary":""},{"Date":"Feb. 8, 2016 at 10:44 a.m. ET","Headline":"The market in a minute: 5 stocks I really like","Summary":""},{"Date":"Jan. 7, 2016 at 12:01 a.m. ET","Headline":"Barrons.com Stock Picks Just Behind Index in \u201915","Summary":""},{"Date":"Feb. 11, 2016 at 5:08 a.m. ET","Headline":"The one stock sector you need to fight the bear-market flu","Summary":""},{"Date":"Feb. 12, 2016 at 10:33 a.m. ET","Headline":"20 dividend stocks that Wall Street loves the most","Summary":""},{"Date":"Feb. 11, 2016 at 12:01 a.m. ET","Headline":"J&J May See $4 Cash-Flow Cut From Remicade Copy","Summary":""},{"Date":"Feb. 16, 2016 at 4:23 p.m. ET","Headline":"U.S. stocks close at session highs despite drop in oil prices","Summary":""},{"Date":"Feb. 16, 2016 at 7:41 a.m. ET","Headline":"Pfizer cuts earnings as it settles Medicaid rebate claims","Summary":""},{"Date":"Feb. 16, 2016 at 12:01 a.m. ET","Headline":"9 Oversold Drug Stocks With Big-Gain Potential","Summary":""},{"Date":"Feb. 12, 2016 at 12:01 a.m. ET","Headline":"3 Stock Picks From Only U.S. Fund That Rose in \u201908","Summary":""},{"Date":"Feb. 13, 2016 at 12:01 a.m. ET","Headline":"Bristol-Myers\u2019 Cancer Drug Could Push the Stock 25% Higher","Summary":""},{"Date":"Feb. 27, 2016 at 12:01 a.m. ET","Headline":"9 Drug Makers That Could Boost Their Payouts","Summary":""},{"Date":"Feb. 29, 2016 at 12:01 a.m. ET","Headline":"18 Time Arbitrage Trades That Could Pay Off","Summary":""},{"Date":"Mar. 7, 2016 at 12:01 a.m. ET","Headline":"GlaxoSmithKline Entices With 6.8% Dividend Yield","Summary":""},{"Date":"Mar. 9, 2016 at 7:00 a.m. ET","Headline":"Pfizer launches $5 billion accelerated stock repurchase program","Summary":"Pfizer Inc.  said Wednesday that it launched a $5 billion accelerated share repurchase program with Goldman, Sachs & co. , to be settled during the second quarter of 2016. The drug giant said 136 million of the shares repu..."},{"Date":"Mar. 12, 2016 at 12:01 a.m. ET","Headline":"Move Over, Facebook and Netflix: Value Investing Is Rebounding","Summary":""},{"Date":"Mar. 14, 2016 at 12:01 a.m. ET","Headline":"Charts Agree: Big Value Stocks Are Finally Back","Summary":""},{"Date":"Mar. 18, 2016 at 4:01 p.m. ET","Headline":"Bernie Sanders urges Treasury to set tax restrictions on inversions","Summary":""},{"Date":"Mar. 22, 2016 at 2:49 p.m. ET","Headline":"You can easily mimic a hedge fund\u2019s performance \u2014 without the blowups","Summary":""},{"Date":"Mar. 21, 2016 at 2:01 p.m. ET","Headline":"IHS-Markit deal ranks among biggest inversions","Summary":""},{"Date":"Apr. 5, 2016 at 11:02 p.m. ET","Headline":"Pfizer to scuttle its $150 billion Allergan takeover","Summary":"Pfizer Inc.  said Tuesday it had positive results in a late-stage trial of Broaden, a treatment for psoriatic arthritis in adults. The company said a first Phase 3 trial of the drug met its primary endpoints. Psoriatic art..."},{"Date":"Apr. 5, 2016 at 4:40 p.m. ET","Headline":"Wall Street closes lower for 2nd day as earnings, overseas worries weigh","Summary":"Pfizer Inc.  said Tuesday it had positive results in a late-stage trial of Broaden, a treatment for psoriatic arthritis in adults. The company said a first Phase 3 trial of the drug met its primary endpoints. Psoriatic art..."},{"Date":"Apr. 5, 2016 at 11:48 a.m. ET","Headline":"Why Treasury\u2019s new inversion rules could hit the Pfizer-Allergan deal but not others","Summary":"Pfizer Inc.  said Tuesday it had positive results in a late-stage trial of Broaden, a treatment for psoriatic arthritis in adults. The company said a first Phase 3 trial of the drug met its primary endpoints. Psoriatic art..."},{"Date":"Apr. 5, 2016 at 9:16 a.m. ET","Headline":"The no-headache ETF that\u2019s beating the S&P 500","Summary":"Pfizer Inc.  said Tuesday it had positive results in a late-stage trial of Broaden, a treatment for psoriatic arthritis in adults. The company said a first Phase 3 trial of the drug met its primary endpoints. Psoriatic art..."},{"Date":"Apr. 5, 2016 at 7:22 a.m. ET","Headline":"Pfizer reports positive results from late-stage trial of psoriatic arthritis drug","Summary":"Pfizer Inc.  said Tuesday it had positive results in a late-stage trial of Broaden, a treatment for psoriatic arthritis in adults. The company said a first Phase 3 trial of the drug met its primary endpoints. Psoriatic art..."},{"Date":"Apr. 4, 2016 at 1:35 p.m. ET","Headline":"Stock bulls are rejuvenated as no \u2018sell\u2019 signals lurk","Summary":""},{"Date":"Apr. 7, 2016 at 12:10 p.m. ET","Headline":"European stocks end lower as growth concerns linger","Summary":"U.S. stocks ended higher as oil futures notched their largest one-day gain in three weeks, driven by an unexpected drop in crude-oil inventories. The S&P 500 gained 21.49 points, or 1.1%, to 2,066.66, led by strong gains i..."},{"Date":"Apr. 7, 2016 at 12:04 p.m. ET","Headline":"FTSE 100 rally loses steam as oil prices drop","Summary":"U.S. stocks ended higher as oil futures notched their largest one-day gain in three weeks, driven by an unexpected drop in crude-oil inventories. The S&P 500 gained 21.49 points, or 1.1%, to 2,066.66, led by strong gains i..."},{"Date":"Apr. 6, 2016 at 9:16 p.m. ET","Headline":"In focus: Sell signals, but no break in price","Summary":"U.S. stocks ended higher as oil futures notched their largest one-day gain in three weeks, driven by an unexpected drop in crude-oil inventories. The S&P 500 gained 21.49 points, or 1.1%, to 2,066.66, led by strong gains i..."},{"Date":"Apr. 6, 2016 at 4:39 p.m. ET","Headline":"Stocks rally as oil soars after Fed minutes","Summary":"U.S. stocks ended higher as oil futures notched their largest one-day gain in three weeks, driven by an unexpected drop in crude-oil inventories. The S&P 500 gained 21.49 points, or 1.1%, to 2,066.66, led by strong gains i..."},{"Date":"Apr. 6, 2016 at 4:17 p.m. ET","Headline":"U.S. stocks end higher as oil prices surge","Summary":"U.S. stocks ended higher as oil futures notched their largest one-day gain in three weeks, driven by an unexpected drop in crude-oil inventories. The S&P 500 gained 21.49 points, or 1.1%, to 2,066.66, led by strong gains i..."},{"Date":"Apr. 6, 2016 at 3:07 p.m. ET","Headline":"Baxalta's stock jumps after Shire says merger should close as planned","Summary":"Shares of Baxalta Inc.  shot up 6.4% in afternoon trade, after Shire PLC  said it expects its merger with the biopharmaceutical company to close as planned, despite new government measures aimed at blocking tax inversion d..."},{"Date":"Apr. 6, 2016 at 12:07 p.m. ET","Headline":"FTSE 100 logs gain after upbeat China data, oil rally","Summary":""},{"Date":"Apr. 6, 2016 at 11:52 a.m. ET","Headline":"The easiest way to understand the Pfizer deal and tax inversions, explained using burgers","Summary":""},{"Date":"Apr. 6, 2016 at 11:21 a.m. ET","Headline":"Here are the top 10 inversions by value after Pfizer deal collapse","Summary":""},{"Date":"Apr. 6, 2016 at 9:39 a.m. ET","Headline":"Medtronic says new inversion rules won\u2019t hurt finances","Summary":""},{"Date":"Apr. 6, 2016 at 7:56 a.m. ET","Headline":"This chart predicts when the S&P\u2019s bull market will hit its top","Summary":""},{"Date":"Apr. 6, 2016 at 7:03 a.m. ET","Headline":"Pfizer walks away from its $150 billion Allergan deal","Summary":""},{"Date":"Apr. 5, 2016 at 12:01 a.m. ET","Headline":"Deal or No Deal, Allergan and Pfizer Are Both Buys","Summary":""},{"Date":"Apr. 9, 2016 at 12:01 a.m. ET","Headline":"They Said What?","Summary":""},{"Date":"Apr. 9, 2016 at 12:01 a.m. ET","Headline":"They Said What?","Summary":""},{"Date":"Apr. 2, 2016 at 12:01 a.m. ET","Headline":"5 Hot New Drugs","Summary":""},{"Date":"Jan. 9, 2016 at 12:01 a.m. ET","Headline":"Stock Market Could Take a Breather After China\u2019s Selloff","Summary":""},{"Date":"Apr. 11, 2016 at 4:25 p.m. ET","Headline":"Stocks cough up oil-fueled gains to end lower","Summary":"By"},{"Date":"Apr. 9, 2016 at 12:01 a.m. ET","Headline":"How the Yen\u2019s Rise Could Affect the Stock Market","Summary":"By"},{"Date":"Apr. 8, 2016 at 12:01 a.m. ET","Headline":"Trevena Stock Could Double to $20","Summary":""},{"Date":"Apr. 13, 2016 at 11:48 a.m. ET","Headline":"Analysts divided on Clovis stock after drug approval is delayed","Summary":""},{"Date":"Apr. 12, 2016 at 8:25 a.m. ET","Headline":"A good trick to picking the best dividend stocks","Summary":""},{"Date":"Apr. 14, 2016 at 8:41 a.m. ET","Headline":"Politics is killing health-care stocks","Summary":""},{"Date":"Apr. 14, 2016 at 12:01 a.m. ET","Headline":"How corporate tax avoidance is hurting America and the rest of the world","Summary":""},{"Date":"Apr. 16, 2016 at 12:01 a.m. ET","Headline":"After Pfizer and Allergan, Mergers Get Trickier","Summary":"By"},{"Date":"Apr. 15, 2016 at 12:01 a.m. ET","Headline":"Best Bets in Biopharma","Summary":""},{"Date":"Apr. 27, 2016 at 5:56 p.m. ET","Headline":"Why Dan Loeb fears this is \u20181st inning of a washout in hedge funds\u2019","Summary":"By"},{"Date":"Apr. 27, 2016 at 7:22 a.m. ET","Headline":"Exxon Mobil\u2019s downgrade leaves just two AAA-rated companies in the U.S.","Summary":"By"},{"Date":"Dec. 24, 2013 at 12:01 a.m. ET","Headline":"Best Stocks for 2014","Summary":"By"},{"Date":"Dec. 20, 2010 at 12:01 a.m. ET","Headline":"Outlook 2011","Summary":"By"},{"Date":"Apr. 27, 2009 at 12:01 a.m. ET","Headline":"The Long View","Summary":"By"},{"Date":"Mar. 30, 1998 at 12:01 a.m. ET","Headline":"Exactly How Nifty?","Summary":"By"},{"Date":"Apr. 30, 2016 at 9:11 p.m. ET","Headline":"Wall Street isn\u2019t rewarding low-expectation earnings beats","Summary":""},{"Date":"Apr. 30, 2016 at 10:14 a.m. ET","Headline":"Looking for income? These 23 dividend stocks provide it","Summary":""},{"Date":"May. 3, 2016 at 7:19 p.m. ET","Headline":"Pfizer said to ponder Medivation acquisition","Summary":"Pfizer Inc. PFE has approached Medivation Inc. MDVN about a possible purchase of the biotech company, Reuters reported Tuesday, citing people familiar with the matter. On Friday, Medivation rejected Sanofi SA's SNY $9.3 bi..."},{"Date":"May. 3, 2016 at 4:30 p.m. ET","Headline":"U.S. stocks end at 3-week low as energy, banks sell off","Summary":"Pfizer Inc.'s stock  surged 3.4% in premarket trade Tuesday, after the drug giant beat first-quarter profit and sales expectations, and raised its full-year outlook. Earnings for the latest quarter rose to $3.02 billion, o..."},{"Date":"May. 3, 2016 at 6:58 a.m. ET","Headline":"Pfizer's stock surges after results beat expectations, outlook raised","Summary":"Pfizer Inc.'s stock  surged 3.4% in premarket trade Tuesday, after the drug giant beat first-quarter profit and sales expectations, and raised its full-year outlook. Earnings for the latest quarter rose to $3.02 billion, o..."},{"Date":"May. 5, 2016 at 10:27 a.m. ET","Headline":"Why oil prices have nowhere left to go but down","Summary":""},{"Date":"May. 5, 2016 at 12:10 a.m. ET","Headline":"In focus: The bears finally decide to show up","Summary":""},{"Date":"May. 8, 2016 at 8:59 p.m. ET","Headline":"2016 turning out to be record year for failed mergers","Summary":""},{"Date":"May. 7, 2016 at 12:01 a.m. ET","Headline":"They Said What?","Summary":""},{"Date":"May. 10, 2016 at 8:47 a.m. ET","Headline":"6 favorite dividend stocks from a conservative money manager","Summary":""},{"Date":"May. 10, 2016 at 12:01 a.m. ET","Headline":"Three Big Pharma Stocks Headed Higher","Summary":""},{"Date":"May. 12, 2016 at 10:24 a.m. ET","Headline":"Banks lose $300 million in fees as broken deals set record","Summary":""},{"Date":"May. 16, 2016 at 7:13 p.m. ET","Headline":"Paulson & Co. sheds AbbVie, picks up more Pfizer","Summary":"Hedge-fund manager James Paulson shed some positions in healthcare stocks while taking a few new positions in tech, according to a Securities and Exchange Commission filing late Monday. Paulson & Co. eliminated its stake i..."},{"Date":"May. 16, 2016 at 4:24 p.m. ET","Headline":"U.S. stocks close higher on energy, tech share rally","Summary":"U.S. stocks finished sharply higher Monday as gains in tech and a rally in crude futures helped boost investor sentiment. Tech's rally was partially inspired by a 3.7% rise in the shares of Apple Inc. . The Dow Jones Indus..."},{"Date":"May. 16, 2016 at 4:19 p.m. ET","Headline":"CORRECT: U.S. stocks rally as energy, Apple lift Wall Street mood","Summary":"U.S. stocks finished sharply higher Monday as gains in tech and a rally in crude futures helped boost investor sentiment. Tech's rally was partially inspired by a 3.7% rise in the shares of Apple Inc. . The Dow Jones Indus..."},{"Date":"May. 16, 2016 at 2:57 p.m. ET","Headline":"4 things to know about Pfizer\u2019s $5.2 billion acquisition target, Anacor","Summary":"U.S. stocks opened slightly higher Monday as investors weighed weak economic data from China against a renewed push higher for oil prices . A steep drop in a reading of New York-area business conditions also weighed on sen..."},{"Date":"May. 16, 2016 at 1:13 p.m. ET","Headline":"Just one of these 6 things could trigger the next market slide","Summary":"U.S. stocks opened slightly higher Monday as investors weighed weak economic data from China against a renewed push higher for oil prices . A steep drop in a reading of New York-area business conditions also weighed on sen..."},{"Date":"May. 16, 2016 at 9:32 a.m. ET","Headline":"U.S. stocks open slightly higher amid oil's surge, weak economic data","Summary":"U.S. stocks opened slightly higher Monday as investors weighed weak economic data from China against a renewed push higher for oil prices . A steep drop in a reading of New York-area business conditions also weighed on sen..."},{"Date":"May. 16, 2016 at 7:32 a.m. ET","Headline":"Pfizer to buy Anacor for $4.5 billion","Summary":"Anacor Pharmaceuticals Inc.'s stock  rocketed 53% in premarket trade Monday, after the maker of an eczema treatment agreed to be acquired by Pfizer Inc.  in a deal valued at $5.2 billion. Under terms of the deal, Pfizer wi..."},{"Date":"May. 16, 2016 at 7:03 a.m. ET","Headline":"Anacor stock soars after agreeing to be bought by Pfizer for $5.2 billion","Summary":"Anacor Pharmaceuticals Inc.'s stock  rocketed 53% in premarket trade Monday, after the maker of an eczema treatment agreed to be acquired by Pfizer Inc.  in a deal valued at $5.2 billion. Under terms of the deal, Pfizer wi..."},{"Date":"May. 19, 2016 at 11:06 a.m. ET","Headline":"Jim O\u2019Neill wants to offer $1 billion prizes for new antibiotics","Summary":""},{"Date":"May. 20, 2016 at 9:16 a.m. ET","Headline":"Here\u2019s everything billionaires like Soros and Buffett don\u2019t reveal in their 13F filings","Summary":""},{"Date":"May. 20, 2016 at 8:36 a.m. ET","Headline":"Four reasons for investors to buy biotechnology stocks now","Summary":""},{"Date":"May. 23, 2016 at 6:22 p.m. ET","Headline":"Samsung hopes to expand U.S. reach with replica drugs","Summary":""},{"Date":"May. 28, 2016 at 12:01 a.m. ET","Headline":"Amgen\u2019s Autumn Gems","Summary":""},{"Date":"May. 31, 2016 at 10:56 a.m. ET","Headline":"Carl Icahn takes \u2018large\u2019 stake in Allergan","Summary":""},{"Date":"Jun. 1, 2016 at 12:01 a.m. ET","Headline":"Why You Should Follow Carl Icahn Into Allergan","Summary":""},{"Date":"Jun. 7, 2016 at 7:11 a.m. ET","Headline":"Pfizer reports positive results in trial of drug for adults with psoriatic arthritis","Summary":"Pfizer Inc.  on Tuesday reported positive results from a late-stage trial of a treatment for adults with psoriatic arthritis. The company said results from  Oral Psoriatic Arthritis triaL (OPAL) Beyond, the second Phase 3 ..."},{"Date":"Jun. 10, 2016 at 12:01 a.m. ET","Headline":"Bristol-Myers, a Top Pharmaceuticals Pick","Summary":""},{"Date":"Jun. 11, 2016 at 12:01 a.m. ET","Headline":"Barron\u2019s 2016 Midyear Roundtable: 24 Investment Ideas","Summary":""},{"Date":"Jun. 15, 2016 at 12:13 p.m. ET","Headline":"Why many dividend stocks aren\u2019t overvalued","Summary":""},{"Date":"Jun. 22, 2016 at 2:58 p.m. ET","Headline":"U.S. companies spent record amount on buybacks over past 12 months","Summary":""},{"Date":"Jun. 24, 2016 at 4:39 p.m. ET","Headline":"Brexit may make health care stocks a good defensive play","Summary":"FRANKFURT--German healthcare company Fresenius SE & Co. KGaA (FRE.XE) has a good chance of acquiring Pfizer Inc.'s (PFE) medical devices arm in a deal that could be announced soon, according to two people familiar with the..."},{"Date":"Jun. 24, 2016 at 12:29 p.m. ET","Headline":"Germany's Fresenius near deal to buy Pfizer unit","Summary":"FRANKFURT--German healthcare company Fresenius SE & Co. KGaA (FRE.XE) has a good chance of acquiring Pfizer Inc.'s (PFE) medical devices arm in a deal that could be announced soon, according to two people familiar with the..."},{"Date":"Jun. 29, 2016 at 12:08 p.m. ET","Headline":"Dow takes back more than half what it lost post Brexit","Summary":"The Dow Jones Industrial Average  surged 229 points in midday trade Wednesday, to take back more than half of what it lost during the . The Dow has not gained 499 points since Monday, after tumbling 871 points in the two s..."},{"Date":"Jun. 30, 2016 at 12:01 a.m. ET","Headline":"Who Will Acquire Medivation?","Summary":""},{"Date":"Jul. 6, 2016 at 7:50 p.m. ET","Headline":"In focus: Bulls remain in control","Summary":"Medivation Inc.  said Tuesday that an acquisition bid of $58 a share from Sanofi SA  had been rejected by its board of directors, and the San Francisco biotech appears ready to explore a potential sale to multiple parties...."},{"Date":"Jul. 5, 2016 at 5:52 p.m. ET","Headline":"Medivation officially rejects latest Sanofi offer, may field more bids","Summary":"Medivation Inc.  said Tuesday that an acquisition bid of $58 a share from Sanofi SA  had been rejected by its board of directors, and the San Francisco biotech appears ready to explore a potential sale to multiple parties...."},{"Date":"Jul. 7, 2016 at 5:02 p.m. ET","Headline":"Spike in drug prices comes from sector without competition","Summary":""},{"Date":"Jul. 6, 2016 at 12:01 a.m. ET","Headline":"Top U.S. Pharma Themes for the Second Half","Summary":""},{"Date":"Jul. 12, 2016 at 4:25 p.m. ET","Headline":"FDA approves Pfizer's pneumonia vaccine for younger adults","Summary":"Pfizer Inc.  said late Tuesday the Food and Drug Administration has approved its pneumonia vaccine Prevnar 13 for adults ages 18 through 49. The vaccine is already approved for adults over 50 and children. The vaccine prot..."},{"Date":"Jul. 14, 2016 at 7:50 a.m. ET","Headline":"These 32 century-old companies pay dividends of more than 3%","Summary":""},{"Date":"Jul. 13, 2016 at 3:37 p.m. ET","Headline":"Businesses step up fight vs. Obama White House rules to target tax avoidance","Summary":""},{"Date":"Jul. 13, 2016 at 12:39 p.m. ET","Headline":"Why Amgen\u2019s positive biosimilar news isn\u2019t as good as it seems","Summary":""},{"Date":"Jul. 17, 2016 at 12:19 p.m. ET","Headline":"Foreigners made record U.S. investments in 2015, but not for all best reasons","Summary":""},{"Date":"Jul. 23, 2016 at 12:01 a.m. ET","Headline":"Columbia Large Cap Growth Takes a Long-Term View","Summary":""},{"Date":"Jul. 30, 2016 at 2:16 p.m. ET","Headline":"This aging bull market can grind out more all-time highs","Summary":""},{"Date":"Jul. 30, 2016 at 12:01 a.m. ET","Headline":"New Robo-Investment Advisors Target Female Clients","Summary":""},{"Date":"Aug. 3, 2016 at 7:14 a.m. ET","Headline":"Wall Street wants answers on a potential Pfizer split, but Pfizer won\u2019t give one yet","Summary":"Drug maker Pfizer Inc.  on Tuesday posted second-quarter results that exceeded Wall Street's targets. Net earnings were $2.01 billion, or 33 cents a share, compared with $2.63 billion, or 42 cents a share, a year ago. Pfiz..."},{"Date":"Aug. 2, 2016 at 4:26 p.m. ET","Headline":"Dow industrials close lower for 7th straight session","Summary":"Drug maker Pfizer Inc.  on Tuesday posted second-quarter results that exceeded Wall Street's targets. Net earnings were $2.01 billion, or 33 cents a share, compared with $2.63 billion, or 42 cents a share, a year ago. Pfiz..."},{"Date":"Aug. 2, 2016 at 8:42 a.m. ET","Headline":"$35 oil lies ahead \u2014 and it could block stocks\u2019 run higher","Summary":"Drug maker Pfizer Inc.  on Tuesday posted second-quarter results that exceeded Wall Street's targets. Net earnings were $2.01 billion, or 33 cents a share, compared with $2.63 billion, or 42 cents a share, a year ago. Pfiz..."},{"Date":"Aug. 2, 2016 at 7:15 a.m. ET","Headline":"Pfizer earnings, sales above expectations","Summary":"Drug maker Pfizer Inc.  on Tuesday posted second-quarter results that exceeded Wall Street's targets. Net earnings were $2.01 billion, or 33 cents a share, compared with $2.63 billion, or 42 cents a share, a year ago. Pfiz..."},{"Date":"Aug. 2, 2016 at 12:01 a.m. ET","Headline":"8 Dividend Stocks With Pristine Balance Sheets","Summary":""},{"Date":"Aug. 4, 2016 at 4:50 p.m. ET","Headline":"Business groups sue U.S. over tax-inversion rules","Summary":""},{"Date":"Aug. 9, 2016 at 4:27 p.m. ET","Headline":"Nasdaq closes at all-time high as stocks eke out small gains","Summary":""},{"Date":"Aug. 8, 2016 at 4:24 p.m. ET","Headline":"Stocks retreat from all-time high to end slightly lower","Summary":""},{"Date":"Aug. 8, 2016 at 12:01 a.m. ET","Headline":"\u827e\u723e\u5efa\u80a1\u50f9\u4e0b\u8dcc\u5275\u9020\u4e86\u8cb7\u5165\u826f\u6a5f","Summary":""},{"Date":"Aug. 8, 2016 at 12:01 a.m. ET","Headline":"Allergan Selloff Makes for Great Buying Opportunity","Summary":""},{"Date":"Aug. 5, 2016 at 12:01 a.m. ET","Headline":"Today\u2019s Top 5 Stock Picks: Dividends, Value and Oil","Summary":""},{"Date":"Aug. 10, 2016 at 7:05 p.m. ET","Headline":"Two charged with insider trading over 2010 Pfizer acquisition","Summary":""},{"Date":"Aug. 13, 2016 at 12:01 a.m. ET","Headline":"T. Rowe Price Dividend Growth Fund: Where Yield Isn\u2019t the Only Thing","Summary":"Famed billionaire investor David Tepper's Appaloosa LP hedge fund reduced its exposure to stocks by one third in the latest quarter, to $3.80 billion as of June 30 from $5.66 billion on March 31, according to regulatory fi..."},{"Date":"Aug. 12, 2016 at 4:53 p.m. ET","Headline":"David Tepper Appaloosa sold off Facebook, Bank of America, Valeant holdings during latest quarter","Summary":"Famed billionaire investor David Tepper's Appaloosa LP hedge fund reduced its exposure to stocks by one third in the latest quarter, to $3.80 billion as of June 30 from $5.66 billion on March 31, according to regulatory fi..."},{"Date":"Aug. 11, 2016 at 12:01 a.m. ET","Headline":"Today\u2019s Top 5 Stock Picks: Underpriced Growth","Summary":""},{"Date":"Aug. 17, 2016 at 4:11 p.m. ET","Headline":"Stocks close slightly higher as Fed rate-hike debate rages on","Summary":""},{"Date":"Aug. 16, 2016 at 12:01 a.m. ET","Headline":"Lilly and Allergan Are Large-Cap Pharma Picks","Summary":""},{"Date":"Aug. 16, 2016 at 12:01 a.m. ET","Headline":"4 Stocks That Promise to Deliver Strong Growth","Summary":""},{"Date":"Aug. 21, 2016 at 6:39 p.m. ET","Headline":"Pfizer said to be near $14 billion acquisition of Medivation","Summary":"Pfizer Inc.  is closing in on a deal to acquire Medivation Inc.  for about $14 billion, according to multiple reports. The deal may be announced as soon as Monday, according to the Financial Times, which first reported the..."},{"Date":"Aug. 21, 2016 at 6:38 p.m. ET","Headline":"Pfizer said to be near $14 billion acquisition of Medivation","Summary":"Pfizer Inc.  is closing in on a deal to acquire Medivation Inc.  for about $14 billion, according to multiple reports. The deal may be announced as soon as Monday, according to the Financial Times, which first reported the..."},{"Date":"Aug. 21, 2016 at 6:37 p.m. ET","Headline":"Pfizer said to be near $14 billion acquisition of Medivation","Summary":"Pfizer Inc.  is closing in on a deal to acquire Medivation Inc.  for about $14 billion, according to multiple reports. The deal may be announced as soon as Monday, according to the Financial Times, which first reported the..."},{"Date":"Aug. 22, 2016 at 5:01 p.m. ET","Headline":"Dow, S&P 500 end lower as oil snaps win streak; Nasdaq closes up","Summary":"U.S. stocks closed mostly lower Monday as oil futures snapped a seven-session win streak to finish sharply in negative territory. Losses in West Texas Intermediate oil trading on the New York Mercantile Exchange for Septem..."},{"Date":"Aug. 22, 2016 at 4:57 p.m. ET","Headline":"S&P 500, Dow industrials book a loss as oil snaps win streak","Summary":"Shares of Medivation Inc.  soared 19% in premarket trade Monday, after the developer of cancer treatments confirmed an agreement to be acquired by Pfizer Inc.  in a deal valued at $14 billion. Under terms of the agreement,..."},{"Date":"Aug. 22, 2016 at 12:46 p.m. ET","Headline":"Medivation shareholders should be \u2018thrilled\u2019 about price of Pfizer deal: analysts","Summary":"Shares of Medivation Inc.  soared 19% in premarket trade Monday, after the developer of cancer treatments confirmed an agreement to be acquired by Pfizer Inc.  in a deal valued at $14 billion. Under terms of the agreement,..."},{"Date":"Aug. 22, 2016 at 7:38 a.m. ET","Headline":"Pfizer agrees to buy cancer behemoth Medivation for $14 billion","Summary":"Shares of Medivation Inc.  soared 19% in premarket trade Monday, after the developer of cancer treatments confirmed an agreement to be acquired by Pfizer Inc.  in a deal valued at $14 billion. Under terms of the agreement,..."},{"Date":"Aug. 22, 2016 at 7:00 a.m. ET","Headline":"Medivation's stock soars after Pfizer buyout deal","Summary":"Shares of Medivation Inc.  soared 19% in premarket trade Monday, after the developer of cancer treatments confirmed an agreement to be acquired by Pfizer Inc.  in a deal valued at $14 billion. Under terms of the agreement,..."},{"Date":"Aug. 22, 2016 at 6:00 a.m. ET","Headline":"How the \u2018charged\u2019 air around Yellen could send gold miners higher","Summary":""},{"Date":"Aug. 25, 2016 at 5:09 a.m. ET","Headline":"Time for a Pension Protection Act of 2016\/17","Summary":""},{"Date":"Aug. 24, 2016 at 10:15 p.m. ET","Headline":"In focus: Struggling to maintain the bullish trend","Summary":""},{"Date":"Aug. 24, 2016 at 4:33 p.m. ET","Headline":"Stocks end at 2-week low as drop in Mylan shares punishes health care","Summary":""},{"Date":"Aug. 24, 2016 at 12:07 p.m. ET","Headline":"FTSE 100 posts a loss as Glencore leads miners lower","Summary":""},{"Date":"Aug. 24, 2016 at 9:27 a.m. ET","Headline":"This market\u2019s new kids are flying high \u2014 and that\u2019s super-bullish","Summary":""},{"Date":"Aug. 24, 2016 at 12:01 a.m. ET","Headline":"Smaller Biotech Buyout Targets After Medivation","Summary":""},{"Date":"Aug. 23, 2016 at 12:01 a.m. ET","Headline":"5 Dividend-Rich Stocks to Hold for the Long Term","Summary":""},{"Date":"Aug. 26, 2016 at 12:01 a.m. ET","Headline":"Seattle Genetics Stock Surges, Execs Sell","Summary":""},{"Date":"Aug. 31, 2016 at 10:38 p.m. ET","Headline":"In focus: Awaiting a breakout","Summary":""},{"Date":"Aug. 29, 2016 at 12:01 a.m. ET","Headline":"Health Care Stocks Are Looking Sick, Charts Say","Summary":""},{"Date":"Aug. 27, 2016 at 12:01 a.m. ET","Headline":"U.K. Diners Are Nuts for Online Takeout","Summary":""},{"Date":"Sep. 7, 2016 at 10:02 p.m. ET","Headline":"In focus: No breakout yet","Summary":""},{"Date":"Sep. 9, 2016 at 4:33 p.m. ET","Headline":"Would Gilead Pick Up Tesaro\u2019s PARP?","Summary":""},{"Date":"Sep. 13, 2016 at 3:06 p.m. ET","Headline":"Mylan top executive pay was second-highest in industry just as company raised EpiPen prices","Summary":""},{"Date":"Sep. 15, 2016 at 8:41 a.m. ET","Headline":"Merck and Pfizer's diabetes treatment meets primary endpoint of late-stage trial","Summary":"Merck & Co. Inc.  and Pfizer Inc.  said Thursday a Phase 3 study of ertugliflozin, an investigational oral treatment for type 2 diabetes, met its primary endpoint. The drug giants plan to submit a new drug application for ..."},{"Date":"Sep. 15, 2016 at 7:47 a.m. ET","Headline":"Pfizer may soon be allowed to remove suicide warning from Chantix label","Summary":""},{"Date":"Sep. 3, 2016 at 12:01 a.m. ET","Headline":"Animal Spirits: Zoetis Shares Could Rise More Than 15%","Summary":""},{"Date":"Sep. 17, 2016 at 8:38 a.m. ET","Headline":"Yes, you are paying a lot more for prescription drugs (and not just the EpiPen)","Summary":""},{"Date":"Sep. 17, 2016 at 2:54 a.m. ET","Headline":"Seeking the Best of Both Growth and Value Stocks","Summary":""},{"Date":"Sep. 17, 2016 at 2:27 a.m. ET","Headline":"Will Bayer\u2019s Takeover of Monsanto Be a Bust?","Summary":""},{"Date":"Sep. 20, 2016 at 5:09 p.m. ET","Headline":"This ETF bets that companies with female leadership will outperform","Summary":""},{"Date":"Sep. 20, 2016 at 3:38 p.m. ET","Headline":"Deutsche Bank breaks down Clinton-vs.-Trump stock-trading plan","Summary":""},{"Date":"Sep. 19, 2016 at 12:48 p.m. ET","Headline":"Sarepta\u2019s controversial Duchenne muscular dystrophy drug was contested right up to approval","Summary":""},{"Date":"Sep. 22, 2016 at 11:17 a.m. ET","Headline":"Teva, Allergan Pump Up the Pipelines","Summary":""},{"Date":"Sep. 26, 2016 at 6:05 p.m. ET","Headline":"Pfizer Won\u2019t Split and Neither Should Investors","Summary":"Pfizer Inc.  said Monday that it has decided not to split into two separate publicly-traded companies, , but reignited after its proposed merger with Allergan PLC  fell through. The company said it determined that the best..."},{"Date":"Sep. 26, 2016 at 4:28 p.m. ET","Headline":"U.S. stocks retreat on Deutsche Bank worries, Clinton-Trump debate","Summary":"Pfizer Inc.  said Monday that it has decided not to split into two separate publicly-traded companies, , but reignited after its proposed merger with Allergan PLC  fell through. The company said it determined that the best..."},{"Date":"Sep. 26, 2016 at 8:28 a.m. ET","Headline":"Pfizer says it won\u2019t split into two separate companies","Summary":"Pfizer Inc.  said Monday that it has decided not to split into two separate publicly-traded companies, , but reignited after its proposed merger with Allergan PLC  fell through. The company said it determined that the best..."},{"Date":"Sep. 26, 2016 at 6:59 a.m. ET","Headline":"Pfizer decides against splitting into two companies","Summary":"Pfizer Inc.  said Monday that it has decided not to split into two separate publicly-traded companies, , but reignited after its proposed merger with Allergan PLC  fell through. The company said it determined that the best..."},{"Date":"Sep. 28, 2016 at 7:51 a.m. ET","Headline":"Today\u2019s Top 5 Stock Picks: Pfizer, Apple, GE, More","Summary":""},{"Date":"Sep. 27, 2016 at 6:19 a.m. ET","Headline":"Two Cancer Biotechs See Bullish Insider Buying","Summary":""},{"Date":"Sep. 30, 2016 at 1:28 p.m. ET","Headline":"Biotech stocks have plenty of catalysts around the corner","Summary":""},{"Date":"Sep. 24, 2016 at 12:01 a.m. ET","Headline":"Pharma Shares Slump, but Payout Yields Tempt","Summary":""},{"Date":"Oct. 4, 2016 at 6:07 a.m. ET","Headline":"Queens Road Value: Finding Bargains in a Pricey Market","Summary":""},{"Date":"Oct. 3, 2016 at 3:27 p.m. ET","Headline":"3 things to know about Janus Capital\u2019s planned merger with Henderson","Summary":""},{"Date":"Oct. 9, 2016 at 12:51 p.m. ET","Headline":"29 undervalued dividend stocks in all U.S. sectors","Summary":""},{"Date":"Oct. 11, 2016 at 5:20 p.m. ET","Headline":"The Health-Care Sector Is Anything but Healthy","Summary":""},{"Date":"Oct. 14, 2016 at 6:02 a.m. ET","Headline":"4 Stocks With 3% Yields, Rising Earnings Estimates","Summary":"The World Health Organization said Thursday that efforts to fight the global tuberculosis epidemic were far behind schedule, which the WHO attributed to not enough action or investment in this area. About $1 billion more a..."},{"Date":"Oct. 13, 2016 at 12:03 p.m. ET","Headline":"WHO warns global tuberculosis fight is billions of dollars behind","Summary":"The World Health Organization said Thursday that efforts to fight the global tuberculosis epidemic were far behind schedule, which the WHO attributed to not enough action or investment in this area. About $1 billion more a..."},{"Date":"Oct. 13, 2016 at 10:00 a.m. ET","Headline":"World Health Organization warns that global tuberculosis fight is billions of dollars behind","Summary":"The World Health Organization said Thursday that efforts to fight the global tuberculosis epidemic were far behind schedule, which the WHO attributed to not enough action or investment in this area. About $1 billion more a..."},{"Date":"Oct. 15, 2016 at 12:19 a.m. ET","Headline":"Payouts Will Benefit as Buybacks Lose Favor","Summary":""},{"Date":"Oct. 18, 2016 at 8:49 a.m. ET","Headline":"Trump says he could meet Putin before inauguration | Companies used Clinton fundraisers to lobby State Department","Summary":""},{"Date":"Oct. 17, 2016 at 1:56 p.m. ET","Headline":"What to expect from Johnson & Johnson earnings","Summary":""},{"Date":"Oct. 24, 2016 at 12:51 p.m. ET","Headline":"These investors, many with religious ties, are calling for drug price transparency","Summary":""},{"Date":"Oct. 25, 2016 at 6:14 a.m. ET","Headline":"The Next Big Moves in Health-Care Stocks","Summary":""},{"Date":"Oct. 22, 2016 at 12:01 a.m. ET","Headline":"Allergan\u2019s Upside: 20%-30%","Summary":""},{"Date":"Oct. 1, 2016 at 12:01 a.m. ET","Headline":"Donald Trump vs. the Peso","Summary":""},{"Date":"Oct. 1, 2016 at 12:01 a.m. ET","Headline":"How to Play the Next Biotech M&A Surge","Summary":""},{"Date":"Oct. 29, 2016 at 12:01 a.m. ET","Headline":"These Top Stockpickers Have Stumbled","Summary":""},{"Date":"Nov. 1, 2016 at 4:57 p.m. ET","Headline":"Stocks end at nearly 4-month low as election race tightens","Summary":"Pfizer Inc. shares  tumbled 2.2% in premarket trade Tuesday, after the company missed third-quarter profit and sales estimates and offered a below-consensus outlook for the full year. The drugs company said it had net inco..."},{"Date":"Nov. 1, 2016 at 8:18 a.m. ET","Headline":"This trigger for a stock rally is hiding in plain sight","Summary":"Pfizer Inc. shares  tumbled 2.2% in premarket trade Tuesday, after the company missed third-quarter profit and sales estimates and offered a below-consensus outlook for the full year. The drugs company said it had net inco..."},{"Date":"Nov. 1, 2016 at 7:00 a.m. ET","Headline":"Pfizer shares slump premarket as profit falls short, company offers softer-than-expected outlook","Summary":"Pfizer Inc. shares  tumbled 2.2% in premarket trade Tuesday, after the company missed third-quarter profit and sales estimates and offered a below-consensus outlook for the full year. The drugs company said it had net inco..."},{"Date":"Nov. 3, 2016 at 4:34 p.m. ET","Headline":"Stock market falls for 8th straight session","Summary":"The S&P 500 extended a historic losing streak for an eighth session on Thursday, its longest since October 2008, as investors grappled with mixed economic data and corporate earnings, as well as Democratic presidential nom..."},{"Date":"Nov. 3, 2016 at 4:03 p.m. ET","Headline":"S&P 500's 8-day losing streak longest since 2008","Summary":"The S&P 500 extended a historic losing streak for an eighth session on Thursday, its longest since October 2008, as investors grappled with mixed economic data and corporate earnings, as well as Democratic presidential nom..."},{"Date":"Nov. 5, 2016 at 12:01 a.m. ET","Headline":"Samsung BioLogics IPO: Too Expensive","Summary":""},{"Date":"Nov. 6, 2016 at 7:26 a.m. ET","Headline":"Drug companies spend $109 million to block vote to lower drug prices","Summary":""},{"Date":"Nov. 9, 2016 at 4:41 p.m. ET","Headline":"Dow ends near record highs following election of Trump","Summary":"U.S. stocks finished higher on Wednesday, led by a surge in financial, health-care and industrial stocks, as investors bet President-elect Donald Trump would increase spending on infrastructure. Stocks opened lower followi..."},{"Date":"Nov. 9, 2016 at 4:03 p.m. ET","Headline":"U.S. stocks finish higher after Trump's surprise election victory","Summary":"U.S. stocks finished higher on Wednesday, led by a surge in financial, health-care and industrial stocks, as investors bet President-elect Donald Trump would increase spending on infrastructure. Stocks opened lower followi..."},{"Date":"Nov. 9, 2016 at 2:12 p.m. ET","Headline":"\u2018The unthinkable has happened\u2019: President-elect Trump sends drug stocks up and other players tumbling","Summary":"Health care stocks were mixed in premarket trade Wednesday, with drug stocks benefiting from expectations that a Trump administration will take a less harsh view on drug pricing, while health insurers fell on expectations ..."},{"Date":"Nov. 9, 2016 at 10:09 a.m. ET","Headline":"Trump\u2019s victory is just the beginning of the shocks for stocks","Summary":"Health care stocks were mixed in premarket trade Wednesday, with drug stocks benefiting from expectations that a Trump administration will take a less harsh view on drug pricing, while health insurers fell on expectations ..."},{"Date":"Nov. 9, 2016 at 6:56 a.m. ET","Headline":"Drug stocks rally premarket, while health insurers and hospital operators slide","Summary":"Health care stocks were mixed in premarket trade Wednesday, with drug stocks benefiting from expectations that a Trump administration will take a less harsh view on drug pricing, while health insurers fell on expectations ..."},{"Date":"Nov. 9, 2016 at 6:56 a.m. ET","Headline":"Dow stocks tumble as tech leads losers, but healthcare gains","Summary":"Dow Jones Industrial Average  futures are plunging, but the feeling isn't unanimously bearish about D. Of the 29 Dow stocks that are trading premarket, 24 are selling off, with 21 down at least 1%. The most-active decliner..."},{"Date":"Nov. 11, 2016 at 7:10 a.m. ET","Headline":"Fearing changes under President-elect Trump, women are getting IUDs and stockpiling Plan B","Summary":""},{"Date":"Nov. 10, 2016 at 4:25 p.m. ET","Headline":"Dow rallies to record close as investors reposition for Trump presidency","Summary":""},{"Date":"Nov. 10, 2016 at 11:26 a.m. ET","Headline":"The death of Obamacare will bring new opportunities for investors","Summary":""},{"Date":"Nov. 10, 2016 at 9:46 a.m. ET","Headline":"President-elect Trump puts Obamacare\u2019s future up in the air","Summary":""},{"Date":"Nov. 12, 2016 at 12:01 a.m. ET","Headline":"Pharma M&A Is on the Way","Summary":""},{"Date":"Nov. 12, 2016 at 12:01 a.m. ET","Headline":"Trump Win Creates Winners, Losers","Summary":""},{"Date":"Nov. 14, 2016 at 8:56 a.m. ET","Headline":"5 big hurdles to repealing Obamacare","Summary":""},{"Date":"Nov. 17, 2016 at 9:28 a.m. ET","Headline":"10 biotech companies ripe for a buyout, courtesy of Donald Trump","Summary":""},{"Date":"Nov. 16, 2016 at 8:15 a.m. ET","Headline":"Biotech takes Trump presidency as a green light \u2014 and end to drug price worries","Summary":""},{"Date":"Nov. 22, 2016 at 2:34 p.m. ET","Headline":"Share buybacks will rise 30% to $780 billion next year, says Goldman Sachs","Summary":""},{"Date":"Nov. 26, 2016 at 12:01 a.m. ET","Headline":"The Trump Rally Has Legs","Summary":""},{"Date":"Nov. 26, 2016 at 12:01 a.m. ET","Headline":"ETF Investing to Suit Your Career","Summary":""},{"Date":"Nov. 30, 2016 at 6:17 a.m. ET","Headline":"Pfizer: Easy to Swallow With Low P\/E, 3.8% Yield","Summary":""},{"Date":"Dec. 3, 2016 at 12:01 a.m. ET","Headline":"The Catalyst Seekers","Summary":""},{"Date":"Dec. 7, 2016 at 11:36 a.m. ET","Headline":"This indicator says the stock market\u2019s celebration has gone too far","Summary":""},{"Date":"Dec. 7, 2016 at 5:14 a.m. ET","Headline":"Pfizer fined $107 million in U.K. over drug price hike","Summary":""},{"Date":"Dec. 8, 2016 at 2:05 p.m. ET","Headline":"This buying panic may last until Dow 20,000","Summary":""},{"Date":"Dec. 8, 2016 at 7:28 a.m. ET","Headline":"Stocks close at new heights as investors shake off Trump-inspired health-care woes","Summary":""},{"Date":"Dec. 10, 2016 at 12:01 a.m. ET","Headline":"J&J Deserves More Respect from Wall Street","Summary":""},{"Date":"Dec. 10, 2016 at 12:01 a.m. ET","Headline":"Get Ready for Dow 20,000","Summary":""},{"Date":"Dec. 12, 2016 at 4:03 p.m. ET","Headline":"Dow logs 6th consecutive record close","Summary":"The Dow Jones Industrial Average notched its sixth consecutive record close on Monday, even as the other main stock-market benchmarks finished lower. The blue-chip gauge [s:djia] gained 39.37 points, or 0.2%, to 19,796.22,..."},{"Date":"Dec. 12, 2016 at 12:03 p.m. ET","Headline":"Pfizer raises dividend 7%; stock surges","Summary":"Shares of Pfizer Inc.  surged 2.5% in midday trade Monday, after the drug giant said it was raising its quarterly dividend by 6.7%. The company said the new dividend of 32 cents a share, up from 30 cents, will be payable M..."},{"Date":"Dec. 16, 2016 at 11:28 a.m. ET","Headline":"The bizarre connection between Pfizer and the synthetic drug turning people into \u2018zombies\u2019","Summary":""},{"Date":"Dec. 16, 2016 at 8:46 a.m. ET","Headline":"18 companies that will score big if Trump chops taxes","Summary":""},{"Date":"Dec. 20, 2016 at 11:19 a.m. ET","Headline":"Pharma Picks as Fundamentals Weaken","Summary":""},{"Date":"Dec. 23, 2016 at 8:18 a.m. ET","Headline":"Trump health secretary nominee has bought and sold $300,000 in health care stocks while in office","Summary":""},{"Date":"Dec. 17, 2016 at 12:01 a.m. ET","Headline":"S&P 500 Dividend Growth Likely to Slow in 2017","Summary":""},{"Date":"Dec. 27, 2016 at 12:28 a.m. ET","Headline":"Health-Care Stocks Could Gain 20% in 2017","Summary":""},{"Date":"Dec. 29, 2016 at 7:57 a.m. ET","Headline":"Seattle Genetics Takes a Hit","Summary":""},{"Date":"Dec. 28, 2016 at 1:34 p.m. ET","Headline":"Portola Pharmaceuticals\u2019 Pivotal Year","Summary":""},{"Date":"Jan. 2, 2017 at 12:01 a.m. ET","Headline":"Where to Find Yield","Summary":""},{"Date":"Dec. 31, 2016 at 12:01 a.m. ET","Headline":"Charting the Market","Summary":""},{"Date":"Jan. 3, 2017 at 11:56 a.m. ET","Headline":"The real reason drug makers offer discount cards (you\u2019ll pay eventually)","Summary":""},{"Date":"Jan. 3, 2017 at 11:56 a.m. ET","Headline":"Big pharma won\u2019t stop raising prices in 2017 \u2014 it\u2019ll just do it smarter","Summary":""},{"Date":"Jan. 9, 2017 at 5:41 p.m. ET","Headline":"Five unpopular, but prudent, things for investors to do near Dow 20,000","Summary":""},{"Date":"Jan. 9, 2017 at 4:35 p.m. ET","Headline":"The Best Dow Stocks As 20,000 Looms","Summary":""},{"Date":"Jan. 11, 2017 at 3:14 p.m. ET","Headline":"What pharma investors ought to do after Donald Trump fires a salvo","Summary":""},{"Date":"Jan. 13, 2017 at 8:58 a.m. ET","Headline":"16 cheap stocks that top investment newsletters say to buy now","Summary":""},{"Date":"Jan. 21, 2017 at 12:01 a.m. ET","Headline":"5 Drug Stocks With Rising Dividends and Yields Up to 4.1%","Summary":""},{"Date":"Jan. 24, 2017 at 10:23 a.m. ET","Headline":"Health care sector ETF falls for sixth-straight day, longest such streak in 16 months","Summary":"The SPDR Health Care Select Sector ETF  is shedding 1% in morning trade, putting it on track for a sixth-straight loss, amid uncertainty over the fallout from President Donald Trump's intent to repeal the Affordable Care A..."},{"Date":"Jan. 23, 2017 at 3:21 p.m. ET","Headline":"We\u2019re in the year of the biotech buyout, and here are five prime targets","Summary":""},{"Date":"Jan. 23, 2017 at 11:02 a.m. ET","Headline":"What to expect from Johnson & Johnson earnings","Summary":""},{"Date":"Jan. 26, 2017 at 8:14 a.m. ET","Headline":"Dow\u2019s road to 20,000 paved by Goldman, Boeing, and IBM","Summary":"Pfizer Inc.  said early Thursday that its phase 2 clinical trial for a C. difficile vaccine had positive results. The bacterium, which causes infectious diarrhea, typically affects older adults in medical facilities and ca..."},{"Date":"Jan. 26, 2017 at 8:13 a.m. ET","Headline":"Pfizer says mid-stage trial for C. difficile vaccine had positive results","Summary":"Pfizer Inc.  said early Thursday that its phase 2 clinical trial for a C. difficile vaccine had positive results. The bacterium, which causes infectious diarrhea, typically affects older adults in medical facilities and ca..."},{"Date":"Jan. 25, 2017 at 9:38 a.m. ET","Headline":"The Trump factor: Should investors be bullish or bearish \u2014 or neither?","Summary":""},{"Date":"Jan. 24, 2017 at 6:20 p.m. ET","Headline":"How Trumponomics Will Play Out for Stocks","Summary":""},{"Date":"Dec. 3, 2016 at 12:01 a.m. ET","Headline":"Top 10 Stock Picks for 2017","Summary":""},{"Date":"Jan. 28, 2017 at 7:58 a.m. ET","Headline":"Outlooks for the Age of Trump are top focus of earnings season","Summary":""},{"Date":"Jan. 28, 2017 at 12:01 a.m. ET","Headline":"Brain-Computer Link Could Be Boon for the Disabled","Summary":""},{"Date":"Jan. 27, 2017 at 11:48 a.m. ET","Headline":"Two things are happening in the U.S. stock market for the first time since 1900","Summary":""},{"Date":"Jan. 30, 2017 at 4:04 p.m. ET","Headline":"This trader bets it all on Apple getting crushed after earnings","Summary":""},{"Date":"Jan. 30, 2017 at 8:44 a.m. ET","Headline":"What to expect from Pfizer earnings: competition on two fronts","Summary":""},{"Date":"Jan. 28, 2017 at 12:01 a.m. ET","Headline":"Barron\u2019s 2017 Roundtable, Part 3: 17 Picks From Three Pros","Summary":""},{"Date":"Jan. 31, 2017 at 3:39 p.m. ET","Headline":"The Trump travel-ban selloff may just be the tip of the iceberg","Summary":"U.S. stocks opened lower on Tuesday as investors continued to grapple with political uncertainty stemming from the newly inaugurated President Donald Trump's administration. Late Monday, Trump fired the acting attorney gen..."},{"Date":"Jan. 31, 2017 at 9:32 a.m. ET","Headline":"U.S. stocks open lower on continued political uncertainty","Summary":"U.S. stocks opened lower on Tuesday as investors continued to grapple with political uncertainty stemming from the newly inaugurated President Donald Trump's administration. Late Monday, Trump fired the acting attorney gen..."},{"Date":"Jan. 31, 2017 at 6:57 a.m. ET","Headline":"Pfizer's stock drops after profit miss, downbeat sales outlook","Summary":"Shares of Pfizer Inc.  fell 1.3% in premarket trade Tuesday, after the drugmaker reported a fourth-quarter profit that missed expectations. The company swung to earnings of $775 million, or 13 cents a share, from a loss of..."},{"Date":"Jan. 31, 2017 at 5:53 a.m. ET","Headline":"Finding Value in Apple, Nike, Allergan, Wal-Mart","Summary":""},{"Date":"Feb. 3, 2017 at 9:48 a.m. ET","Headline":"What Alicia Keys and Daft Punk are bringing home after the Grammys","Summary":"Pfizer Inc.  has agreed to buyback $5 billion of its common stock as part of an accelerated repurchase program, the company said early Friday. The about 126 million shares will be received on Feb. 6. The buyback agreement ..."},{"Date":"Feb. 3, 2017 at 8:16 a.m. ET","Headline":"Pfizer to buyback $5 billion of its common stock","Summary":"Pfizer Inc.  has agreed to buyback $5 billion of its common stock as part of an accelerated repurchase program, the company said early Friday. The about 126 million shares will be received on Feb. 6. The buyback agreement ..."},{"Date":"Feb. 2, 2017 at 11:21 a.m. ET","Headline":"The 10 cheapest, fastest-growing and most beloved Dow stocks","Summary":""},{"Date":"Feb. 5, 2017 at 9:47 a.m. ET","Headline":"5 reasons to bank on biotech stocks now","Summary":""},{"Date":"Feb. 7, 2017 at 4:42 p.m. ET","Headline":"Drug stocks dip after Spicer affirms Trump\u2019s stance on cutting costs","Summary":""},{"Date":"Feb. 7, 2017 at 1:15 p.m. ET","Headline":"Biotech executives say President Trump\u2019s \u2018misguided\u2019 travel ban will harm the industry","Summary":""},{"Date":"Feb. 8, 2017 at 5:21 a.m. ET","Headline":"Driven by Botox, Allergan\u2019s 2017 expected to be a standout","Summary":"PARIS--French drugmaker Sanofi SA SNY said fourth-quarter net profit more than doubled, aided by lower amortization and restructuring costs. On Wednesday, the Paris-based drugmaker said net profit rose to 790 million euros..."},{"Date":"Feb. 8, 2017 at 3:04 a.m. ET","Headline":"Sanofi 4Q net profit more than doubles","Summary":"PARIS--French drugmaker Sanofi SA SNY said fourth-quarter net profit more than doubled, aided by lower amortization and restructuring costs. On Wednesday, the Paris-based drugmaker said net profit rose to 790 million euros..."},{"Date":"Feb. 13, 2017 at 2:05 p.m. ET","Headline":"Let\u2019s just call it an \u2018American Rally,\u2019 OK?","Summary":""},{"Date":"Feb. 17, 2017 at 6:41 p.m. ET","Headline":"Momenta Pharma shares halted as drug application hits speed bump","Summary":"Momenta Pharmaceuticals Inc.  were halted in the extended session Friday after the biotech company said a supplier's compliance issue could delay approval of a higher dose of one of its multiple sclerosis drugs. Momenta sh..."},{"Date":"Feb. 16, 2017 at 1:42 p.m. ET","Headline":"Trump is playing a starring role on U.S. companies\u2019 quarterly conference calls","Summary":"Pfizer Inc.  said early Thursday that its Xeljanz drug met its primary endpoint in combination with methotrexate as compared to AbbVie's  blockbuster drug Humira, although it didn't meet the primary endpoint on its own. Th..."},{"Date":"Feb. 16, 2017 at 8:16 a.m. ET","Headline":"Pfizer says rheumatoid arthritis drug is comparable to Humira as combination treatment but not alone","Summary":"Pfizer Inc.  said early Thursday that its Xeljanz drug met its primary endpoint in combination with methotrexate as compared to AbbVie's  blockbuster drug Humira, although it didn't meet the primary endpoint on its own. Th..."},{"Date":"Feb. 23, 2017 at 4:37 p.m. ET","Headline":"Dow logs 10th straight record, but Nasdaq stumbles a second day","Summary":""},{"Date":"Mar. 1, 2017 at 5:29 p.m. ET","Headline":"The Dow\u2019s 21,000 rally was powered by Apple\u2019s 15% rally since Jan. 25","Summary":""},{"Date":"Feb. 28, 2017 at 5:37 a.m. ET","Headline":"Tepper, Buffett join bullish chorus betting on unrelenting stock-market climb","Summary":""},{"Date":"Mar. 4, 2017 at 12:01 a.m. ET","Headline":"The Top Stories From This Week\u2019s Barron\u2019s","Summary":""},{"Date":"Mar. 9, 2017 at 8:59 a.m. ET","Headline":"Pharma says high prices fund drug development \u2014 but this study finds otherwise","Summary":""},{"Date":"Mar. 9, 2017 at 4:09 a.m. ET","Headline":"Trump\u2019s \u2018Obamacare Lite\u2019 presents opportunities and perils for investors","Summary":""},{"Date":"Mar. 8, 2017 at 5:33 p.m. ET","Headline":"David Tepper has a clear reason why the stock market\u2019s \u2018Trump rally\u2019 has room to run","Summary":""},{"Date":"Mar. 15, 2017 at 3:48 p.m. ET","Headline":"Drug Stocks Look Ready to Move Higher","Summary":""},{"Date":"Mar. 15, 2017 at 10:34 a.m. ET","Headline":"The Dogs of the Dow are falling behind in the 2017 rally","Summary":""},{"Date":"Mar. 14, 2017 at 8:31 a.m. ET","Headline":"Don\u2019t Expect Pfizer to Make a Mega Acquisition","Summary":""},{"Date":"Mar. 17, 2017 at 3:21 p.m. ET","Headline":"Republican health-care bill would be credit negative for hospitals, pharma and medical device makers in 2020: Moody\u2019s","Summary":""},{"Date":"Mar. 17, 2017 at 8:33 a.m. ET","Headline":"Why PTC Therapeutics may have to lower the price on a $89,000-a-year drug it just bought","Summary":""},{"Date":"Mar. 21, 2017 at 5:41 a.m. ET","Headline":"7 Growth Stocks With Downside Protection","Summary":""},{"Date":"Mar. 28, 2017 at 11:31 a.m. ET","Headline":"Could Pfizer Make Cash Bid for Bristol-Myers?","Summary":""},{"Date":"Mar. 28, 2017 at 7:42 a.m. ET","Headline":"Trumpcare\u2019s collapse creates some certainty for health-care stocks","Summary":""},{"Date":"Mar. 24, 2017 at 3:18 p.m. ET","Headline":"One-Time Whiz Kid Shuttering Hedge Fund","Summary":""},{"Date":"Mar. 31, 2017 at 6:04 p.m. ET","Headline":"Mylan stock slumps 1.3% after company says voluntary recall will include U.S. EpiPens","Summary":"Mylan NV  shares slumped 1.3% in after-hours trade Friday afternoon after the company said that a previously announced voluntary recall of EpiPens would include U.S. EpiPens and EpiPen Jrs. The recall was initiated after t..."},{"Date":"Apr. 4, 2017 at 1:22 p.m. ET","Headline":"TG Therapeutics stock rises 2% on preclinical data for cancer drug","Summary":"TG Therapeutics Inc.  shares rose 2.0% in afternoon trade Tuesday after the company presented preclinical data on its anti-PD-L1 monoclonal antibody, part of a class of immunotherapy drugs that try to use the patient's imm..."},{"Date":"Apr. 4, 2017 at 9:08 a.m. ET","Headline":"Onconova Therapeutics stock surges 18% on positive pre-clinical data for cancer drugs","Summary":"Onconova Therapeutics Inc.  stock surged as much as 18% in premarket trade Tuesday after the company said its two cancer drugs had positive pre-clinical results. Onconova shares were valued at $3.01 as of Monday's close. O..."},{"Date":"Apr. 5, 2017 at 8:49 a.m. ET","Headline":"Here\u2019s how much Mylan\u2019s U.S. EpiPen recall could cost it","Summary":""},{"Date":"Apr. 5, 2017 at 8:39 a.m. ET","Headline":"These corporate ties will be on display at Scott Gottlieb\u2019s FDA commissioner confirmation hearing today","Summary":""},{"Date":"Apr. 10, 2017 at 11:39 a.m. ET","Headline":"Axovant stock surges 28% on new CEO","Summary":"Axovant Sciences Ltd.  shares surged 28% in morning trade Monday after the biotech company said that David Hung is its new chief executive officer. Hung was the founder and CEO of the biotech Medivation, which was by Pfize..."},{"Date":"Apr. 15, 2017 at 12:23 a.m. ET","Headline":"As Drug Prices Fall, These Stocks Could Rise","Summary":""},{"Date":"Apr. 19, 2017 at 4:12 p.m. ET","Headline":"Steven A. Cohen among the million-dollar donors to Trump inauguration","Summary":"Pfizer Inc.  has been subpoenaed by the Justice Department as part of an antitrust investigation into intravenous saline sales practices, requests that it is \"evaluating,\" the company said Wednesday. Saline is a salt water..."},{"Date":"Apr. 19, 2017 at 4:03 p.m. ET","Headline":"Pfizer is latest to get Justice Department subpoena in intravenous saline investigation","Summary":"Pfizer Inc.  has been subpoenaed by the Justice Department as part of an antitrust investigation into intravenous saline sales practices, requests that it is \"evaluating,\" the company said Wednesday. Saline is a salt water..."},{"Date":"Apr. 26, 2017 at 7:13 a.m. ET","Headline":"A big chunk of the Dow\u2019s gains have come from earnings","Summary":""},{"Date":"Apr. 25, 2017 at 9:49 a.m. ET","Headline":"How to lose a billion dollars","Summary":""},{"Date":"Apr. 28, 2017 at 2:15 p.m. ET","Headline":"Try the total-return approach for retirement income","Summary":"This is what advisers think is the best way to invest in this interest rate environment."},{"Date":"Apr. 28, 2017 at 2:23 a.m. ET","Headline":"Sanofi profit jumps on sale of animal-health unit","Summary":"PARIS--French drugmaker Sanofi SA (SAN.FR) said first-quarter net profit jumped, boosted by the sale of its animal-health business. On Friday, the Paris-based drugmaker said net profit rose to 5.7 billion euros ($6.2 billi..."},{"Date":"Apr. 29, 2017 at 8:00 a.m. ET","Headline":"Fed, jobs data and Apple earnings will keep stock-market investors busy","Summary":""},{"Date":"May. 2, 2017 at 4:30 p.m. ET","Headline":"Stocks eke out gains as Nasdaq closes at record for second day","Summary":"Pfizer Inc.  reported a first-quarter profit beat and revenue miss early Tuesday. Earnings for the latest quarter rose to $3.12 billion, or 51 cents per share, from $3.04 billion, or 49 cents per share, in the year-earlier..."},{"Date":"May. 2, 2017 at 9:16 a.m. ET","Headline":"Here\u2019s the \u2018last remaining cheap asset\u2019 as the Fed pumps up prices for everything else","Summary":"Pfizer Inc.  reported a first-quarter profit beat and revenue miss early Tuesday. Earnings for the latest quarter rose to $3.12 billion, or 51 cents per share, from $3.04 billion, or 49 cents per share, in the year-earlier..."},{"Date":"May. 2, 2017 at 7:01 a.m. ET","Headline":"Pfizer reports Q1 profit beat, revenue miss","Summary":"Pfizer Inc.  reported a first-quarter profit beat and revenue miss early Tuesday. Earnings for the latest quarter rose to $3.12 billion, or 51 cents per share, from $3.04 billion, or 49 cents per share, in the year-earlier..."},{"Date":"May. 3, 2017 at 5:51 a.m. ET","Headline":"Four Small Biotechs See Bullish April Stock Buys","Summary":""},{"Date":"May. 6, 2017 at 12:53 a.m. ET","Headline":"Novartis Has the Right Prescription for Profits","Summary":""},{"Date":"May. 10, 2017 at 5:18 p.m. ET","Headline":"Sangamo shares jump on Pfizer collaboration, quarterly results","Summary":"Sangamo Therapeutics Inc.  shares surged after the gene therapy company reported a narrower-than-expected loss for the quarter and a collaboration with pharmaceutical giant Pfizer Inc. . Sangamo shares jumped 42% to $6.15 ..."},{"Date":"May. 10, 2017 at 7:16 a.m. ET","Headline":"Allergan Stock Can Inject Profits Into Your Portfolio","Summary":""},{"Date":"May. 13, 2017 at 12:23 a.m. ET","Headline":"Charting the Market","Summary":""},{"Date":"May. 16, 2017 at 4:36 p.m. ET","Headline":"Nasdaq closes at record while S&P 500, Dow slip amid political uncertainty","Summary":""},{"Date":"May. 16, 2017 at 11:31 a.m. ET","Headline":"Three Top Picks in U.S. Big Pharma","Summary":""},{"Date":"May. 17, 2017 at 12:01 p.m. ET","Headline":"Most Dow stocks are below their 50-day moving averages","Summary":"As the Dow Jones Industrial Average  slips Wednesday  (MA), which many technicians use to define the short-term trend, 17 of its 30 components are also below their respective 50-day MAs. Of that total, shares of Boeing Co...."},{"Date":"May. 24, 2017 at 10:03 a.m. ET","Headline":"The contrarian investor\u2019s best bet is coming down the pike","Summary":""},{"Date":"Jun. 6, 2017 at 4:24 p.m. ET","Headline":"Beyond tech: How other sectors are driving the stock market","Summary":""},{"Date":"Jun. 8, 2017 at 7:46 a.m. ET","Headline":"Johnson & Johnson\u2019s new prostate cancer advances could signal trouble for Pfizer","Summary":""},{"Date":"Jun. 11, 2017 at 7:52 a.m. ET","Headline":"Weekend roundup: What Apple expects you to do | Millennials enter the stock market | Arguing over Tesla\u2019s stock","Summary":""},{"Date":"Jun. 13, 2017 at 4:38 p.m. ET","Headline":"Dow, S&P 500 close at records as tech stocks rebound","Summary":"Eli Lilly & Co.  shares rose 1.5% in premarket trade Tuesday after the company said its pain drug with Pfizer Inc.  has received fast track designation from the Food and Drug Administration, which is intended to hasten the..."},{"Date":"Jun. 13, 2017 at 8:53 a.m. ET","Headline":"Eli Lilly stock rises 1.5% after pain drug gets fast track designation from FDA","Summary":"Eli Lilly & Co.  shares rose 1.5% in premarket trade Tuesday after the company said its pain drug with Pfizer Inc.  has received fast track designation from the Food and Drug Administration, which is intended to hasten the..."},{"Date":"Jun. 14, 2017 at 11:12 a.m. ET","Headline":"JNJ Diabetes Data Benefit Lilly, Hurt Merck","Summary":""},{"Date":"Jun. 19, 2017 at 5:37 p.m. ET","Headline":"Three must-own cancer stocks for your biotechnology portfolio","Summary":""},{"Date":"Jun. 19, 2017 at 5:37 p.m. ET","Headline":"A major value fund mirrors a major growth one more than you may expect","Summary":""},{"Date":"Jun. 20, 2017 at 12:25 p.m. ET","Headline":"Five reasons you have to buy biotech stocks now","Summary":""},{"Date":"Jun. 27, 2017 at 4:03 p.m. ET","Headline":"Merck Cholesterol Drug Could Help Unlock Value","Summary":""},{"Date":"Jun. 27, 2017 at 3:22 p.m. ET","Headline":"Vuzix Can Win Where Intel Failed","Summary":""},{"Date":"Jul. 3, 2017 at 1:02 p.m. ET","Headline":"Justice Department ethics watchdog quits because Trump made her feel like a hypocrite","Summary":""},{"Date":"Jul. 8, 2017 at 12:41 a.m. ET","Headline":"5 Small-Cap Stocks for Dividend Investors","Summary":""},{"Date":"Jul. 8, 2017 at 1:04 a.m. ET","Headline":"Wonder Women: Capitalizing on Gender Equality","Summary":""},{"Date":"Jul. 20, 2017 at 4:14 p.m. ET","Headline":"Trump Today: President won\u2019t say if he has  confidence in Sessions","Summary":""},{"Date":"Jul. 29, 2017 at 8:03 a.m. ET","Headline":"Biotech companies lose $21 billion in research funds amid political squabbling","Summary":""},{"Date":"Jul. 31, 2017 at 1:53 a.m. ET","Headline":"Sanofi profit falls 10% as restructuring costs hit","Summary":"PARIS--French drugmaker Sanofi (SAN.FR) said net profit fell in the second quarter as it was hit by higher restructuring costs, but lifted its earnings guidance for 2017. On Monday, the Paris-based drugmaker said net profi..."},{"Date":"Aug. 2, 2017 at 1:19 p.m. ET","Headline":"What could push stocks even higher? Trump\u2019s latest idea","Summary":"Pfizer Inc.  was upgraded to outperform with a $37 price target by BMO Capital Markets early Wednesday. Pfizer shares, which were up 0.6% premarket, closed at $32.76 on Tuesday. BMO Capital Markets analyst Alex Arfaei said..."},{"Date":"Aug. 2, 2017 at 9:08 a.m. ET","Headline":"Pfizer upgraded to outperform at BMO Capital Markets on drug pipeline progress","Summary":"Pfizer Inc.  was upgraded to outperform with a $37 price target by BMO Capital Markets early Wednesday. Pfizer shares, which were up 0.6% premarket, closed at $32.76 on Tuesday. BMO Capital Markets analyst Alex Arfaei said..."},{"Date":"Aug. 2, 2017 at 2:28 a.m. ET","Headline":"Here\u2019s how a slap-happy stock market may get derailed","Summary":"Pfizer Inc.  reported a second-quarter profit beat and revenue miss early Tuesday. Earnings for the latest quarter rose to $3.07 billion, or 51 cents per share, from $2.05 billion, or 33 cents per share. Adjusted earnings-..."},{"Date":"Aug. 1, 2017 at 4:34 p.m. ET","Headline":"Dow books 31st record in 2017, nears 22,000 as earnings fuel stock gains","Summary":"Pfizer Inc.  reported a second-quarter profit beat and revenue miss early Tuesday. Earnings for the latest quarter rose to $3.07 billion, or 51 cents per share, from $2.05 billion, or 33 cents per share. Adjusted earnings-..."},{"Date":"Aug. 1, 2017 at 3:57 p.m. ET","Headline":"Investing icon Burton Malkiel talks Trump, valuations, and the ETFs he\u2019s bullish on","Summary":"Pfizer Inc.  reported a second-quarter profit beat and revenue miss early Tuesday. Earnings for the latest quarter rose to $3.07 billion, or 51 cents per share, from $2.05 billion, or 33 cents per share. Adjusted earnings-..."},{"Date":"Aug. 1, 2017 at 7:02 a.m. ET","Headline":"Pfizer reports Q2 profit beat, revenue miss","Summary":"Pfizer Inc.  reported a second-quarter profit beat and revenue miss early Tuesday. Earnings for the latest quarter rose to $3.07 billion, or 51 cents per share, from $2.05 billion, or 33 cents per share. Adjusted earnings-..."},{"Date":"Aug. 4, 2017 at 11:13 a.m. ET","Headline":"CVS Formulary Changes Boost JNJ, Pfizer; Hurt Lilly","Summary":""},{"Date":"Aug. 3, 2017 at 5:19 p.m. ET","Headline":"Dow bags 7th straight record, but energy slump weighs on broader stock market","Summary":""},{"Date":"Aug. 3, 2017 at 11:56 a.m. ET","Headline":"What Does Dow 22,000 Even Mean?","Summary":""},{"Date":"Aug. 3, 2017 at 7:29 a.m. ET","Headline":"How each Dow stock contributed to the 22,000 milestone","Summary":""},{"Date":"Aug. 8, 2017 at 4:47 p.m. ET","Headline":"This pack of dividend-paying stocks outruns the \u2018Dow Dogs\u2019","Summary":""},{"Date":"Aug. 10, 2017 at 3:15 p.m. ET","Headline":"Opioids are ravaging the U.S., but they\u2019re still the best pain drug we\u2019ve got","Summary":""},{"Date":"Aug. 10, 2017 at 12:53 p.m. ET","Headline":"Underpriced Stocks to Hedge Against a Downturn","Summary":""},{"Date":"Aug. 11, 2017 at 10:27 a.m. ET","Headline":"More than half of women who got an abortion last year were using contraception","Summary":""},{"Date":"Aug. 14, 2017 at 5:26 p.m. ET","Headline":"Tepper's Appaloosa dumps Snap Inc., stake, loads up on tech, health care","Summary":"David Tepper's hedge fund Appaloosa Management unloaded its position in Snapchat-parent Snap Inc., and disclosed increases in the tech and health-care sectors at the end of the second quarter. As of June 30, Tepper's fund ..."},{"Date":"Aug. 16, 2017 at 3:31 p.m. ET","Headline":"Bristol-Myers Can Overcome Market\u2019s Pessimism","Summary":""},{"Date":"Aug. 18, 2017 at 3:01 p.m. ET","Headline":"This market leader was the most-purchased stock by hedge funds last quarter","Summary":""},{"Date":"Aug. 19, 2017 at 1:01 a.m. ET","Headline":"Healthy Dividends","Summary":""},{"Date":"Jul. 15, 2017 at 12:01 a.m. ET","Headline":"\u201cA Great Time\u201d to Invest in the Health-Care Sector","Summary":""},{"Date":"Aug. 26, 2017 at 12:01 a.m. ET","Headline":"Dividend Investing: Beyond the Basics","Summary":""},{"Date":"Aug. 30, 2017 at 12:44 p.m. ET","Headline":"Investors ought to get ahead of Trump\u2019s tax-reform push","Summary":""},{"Date":"Aug. 30, 2017 at 12:00 p.m. ET","Headline":"Harry Boxer\u2019s four biotech stocks to watch","Summary":""},{"Date":"Aug. 31, 2017 at 4:50 p.m. ET","Headline":"S&P 500, Dow end fifth straight month with gains","Summary":""},{"Date":"Sep. 7, 2017 at 2:11 p.m. ET","Headline":"FDA warns of serious manufacturing violations in letter to EpiPen manufacturing facility","Summary":"The Food and Drug Administration described \"significant violations of current good manufacturing practice\" in a warning letter to a Pfizer  unit that manufactures Mylan's  EpiPen allergic reaction treatment. The unit, Meri..."},{"Date":"Sep. 8, 2017 at 7:49 a.m. ET","Headline":"Pfizer CEO, CFO Sell $13 Million in Stock","Summary":""},{"Date":"Sep. 8, 2017 at 6:53 a.m. ET","Headline":"FDA warns of serious manufacturing violations in letter to EpiPen manufacturing facility","Summary":""},{"Date":"Sep. 11, 2017 at 2:52 p.m. ET","Headline":"This drug industry leader could be healthy for your stock portfolio","Summary":""},{"Date":"Sep. 11, 2017 at 2:38 p.m. ET","Headline":"Health-Care Stocks Poised for More Gains","Summary":""},{"Date":"Sep. 15, 2017 at 4:32 p.m. ET","Headline":"JNJ May Benefit From Celltrion Issues","Summary":"Pfizer Inc.  shares rose as much as 1.4% in premarket trade Thursday on news that its late-stage clinical trial examining its key cancer drug Xtandi in non-metastatic castration-resistant prostate cancer met its primary en..."},{"Date":"Sep. 14, 2017 at 8:16 a.m. ET","Headline":"Pfizer shares rise 1.4% after news of positive late-stage cancer trial","Summary":"Pfizer Inc.  shares rose as much as 1.4% in premarket trade Thursday on news that its late-stage clinical trial examining its key cancer drug Xtandi in non-metastatic castration-resistant prostate cancer met its primary en..."},{"Date":"Sep. 15, 2017 at 11:40 p.m. ET","Headline":"Clashing Points on FANG","Summary":""},{"Date":"Sep. 21, 2017 at 5:04 p.m. ET","Headline":"Versartis shares down 82%","Summary":"Shares of Versartis Inc.  plummet 82% late Thursday after the biopharmaceutical company said its drug somavaratan failed to meet its primary endpoint in a phase 3 trial. The drug, a form of human growth hormone that seeks ..."},{"Date":"Sep. 21, 2017 at 1:33 p.m. ET","Headline":"Pfizer\u2019s Underappreciated Global Opportunity","Summary":"Shares of Pfizer Inc.  surged 1.3% in morning trade Wednesday toward a 13-month high, after the drug maker was upgraded at Morgan Stanley, which cited valuation following \"a long period of middling performance.\" The stock ..."},{"Date":"Sep. 21, 2017 at 6:48 a.m. ET","Headline":"This squabble between two big drugmakers could have major implications for the U.S. health care system","Summary":"Shares of Pfizer Inc.  surged 1.3% in morning trade Wednesday toward a 13-month high, after the drug maker was upgraded at Morgan Stanley, which cited valuation following \"a long period of middling performance.\" The stock ..."},{"Date":"Sep. 20, 2017 at 4:57 p.m. ET","Headline":"Dow, S&P 500 finish at records as Fed announces October start to \u2018great unwind\u2019","Summary":"Shares of Pfizer Inc.  surged 1.3% in morning trade Wednesday toward a 13-month high, after the drug maker was upgraded at Morgan Stanley, which cited valuation following \"a long period of middling performance.\" The stock ..."},{"Date":"Sep. 20, 2017 at 11:55 a.m. ET","Headline":"Pfizer is suing Johnson & Johnson, saying it prevented uptake of cheaper Remicade rival","Summary":"Shares of Pfizer Inc.  surged 1.3% in morning trade Wednesday toward a 13-month high, after the drug maker was upgraded at Morgan Stanley, which cited valuation following \"a long period of middling performance.\" The stock ..."},{"Date":"Sep. 20, 2017 at 9:52 a.m. ET","Headline":"Pfizer's stock jumps to 13-month high to lead Dow gainers after analyst upgrade","Summary":"Shares of Pfizer Inc.  surged 1.3% in morning trade Wednesday toward a 13-month high, after the drug maker was upgraded at Morgan Stanley, which cited valuation following \"a long period of middling performance.\" The stock ..."},{"Date":"Sep. 25, 2017 at 12:01 a.m. ET","Headline":"Home for the Tax Holiday","Summary":""},{"Date":"Sep. 25, 2017 at 12:01 a.m. ET","Headline":"Gene Therapy Is Nearing a Major Breakthrough","Summary":""},{"Date":"Sep. 29, 2017 at 7:24 a.m. ET","Headline":"Amgen\u2019s rival to AbbVie\u2019s Humira to launch in 2023","Summary":""},{"Date":"Oct. 1, 2017 at 5:11 p.m. ET","Headline":"Congressman urges President Trump to take action on $90,000 multiple sclerosis drug","Summary":""},{"Date":"Oct. 3, 2017 at 10:19 a.m. ET","Headline":"Big Questions for Big Pharma","Summary":""},{"Date":"Oct. 2, 2017 at 11:14 a.m. ET","Headline":"Lilly Faces Off With Pfizer, Novartis","Summary":""},{"Date":"Oct. 6, 2017 at 3:58 a.m. ET","Headline":"A breakout in this cheap, forgotten stock is powering the Dow Jones Industrial Average","Summary":""},{"Date":"Oct. 9, 2017 at 7:22 a.m. ET","Headline":"This Dow stock looks poised to \u2018pull an Intel\u2019 and break out to a multi-year high","Summary":""},{"Date":"Oct. 10, 2017 at 9:23 a.m. ET","Headline":"Here\u2019s how the U.S. could deliver the events that \u2018upend\u2019 global markets","Summary":"Shares of Pfizer Inc.  rallied 1.1% in premarket trade Tuesday, after the drug giant said it was reviewing alternatives for its consumer healthcare business. The company said the alternatives could include a potential sale..."},{"Date":"Oct. 10, 2017 at 7:08 a.m. ET","Headline":"Pfizer to explore potential sale, spinoff of consumer healthcare business","Summary":"Shares of Pfizer Inc.  rallied 1.1% in premarket trade Tuesday, after the drug giant said it was reviewing alternatives for its consumer healthcare business. The company said the alternatives could include a potential sale..."},{"Date":"Oct. 13, 2017 at 8:20 a.m. ET","Headline":"How to invest in health-care stocks regardless of what happens in Washington, D.C.","Summary":""},{"Date":"Oct. 12, 2017 at 11:04 a.m. ET","Headline":"Pfizer Seen Mulling Options","Summary":""},{"Date":"Oct. 14, 2017 at 7:49 a.m. ET","Headline":"Here are the actual tax rates the biggest companies in America pay","Summary":""},{"Date":"Oct. 16, 2017 at 12:15 p.m. ET","Headline":"Lost beneath headlines of five-figure drug costs \u2014 pharmaceutical price growth is weakening","Summary":""},{"Date":"Oct. 16, 2017 at 7:39 a.m. ET","Headline":"This drug may be able to treat both women\u2019s health disorders and prostate cancer","Summary":""},{"Date":"Oct. 23, 2017 at 12:52 p.m. ET","Headline":"Byron Wien Measures China\u2019s Tech Success","Summary":""},{"Date":"Oct. 25, 2017 at 12:54 p.m. ET","Headline":"GlaxoSmithKline stock plummets 6% after concerns about dividend risk","Summary":"GlaxoSmithKline PLC  shares plummeted 6% in extremely heavy midday trade Wednesday on concerns that the company's interest in Pfizer Inc.'s  over-the-counter business could put its dividend at risk. After being asked if sh..."},{"Date":"Oct. 24, 2017 at 11:50 a.m. ET","Headline":"These stocks have popped more than 75% since Trump was elected","Summary":""},{"Date":"Oct. 19, 2017 at 8:37 a.m. ET","Headline":"4 Cheap Stock Picks for the Impatient","Summary":""},{"Date":"Oct. 28, 2017 at 12:01 a.m. ET","Headline":"No Tax Cut? No Worry for Wall Street","Summary":"Pfizer Inc.  will begin the auction process for its consumer healthcare unit in November, which it hopes will end in a $15 billion sale, , citing sources close to the matter. .  and Reckitt Benckiser  are among those compa..."},{"Date":"Oct. 26, 2017 at 4:50 p.m. ET","Headline":"Dow, S&P 500 end higher amid earnings parade; Nasdaq weighed by biotech slump","Summary":"Pfizer Inc.  will begin the auction process for its consumer healthcare unit in November, which it hopes will end in a $15 billion sale, , citing sources close to the matter. .  and Reckitt Benckiser  are among those compa..."},{"Date":"Oct. 26, 2017 at 3:46 p.m. ET","Headline":"Apple and Nike show that stock performance is linked to how CEOs invest money","Summary":"Pfizer Inc.  will begin the auction process for its consumer healthcare unit in November, which it hopes will end in a $15 billion sale, , citing sources close to the matter. .  and Reckitt Benckiser  are among those compa..."},{"Date":"Oct. 26, 2017 at 3:39 a.m. ET","Headline":"Pfizer sets date for auction of consumer healthcare unit: Reuters","Summary":"Pfizer Inc.  will begin the auction process for its consumer healthcare unit in November, which it hopes will end in a $15 billion sale, , citing sources close to the matter. .  and Reckitt Benckiser  are among those compa..."},{"Date":"Oct. 31, 2017 at 2:04 p.m. ET","Headline":"Why you should consider buying large-cap stocks now and small-caps in January","Summary":"Pfizer Inc.  shares surged 1.7% premarket on Tuesday after the company reported a third-quarter profit beat and updated its 2017 guidance. Earnings for the latest quarter rose to $2.8 billion, or 47 cents per share, from $..."},{"Date":"Oct. 31, 2017 at 8:55 a.m. ET","Headline":"EarningsWatch: Apple, Tesla and Facebook are post-Halloween treats","Summary":"Pfizer Inc.  shares surged 1.7% premarket on Tuesday after the company reported a third-quarter profit beat and updated its 2017 guidance. Earnings for the latest quarter rose to $2.8 billion, or 47 cents per share, from $..."},{"Date":"Oct. 31, 2017 at 8:44 a.m. ET","Headline":"Here\u2019s how a new Fed chief typically spooks the Dow","Summary":"Pfizer Inc.  shares surged 1.7% premarket on Tuesday after the company reported a third-quarter profit beat and updated its 2017 guidance. Earnings for the latest quarter rose to $2.8 billion, or 47 cents per share, from $..."},{"Date":"Oct. 31, 2017 at 7:01 a.m. ET","Headline":"Pfizer shares surge on Q3 profit beat, raised 2017 earnings outlook","Summary":"Pfizer Inc.  shares surged 1.7% premarket on Tuesday after the company reported a third-quarter profit beat and updated its 2017 guidance. Earnings for the latest quarter rose to $2.8 billion, or 47 cents per share, from $..."},{"Date":"Nov. 1, 2017 at 11:10 a.m. ET","Headline":"Big, old companies drive the Dow\u2019s outperformance","Summary":""},{"Date":"Nov. 4, 2017 at 12:01 a.m. ET","Headline":"The Uncivil Society and Its Discontents","Summary":"Plus, analysts\u2019 takes on Pfizer, Est\u00e9e Lauder, McKesson, and CDK Global"},{"Date":"Nov. 4, 2017 at 12:01 a.m. ET","Headline":"Scoffing at Shorts, Canaccord Calls Shopify a Buy","Summary":"Plus, analysts\u2019 takes on Pfizer, Est\u00e9e Lauder, McKesson, and CDK Global"},{"Date":"Nov. 10, 2017 at 8:25 a.m. ET","Headline":"Sarepta: Too Much Good News to Ignore","Summary":"As the Dow Jones Industrial Average  threatens to open with a triple-digit loss, 26 of the 30 components traded lower in premarket trade. Among the biggest decliners, shares of Intel Corp.  fell 1.3%, American Express Co. ..."},{"Date":"Nov. 9, 2017 at 9:25 a.m. ET","Headline":"Dow futures fall as 26 of 30 components trade lower premarket","Summary":"As the Dow Jones Industrial Average  threatens to open with a triple-digit loss, 26 of the 30 components traded lower in premarket trade. Among the biggest decliners, shares of Intel Corp.  fell 1.3%, American Express Co. ..."},{"Date":"Nov. 13, 2017 at 10:06 a.m. ET","Headline":"Pfizer creates chief operating officer role","Summary":""},{"Date":"Nov. 22, 2017 at 11:07 a.m. ET","Headline":"ViiV Healthcare says FDA has approved its two-drug HIV regimen, in first such instance","Summary":"ViiV Healthcare, which is majority-owned by GlaxoSmithKline  and has Pfizer Inc.  and Shionogi as shareholders, said on Tuesday that the Food and Drug Administration has approved its two-drug HIV regimen. The therapy, Julu..."},{"Date":"Nov. 21, 2017 at 8:30 a.m. ET","Headline":"Six promising stocks to buy for the biotech rebound ahead","Summary":""},{"Date":"Nov. 21, 2017 at 6:41 a.m. ET","Headline":"How to avoid the next GE \u2014 and find industrial winners of the future","Summary":""},{"Date":"Nov. 28, 2017 at 8:50 a.m. ET","Headline":"Merck KGaA,  Pfizer's Avelumab fails to meet goal","Summary":"Merck KGaA (MRK.XE) and Pfizer Inc. PFE said on Tuesday that avelumab, a cancer immunotherapy, failed to meet the primary objective of a phase 3 trial in patients with certain gastric cancers. The trial assessed avelumab a..."},{"Date":"Nov. 28, 2017 at 8:12 a.m. ET","Headline":"Pfizer, Germany's Merck cancer treatment trial misses primary endpoint","Summary":"Pfizer Inc.  and German-based Merck KGaA  said Tuesday a phase 3 trial of a cancer treatment did not meet its primary endpoint of superior overall survival. Pfizer's stock slipped 0.9% in premarket trade. The trial tested ..."},{"Date":"Nov. 29, 2017 at 8:23 a.m. ET","Headline":"Even GE Is Buying GE Stock","Summary":""},{"Date":"Dec. 6, 2017 at 6:35 p.m. ET","Headline":"Bitcoin passes $14,000, has gained more than 1,400% in 2017","Summary":"Spark Therapeutics Inc.  stock surged Wednesday afternoon after the company announced positive results from a study of a gene-therapy approach to hemophilia. The drug, developed and tested in a collaboration with Pfizer In..."},{"Date":"Dec. 6, 2017 at 5:16 p.m. ET","Headline":"Gene-therapy approach to hemophilia finds success in study, Spark stock surges","Summary":"Spark Therapeutics Inc.  stock surged Wednesday afternoon after the company announced positive results from a study of a gene-therapy approach to hemophilia. The drug, developed and tested in a collaboration with Pfizer In..."},{"Date":"Dec. 5, 2017 at 5:45 p.m. ET","Headline":"Tax Reform Could Shake Up Corporate Bonds","Summary":""},{"Date":"Dec. 5, 2017 at 2:57 a.m. ET","Headline":"Why your doctor may soon have you playing video games","Summary":""},{"Date":"Dec. 7, 2017 at 1:53 p.m. ET","Headline":"Lighting a Spark for Gene Therapy","Summary":""},{"Date":"Dec. 11, 2017 at 1:05 p.m. ET","Headline":"Spark Therapeutics Selloff Looks Overdone","Summary":"Shares of Teva Pharmaceutical Industries Ltd.  rose 0.4% in morning trade Monday, after the drug maker announced the exclusive launch of its generic Viagra tablets in the U.S. The company said it will offer support service..."},{"Date":"Dec. 11, 2017 at 9:31 a.m. ET","Headline":"Teva's stock gains after exclusive launch of generic Viagra","Summary":"Shares of Teva Pharmaceutical Industries Ltd.  rose 0.4% in morning trade Monday, after the drug maker announced the exclusive launch of its generic Viagra tablets in the U.S. The company said it will offer support service..."},{"Date":"Dec. 16, 2017 at 12:01 a.m. ET","Headline":"There\u2019s Still Life in Spark Therapeutics","Summary":""},{"Date":"Dec. 18, 2017 at 11:58 a.m. ET","Headline":"Pfizer sets new $10 billion stock buyback program, bumps up dividend by 6.3%","Summary":"Shares of Pfizer Inc.  edged up 0.3% in midday trade Monday, after the drug giant said it authorized a new $10 billion share repurchase program, and that it will raise its quarterly cash dividend by 6.3%. Pfizer said the n..."},{"Date":"Dec. 20, 2017 at 8:26 a.m. ET","Headline":"Republican tax bill makes big winners of Amgen, Gilead and other drugmakers","Summary":""},{"Date":"Dec. 19, 2017 at 3:04 p.m. ET","Headline":"These 55 stocks have at least doubled since Trump was elected","Summary":""},{"Date":"Dec. 22, 2017 at 7:15 a.m. ET","Headline":"Merck and Pfizer diabetes drug approved by the FDA","Summary":"Merck & Co. Inc.  and Pfizer Inc.  said Friday that the Food and Drug Administration has approved diabetes drug Steglatro tablets, and the fixed-dose combination Steglujan tablets. Steglatro (ertugliflozin) is indicated, a..."},{"Date":"Dec. 30, 2017 at 12:01 a.m. ET","Headline":"Glaxo: Expect a Speedy Recovery","Summary":""},{"Date":"Jan. 3, 2018 at 7:51 a.m. ET","Headline":"Sangamo shares surge 3.4% on $12 mln ALS gene therapy collaboration with Pfizer","Summary":"Sangamo Therapeutics Inc.  shares surged 3.4% in premarket trade on Wednesday after news of the company's $12 million collaboration with Pfizer Inc.  on a gene therapy for two neurodegenerative disorders, amyotrophic later..."},{"Date":"Dec. 30, 2017 at 12:01 a.m. ET","Headline":"Corning Shares Could Gain More Than 25%","Summary":""},{"Date":"Jan. 4, 2018 at 1:53 p.m. ET","Headline":"Boeing\u2019s stock leads the charge to Dow 25,000, adding about 150 points","Summary":""},{"Date":"Jan. 7, 2018 at 5:24 p.m. ET","Headline":"Pfizer abandons costly hunt for new Alzheimer\u2019s, Parkinson\u2019s drugs","Summary":""},{"Date":"Jan. 8, 2018 at 10:52 a.m. ET","Headline":"Be afraid? Investors are eating up stocks at the fastest pace in years","Summary":""},{"Date":"Jan. 13, 2018 at 12:01 a.m. ET","Headline":"Big Pharma and Start-Ups Are Key to Health Gains","Summary":""},{"Date":"Jan. 13, 2018 at 12:01 a.m. ET","Headline":"Charting the Market","Summary":""},{"Date":"Jan. 13, 2018 at 12:01 a.m. ET","Headline":"The Right Rx for Income Investors","Summary":""},{"Date":"Jan. 14, 2018 at 2:17 p.m. ET","Headline":"Here\u2019s what all 30 companies that make up the Dow industrials think about the tax cuts","Summary":""},{"Date":"Jan. 16, 2018 at 12:31 p.m. ET","Headline":"Here\u2019s what all 30 companies that make up the Dow industrials think about blockchain","Summary":""},{"Date":"Jan. 23, 2018 at 8:47 a.m. ET","Headline":"With deferred liabilities, Verizon will get earnings benefit from tax bill","Summary":""},{"Date":"Jan. 24, 2018 at 10:16 a.m. ET","Headline":"Solid Biosciences, Sarepta Square Off In Fight to Treat Duchenne","Summary":""},{"Date":"Jan. 27, 2018 at 12:01 a.m. ET","Headline":"Drones to the Rescue","Summary":""},{"Date":"Jan. 26, 2018 at 11:36 a.m. ET","Headline":"S&P 500\u2019s bull trend absorbs U.S. dollar-induced volatility uptick","Summary":""},{"Date":"Jan. 29, 2018 at 4:54 p.m. ET","Headline":"13 stocks these winning stockpickers recommend now","Summary":""},{"Date":"Jan. 29, 2018 at 11:14 a.m. ET","Headline":"Charting a bull-trend pullback, S&P 500 slips from record high","Summary":""},{"Date":"Jan. 31, 2018 at 11:51 a.m. ET","Headline":"Charting a bull-trend whipsaw, S&P 500 digests (respectable) shot across the bow","Summary":"Shares of all 30 Dow Jones Industrial Average  companies fell in premarket trade Tuesday, with Dow futures  pointing toward the biggest point decline for the blue-chip barometer in over five months. The biggest weight on t..."},{"Date":"Jan. 31, 2018 at 9:03 a.m. ET","Headline":"5 Dow stocks have fallen 4% or more over the past week","Summary":"Shares of all 30 Dow Jones Industrial Average  companies fell in premarket trade Tuesday, with Dow futures  pointing toward the biggest point decline for the blue-chip barometer in over five months. The biggest weight on t..."},{"Date":"Jan. 30, 2018 at 4:34 p.m. ET","Headline":"Dow suffers biggest drop in eight months","Summary":"Shares of all 30 Dow Jones Industrial Average  companies fell in premarket trade Tuesday, with Dow futures  pointing toward the biggest point decline for the blue-chip barometer in over five months. The biggest weight on t..."},{"Date":"Jan. 30, 2018 at 12:39 p.m. ET","Headline":"Cracks surface in the bull trend, S&P 500 pulls in from uncharted territory","Summary":"Shares of all 30 Dow Jones Industrial Average  companies fell in premarket trade Tuesday, with Dow futures  pointing toward the biggest point decline for the blue-chip barometer in over five months. The biggest weight on t..."},{"Date":"Jan. 30, 2018 at 12:09 p.m. ET","Headline":"Cracks surface in the bull trend, S&P 500 pulls in from uncharted territory","Summary":"Shares of all 30 Dow Jones Industrial Average  companies fell in premarket trade Tuesday, with Dow futures  pointing toward the biggest point decline for the blue-chip barometer in over five months. The biggest weight on t..."},{"Date":"Jan. 30, 2018 at 8:10 a.m. ET","Headline":"All 30 Dow company stocks drop, as UnitedHealth lops over 100 points off Dow's price","Summary":"Shares of all 30 Dow Jones Industrial Average  companies fell in premarket trade Tuesday, with Dow futures  pointing toward the biggest point decline for the blue-chip barometer in over five months. The biggest weight on t..."},{"Date":"Jan. 30, 2018 at 7:40 a.m. ET","Headline":"Here\u2019s the line in the sand for bonds \u2014 and stocks \u2014 that \u2018everyone\u2019s talking about\u2019","Summary":"Pfizer Inc.  shares rose 1.4% in premarket trade Tuesday after the company reported fourth-quarter profit and revenue beats and upbeat 2018 guidance. Earnings for the latest quarter rose rose to $12.27 billion, or $2.02 pe..."},{"Date":"Jan. 30, 2018 at 7:05 a.m. ET","Headline":"Pfizer shares rise after Q4 profit, revenue beats; upbeat guidance","Summary":"Pfizer Inc.  shares rose 1.4% in premarket trade Tuesday after the company reported fourth-quarter profit and revenue beats and upbeat 2018 guidance. Earnings for the latest quarter rose rose to $12.27 billion, or $2.02 pe..."},{"Date":"Feb. 2, 2018 at 11:57 a.m. ET","Headline":"S&P 500 ventures under key support, VIX signals investor complacency","Summary":""},{"Date":"Feb. 1, 2018 at 1:38 p.m. ET","Headline":"Fast-growing Amazon should replace sluggish GE in the Dow","Summary":""},{"Date":"Feb. 1, 2018 at 11:34 a.m. ET","Headline":"S&P 500 digests market downdraft, capped by near-term resistance","Summary":""},{"Date":"Feb. 6, 2018 at 6:26 a.m. ET","Headline":"Here are the biggest losers among Dow and S&P 500 stocks in Monday\u2019s rout","Summary":"GlaxoSmithKline PLC (GSK.LN) reports its fourth-quarter results on Wednesday at 1200 GMT. Here's what to expect: CORE OPERATING PROFIT: The U.K. pharmaceutical group is expected to report a core operating profit of 2 billi..."},{"Date":"Feb. 6, 2018 at 5:43 a.m. ET","Headline":"What to watch in GlaxoSmithKline earnings","Summary":"GlaxoSmithKline PLC (GSK.LN) reports its fourth-quarter results on Wednesday at 1200 GMT. Here's what to expect: CORE OPERATING PROFIT: The U.K. pharmaceutical group is expected to report a core operating profit of 2 billi..."},{"Date":"Feb. 5, 2018 at 2:11 p.m. ET","Headline":"Health-care ETF tumbles, pressured by pharmaceutical company weakness","Summary":""},{"Date":"Feb. 5, 2018 at 12:08 p.m. ET","Headline":"Charting a 9-to-1 down day, market downdraft inflicts technical damage","Summary":""},{"Date":"Feb. 2, 2018 at 1:54 p.m. ET","Headline":"Big, Bold Blue-Chip Buys: GE, Pfizer, Disney, Apple","Summary":""},{"Date":"Feb. 7, 2018 at 6:48 a.m. ET","Headline":"These U.S. stocks rose as much as 15% Tuesday as the market bounced back","Summary":""},{"Date":"Feb. 10, 2018 at 7:22 a.m. ET","Headline":"Dow Jones Industrial Average rebounds, powered by Nike and Microsoft","Summary":""},{"Date":"Feb. 10, 2018 at 12:01 a.m. ET","Headline":"Europe\u2019s Stock Selloff: From Overdue to Overdone","Summary":""},{"Date":"Feb. 9, 2018 at 6:23 a.m. ET","Headline":"These Dow and S&P 500 stocks have taken the worst beatings","Summary":""},{"Date":"Feb. 12, 2018 at 4:06 a.m. ET","Headline":"This market selloff was overdue, but now it looks overdone, strategists say","Summary":""},{"Date":"Feb. 14, 2018 at 8:21 a.m. ET","Headline":"Pimco\u2019s Big Buys: Apple, Intel, Merck, Pfizer, GE","Summary":""},{"Date":"Feb. 16, 2018 at 3:30 p.m. ET","Headline":"How Amazon could lose its health-care bid while drug distributor stocks win","Summary":"(Adds Merck KGaA comment and additional avelumab trial in seventh paragraph.) Merck KGaA (MRK.XE) and Pfizer Inc. PFE said on Thursday that avelumab, a cancer immunotherapy, failed to meet the primary objective of a phase ..."},{"Date":"Feb. 16, 2018 at 1:11 p.m. ET","Headline":"Big Stock Buys in GE, Citi, DowDuPont, Merck","Summary":"(Adds Merck KGaA comment and additional avelumab trial in seventh paragraph.) Merck KGaA (MRK.XE) and Pfizer Inc. PFE said on Thursday that avelumab, a cancer immunotherapy, failed to meet the primary objective of a phase ..."},{"Date":"Feb. 15, 2018 at 10:38 a.m. ET","Headline":"Merck KGaA and Pfizer's Avelumab fails in trial","Summary":"(Adds Merck KGaA comment and additional avelumab trial in seventh paragraph.) Merck KGaA (MRK.XE) and Pfizer Inc. PFE said on Thursday that avelumab, a cancer immunotherapy, failed to meet the primary objective of a phase ..."},{"Date":"Feb. 15, 2018 at 7:02 a.m. ET","Headline":"This might be the time when you can finally get quality stocks on sale","Summary":""},{"Date":"Feb. 19, 2018 at 7:21 a.m. ET","Headline":"Here\u2019s what the 30 companies that make up the Dow industrials are doing to address sexual-harassment claims","Summary":""},{"Date":"Feb. 21, 2018 at 6:06 a.m. ET","Headline":"Chipotle Stock Buyer: Time Warner Executive","Summary":""},{"Date":"Feb. 24, 2018 at 12:01 a.m. ET","Headline":"Charting the Market","Summary":""},{"Date":"Mar. 1, 2018 at 8:22 a.m. ET","Headline":"Selling Nvidia, GE, Applied Materials, Buying Pfizer","Summary":""},{"Date":"Mar. 1, 2018 at 6:36 a.m. ET","Headline":"These Dow stocks were clobbered in February \u2014 but there were winners too","Summary":""},{"Date":"Mar. 6, 2018 at 8:34 a.m. ET","Headline":"This could be the next $1 billion drug, if patients get on board","Summary":"GlaxoSmithKline PLC (GSK.LN) said on Monday that its majority-owned ViiV Healthcare joint venture has reported positive interim results from a study of dolutegravir, a treatment for adults with both HIV and tuberculosis."},{"Date":"Mar. 5, 2018 at 2:08 p.m. ET","Headline":"GlaxoSmithKline posts positive data on HIV\/TB drug","Summary":"GlaxoSmithKline PLC (GSK.LN) said on Monday that its majority-owned ViiV Healthcare joint venture has reported positive interim results from a study of dolutegravir, a treatment for adults with both HIV and tuberculosis."},{"Date":"Mar. 7, 2018 at 1:17 p.m. ET","Headline":"Here\u2019s what the 30 Dow industrials companies say about a potential trade war","Summary":""},{"Date":"Mar. 12, 2018 at 4:53 p.m. ET","Headline":"Stock market ends mostly lower, while tech lifts Nasdaq","Summary":"Biogen Inc.  said Monday it reached a deal to buy a phase-2b-trial-ready schizophrenia treatment, PF-04958242, from Pfizer Inc.  for up to $590 million. The deal includes an upfront payment of $75 million and up to $515 mi..."},{"Date":"Mar. 12, 2018 at 7:40 a.m. ET","Headline":"Biogen to buy schizophrenia treatment from Pfizer for up to $590 million","Summary":"Biogen Inc.  said Monday it reached a deal to buy a phase-2b-trial-ready schizophrenia treatment, PF-04958242, from Pfizer Inc.  for up to $590 million. The deal includes an upfront payment of $75 million and up to $515 mi..."},{"Date":"Mar. 10, 2018 at 12:01 a.m. ET","Headline":"How to Outrun Amazon","Summary":""},{"Date":"Mar. 14, 2018 at 2:34 p.m. ET","Headline":"Big Stock Sales: GE, P&G, Pfizer, Bristol-Myers","Summary":""},{"Date":"Mar. 14, 2018 at 9:31 a.m. ET","Headline":"How stock-market investors can play health care\u2019s latest merger mania","Summary":""},{"Date":"Mar. 20, 2018 at 7:05 a.m. ET","Headline":"The Dow is now down for 2018, but it still has plenty of winners","Summary":""},{"Date":"Mar. 22, 2018 at 1:40 p.m. ET","Headline":"European stocks close at 3-week low as global growth worries ramp up","Summary":"Reckitt Benckiser Group PLC (RB.LN) said Thursday that it has ended discussions about its potential acquisition of Pfizer Inc.'s PFE consumer health-care business. The consumer-goods company said it had only been looking t..."},{"Date":"Mar. 22, 2018 at 1:12 p.m. ET","Headline":"FTSE 100 fall sharply, posts lowest close since December 2016","Summary":"Reckitt Benckiser Group PLC (RB.LN) said Thursday that it has ended discussions about its potential acquisition of Pfizer Inc.'s PFE consumer health-care business. The consumer-goods company said it had only been looking t..."},{"Date":"Mar. 22, 2018 at 4:10 a.m. ET","Headline":"Reckitt Benckiser ends talks to buy Pfizer unit","Summary":"Reckitt Benckiser Group PLC (RB.LN) said Thursday that it has ended discussions about its potential acquisition of Pfizer Inc.'s PFE consumer health-care business. The consumer-goods company said it had only been looking t..."},{"Date":"Mar. 21, 2018 at 4:27 p.m. ET","Headline":"Drug companies are beginning to wake up to this new risk factor","Summary":""},{"Date":"Mar. 23, 2018 at 1:42 p.m. ET","Headline":"FTSE 100 suffers 3.4% weekly slide as markets tumble on trade-war fears","Summary":"GlaxoSmithKline PLC (GSK.LN) said Friday that it has withdrawn from discussions to buy Pfizer Inc.'s PFE consumer-healthcare business. \"While we will continue to review opportunities that may accelerate our strategy, they ..."},{"Date":"Mar. 23, 2018 at 1:07 p.m. ET","Headline":"European stocks slide to 1-year low as U.S.-China trade tensions spook traders","Summary":"GlaxoSmithKline PLC (GSK.LN) said Friday that it has withdrawn from discussions to buy Pfizer Inc.'s PFE consumer-healthcare business. \"While we will continue to review opportunities that may accelerate our strategy, they ..."},{"Date":"Mar. 23, 2018 at 11:40 a.m. ET","Headline":"GSK ends talks for Pfizer consumer-health unit","Summary":"GlaxoSmithKline PLC (GSK.LN) said Friday that it has withdrawn from discussions to buy Pfizer Inc.'s PFE consumer-healthcare business. \"While we will continue to review opportunities that may accelerate our strategy, they ..."},{"Date":"Mar. 23, 2018 at 7:49 a.m. ET","Headline":"Nike's stock surges to pace the Dow's early gainers","Summary":"Nike Inc.'s stock  surged 4.5% in premarket trade Friday, in the wake of the athletic apparel and accessories , to pace the handful of Dow Jones Industrial Average  components trading higher ahead of the open. Six of the 3..."},{"Date":"Mar. 23, 2018 at 7:01 a.m. ET","Headline":"Here are the biggest Dow and S&P 500 stock losers in March","Summary":""},{"Date":"Mar. 27, 2018 at 2:20 a.m. ET","Headline":"GSK to buy out Novartis stake in JV for $13 bln","Summary":"GlaxoSmithKline PLC (GSK.LN) said Tuesday that it would buy out Novartis AG's (NOVN.EB) 36.5% stake in the consumer health-care joint venture operated by the two companies for $13 billion in cash, less than a week after GS..."},{"Date":"Mar. 30, 2018 at 8:18 a.m. ET","Headline":"Do drug prices affect CEO pay? Faith-based investor group wants to know","Summary":"Pfizer Inc.  shares rose 0.7% in heavy Thursday afternoon trade after the company said its therapy for a rare and fatal form of  cardiomyopathy met its primary endpoint in a late-stage clinical trial. Compared with the pla..."},{"Date":"Mar. 29, 2018 at 3:32 p.m. ET","Headline":"Pfizer shares rise on late-stage results for cardiomyopathy therapy","Summary":"Pfizer Inc.  shares rose 0.7% in heavy Thursday afternoon trade after the company said its therapy for a rare and fatal form of  cardiomyopathy met its primary endpoint in a late-stage clinical trial. Compared with the pla..."},{"Date":"Mar. 29, 2018 at 12:06 p.m. ET","Headline":"FDA push for cheaper \u2018biosimilar\u2019 drugs could challenge pharma\u2019s biggest blockbusters","Summary":""},{"Date":"Mar. 17, 2018 at 12:01 a.m. ET","Headline":"Allergan\u2019s Stock Is Headed for a Face-Lift","Summary":""},{"Date":"Apr. 3, 2018 at 6:57 a.m. ET","Headline":"Intel, Amazon and Tesla lead tech stocks lower on the first trading day of April","Summary":""},{"Date":"Apr. 4, 2018 at 7:34 a.m. ET","Headline":"How a failed Pfizer rare-disease drug came back to flatten its rivals","Summary":""},{"Date":"Apr. 7, 2018 at 7:43 a.m. ET","Headline":"Here are Friday\u2019s worst stocks as trade conflict and a weak jobs report disappoint investors","Summary":""},{"Date":"Apr. 6, 2018 at 10:31 a.m. ET","Headline":"Can P&G Still Be Saved?","Summary":""},{"Date":"Apr. 16, 2018 at 10:18 a.m. ET","Headline":"Merck leads Dow industrials higher","Summary":"Shares of Merck & Co. rose on Monday, providing an outsize boost to the Dow Jones Industrial Average in early trading. The stock  rose 2.4%, by far the biggest gainer among the blue-chip average's 30 components. The rally ..."},{"Date":"Apr. 23, 2018 at 10:00 a.m. ET","Headline":"How the 2018 election will affect your money","Summary":"Pfizer Inc.  said early Monday that the Food and Drug Administration failed to approve its trastuzumab biosimilar, intended as a lower-cost version of Roche's  cancer drug Herceptin. The FDA asked for more technical inform..."},{"Date":"Apr. 23, 2018 at 7:58 a.m. ET","Headline":"Pfizer says FDA failed to approve Herceptin biosimilar","Summary":"Pfizer Inc.  said early Monday that the Food and Drug Administration failed to approve its trastuzumab biosimilar, intended as a lower-cost version of Roche's  cancer drug Herceptin. The FDA asked for more technical inform..."},{"Date":"Apr. 24, 2018 at 11:07 a.m. ET","Headline":"Wegmans EpiPens out of stock, but no U.S. shortage currently seen, FDA says","Summary":"In spite of reports that Wegmans pharmacies are out of stock of the EpiPen allergic reaction treatment, the Food and Drug Administration is not currently aware of any U.S. shortage, though the regulator continues to monito..."},{"Date":"Apr. 24, 2018 at 10:05 a.m. ET","Headline":"GSK earnings preview: Consumer healthcare in focus","Summary":"GlaxoSmithKline PLC (GSK.LN) reports its first-quarter results on Wednesday at 1100 GMT. Here's what to expect: ADJUSTED OPERATING PROFIT: According to a FactSet consensus estimate, GSK is forecast to post adjusted operati..."},{"Date":"Apr. 28, 2018 at 12:01 a.m. ET","Headline":"In This Earnings Season, The Beats Roll On","Summary":""},{"Date":"May. 1, 2018 at 4:24 p.m. ET","Headline":"Tech rally lifts S&P 500, Nasdaq; Dow falls for 3rd straight session","Summary":"Pfizer Inc.  shares declined 2.2% in premarket trade Tuesday after the company reported a first-quarter sales miss. Earnings for the latest quarter rose to $3.56 billion, or 59 cents per share, from $3.12 billion, or 51 ce..."},{"Date":"May. 1, 2018 at 8:58 a.m. ET","Headline":"Billionaire Sam Zell warns on stocks and real estate: \u2018Where\u2019s the beef?\u2019","Summary":"Pfizer Inc.  shares declined 2.2% in premarket trade Tuesday after the company reported a first-quarter sales miss. Earnings for the latest quarter rose to $3.56 billion, or 59 cents per share, from $3.12 billion, or 51 ce..."},{"Date":"May. 1, 2018 at 6:59 a.m. ET","Headline":"Pfizer shares decline after Q1 sales miss","Summary":"Pfizer Inc.  shares declined 2.2% in premarket trade Tuesday after the company reported a first-quarter sales miss. Earnings for the latest quarter rose to $3.56 billion, or 59 cents per share, from $3.12 billion, or 51 ce..."},{"Date":"May. 3, 2018 at 9:11 a.m. ET","Headline":"Drugmakers eye a new threat to sales but say it hasn\u2019t affected them \u2014 yet","Summary":""},{"Date":"May. 5, 2018 at 12:01 a.m. ET","Headline":"Sarepta Raises New Hopes","Summary":""},{"Date":"May. 7, 2018 at 6:52 a.m. ET","Headline":"Here\u2019s a powerful argument for favoring value stocks over growth stocks","Summary":""},{"Date":"May. 8, 2018 at 2:33 p.m. ET","Headline":"Allergy group says U.S. has shortage of EpiPens, other allergic reaction treatments","Summary":"Allergy advocacy group Food Allergy Research and Education says that the U.S. is facing a growing national shortage of EpiPens and other allergic reaction treatments called epinephrine auto-injectors. Individuals with food..."},{"Date":"May. 11, 2018 at 2:41 p.m. ET","Headline":"Drug stocks slip, then swing back even higher after Trump unveils drug cost cutting plan","Summary":"Healthcare stocks dipped after President Donald Trump started presenting his plan to cut prescription drug costs, then bounced sharply to trade even higher than pre-speech levels. The SPDR Health Care Select Sector ETF  wa..."},{"Date":"May. 11, 2018 at 2:30 p.m. ET","Headline":"Dow tips higher, but knocked around, after Trump proposes sweeping change to health-care policy","Summary":"The Dow Jones Industrial Average briefly turned negative Friday afternoon, as President Donald Trump announced a series of changes intended to overhaul health-care policy in the U.S. At last check, the Dow  was up 51 point..."},{"Date":"May. 11, 2018 at 8:17 a.m. ET","Headline":"There\u2019s a shortage of U.S. EpiPens and other allergic reaction treatments","Summary":""},{"Date":"May. 15, 2018 at 5:11 a.m. ET","Headline":"Merck KGaA sales hurt by currency, China headwinds","Summary":"Merck KGaA (MRK.XE) shares fell by as much as 4.8% in early trade Tuesday after the company said that, despite organic growth, its first-quarter sales declined, dragged by currency headwinds and continuing market-share dec..."},{"Date":"May. 15, 2018 at 1:41 a.m. ET","Headline":"Merck KGaA's sales hit by currency headwinds","Summary":"Merck KGaA (MRK.XE) said Tuesday that despite attaining organic growth its first-quarter sales declined, dragged down by currency headwinds. The company reported a 4.4% sales decline to 3.69 billion euros ($4.41 billion), ..."},{"Date":"May. 14, 2018 at 1:43 p.m. ET","Headline":"Why Trump\u2019s drug-price pitch makes no sense","Summary":""},{"Date":"May. 14, 2018 at 8:41 a.m. ET","Headline":"President Trump\u2019s big drug price speech boosts pharma stocks","Summary":""},{"Date":"May. 16, 2018 at 10:07 a.m. ET","Headline":"Iterum Therapeutics sets terms of IPO, to raise up to $85 million","Summary":"Iterum Therapeutics  set terms Tuesday for its initial public offering, in which the drugmaker could raise up to $85.3 million. The company, which is developing sulopenem antibiotic that could potentially be the first and ..."},{"Date":"May. 21, 2018 at 7:08 a.m. ET","Headline":"EU approves GlaxoSmithKline JV's Juluca HIV drug","Summary":"GlaxoSmithKline PLC (GSK.LN) said that its majority-owned joint venture ViiV Healthcare has been granted marketing authorization by the European Commission for its HIV treatment Juluca. Juluca has been approved for HIV-1 i..."},{"Date":"May. 23, 2018 at 10:17 a.m. ET","Headline":"FDA warns that pain-relieving teething products are unsafe, asks companies to stop selling them","Summary":"The Food and Drug Administration issued a warning early Wednesday about over-the-counter teething products that contain the pain reliever benzocaine, saying the products were unsafe and asking the companies that make them ..."},{"Date":"May. 24, 2018 at 12:12 p.m. ET","Headline":"Pfizer to pay $23.85 million to settle kickback allegations","Summary":"The Department of Justice said on Thursday that global pharmaceutical company Pfizer, Inc.  settled allegations that it used a foundation as a conduit to pay the copays of Medicare patients taking three Pfizer drugs, in vi..."},{"Date":"May. 29, 2018 at 1:36 a.m. ET","Headline":"Smiths confirms merger talks with ICU Medical","Summary":"Smiths Group PLC (SMIN.LN) confirmed that it has entered talks with ICU Medical Inc. ICUI over a potential merger of both companies' healthcare operations. The U.K. engineering company said in a statement Sunday that it wa..."},{"Date":"Jun. 4, 2018 at 10:08 a.m. ET","Headline":"Some cancer patients can skip costly chemo  \u2014 without harming survival rates","Summary":""},{"Date":"Jun. 3, 2018 at 6:29 p.m. ET","Headline":"Cancer researchers suggest \u2018less is more\u2019 approach to treatment","Summary":""},{"Date":"Jun. 6, 2018 at 8:14 a.m. ET","Headline":"Pfizer to invest $600 mln in venture capital arm","Summary":"Pfizer Inc.  plans to invest $600 million in its venture capital arm, Pfizer Ventures, the company announced early Wednesday. The company also plans to expand its venture capital efforts and its team. Pfizer will add five ..."},{"Date":"Jun. 6, 2018 at 7:09 a.m. ET","Headline":"This outperforming fund manager \u2018rents\u2019 dividend stocks for a higher yield","Summary":""},{"Date":"May. 26, 2018 at 12:01 a.m. ET","Headline":"World\u2019s Best CEOs: Growth Leaders","Summary":""},{"Date":"Jun. 14, 2018 at 8:20 a.m. ET","Headline":"ViiV Healthcare reports positive results for late-stage HIV trials","Summary":"ViiV Healthcare, which is majority-owned by GlaxoSmithKline  and has Pfizer Inc.  and Shionogi  as shareholders, reported on Thursday positive early results from two late-stage trials testing its two-drug regimen in patien..."},{"Date":"Jun. 20, 2018 at 4:26 p.m. ET","Headline":"What GE\u2019s stock being replaced by Walgreens in the Dow Jones Industrial Average may mean","Summary":""},{"Date":"Feb. 17, 2018 at 12:01 a.m. ET","Headline":"General Electric\u2019s Dim Prospects","Summary":""},{"Date":"Jun. 25, 2018 at 12:58 p.m. ET","Headline":"Buybacks Set Record, Led by Apple","Summary":""},{"Date":"Jun. 28, 2018 at 8:20 a.m. ET","Headline":"Global Blood Therapeutics is making a big gamble on its sickle cell drug","Summary":""},{"Date":"Jun. 28, 2018 at 7:49 a.m. ET","Headline":"Five outperforming health-care funds and the top 10 stocks they hold","Summary":""},{"Date":"Jul. 2, 2018 at 6:06 p.m. ET","Headline":"Pfizer hikes prices on dozens of drugs for second time this year","Summary":""},{"Date":"Jul. 10, 2018 at 7:57 p.m. ET","Headline":"Pfizer agrees to postpone drug-price hikes after talk with Trump","Summary":"President Donald Trump claimed Tuesday evening that Pfizer Inc.  had promised to roll back drug-price increases that he had targeted earlier this week, sending Pfizer stock down. \"Pfizer is rolling back price hikes, so Ame..."},{"Date":"Jul. 10, 2018 at 7:16 p.m. ET","Headline":"Pfizer stock dips as Trump says Pfizer CEO agreed to drop drug price hikes","Summary":"President Donald Trump claimed Tuesday evening that Pfizer Inc.  had promised to roll back drug-price increases that he had targeted earlier this week, sending Pfizer stock down. \"Pfizer is rolling back price hikes, so Ame..."},{"Date":"Jul. 10, 2018 at 5:21 p.m. ET","Headline":"Trump\u2019s Pfizer Tweet: Why the Market Shrugged","Summary":"President Donald Trump criticized pharmaceutical giant Pfizer Inc.  in a Monday tweet for recently increasing the prices of many of its prescription drugs. In the , which referred to Pfizer and unspecified \"others,\" Trump ..."},{"Date":"Jul. 9, 2018 at 6:08 p.m. ET","Headline":"Trump slams Pfizer in tweet over drug prices, but stock still ends day up","Summary":"President Donald Trump criticized pharmaceutical giant Pfizer Inc.  in a Monday tweet for recently increasing the prices of many of its prescription drugs. In the , which referred to Pfizer and unspecified \"others,\" Trump ..."},{"Date":"Jul. 9, 2018 at 3:42 p.m. ET","Headline":"Trump Today: President blasts NATO allies, Pfizer and China ahead of Supreme Court decision","Summary":"President Donald Trump criticized pharmaceutical giant Pfizer Inc.  in a Monday tweet for recently increasing the prices of many of its prescription drugs. In the , which referred to Pfizer and unspecified \"others,\" Trump ..."},{"Date":"Jul. 9, 2018 at 1:28 p.m. ET","Headline":"Pfizer shares rise after President Trump attacks its drug price hikes","Summary":"President Donald Trump criticized pharmaceutical giant Pfizer Inc.  in a Monday tweet for recently increasing the prices of many of its prescription drugs. In the , which referred to Pfizer and unspecified \"others,\" Trump ..."},{"Date":"Jul. 12, 2018 at 2:11 p.m. ET","Headline":"Novartis to exit antibiotic, antiviral research","Summary":"Novartis AG (NOVN.EB) confirmed Thursday it would exit antibacterial and antiviral research, the latest in a string of big-pharma departures from the field and the latest move in the company's efforts to reconfigure itself..."},{"Date":"Jul. 11, 2018 at 4:31 p.m. ET","Headline":"U.S. stocks halt 4-day win streak as latest China tariffs rekindle trade-war jitters","Summary":"Pfizer Inc.  announced Wednesday a plan to reorganize into three businesses, including a new hospital business unit for anti-infectives and sterile injectables. The new hospital medicines unit will be part of Innovative Me..."},{"Date":"Jul. 11, 2018 at 4:03 p.m. ET","Headline":"Pfizer did win an important concession for letting Trump take a victory lap on drug prices","Summary":"Pfizer Inc.  announced Wednesday a plan to reorganize into three businesses, including a new hospital business unit for anti-infectives and sterile injectables. The new hospital medicines unit will be part of Innovative Me..."},{"Date":"Jul. 11, 2018 at 3:56 p.m. ET","Headline":"Investors Should Be Worried About Pfizer\u2019s Reversal","Summary":"Pfizer Inc.  announced Wednesday a plan to reorganize into three businesses, including a new hospital business unit for anti-infectives and sterile injectables. The new hospital medicines unit will be part of Innovative Me..."},{"Date":"Jul. 11, 2018 at 11:09 a.m. ET","Headline":"Pfizer will reorganize into three internal divisions","Summary":"Pfizer Inc.  announced Wednesday a plan to reorganize into three businesses, including a new hospital business unit for anti-infectives and sterile injectables. The new hospital medicines unit will be part of Innovative Me..."},{"Date":"Jul. 11, 2018 at 7:55 a.m. ET","Headline":"World\u2019s largest asset manager: It\u2019s not a trade war yet \u2014 here\u2019s when to really worry","Summary":"Pfizer Inc.  announced Wednesday a plan to reorganize into three businesses, including a new hospital business unit for anti-infectives and sterile injectables. The new hospital medicines unit will be part of Innovative Me..."},{"Date":"Jul. 11, 2018 at 7:00 a.m. ET","Headline":"Pfizer to reorganize into 3 business units, including a new hospital medicines business","Summary":"Pfizer Inc.  announced Wednesday a plan to reorganize into three businesses, including a new hospital business unit for anti-infectives and sterile injectables. The new hospital medicines unit will be part of Innovative Me..."},{"Date":"Jun. 7, 2018 at 11:30 a.m. ET","Headline":"Big Pharma\u2019s Tempting Payouts","Summary":""},{"Date":"Jul. 16, 2018 at 2:18 p.m. ET","Headline":"Johnson & Johnson earnings: Time to talk about drug prices","Summary":""},{"Date":"Jul. 18, 2018 at 3:26 p.m. ET","Headline":"Pfizer, Eli Lilly non-opioid pain drug nears finish line","Summary":"A new non-opioid drug for osteoarthritis pain being developed by Pfizer Inc.  and Eli Lilly & Co.  had positive early results in a phase 3 clinical trial, the companies announced on Wednesday. The drug, tanezumab, met all ..."},{"Date":"Jul. 17, 2018 at 7:08 a.m. ET","Headline":"Trade war, tariffs and inflation will be the big worries this earnings season","Summary":""},{"Date":"Jul. 20, 2018 at 5:43 p.m. ET","Headline":"Pfizer gets FDA approval for drug similar to Amgen's Neupogen","Summary":"Pfizer Inc.  said late Friday it received Food and Drug Administration approval to sell a biotech drug that is similar to Amgen Inc.'s  Neupogen. Pfizer's product is named Nivestym, which is intended to reduce the likeliho..."},{"Date":"Jul. 19, 2018 at 10:14 a.m. ET","Headline":"AbbVie shares drop 5.5% after short seller Citron calls it 'next great drug short'","Summary":"AbbVie Inc.  shares dropped 5.5% in heavy Thursday morning trade after short seller Citron Research described the company as \"the next great drug short\" in a and said it planned to release reports about the company. The Ci..."},{"Date":"Jul. 24, 2018 at 1:48 p.m. ET","Headline":"Pfizer to create 450 new jobs in Michigan as it builds a new sterile injectable facility","Summary":"Pfizer Inc.  said Tuesday it will create 450 new jobs, as it unveiled plans to build a new $465 million sterile injectable facility in Portage, Mich. The drugmaker said the new plant is part of its previously announced pla..."},{"Date":"Jul. 20, 2018 at 2:02 p.m. ET","Headline":"Big Bet on Pfizer for a Market-Beating Investment Firm","Summary":""},{"Date":"Jul. 26, 2018 at 11:48 a.m. ET","Headline":"Charting market rotation: S&P 500 and Dow industrials take flight","Summary":""},{"Date":"Jul. 25, 2018 at 12:00 p.m. ET","Headline":"Charting market cross currents, Nasdaq absorbs bearish single-day reversal","Summary":""},{"Date":"Jul. 28, 2018 at 10:30 a.m. ET","Headline":"Drugmakers sure are eager to talk about drug prices lately","Summary":""},{"Date":"Jul. 27, 2018 at 11:42 a.m. ET","Headline":"Dow industrials extend July breakout, Nasdaq pulls in to major support","Summary":""},{"Date":"Jul. 27, 2018 at 11:26 a.m. ET","Headline":"Azar says HHS will create more open market for prescription drugs","Summary":""},{"Date":"Jul. 30, 2018 at 11:56 a.m. ET","Headline":"Nasdaq violates major support, rattles cage on 50-day average","Summary":""},{"Date":"Jul. 30, 2018 at 7:00 a.m. ET","Headline":"Earnings Watch: Even Apple takes a back seat to Elon Musk right now","Summary":""},{"Date":"Jul. 28, 2018 at 12:01 a.m. ET","Headline":"How to Get a Share in a Vintage Car","Summary":""},{"Date":"Aug. 1, 2018 at 11:41 a.m. ET","Headline":"S&P 500 holds the breakout point, Nasdaq maintains key trendline ahead of Fed","Summary":"Pfizer Inc.  said Tuesday it had net income of $3.872 billion, or 65 cents a share, in the second quarter, up from $3.073 billion, or 51 cents a share, in the year-earlier period. Adjusted per-share earnings came to 81 cen..."},{"Date":"Jul. 31, 2018 at 4:43 p.m. ET","Headline":"S&P 500, Nasdaq rise, book 4th straight monthly gain","Summary":"Pfizer Inc.  said Tuesday it had net income of $3.872 billion, or 65 cents a share, in the second quarter, up from $3.073 billion, or 51 cents a share, in the year-earlier period. Adjusted per-share earnings came to 81 cen..."},{"Date":"Jul. 31, 2018 at 8:48 a.m. ET","Headline":"Apple\u2019s shaping up for a massive earnings beat, strategist predicts","Summary":"Pfizer Inc.  said Tuesday it had net income of $3.872 billion, or 65 cents a share, in the second quarter, up from $3.073 billion, or 51 cents a share, in the year-earlier period. Adjusted per-share earnings came to 81 cen..."},{"Date":"Jul. 31, 2018 at 6:55 a.m. ET","Headline":"Pfizer tops estimates for the second quarter and raises profit guidance","Summary":"Pfizer Inc.  said Tuesday it had net income of $3.872 billion, or 65 cents a share, in the second quarter, up from $3.073 billion, or 51 cents a share, in the year-earlier period. Adjusted per-share earnings came to 81 cen..."},{"Date":"Jul. 31, 2018 at 6:40 a.m. ET","Headline":"Pfizer wins EU approval for biosimilar Trazimera","Summary":"Pfizer Inc. PFE on Tuesday said the European Commission approved Trazimera, the company's biosimilar to Genentech's Herceptin, in certain breast and gastric cancers. The New York drug maker said the approval follows the re..."},{"Date":"Aug. 3, 2018 at 11:29 a.m. ET","Headline":"Charting a bullish reversal, Nasdaq knifes to the breakdown point","Summary":""},{"Date":"Aug. 3, 2018 at 8:23 a.m. ET","Headline":"Big Pharma games the system to make generic drugs more expensive","Summary":""},{"Date":"Aug. 3, 2018 at 8:23 a.m. ET","Headline":"Doctor payments increased drug prescribing by 73%, new study finds","Summary":""},{"Date":"Aug. 2, 2018 at 11:57 a.m. ET","Headline":"Nasdaq nails trendline support (again), bullish intraday reversal underway","Summary":""},{"Date":"Aug. 4, 2018 at 12:15 p.m. ET","Headline":"Stock-market shift from growth to value \u2018a meaningful bounce\u2019 but not yet a \u2018trend change\u2019","Summary":""},{"Date":"Aug. 7, 2018 at 1:27 p.m. ET","Headline":"Papa John\u2019s and 3 Other Small-Cap Value Plays","Summary":""},{"Date":"Aug. 7, 2018 at 12:21 p.m. ET","Headline":"Charting a bullish technical tilt:  S&P 500, Nasdaq rise within view of record territory","Summary":""},{"Date":"Aug. 7, 2018 at 11:48 a.m. ET","Headline":"Charting a bullish technical tilt:  S&P 500, Nasdaq rise within view of record territory","Summary":""},{"Date":"Aug. 6, 2018 at 11:30 a.m. ET","Headline":"S&P 500 extends rally from major support, Nasdaq reclaims the breakdown point","Summary":""},{"Date":"Aug. 9, 2018 at 11:18 a.m. ET","Headline":"Charting a bull trend holding pattern, U.S. benchmarks maintain first support","Summary":""},{"Date":"Aug. 8, 2018 at 11:23 a.m. ET","Headline":"Charting the Nasdaq\u2019s slow-motion approach of record territory","Summary":""},{"Date":"Aug. 8, 2018 at 8:43 a.m. ET","Headline":"5 smart trades that will get you away from pricey tech stocks","Summary":""},{"Date":"Aug. 10, 2018 at 11:44 a.m. ET","Headline":"S&P 500 ventures under the breakout point amid currency cross currents","Summary":""},{"Date":"Aug. 13, 2018 at 11:40 a.m. ET","Headline":"Charting a bull-trend whipsaw, S&P 500 absorbs Turkey-fueled downdraft","Summary":""},{"Date":"Aug. 15, 2018 at 1:35 p.m. ET","Headline":"GlaxoSmithKline unit enjoys positive HIV trial","Summary":"GlaxoSmithKline PLC (GSK.LN) said Wednesday that its subsidiary has reported positive results in its first phase 3 study for an injectable two-drug regimen for the treatment of HIV. GSK said ViiV Healthcare Ltd.'s study sh..."},{"Date":"Aug. 15, 2018 at 11:39 a.m. ET","Headline":"S&P 500 nails the 2,802 breakout point, Dow industrials venture under key trendline","Summary":"Shares of Caterpillar Inc.  sank 3.4% in morning trade Wednesday, to pace the 26-of-30 Dow Jones Industrial Average  components that are losing ground. The Dow dropped 288 points, as investors expressed concern over . The ..."},{"Date":"Aug. 15, 2018 at 10:29 a.m. ET","Headline":"Caterpillar's stock sinks to 10-month low, to pace Dow decliners","Summary":"Shares of Caterpillar Inc.  sank 3.4% in morning trade Wednesday, to pace the 26-of-30 Dow Jones Industrial Average  components that are losing ground. The Dow dropped 288 points, as investors expressed concern over . The ..."},{"Date":"Aug. 14, 2018 at 12:27 p.m. ET","Headline":"Bull trend absorbs shot across bow, Dow industrials maintain trendline support","Summary":""},{"Date":"Aug. 14, 2018 at 11:54 a.m. ET","Headline":"Bull trend absorbs shot across bow, Dow industrials maintain trendline support","Summary":""},{"Date":"Aug. 18, 2018 at 12:01 a.m. ET","Headline":"The Two Biggest Risks Facing the Market Today\u2013and What to Do","Summary":""},{"Date":"Aug. 21, 2018 at 12:36 p.m. ET","Headline":"Charting an August breakout attempt, S&P 500 approaches record territory","Summary":""},{"Date":"Aug. 21, 2018 at 11:50 a.m. ET","Headline":"Charting an August breakout attempt, S&P 500 approaches record territory","Summary":""},{"Date":"Aug. 20, 2018 at 12:14 p.m. ET","Headline":"Charting a bullish reversal:  S&P 500 extends rally from major support","Summary":""},{"Date":"Aug. 23, 2018 at 11:54 a.m. ET","Headline":"Charting a bull-trend pullback, S&P 500 hesitates at major resistance","Summary":"Exact Sciences Corp. shares  soared about 11% in premarket trade Wednesday, after the company said it will collaborate with Pfizer Inc.  in co-promoting Cologuard, the first and only FDA-approved non-invasive stool DNA scr..."},{"Date":"Aug. 22, 2018 at 11:57 a.m. ET","Headline":"S&P 500 briefly tags fractional record high, extended breakout attempt underway","Summary":"Exact Sciences Corp. shares  soared about 11% in premarket trade Wednesday, after the company said it will collaborate with Pfizer Inc.  in co-promoting Cologuard, the first and only FDA-approved non-invasive stool DNA scr..."},{"Date":"Aug. 22, 2018 at 7:13 a.m. ET","Headline":"Exact Sciences shares jump 11% premarket on news of Pfizer collaboration on Cologuard","Summary":"Exact Sciences Corp. shares  soared about 11% in premarket trade Wednesday, after the company said it will collaborate with Pfizer Inc.  in co-promoting Cologuard, the first and only FDA-approved non-invasive stool DNA scr..."},{"Date":"Aug. 25, 2018 at 9:18 a.m. ET","Headline":"There\u2019s an EpiPen shortage\u2014and parents fear for their allergic children headed back to school","Summary":""},{"Date":"Aug. 24, 2018 at 8:00 p.m. ET","Headline":"What\u2019s Waymo Worth?","Summary":""},{"Date":"Aug. 24, 2018 at 11:46 a.m. ET","Headline":"S&P 500, Nasdaq edge to uncharted territory, headline breakout attempt underway","Summary":""},{"Date":"Aug. 24, 2018 at 8:44 a.m. ET","Headline":"The 15 U.S. companies that are investing the most in tomorrow\u2019s big ideas","Summary":""},{"Date":"Aug. 27, 2018 at 11:35 a.m. ET","Headline":"S&P 500, Nasdaq take flight, extend August rally to uncharted territory","Summary":"Pfizer Inc.  shares rose just under 1% in Monday premarket trade after the company announced positive results from a late-stage trial of its drug tafamidis, which is being developed for the rare disease transthyretin amylo..."},{"Date":"Aug. 27, 2018 at 8:38 a.m. ET","Headline":"Pfizer rare-disease drug results lift its shares and those of rival","Summary":"Pfizer Inc.  shares rose just under 1% in Monday premarket trade after the company announced positive results from a late-stage trial of its drug tafamidis, which is being developed for the rare disease transthyretin amylo..."},{"Date":"Aug. 29, 2018 at 11:32 a.m. ET","Headline":"Charting a runaway gap:  S&P 500, Nasdaq extend break to uncharted territory","Summary":""},{"Date":"Aug. 29, 2018 at 7:30 a.m. ET","Headline":"Portola Pharmaceuticals Director Scores With Stock Purchase","Summary":""},{"Date":"Aug. 29, 2018 at 7:09 a.m. ET","Headline":"Ionis stock drops 13% as FDA fails to approve key drug","Summary":""},{"Date":"Aug. 28, 2018 at 12:38 p.m. ET","Headline":"Charting the break to \u2018clear skies\u2019 territory:  S&P 500, Nasdaq tag record highs","Summary":""},{"Date":"Aug. 28, 2018 at 11:52 a.m. ET","Headline":"Charting the break to \u2018clear skies\u2019 territory:  S&P 500, Nasdaq tag record highs","Summary":""},{"Date":"Aug. 28, 2018 at 8:23 a.m. ET","Headline":"Pfizer stock drops 2% as positive rare-disease drug results won\u2019t stop competitors","Summary":""},{"Date":"Aug. 24, 2018 at 7:25 p.m. ET","Headline":"Why Health Care\u2019s Rally May Be Just Getting Started","Summary":""},{"Date":"Aug. 31, 2018 at 11:32 a.m. ET","Headline":"S&P 500, Nasdaq digest two standard deviation August breakout","Summary":"Scholar Rock Holding Corp.  shares dropped 11% in active Thursday trade after Pfizer Inc.  announced it plans to stop two ongoing clinical trials for a similar rare-disease drug. The Pfizer drug in question, domagrozumab, ..."},{"Date":"Aug. 30, 2018 at 12:47 p.m. ET","Headline":"Scholar Rock stock tumbles 11% as Pfizer discontinues similar medication","Summary":"Scholar Rock Holding Corp.  shares dropped 11% in active Thursday trade after Pfizer Inc.  announced it plans to stop two ongoing clinical trials for a similar rare-disease drug. The Pfizer drug in question, domagrozumab, ..."},{"Date":"Aug. 30, 2018 at 11:20 a.m. ET","Headline":"S&P 500 and Nasdaq register powerful spike atop 20-day volatility bands","Summary":"Pfizer Inc.  is ending ongoing research for a Duchenne muscular dystrophy drug after finding that the evidence \"did not support a significant treatment effect,\" the company said on Thursday. Shares slumped 0.5% premarket, ..."},{"Date":"Aug. 30, 2018 at 8:28 a.m. ET","Headline":"Pfizer stops developing therapy for the rare disease Duchenne muscular dystrophy","Summary":"Pfizer Inc.  is ending ongoing research for a Duchenne muscular dystrophy drug after finding that the evidence \"did not support a significant treatment effect,\" the company said on Thursday. Shares slumped 0.5% premarket, ..."},{"Date":"Sep. 4, 2018 at 12:36 p.m. ET","Headline":"Charting a bull-trend pullback, S&P 500 digests rally atop 20-day volatility bands","Summary":""},{"Date":"Sep. 4, 2018 at 11:50 a.m. ET","Headline":"Charting a bull-trend pullback, S&P 500 digests rally atop 20-day volatility bands","Summary":""},{"Date":"Sep. 6, 2018 at 11:38 a.m. ET","Headline":"Nasdaq ventures under major support, S&P 500 back for second crack at 2,873 breakout point","Summary":""},{"Date":"Sep. 5, 2018 at 11:40 a.m. ET","Headline":"S&P 500 pulls in to the breakout point (2,873), initial retest underway","Summary":""},{"Date":"Sep. 8, 2018 at 7:50 a.m. ET","Headline":"How to cut your investment risk with large-cap dividend stocks","Summary":""},{"Date":"Sep. 7, 2018 at 11:59 a.m. ET","Headline":"Charting a garden-variety pullback, S&P 500 maintains the breakout point","Summary":""},{"Date":"Sep. 10, 2018 at 11:26 a.m. ET","Headline":"Nasdaq maintains key trendline support, S&P 500 nails the breakout point","Summary":""},{"Date":"Sep. 9, 2018 at 8:36 a.m. ET","Headline":"An easy way for investors to buy protection: Consider value stocks with high dividend yields","Summary":""},{"Date":"Sep. 12, 2018 at 11:35 a.m. ET","Headline":"S&P 500 rallies from the breakout point, Nasdaq holds key trendline","Summary":""},{"Date":"Sep. 11, 2018 at 12:51 p.m. ET","Headline":"Charting a bullish September backdrop:  S&P 500, Nasdaq maintain major support","Summary":""},{"Date":"Sep. 11, 2018 at 12:16 p.m. ET","Headline":"Charting a bullish September backdrop:  S&P 500, Nasdaq maintain major support","Summary":""},{"Date":"Sep. 11, 2018 at 10:00 a.m. ET","Headline":"Why you should avoid small caps for the rest of the year","Summary":""},{"Date":"Sep. 14, 2018 at 3:48 p.m. ET","Headline":"These 4 major health-care stock spinoffs could make you money","Summary":""},{"Date":"Sep. 14, 2018 at 11:37 a.m. ET","Headline":"Charting the Dow industrials\u2019 bull-flag breakout attempt","Summary":""},{"Date":"Sep. 13, 2018 at 11:44 a.m. ET","Headline":"Charting a successful technical test: S&P 500 rallies from major support","Summary":""},{"Date":"Sep. 12, 2018 at 4:07 p.m. ET","Headline":"Rate Hikes Could Hurt These High-Yielding Sectors","Summary":""},{"Date":"Sep. 18, 2018 at 2:57 p.m. ET","Headline":"Health care ETF surges toward record in a broad sector rally","Summary":"The SPDR Health Care Select Sector ETF  rose 0.7% toward a record high in afternoon trade Tuesday, with 55 of its 63 equity components gaining ground. Among the ETF's (XLV) members which are also Dow Jones Industrial Avera..."},{"Date":"Sep. 18, 2018 at 12:47 p.m. ET","Headline":"Charting a bull-flag breakout attempt:  Dow industrials challenge seven-month highs","Summary":""},{"Date":"Sep. 18, 2018 at 12:11 p.m. ET","Headline":"Charting a bull-flag breakout attempt:  Dow industrials challenge seven-month highs","Summary":""},{"Date":"Sep. 17, 2018 at 11:32 a.m. ET","Headline":"S&P 500 traverses the September range as trade-policy tensions persist","Summary":""},{"Date":"Sep. 20, 2018 at 11:51 a.m. ET","Headline":"Charting a break to \u2018clear skies\u2019 territory:  S&P 500, Dow industrials tag record highs","Summary":""},{"Date":"Sep. 19, 2018 at 11:50 a.m. ET","Headline":"Dow industrials extend technical breakout, rise within view of record highs","Summary":""},{"Date":"Sep. 22, 2018 at 3:35 p.m. ET","Headline":"Here\u2019s how all 30 Dow Jones Industrial Average stocks performed as the benchmark set another record","Summary":""},{"Date":"Sep. 21, 2018 at 11:42 a.m. ET","Headline":"S&P 500, Dow industrials knife to uncharted territory, close atop 20-day volatility bands","Summary":""},{"Date":"Sep. 21, 2018 at 7:13 a.m. ET","Headline":"These Dow Jones Industrial Average stocks have been left behind as the index hits a record","Summary":""},{"Date":"Sep. 24, 2018 at 11:36 a.m. ET","Headline":"S&P 500 pulls in to the breakout point (2,916), initial retest underway","Summary":""},{"Date":"Sep. 26, 2018 at 11:16 a.m. ET","Headline":"S&P 500 nails the breakout point (again) amid garden-variety pullback","Summary":""},{"Date":"Sep. 25, 2018 at 12:38 p.m. ET","Headline":"Bull trend pauses:  S&P 500 holds the breakout point (2,916) ahead of the Fed","Summary":""},{"Date":"Sep. 25, 2018 at 12:00 p.m. ET","Headline":"Bull trend pauses:  S&P 500 holds the breakout point (2,916) ahead of the Fed","Summary":""},{"Date":"Sep. 28, 2018 at 11:16 a.m. ET","Headline":"Closing out a bullish third quarter, Nasdaq rattles the cage on a breakout","Summary":""},{"Date":"Sep. 27, 2018 at 12:04 p.m. ET","Headline":"Charting market rotation, bull trend absorbs Fed-fueled volatility","Summary":""},{"Date":"Sep. 30, 2018 at 5:00 a.m. ET","Headline":"\u2018People Treat Animals Like Parts of Their Family.\u2019 Henry Schein Is Spinning Off Its Pet-Health Business","Summary":""},{"Date":"Oct. 2, 2018 at 12:34 p.m. ET","Headline":"Charting a bullish Q4 start, S&P 500 rises to challenge record close","Summary":""},{"Date":"Oct. 2, 2018 at 12:08 p.m. ET","Headline":"Charting a bullish Q4 start, S&P 500 rises to challenge record close","Summary":""},{"Date":"Oct. 1, 2018 at 4:27 p.m. ET","Headline":"Stocks close mostly higher on new U.S.-Canada Nafta deal","Summary":""},{"Date":"Oct. 1, 2018 at 11:39 a.m. ET","Headline":"Charting a trade-fueled breakout attempt, S&P 500 challenges record close","Summary":""},{"Date":"Oct. 1, 2018 at 10:55 a.m. ET","Headline":"Stocks Are Rallying After the U.S. and Canada Struck a Deal on NAFTA","Summary":""},{"Date":"Oct. 4, 2018 at 12:04 p.m. ET","Headline":"Market bears resurface as Treasury yields spike, S&P 500 nails major resistance","Summary":""},{"Date":"Oct. 3, 2018 at 11:35 a.m. ET","Headline":"Charting the approach of Dow 27,000 as technical divergence persists","Summary":""},{"Date":"Oct. 6, 2018 at 3:59 p.m. ET","Headline":"Invest in these 5 high-margin stocks to beat the specter of worrisome inflation","Summary":""},{"Date":"Oct. 5, 2018 at 3:46 p.m. ET","Headline":"Eli Lilly Stock Is Climbing on Upbeat Drug Data and an Upgrade","Summary":""},{"Date":"Oct. 5, 2018 at 11:57 a.m. ET","Headline":"Charting fourth-quarter cross currents, Nasdaq violates key trendline support","Summary":""},{"Date":"Oct. 8, 2018 at 12:03 p.m. ET","Headline":"October downturn accelerates, placing major S&P 500 support (2,873) under siege","Summary":""},{"Date":"Oct. 10, 2018 at 4:40 p.m. ET","Headline":"Stocks close sharply lower as Dow sinks over 800 points in worst day since February","Summary":"Shares of Myriad Genetics Inc.  soared 7% Wednesday in a down market, after it announced an agreement to carry out testing for Pfizer Inc.  of a treatment for breast cancer. The Salt Lake City, Utah-based company said it w..."},{"Date":"Oct. 10, 2018 at 11:35 a.m. ET","Headline":"Charting a bearish technical tilt, S&P 500 violates major support","Summary":"Shares of Myriad Genetics Inc.  soared 7% Wednesday in a down market, after it announced an agreement to carry out testing for Pfizer Inc.  of a treatment for breast cancer. The Salt Lake City, Utah-based company said it w..."},{"Date":"Oct. 10, 2018 at 10:12 a.m. ET","Headline":"Myriad Genetics shares soar 7% on news it will conduct testing for Pfizer breast cancer treatment","Summary":"Shares of Myriad Genetics Inc.  soared 7% Wednesday in a down market, after it announced an agreement to carry out testing for Pfizer Inc.  of a treatment for breast cancer. The Salt Lake City, Utah-based company said it w..."},{"Date":"Oct. 9, 2018 at 12:49 p.m. ET","Headline":"Cracks surface in the bull trend, S&P 500 nails major support","Summary":""},{"Date":"Oct. 9, 2018 at 12:11 p.m. ET","Headline":"Cracks surface in the bull trend, S&P 500 nails major support","Summary":""},{"Date":"Oct. 12, 2018 at 12:50 p.m. ET","Headline":"Bayer Stock Is Battling Back Against Legal Worries","Summary":"Pfizer Inc.  will pay over $700,000 to settle charges for \"deceptive advertising,\" according to a statement from New York Attorney General Barbara Underwood. Pfizer's stock  dropped 2.7% in morning trade, enough to pace th..."},{"Date":"Oct. 12, 2018 at 11:56 a.m. ET","Headline":"Charting a dead-cat bounce, S&P 500 retests 200-day average from underneath","Summary":"Pfizer Inc.  will pay over $700,000 to settle charges for \"deceptive advertising,\" according to a statement from New York Attorney General Barbara Underwood. Pfizer's stock  dropped 2.7% in morning trade, enough to pace th..."},{"Date":"Oct. 12, 2018 at 5:30 a.m. ET","Headline":"The Stock Market Was Scary This Week. Here Are 5 Mutual Funds for Income Investors","Summary":"Pfizer Inc.  will pay over $700,000 to settle charges for \"deceptive advertising,\" according to a statement from New York Attorney General Barbara Underwood. Pfizer's stock  dropped 2.7% in morning trade, enough to pace th..."},{"Date":"Oct. 11, 2018 at 12:24 p.m. ET","Headline":"Bearish momentum accelerates, 10-to-1 down day inflicts technical damage","Summary":"Pfizer Inc.  will pay over $700,000 to settle charges for \"deceptive advertising,\" according to a statement from New York Attorney General Barbara Underwood. Pfizer's stock  dropped 2.7% in morning trade, enough to pace th..."},{"Date":"Oct. 11, 2018 at 11:56 a.m. ET","Headline":"Pfizer to pay $700,000 to settle 'deceptive advertising' charges; stock drops to pace Dow losers","Summary":"Pfizer Inc.  will pay over $700,000 to settle charges for \"deceptive advertising,\" according to a statement from New York Attorney General Barbara Underwood. Pfizer's stock  dropped 2.7% in morning trade, enough to pace th..."},{"Date":"Oct. 11, 2018 at 6:47 a.m. ET","Headline":"These stocks in the Dow Jones Industrial Average, S&P 500 and Nasdaq declined the most on Wednesday","Summary":""},{"Date":"Oct. 16, 2018 at 12:54 p.m. ET","Headline":"Charting a corrective bounce, S&P 500 reclaims 200-day average","Summary":""},{"Date":"Oct. 16, 2018 at 12:25 p.m. ET","Headline":"Charting a corrective bounce, S&P 500 reclaims 200-day average","Summary":""},{"Date":"Oct. 15, 2018 at 11:49 a.m. ET","Headline":"S&P 500 nails the 200-day average, initial retest from underneath still underway","Summary":""},{"Date":"Oct. 18, 2018 at 11:39 a.m. ET","Headline":"Charting a fragile recovery attempt, S&P 500 digests initial technical progress","Summary":""},{"Date":"Oct. 17, 2018 at 11:42 a.m. ET","Headline":"Charting a market recovery attempt:  S&P 500, Nasdaq venture atop 200-day average","Summary":""},{"Date":"Oct. 19, 2018 at 11:58 a.m. ET","Headline":"Charting October volatility:  S&P 500, Nasdaq whipsaw at the 200-day average","Summary":""},{"Date":"Oct. 22, 2018 at 11:49 a.m. ET","Headline":"S&P 500, Nasdaq nail 200-day average amid lackluster recovery attempt","Summary":""},{"Date":"Oct. 24, 2018 at 3:00 p.m. ET","Headline":"Down More Than 30%, Biosimilar Stocks Still Aren\u2019t Healthy for Investors","Summary":""},{"Date":"Oct. 24, 2018 at 12:25 p.m. ET","Headline":"Charting a second corrective bounce, S&P 500 lifts from four-month lows","Summary":""},{"Date":"Oct. 24, 2018 at 7:12 a.m. ET","Headline":"New pain drug from Pfizer and Eli Lilly shows promise as opioid alternative","Summary":""},{"Date":"Oct. 23, 2018 at 12:49 p.m. ET","Headline":"Charting an ominous technical tilt, S&P 500 plunges from the 200-day average","Summary":""},{"Date":"Oct. 23, 2018 at 12:18 p.m. ET","Headline":"Charting an ominous technical tilt, S&P 500 plunges from the 200-day average","Summary":""},{"Date":"Oct. 23, 2018 at 10:46 a.m. ET","Headline":"Here are Tuesday\u2019s biggest stock-market losers","Summary":""},{"Date":"Oct. 23, 2018 at 10:29 a.m. ET","Headline":"Caterpillar Tanks, 3M Slumps Because Trade Woes Are Not Just for China Anymore","Summary":""},{"Date":"Oct. 26, 2018 at 7:25 p.m. ET","Headline":"As Trade Disputes Fester, There\u2019s No Haven for Small-Caps","Summary":""},{"Date":"Oct. 26, 2018 at 11:47 a.m. ET","Headline":"Bearish momentum intact, S&P 500 tags the 10% correction mark","Summary":""},{"Date":"Oct. 25, 2018 at 3:57 p.m. ET","Headline":"Trump Today: President blames media for \u2018anger\u2019 after bombs sent to Democrats","Summary":""},{"Date":"Oct. 25, 2018 at 12:34 p.m. ET","Headline":"Charting a primary trend shift, October downdraft inflicts extensive damage","Summary":""},{"Date":"Oct. 28, 2018 at 10:00 a.m. ET","Headline":"Facebook, GE, Apple, Berkshire, Jobs Report: The Week Ahead","Summary":""},{"Date":"Oct. 28, 2018 at 7:32 a.m. ET","Headline":"Here are this week\u2019s worst stocks in the Dow Jones Industrial Average, S&P 500 and Nasdaq","Summary":""},{"Date":"Oct. 30, 2018 at 4:31 p.m. ET","Headline":"Stocks rally to close higher after Monday\u2019s big reversal","Summary":"GlaxoSmithKline PLC's (GSK.LN) ViiV Healthcare said that a phase 3 study of a two-drug regimen of cabotegravir and rilpivirine to treat HIV had positive results and met its primary trial objective. ViiV Healthcare said tha..."},{"Date":"Oct. 30, 2018 at 1:12 p.m. ET","Headline":"GlaxoSmithKline's ViiV says HIV study succeeded","Summary":"GlaxoSmithKline PLC's (GSK.LN) ViiV Healthcare said that a phase 3 study of a two-drug regimen of cabotegravir and rilpivirine to treat HIV had positive results and met its primary trial objective. ViiV Healthcare said tha..."},{"Date":"Oct. 30, 2018 at 12:42 p.m. ET","Headline":"Charting a second dead-cat bounce, S&P 500 rises from 10% correction mark","Summary":"U.S. stock benchmarks early Tuesday struggled for direction, a day after the Dow Jones Industrial Average staged an ugly reversal to end the session. Concerns about slowing global growth, mixed quarterly results from Ameri..."},{"Date":"Oct. 30, 2018 at 12:07 p.m. ET","Headline":"Charting a second dead-cat bounce, S&P 500 rises from 10% correction mark","Summary":"U.S. stock benchmarks early Tuesday struggled for direction, a day after the Dow Jones Industrial Average staged an ugly reversal to end the session. Concerns about slowing global growth, mixed quarterly results from Ameri..."},{"Date":"Oct. 30, 2018 at 10:04 a.m. ET","Headline":"McDonald\u2019s, Walmart and other U.S. stocks that could rise from the ashes of a correction","Summary":"U.S. stock benchmarks early Tuesday struggled for direction, a day after the Dow Jones Industrial Average staged an ugly reversal to end the session. Concerns about slowing global growth, mixed quarterly results from Ameri..."},{"Date":"Oct. 30, 2018 at 9:37 a.m. ET","Headline":"Stocks struggle to rebound after mixed earnings from Coca-Cola and Pfizer, downbeat housing report","Summary":"U.S. stock benchmarks early Tuesday struggled for direction, a day after the Dow Jones Industrial Average staged an ugly reversal to end the session. Concerns about slowing global growth, mixed quarterly results from Ameri..."},{"Date":"Oct. 30, 2018 at 9:20 a.m. ET","Headline":"Nvidia Edges Higher, GE Slips as Markets Pause to Breathe","Summary":"Shares of Pfizer Inc.  fell 1.7% in premarket trade Tuesday, after the pharmaceutical giant reported third-quarter earnings that beat expectations but revenue that missed, and provided a downbeat revenue outlook. Net incom..."},{"Date":"Oct. 30, 2018 at 6:57 a.m. ET","Headline":"Pfizer's stock falls after profit beats, but revenue misses","Summary":"Shares of Pfizer Inc.  fell 1.7% in premarket trade Tuesday, after the pharmaceutical giant reported third-quarter earnings that beat expectations but revenue that missed, and provided a downbeat revenue outlook. Net incom..."},{"Date":"Oct. 30, 2018 at 6:44 a.m. ET","Headline":"Dow Gains 91 Points, but Earnings Could Change That","Summary":"ViiV Healthcare, majority-owned by GlaxoSmithKline PLC (GSK.LN), said a phase 2 trial of a two-drug regimen to treat HIV showed positive results. The Latte-2 trial is a phase 2 study examining an injectable cabotegravir an..."},{"Date":"Oct. 29, 2018 at 3:02 p.m. ET","Headline":"Pfizer earnings: Looking toward an ambitious 2022 agenda","Summary":"ViiV Healthcare, majority-owned by GlaxoSmithKline PLC (GSK.LN), said a phase 2 trial of a two-drug regimen to treat HIV showed positive results. The Latte-2 trial is a phase 2 study examining an injectable cabotegravir an..."},{"Date":"Oct. 29, 2018 at 1:44 p.m. ET","Headline":"German stocks log best day in 2 months as Merkel plots exit; Banks, auto shares climb","Summary":"ViiV Healthcare, majority-owned by GlaxoSmithKline PLC (GSK.LN), said a phase 2 trial of a two-drug regimen to treat HIV showed positive results. The Latte-2 trial is a phase 2 study examining an injectable cabotegravir an..."},{"Date":"Oct. 29, 2018 at 11:54 a.m. ET","Headline":"S&P 500 lifts to the breakdown point (2,710), latest retest underway","Summary":"ViiV Healthcare, majority-owned by GlaxoSmithKline PLC (GSK.LN), said a phase 2 trial of a two-drug regimen to treat HIV showed positive results. The Latte-2 trial is a phase 2 study examining an injectable cabotegravir an..."},{"Date":"Oct. 29, 2018 at 11:24 a.m. ET","Headline":"The bigger message behind Amgen\u2019s decision to slash cost of its Repatha cholesterol drug","Summary":"ViiV Healthcare, majority-owned by GlaxoSmithKline PLC (GSK.LN), said a phase 2 trial of a two-drug regimen to treat HIV showed positive results. The Latte-2 trial is a phase 2 study examining an injectable cabotegravir an..."},{"Date":"Oct. 29, 2018 at 8:25 a.m. ET","Headline":"Red Hat Soars, Ford Flies as Dow Jumps on China Stimulus","Summary":"ViiV Healthcare, majority-owned by GlaxoSmithKline PLC (GSK.LN), said a phase 2 trial of a two-drug regimen to treat HIV showed positive results. The Latte-2 trial is a phase 2 study examining an injectable cabotegravir an..."},{"Date":"Oct. 29, 2018 at 7:25 a.m. ET","Headline":"GlaxoSmithKline HIV study shows 'positive' results","Summary":"ViiV Healthcare, majority-owned by GlaxoSmithKline PLC (GSK.LN), said a phase 2 trial of a two-drug regimen to treat HIV showed positive results. The Latte-2 trial is a phase 2 study examining an injectable cabotegravir an..."},{"Date":"Oct. 29, 2018 at 2:54 a.m. ET","Headline":"Novartis, Pfizer team up on liver-disease drugs","Summary":"Novartis AG (NOVN.EB) and Pfizer Inc. (PFE) are teaming up to target a complex type of liver disease, underscoring the growing willingness of drug makers to work with rivals to tackle difficult-to-treat conditions."},{"Date":"Nov. 1, 2018 at 11:40 a.m. ET","Headline":"Charting a shooting star, S&P 500 nails the breakdown point (2,710)","Summary":""},{"Date":"Nov. 1, 2018 at 7:33 a.m. ET","Headline":"Pfizer will go back to price hikes \u2018as normal\u2019 come January, CEO suggests","Summary":""},{"Date":"Oct. 31, 2018 at 11:59 a.m. ET","Headline":"Closing out a damaging October plunge, U.S. benchmarks rise from multi-month lows","Summary":""},{"Date":"Nov. 2, 2018 at 8:00 p.m. ET","Headline":"Reports on MasterCard, ADP, Facebook, and 4 Others","Summary":""},{"Date":"Nov. 2, 2018 at 6:06 p.m. ET","Headline":"General Electric Takes the Gold at Cutting Dividends","Summary":""},{"Date":"Nov. 2, 2018 at 11:44 a.m. ET","Headline":"Market bears resurface as major U.S. benchmarks tag next resistance","Summary":""},{"Date":"Nov. 5, 2018 at 11:43 a.m. ET","Headline":"Charting a near-term holding pattern, S&P 500 asserts the range","Summary":""},{"Date":"Nov. 7, 2018 at 11:47 a.m. ET","Headline":"Charting November follow-through, S&P 500 ventures atop 200-day average","Summary":""},{"Date":"Nov. 6, 2018 at 12:33 p.m. ET","Headline":"Charting the S&P 500\u2019s November bounce ahead of U.S. midterms","Summary":""},{"Date":"Nov. 6, 2018 at 12:03 p.m. ET","Headline":"Charting the S&P 500\u2019s November bounce ahead of U.S. midterms","Summary":""},{"Date":"Nov. 6, 2018 at 8:35 a.m. ET","Headline":"How Trump could rescue Apple\u2019s fast-sinking stock","Summary":""},{"Date":"Nov. 9, 2018 at 11:52 a.m. ET","Headline":"S&P 500 nails the range top (2,817), stalls at well-defined resistance","Summary":""},{"Date":"Nov. 8, 2018 at 12:09 p.m. ET","Headline":"Bull case strengthens:  S&P 500, Nasdaq knife atop 200-day average","Summary":""},{"Date":"Nov. 8, 2018 at 5:34 a.m. ET","Headline":"Here are the post-election stock-market winners in the Dow, S&P 500 and Nasdaq","Summary":""},{"Date":"Sep. 14, 2018 at 8:00 p.m. ET","Headline":"Nike Sets Up to Sprint","Summary":""},{"Date":"Nov. 13, 2018 at 1:07 p.m. ET","Headline":"Charting a post-election downdraft, S&P 500 returns to mini-crash range","Summary":""},{"Date":"Nov. 13, 2018 at 12:38 p.m. ET","Headline":"Charting a post-election downdraft, S&P 500 returns to mini-crash range","Summary":""},{"Date":"Nov. 12, 2018 at 11:57 a.m. ET","Headline":"Charting a failed technical test:  S&P 500, Nasdaq violate 200-day average","Summary":""},{"Date":"Nov. 14, 2018 at 12:23 p.m. ET","Headline":"Charting persistent November volatility, Dow industrials challenge 200-day average","Summary":""},{"Date":"Nov. 16, 2018 at 4:35 p.m. ET","Headline":"Pfizer to raise prices on 41 drugs: report","Summary":"Pfizer  plans to raise the list prices of 41 of its prescription drugs, or 10% of its portfolio, in January,  citing a person familiar with the matter. Most of the increases will be around 5% and would take effect Jan. 15,..."},{"Date":"Nov. 16, 2018 at 10:39 a.m. ET","Headline":"This Biotech Stock Is a Remedy for Tougher Times","Summary":""},{"Date":"Nov. 19, 2018 at 12:00 p.m. ET","Headline":"Bearish momentum persists:  S&P 500, Nasdaq stall at well-defined resistance","Summary":"Merck KGaA  and Pfizer Inc.  said early Monday that the cancer immunotherapy avelumab did not meet the primary endpoints of a phase 3 ovarian cancer trial. The trial, JAVELIN Ovarian 200, tested avelumab both alone and in ..."},{"Date":"Nov. 19, 2018 at 7:38 a.m. ET","Headline":"Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial","Summary":"Merck KGaA  and Pfizer Inc.  said early Monday that the cancer immunotherapy avelumab did not meet the primary endpoints of a phase 3 ovarian cancer trial. The trial, JAVELIN Ovarian 200, tested avelumab both alone and in ..."},{"Date":"Nov. 18, 2018 at 10:31 a.m. ET","Headline":"Cutting-edge biotech Sangamo stock dives 12% after JPMorgan cites \u2018growing skepticism\u2019 in downgrade","Summary":""},{"Date":"Nov. 21, 2018 at 12:21 p.m. ET","Headline":"S&P 500 tags negative YTD territory, back for initial crack at the breakdown point","Summary":""},{"Date":"Nov. 20, 2018 at 12:46 p.m. ET","Headline":"Bearish momentum accelerates, S&P 500 ventures under major support","Summary":""},{"Date":"Nov. 20, 2018 at 12:06 p.m. ET","Headline":"Bearish momentum accelerates, S&P 500 ventures under major support","Summary":""},{"Date":"Nov. 20, 2018 at 6:00 a.m. ET","Headline":"Pfizer and 3 Other Stock Picks From a 5-Star Growth Fund","Summary":""},{"Date":"Nov. 23, 2018 at 7:49 p.m. ET","Headline":"Give Thanks: 10 Stocks That Bucked the Red Tide","Summary":""},{"Date":"Nov. 25, 2018 at 3:00 p.m. ET","Headline":"This Week: Consumer Confidence, Campbell Votes on Loeb Nominees","Summary":""},{"Date":"Nov. 27, 2018 at 12:36 p.m. ET","Headline":"S&P 500 nails the breakdown point (2,673), pulling-teeth retest underway","Summary":""},{"Date":"Nov. 27, 2018 at 12:07 p.m. ET","Headline":"S&P 500 nails the breakdown point (2,673), pulling-teeth retest underway","Summary":""},{"Date":"Nov. 26, 2018 at 11:46 a.m. ET","Headline":"Charting a bull-bear technical test:  S&P 500 nails the breakdown point (2,673)","Summary":""},{"Date":"Nov. 26, 2018 at 10:36 a.m. ET","Headline":"Celgene Stock Could Nearly Double, Analyst Says","Summary":""},{"Date":"Nov. 29, 2018 at 12:16 p.m. ET","Headline":"Charting a Fed-fueled nearly 8-to-1 up day, S&P 500 spikes to major resistance","Summary":""},{"Date":"Nov. 29, 2018 at 7:10 a.m. ET","Headline":"Here are the stocks that powered the Dow after the Fed\u2019s Powell soothed investors","Summary":""},{"Date":"Nov. 28, 2018 at 12:23 p.m. ET","Headline":"Big Changes Are Coming to the Dow as United Technologies and DowDuPont Get Ready for Breakups","Summary":""},{"Date":"Nov. 28, 2018 at 11:52 a.m. ET","Headline":"S&P 500 extends bounce ahead of the Fed, reclaims first resistance","Summary":""},{"Date":"Nov. 28, 2018 at 6:59 a.m. ET","Headline":"Dow changes are coming, as United Technologies and DowDuPont head for breakups","Summary":""},{"Date":"Nov. 30, 2018 at 5:24 p.m. ET","Headline":"U.S. Stocks Sprint Ahead to End a Blockbuster Week","Summary":""},{"Date":"Nov. 30, 2018 at 11:57 a.m. ET","Headline":"S&P 500 nails major resistance (2,742), sustains initial Fed-fueled gains","Summary":""},{"Date":"Dec. 3, 2018 at 4:39 p.m. ET","Headline":"Here are the best-performing U.S. stocks in Monday\u2019s rally","Summary":""},{"Date":"Dec. 3, 2018 at 11:58 a.m. ET","Headline":"Charting a trade-fueled rally attempt, S&P 500 reclaims 200-day average","Summary":""},{"Date":"Dec. 5, 2018 at 5:33 p.m. ET","Headline":"This stable value stock is built to weather market storms","Summary":""},{"Date":"Dec. 4, 2018 at 1:21 p.m. ET","Headline":"Market bears resurface:  S&P 500 nails major resistance amid flattening yield curve","Summary":""},{"Date":"Dec. 4, 2018 at 12:51 p.m. ET","Headline":"Market bears resurface:  S&P 500 nails major resistance amid flattening yield curve","Summary":""},{"Date":"Dec. 4, 2018 at 7:00 a.m. ET","Headline":"Bayer Is Just the Latest Pharma Giant to Get Back to Basics","Summary":""},{"Date":"Dec. 7, 2018 at 12:02 p.m. ET","Headline":"Charting a bearish market whipsaw, S&P 500 asserts wide December range","Summary":""},{"Date":"Dec. 6, 2018 at 11:33 p.m. ET","Headline":"Generic drugmaker Sandoz to sell alternative to EpiPen injectors","Summary":""},{"Date":"Dec. 6, 2018 at 12:00 p.m. ET","Headline":"Charting an aggressive December downdraft amid S&P 500\u2019s pending death cross","Summary":""},{"Date":"Dec. 6, 2018 at 7:06 a.m. ET","Headline":"Here are the worst-performing stocks on \u2018Tariff Man\u2019 Tuesday","Summary":""},{"Date":"Dec. 11, 2018 at 4:24 p.m. ET","Headline":"U.S. stocks close mostly lower in volatile trade","Summary":"Pfizer Inc. shares  slid 1.1% in premarket trade Tuesday, after JP Morgan downgraded the stock to neutral from overweight and said it's moving to the sidelines after a strong 2018. \"We clearly have seen a positive shift in..."},{"Date":"Dec. 11, 2018 at 12:44 p.m. ET","Headline":"Charting a December bounce:  S&P 500 nails major support","Summary":"Pfizer Inc. shares  slid 1.1% in premarket trade Tuesday, after JP Morgan downgraded the stock to neutral from overweight and said it's moving to the sidelines after a strong 2018. \"We clearly have seen a positive shift in..."},{"Date":"Dec. 11, 2018 at 12:09 p.m. ET","Headline":"Charting a December bounce:  S&P 500 nails major support","Summary":"Pfizer Inc. shares  slid 1.1% in premarket trade Tuesday, after JP Morgan downgraded the stock to neutral from overweight and said it's moving to the sidelines after a strong 2018. \"We clearly have seen a positive shift in..."},{"Date":"Dec. 11, 2018 at 8:18 a.m. ET","Headline":"Pfizer shares fall premarket after JPMorgan downgrades to neutral","Summary":"Pfizer Inc. shares  slid 1.1% in premarket trade Tuesday, after JP Morgan downgraded the stock to neutral from overweight and said it's moving to the sidelines after a strong 2018. \"We clearly have seen a positive shift in..."},{"Date":"Dec. 11, 2018 at 6:57 a.m. ET","Headline":"Generic-drug stocks slammed by report of expanded price-fixing probe","Summary":"Shares of generic drug makers fell sharply Monday, after a Washington Post report that an antitrust lawsuit brought by states over two drugs in 2016 has expanded into a major probe of alleged price-fixing. The case now inv..."},{"Date":"Dec. 10, 2018 at 11:31 a.m. ET","Headline":"Bearish momentum accelerates:  S&P 500 ventures under major support","Summary":"Shares of generic drug makers fell sharply Monday, after a Washington Post report that an antitrust lawsuit brought by states over two drugs in 2016 has expanded into a major probe of alleged price-fixing. The case now inv..."},{"Date":"Dec. 10, 2018 at 11:30 a.m. ET","Headline":"Generic drug makers stocks fall sharply after report of expanded price-fixing probe","Summary":"Shares of generic drug makers fell sharply Monday, after a Washington Post report that an antitrust lawsuit brought by states over two drugs in 2016 has expanded into a major probe of alleged price-fixing. The case now inv..."},{"Date":"Dec. 10, 2018 at 6:57 a.m. ET","Headline":"These stocks suffered the biggest losses of the week","Summary":""},{"Date":"Dec. 13, 2018 at 2:48 p.m. ET","Headline":"Look to these stock market sectors in 2019 instead of FAANGs and tech","Summary":""},{"Date":"Dec. 13, 2018 at 11:36 a.m. ET","Headline":"S&P 500 balks at major resistance as December bounce fades","Summary":""},{"Date":"Dec. 13, 2018 at 10:09 a.m. ET","Headline":"Three low-volatility investing strategies for a highly volatile stock market","Summary":""},{"Date":"Dec. 12, 2018 at 12:01 p.m. ET","Headline":"Regulators revive China audit dispute, but miss prime opportunity to fully explain why","Summary":""},{"Date":"Dec. 12, 2018 at 11:15 a.m. ET","Headline":"S&P 500 extends corrective bounce, major resistance (2,673) under siege","Summary":""},{"Date":"Dec. 14, 2018 at 11:17 a.m. ET","Headline":"Charting a failed technical test, S&P 500 traverses negative YTD territory","Summary":""},{"Date":"Dec. 17, 2018 at 11:42 a.m. ET","Headline":"S&P 500 reaches less-charted territory, second test of major support (2,581) underway","Summary":""},{"Date":"Dec. 16, 2018 at 10:36 a.m. ET","Headline":"These are the U.S. stock market\u2019s biggest losers this week","Summary":""},{"Date":"Dec. 19, 2018 at 4:18 p.m. ET","Headline":"Stocks tumble after Fed raises rates again, lowers expectations for hikes next year","Summary":"GlaxoSmithKline PLC (GSK.LN) said Wednesday that it will create a consumer-health-focused joint venture with U.S. drugmaker Pfizer Inc. PFE, with an eye on an eventual spinoff. The two companies will combine their consumer..."},{"Date":"Dec. 19, 2018 at 2:59 p.m. ET","Headline":"Eli Lilly Forecast Points to a Strong Year","Summary":"GlaxoSmithKline PLC (GSK.LN) said Wednesday that it will create a consumer-health-focused joint venture with U.S. drugmaker Pfizer Inc. PFE, with an eye on an eventual spinoff. The two companies will combine their consumer..."},{"Date":"Dec. 19, 2018 at 1:04 p.m. ET","Headline":"Allergan Stock Sinks, Under Armour Slips, and 4 More Midday Movers","Summary":"GlaxoSmithKline PLC (GSK.LN) said Wednesday that it will create a consumer-health-focused joint venture with U.S. drugmaker Pfizer Inc. PFE, with an eye on an eventual spinoff. The two companies will combine their consumer..."},{"Date":"Dec. 19, 2018 at 12:37 p.m. ET","Headline":"GlaxoSmithKline to Break Up After Big Deal with Pfizer","Summary":"GlaxoSmithKline PLC (GSK.LN) said Wednesday that it will create a consumer-health-focused joint venture with U.S. drugmaker Pfizer Inc. PFE, with an eye on an eventual spinoff. The two companies will combine their consumer..."},{"Date":"Dec. 19, 2018 at 11:40 a.m. ET","Headline":"S&P 500 establishes near-term floor, bounces modestly ahead of Fed","Summary":"GlaxoSmithKline PLC (GSK.LN) said Wednesday that it will create a consumer-health-focused joint venture with U.S. drugmaker Pfizer Inc. PFE, with an eye on an eventual spinoff. The two companies will combine their consumer..."},{"Date":"Dec. 19, 2018 at 9:31 a.m. ET","Headline":"Brace for a sudden, sharp rally for the S&P 500 in 2019, says strategist David Bianco","Summary":"GlaxoSmithKline PLC (GSK.LN) said Wednesday that it will create a consumer-health-focused joint venture with U.S. drugmaker Pfizer Inc. PFE, with an eye on an eventual spinoff. The two companies will combine their consumer..."},{"Date":"Dec. 19, 2018 at 8:40 a.m. ET","Headline":"Heavyweight GlaxoSmithKline soars on deal news, helping drive FTSE 100 gains","Summary":"GlaxoSmithKline PLC (GSK.LN) said Wednesday that it will create a consumer-health-focused joint venture with U.S. drugmaker Pfizer Inc. PFE, with an eye on an eventual spinoff. The two companies will combine their consumer..."},{"Date":"Dec. 19, 2018 at 8:29 a.m. ET","Headline":"FedEx Falls, Glaxo Gains as Stocks Rise, Awaiting Word From Fed","Summary":"GlaxoSmithKline PLC (GSK.LN) said Wednesday that it will create a consumer-health-focused joint venture with U.S. drugmaker Pfizer Inc. PFE, with an eye on an eventual spinoff. The two companies will combine their consumer..."},{"Date":"Dec. 19, 2018 at 8:12 a.m. ET","Headline":"Italy leads European markets higher; investors hope for a dovish Fed hike","Summary":"GlaxoSmithKline PLC (GSK.LN) said Wednesday that it will create a consumer-health-focused joint venture with U.S. drugmaker Pfizer Inc. PFE, with an eye on an eventual spinoff. The two companies will combine their consumer..."},{"Date":"Dec. 19, 2018 at 2:38 a.m. ET","Headline":"GlaxoSmithKline, Pfizer team up on consumer health","Summary":"GlaxoSmithKline PLC (GSK.LN) said Wednesday that it will create a consumer-health-focused joint venture with U.S. drugmaker Pfizer Inc. PFE, with an eye on an eventual spinoff. The two companies will combine their consumer..."},{"Date":"Dec. 18, 2018 at 12:42 p.m. ET","Headline":"Charting a falling-knife backdrop, S&P 500 confirms primary downtrend","Summary":""},{"Date":"Dec. 18, 2018 at 12:07 p.m. ET","Headline":"Charting a falling-knife backdrop, S&P 500 confirms primary downtrend","Summary":""},{"Date":"Dec. 21, 2018 at 3:14 p.m. ET","Headline":"Perrigo Tumbles 27% After Getting Slapped With a $1.8 Billion Tax Bill","Summary":""},{"Date":"Dec. 21, 2018 at 12:05 p.m. ET","Headline":"Charting the December carnage, S&P 500 tags the 2,450 target","Summary":""},{"Date":"Dec. 20, 2018 at 11:57 a.m. ET","Headline":"Falling-knife backdrop persists, S&P 500 extends to less-charted territory","Summary":""},{"Date":"Dec. 20, 2018 at 9:55 a.m. ET","Headline":"Eli Lilly and Pfizer Are Boosting Dividends","Summary":""},{"Date":"Dec. 20, 2018 at 6:48 a.m. ET","Headline":"Powell party pooper: Here are the worst-performing stocks after the Fed wrecks the market","Summary":""},{"Date":"Dec. 23, 2018 at 1:59 p.m. ET","Headline":"There will be \u2018plenty of opportunity\u2019 for investors in 2019, says manager of $74 billion Franklin Income Fund","Summary":""},{"Date":"Dec. 21, 2018 at 8:00 p.m. ET","Headline":"The Right Rx for Health-Care Investors","Summary":""},{"Date":"Dec. 27, 2018 at 5:03 a.m. ET","Headline":"The road to homeownership: buying a house in Philadelphia","Summary":""},{"Date":"Dec. 31, 2018 at 9:57 a.m. ET","Headline":"Countdown to 2019: Lessons From the Dow\u2019s Painful Year","Summary":""},{"Date":"Dec. 31, 2018 at 6:30 a.m. ET","Headline":"Merck Stock Was the Best in the Dow in 2018 \u2014 by Far","Summary":""},{"Date":"Dec. 31, 2018 at 5:30 a.m. ET","Headline":"Pfizer Stock Withstood a Health Care Sector Stumble to Be a 2018 Winner","Summary":""},{"Date":"Jan. 2, 2019 at 2:46 p.m. ET","Headline":"Biotech Stocks in 2019 May Be Facing Another Tough Year","Summary":""},{"Date":"Jan. 2, 2019 at 12:07 p.m. ET","Headline":"Charting a \u2018near-term\u2019 rally attempt, S&P 500 rises amid major technical damage","Summary":""},{"Date":"Jan. 2, 2019 at 10:48 a.m. ET","Headline":"Bausch Stock Is Soaring After an Analyst Upgrade","Summary":""},{"Date":"Jan. 1, 2019 at 8:35 p.m. ET","Headline":"Dozens of pharmaceutical makers raise prices on hundreds of drugs to ring in the new year","Summary":""},{"Date":"Jan. 4, 2019 at 11:37 a.m. ET","Headline":"S&P 500 back for second crack at resistance (2,520) amid Fed-fueled rally attempt","Summary":""},{"Date":"Jan. 4, 2019 at 7:21 a.m. ET","Headline":"These are the top stock picks for 2019 among Wall Street analysts","Summary":""},{"Date":"Jan. 3, 2019 at 11:56 a.m. ET","Headline":"S&P 500 nails resistance (2,520), pulls in amid Apple-fueled volatility","Summary":""},{"Date":"Jan. 3, 2019 at 9:27 a.m. ET","Headline":"The best and worst stocks of 2018","Summary":""},{"Date":"Jan. 5, 2019 at 12:10 p.m. ET","Headline":"The biggest stock-market winners and losers on the best day for jobs news in 10 months","Summary":""},{"Date":"Jan. 8, 2019 at 12:23 p.m. ET","Headline":"Charting a bull-bear battleground:  S&P 500, Nasdaq nail major resistance","Summary":""},{"Date":"Jan. 8, 2019 at 11:57 a.m. ET","Headline":"Charting a bull-bear battleground:  S&P 500, Nasdaq nail major resistance","Summary":""},{"Date":"Jan. 7, 2019 at 11:39 a.m. ET","Headline":"Second 20-to-1 up day strengthens S&P 500\u2019s \u2018near-term\u2019 recovery attempt","Summary":""},{"Date":"Jan. 10, 2019 at 11:58 a.m. ET","Headline":"Charting a bullish divergence:  Nasdaq reclaims the breakdown point","Summary":""},{"Date":"Jan. 9, 2019 at 11:31 a.m. ET","Headline":"2 Consumer-Staples Stocks That Could Break Out","Summary":""},{"Date":"Jan. 9, 2019 at 11:29 a.m. ET","Headline":"Charting a bull-bear stalemate:  S&P 500 hesitates at major resistance (2,581)","Summary":""},{"Date":"Jan. 11, 2019 at 4:43 p.m. ET","Headline":"Here are the best Dow and S&P stocks so far in 2019","Summary":""},{"Date":"Jan. 11, 2019 at 11:51 a.m. ET","Headline":"S&P 500 edges atop major resistance (2,581) amid persistent January rally attempt","Summary":""},{"Date":"Jan. 14, 2019 at 12:55 p.m. ET","Headline":"House Democrats launch probe into drug prices","Summary":"Pfizer Inc's  two new drug applications for tafamidis for the treatment of a fatal heart condition have been accepted for filing by the U.S. Food and Drug Administration, the company announced Monday. Pfizer submitted the ..."},{"Date":"Jan. 14, 2019 at 11:19 a.m. ET","Headline":"Charting a near-term holding pattern, S&P 500 digests January gains","Summary":"Pfizer Inc's  two new drug applications for tafamidis for the treatment of a fatal heart condition have been accepted for filing by the U.S. Food and Drug Administration, the company announced Monday. Pfizer submitted the ..."},{"Date":"Jan. 14, 2019 at 8:56 a.m. ET","Headline":"Pfizer's new drug applications for tafamidis accepted for filing by FDA","Summary":"Pfizer Inc's  two new drug applications for tafamidis for the treatment of a fatal heart condition have been accepted for filing by the U.S. Food and Drug Administration, the company announced Monday. Pfizer submitted the ..."},{"Date":"Jan. 16, 2019 at 11:51 a.m. ET","Headline":"Bull case strengthens, Nasdaq reclaims the 50-day average","Summary":""},{"Date":"Jan. 15, 2019 at 4:48 p.m. ET","Headline":"Here\u2019s your guide to the upcoming biotechnology takeover wave","Summary":""},{"Date":"Jan. 15, 2019 at 12:18 p.m. ET","Headline":"Charting a bull flag:  S&P 500, Nasdaq maintain major support","Summary":""},{"Date":"Jan. 15, 2019 at 11:46 a.m. ET","Headline":"Charting a bull flag:  S&P 500, Nasdaq maintain major support","Summary":""},{"Date":"Jan. 11, 2019 at 6:00 a.m. ET","Headline":"For Strong Returns, Try Stock in Top Spenders on R&D","Summary":""},{"Date":"Jan. 18, 2019 at 7:52 p.m. ET","Headline":"Marching Toward the Madness","Summary":""},{"Date":"Jan. 18, 2019 at 11:50 a.m. ET","Headline":"Bull case strengthens (again), S&P 500 signals intermediate-term \u2018trend\u2019 shift","Summary":""},{"Date":"Jan. 17, 2019 at 11:44 a.m. ET","Headline":"Charting a persistent rally attempt, S&P 500 nails major resistance","Summary":""},{"Date":"Jan. 22, 2019 at 1:05 p.m. ET","Headline":"S&P 500 reaches firmer technical ground, pulls in from major resistance","Summary":""},{"Date":"Jan. 22, 2019 at 12:32 p.m. ET","Headline":"S&P 500 reaches firmer technical ground, pulls in from major resistance","Summary":""},{"Date":"Jan. 24, 2019 at 11:11 a.m. ET","Headline":"Charting a successful technical test, S&P 500 maintains major support","Summary":""},{"Date":"Jan. 23, 2019 at 4:25 p.m. ET","Headline":"Big Pharma Stocks Were Downgraded by Analysts Today","Summary":""},{"Date":"Jan. 23, 2019 at 12:01 p.m. ET","Headline":"S&P 500 retests major support (2,631) as first January selling pressure surfaces","Summary":""},{"Date":"Jan. 23, 2019 at 8:23 a.m. ET","Headline":"IBM, P&G, United Technologies Earnings Lift Dow Above a Sea of Troubles","Summary":""},{"Date":"Jan. 25, 2019 at 8:11 p.m. ET","Headline":"Investors Remain Upbeat\u2014for Now\u2014as Housing Data Dive","Summary":""},{"Date":"Jan. 28, 2019 at 10:54 a.m. ET","Headline":"Don\u2019t worry, Mr. President, the media is about to pay a lot more attention to earnings","Summary":""},{"Date":"Jan. 27, 2019 at 5:05 p.m. ET","Headline":"In turnaround, Pfizer pins growth on cancer drugs","Summary":""},{"Date":"Jan. 27, 2019 at 4:00 p.m. ET","Headline":"A Slew of Earnings This Week: GE, Apple, Facebook, Amazon","Summary":""},{"Date":"Jan. 30, 2019 at 8:30 p.m. ET","Headline":"Here are the biggest stock winners on the day the Fed went soft on interest rates","Summary":"The shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings ahead of the open would add about a combined 11 points to the Dow's price. Dow futures  were last up 35 points. Shares ..."},{"Date":"Jan. 30, 2019 at 9:31 a.m. ET","Headline":"The \u2018dangerous\u2019 game investors are playing in this wild earnings season","Summary":"The shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings ahead of the open would add about a combined 11 points to the Dow's price. Dow futures  were last up 35 points. Shares ..."},{"Date":"Jan. 30, 2019 at 7:00 a.m. ET","Headline":"New Jersey\u2019s College Savings Plan Bought Up AT&T, Amazon, and GM Stock","Summary":"The shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings ahead of the open would add about a combined 11 points to the Dow's price. Dow futures  were last up 35 points. Shares ..."},{"Date":"Jan. 29, 2019 at 4:35 p.m. ET","Headline":"Stocks end mostly lower on big day for earnings","Summary":"The shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings ahead of the open would add about a combined 11 points to the Dow's price. Dow futures  were last up 35 points. Shares ..."},{"Date":"Jan. 29, 2019 at 12:17 p.m. ET","Headline":"The Dow Rises 76 Points Because Corporate Earnings Are Only So-So","Summary":"The shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings ahead of the open would add about a combined 11 points to the Dow's price. Dow futures  were last up 35 points. Shares ..."},{"Date":"Jan. 29, 2019 at 10:40 a.m. ET","Headline":"Pfizer\u2019s \u2018Promising Outlook\u2019 Still Shines for Analysts After Earnings Report","Summary":"The shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings ahead of the open would add about a combined 11 points to the Dow's price. Dow futures  were last up 35 points. Shares ..."},{"Date":"Jan. 29, 2019 at 10:26 a.m. ET","Headline":"Harley-Davidson hits rough road, and now all eyes move to Apple","Summary":"The shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings ahead of the open would add about a combined 11 points to the Dow's price. Dow futures  were last up 35 points. Shares ..."},{"Date":"Jan. 29, 2019 at 9:41 a.m. ET","Headline":"The global dominators you invest in when Apple and the chips are down","Summary":"The shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings ahead of the open would add about a combined 11 points to the Dow's price. Dow futures  were last up 35 points. Shares ..."},{"Date":"Jan. 29, 2019 at 9:37 a.m. ET","Headline":"An earnings tsunami \u2014 with 113 S&P 500 components \u2014 marks \u2018pivot point\u2019 for stock market","Summary":"The shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings ahead of the open would add about a combined 11 points to the Dow's price. Dow futures  were last up 35 points. Shares ..."},{"Date":"Jan. 29, 2019 at 9:25 a.m. ET","Headline":"Dow earnings reporters' stocks would boost Dow's price by 11 points","Summary":"The shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings ahead of the open would add about a combined 11 points to the Dow's price. Dow futures  were last up 35 points. Shares ..."},{"Date":"Jan. 29, 2019 at 6:58 a.m. ET","Headline":"Pfizer shares slide 2% premarket after it swings to loss, guidance lags consensus","Summary":"Pfizer Inc. shares  slid 2% in premarket trade Tuesday, after the company posted a loss for the fourth quarter and offered guidance that was below consensus. The drugs giant said it had a net loss of $394 million, or 7 cen..."},{"Date":"Jan. 31, 2019 at 11:27 a.m. ET","Headline":"Pfizer Stock\u2019s \u2018Dark Period\u2019 Might Finally Be Over","Summary":""},{"Date":"Feb. 2, 2019 at 2:17 p.m. ET","Headline":"Pricing Pressure a Hard Pill for Pharma to Swallow","Summary":""},{"Date":"Feb. 7, 2019 at 1:47 p.m. ET","Headline":"A Setback for Solid Is a Win for Sarepta in Race to Treat Muscular Dystrophy","Summary":""},{"Date":"Feb. 6, 2019 at 1:48 p.m. ET","Headline":"Eli Lilly Stock Falls Because 2019 Isn\u2019t 2018","Summary":""},{"Date":"Feb. 8, 2019 at 11:20 a.m. ET","Headline":"Eli Lilly to Unload Its Remaining Stock in Elanco Animal Health","Summary":""},{"Date":"Feb. 8, 2019 at 5:00 a.m. ET","Headline":"Buying the Dow Stocks With the Highest Dividends Is a Winning Strategy","Summary":""},{"Date":"Feb. 11, 2019 at 11:45 a.m. ET","Headline":"Regeneron\u2019s 60% Price Cut Shows Heat Is Still on Drug Companies","Summary":""},{"Date":"Feb. 11, 2019 at 6:00 a.m. ET","Headline":"Big Pharma Wants to Borrow Cash for M&A, but Could Run Into Credit Downgrades","Summary":""},{"Date":"Feb. 13, 2019 at 7:03 a.m. ET","Headline":"Here are the stock market\u2019s biggest winners as Washington (apparently) avoids another shutdown","Summary":""},{"Date":"Feb. 12, 2019 at 1:53 p.m. ET","Headline":"The Biotech Stock Rally May Just Be Getting Started","Summary":""},{"Date":"Feb. 14, 2019 at 1:08 p.m. ET","Headline":"Zoetis Stock Gains Because People Keep Spending on Their Pets","Summary":"Shares of Cisco Systems Inc.  surged 4.2% in premarket trade Thursday, putting them on track to open at the higher level seen during regular-session hours since December 2000, after the networking giant reported . Despite ..."},{"Date":"Feb. 14, 2019 at 7:57 a.m. ET","Headline":"Cisco's stock surges toward 18-year high, would add about 14 points to Dow's price","Summary":"Shares of Cisco Systems Inc.  surged 4.2% in premarket trade Thursday, putting them on track to open at the higher level seen during regular-session hours since December 2000, after the networking giant reported . Despite ..."},{"Date":"Feb. 18, 2019 at 6:00 a.m. ET","Headline":"Big Pharma Can\u2019t Resist Big Mergers. Here\u2019s Why.","Summary":""},{"Date":"Feb. 20, 2019 at 2:02 p.m. ET","Headline":"Intercept Pharmaceuticals is one step closer to getting FDA approval for the first-ever NASH drug","Summary":""},{"Date":"Feb. 25, 2019 at 12:00 p.m. ET","Headline":"Dow\u2019s Best-Performing Stock in 2018 Gets Vote of Confidence","Summary":""},{"Date":"Feb. 25, 2019 at 11:17 a.m. ET","Headline":"Gene-therapy stocks surge on Roche-Spark deal","Summary":""},{"Date":"Feb. 7, 2019 at 11:43 a.m. ET","Headline":"4 Health-Care Stocks With Hefty Dividends","Summary":""},{"Date":"Feb. 26, 2019 at 2:48 p.m. ET","Headline":"Drugmakers\u2019 CEOs clash with senators in hearing on drug price hikes","Summary":""},{"Date":"Feb. 26, 2019 at 10:34 a.m. ET","Headline":"The $1 reason to keep buying one of the S&P\u2019s hottest stocks: Netflix","Summary":""},{"Date":"Feb. 26, 2019 at 9:45 a.m. ET","Headline":"Drugmakers\u2019 CEOs set to get grilled at Senate hearing on rising drug prices","Summary":""},{"Date":"Feb. 26, 2019 at 8:22 a.m. ET","Headline":"Curtain rises on 3 days of Michael Cohen drama | Republican senator says he\u2019ll vote against Trump\u2019s border emergency","Summary":""},{"Date":"Feb. 1, 2019 at 8:00 p.m. ET","Headline":"Corning Stock Still Looks Like a Buy, on Strong 2019 Outlook","Summary":""},{"Date":"Jan. 11, 2019 at 8:00 p.m. ET","Headline":"Why Bristol-Myers Squibb Can Be a Sweet Pill for Investors","Summary":""},{"Date":"Mar. 11, 2019 at 3:41 p.m. ET","Headline":"Allergan Stock Could Get a Boost From a Company Breakup, Analyst Says","Summary":""},{"Date":"Mar. 12, 2019 at 5:26 p.m. ET","Headline":"5 rock-solid ETFs for an uncertain 2019 stock market","Summary":""},{"Date":"Mar. 12, 2019 at 12:49 p.m. ET","Headline":"Prescription drug prices aren\u2019t rising \u2014 they\u2019re falling for the first time in 47 years","Summary":""},{"Date":"Mar. 12, 2019 at 7:53 a.m. ET","Headline":"Here are Monday\u2019s stock-market winners after five-day losing streak is broken","Summary":""},{"Date":"Mar. 14, 2019 at 6:00 a.m. ET","Headline":"The Top 5 Actively Managed Dividend Funds","Summary":""},{"Date":"Mar. 18, 2019 at 1:36 p.m. ET","Headline":"Big Pharma Earnings Might Not Be as Good as They Look","Summary":""},{"Date":"Mar. 18, 2019 at 12:26 p.m. ET","Headline":"Gilead Sciences Increased Some Drug Prices. Why That\u2019s Good News and Bad News for the Stock.","Summary":""},{"Date":"Mar. 20, 2019 at 2:55 p.m. ET","Headline":"Allergan Stock Won\u2019t Benefit From a Breakup, Analyst Says","Summary":"Merck KGaA, Darmstadt, Germany (MRK.XE), and Pfizer Inc. PFE said Wednesday they discontinued the Phase III JAVELIN Ovarian PARP 100 study. The study was evaluating avelumab in combination with chemotherapy followed by mai..."},{"Date":"Mar. 20, 2019 at 12:55 p.m. ET","Headline":"Merck KGaA, Pfizer end ovarian cancer trial","Summary":"Merck KGaA, Darmstadt, Germany (MRK.XE), and Pfizer Inc. PFE said Wednesday they discontinued the Phase III JAVELIN Ovarian PARP 100 study. The study was evaluating avelumab in combination with chemotherapy followed by mai..."},{"Date":"Mar. 20, 2019 at 9:14 a.m. ET","Headline":"General Mills Stock Gains, FedEx Drops, and 3 More Wednesday Morning Movers","Summary":"Pfizer Inc.  said Wednesday it has paid 45 million euro, or the equivalent of $51 million to acquire a 15% equity stake in privately held gene therapy company Vivet Therapeutics, and has acquired an option to buy the rest ..."},{"Date":"Mar. 20, 2019 at 7:20 a.m. ET","Headline":"Pfizer acquires option to buy Vivet Therapeutics for equivalent of $635.8 million","Summary":"Pfizer Inc.  said Wednesday it has paid 45 million euro, or the equivalent of $51 million to acquire a 15% equity stake in privately held gene therapy company Vivet Therapeutics, and has acquired an option to buy the rest ..."},{"Date":"Mar. 25, 2019 at 10:56 a.m. ET","Headline":"Allergan Stock Is Falling Because It\u2019s Facing Off With an Activist Investor","Summary":""},{"Date":"Mar. 25, 2019 at 8:49 a.m. ET","Headline":"5 biotech stocks that could be the next big winners","Summary":""},{"Date":"Mar. 24, 2019 at 9:25 a.m. ET","Headline":"Stocks took a big hit Friday, and these shares fell the most","Summary":""},{"Date":"Mar. 27, 2019 at 10:25 a.m. ET","Headline":"Pfizer Stock Will Gain Because Its Pipeline Has Promise, Analyst Says","Summary":""},{"Date":"Mar. 26, 2019 at 1:37 p.m. ET","Headline":"Wall Street is ditching amyloid-based Alzheimer\u2019s drugs \u2014 it shouldn't, scientists say","Summary":""},{"Date":"Mar. 29, 2019 at 3:23 p.m. ET","Headline":"Wall Street is buzzing about Gilead\u2019s rheumatoid arthritis drug. Here\u2019s why","Summary":""},{"Date":"Mar. 29, 2019 at 10:53 a.m. ET","Headline":"Celgene Stock Is Surging After ISS Backs Bristol Deal","Summary":""},{"Date":"Mar. 29, 2019 at 8:34 p.m. ET","Headline":"There Are Animal Spirits in This Health-Care Business","Summary":""},{"Date":"Apr. 2, 2019 at 3:06 p.m. ET","Headline":"You Can Play the Flurry of M&A With Merger Arbitrage Funds. Here\u2019s How They Work.","Summary":"Shares of Sangamo Therapeutics Inc.  soared 27% in premarket trade Tuesday, after the genomic medicine company and Pfizer Inc.  announced \"encouraging\" results from a phase 1\/2 study of SB-525 gene therapy for the treatmen..."},{"Date":"Apr. 2, 2019 at 11:15 a.m. ET","Headline":"AstraZeneca May Not Have the Cash Flow to Pull Off Its Big Expansion","Summary":"Shares of Sangamo Therapeutics Inc.  soared 27% in premarket trade Tuesday, after the genomic medicine company and Pfizer Inc.  announced \"encouraging\" results from a phase 1\/2 study of SB-525 gene therapy for the treatmen..."},{"Date":"Apr. 2, 2019 at 8:10 a.m. ET","Headline":"Sangamo's stock soars after upbeat trial data for hemophilia treatment","Summary":"Shares of Sangamo Therapeutics Inc.  soared 27% in premarket trade Tuesday, after the genomic medicine company and Pfizer Inc.  announced \"encouraging\" results from a phase 1\/2 study of SB-525 gene therapy for the treatmen..."},{"Date":"Apr. 3, 2019 at 4:41 a.m. ET","Headline":"Micron Technology, Tencent and two dozen other companies most likely to benefit from a China trade deal","Summary":""},{"Date":"Apr. 11, 2019 at 2:57 p.m. ET","Headline":"What \u2018Medicare for All\u2019 would do to the  health-care sector","Summary":""},{"Date":"Apr. 11, 2019 at 8:25 a.m. ET","Headline":"Brexit: What it means for U.S. banks, car makers, drug companies","Summary":""},{"Date":"Apr. 11, 2019 at 7:30 a.m. ET","Headline":"A Giant U.K. Pension Fund Is Making Big Bets on Verizon, Home Depot, J&J, and Mastercard Stock","Summary":""},{"Date":"Apr. 18, 2019 at 6:37 p.m. ET","Headline":"Pfizer, Lilly shares decline as osteoarthritis drug misses goals in study","Summary":"Shares of drug makers Pfizer Inc.  and Eli Lilly & Co.  declined in the extended session Thursday after the companies said a clinical study of an osteoarthritis drug didn't meet certain goals. Pfizer shares declined 1% aft..."},{"Date":"Apr. 18, 2019 at 7:26 a.m. ET","Headline":"5 things to know about Hookipa Pharma ahead of its IPO","Summary":""},{"Date":"Apr. 18, 2019 at 7:20 a.m. ET","Headline":"Health-care stocks keep getting hammered \u2014 Wall Street says this is why","Summary":""},{"Date":"Apr. 19, 2019 at 9:27 a.m. ET","Headline":"Health-care drama has now spread to biopharma stocks","Summary":""},{"Date":"Apr. 22, 2019 at 12:09 p.m. ET","Headline":"Amazon, Facebook, Microsoft, and More Stocks to Watch This Week","Summary":""},{"Date":"Apr. 19, 2019 at 6:52 p.m. ET","Headline":"What\u2019s in a Name? Trouble for Some Would-Be Zoom Video Buyers","Summary":""},{"Date":"Apr. 23, 2019 at 2:14 p.m. ET","Headline":"12 ways to make your workplace more inclusive of transgender people","Summary":""},{"Date":"Apr. 25, 2019 at 7:00 a.m. ET","Headline":"Investec Sells Broadcom Stock and Doubles Down on Alibaba","Summary":""},{"Date":"Apr. 30, 2019 at 4:22 p.m. ET","Headline":"S&P 500 ekes out third straight record close; Nasdaq retreats after Google revenue miss","Summary":"Johnson & Johnson's (JNJ) Janssen Pharmaceutical Cos. unit and ViiV Healthcare on Monday said ViiV has filed a new-drug application with the U.S. Food and Drug Administration for the combination of Janssen's rilpivirine an..."},{"Date":"Apr. 30, 2019 at 10:24 a.m. ET","Headline":"GE\u2019s free-cash improvement might not be all that, Apple still has a China problem","Summary":"Johnson & Johnson's (JNJ) Janssen Pharmaceutical Cos. unit and ViiV Healthcare on Monday said ViiV has filed a new-drug application with the U.S. Food and Drug Administration for the combination of Janssen's rilpivirine an..."},{"Date":"Apr. 30, 2019 at 10:20 a.m. ET","Headline":"Merck and Pfizer Stock Rise but Eli Lilly Slips as Big Pharma Earnings Roll in","Summary":"Johnson & Johnson's (JNJ) Janssen Pharmaceutical Cos. unit and ViiV Healthcare on Monday said ViiV has filed a new-drug application with the U.S. Food and Drug Administration for the combination of Janssen's rilpivirine an..."},{"Date":"Apr. 30, 2019 at 9:52 a.m. ET","Headline":"Fed and tech stocks could crack the market rally, warns Wall Street strategist","Summary":"Johnson & Johnson's (JNJ) Janssen Pharmaceutical Cos. unit and ViiV Healthcare on Monday said ViiV has filed a new-drug application with the U.S. Food and Drug Administration for the combination of Janssen's rilpivirine an..."},{"Date":"Apr. 30, 2019 at 7:05 a.m. ET","Headline":"Dow Futures Are Going Nowhere but General Electric Is Soaring Following Earnings","Summary":"Johnson & Johnson's (JNJ) Janssen Pharmaceutical Cos. unit and ViiV Healthcare on Monday said ViiV has filed a new-drug application with the U.S. Food and Drug Administration for the combination of Janssen's rilpivirine an..."},{"Date":"Apr. 30, 2019 at 5:32 a.m. ET","Headline":"Today Is Earnings Day for Big Pharma. Here\u2019s What to Watch.","Summary":"Johnson & Johnson's (JNJ) Janssen Pharmaceutical Cos. unit and ViiV Healthcare on Monday said ViiV has filed a new-drug application with the U.S. Food and Drug Administration for the combination of Janssen's rilpivirine an..."},{"Date":"Apr. 29, 2019 at 4:45 p.m. ET","Headline":"Insulin-maker Eli Lilly is scheduled to report earnings Tuesday. Here\u2019s what to expect","Summary":"Johnson & Johnson's (JNJ) Janssen Pharmaceutical Cos. unit and ViiV Healthcare on Monday said ViiV has filed a new-drug application with the U.S. Food and Drug Administration for the combination of Janssen's rilpivirine an..."},{"Date":"Apr. 29, 2019 at 1:42 p.m. ET","Headline":"Beaten-down health-care companies join Apple and Google in earnings parade","Summary":"Johnson & Johnson's (JNJ) Janssen Pharmaceutical Cos. unit and ViiV Healthcare on Monday said ViiV has filed a new-drug application with the U.S. Food and Drug Administration for the combination of Janssen's rilpivirine an..."},{"Date":"Apr. 29, 2019 at 1:41 p.m. ET","Headline":"Merck is reporting earnings on Tuesday. Here\u2019s what to expect","Summary":"Johnson & Johnson's (JNJ) Janssen Pharmaceutical Cos. unit and ViiV Healthcare on Monday said ViiV has filed a new-drug application with the U.S. Food and Drug Administration for the combination of Janssen's rilpivirine an..."},{"Date":"Apr. 29, 2019 at 11:35 a.m. ET","Headline":"Sen. Tina Smith Sells Entire Abbott Stock Investment","Summary":"Johnson & Johnson's (JNJ) Janssen Pharmaceutical Cos. unit and ViiV Healthcare on Monday said ViiV has filed a new-drug application with the U.S. Food and Drug Administration for the combination of Janssen's rilpivirine an..."},{"Date":"Apr. 29, 2019 at 7:50 a.m. ET","Headline":"ViiV seeks approval for injectable HIV treatment","Summary":"Johnson & Johnson's (JNJ) Janssen Pharmaceutical Cos. unit and ViiV Healthcare on Monday said ViiV has filed a new-drug application with the U.S. Food and Drug Administration for the combination of Janssen's rilpivirine an..."},{"Date":"Apr. 29, 2019 at 6:35 a.m. ET","Headline":"Apple, Google, GE, and More Stocks to Watch This Week","Summary":""},{"Date":"Apr. 29, 2019 at 6:28 a.m. ET","Headline":"A tale of two earnings seasons: The stocks hit by weak global growth and those that are immune","Summary":""},{"Date":"May. 2, 2019 at 1:21 p.m. ET","Headline":"These 6 biotech stocks are promising takeover targets","Summary":"GlaxoSmithKline PLC (GSK.LN) said Wednesday that pretax profit rose 17% in the first quarter as the British pharmaceutical major beat analyst expectations at both the top and bottom line. Profit before tax for the quarter ..."},{"Date":"May. 1, 2019 at 10:59 a.m. ET","Headline":"Qualcomm Stock Investors Are Benefiting From the New Tax Law","Summary":"GlaxoSmithKline PLC (GSK.LN) said Wednesday that pretax profit rose 17% in the first quarter as the British pharmaceutical major beat analyst expectations at both the top and bottom line. Profit before tax for the quarter ..."},{"Date":"May. 1, 2019 at 8:26 a.m. ET","Headline":"GlaxoSmithKline earnings top estimates","Summary":"GlaxoSmithKline PLC (GSK.LN) said Wednesday that pretax profit rose 17% in the first quarter as the British pharmaceutical major beat analyst expectations at both the top and bottom line. Profit before tax for the quarter ..."},{"Date":"May. 6, 2019 at 10:43 a.m. ET","Headline":"Here are the biggest stock-market losers after Trump threatens more tariffs","Summary":""},{"Date":"May. 9, 2019 at 1:10 p.m. ET","Headline":"Here are this week\u2019s biggest stock-market losers as Trump\u2019s trade war on China continues","Summary":""},{"Date":"May. 14, 2019 at 10:07 a.m. ET","Headline":"Here are the stocks to buy if an all-out U.S.-China trade war erupts, says Goldman","Summary":""},{"Date":"May. 14, 2019 at 7:08 a.m. ET","Headline":"Here are Monday\u2019s worst stock-market performers as U.S.-China trade dispute escalates","Summary":""},{"Date":"May. 13, 2019 at 2:59 p.m. ET","Headline":"Stocks of generic drug companies fall after more than 40 states file suit alleging price fixing","Summary":""},{"Date":"May. 13, 2019 at 2:47 p.m. ET","Headline":"Teva Stock Is Sinking as a Lawsuit Alleges a Drug-Pricing Conspiracy","Summary":""},{"Date":"May. 13, 2019 at 2:29 p.m. ET","Headline":"Most of the profit in the health-care industry is going to drug companies \u2014 here\u2019s why you should care","Summary":""},{"Date":"May. 20, 2019 at 12:31 p.m. ET","Headline":"Drugmakers\u2019 lobbying spending at 10-year high as Washington targets soaring prices","Summary":""},{"Date":"May. 21, 2019 at 2:07 p.m. ET","Headline":"Could drug-price transparency raise prices? These lobbyists and lawmakers think so","Summary":""},{"Date":"May. 24, 2019 at 4:20 p.m. ET","Headline":"Pfizer's Lyrica doesn't meet endpoint in epilepsy study","Summary":"Pfizer Inc.  said late Friday one of its drugs did not meet set goals for the treatment of epilepsy in a late stage clinical trial. Pfizer said a Phase 3 clinical trial showed its drug Lyrica did not significantly reduce s..."},{"Date":"May. 29, 2019 at 9:52 a.m. ET","Headline":"Pro-choice groups lost in Alabama despite outspending the pro-life side by 100-to-1","Summary":""},{"Date":"May. 29, 2019 at 7:47 a.m. ET","Headline":"Teva stock downgraded to neutral by UBS on heels of $85 million opioid settlement","Summary":""},{"Date":"May. 29, 2019 at 7:45 a.m. ET","Headline":"Pfizer, Eli Lilly, Bristol-Myer and J&J initiated with buy ratings by Goldman Sachs","Summary":""},{"Date":"Jun. 5, 2019 at 4:11 a.m. ET","Headline":"JAMA study: The cost of brand-name prescription drugs doubles every 7 to 8 years","Summary":""},{"Date":"Jun. 7, 2019 at 7:00 a.m. ET","Headline":"How Funds That Chase the Hottest Stocks Can Still Lag Behind","Summary":""},{"Date":"Jun. 10, 2019 at 3:07 p.m. ET","Headline":"Investors Should Be Wary of United Technologies\u2019 Spinoffs and the Raytheon Merger","Summary":""},{"Date":"Jun. 14, 2019 at 10:07 a.m. ET","Headline":"Merck Plans Its First Investor Day in 5 Years. Here\u2019s What to Watch.","Summary":""},{"Date":"Jun. 17, 2019 at 5:31 p.m. ET","Headline":"The Dow Is Treading Lightly Ahead of an Expected Fed Rate Cut","Summary":"U.S. stocks struggled for direction on Monday after the opening bell as investors hoped to glean clues from the Federal Reserve later this week on the likelihood of rate cuts this year. The S&P 500  was up less than 0.1% t..."},{"Date":"Jun. 17, 2019 at 4:17 p.m. ET","Headline":"Stocks close higher as social media, real estate shares lead","Summary":"U.S. stocks struggled for direction on Monday after the opening bell as investors hoped to glean clues from the Federal Reserve later this week on the likelihood of rate cuts this year. The S&P 500  was up less than 0.1% t..."},{"Date":"Jun. 17, 2019 at 3:23 p.m. ET","Headline":"Pfizer Is Buying Array BioPharma, Seeking to Broaden Lineup of Cancer Drugs","Summary":"U.S. stocks struggled for direction on Monday after the opening bell as investors hoped to glean clues from the Federal Reserve later this week on the likelihood of rate cuts this year. The S&P 500  was up less than 0.1% t..."},{"Date":"Jun. 17, 2019 at 3:20 p.m. ET","Headline":"Pfizer Is the Latest Drug Company to Put Its Credit Rating at Risk With M&A","Summary":"U.S. stocks struggled for direction on Monday after the opening bell as investors hoped to glean clues from the Federal Reserve later this week on the likelihood of rate cuts this year. The S&P 500  was up less than 0.1% t..."},{"Date":"Jun. 17, 2019 at 9:49 a.m. ET","Headline":"Pfizer to buy cancer dug maker Array BioPharma for $10.64 billion","Summary":"U.S. stocks struggled for direction on Monday after the opening bell as investors hoped to glean clues from the Federal Reserve later this week on the likelihood of rate cuts this year. The S&P 500  was up less than 0.1% t..."},{"Date":"Jun. 17, 2019 at 9:35 a.m. ET","Headline":"Stocks mixed as Fed meeting comes into view","Summary":"U.S. stocks struggled for direction on Monday after the opening bell as investors hoped to glean clues from the Federal Reserve later this week on the likelihood of rate cuts this year. The S&P 500  was up less than 0.1% t..."},{"Date":"Jun. 17, 2019 at 9:32 a.m. ET","Headline":"Dish Stock Is Up as the Dow Squeaks Higher","Summary":"Shares of Array BioPharma Inc.  rocketed 56% toward a record high in premarket trading Monday, after biopharmaceutical company developing cancer treatments agreed to be acquired by Pfizer Inc.  in a deal valued at $11.4 bi..."},{"Date":"Jun. 17, 2019 at 6:56 a.m. ET","Headline":"Array BioPharma's stock rockets after $11.4 billion buyout deal with Pfizer","Summary":"Shares of Array BioPharma Inc.  rocketed 56% toward a record high in premarket trading Monday, after biopharmaceutical company developing cancer treatments agreed to be acquired by Pfizer Inc.  in a deal valued at $11.4 bi..."},{"Date":"Jun. 18, 2019 at 7:09 a.m. ET","Headline":"Shares of cancer-therapy companies skyrocket after Pfizer acquisition news","Summary":""},{"Date":"Jun. 24, 2019 at 6:00 a.m. ET","Headline":"The U.S. Gets Hundreds of Millions From Big Pharma in Co-Pay Settlements","Summary":""},{"Date":"Jun. 28, 2019 at 10:55 a.m. ET","Headline":"Former FDA Commissioner Scott Gottlieb joins Pfizer's board of directors","Summary":"Former U.S. Food and Drug Administration Commissioner Scott Gottlieb has joined the board of directors at Pfizer Inc. , the company announced Thursday. He was also appointed to the board's regulatory and compliance committ..."},{"Date":"Jun. 28, 2019 at 7:49 a.m. ET","Headline":"Pfizer says FDA has approved its oncology biosimilar Zirabev to treat 5 types of cancer","Summary":"Pfizer Inc.  said Friday the U.S. Food and Drug Administration has approved its oncology biosimilar Zirabev for the treatment of five types of cancer. The FDA has approved the drug to treat metastatic colorectal cancer, un..."},{"Date":"Jul. 1, 2019 at 4:21 p.m. ET","Headline":"S&P 500 settles below intraday high sparked by U.S.-China trade truce","Summary":"Cosmetics maker to take $3 billion write-down on P&G brands it bought three years ago"},{"Date":"Jul. 1, 2019 at 3:24 p.m. ET","Headline":"Struggling Beauty Giant Coty to Restructure Operations","Summary":"Cosmetics maker to take $3 billion write-down on P&G brands it bought three years ago"},{"Date":"Jul. 1, 2019 at 1:46 p.m. ET","Headline":"Here are the stock market\u2019s winners and losers in the first half of 2019","Summary":"Shares of Pfizer Inc.  ticked up 1.2% in premarket trade Monday after the drugmaker said a Phase 4 study showed that an eczema treatment was well-tolerated in babies between 3 months and two years of age when used over a p..."},{"Date":"Jul. 1, 2019 at 10:11 a.m. ET","Headline":"Sarepta Therapeutics Stock Could Capitalize From Pfizer\u2019s Stumble","Summary":"Shares of Pfizer Inc.  ticked up 1.2% in premarket trade Monday after the drugmaker said a Phase 4 study showed that an eczema treatment was well-tolerated in babies between 3 months and two years of age when used over a p..."},{"Date":"Jul. 1, 2019 at 8:27 a.m. ET","Headline":"Pfizer stock up 1.2% premarket after drugmaker announces positive results from Phase 4 eczema study","Summary":"Shares of Pfizer Inc.  ticked up 1.2% in premarket trade Monday after the drugmaker said a Phase 4 study showed that an eczema treatment was well-tolerated in babies between 3 months and two years of age when used over a p..."},{"Date":"Jul. 3, 2019 at 8:44 a.m. ET","Headline":"A recession-proof industry you can count on: pet care","Summary":""},{"Date":"Jul. 5, 2019 at 8:53 p.m. ET","Headline":"The Stock Market May Be Pointing to Trump\u2019s Reelection","Summary":""},{"Date":"Jul. 4, 2019 at 7:00 a.m. ET","Headline":"Attorney General Bill Barr Sold Millions in AT&T Stock","Summary":""},{"Date":"Jul. 4, 2019 at 5:05 a.m. ET","Headline":"The \u2018Dogs of the Dow\u2019 Are Neck and Neck With the Stock Market","Summary":""},{"Date":"Jul. 8, 2019 at 11:43 a.m. ET","Headline":"Pfizer Looks Pretty Smart With Array BioPharma Purchase. Here\u2019s Why.","Summary":""},{"Date":"Jul. 8, 2019 at 9:24 a.m. ET","Headline":"Apple Stock, Boeing Are Dropping and the Dow Looks Set to Slip","Summary":""},{"Date":"Jul. 11, 2019 at 4:05 p.m. ET","Headline":"The Dow components that drove the blue-chip stock index to a 27,000 milestone","Summary":"European Union antitrust authorities conditionally approved late Wednesday the acquisition by GlaxoSmithKline PLC (GSK.LN) of Pfizer Inc.'s PFE consumer health business. The approval is contingent on the sale of Pfizer's T..."},{"Date":"Jul. 11, 2019 at 1:35 p.m. ET","Headline":"Drug Stocks Are Falling Because Trump\u2019s Next Move on Pricing Could Be Trouble","Summary":"European Union antitrust authorities conditionally approved late Wednesday the acquisition by GlaxoSmithKline PLC (GSK.LN) of Pfizer Inc.'s PFE consumer health business. The approval is contingent on the sale of Pfizer's T..."},{"Date":"Jul. 11, 2019 at 1:02 p.m. ET","Headline":"Weight Watchers Stock Is Soaring and the Dow Is Jumping","Summary":"European Union antitrust authorities conditionally approved late Wednesday the acquisition by GlaxoSmithKline PLC (GSK.LN) of Pfizer Inc.'s PFE consumer health business. The approval is contingent on the sale of Pfizer's T..."},{"Date":"Jul. 11, 2019 at 10:42 a.m. ET","Headline":"Stocks of drug distributors and PBM-owners surge after Trump administration pulls rebate proposal","Summary":"European Union antitrust authorities conditionally approved late Wednesday the acquisition by GlaxoSmithKline PLC (GSK.LN) of Pfizer Inc.'s PFE consumer health business. The approval is contingent on the sale of Pfizer's T..."},{"Date":"Jul. 11, 2019 at 4:36 a.m. ET","Headline":"EU OKs Glaxo buy of Pfizer unit, with conditions","Summary":"European Union antitrust authorities conditionally approved late Wednesday the acquisition by GlaxoSmithKline PLC (GSK.LN) of Pfizer Inc.'s PFE consumer health business. The approval is contingent on the sale of Pfizer's T..."},{"Date":"Jul. 10, 2019 at 2:40 a.m. ET","Headline":"GlaxoSmithKline, Pfizer HIV drug in positive trial","Summary":"GlaxoSmithKline PLC (GSK.LN) said Wednesday that ViiV Healthcare, its HIV venture with Pfizer Inc. (PFE), has met primary endpoint in a phase 3 clinical trial. The trial demonstrated the ability to control HIV with a two-d..."},{"Date":"Jul. 15, 2019 at 6:58 a.m. ET","Headline":"Health companies start reporting earnings next week: Here are 3 things to keep in mind","Summary":""},{"Date":"Jul. 27, 2019 at 11:15 a.m. ET","Headline":"Pfizer Nears Deal to Combine off-Patent Drug Business With Mylan","Summary":""},{"Date":"Jul. 26, 2019 at 10:56 p.m. ET","Headline":"Earnings Season So Far: Revenue Beats Meet Low Expectations","Summary":""},{"Date":"Jul. 26, 2019 at 12:29 p.m. ET","Headline":"FDA requires box warnings for Pfizer drug Xeljanz","Summary":""},{"Date":"Jul. 26, 2019 at 9:55 a.m. ET","Headline":"Array Acquisition Could Be a Huge Win for Pfizer, Analyst Says","Summary":""},{"Date":"Jul. 29, 2019 at 4:42 p.m. ET","Headline":"Dow logs small gain but S&P 500, Nasdaq retreat from records ahead of Fed meeting","Summary":"Shares of companies in the generic drugs business rallied Monday, after Mylan N.V.  announced with Pfizer Inc.'s  Upjohn. The deal announcement, which didn't include what Mylan's stock would be valued at, sent Mylan's stoc..."},{"Date":"Jul. 29, 2019 at 3:19 p.m. ET","Headline":"Why Is Pfizer Stock Down Despite the Deal With Mylan? Look at the Numbers.","Summary":"Shares of companies in the generic drugs business rallied Monday, after Mylan N.V.  announced with Pfizer Inc.'s  Upjohn. The deal announcement, which didn't include what Mylan's stock would be valued at, sent Mylan's stoc..."},{"Date":"Jul. 29, 2019 at 12:39 p.m. ET","Headline":"The Dow Gains 45 Because the Market Is Waiting for Lower Interest Rates","Summary":"Shares of companies in the generic drugs business rallied Monday, after Mylan N.V.  announced with Pfizer Inc.'s  Upjohn. The deal announcement, which didn't include what Mylan's stock would be valued at, sent Mylan's stoc..."},{"Date":"Jul. 29, 2019 at 12:09 p.m. ET","Headline":"Wall Street is not exactly impressed with the Pfizer-Mylan deal","Summary":"Shares of companies in the generic drugs business rallied Monday, after Mylan N.V.  announced with Pfizer Inc.'s  Upjohn. The deal announcement, which didn't include what Mylan's stock would be valued at, sent Mylan's stoc..."},{"Date":"Jul. 29, 2019 at 9:24 a.m. ET","Headline":"Generic drug maker stocks rally after Mylan deal to merge with Pfizer's Upjohn","Summary":"Shares of companies in the generic drugs business rallied Monday, after Mylan N.V.  announced with Pfizer Inc.'s  Upjohn. The deal announcement, which didn't include what Mylan's stock would be valued at, sent Mylan's stoc..."},{"Date":"Jul. 29, 2019 at 9:22 a.m. ET","Headline":"The Dow Is Inching Higher, While Pfizer and Starbucks Are Falling","Summary":"Shares of Pfizer Inc.  fell 3% in premarket trade Monday after the company announced a deal to merge its Upjohn business with Mylan and reported second-quarter earnings that topped profit expectations, though the drugmaker..."},{"Date":"Jul. 29, 2019 at 8:56 a.m. ET","Headline":"Pfizer stock down after revenue miss, merger announcement","Summary":"Shares of Pfizer Inc.  fell 3% in premarket trade Monday after the company announced a deal to merge its Upjohn business with Mylan and reported second-quarter earnings that topped profit expectations, though the drugmaker..."},{"Date":"Jul. 29, 2019 at 8:38 a.m. ET","Headline":"Mylan Shares Soar on Merger News, but Pfizer\u2019s Stock Is Sagging","Summary":"Mylan N.V.  said that  with Pfizer Inc.'s  Upjohn business announced Monday, Chief Executive Heather Bresch will retire, after more than 8 years in the role and 28 years at the company. The retirement will be effective whe..."},{"Date":"Jul. 29, 2019 at 8:14 a.m. ET","Headline":"The earnings menu: Beyond Meat, Apple and a big bag of chips","Summary":"Mylan N.V.  said that  with Pfizer Inc.'s  Upjohn business announced Monday, Chief Executive Heather Bresch will retire, after more than 8 years in the role and 28 years at the company. The retirement will be effective whe..."},{"Date":"Jul. 29, 2019 at 8:12 a.m. ET","Headline":"The Dow Is Ticking Up as European Stocks Edge Higher on Merger Monday","Summary":"Mylan N.V.  said that  with Pfizer Inc.'s  Upjohn business announced Monday, Chief Executive Heather Bresch will retire, after more than 8 years in the role and 28 years at the company. The retirement will be effective whe..."},{"Date":"Jul. 29, 2019 at 7:35 a.m. ET","Headline":"Mylan CEO Heather Bresch to retire after deal to merge with Pfizer's Upjohn closes","Summary":"Mylan N.V.  said that  with Pfizer Inc.'s  Upjohn business announced Monday, Chief Executive Heather Bresch will retire, after more than 8 years in the role and 28 years at the company. The retirement will be effective whe..."},{"Date":"Jul. 29, 2019 at 7:29 a.m. ET","Headline":"Is the stock market set up for another late-year nose dive?","Summary":"Shares of Mylan N.V.  soared 24% in premarket trading Monday, after the generic drug maker  with Pfizer Inc.'s  Upjohn and reported a second-quarter adjusted profit and revenue that beat expectations. Mylan reported a net ..."},{"Date":"Jul. 29, 2019 at 7:09 a.m. ET","Headline":"Mylan beats adjusted profit, revenue expectations","Summary":"Shares of Mylan N.V.  soared 24% in premarket trading Monday, after the generic drug maker  with Pfizer Inc.'s  Upjohn and reported a second-quarter adjusted profit and revenue that beat expectations. Mylan reported a net ..."},{"Date":"Jul. 29, 2019 at 6:59 a.m. ET","Headline":"Mylan's stock soars after merger deal with Pfizer's Upjohn","Summary":"Shares of Mylan N.V.  soared 24% in premarket trading Monday, after the generic drug maker confirmed it was merging with Pfizer Inc.'s  off-patent and generics business Upjohn. Mylan also reported second-quarter results th..."},{"Date":"Jul. 29, 2019 at 6:00 a.m. ET","Headline":"Podcast: Beyond Meat\u2019s 720% Jump, and Two More Numbers to Know","Summary":"3 numbers to help you navigate the market\u2014in just two minutes."},{"Date":"Jul. 28, 2019 at 3:00 p.m. ET","Headline":"Apple, GE, Qualcomm and More Stocks to Watch This Week","Summary":""},{"Date":"Jul. 28, 2019 at 9:52 a.m. ET","Headline":"These dividend stocks haven\u2019t been scooped up by investors yet","Summary":""},{"Date":"Jul. 30, 2019 at 1:52 p.m. ET","Headline":"Gilead and Amgen will report second-quarter earnings after the closing bell. Here\u2019s what to expect","Summary":"Shares of Pfizer Inc.  tumbled 5.2% to pace the Dow Jones Industrial Average's  decliners in morning trading Tuesday, after Bank of America Merrill Lynch analyst Jason Gerberry downgraded the drug maker in the wake of the ..."},{"Date":"Jul. 30, 2019 at 12:46 p.m. ET","Headline":"The Dow Drops 31 Points Because a Trump Tweet Is All It Takes","Summary":"Shares of Pfizer Inc.  tumbled 5.2% to pace the Dow Jones Industrial Average's  decliners in morning trading Tuesday, after Bank of America Merrill Lynch analyst Jason Gerberry downgraded the drug maker in the wake of the ..."},{"Date":"Jul. 30, 2019 at 10:32 a.m. ET","Headline":"Pfizer Stock Falls for the Second Day After Mylan Deal","Summary":"Shares of Pfizer Inc.  tumbled 5.2% to pace the Dow Jones Industrial Average's  decliners in morning trading Tuesday, after Bank of America Merrill Lynch analyst Jason Gerberry downgraded the drug maker in the wake of the ..."},{"Date":"Jul. 30, 2019 at 10:15 a.m. ET","Headline":"Pfizer's stock tumbles toward worst 2-day stretch in 10 1\/2-years","Summary":"Shares of Pfizer Inc.  tumbled 5.2% to pace the Dow Jones Industrial Average's  decliners in morning trading Tuesday, after Bank of America Merrill Lynch analyst Jason Gerberry downgraded the drug maker in the wake of the ..."},{"Date":"Jul. 30, 2019 at 9:17 a.m. ET","Headline":"Beyond Meat Stock Is Plunging as the Dow Is Set to Slip","Summary":""},{"Date":"Aug. 1, 2019 at 10:31 a.m. ET","Headline":"Inversion reversions arrive as companies get smaller tax edge from foreign addresses","Summary":""},{"Date":"Aug. 6, 2019 at 11:33 a.m. ET","Headline":"Zoetis Stock Is Up as Pet Products Lift Revenue","Summary":"Shares of GlycoMimetics Inc.  fell 53% in premarket trade Monday after the company announced Friday evening that a Phase 3 trial of a sickle-cell disease drug, developed in partnership with Pfizer Inc. , did not meet prima..."},{"Date":"Aug. 5, 2019 at 4:47 p.m. ET","Headline":"These stocks have plunged the most since Powell and Trump crashed investors\u2019 party","Summary":"Shares of GlycoMimetics Inc.  fell 53% in premarket trade Monday after the company announced Friday evening that a Phase 3 trial of a sickle-cell disease drug, developed in partnership with Pfizer Inc. , did not meet prima..."},{"Date":"Aug. 5, 2019 at 2:09 p.m. ET","Headline":"Investors Don\u2019t Like Mylan\u2019s Deal With Pfizer","Summary":"Shares of GlycoMimetics Inc.  fell 53% in premarket trade Monday after the company announced Friday evening that a Phase 3 trial of a sickle-cell disease drug, developed in partnership with Pfizer Inc. , did not meet prima..."},{"Date":"Aug. 5, 2019 at 10:01 a.m. ET","Headline":"5 Winners and 5 Losers From Earnings Season","Summary":"Shares of GlycoMimetics Inc.  fell 53% in premarket trade Monday after the company announced Friday evening that a Phase 3 trial of a sickle-cell disease drug, developed in partnership with Pfizer Inc. , did not meet prima..."},{"Date":"Aug. 5, 2019 at 8:56 a.m. ET","Headline":"GlycoMimetics stock down 53% after Phase 3 trial failure","Summary":"Shares of GlycoMimetics Inc.  fell 53% in premarket trade Monday after the company announced Friday evening that a Phase 3 trial of a sickle-cell disease drug, developed in partnership with Pfizer Inc. , did not meet prima..."},{"Date":"Aug. 8, 2019 at 10:37 a.m. ET","Headline":"Sarepta Stock Is Falling Because Its Lead on Pfizer May Be Shrinking","Summary":""},{"Date":"Aug. 12, 2019 at 1:57 p.m. ET","Headline":"Pfizer's stock sinks again, toward 14-month low to pace 'Dow's' losers","Summary":"Shares of Pfizer Inc.  dropped 3.6% in afternoon grading Monday, putting them on track to close at a 14-month low, as the drugmaker extends the rough patch in the wake of its  and announcement to merge its Upjohn business ..."},{"Date":"Aug. 12, 2019 at 5:00 a.m. ET","Headline":"5 Big Pharma Showdowns to Watch","Summary":""},{"Date":"Aug. 14, 2019 at 8:03 a.m. ET","Headline":"These stocks rose the most as Trump backed off (a bit) from tariffs","Summary":""},{"Date":"Aug. 14, 2019 at 6:45 a.m. ET","Headline":"Dividend Forecasts Are Too Pessimistic, Goldman Sachs Says","Summary":""},{"Date":"Aug. 15, 2019 at 1:26 p.m. ET","Headline":"Pfizer recalls two lots of migraine drug due to potential bacterial contamination","Summary":"Pfizer Inc.  is recalling two lots of its migraine medication Relpax, the U.S. Food and Drug Administration said Thursday. \n\nThe pharmaceutical company is voluntarily recalling those particular lots because they could pote..."},{"Date":"Aug. 15, 2019 at 8:28 a.m. ET","Headline":"Here are the worst stock performers as the Dow drops 800 points","Summary":""},{"Date":"Aug. 17, 2019 at 12:22 p.m. ET","Headline":"Market Volatility Got You Nervous? The Merger Fund Might Be the Answer","Summary":""},{"Date":"Aug. 19, 2019 at 5:15 a.m. ET","Headline":"The 6 Worst Health-Care Stocks So Far This Month","Summary":""},{"Date":"Aug. 22, 2019 at 3:21 a.m. ET","Headline":"GlaxoSmithKline ViiV reports positive HIV study","Summary":"GlaxoSmithKline PLC's (GSK.LN) joint-venture company ViiV Healthcare said Thursday that a global phase 3 \"Atlas-2M\" study of rilpivirine for the treatment of HIV met its primary endpoint. ViiV Healthcare--which is jointly ..."},{"Date":"Aug. 30, 2019 at 7:08 a.m. ET","Headline":"Here are 2019\u2019s biggest stock market winners and losers in the Dow, S&P 500 and Nasdaq","Summary":""},{"Date":"Aug. 29, 2019 at 1:22 p.m. ET","Headline":"John Thiel: The Future of Brokerage","Summary":""},{"Date":"Aug. 29, 2019 at 7:12 a.m. ET","Headline":"Seeking attractive dividend stocks? Here\u2019s how to separate winners from losers","Summary":""},{"Date":"Sep. 3, 2019 at 6:45 a.m. ET","Headline":"The 3 Worst Health Care Stocks So Far This Year","Summary":""},{"Date":"Sep. 6, 2019 at 2:41 p.m. ET","Headline":"Amid rising reports of a vaping-related lung illness, here\u2019s how to kick your e-cigarette addiction","Summary":""},{"Date":"Sep. 16, 2019 at 2:46 p.m. ET","Headline":"This low-volatility dividend-stock strategy can give you peace of mind","Summary":""},{"Date":"Sep. 19, 2019 at 9:10 a.m. ET","Headline":"Pfizer Is Spinning Off Upjohn. What\u2019s Left Will Be No Bargain, Analyst Says","Summary":""},{"Date":"Sep. 21, 2019 at 9:02 a.m. ET","Headline":"NFL legend Terry Bradshaw buys and sells $5 million planes the way some people flip houses","Summary":"The health care sector was Friday's best performer, as drug stocks got a lift after reports that Senate Republican leaders said the unveiled by House Speaker Nancy Pelosi and other top Democrats would be dead on arrival. T..."},{"Date":"Sep. 20, 2019 at 2:15 p.m. ET","Headline":"Lessons of a flat market for retirees","Summary":"The health care sector was Friday's best performer, as drug stocks got a lift after reports that Senate Republican leaders said the unveiled by House Speaker Nancy Pelosi and other top Democrats would be dead on arrival. T..."},{"Date":"Sep. 20, 2019 at 12:56 p.m. ET","Headline":"Drug stocks pacing the Dow's gainers Senate GOP leaders dismiss Democrats' drug-pricing plan","Summary":"The health care sector was Friday's best performer, as drug stocks got a lift after reports that Senate Republican leaders said the unveiled by House Speaker Nancy Pelosi and other top Democrats would be dead on arrival. T..."},{"Date":"Sep. 20, 2019 at 9:49 a.m. ET","Headline":"Merck KGaA, Pfizer' Bavencio gets positive opinion","Summary":"Merck KGaA's (MRK.XE) EMD Serono biopharmaceutical unit and Pfizer Inc. (PFE) on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Bavencio in combination wi..."},{"Date":"Sep. 27, 2019 at 4:25 p.m. ET","Headline":"Stocks close down as investors weigh potential curbs on U.S. portfolio investments into China","Summary":"Pfizer Inc. shares  rose 1.3% in premarket trade Friday, after the drug giant reported positive results in a second late-stage trial of a treatment for moderate to severe atopic dermatitis, a chronic skin disease. Pfizer s..."},{"Date":"Sep. 27, 2019 at 7:01 a.m. ET","Headline":"Pfizer shares up 1.3% premarket after reporting positive results in second trial of dermatitis treatment","Summary":"Pfizer Inc. shares  rose 1.3% in premarket trade Friday, after the drug giant reported positive results in a second late-stage trial of a treatment for moderate to severe atopic dermatitis, a chronic skin disease. Pfizer s..."},{"Date":"Sep. 26, 2019 at 8:59 a.m. ET","Headline":"Five points every investor ought to consider about the Trump impeachment inquiry","Summary":""},{"Date":"Sep. 26, 2019 at 7:06 a.m. ET","Headline":"7 in 10 parents admit to sending sick kids to school, but they have 3 good reasons why","Summary":""},{"Date":"Sep. 30, 2019 at 2:07 p.m. ET","Headline":"Seattle Genetics, Merck, Bristol-Myers Unveil Upbeat Treatment Data at Cancer Conference","Summary":""},{"Date":"Oct. 3, 2019 at 8:00 a.m. ET","Headline":"Zoetis names Kristin Peck as CEO effective Jan 1, replacing Juan Ramon Alaix who is retiring","Summary":"Zoetis Inc.  said Thursday it has named Kristin Peck as chief executive effective Jan. 1, replacing Juan Ramon Alaix, who is retiring. Peck is currently executive vice president and group president responsible for U.S. ope..."},{"Date":"Oct. 2, 2019 at 11:21 a.m. ET","Headline":"Here are the stocks that have soared and sunk the most in 2019","Summary":""},{"Date":"Oct. 1, 2019 at 1:43 p.m. ET","Headline":"Biotech Roundtable: How to Invest in Medicine\u2019s Future","Summary":""},{"Date":"Oct. 4, 2019 at 3:57 p.m. ET","Headline":"Few stocks pass this rigorous test, but those that do may serve you well through market turmoil","Summary":""},{"Date":"Oct. 4, 2019 at 11:55 a.m. ET","Headline":"Merck\u2019s Keytruda Will Become Best-Selling Drug Worldwide, Research Group Says","Summary":""},{"Date":"Oct. 7, 2019 at 5:00 p.m. ET","Headline":"Stocks to Buy as Earnings Growth Slows, According to Goldman Sachs","Summary":""},{"Date":"Oct. 11, 2019 at 7:28 a.m. ET","Headline":"Low-Volatility Stocks Are Riskier Than You Might Think. Here\u2019s a Better Way to Play Them.","Summary":""},{"Date":"Oct. 12, 2019 at 12:26 p.m. ET","Headline":"These battered biotech stocks are now buying opportunities as Elizabeth Warren climbs in the polls","Summary":""},{"Date":"Oct. 17, 2019 at 9:28 a.m. ET","Headline":"Fitbit stock gains after company announces biotech partnership","Summary":"Fitbit Inc.  shares are up 3.7% in premarket trading Thursday after the company announced a partnership with the Bristol-Myers Squibb-Pfizer Alliance focused on the detection of atrial fibrillation using Fitbit devices. As..."},{"Date":"Oct. 21, 2019 at 8:21 a.m. ET","Headline":"Opko and Pfizer announce positive results in late-stage trial of human growth hormone treatment","Summary":"Opko Health Inc. shares  soared 21% in premarket trade Monday, while Pfizer Inc. shares  rose 0.6%, after the companies announced positive results in a late-stage trial of a human growth hormone treatment for children with..."},{"Date":"Oct. 18, 2019 at 8:52 p.m. ET","Headline":"Health-Care Stocks Are Getting Back on Their Feet","Summary":""},{"Date":"Oct. 24, 2019 at 9:35 a.m. ET","Headline":"Why your best stock bets for the next 10 years are Disney and Target, says this CEO","Summary":""},{"Date":"Oct. 29, 2019 at 5:15 p.m. ET","Headline":"The Dow Slipped 19 Points Because the Fed Could Play Trick or Treat","Summary":"Shares of Merck & Co. Inc.  and Pfizer Inc.  rallied in premarket trading Tuesday after earnings beats, and were the best performers among Dow Jones Industrial Average  components, but not enough to lift the Dow into posit..."},{"Date":"Oct. 29, 2019 at 4:19 p.m. ET","Headline":"S&P 500 retreats from record high; Google miss weighs on tech shares","Summary":"Shares of Merck & Co. Inc.  and Pfizer Inc.  rallied in premarket trading Tuesday after earnings beats, and were the best performers among Dow Jones Industrial Average  components, but not enough to lift the Dow into posit..."},{"Date":"Oct. 29, 2019 at 3:13 p.m. ET","Headline":"Pfizer and Merck\u2019s third-quarter numbers bolster hopes for drug company earnings","Summary":"Shares of Merck & Co. Inc.  and Pfizer Inc.  rallied in premarket trading Tuesday after earnings beats, and were the best performers among Dow Jones Industrial Average  components, but not enough to lift the Dow into posit..."},{"Date":"Oct. 29, 2019 at 10:12 a.m. ET","Headline":"Merck and Pfizer Stocks Are on a Roll as Earnings Beat Forecasts, Raise Hope About Big Pharma","Summary":"Shares of Merck & Co. Inc.  and Pfizer Inc.  rallied in premarket trading Tuesday after earnings beats, and were the best performers among Dow Jones Industrial Average  components, but not enough to lift the Dow into posit..."},{"Date":"Oct. 29, 2019 at 10:06 a.m. ET","Headline":"A bear-market catalyst is lying in wait for stocks, warns UBS","Summary":"Shares of Merck & Co. Inc.  and Pfizer Inc.  rallied in premarket trading Tuesday after earnings beats, and were the best performers among Dow Jones Industrial Average  components, but not enough to lift the Dow into posit..."},{"Date":"Oct. 29, 2019 at 9:00 a.m. ET","Headline":"The Dow Is Edging Lower as Grubhub Gets Drubbed After a Big Earnings Miss","Summary":"Shares of Merck & Co. Inc.  and Pfizer Inc.  rallied in premarket trading Tuesday after earnings beats, and were the best performers among Dow Jones Industrial Average  components, but not enough to lift the Dow into posit..."},{"Date":"Oct. 29, 2019 at 8:31 a.m. ET","Headline":"Merck, Pfizer stock gains on earnings beats would add 23 points to the Dow's price","Summary":"Shares of Merck & Co. Inc.  and Pfizer Inc.  rallied in premarket trading Tuesday after earnings beats, and were the best performers among Dow Jones Industrial Average  components, but not enough to lift the Dow into posit..."},{"Date":"Oct. 29, 2019 at 8:27 a.m. ET","Headline":"U.S. Stocks Look Set to Take a Breather After Record Day","Summary":"Pfizer Inc. shares  rose 3.3% in premarket trade Tuesday, after the drug company beat earnings estimates for the third quarter and raised its profit guidance. New York-based Pfizer said it had net income of $7.680 billion,..."},{"Date":"Oct. 29, 2019 at 8:08 a.m. ET","Headline":"Pfizer Stock Is Getting a Lift Because Things Are a Lot Better Than Wall Street Thought","Summary":"Pfizer Inc. shares  rose 3.3% in premarket trade Tuesday, after the drug company beat earnings estimates for the third quarter and raised its profit guidance. New York-based Pfizer said it had net income of $7.680 billion,..."},{"Date":"Oct. 29, 2019 at 6:57 a.m. ET","Headline":"Pfizer shares jump premarket as earnings beat estimates and company raises guidance","Summary":"Pfizer Inc. shares  rose 3.3% in premarket trade Tuesday, after the drug company beat earnings estimates for the third quarter and raised its profit guidance. New York-based Pfizer said it had net income of $7.680 billion,..."},{"Date":"Oct. 28, 2019 at 7:48 a.m. ET","Headline":"Apple, Facebook and Exxon are about to lead a big test of the earnings recession","Summary":""},{"Date":"Oct. 28, 2019 at 6:30 a.m. ET","Headline":"Pfizer Reports Earnings Tomorrow. Here\u2019s What to Expect.","Summary":""},{"Date":"Oct. 30, 2019 at 12:17 p.m. ET","Headline":"U.S. lobbying for U.K. drug price rise prompts Johnson, Corbyn clash over post-Brexit trade pact","Summary":"--Glaxo revises guidance to flat on year adjusted EPS performance --Performance, guidance upgrade supported by vaccines sales beat, newer drugs --Advair sales fall following launch of generic competitor from Mylan GlaxoSmi..."},{"Date":"Oct. 30, 2019 at 11:21 a.m. ET","Headline":"Why would the Fed cut interest rates a 3rd time in a row even as stocks near records? Investors may soon find out","Summary":"--Glaxo revises guidance to flat on year adjusted EPS performance --Performance, guidance upgrade supported by vaccines sales beat, newer drugs --Advair sales fall following launch of generic competitor from Mylan GlaxoSmi..."},{"Date":"Oct. 30, 2019 at 11:09 a.m. ET","Headline":"GlaxoSmithKline raises guidance as profit rises","Summary":"--Glaxo revises guidance to flat on year adjusted EPS performance --Performance, guidance upgrade supported by vaccines sales beat, newer drugs --Advair sales fall following launch of generic competitor from Mylan GlaxoSmi..."},{"Date":"Nov. 5, 2019 at 12:37 p.m. ET","Headline":"Mylan shares slide 5.5% as CFRA downgrades to sell from hold","Summary":"CFRA downgraded Mylan N.V. stock  to sell from hold on Tuesday, after the company's reported third-quarter earnings that showed adjusted EPS down 8% in the year to date and adjusted free cash flow down 36%. Analyst Colin S..."},{"Date":"Nov. 8, 2019 at 8:41 a.m. ET","Headline":"Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial","Summary":"Merck KGaA  and Pfizer  said Friday that a late-stage clinical trial testing Bavencio as a first-line maintenance treatment for patients with certain forms of gastric cancer failed to meet the study's primary endpoints for..."},{"Date":"Nov. 7, 2019 at 10:49 a.m. ET","Headline":"Zoetis Stock Climbs Because the Pet Business Is Still Booming","Summary":""},{"Date":"Nov. 9, 2019 at 11:44 a.m. ET","Headline":"Marine algae keys Chinese claim to Alzheimer\u2019s breakthrough","Summary":""},{"Date":"Nov. 9, 2019 at 10:14 a.m. ET","Headline":"This simple stock investing strategy combines value, quality and dividends into a winning formula","Summary":""},{"Date":"Nov. 12, 2019 at 10:15 a.m. ET","Headline":"Solid Biosciences Stock Crashes Over Safety Concerns About Its Gene Therapy","Summary":"The 6.3% rally in Walgreens Boots Alliance Inc.'s stock , after  of KKR & Co.'s  interest in a leveraged buyout of the drugstore chain, was the leading gainer of the 8-of-30 Dow Jones Industrial Average  components gaining..."},{"Date":"Nov. 11, 2019 at 10:16 a.m. ET","Headline":"Walgreens' stock surge providing a 25-point cushion to the Dow's price","Summary":"The 6.3% rally in Walgreens Boots Alliance Inc.'s stock , after  of KKR & Co.'s  interest in a leveraged buyout of the drugstore chain, was the leading gainer of the 8-of-30 Dow Jones Industrial Average  components gaining..."},{"Date":"Nov. 13, 2019 at 9:30 a.m. ET","Headline":"Abbott Labs Chooses an Insider to Be Its New CEO","Summary":""},{"Date":"Nov. 25, 2019 at 8:24 a.m. ET","Headline":"Pfizer Has 5 Drugs in Its Pipeline That Could Turn Its Stock Around","Summary":""},{"Date":"Nov. 25, 2019 at 5:04 a.m. ET","Headline":"The Chinese Vape Market Is Booming. But Heavy Regulation Is Coming.","Summary":""},{"Date":"Nov. 28, 2019 at 7:00 a.m. ET","Headline":"The 3 Worst-Performing Health Care Stocks of 2019 So Far","Summary":""},{"Date":"Nov. 29, 2019 at 8:48 a.m. ET","Headline":"China Negotiates Bargain Prices With Big Pharma","Summary":""},{"Date":"Dec. 3, 2019 at 12:27 p.m. ET","Headline":"Here are the worst-performing U.S. stocks on Tuesday","Summary":""},{"Date":"Nov. 23, 2019 at 3:41 p.m. ET","Headline":"Pfizer Is the Dow\u2019s Worst Stock. A New Strategy Makes It Worth Another Look.","Summary":""},{"Date":"Dec. 10, 2019 at 7:14 a.m. ET","Headline":"Drug manufacturers have spent a record $342 billion on M&A in 2019","Summary":""},{"Date":"Dec. 9, 2019 at 4:44 p.m. ET","Headline":"Sanofi\u2019s New CEO Is Aiming for a Narrower Focus in Drug Development","Summary":""},{"Date":"Dec. 12, 2019 at 9:04 a.m. ET","Headline":"Big Pharma\u2019s Coming Back in 2020. Don\u2019t Hold Your Breath for Generic Drug Stocks","Summary":""},{"Date":"Dec. 14, 2019 at 4:47 p.m. ET","Headline":"Biotech stocks are producing outsized gains \u2014 here\u2019s how to get your share","Summary":""},{"Date":"Dec. 13, 2019 at 9:00 a.m. ET","Headline":"Sarepta Stock Is Spiking as FDA Reverses Course, Approving Drug","Summary":""},{"Date":"Dec. 16, 2019 at 6:25 p.m. ET","Headline":"Pfizer stock ticks higher on new FDA approval for prostate cancer drug","Summary":"Pfizer Inc.  shares ticked higher in the extended session Monday after the drug maker said the Food and Drug Administration approved a new indication for a cancer drug it makes with Astellas Pharma Inc. . Pfizer shares ros..."},{"Date":"Dec. 16, 2019 at 8:50 a.m. ET","Headline":"Pfizer raises dividend by nearly 6%, stock gains","Summary":"Pfizer Inc.  said Monday it was raising its dividend by 5.6%, as the dividend yield stays more than double its health-care peer group. The new quarterly dividend of 38 cents a share, up from 36 cents a share, will be payab..."},{"Date":"Dec. 14, 2019 at 8:00 a.m. ET","Headline":"Animal-Care Provider Zoetis and 6 More Companies Are Raising Dividends","Summary":""},{"Date":"Dec. 17, 2019 at 4:47 p.m. ET","Headline":"S&P 500, Dow and Nasdaq score fresh records at close","Summary":""},{"Date":"Dec. 17, 2019 at 11:33 a.m. ET","Headline":"Exact Sciences, Maker of the Cancer Test Cologuard, Is Vastly Undervalued, Analyst Says","Summary":""},{"Date":"Dec. 19, 2019 at 10:51 a.m. ET","Headline":"The S&P 500 Is Stocks\u2019 Modern Benchmark. But the Old-Fashioned Dow Has Beat It Over the Past 5 Years.","Summary":""},{"Date":"Dec. 21, 2019 at 12:29 p.m. ET","Headline":"64 million Americans have tried CBD and now the FDA says it could cause liver damage","Summary":""},{"Date":"Dec. 21, 2019 at 11:08 a.m. ET","Headline":"Amarin\u2019s fish-oil pill is now available to millions more patients, but it\u2019s still no Lipitor","Summary":""},{"Date":"Dec. 24, 2019 at 9:49 a.m. ET","Headline":"Mylan, Micro Labs receive FDA approval to market generic Eliquis","Summary":"Shares of Mylan  are up 0.2% in premarket trading on Tuesday. The Food and Drug Administration said Monday that the company and Micro Labs Ltd., a privately held generic drugmaker, had each received approval to market gene..."},{"Date":"Dec. 23, 2019 at 5:17 p.m. ET","Headline":"The Dow Closed at a Record Because China Is Giving Trade Partners a Christmas Gift","Summary":""},{"Date":"Dec. 25, 2019 at 6:02 a.m. ET","Headline":"Pfizer Stock\u2019s Dismal 2019 Could Be a Prelude to a Comeback","Summary":""},{"Date":"Dec. 28, 2019 at 4:18 p.m. ET","Headline":"Top stock picks for 2020: The best of the biggest","Summary":""},{"Date":"Dec. 27, 2019 at 5:30 a.m. ET","Headline":"The Biotech Sector Is Roaring Into 2020. Here\u2019s Why.","Summary":""},{"Date":"Dec. 27, 2019 at 5:15 a.m. ET","Headline":"Pfizer Is a Top Stock for 2020. Here\u2019s Why.","Summary":""},{"Date":"Dec. 30, 2019 at 11:09 a.m. ET","Headline":"Here are the best and worst Dow and S&P 500 stocks of 2019","Summary":""},{"Date":"Dec. 31, 2019 at 5:14 p.m. ET","Headline":"The Best\u2014and Worst\u2014Company Stocks in the Dow This Year","Summary":"Although it's debatable whether following the Dogs of the Dow strategy--buying and holding the 10 highest yielding Dow Jones Industrial Average  components at year end--actually works better than its catchy name, here are ..."},{"Date":"Dec. 31, 2019 at 3:00 p.m. ET","Headline":"Dow, Exxon Mobil and IBM top the 'Dogs of the Dow' list as 2019 ends","Summary":"Although it's debatable whether following the Dogs of the Dow strategy--buying and holding the 10 highest yielding Dow Jones Industrial Average  components at year end--actually works better than its catchy name, here are ..."},{"Date":"Jan. 2, 2020 at 10:08 a.m. ET","Headline":"Drug-Price Increases Show Business as Usual Despite Public Pressure","Summary":""},{"Date":"Jan. 4, 2020 at 7:30 p.m. ET","Headline":"These 2 stocks dominated S&P 500 returns in 2019 \u2014 and the decade","Summary":""},{"Date":"Jan. 4, 2020 at 7:30 a.m. ET","Headline":"Pfizer Bought a Penny Biotech Stock Just Before It Doubled","Summary":""},{"Date":"Jan. 3, 2020 at 8:30 p.m. ET","Headline":"Barron\u2019s Best Income Investments for 2020","Summary":""},{"Date":"Dec. 31, 2019 at 4:25 p.m. ET","Headline":"Dogs of the Dow Stock-Picking Strategy Was a Winner for the Decade","Summary":""},{"Date":"Jan. 7, 2020 at 9:17 a.m. ET","Headline":"It\u2019s Time to Buy Bristol-Myers Stock, According to 1 Analyst. Here\u2019s Why.","Summary":""},{"Date":"Jan. 9, 2020 at 10:05 a.m. ET","Headline":"Viatris Will Be the New Kid in Generic Drugs. Don\u2019t Expect the Stock to Surge, Analyst Says.","Summary":""},{"Date":"Jan. 11, 2020 at 9:35 a.m. ET","Headline":"This may be one of the worst flu seasons in decades \u2014 so fight it with these 10 proven treatments","Summary":""},{"Date":"Jan. 10, 2020 at 4:33 p.m. ET","Headline":"Eli Lilly Made a Deal for Dermira. The Biotech\u2019s Stock Price Shows Investors Expect More.","Summary":""},{"Date":"Dec. 15, 2019 at 10:20 a.m. ET","Headline":"Barron\u2019s 10 Stock Picks for 2020","Summary":""},{"Date":"Jan. 13, 2020 at 7:51 a.m. ET","Headline":"Biogen to buy from Pfizer an asset to develop into potential Alzheimer's, Parkinson's treatments","Summary":"Biogen Inc.  said Monday it will buy from Pfizer Inc.  a potential treatment for behavioral and neurological symptoms, as a potential treatment for Alzheimer's and Parkinson's, for an upfront payment of $75 million and up ..."},{"Date":"Jan. 9, 2020 at 6:45 a.m. ET","Headline":"For Dividend Growth, Consider Health-Care and Tech Stocks","Summary":""},{"Date":"Jan. 15, 2020 at 12:05 p.m. ET","Headline":"Charting a trade-fueled breakout, S&P 500 tags record high amid market rotation","Summary":""},{"Date":"Jan. 14, 2020 at 12:39 p.m. ET","Headline":"Charting a bullish 2020 start: S&P 500 extends break to record territory","Summary":""},{"Date":"Jan. 14, 2020 at 12:10 p.m. ET","Headline":"Charting a bullish 2020 start: S&P 500 extends break to record territory","Summary":""},{"Date":"Jan. 17, 2020 at 5:40 p.m. ET","Headline":"Pharma and Biotech Aren\u2019t Worried About Democratic Candidates\u2019 Attacks Against Drugmakers","Summary":""},{"Date":"Jan. 17, 2020 at 12:04 p.m. ET","Headline":"Charting bullish momentum:  Small- and mid-caps clear 20-day volatility bands","Summary":""},{"Date":"Jan. 16, 2020 at 12:00 p.m. ET","Headline":"Charting market rotation:  Bull trend strengthens as small- and mid-caps take flight","Summary":""},{"Date":"Jan. 21, 2020 at 12:54 p.m. ET","Headline":"Bull trend persists, S&P 500 digests powerful rally atop 20-day volatility bands","Summary":""},{"Date":"Jan. 21, 2020 at 12:24 p.m. ET","Headline":"Bull trend persists, S&P 500 digests powerful rally atop 20-day volatility bands","Summary":""},{"Date":"Jan. 20, 2020 at 7:30 a.m. ET","Headline":"Perrigo, McKesson Are Best-Performing Healthcare Stocks So Far in 2020. Incyte and Biogen Are the Worst.","Summary":""},{"Date":"Jan. 23, 2020 at 11:47 a.m. ET","Headline":"Charting a bull-trend pullback, S&P 500 retests gap support","Summary":""},{"Date":"Jan. 22, 2020 at 12:15 p.m. ET","Headline":"The Case for \u2018Cash Cows\u2019 Like Alphabet, Ford, and Facebook","Summary":""},{"Date":"Jan. 22, 2020 at 11:59 a.m. ET","Headline":"Charting successful technical tests:  S&P 500, Nasdaq rally from first support","Summary":""},{"Date":"Jan. 24, 2020 at 9:32 p.m. ET","Headline":"Grocer Albertsons Has Tried Twice to Go Public and Failed. Now It\u2019s Mulling a Third Try.","Summary":""},{"Date":"Jan. 24, 2020 at 11:50 a.m. ET","Headline":"Charting a bullish holding pattern, S&P 500 nails gap support","Summary":""},{"Date":"Jan. 27, 2020 at 4:35 p.m. ET","Headline":"Tesla, Apple, Boeing, Amazon, and Other Stocks for Investors to Watch This Week","Summary":""},{"Date":"Jan. 27, 2020 at 2:09 p.m. ET","Headline":"These U.S. stocks are down the most as the coronavirus spreads","Summary":""},{"Date":"Jan. 27, 2020 at 11:53 a.m. ET","Headline":"Charting a virus-fueled downdraft, S&P 500 dives toward major support","Summary":""},{"Date":"Jan. 27, 2020 at 10:28 a.m. ET","Headline":"Mylan Stock Is Falling Because the Upjohn Deal Won\u2019t Soon Help Earnings, Analyst Says","Summary":""},{"Date":"Jan. 26, 2020 at 11:59 a.m. ET","Headline":"The Dow is about to face its stiffest test in years","Summary":""},{"Date":"Jan. 28, 2020 at 4:58 p.m. ET","Headline":"Dow closes higher to snap 5-day losing streak after worst single session loss since October","Summary":"Shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings early Tuesday are falling in premarket trading, and shaving a combined 49 points off the Dow's price. Dow futures  rose 135..."},{"Date":"Jan. 28, 2020 at 12:58 p.m. ET","Headline":"Charting near-term technical damage, S&P 500 ventures under key support","Summary":"Shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings early Tuesday are falling in premarket trading, and shaving a combined 49 points off the Dow's price. Dow futures  rose 135..."},{"Date":"Jan. 28, 2020 at 12:44 p.m. ET","Headline":"The Dow Is Up 249 Points as Stocks Snap Back on Earnings Strength","Summary":"Shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings early Tuesday are falling in premarket trading, and shaving a combined 49 points off the Dow's price. Dow futures  rose 135..."},{"Date":"Jan. 28, 2020 at 12:26 p.m. ET","Headline":"Charting near-term technical damage, S&P 500 ventures under key support","Summary":"Shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings early Tuesday are falling in premarket trading, and shaving a combined 49 points off the Dow's price. Dow futures  rose 135..."},{"Date":"Jan. 28, 2020 at 8:41 a.m. ET","Headline":"Pfizer Stock Is Dropping Because Its Earnings Missed Expectations","Summary":"Shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings early Tuesday are falling in premarket trading, and shaving a combined 49 points off the Dow's price. Dow futures  rose 135..."},{"Date":"Jan. 28, 2020 at 8:15 a.m. ET","Headline":"Beyond Meat Stock Is Dropping, Pfizer Is Falling, and the Dow Is Trying to Rally","Summary":"Shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings early Tuesday are falling in premarket trading, and shaving a combined 49 points off the Dow's price. Dow futures  rose 135..."},{"Date":"Jan. 28, 2020 at 7:38 a.m. ET","Headline":"Stock drops of earnings reporters nearly 50 points off the Dow's price","Summary":"Shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings early Tuesday are falling in premarket trading, and shaving a combined 49 points off the Dow's price. Dow futures  rose 135..."},{"Date":"Jan. 28, 2020 at 7:37 a.m. ET","Headline":"U.S. Stocks Set For Modest Bounce as Investors Hope For Coronavirus Distraction From Earnings and Data","Summary":"Shares of Pfizer Inc.  fell 0.9% in premarket trading Tuesday, after the drug maker reported a fourth-quarter profit that missed expectations, while revenue rose in line with forecasts. The company reported a net loss that..."},{"Date":"Jan. 28, 2020 at 7:09 a.m. ET","Headline":"Pfizer Reports Earnings Today. Here\u2019s What to Expect.","Summary":"Shares of Pfizer Inc.  fell 0.9% in premarket trading Tuesday, after the drug maker reported a fourth-quarter profit that missed expectations, while revenue rose in line with forecasts. The company reported a net loss that..."},{"Date":"Jan. 28, 2020 at 7:05 a.m. ET","Headline":"Pfizer's stock falls after profit misses expectations, while revenue was in line","Summary":"Shares of Pfizer Inc.  fell 0.9% in premarket trading Tuesday, after the drug maker reported a fourth-quarter profit that missed expectations, while revenue rose in line with forecasts. The company reported a net loss that..."},{"Date":"Jan. 28, 2020 at 6:51 a.m. ET","Headline":"Apple and AMD to take earnings stage amid coronavirus fears, stocks\u2019 sudden swoon","Summary":""},{"Date":"Jan. 31, 2020 at 10:52 a.m. ET","Headline":"Some Drugmakers Are Racing to Develop a Coronavirus Vaccine. Why Big Pharma Isn\u2019t Rushing In.","Summary":""},{"Date":"Feb. 5, 2020 at 9:22 a.m. ET","Headline":"Merck Is Spinning Off 3 Divisions to Focus on \u2018Key Growth Drivers,\u2019 CEO Ken Frazier Said","Summary":"U.K. pharmaceutical giant GlaxoSmithKline  said fourth-quarter adjusted earnings per share fell 21% to 24.8 pence, while revenue rose 9% to \u00a38.9 billion, as it also said it's planning to split into two companies in two yea..."},{"Date":"Feb. 5, 2020 at 7:15 a.m. ET","Headline":"Glaxo says adjusted EPS slips as it prepares to split into two companies","Summary":"U.K. pharmaceutical giant GlaxoSmithKline  said fourth-quarter adjusted earnings per share fell 21% to 24.8 pence, while revenue rose 9% to \u00a38.9 billion, as it also said it's planning to split into two companies in two yea..."},{"Date":"Feb. 14, 2020 at 8:00 p.m. ET","Headline":"Wall Street Views on Shopify, Pfizer, Quotient Tech, CN Railway, Lithia Motors","Summary":"Pfizer Inc.-backed biopharma company Imara Inc. filed  late Friday with the Securities and Exchange Commission, planning to list on the Nasdaq Global Market under the ticker symbol \"IMRA.\" According to the documents, Imara..."},{"Date":"Feb. 14, 2020 at 6:24 p.m. ET","Headline":"Pfizer-backed biopharma company Imara files for IPO","Summary":"Pfizer Inc.-backed biopharma company Imara Inc. filed  late Friday with the Securities and Exchange Commission, planning to list on the Nasdaq Global Market under the ticker symbol \"IMRA.\" According to the documents, Imara..."},{"Date":"Feb. 14, 2020 at 4:23 p.m. ET","Headline":"When Dividend Aristocrats Lose Their Status, Their Returns Often Improve","Summary":""},{"Date":"Feb. 13, 2020 at 12:29 p.m. ET","Headline":"Zoetis Stock Is Up Despite Disappointing Forecast. There\u2019s a Blockbuster Coming.","Summary":""},{"Date":"Feb. 13, 2020 at 7:15 a.m. ET","Headline":"Value-Oriented Dividend Stocks Will Pay Investors Who Wait, Strategist Says","Summary":""},{"Date":"Feb. 24, 2020 at 4:56 p.m. ET","Headline":"Here are the worst-performing stocks Monday as investors panic over the coronavirus","Summary":""},{"Date":"Feb. 25, 2020 at 4:44 p.m. ET","Headline":"These U.S. stocks skidded the most Tuesday as the market slides for the fourth straight day","Summary":"Back-to-back sharp selloffs for stock has sent the number of new 52-week lows on the NYSE spiking to a 14-month high. The Dow Jones Industrial Average  tumbled 907 points, or 3.2%, with all 30 components lowing ground in a..."},{"Date":"Feb. 25, 2020 at 2:42 p.m. ET","Headline":"New 52-week lows jump to 14-month high on NYSE; 6 Dow stocks hit new lows","Summary":"Back-to-back sharp selloffs for stock has sent the number of new 52-week lows on the NYSE spiking to a 14-month high. The Dow Jones Industrial Average  tumbled 907 points, or 3.2%, with all 30 components lowing ground in a..."},{"Date":"Feb. 25, 2020 at 2:41 p.m. ET","Headline":"These 2 Stocks in the Dow \u2014 and General Electric \u2014 Have Declined for 8 Straight Days","Summary":""},{"Date":"Feb. 28, 2020 at 9:07 a.m. ET","Headline":"FDA Reports First Drug Shortage Due to Coronavirus, Far Earlier Than Expected","Summary":""},{"Date":"Feb. 28, 2020 at 7:28 a.m. ET","Headline":"Here\u2019s how the 30 Dow industrials companies are prepping for the impact of the coronavirus","Summary":""},{"Date":"Mar. 3, 2020 at 4:48 p.m. ET","Headline":"These stocks took the biggest hit after the Fed\u2019s interest-rate cut sent markets reeling","Summary":""},{"Date":"Mar. 3, 2020 at 9:19 a.m. ET","Headline":"Pfizer Announced a Plan to Identify a Possible Coronavirus Treatment","Summary":""},{"Date":"Mar. 3, 2020 at 6:46 a.m. ET","Headline":"These are the 10 biggest stock winners Monday as the market rebounds from coronavirus rout","Summary":""},{"Date":"Mar. 5, 2020 at 6:36 a.m. ET","Headline":"These stocks soared the most after Biden burned Bernie on Super Tuesday","Summary":""},{"Date":"Mar. 4, 2020 at 2:01 p.m. ET","Headline":"UnitedHealth stock leads health-care stock rally after Biden\u2019s Super Tuesday victory","Summary":""},{"Date":"Mar. 4, 2020 at 7:30 a.m. ET","Headline":"A Healthy Dose of Income as Coronavirus Fears Grow","Summary":""},{"Date":"Mar. 7, 2020 at 9:21 a.m. ET","Headline":"Here are Friday\u2019s worst stock-market performers as oil takes the market down","Summary":""},{"Date":"Mar. 8, 2020 at 1:04 a.m. ET","Headline":"\u2018There is haunting silence\u2019: Life in Italy, one year after the nationwide lockdown to stop the spread of COVID-19","Summary":""},{"Date":"Mar. 13, 2020 at 5:47 a.m. ET","Headline":"These stocks sank the most during Thursday\u2019s rout, with declines of up to 53%","Summary":""},{"Date":"Mar. 12, 2020 at 6:56 a.m. ET","Headline":"These U.S. stocks fell the most after the coronavirus was upgraded to a pandemic","Summary":""},{"Date":"Mar. 17, 2020 at 9:17 a.m. ET","Headline":"Pfizer and BioNTech Are Teaming Up to Develop a Coronavirus Vaccine","Summary":"Pfizer Inc.  said Tuesday it will help develop and distribute BioNTech SE's COVID-19 vaccine candidate, though the deal excludes China. BioNTech , a German life sciences company, plans to put its vaccine candidate, BNT162,..."},{"Date":"Mar. 17, 2020 at 8:09 a.m. ET","Headline":"BioNTech, Pfizer to develop COVID-19 vaccine candidate","Summary":"Pfizer Inc.  said Tuesday it will help develop and distribute BioNTech SE's COVID-19 vaccine candidate, though the deal excludes China. BioNTech , a German life sciences company, plans to put its vaccine candidate, BNT162,..."},{"Date":"Mar. 16, 2020 at 10:27 a.m. ET","Headline":"A German Biotech\u2019s Stock Is Skyrocketing on Coronavirus Vaccine Hopes","Summary":""},{"Date":"Mar. 20, 2020 at 9:40 a.m. ET","Headline":"Does ibuprofen make the coronavirus worse? Is it still safe to take aspirin?","Summary":""},{"Date":"Mar. 27, 2020 at 4:33 p.m. ET","Headline":"Another mRNA Company Announced a Covid-19 Vaccine Program","Summary":""},{"Date":"Mar. 27, 2020 at 10:27 a.m. ET","Headline":"Coronavirus Means Fewer Stock Buybacks, Analyst Says. It Could Shake Up Biopharma.","Summary":""},{"Date":"Mar. 27, 2020 at 9:10 a.m. ET","Headline":"Pfizer and Mylan Postpone Upjohn Deal. Analysts Aren\u2019t Worried.","Summary":""},{"Date":"Mar. 27, 2020 at 7:50 a.m. ET","Headline":"This portfolio manager draws on 2008 lessons to find stocks that will outlast a pandemic","Summary":""},{"Date":"Mar. 27, 2020 at 6:43 a.m. ET","Headline":"Here are Thursday\u2019s best-performing stocks as the Dow Jones Industrial Average produces a three-day gain of 21%","Summary":""},{"Date":"Mar. 29, 2020 at 11:49 a.m. ET","Headline":"Drug makers on shaky ground as clinical trials are postponed and drug launches delayed amid pandemic","Summary":""},{"Date":"Mar. 30, 2020 at 2:05 p.m. ET","Headline":"When Will a Coronavirus Vaccine be Ready? These 9 Programs Are Making Progress.","Summary":""},{"Date":"Mar. 27, 2020 at 11:00 a.m. ET","Headline":"Big Pharma and Biotech Need to Do More in the Fight Against Covid-19","Summary":""},{"Date":"Apr. 2, 2020 at 3:13 p.m. ET","Headline":"Will companies in the Dow report earnings as usual despite COVID-19 disruptions, or delay them because they can?","Summary":""},{"Date":"Apr. 2, 2020 at 8:00 a.m. ET","Headline":"Thousands of U.S. Factories May Be Able to Be Retooled to Fight Coronavirus, According to a New Survey","Summary":""},{"Date":"Apr. 2, 2020 at 5:15 a.m. ET","Headline":"These U.S. stocks fell the most April 1 after Trump turned grim on coronavirus forecast","Summary":""},{"Date":"Apr. 1, 2020 at 6:36 a.m. ET","Headline":"Only one stock in the Dow rose during the first quarter \u2014 and it was up by only one penny","Summary":""},{"Date":"Apr. 3, 2020 at 5:24 p.m. ET","Headline":"3 S&P sectors climbed this week \u2014 here are the stocks that rose and fell the most","Summary":""},{"Date":"Apr. 6, 2020 at 5:16 p.m. ET","Headline":"Here are the biggest stock-market winners April 6, as major indexes jump at least 7%","Summary":""},{"Date":"Apr. 8, 2020 at 5:15 p.m. ET","Headline":"These stocks rose the most Wednesday, as laggards from previous trading sessions bounced back","Summary":""},{"Date":"Apr. 10, 2020 at 12:01 a.m. ET","Headline":"Oil Loses Gains After Saudi Arabia and Russia Reach a Tentative Deal","Summary":"Shares of Pfizer Inc.  were up 0.6% in premarket trading on Thursday after the drugmaker disclosed it is paying BioNTech  $185 million for their COVID-19 vaccine development collaboration, with additional possible future m..."},{"Date":"Apr. 9, 2020 at 5:28 p.m. ET","Headline":"The Dow Gained 286 Points Because the Fed Stepped Up Again","Summary":"Shares of Pfizer Inc.  were up 0.6% in premarket trading on Thursday after the drugmaker disclosed it is paying BioNTech  $185 million for their COVID-19 vaccine development collaboration, with additional possible future m..."},{"Date":"Apr. 9, 2020 at 4:37 p.m. ET","Headline":"Stocks Post Strong Gains for the Week","Summary":"Shares of Pfizer Inc.  were up 0.6% in premarket trading on Thursday after the drugmaker disclosed it is paying BioNTech  $185 million for their COVID-19 vaccine development collaboration, with additional possible future m..."},{"Date":"Apr. 9, 2020 at 9:56 a.m. ET","Headline":"Pfizer discloses $185 million upfront payment to BioNTech for COVID-19 vaccine program","Summary":"Shares of Pfizer Inc.  were up 0.6% in premarket trading on Thursday after the drugmaker disclosed it is paying BioNTech  $185 million for their COVID-19 vaccine development collaboration, with additional possible future m..."},{"Date":"Apr. 17, 2020 at 7:20 p.m. ET","Headline":"In a Pandemic, Pharma\u2019s Strengths Emerge: Pipelines With Essential Drugs","Summary":""},{"Date":"Apr. 22, 2020 at 8:17 a.m. ET","Headline":"The Dow's bounce is so far unanimous, with all 30 stocks gaining ground","Summary":"The Dow Jones Industrial Average's , following the first two-day drop in three weeks, is so far unanimous, as all 30 components are gaining ground in premarket trading. Leading the way, shares of Pfizer Inc.  rose 3.6%, Bo..."},{"Date":"Apr. 21, 2020 at 8:44 p.m. ET","Headline":"Here are Tuesday\u2019s worst stocks as the S&P 500 posts the biggest decline in three weeks","Summary":""},{"Date":"Apr. 24, 2020 at 11:07 a.m. ET","Headline":"Big Pharma Will Turn to Mergers After Crisis, Says RBC","Summary":""},{"Date":"Apr. 23, 2020 at 9:50 a.m. ET","Headline":"Should patents come before patients? How drug monopolies hamper the fight against coronavirus","Summary":""},{"Date":"Apr. 26, 2020 at 3:00 p.m. ET","Headline":"Tesla, Amazon, Boeing, and Other Stocks for Investors to Watch This Week","Summary":""},{"Date":"Apr. 28, 2020 at 4:49 p.m. ET","Headline":"U.S. stocks end lower as investors weigh earnings reports and prospects for reopening economy","Summary":"U.S. stock benchmarks opened higher Tuesday morning, with analysts citing progress toward easing coronavirus lockdowns as investors weighed earnings from blue-chip companies, including Merck and 3M Co. , Caterpillar  and P..."},{"Date":"Apr. 28, 2020 at 3:04 p.m. ET","Headline":"Coronavirus update: German infection rate ticks higher after reopening moves, offers lesson to U.S. governors","Summary":"U.S. stock benchmarks opened higher Tuesday morning, with analysts citing progress toward easing coronavirus lockdowns as investors weighed earnings from blue-chip companies, including Merck and 3M Co. , Caterpillar  and P..."},{"Date":"Apr. 28, 2020 at 2:00 p.m. ET","Headline":"Pfizer says coronavirus vaccine could be ready by the fall for emergency use","Summary":"U.S. stock benchmarks opened higher Tuesday morning, with analysts citing progress toward easing coronavirus lockdowns as investors weighed earnings from blue-chip companies, including Merck and 3M Co. , Caterpillar  and P..."},{"Date":"Apr. 28, 2020 at 9:36 a.m. ET","Headline":"Dow jumps more than 300 points at Tuesday's open, nears best level since early March as lockdown easing fuels bulls","Summary":"U.S. stock benchmarks opened higher Tuesday morning, with analysts citing progress toward easing coronavirus lockdowns as investors weighed earnings from blue-chip companies, including Merck and 3M Co. , Caterpillar  and P..."},{"Date":"Apr. 28, 2020 at 9:25 a.m. ET","Headline":"Dow's earnings reporters add nearly a net 50 points to the Dow's price, led by 3M's stock rally","Summary":"The four components of the Dow Jones Industrial Average  that reported first-quarter earnings Tuesday are providing a net boost of about 47 points to the Dow's price, with 3M Co.'s stock  adding the most and .'s stock  the..."},{"Date":"Apr. 28, 2020 at 9:16 a.m. ET","Headline":"Pfizer and Merck Earnings Were Good. Here\u2019s Why Their Stocks Are Going In Opposite Directions.","Summary":"Shares of Pfizer Inc.  gained 2.0% in premarket trading on Tuesday after the drugmaker beat expectations for the first quarter. The company had net earnings of $3.4 billion, or 60 cents a share, in the quarter, down from $..."},{"Date":"Apr. 28, 2020 at 7:38 a.m. ET","Headline":"Pfizer said sales of Eliquis, hospital products rose in Q1 on COVID-19 demand","Summary":"Shares of Pfizer Inc.  gained 2.0% in premarket trading on Tuesday after the drugmaker beat expectations for the first quarter. The company had net earnings of $3.4 billion, or 60 cents a share, in the quarter, down from $..."},{"Date":"Apr. 29, 2020 at 5:15 p.m. ET","Headline":"Here are the stock market\u2019s biggest winners on Wednesday as investors see new hope","Summary":""},{"Date":"May. 2, 2020 at 7:18 a.m. ET","Headline":"Here are Friday\u2019s biggest stock-market losers, driven lower by disappointing earnings and a shrinking manufacturing sector","Summary":""},{"Date":"May. 6, 2020 at 2:50 p.m. ET","Headline":"These 23 companies are working on coronavirus treatments or vaccines \u2014 here\u2019s where things stand","Summary":"Shares of BioNTech SE  rallied 4.8% in premarket trading, after the immunotherapy company and Pfizer Inc.  said Tuesday that the first participants in the phase 1\/2 trial for the BNT162 vaccine program to prevent COVID-19 ..."},{"Date":"May. 5, 2020 at 5:43 p.m. ET","Headline":"The Dow Rose 133 Points Because a Restarted Economy Can Mask Some Problems","Summary":"Shares of BioNTech SE  rallied 4.8% in premarket trading, after the immunotherapy company and Pfizer Inc.  said Tuesday that the first participants in the phase 1\/2 trial for the BNT162 vaccine program to prevent COVID-19 ..."},{"Date":"May. 5, 2020 at 4:53 p.m. ET","Headline":"U.S. stocks eke out second day of gains as states work to ease lockdowns and researchers race for vaccines","Summary":"Shares of BioNTech SE  rallied 4.8% in premarket trading, after the immunotherapy company and Pfizer Inc.  said Tuesday that the first participants in the phase 1\/2 trial for the BNT162 vaccine program to prevent COVID-19 ..."},{"Date":"May. 5, 2020 at 2:34 p.m. ET","Headline":"Coronavirus update: Death tally tops 250,000; reports say internal projections show government expects surge in COVID-19 cases","Summary":"Shares of BioNTech SE  rallied 4.8% in premarket trading, after the immunotherapy company and Pfizer Inc.  said Tuesday that the first participants in the phase 1\/2 trial for the BNT162 vaccine program to prevent COVID-19 ..."},{"Date":"May. 5, 2020 at 1:59 p.m. ET","Headline":"Gold prices post first loss in 3 sessions","Summary":"Shares of BioNTech SE  rallied 4.8% in premarket trading, after the immunotherapy company and Pfizer Inc.  said Tuesday that the first participants in the phase 1\/2 trial for the BNT162 vaccine program to prevent COVID-19 ..."},{"Date":"May. 5, 2020 at 12:49 p.m. ET","Headline":"ICE partners with Amazon, 3M and Pfizer to identify counterfeit coronavirus gear","Summary":"Shares of BioNTech SE  rallied 4.8% in premarket trading, after the immunotherapy company and Pfizer Inc.  said Tuesday that the first participants in the phase 1\/2 trial for the BNT162 vaccine program to prevent COVID-19 ..."},{"Date":"May. 5, 2020 at 10:11 a.m. ET","Headline":"Pfizer and BioNTech Begin Giving U.S. Test Participants a Potential Covid-19 Vaccine","Summary":"Shares of BioNTech SE  rallied 4.8% in premarket trading, after the immunotherapy company and Pfizer Inc.  said Tuesday that the first participants in the phase 1\/2 trial for the BNT162 vaccine program to prevent COVID-19 ..."},{"Date":"May. 5, 2020 at 6:57 a.m. ET","Headline":"BioNTech, Pfizer stocks rally after first participants in U.S. trial of COVID-19 vaccine were dosed","Summary":"Shares of BioNTech SE  rallied 4.8% in premarket trading, after the immunotherapy company and Pfizer Inc.  said Tuesday that the first participants in the phase 1\/2 trial for the BNT162 vaccine program to prevent COVID-19 ..."},{"Date":"May. 8, 2020 at 4:53 p.m. ET","Headline":"This PayPal Options Move Is Better Than Cash","Summary":""},{"Date":"May. 7, 2020 at 5:45 p.m. ET","Headline":"The Dow Rose 211 Points Because Coronavirus Vaccines and Trade Talks Look Possible","Summary":""},{"Date":"May. 7, 2020 at 4:56 p.m. ET","Headline":"Dow ends up 211 points but gains were cut in half headed into the close as Pfizer\u2019s stock slump weighed","Summary":""},{"Date":"May. 11, 2020 at 4:51 p.m. ET","Headline":"Dow ends 100 points lower, leaving stock benchmarks mixed amid skepticism over re-openings","Summary":"Exchange-traded funds that track the health care sector pushed higher Monday as investors watched for progress on coronavirus treatments. The Select Sector SPDR ETF that tracks health care, often known by its ticker, XLV, ..."},{"Date":"May. 11, 2020 at 1:12 p.m. ET","Headline":"Health-care ETFs rise as coronavirus treatments take center stage","Summary":"Exchange-traded funds that track the health care sector pushed higher Monday as investors watched for progress on coronavirus treatments. The Select Sector SPDR ETF that tracks health care, often known by its ticker, XLV, ..."},{"Date":"May. 11, 2020 at 8:50 a.m. ET","Headline":"Mylan's stock gains 2%; guidance for 2020 reaffirmed","Summary":"Shares of Mylan  gained 0.1% in premarket trading on Monday after the drugmaker reaffirmed its revenue guidance for the year. Mylan had earnings of $20.8 million, or 4 cents per share, in the first quarter of 2020, after a..."},{"Date":"May. 16, 2020 at 3:10 p.m. ET","Headline":"Economic expert with perfect record calling recessions is betting this one will be over by the end of 2020","Summary":""},{"Date":"May. 18, 2020 at 5:01 p.m. ET","Headline":"Here are Monday\u2019s best stock-market performers as airlines and cruise lines shine","Summary":"A company mostly held by GlaxoSmithKline said it's ending its study early after finding long-acting injectable formulation of cabotegravir dosed every two months shows higher efficacy than daily oral PrEP in preventing HIV..."},{"Date":"May. 18, 2020 at 2:05 p.m. ET","Headline":"Here\u2019s what it will take for the stock market to hit a new record within 2 months","Summary":"A company mostly held by GlaxoSmithKline said it's ending its study early after finding long-acting injectable formulation of cabotegravir dosed every two months shows higher efficacy than daily oral PrEP in preventing HIV..."},{"Date":"May. 18, 2020 at 2:29 a.m. ET","Headline":"Glaxo-held firm ends HIV study early as injectable shows higher efficacy than daily pill","Summary":"A company mostly held by GlaxoSmithKline said it's ending its study early after finding long-acting injectable formulation of cabotegravir dosed every two months shows higher efficacy than daily oral PrEP in preventing HIV..."},{"Date":"May. 15, 2020 at 7:16 p.m. ET","Headline":"Inside the Science and Companies Racing to Develop a Covid-19 Vaccine","Summary":""},{"Date":"May. 19, 2020 at 11:39 a.m. ET","Headline":"A Covid-19 Vaccine Could Be Worth Billions for Moderna and Its Rivals","Summary":""},{"Date":"May. 6, 2020 at 7:59 a.m. ET","Headline":"Disney Is the Unhappiest Place on Earth Right Now and 5 Other Things to Know This Morning","Summary":""},{"Date":"May. 22, 2020 at 3:49 p.m. ET","Headline":"Chinese Covid-19 Vaccine Trial Results Are a Good Sign for J&J and AstraZeneca\u2019s Efforts","Summary":""},{"Date":"May. 22, 2020 at 7:29 a.m. ET","Headline":"Everything you need to know about the Oxford University vaccine and other efforts to beat coronavirus","Summary":""},{"Date":"May. 21, 2020 at 10:46 a.m. ET","Headline":"For Moderna, a Coronavirus Vaccine Would Be the \u201cTip of the Iceberg\u201d","Summary":""},{"Date":"May. 21, 2020 at 8:31 a.m. ET","Headline":"U.S. to invest $1.2 billion to secure potential coronavirus vaccine from AstraZeneca, Oxford University","Summary":""},{"Date":"May. 21, 2020 at 8:25 a.m. ET","Headline":"Stocks Sink on Trump Tweets and Five More Things to Know","Summary":""},{"Date":"May. 26, 2020 at 10:54 a.m. ET","Headline":"Anti-anxiety medication prescriptions have spiked 34% during the coronavirus pandemic","Summary":""},{"Date":"May. 26, 2020 at 8:17 a.m. ET","Headline":"Vaccines Are All That Matter for the Market and 5 More Things to Know","Summary":""},{"Date":"May. 26, 2020 at 10:13 a.m. ET","Headline":"Merck Dives Into Covid-19 Fray With Two Vaccines and One Antiviral","Summary":""},{"Date":"May. 29, 2020 at 4:46 p.m. ET","Headline":"Pfizer stock plunges 7% after breast cancer study halted","Summary":"Pfizer Inc.  shares fell 7% in after-hours trading Friday after the company reported that a study of a potential breast-cancer treatment was halted because it was unlikely to achieve its goal. Pfizer said that a phase 3 st..."},{"Date":"Jun. 1, 2020 at 4:45 p.m. ET","Headline":"Stocks Rose But There\u2019s Still Tension With China","Summary":"The Dow Jones Industrial booked its first gain of the past three sessions on Monday to start trading for the week and month of June. Markets appeared to be heartened by upbeat data from the Institute for Supply Management,..."},{"Date":"Jun. 1, 2020 at 4:37 p.m. ET","Headline":"Dow ends modestly higher as Wall Street looks beyond civil unrest to hopes for economic recovery","Summary":"The Dow Jones Industrial booked its first gain of the past three sessions on Monday to start trading for the week and month of June. Markets appeared to be heartened by upbeat data from the Institute for Supply Management,..."},{"Date":"Jun. 1, 2020 at 4:09 p.m. ET","Headline":"Dow notches first gain in 3 sessions to kick of June as stock market shakes off worry about civil unrest and China","Summary":"The Dow Jones Industrial booked its first gain of the past three sessions on Monday to start trading for the week and month of June. Markets appeared to be heartened by upbeat data from the Institute for Supply Management,..."},{"Date":"Jun. 1, 2020 at 3:18 p.m. ET","Headline":"The Stock Market Is Rising Despite All the Negative Headlines. Here\u2019s Why.","Summary":"Share of Pfizer Inc.  tumbled 6.5% in premarket trading Monday, enough to pace all of the Dow Jones Industrial Average'  s early decliners after the drug maker said it . The implied price decline would shave about 17 point..."},{"Date":"Jun. 1, 2020 at 12:17 p.m. ET","Headline":"Pfizer\u2019s Breast Cancer Treatment Fails in an Advanced Trial. The Stock Is Falling.","Summary":"Share of Pfizer Inc.  tumbled 6.5% in premarket trading Monday, enough to pace all of the Dow Jones Industrial Average'  s early decliners after the drug maker said it . The implied price decline would shave about 17 point..."},{"Date":"Jun. 1, 2020 at 8:57 a.m. ET","Headline":"Pfizer's stock tumbles to pace the Dow's decliners, would cut about 17 points off the Dow's price","Summary":"Share of Pfizer Inc.  tumbled 6.5% in premarket trading Monday, enough to pace all of the Dow Jones Industrial Average'  s early decliners after the drug maker said it . The implied price decline would shave about 17 point..."},{"Date":"Jun. 1, 2020 at 8:04 a.m. ET","Headline":"Tesla, Space Stocks Are Soaring. China Tensions, Protests Fail to Move the Dow.","Summary":""},{"Date":"Jun. 1, 2020 at 6:42 a.m. ET","Headline":"These stocks performed best in May as the market rally continued","Summary":""},{"Date":"Jun. 2, 2020 at 4:42 p.m. ET","Headline":"Dow closes 267 points higher as Wall Street focuses on easing coronavirus lockdowns amid civil unrest","Summary":"Pfizer Inc.  said Tuesday it is planning to invest up to $500 million in biotech companies to support the sector's most promising clinical development programs. \"There has never been a more important moment to pursue new c..."},{"Date":"Jun. 2, 2020 at 3:12 p.m. ET","Headline":"Coronavirus update: U.S. case tally tops 1.8 million; study finds face masks, social distancing effective at reducing infections","Summary":"Pfizer Inc.  said Tuesday it is planning to invest up to $500 million in biotech companies to support the sector's most promising clinical development programs. \"There has never been a more important moment to pursue new c..."},{"Date":"Jun. 2, 2020 at 9:16 a.m. ET","Headline":"Buy Lilly, AbbVie and Merck Stocks, J.P. Morgan Says, but Pfizer Is Still Expensive","Summary":"Pfizer Inc.  said Tuesday it is planning to invest up to $500 million in biotech companies to support the sector's most promising clinical development programs. \"There has never been a more important moment to pursue new c..."},{"Date":"Jun. 2, 2020 at 6:09 a.m. ET","Headline":"Pfizer to invest up to $500 million in small and medium-sized biotech companies","Summary":"Pfizer Inc.  said Tuesday it is planning to invest up to $500 million in biotech companies to support the sector's most promising clinical development programs. \"There has never been a more important moment to pursue new c..."},{"Date":"Jun. 4, 2020 at 11:38 a.m. ET","Headline":"Gates Pledges $1.6 Billion for Vaccines. What That Means for Covid-19 and Other Diseases.","Summary":""},{"Date":"Jun. 4, 2020 at 4:30 a.m. ET","Headline":"GlaxoSmithKline\u2019s Promising Drug Pipeline Should Drive the Stock Higher","Summary":""},{"Date":"Jun. 6, 2020 at 3:38 p.m. ET","Headline":"These stocks rose by double digits Friday as underperforming sectors bounced back","Summary":""},{"Date":"Jun. 6, 2020 at 12:03 p.m. ET","Headline":"Buy this, not that \u2014 5 stocks to trade into now and 5 to avoid","Summary":""},{"Date":"Jun. 11, 2020 at 8:23 a.m. ET","Headline":"Moderna Will Start Testing Its Covid-19 Vaccine on 30,000 People in July","Summary":""},{"Date":"Jun. 7, 2020 at 3:44 p.m. ET","Headline":"AstraZeneca Reportedly Talked to Gilead About a Merger. Why There\u2019s Reason to Be Skeptical.","Summary":""},{"Date":"Jun. 12, 2020 at 6:49 a.m. ET","Headline":"These U.S. stocks led the market\u2019s brutal decline Thursday","Summary":""},{"Date":"Jun. 15, 2020 at 11:45 a.m. ET","Headline":"Germany Makes a Big Bet On a Covid-19 Vaccine Developer Once Coveted by Trump","Summary":""},{"Date":"Jun. 15, 2020 at 8:40 a.m. ET","Headline":"Lilly Is Testing Its Arthritis Drug as a Coronavirus Treatment","Summary":""},{"Date":"Jun. 17, 2020 at 10:11 a.m. ET","Headline":"Lilly Stock Has a 10% Upside, Guggenheim Says","Summary":""},{"Date":"Jun. 17, 2020 at 9:47 a.m. ET","Headline":"Thirty-nine-year-old wife of Kentucky congressman dies suddenly","Summary":""},{"Date":"Jun. 16, 2020 at 3:21 p.m. ET","Headline":"Royalty Pharma Jumps 58% From Its IPO. That\u2019s More Money for Drug Research.","Summary":""},{"Date":"Jun. 16, 2020 at 12:06 p.m. ET","Headline":"Moderna Is Racing Toward a Covid-19 Vaccine, but the Field Is Getting Crowded","Summary":""},{"Date":"Jun. 16, 2020 at 10:49 a.m. ET","Headline":"Eli Lilly\u2019s Cancer Drug Succeeded Where Pfizer Failed. What It Means for Their Stocks.","Summary":""},{"Date":"Jun. 19, 2020 at 11:00 a.m. ET","Headline":"Mylan Is Eager to Launch Rival Version of Biogen\u2019s Biggest-Selling Drug After Court Win","Summary":""},{"Date":"Jun. 18, 2020 at 4:12 p.m. ET","Headline":"A Stockpicker on the Reshaping of Health Care","Summary":""},{"Date":"Jun. 20, 2020 at 8:45 p.m. ET","Headline":"Here are the best and worst stocks during the first 100 days of the coronavirus pandemic","Summary":""},{"Date":"Jun. 20, 2020 at 12:11 p.m. ET","Headline":"Here\u2019s why the FDA may approve a Covid-19 vaccine before the November elections, according to Jefferies\u2019 biotech-research team","Summary":""},{"Date":"Jun. 23, 2020 at 5:00 p.m. ET","Headline":"Fauci Say Testing Will Increase, Vaccine Expected by Early 2021","Summary":""},{"Date":"Jun. 23, 2020 at 10:28 a.m. ET","Headline":"Translate Bio Stock Up 50% as Sanofi Commits $1.9 Billion to Its Covid-19 Vaccine","Summary":""},{"Date":"Jun. 25, 2020 at 11:43 a.m. ET","Headline":"Moderna Is the Latest Coronavirus Vaccine Partner for Catalent","Summary":""},{"Date":"Jun. 24, 2020 at 5:00 a.m. ET","Headline":"355 Retailers File for Bankruptcy, and Two More Numbers to Know","Summary":""},{"Date":"Jun. 26, 2020 at 9:41 a.m. ET","Headline":"Regeneron Used a Charity to Pay Kickbacks, Justice Department Alleges","Summary":""},{"Date":"Jun. 29, 2020 at 2:06 p.m. ET","Headline":"Race for a COVID-19 vaccine has drug makers scaling up manufacturing \u2014 before one is developed","Summary":""},{"Date":"Jun. 29, 2020 at 8:46 a.m. ET","Headline":"Trump Is Losing in the Polls. How to Invest for a Joe Biden Presidency.","Summary":""},{"Date":"Jun. 28, 2020 at 6:19 p.m. ET","Headline":"FedEx, Micron, June Jobs Data, Fed Minutes, and More for Investors to Watch This Week","Summary":""},{"Date":"Jun. 28, 2020 at 11:51 a.m. ET","Headline":"Why Amazon Should Buy Macy\u2019s","Summary":""},{"Date":"Jul. 1, 2020 at 11:41 p.m. ET","Headline":"Asian markets rise on vaccine hopes, signs of improving global economy","Summary":"The Nasdaq Composite on Wednesday closed at a record high to kick off July but the Dow industrials lagged behind, after minutes from the Federal Reserve's meeting  last month indicated that policy makers would aim to provi..."},{"Date":"Jul. 1, 2020 at 5:35 p.m. ET","Headline":"The Dow Just Dropped 78 Points. Here Are 3 Reasons to Be Optimistic About the Market.","Summary":"The Nasdaq Composite on Wednesday closed at a record high to kick off July but the Dow industrials lagged behind, after minutes from the Federal Reserve's meeting  last month indicated that policy makers would aim to provi..."},{"Date":"Jul. 1, 2020 at 4:54 p.m. ET","Headline":"Nasdaq Hits New High But Dow Closes Down Slightly","Summary":"The Nasdaq Composite on Wednesday closed at a record high to kick off July but the Dow industrials lagged behind, after minutes from the Federal Reserve's meeting  last month indicated that policy makers would aim to provi..."},{"Date":"Jul. 1, 2020 at 4:51 p.m. ET","Headline":"Nasdaq sets record close, Dow ends lower to kick off July after Fed vows to guide markets on rates path","Summary":"The Nasdaq Composite on Wednesday closed at a record high to kick off July but the Dow industrials lagged behind, after minutes from the Federal Reserve's meeting  last month indicated that policy makers would aim to provi..."},{"Date":"Jul. 1, 2020 at 4:09 p.m. ET","Headline":"Nasdaq notches record close to start July after Fed minutes, but Dow slumps as Boeing, Exxon shares weigh","Summary":"The Nasdaq Composite on Wednesday closed at a record high to kick off July but the Dow industrials lagged behind, after minutes from the Federal Reserve's meeting  last month indicated that policy makers would aim to provi..."},{"Date":"Jul. 1, 2020 at 12:05 p.m. ET","Headline":"Stocks Are Wavering. There\u2019s Good News on a Vaccine as Virus Spreads.","Summary":"BioNTech's  stock was halted and shares of Pfizer Inc.  gained 4.7% in trading on Wednesday morning after the companies said that all 24 participants in the Phase 1\/2 clinical trial who received one of two lower doses of a..."},{"Date":"Jul. 1, 2020 at 11:06 a.m. ET","Headline":"Dow Turns Losses Into Gains After Pfizer Releases Vaccine Data","Summary":"BioNTech's  stock was halted and shares of Pfizer Inc.  gained 4.7% in trading on Wednesday morning after the companies said that all 24 participants in the Phase 1\/2 clinical trial who received one of two lower doses of a..."},{"Date":"Jul. 1, 2020 at 10:21 a.m. ET","Headline":"Pfizer Offers Hope, and Details, on Potential Coronavirus Vaccine","Summary":"BioNTech's  stock was halted and shares of Pfizer Inc.  gained 4.7% in trading on Wednesday morning after the companies said that all 24 participants in the Phase 1\/2 clinical trial who received one of two lower doses of a..."},{"Date":"Jul. 1, 2020 at 9:36 a.m. ET","Headline":"BioNTech's stock halted, Pfizer shares jump on promising COVID-19 vaccine data","Summary":"BioNTech's  stock was halted and shares of Pfizer Inc.  gained 4.7% in trading on Wednesday morning after the companies said that all 24 participants in the Phase 1\/2 clinical trial who received one of two lower doses of a..."},{"Date":"Jul. 1, 2020 at 9:36 a.m. ET","Headline":"Stocks open  moderately higher after promising vaccine news","Summary":"U.S. stocks opened moderately higher Wednesday, lifted by encouraging news on a vaccine for COVID-19. The Dow Jones Industrial Average  rose 76 points, 0.3%, to start trading near 25,889, while the S&P 500  added 7 points,..."},{"Date":"Jun. 30, 2020 at 11:14 a.m. ET","Headline":"Facebook Stock Takes a Pounding. How to Play Its Likely Comeback.","Summary":""},{"Date":"Jul. 2, 2020 at 7:30 p.m. ET","Headline":"Sold on eBay Stock","Summary":""},{"Date":"Jul. 2, 2020 at 4:38 p.m. ET","Headline":"Stocks Close Higher on Strong U.S. Jobs Data","Summary":""},{"Date":"Jul. 2, 2020 at 4:37 p.m. ET","Headline":"The Number of Covid-19 Cases Is Rising. What Comes Next.","Summary":""},{"Date":"Jul. 2, 2020 at 2:10 p.m. ET","Headline":"Moderna Stock Tumbles on Report of Covid-19 Vaccine Trial Delay","Summary":""},{"Date":"Jul. 2, 2020 at 12:43 p.m. ET","Headline":"Strong Jobs Data Boost Stocks Even as Covid Cases Reach Record","Summary":""},{"Date":"Jul. 2, 2020 at 12:39 p.m. ET","Headline":"U.K. stocks rise after U.S. jobs boost but lag behind European peers","Summary":""},{"Date":"Jul. 2, 2020 at 12:34 p.m. ET","Headline":"European stocks surge as U.S. economy adds 4.8 million jobs in June","Summary":""},{"Date":"Jul. 2, 2020 at 9:32 a.m. ET","Headline":"What could save the stock market in July? More government borrowing and Federal Reserve money printing","Summary":""},{"Date":"Jul. 2, 2020 at 9:09 a.m. ET","Headline":"Pfizer Stock Rises as Company Unveils Aggressive Timeline for Coronavirus Vaccine","Summary":""},{"Date":"Jul. 2, 2020 at 8:07 a.m. ET","Headline":"An Unhappy 4th of July","Summary":""},{"Date":"Jul. 2, 2020 at 6:21 a.m. ET","Headline":"Coronavirus update: U.S. case tally climbs above 2.6 million, and top Republicans now call on Americans to wear face masks","Summary":""},{"Date":"Jul. 4, 2020 at 11:20 a.m. ET","Headline":"These stocks, including Tesla and Apple, are the real winners for the second quarter of 2020","Summary":""},{"Date":"Jul. 4, 2020 at 9:25 a.m. ET","Headline":"After months of speculation, investors get excited about Pfizer, BioNTech\u2019s coronavirus vaccine candidate","Summary":""},{"Date":"Jul. 7, 2020 at 9:02 a.m. ET","Headline":"Novavax Stock Soars After a $1.6 Billion U.S. Infusion for a Covid-19 Vaccine","Summary":""},{"Date":"Jul. 6, 2020 at 7:47 a.m. ET","Headline":"Stock Market Soars Because Good News Comes in Threes","Summary":""},{"Date":"Jul. 6, 2020 at 5:00 a.m. ET","Headline":"What a Democratic Sweep Could Mean for the Market","Summary":""},{"Date":"Jul. 8, 2020 at 8:46 a.m. ET","Headline":"Can Biotechs Finish the Race for a Covid-19 Vaccine?","Summary":""},{"Date":"Jul. 10, 2020 at 4:26 p.m. ET","Headline":"BioNTech\u2019s CEO Strikes Sober Note Amid Vaccine Scramble, While Warning It Could Take a Decade to Beat Covid-19","Summary":""},{"Date":"Jul. 10, 2020 at 12:39 p.m. ET","Headline":"United and Other Airline Stocks Are Up on Coronavirus Treatments and Cost-Cutting","Summary":""},{"Date":"Jul. 13, 2020 at 5:21 p.m. ET","Headline":"The Dow Gained 11 Points Because Tech Stocks Finally Sold Off","Summary":"U.S. stock indexes squandered a powerful, technology-led rally Monday, with gains collapsing as California signaled that it was re-imposing some restrictions on business reopenings as coronavirus cases rise in the Golden s..."},{"Date":"Jul. 13, 2020 at 4:37 p.m. ET","Headline":"Nasdaq, S&P 500 end lower as coronavirus cases rise and tech stock fall, erasing rally sparked by renewed vaccine hopes","Summary":"U.S. stock indexes squandered a powerful, technology-led rally Monday, with gains collapsing as California signaled that it was re-imposing some restrictions on business reopenings as coronavirus cases rise in the Golden s..."},{"Date":"Jul. 13, 2020 at 4:13 p.m. ET","Headline":"Nasdaq tumbles 2.1% to mark biggest intraday reversal in 3 months as California orders rollback on eased coronavirus restrictions","Summary":"U.S. stock indexes squandered a powerful, technology-led rally Monday, with gains collapsing as California signaled that it was re-imposing some restrictions on business reopenings as coronavirus cases rise in the Golden s..."},{"Date":"Jul. 13, 2020 at 4:13 p.m. ET","Headline":"California Closes Indoor Dining, Bars and Movie Theaters as Cases Rise","Summary":"U.S. stocks jumped at the start of trading Monday after the Food and Drug Administration granted \"fast track\" status to two coronavirus vaccine candidates. The Dow Jones Industrial Average  rose 217 points, 0.8%, to open n..."},{"Date":"Jul. 13, 2020 at 3:40 p.m. ET","Headline":"Stocks\u2019 Rally Loses Steam With S&P and Nasdaq Both Closing Down","Summary":"U.S. stocks jumped at the start of trading Monday after the Food and Drug Administration granted \"fast track\" status to two coronavirus vaccine candidates. The Dow Jones Industrial Average  rose 217 points, 0.8%, to open n..."},{"Date":"Jul. 13, 2020 at 12:03 p.m. ET","Headline":"Hope for a Vaccine and Strong Earnings Is Sending Stocks Higher","Summary":"U.S. stocks jumped at the start of trading Monday after the Food and Drug Administration granted \"fast track\" status to two coronavirus vaccine candidates. The Dow Jones Industrial Average  rose 217 points, 0.8%, to open n..."},{"Date":"Jul. 13, 2020 at 9:44 a.m. ET","Headline":"Pfizer, BioNTech Are Surging Because the FDA Fast Tracked Their Covid-19 Vaccines","Summary":"U.S. stocks jumped at the start of trading Monday after the Food and Drug Administration granted \"fast track\" status to two coronavirus vaccine candidates. The Dow Jones Industrial Average  rose 217 points, 0.8%, to open n..."},{"Date":"Jul. 13, 2020 at 9:38 a.m. ET","Headline":"Nasdaq hits record high Monday's open as stock market buoyed by coronavirus vaccine hope","Summary":"U.S. stocks jumped at the start of trading Monday after the Food and Drug Administration granted \"fast track\" status to two coronavirus vaccine candidates. The Dow Jones Industrial Average  rose 217 points, 0.8%, to open n..."},{"Date":"Jul. 13, 2020 at 8:28 a.m. ET","Headline":"The Dow Is Flying, PepsiCo Stock Is Jumping, and Tesla Is Climbing Again","Summary":"Shares of Pfizer Inc.  rallied 2.3% and of BioNTech SE  jumped 5.3% in premarket trading Monday, after the companies said two of their vaccine candidates to protect against the virus that causes COVID-19 received Fast Trac..."},{"Date":"Jul. 13, 2020 at 6:57 a.m. ET","Headline":"Pfizer, BioNTech stocks surge after COVID-19 vaccine candidates get Fast Track designation","Summary":"Shares of Pfizer Inc.  rallied 2.3% and of BioNTech SE  jumped 5.3% in premarket trading Monday, after the companies said two of their vaccine candidates to protect against the virus that causes COVID-19 received Fast Trac..."},{"Date":"Jul. 15, 2020 at 11:23 a.m. ET","Headline":"AstraZeneca Stock Jumps on Report of Positive Data on Covid-19 Vaccine Trial","Summary":""},{"Date":"Jul. 15, 2020 at 10:13 a.m. ET","Headline":"Moderna Stock Surges as Wall Street Gives Thumbs Up to Vaccine Data","Summary":""},{"Date":"Jul. 14, 2020 at 10:48 a.m. ET","Headline":"Looking for extra income? These blue-chip stocks may crush bonds with a 5% payout","Summary":""},{"Date":"Jul. 14, 2020 at 6:07 a.m. ET","Headline":"Coronavirus update: Global case tally edges toward 13 million, and Florida trounces one-day case record set by California last week","Summary":""},{"Date":"Jul. 17, 2020 at 2:44 p.m. ET","Headline":"Race for a Covid-19 Vaccine Might Have Political Side Effects","Summary":""},{"Date":"Jul. 17, 2020 at 12:57 p.m. ET","Headline":"Here are the major brands that have pulled ads from Facebook","Summary":""},{"Date":"Jul. 17, 2020 at 6:30 a.m. ET","Headline":"5 Biopharma Stocks That Are Affordable And Growing","Summary":""},{"Date":"Jul. 16, 2020 at 6:23 a.m. ET","Headline":"Moderna\u2019s stock extends rally as experts await details of the coming Phase 3 study of the coronavirus vaccine candidate","Summary":""},{"Date":"Jul. 21, 2020 at 4:09 p.m. ET","Headline":"Lawmaker Presses Drugmakers on Covid-19 Vaccine Pricing","Summary":"BioNTech SE  said Tuesday it is planning an offering of 5 million American Depositary Shares in a syndicated deal and will follow it with a rights offering. The German biotech, which is working with Pfizer Inc.  to develop..."},{"Date":"Jul. 21, 2020 at 3:40 p.m. ET","Headline":"Oil prices climb by more than 2% to four-month high as EU agrees to stimulus package","Summary":"BioNTech SE  said Tuesday it is planning an offering of 5 million American Depositary Shares in a syndicated deal and will follow it with a rights offering. The German biotech, which is working with Pfizer Inc.  to develop..."},{"Date":"Jul. 21, 2020 at 2:24 p.m. ET","Headline":"You should invest in big banks now for their rich dividends","Summary":"BioNTech SE  said Tuesday it is planning an offering of 5 million American Depositary Shares in a syndicated deal and will follow it with a rights offering. The German biotech, which is working with Pfizer Inc.  to develop..."},{"Date":"Jul. 21, 2020 at 11:16 a.m. ET","Headline":"Vaccine Makers Tell Congress They Are Hopeful, but Challenges Remain","Summary":"BioNTech SE  said Tuesday it is planning an offering of 5 million American Depositary Shares in a syndicated deal and will follow it with a rights offering. The German biotech, which is working with Pfizer Inc.  to develop..."},{"Date":"Jul. 21, 2020 at 9:56 a.m. ET","Headline":"Analysts Are Starting to Pick Their Covid-19 Vaccine Winners, but There\u2019s Still a Long Way to Go","Summary":"BioNTech SE  said Tuesday it is planning an offering of 5 million American Depositary Shares in a syndicated deal and will follow it with a rights offering. The German biotech, which is working with Pfizer Inc.  to develop..."},{"Date":"Jul. 21, 2020 at 9:02 a.m. ET","Headline":"BioNTech to offer 5 million ADS and follow with rights offering","Summary":"BioNTech SE  said Tuesday it is planning an offering of 5 million American Depositary Shares in a syndicated deal and will follow it with a rights offering. The German biotech, which is working with Pfizer Inc.  to develop..."},{"Date":"Jul. 21, 2020 at 8:21 a.m. ET","Headline":"Europe\u2019s Hamiltonian Moment","Summary":"U.S. Treasury yields edge lower on Monday as investors track developments around fiscal stimulus packages by U.S. and European Union leaders."},{"Date":"Jul. 21, 2020 at 6:25 a.m. ET","Headline":"Investors cheer as two coronavirus vaccine candidates report T-cell responses, but findings are still early stage","Summary":"U.S. Treasury yields edge lower on Monday as investors track developments around fiscal stimulus packages by U.S. and European Union leaders."},{"Date":"Jul. 20, 2020 at 4:53 p.m. ET","Headline":"Nasdaq clinches record high as tech stocks propel Dow, S&P 500 ahead of earnings crush","Summary":"U.S. Treasury yields edge lower on Monday as investors track developments around fiscal stimulus packages by U.S. and European Union leaders."},{"Date":"Jul. 20, 2020 at 4:31 p.m. ET","Headline":"Treasury yields edge up off lows on vaccine and fiscal-stimulus hopes","Summary":"U.S. Treasury yields edge lower on Monday as investors track developments around fiscal stimulus packages by U.S. and European Union leaders."},{"Date":"Jul. 20, 2020 at 4:21 p.m. ET","Headline":"A coronavirus vaccine may not be beneficial for your favorite stocks","Summary":"Technology stocks resumed a run to all-time highs on Monday, with the Nasdaq Composite, marking a fresh closing record, ahead of a clutch of corporate results from some of the biggest titans of technology and tech-related ..."},{"Date":"Jul. 20, 2020 at 4:07 p.m. ET","Headline":"Nasdaq books 28th record close of 2020 with 2.5% surge ahead of barrage of tech-stock quarterly results","Summary":"Technology stocks resumed a run to all-time highs on Monday, with the Nasdaq Composite, marking a fresh closing record, ahead of a clutch of corporate results from some of the biggest titans of technology and tech-related ..."},{"Date":"Jul. 20, 2020 at 1:57 p.m. ET","Headline":"The Dow Treads Water as Investors Await Earnings. Amazon Jumps After Upgrade.","Summary":"Shares of AstraZeneca  were down 3.4% in trading on Monday after a medical journal published a study that found the company's COVID-19 vaccine candidate produced antibody and T-cell responses in participants in a Phase 1\/2..."},{"Date":"Jul. 20, 2020 at 12:21 p.m. ET","Headline":"Coronavirus update: Global case tally tops 14.5 million as U.S. death toll climbs above 140,000 with new infections still rising","Summary":"Shares of AstraZeneca  were down 3.4% in trading on Monday after a medical journal published a study that found the company's COVID-19 vaccine candidate produced antibody and T-cell responses in participants in a Phase 1\/2..."},{"Date":"Jul. 20, 2020 at 11:57 a.m. ET","Headline":"AstraZeneca\u2019s Covid-19 Data Look Positive, but Don\u2019t Live up to Last Week\u2019s Hype","Summary":"Shares of AstraZeneca  were down 3.4% in trading on Monday after a medical journal published a study that found the company's COVID-19 vaccine candidate produced antibody and T-cell responses in participants in a Phase 1\/2..."},{"Date":"Jul. 20, 2020 at 11:02 a.m. ET","Headline":"AstraZeneca's stock falls 3% as results from early-stage study on coronavirus vaccine are published","Summary":"Shares of AstraZeneca  were down 3.4% in trading on Monday after a medical journal published a study that found the company's COVID-19 vaccine candidate produced antibody and T-cell responses in participants in a Phase 1\/2..."},{"Date":"Jul. 20, 2020 at 11:01 a.m. ET","Headline":"Moderna Stock Is Too Expensive, Analyst Says. It\u2019s Now 10% Cheaper.","Summary":"Biotech exchange-traded funds moved higher Monday as investors tried to sort through winners and losers of the most recent round of COVID-19 treatment results. The iShares NASDAQ Biotech ETF  was 1% higher in morning trade..."},{"Date":"Jul. 20, 2020 at 10:26 a.m. ET","Headline":"Biotech ETFs trade higher on coronavirus treatment news","Summary":"Biotech exchange-traded funds moved higher Monday as investors tried to sort through winners and losers of the most recent round of COVID-19 treatment results. The iShares NASDAQ Biotech ETF  was 1% higher in morning trade..."},{"Date":"Jul. 23, 2020 at 8:42 p.m. ET","Headline":"Trump scraps Jacksonville portion of Republican National Convention, calls for vigilance in battling coronavirus outbreak","Summary":"BioNTech  and Pfizer Inc.  said they will receive $1.95 billion from the U.S. government to produce at least 100 million doses of their experimental COVID-19 vaccine if it receives approval or emergency use authorization f..."},{"Date":"Jul. 23, 2020 at 8:28 a.m. ET","Headline":"Baseball Is Back. Will Day Trading End?","Summary":"BioNTech  and Pfizer Inc.  said they will receive $1.95 billion from the U.S. government to produce at least 100 million doses of their experimental COVID-19 vaccine if it receives approval or emergency use authorization f..."},{"Date":"Jul. 23, 2020 at 6:40 a.m. ET","Headline":"Coronavirus update: U.S. case tally climbs above 3.9 million and Trump\u2019s late move on face masks criticized by health experts","Summary":"BioNTech  and Pfizer Inc.  said they will receive $1.95 billion from the U.S. government to produce at least 100 million doses of their experimental COVID-19 vaccine if it receives approval or emergency use authorization f..."},{"Date":"Jul. 22, 2020 at 9:13 p.m. ET","Headline":"The Dow\u2019s Rally Above 27,000 Was About More Than Pfizer\u2019s Vaccine","Summary":"BioNTech  and Pfizer Inc.  said they will receive $1.95 billion from the U.S. government to produce at least 100 million doses of their experimental COVID-19 vaccine if it receives approval or emergency use authorization f..."},{"Date":"Jul. 22, 2020 at 4:31 p.m. ET","Headline":"Dow Crosses 27,000 Mark After Pfizer Announces $2 Billion Vaccine Deal","Summary":"BioNTech  and Pfizer Inc.  said they will receive $1.95 billion from the U.S. government to produce at least 100 million doses of their experimental COVID-19 vaccine if it receives approval or emergency use authorization f..."},{"Date":"Jul. 22, 2020 at 1:01 p.m. ET","Headline":"The Dow Is Edging Higher on Hope for a Vaccine and Earnings Expectations","Summary":"BioNTech  and Pfizer Inc.  said they will receive $1.95 billion from the U.S. government to produce at least 100 million doses of their experimental COVID-19 vaccine if it receives approval or emergency use authorization f..."},{"Date":"Jul. 22, 2020 at 12:35 p.m. ET","Headline":"BioNTech, Pfizer shares gain on U.S. funding for coronavirus vaccine doses","Summary":"BioNTech  and Pfizer Inc.  said they will receive $1.95 billion from the U.S. government to produce at least 100 million doses of their experimental COVID-19 vaccine if it receives approval or emergency use authorization f..."},{"Date":"Jul. 22, 2020 at 9:47 a.m. ET","Headline":"Pfizer Will Charge the U.S. $19.50 a Dose for Its Covid-19 Vaccine. The Stock Jumps.","Summary":""},{"Date":"Jul. 22, 2020 at 8:22 a.m. ET","Headline":"Pfizer Stock Is Jumping, Best Buy Soars, and the Dow Edges Down","Summary":""},{"Date":"Jul. 22, 2020 at 8:11 a.m. ET","Headline":"Tesla and Microsoft Earnings Will Move the Market","Summary":""},{"Date":"Jul. 22, 2020 at 7:55 a.m. ET","Headline":"Here\u2019s what\u2019s behind the \u2018perfect storm\u2019 sending silver prices surging","Summary":""},{"Date":"Jul. 22, 2020 at 6:39 a.m. ET","Headline":"Coronavirus update: U.S. case tally climbs above 3.8 million; President Trump appears to have changed his view on face masks","Summary":""},{"Date":"Jul. 22, 2020 at 6:37 a.m. ET","Headline":"Democratic lawmakers signal concern about coronavirus vaccine pricing, speed of development","Summary":""},{"Date":"Jul. 25, 2020 at 12:01 p.m. ET","Headline":"How Much Will Drugmakers Charge for Covid-19 Vaccines? Questions About Pricing Arise.","Summary":""},{"Date":"Jul. 24, 2020 at 8:07 p.m. ET","Headline":"Even as Indy Goes Autonomous, the Race to True Self-Driving Has Been Long","Summary":""},{"Date":"Jul. 24, 2020 at 7:07 p.m. ET","Headline":"Trump Signs 4 Executive Orders Aimed at Lowering Drug Prices. What to Know.","Summary":""},{"Date":"Jul. 23, 2020 at 9:58 a.m. ET","Headline":"Moderna\u2019s Vaccine Will Likely Be Approved, Analyst Says. Why the Stock Is \u2018Unattractive.\u2019","Summary":""},{"Date":"Jul. 27, 2020 at 5:59 p.m. ET","Headline":"Pfizer, BioNTech's COVID vaccine candidate enters late-stage trial","Summary":"Pfizer Inc.  and BioNTech SE  said late Monday they have started a late-stage clinical trial for one of their COVID-19 vaccine candidates, involving 30,000 people around the world. The start of the trial \"is a major step f..."},{"Date":"Jul. 27, 2020 at 10:53 a.m. ET","Headline":"Big Tech\u2019s big test arrives in the busiest week of earnings season","Summary":""},{"Date":"Jul. 27, 2020 at 10:00 a.m. ET","Headline":"Pfizer Reports Earnings Tomorrow. Here\u2019s What to Expect.","Summary":""},{"Date":"Jul. 27, 2020 at 8:00 a.m. ET","Headline":"Nearly 40% of S&P 500 Companies Report Earnings This Week. What\u2019s at Stake.","Summary":""},{"Date":"Jul. 26, 2020 at 6:27 p.m. ET","Headline":"Amazon, Apple,\u00a0Boeing, Starbucks, Visa and Other Stocks to Watch This Week","Summary":""},{"Date":"Jul. 29, 2020 at 11:41 a.m. ET","Headline":"Centene CEO Says Covid-19 Vaccine Profits Should Be Capped for Companies That Took Government Aid","Summary":"U.S. stocks finished lower Tuesday as investors reacted in part to a lack of a progress toward a fresh coronavirus aid package and investors awaited a policy update from the Federal Reserve at the conclusion of their gathe..."},{"Date":"Jul. 29, 2020 at 10:03 a.m. ET","Headline":"GlaxoSmithKline Stock Falls as Covid-19 Hits Drug and Vaccine Sales","Summary":"U.S. stocks finished lower Tuesday as investors reacted in part to a lack of a progress toward a fresh coronavirus aid package and investors awaited a policy update from the Federal Reserve at the conclusion of their gathe..."},{"Date":"Jul. 29, 2020 at 9:18 a.m. ET","Headline":"Glaxo and Sanofi to Provide Covid-19 Vaccine to the U.K. \u2018We Don\u2019t Expect to Profit.\u2019","Summary":"U.S. stocks finished lower Tuesday as investors reacted in part to a lack of a progress toward a fresh coronavirus aid package and investors awaited a policy update from the Federal Reserve at the conclusion of their gathe..."},{"Date":"Jul. 29, 2020 at 1:01 a.m. ET","Headline":"Asian markets mixed amid gloomy earnings and pandemic concerns","Summary":"U.S. stocks finished lower Tuesday as investors reacted in part to a lack of a progress toward a fresh coronavirus aid package and investors awaited a policy update from the Federal Reserve at the conclusion of their gathe..."},{"Date":"Jul. 28, 2020 at 8:31 p.m. ET","Headline":"Moderna Is Asking $60 for Covid-19 Vaccine, According to Report, Drawing Criticism From Capitol Hill","Summary":"U.S. stocks finished lower Tuesday as investors reacted in part to a lack of a progress toward a fresh coronavirus aid package and investors awaited a policy update from the Federal Reserve at the conclusion of their gathe..."},{"Date":"Jul. 28, 2020 at 5:36 p.m. ET","Headline":"Kodak Stock Soared 200% Today. It Has Nothing to Do With Photography.","Summary":"U.S. stocks finished lower Tuesday as investors reacted in part to a lack of a progress toward a fresh coronavirus aid package and investors awaited a policy update from the Federal Reserve at the conclusion of their gathe..."},{"Date":"Jul. 28, 2020 at 4:49 p.m. ET","Headline":"Dow slides 205 points, stocks end near session lows, as investors await coronavirus aid progress","Summary":"U.S. stocks finished lower Tuesday as investors reacted in part to a lack of a progress toward a fresh coronavirus aid package and investors awaited a policy update from the Federal Reserve at the conclusion of their gathe..."},{"Date":"Jul. 28, 2020 at 4:36 p.m. ET","Headline":"Pfizer CEO Says Companies Should Make Profit On Covid-19 Vaccines","Summary":"U.S. stocks finished lower Tuesday as investors reacted in part to a lack of a progress toward a fresh coronavirus aid package and investors awaited a policy update from the Federal Reserve at the conclusion of their gathe..."},{"Date":"Jul. 28, 2020 at 4:30 p.m. ET","Headline":"U.S. Stocks Close Lower as Investors Digest Earnings","Summary":"U.S. stocks finished lower Tuesday as investors reacted in part to a lack of a progress toward a fresh coronavirus aid package and investors awaited a policy update from the Federal Reserve at the conclusion of their gathe..."},{"Date":"Jul. 28, 2020 at 4:08 p.m. ET","Headline":"Dow ends 205 points lower as tensions around coronavirus aid package grow ahead of Fed policy update","Summary":"U.S. stocks finished lower Tuesday as investors reacted in part to a lack of a progress toward a fresh coronavirus aid package and investors awaited a policy update from the Federal Reserve at the conclusion of their gathe..."},{"Date":"Jul. 28, 2020 at 3:11 p.m. ET","Headline":"Pfizer's stock surges toward biggest post-earnings gain in over 9 years","Summary":"Shares of Pfizer Inc.  surged 4.6% in afternoon trading Tuesday, to pace the Dow Jones Industrial Average's  gainers, after the drug maker reported  that beat expectations and raised its financial guidance. The stock is cu..."},{"Date":"Jul. 28, 2020 at 3:08 p.m. ET","Headline":"Coronavirus update: U.S. case tally climbs above 4.30 million as Texas becomes fourth state with more than 400,000 cases","Summary":"Earnings reporters are acting weighing on the Dow Jones Industrial Average  Tuesday, as the net effect of the premarket stock declines is to shave about 37 points off the index's price. Four Dow components reported second-..."},{"Date":"Jul. 28, 2020 at 12:26 p.m. ET","Headline":"The Dow Slips Because Consumers \u2018Are Understandably Cautious\u2019","Summary":"Earnings reporters are acting weighing on the Dow Jones Industrial Average  Tuesday, as the net effect of the premarket stock declines is to shave about 37 points off the index's price. Four Dow components reported second-..."},{"Date":"Jul. 28, 2020 at 10:39 a.m. ET","Headline":"Goldman Sachs has a new blowout forecast for gold","Summary":"Earnings reporters are acting weighing on the Dow Jones Industrial Average  Tuesday, as the net effect of the premarket stock declines is to shave about 37 points off the index's price. Four Dow components reported second-..."},{"Date":"Jul. 28, 2020 at 9:57 a.m. ET","Headline":"As bleak COVID-19 headlines mount, investors worry only about the facts \u2018they can live with,\u2019 analyst says","Summary":"Earnings reporters are acting weighing on the Dow Jones Industrial Average  Tuesday, as the net effect of the premarket stock declines is to shave about 37 points off the index's price. Four Dow components reported second-..."},{"Date":"Jul. 28, 2020 at 9:10 a.m. ET","Headline":"Dow's earnings reporters shaving a net 37 points off the index's price","Summary":"Earnings reporters are acting weighing on the Dow Jones Industrial Average  Tuesday, as the net effect of the premarket stock declines is to shave about 37 points off the index's price. Four Dow components reported second-..."},{"Date":"Jul. 28, 2020 at 8:59 a.m. ET","Headline":"Pfizer Stock Jumps on Earnings Beat and Vaccine Progress","Summary":"Shares of Pfizer Inc.  surged 3.4% in premarket trading Tuesday, after the drug maker reported profit and revenue that beat expectations and raised its full-year outlook, despite the challenges resulting from the COVID-19 ..."},{"Date":"Jul. 28, 2020 at 6:58 a.m. ET","Headline":"Pfizer's stock surges after profit and revenue beats, raised guidance","Summary":"Shares of Pfizer Inc.  surged 3.4% in premarket trading Tuesday, after the drug maker reported profit and revenue that beat expectations and raised its full-year outlook, despite the challenges resulting from the COVID-19 ..."},{"Date":"Jul. 31, 2020 at 8:23 p.m. ET","Headline":"Harley-Davidson Takes a Big Loss to Fuel a Major Turnaround","Summary":""},{"Date":"Jul. 31, 2020 at 7:00 a.m. ET","Headline":"Glaxo and Sanofi Will Sell 100 Million Covid-19 Vaccine Doses to the U.S. for Less Than $10.50 Each","Summary":""},{"Date":"Jul. 30, 2020 at 9:18 a.m. ET","Headline":"Johnson & Johnson Begins Trial of Covid-19 Vaccine in One-Dose Regimen","Summary":""},{"Date":"Aug. 4, 2020 at 8:30 a.m. ET","Headline":"Will Moderna\u2019s Covid Vaccine Work? We Could Have the Answer by Halloween.","Summary":""},{"Date":"Aug. 4, 2020 at 4:54 a.m. ET","Headline":"Dr. Fauci tells MarketWatch: I would not get on a plane or eat inside a restaurant","Summary":""},{"Date":"Aug. 3, 2020 at 12:46 p.m. ET","Headline":"Gilead Stock Is Rising Because Covid-Treatment Sales Could Top $3 Billion","Summary":""},{"Date":"Jul. 25, 2020 at 12:56 p.m. ET","Headline":"There\u2019s Nothing Bad About These \u2018Average\u2019 Stocks","Summary":""},{"Date":"Aug. 6, 2020 at 12:22 p.m. ET","Headline":"Bristol-Myers Squibb Boosts Outlook Now That Patients Are Coming Back","Summary":"Bristol-Myers Squibb Co.  shares rallied in the extended session Wednesday after a federal judge ruled for it and Pfizer Inc.  in a key patent fight over a blood thinner. Bristol-Myers shares surged 4.4% after hours, follo..."},{"Date":"Aug. 6, 2020 at 7:41 a.m. ET","Headline":"Bezos Sells Amazon Stock and Raises $3 Billion. That\u2019s Nothing.","Summary":"Bristol-Myers Squibb Co.  shares rallied in the extended session Wednesday after a federal judge ruled for it and Pfizer Inc.  in a key patent fight over a blood thinner. Bristol-Myers shares surged 4.4% after hours, follo..."},{"Date":"Aug. 6, 2020 at 6:15 a.m. ET","Headline":"Hahn: FDA won\u2019t make regulatory decisions based on preprints or news releases","Summary":"Bristol-Myers Squibb Co.  shares rallied in the extended session Wednesday after a federal judge ruled for it and Pfizer Inc.  in a key patent fight over a blood thinner. Bristol-Myers shares surged 4.4% after hours, follo..."},{"Date":"Aug. 5, 2020 at 9:17 p.m. ET","Headline":"Novavax Stock Soars. Analysts Say Its Covid-19 Vaccine Might Be the Best.","Summary":"Bristol-Myers Squibb Co.  shares rallied in the extended session Wednesday after a federal judge ruled for it and Pfizer Inc.  in a key patent fight over a blood thinner. Bristol-Myers shares surged 4.4% after hours, follo..."},{"Date":"Aug. 5, 2020 at 6:28 p.m. ET","Headline":"Bristol-Myers, Pfizer stocks rise on blood-thinner patent win","Summary":"Bristol-Myers Squibb Co.  shares rallied in the extended session Wednesday after a federal judge ruled for it and Pfizer Inc.  in a key patent fight over a blood thinner. Bristol-Myers shares surged 4.4% after hours, follo..."},{"Date":"Aug. 5, 2020 at 3:26 p.m. ET","Headline":"Scaling Up Output of a Covid Vaccine Is Costly, Says Moderna","Summary":""},{"Date":"Aug. 5, 2020 at 11:18 a.m. ET","Headline":"The stock market will be flying high in a year \u2014 for 2 simple reasons","Summary":""},{"Date":"Aug. 5, 2020 at 10:20 a.m. ET","Headline":"Johnson & Johnson Signs $1 Billion U.S. Government Deal for Vaccine. Its Stock Is Rising.","Summary":""},{"Date":"Aug. 8, 2020 at 11:04 a.m. ET","Headline":"\u2018Will the public be ready for a vaccine?\u2019 Many Americans say they won\u2019t get the coronavirus vaccine if one is developed","Summary":"Shares of Pfizer Inc.  gained 1.0% in premarket trading on Friday after it announced that it will help manufacture Gilead Sciences Inc.'s  COVID-19 treatment remdesivir as part of a multi-year agreement. Gilead's stock was..."},{"Date":"Aug. 7, 2020 at 5:49 p.m. ET","Headline":"Dow, S&P 500 finish higher even as pandemic aid talks break down in DC without a deal","Summary":"Shares of Pfizer Inc.  gained 1.0% in premarket trading on Friday after it announced that it will help manufacture Gilead Sciences Inc.'s  COVID-19 treatment remdesivir as part of a multi-year agreement. Gilead's stock was..."},{"Date":"Aug. 7, 2020 at 1:14 p.m. ET","Headline":"Coronavirus update: Global case tally climbs above 19 million; U.S. death toll moves above 160,000 after 11 straight days with 1,000-plus fatalities","Summary":"Shares of Pfizer Inc.  gained 1.0% in premarket trading on Friday after it announced that it will help manufacture Gilead Sciences Inc.'s  COVID-19 treatment remdesivir as part of a multi-year agreement. Gilead's stock was..."},{"Date":"Aug. 7, 2020 at 11:04 a.m. ET","Headline":"Pfizer Will Help Gilead Sciences Make Its Covid-19 Treatment, Remdesivir","Summary":"Shares of Pfizer Inc.  gained 1.0% in premarket trading on Friday after it announced that it will help manufacture Gilead Sciences Inc.'s  COVID-19 treatment remdesivir as part of a multi-year agreement. Gilead's stock was..."},{"Date":"Aug. 7, 2020 at 8:10 a.m. ET","Headline":"Pfizer to help manufacture Gilead's remdesivir","Summary":"Shares of Pfizer Inc.  gained 1.0% in premarket trading on Friday after it announced that it will help manufacture Gilead Sciences Inc.'s  COVID-19 treatment remdesivir as part of a multi-year agreement. Gilead's stock was..."},{"Date":"Aug. 7, 2020 at 6:00 a.m. ET","Headline":"A Covid Vaccine Could Be Ready Sooner Than You Think","Summary":""},{"Date":"Aug. 6, 2020 at 6:30 a.m. ET","Headline":"Visa, Apple, and Other Dividend-Growth Stocks Are Outshining Higher-Yielding Names This Year","Summary":""},{"Date":"Aug. 12, 2020 at 10:18 a.m. ET","Headline":"Moderna Joins Ranks of U.S. Covid-Vaccine Deals. Here\u2019s What Wall Street Is Saying.","Summary":""},{"Date":"Aug. 12, 2020 at 8:38 a.m. ET","Headline":"Russia\u2019s accelerated COVID-19 vaccine greeted with alarm as experts say Phase 3 trial is essential","Summary":""},{"Date":"Aug. 12, 2020 at 8:07 a.m. ET","Headline":"Moderna\u2019s Covid Vaccine Looks Like a Bargain","Summary":""},{"Date":"Aug. 11, 2020 at 4:34 p.m. ET","Headline":"Here\u2019s How Many People Tried Russia\u2019s Coronavirus Vaccine","Summary":""},{"Date":"Aug. 11, 2020 at 11:09 a.m. ET","Headline":"Russia Registered a Coronavirus Vaccine. The Market Loves It.","Summary":""},{"Date":"Aug. 11, 2020 at 9:27 a.m. ET","Headline":"After 150 days of the COVID-19 pandemic, here are the best- and worst-performing stocks","Summary":""},{"Date":"Aug. 10, 2020 at 12:05 p.m. ET","Headline":"3 Potential 2020 Election Outcomes \u2014 and What They Could Mean for Investors","Summary":""},{"Date":"Aug. 14, 2020 at 12:05 p.m. ET","Headline":"U.K. strikes two Covid-19 vaccine deals for 90 million doses","Summary":""},{"Date":"Aug. 14, 2020 at 9:26 a.m. ET","Headline":"Pfizer Stock Is Treading Water, but Director Ronald Blaylock Made a Big Buy","Summary":""},{"Date":"Aug. 13, 2020 at 10:25 a.m. ET","Headline":"Novavax Stock Jumps on Vaccine Deal With South Korean Firm","Summary":""},{"Date":"Aug. 13, 2020 at 7:56 a.m. ET","Headline":"My fianc\u00e9e\u2019s divorce decree says she\u2019s not liable for her former husband\u2019s $100K tax bill. That should protect her, right?","Summary":""},{"Date":"Aug. 13, 2020 at 6:39 a.m. ET","Headline":"Moderna stock rally fades as analysts weigh in on what U.S. government supply deal means for COVID-19 vaccine pricing","Summary":""},{"Date":"Aug. 4, 2020 at 5:23 p.m. ET","Headline":"Novavax Reported Promising Data on Covid-19 Vaccine. Its Stock Fell Anyway.","Summary":""},{"Date":"Aug. 16, 2020 at 10:19 a.m. ET","Headline":"The World Could Have Enough Covid-19 Vaccines by the End of 2021","Summary":""},{"Date":"Aug. 16, 2020 at 6:41 a.m. ET","Headline":"When will I get my extra $300 a week in unemployment benefits? Why isn\u2019t everyone out of work eligible under Trump\u2019s proposal?","Summary":""},{"Date":"Aug. 16, 2020 at 6:36 a.m. ET","Headline":"I\u2019m still waiting on my FIRST stimulus check. When will I get it? \u2018We, the qualifying taxpayers, should not have to suffer\u2019","Summary":""},{"Date":"Aug. 14, 2020 at 5:39 p.m. ET","Headline":"The Economy May Be Struggling, but the Pet Business and the Stock Market Keep Running Strong","Summary":""},{"Date":"Aug. 14, 2020 at 7:59 a.m. ET","Headline":"Here Are the Covid-19 Vaccines and Antivirals Being Worked on Right Now","Summary":""},{"Date":"Aug. 18, 2020 at 3:17 a.m. ET","Headline":"Does sunshine kill coronavirus? Will antibiotics help? These are the most widely shared misconceptions about COVID-19","Summary":""},{"Date":"Aug. 17, 2020 at 5:05 p.m. ET","Headline":"UNC Moves to Online Classes After Coronavirus Outbreak","Summary":""},{"Date":"Aug. 17, 2020 at 1:22 p.m. ET","Headline":"Dr. Fauci: \u2018We\u2019ve been through a Depression, we\u2019ve been through a World War. We pulled together through 9\/11\u2019","Summary":""},{"Date":"Aug. 17, 2020 at 8:35 a.m. ET","Headline":"Merck Is Barron\u2019s Stock Pick This Week. Here\u2019s Why.","Summary":""},{"Date":"Aug. 20, 2020 at 11:45 p.m. ET","Headline":"Asian markets follow Wall Street higher amid vaccine hopes","Summary":""},{"Date":"Aug. 20, 2020 at 8:32 p.m. ET","Headline":"Johnson & Johnson adds to debt frenzy, borrows $7.5 billion to buy Momenta","Summary":""},{"Date":"Aug. 20, 2020 at 5:30 p.m. ET","Headline":"A Tidal Wave of Vaccine News Is Hitting the Market","Summary":""},{"Date":"Aug. 20, 2020 at 11:11 a.m. ET","Headline":"Pfizer\u2019s Covid Vaccine Could Be Authorized Soon. That\u2019s Not the Only Positive News for the Stock.","Summary":""},{"Date":"Aug. 20, 2020 at 10:26 a.m. ET","Headline":"CureVac Stock Jumps on News of EU Talks to Supply Covid-19","Summary":""},{"Date":"Aug. 20, 2020 at 9:43 a.m. ET","Headline":"BioMarin Stock\u2019s Near-Term Growth Is Gone, Analyst Says. Here\u2019s Why.","Summary":""},{"Date":"Aug. 19, 2020 at 12:19 p.m. ET","Headline":"BioMarin Stock Slumps After FDA\u2019s Surprise Rejection of a Hemophilia Gene Therapy","Summary":""},{"Date":"Aug. 19, 2020 at 10:42 a.m. ET","Headline":"Potential Gilead Blockbusters Were Rejected By the FDA. Why That\u2019s the \u2018Near-Worst-Case Scenario\u2019 for the Stock.","Summary":""},{"Date":"Aug. 19, 2020 at 10:00 a.m. ET","Headline":"High-Yielding Stocks Have Faltered in 2020\u2014But Some See Value","Summary":""},{"Date":"Aug. 21, 2020 at 8:00 p.m. ET","Headline":"A Big Boost in Earnings Estimates for Nvidia","Summary":"U.S. stocks opened mostly lower, but with the tech-heavy Nasdaq Composite index higher, a sign that investors are sticking with their comfort zone as uncertainties about the political landscape and the coronavirus outbreak..."},{"Date":"Aug. 21, 2020 at 7:27 p.m. ET","Headline":"Tech, Tesla, and Apple Star as Stocks Keep Rising","Summary":"U.S. stocks opened mostly lower, but with the tech-heavy Nasdaq Composite index higher, a sign that investors are sticking with their comfort zone as uncertainties about the political landscape and the coronavirus outbreak..."},{"Date":"Aug. 21, 2020 at 7:09 p.m. ET","Headline":"S&P 500, Nasdaq Edge Higher to Finish the Week at New Highs","Summary":"U.S. stocks opened mostly lower, but with the tech-heavy Nasdaq Composite index higher, a sign that investors are sticking with their comfort zone as uncertainties about the political landscape and the coronavirus outbreak..."},{"Date":"Aug. 21, 2020 at 4:28 p.m. ET","Headline":"S&P 500, Nasdaq set fresh records, Dow adds 200 points as investors cheer economic data","Summary":"U.S. stocks opened mostly lower, but with the tech-heavy Nasdaq Composite index higher, a sign that investors are sticking with their comfort zone as uncertainties about the political landscape and the coronavirus outbreak..."},{"Date":"Aug. 21, 2020 at 3:43 p.m. ET","Headline":"Tesla Stock Is Unstoppable","Summary":"U.S. stocks opened mostly lower, but with the tech-heavy Nasdaq Composite index higher, a sign that investors are sticking with their comfort zone as uncertainties about the political landscape and the coronavirus outbreak..."},{"Date":"Aug. 21, 2020 at 12:13 p.m. ET","Headline":"The Dow Is Flat but Apple Stock\u2019s Hot Streak Continues","Summary":"U.S. stocks opened mostly lower, but with the tech-heavy Nasdaq Composite index higher, a sign that investors are sticking with their comfort zone as uncertainties about the political landscape and the coronavirus outbreak..."},{"Date":"Aug. 21, 2020 at 10:38 a.m. ET","Headline":"BioNTech and Pfizer\u2019s Covid-19 Vaccine Could Lead the Pack, New Data Suggest","Summary":"U.S. stocks opened mostly lower, but with the tech-heavy Nasdaq Composite index higher, a sign that investors are sticking with their comfort zone as uncertainties about the political landscape and the coronavirus outbreak..."},{"Date":"Aug. 21, 2020 at 9:33 a.m. ET","Headline":"Stocks open mixed, with strength in tech as investors face headwinds","Summary":"U.S. stocks opened mostly lower, but with the tech-heavy Nasdaq Composite index higher, a sign that investors are sticking with their comfort zone as uncertainties about the political landscape and the coronavirus outbreak..."},{"Date":"Aug. 21, 2020 at 8:40 a.m. ET","Headline":"Here\u2019s why stock prices are unsustainable, according to this fund manager","Summary":""},{"Date":"Aug. 21, 2020 at 8:27 a.m. ET","Headline":"Tesla, Pfizer, and BioNTech Stock Rises as the Stock Market Falls","Summary":""},{"Date":"Aug. 21, 2020 at 7:06 a.m. ET","Headline":"My coworkers cough and sneeze, don\u2019t wear masks, and talk about their parties. I\u2019m worried about coronavirus. What do I do?","Summary":""},{"Date":"Aug. 21, 2020 at 3:11 a.m. ET","Headline":"Pfizer and BioNTech say regulatory review for Covid-19 vaccine could be as early as October","Summary":""},{"Date":"Aug. 24, 2020 at 7:02 p.m. ET","Headline":"Apple stock split leads to major Dow Jones shake-up: Exxon is out, Salesforce is in","Summary":"Salesforce.com Inc. , Amgen Inc. , and Honeywell International Inc.  will become new members of the Dow Jones Industrial Average  by the end of the month, S&P Dow Jones Indices said late Monday. Salesforce will replace Exx..."},{"Date":"Aug. 24, 2020 at 5:46 p.m. ET","Headline":"Salesforce, Amgen, Honeywell to become new Dow Average components","Summary":"Salesforce.com Inc. , Amgen Inc. , and Honeywell International Inc.  will become new members of the Dow Jones Industrial Average  by the end of the month, S&P Dow Jones Indices said late Monday. Salesforce will replace Exx..."},{"Date":"Aug. 24, 2020 at 5:35 p.m. ET","Headline":"The Stock Market Didn\u2019t Need Apple to Hit a New High on Monday","Summary":""},{"Date":"Aug. 24, 2020 at 11:42 a.m. ET","Headline":"COVID-19 vaccine hopes are driving the stock-market rally \u2014 here\u2019s how much","Summary":""},{"Date":"Aug. 24, 2020 at 4:46 a.m. ET","Headline":"Dr. Fauci says the U.S. can learn from Asian countries and island nations in the battle against COVID-19","Summary":""},{"Date":"Aug. 24, 2020 at 4:46 a.m. ET","Headline":"This is when people with COVID-19 are at their most contagious","Summary":""},{"Date":"Aug. 24, 2020 at 4:36 a.m. ET","Headline":"Johns Hopkins scientists examining weird side effects of COVID-19 suggest one way coronavirus \u2018gains a foothold in the body\u2019","Summary":""},{"Date":"Aug. 21, 2020 at 3:53 p.m. ET","Headline":"These Stocks Are \u2018Special.\u2019 Here\u2019s Why","Summary":""},{"Date":"Aug. 26, 2020 at 2:49 p.m. ET","Headline":"Moderna\u2019s Covid-19 Vaccine Shows Promise in Older Adults. Its Stock Is Climbing.","Summary":"Dow-linked ETFs lower one day after overhaul announcement \nExchange-traded funds tracking the Dow Jones Industrial Average  turned in a mixed performance one day after a big shakeup to the index was announced. The SPDR Dow..."},{"Date":"Aug. 26, 2020 at 9:27 a.m. ET","Headline":"Pfizer Got Kicked Out of the Dow Just as Things Were Looking Up","Summary":"Dow-linked ETFs lower one day after overhaul announcement \nExchange-traded funds tracking the Dow Jones Industrial Average  turned in a mixed performance one day after a big shakeup to the index was announced. The SPDR Dow..."},{"Date":"Aug. 25, 2020 at 6:43 p.m. ET","Headline":"The Dow Has a Confidence Problem","Summary":"Dow-linked ETFs lower one day after overhaul announcement \nExchange-traded funds tracking the Dow Jones Industrial Average  turned in a mixed performance one day after a big shakeup to the index was announced. The SPDR Dow..."},{"Date":"Aug. 25, 2020 at 4:57 p.m. ET","Headline":"Forget the Dow Shake-Up. A Tesla Addition to the S&P 500 Would Really Matter.","Summary":"Dow-linked ETFs lower one day after overhaul announcement \nExchange-traded funds tracking the Dow Jones Industrial Average  turned in a mixed performance one day after a big shakeup to the index was announced. The SPDR Dow..."},{"Date":"Aug. 25, 2020 at 4:50 p.m. ET","Headline":"Honeywell Is Going Back in the Dow. Here\u2019s What It Means for the Stock.","Summary":"Dow-linked ETFs lower one day after overhaul announcement \nExchange-traded funds tracking the Dow Jones Industrial Average  turned in a mixed performance one day after a big shakeup to the index was announced. The SPDR Dow..."},{"Date":"Aug. 25, 2020 at 4:39 p.m. ET","Headline":"S&P 500, Nasdaq Close at New Highs","Summary":"Dow-linked ETFs lower one day after overhaul announcement \nExchange-traded funds tracking the Dow Jones Industrial Average  turned in a mixed performance one day after a big shakeup to the index was announced. The SPDR Dow..."},{"Date":"Aug. 25, 2020 at 4:30 p.m. ET","Headline":"S&P 500 and Nasdaq book fresh record highs, but Dow slumps as Apple and Boeing weigh","Summary":"Dow-linked ETFs lower one day after overhaul announcement \nExchange-traded funds tracking the Dow Jones Industrial Average  turned in a mixed performance one day after a big shakeup to the index was announced. The SPDR Dow..."},{"Date":"Aug. 25, 2020 at 3:44 p.m. ET","Headline":"COVID-19 and 1918 \u2018Spanish flu\u2019 have one depressing thing in common","Summary":"Dow-linked ETFs lower one day after overhaul announcement \nExchange-traded funds tracking the Dow Jones Industrial Average  turned in a mixed performance one day after a big shakeup to the index was announced. The SPDR Dow..."},{"Date":"Aug. 25, 2020 at 2:25 p.m. ET","Headline":"Why Dow\u2019s shake-up is bad for stocks added to it\u2014and less bad for those booted","Summary":"Dow-linked ETFs lower one day after overhaul announcement \nExchange-traded funds tracking the Dow Jones Industrial Average  turned in a mixed performance one day after a big shakeup to the index was announced. The SPDR Dow..."},{"Date":"Aug. 25, 2020 at 12:36 p.m. ET","Headline":"Dow-linked ETFs lower one day after overhaul announcement","Summary":"Dow-linked ETFs lower one day after overhaul announcement \nExchange-traded funds tracking the Dow Jones Industrial Average  turned in a mixed performance one day after a big shakeup to the index was announced. The SPDR Dow..."},{"Date":"Aug. 25, 2020 at 12:18 p.m. ET","Headline":"Stocks Are Wobbling as Markets Digest Trade Talks, Consumer Confidence","Summary":"Shares of the three new additions to the Dow Jones Industrial Average  were higher Tuesday, while the three departing members moved lower, a day after S&P Dow Jones Indices announced a shake-up for the 30-member index. Sal..."},{"Date":"Aug. 25, 2020 at 12:15 p.m. ET","Headline":"Here\u2019s what Exxon\u2019s removal from the Dow says about the energy sector","Summary":"Shares of the three new additions to the Dow Jones Industrial Average  were higher Tuesday, while the three departing members moved lower, a day after S&P Dow Jones Indices announced a shake-up for the 30-member index. Sal..."},{"Date":"Aug. 25, 2020 at 10:11 a.m. ET","Headline":"Exxon and Pfizer Just Got Booted From the Dow. Here\u2019s What\u2019s Replacing Them.","Summary":"Shares of the three new additions to the Dow Jones Industrial Average  were higher Tuesday, while the three departing members moved lower, a day after S&P Dow Jones Indices announced a shake-up for the 30-member index. Sal..."},{"Date":"Aug. 25, 2020 at 9:44 a.m. ET","Headline":"Salesforce, Amgen and Honeywell higher premarket on Dow-joining news; Exxon, Pfizer and Raytheon move lower","Summary":"Shares of the three new additions to the Dow Jones Industrial Average  were higher Tuesday, while the three departing members moved lower, a day after S&P Dow Jones Indices announced a shake-up for the 30-member index. Sal..."},{"Date":"Aug. 25, 2020 at 9:37 a.m. ET","Headline":"Stocks open slightly higher as U.S., China reaffirm commitment to trade deal","Summary":"Stocks opened higher Tuesday, with the S&P 500  trading at an all-time intraday high as it built on the previous session's record close. A positive tone for global equities was attributed in part to a phone call between to..."},{"Date":"Aug. 25, 2020 at 8:28 a.m. ET","Headline":"Big Changes Are Coming to the Dow \u2014 Just Not the Right Ones","Summary":""},{"Date":"Aug. 25, 2020 at 8:22 a.m. ET","Headline":"The Dow Is Making Big Changes. Why You Shouldn\u2019t.","Summary":""},{"Date":"Aug. 28, 2020 at 8:01 p.m. ET","Headline":"Salesforce Rises After It\u2019s Included in the Dow. But Earnings Drive the Stock Even More.","Summary":""},{"Date":"Aug. 28, 2020 at 10:52 a.m. ET","Headline":"President Trump Promised a Vaccine Before the End of the Year. What You Need to Know.","Summary":""},{"Date":"Aug. 27, 2020 at 3:22 p.m. ET","Headline":"Coronavirus update: Global case tally tops 24 million as U.S. tally tops 5.8 million, and CDC head walks back testing change amid outcry","Summary":""},{"Date":"Aug. 27, 2020 at 11:35 a.m. ET","Headline":"Will Moderna or Pfizer Have Better Phase 3 Covid-19 Vaccine Data? Analysts Begin To Make Bets.","Summary":""},{"Date":"Aug. 27, 2020 at 8:49 a.m. ET","Headline":"Salesforce\u2019s 30% stock rally this week is a possible \u2018nightmare\u2019 scenario for the Dow committee","Summary":""},{"Date":"Aug. 27, 2020 at 7:58 a.m. ET","Headline":"Interest Rates Will Remain Low for Years. These High-Quality Stocks Might Offer the Income You Need.","Summary":""},{"Date":"Aug. 30, 2020 at 9:59 a.m. ET","Headline":"My wife and her sister are bartering over a vacation home. Does a quitclaim override a will? Is a transfer on death deed better?","Summary":""},{"Date":"Aug. 30, 2020 at 9:29 a.m. ET","Headline":"Exxon\u2019s getting booted from the Dow Jones Industrial Average may be a blessing in disguise for its investors","Summary":""},{"Date":"Aug. 30, 2020 at 7:00 a.m. ET","Headline":"A Huge Sovereign-Wealth Fund Made a Big Bet on GE Stock. Here\u2019s What It Sold.","Summary":""},{"Date":"Aug. 29, 2020 at 7:33 a.m. ET","Headline":"Weekend reads: Where to retire if you want to avoid extreme weather","Summary":""},{"Date":"Sep. 1, 2020 at 8:10 p.m. ET","Headline":"U.S. won\u2019t join WHO-linked global effort to find COVID-19 vaccine","Summary":"U.S. stock benchmarks on Monday were under pressure as Wall Street attempts to close out a strong performance in a seasonally lackluster month, ahead of what's likely to be a turbulent patch for investors heading into autu..."},{"Date":"Sep. 1, 2020 at 2:46 p.m. ET","Headline":"My friends\u2019 wedding was canceled due to coronavirus. They\u2019re having a small ceremony next month with only close friends and family. Do I still send a gift?","Summary":"U.S. stock benchmarks on Monday were under pressure as Wall Street attempts to close out a strong performance in a seasonally lackluster month, ahead of what's likely to be a turbulent patch for investors heading into autu..."},{"Date":"Sep. 1, 2020 at 12:17 p.m. ET","Headline":"AstraZeneca Began a Big Covid Vaccine Trial Monday. It Probably Won\u2019t Be the First to Release Data.","Summary":"U.S. stock benchmarks on Monday were under pressure as Wall Street attempts to close out a strong performance in a seasonally lackluster month, ahead of what's likely to be a turbulent patch for investors heading into autu..."},{"Date":"Sep. 1, 2020 at 9:56 a.m. ET","Headline":"Here are the big winners among U.S. stocks during a sizzling August","Summary":"U.S. stock benchmarks on Monday were under pressure as Wall Street attempts to close out a strong performance in a seasonally lackluster month, ahead of what's likely to be a turbulent patch for investors heading into autu..."},{"Date":"Sep. 1, 2020 at 8:47 a.m. ET","Headline":"The Dow\u2019s Changes Could Impact These Funds in Your Portfolio","Summary":"U.S. stock benchmarks on Monday were under pressure as Wall Street attempts to close out a strong performance in a seasonally lackluster month, ahead of what's likely to be a turbulent patch for investors heading into autu..."},{"Date":"Sep. 1, 2020 at 7:08 a.m. ET","Headline":"My sister-in-law moved in with her mother, changed her will and inherited everything. Is it too late to claim what belongs to us?","Summary":"U.S. stock benchmarks on Monday were under pressure as Wall Street attempts to close out a strong performance in a seasonally lackluster month, ahead of what's likely to be a turbulent patch for investors heading into autu..."},{"Date":"Sep. 1, 2020 at 6:38 a.m. ET","Headline":"Dr. Fauci: It\u2019s \u2018conceivable\u2019 we\u2019ll know by November if a safe, effective vaccine is coming","Summary":"U.S. stock benchmarks on Monday were under pressure as Wall Street attempts to close out a strong performance in a seasonally lackluster month, ahead of what's likely to be a turbulent patch for investors heading into autu..."},{"Date":"Sep. 1, 2020 at 6:04 a.m. ET","Headline":"Gilead\u2019s stock has fallen 21% since April 30, underscoring investor questions about remdesivir\u2019s potential","Summary":"U.S. stock benchmarks on Monday were under pressure as Wall Street attempts to close out a strong performance in a seasonally lackluster month, ahead of what's likely to be a turbulent patch for investors heading into autu..."},{"Date":"Aug. 31, 2020 at 4:49 p.m. ET","Headline":"Dow, S&P 500 end lower, but book best August in 36 years. Nasdaq clinches another record","Summary":"U.S. stock benchmarks on Monday were under pressure as Wall Street attempts to close out a strong performance in a seasonally lackluster month, ahead of what's likely to be a turbulent patch for investors heading into autu..."},{"Date":"Aug. 31, 2020 at 4:47 p.m. ET","Headline":"U.S. Stocks Close Mixed as Record Month Comes to a Close","Summary":"U.S. stock benchmarks on Monday were under pressure as Wall Street attempts to close out a strong performance in a seasonally lackluster month, ahead of what's likely to be a turbulent patch for investors heading into autu..."},{"Date":"Aug. 31, 2020 at 2:44 p.m. ET","Headline":"Of all the major changes to the Dow on Monday, this may be the most important","Summary":"U.S. stock benchmarks on Monday were under pressure as Wall Street attempts to close out a strong performance in a seasonally lackluster month, ahead of what's likely to be a turbulent patch for investors heading into autu..."},{"Date":"Aug. 31, 2020 at 12:26 p.m. ET","Headline":"The Dow Is Slipping After Index Changes, Apple Stock Split","Summary":"U.S. stock benchmarks on Monday were under pressure as Wall Street attempts to close out a strong performance in a seasonally lackluster month, ahead of what's likely to be a turbulent patch for investors heading into autu..."},{"Date":"Aug. 31, 2020 at 12:22 p.m. ET","Headline":"Tesla and Apple Headline a Potentially Wild Monday. Here\u2019s Your Trading Guide.","Summary":"U.S. stock benchmarks on Monday were under pressure as Wall Street attempts to close out a strong performance in a seasonally lackluster month, ahead of what's likely to be a turbulent patch for investors heading into autu..."},{"Date":"Aug. 31, 2020 at 9:35 a.m. ET","Headline":"Dow opens 130 points lower as stocks aim to end close out the best August return in decades","Summary":"U.S. stock benchmarks on Monday were under pressure as Wall Street attempts to close out a strong performance in a seasonally lackluster month, ahead of what's likely to be a turbulent patch for investors heading into autu..."},{"Date":"Aug. 31, 2020 at 7:40 a.m. ET","Headline":"Three things you need to know about Apple\u2019s stock split","Summary":""},{"Date":"Aug. 31, 2020 at 7:16 a.m. ET","Headline":"Five things you should know about Tesla ahead of its 5-for-1 stock split","Summary":""},{"Date":"Aug. 31, 2020 at 6:56 a.m. ET","Headline":"Moderna and Pfizer\u2019s COVID-19 vaccine candidates require ultra-low temperatures, raising questions about storage, distribution","Summary":""},{"Date":"Aug. 31, 2020 at 3:22 a.m. ET","Headline":"My husband and I are worth $3.7 million, but I\u2019m afraid I\u2019ll spend my way into the poor house if he dies. When I was single, I bounced checks. What can I do?","Summary":""},{"Date":"Sep. 3, 2020 at 2:19 p.m. ET","Headline":"Is 30 too old to work in media? This advertising boss has been forced to apologize after ageism row","Summary":""},{"Date":"Sep. 3, 2020 at 9:19 a.m. ET","Headline":"Novavax Stock Is Jumping Again on Positive New Data on Its Covid-19 Vaccine","Summary":""},{"Date":"Sep. 3, 2020 at 1:00 a.m. ET","Headline":"GlaxoSmithKline and Sanofi Just Launched the First Human Trial of Their Covid-19 Vaccine. Why That Matters.","Summary":""},{"Date":"Sep. 4, 2020 at 8:05 p.m. ET","Headline":"Drug companies to issue joint pledge on safety, standards to bolster confidence in COVID-19 vaccine","Summary":"President Donald Trump on Friday urged Americans to \"remain vigilant\" about the spread of the coronavirus over Labor Day weekend and beyond, saying people should wear masks, wash their hands and practice social distancing...."},{"Date":"Sep. 4, 2020 at 5:57 p.m. ET","Headline":"Trump urges Americans to 'remain vigilant' about virus over Labor Day weekend","Summary":"President Donald Trump on Friday urged Americans to \"remain vigilant\" about the spread of the coronavirus over Labor Day weekend and beyond, saying people should wear masks, wash their hands and practice social distancing...."},{"Date":"Sep. 4, 2020 at 10:58 a.m. ET","Headline":"Tech Stocks Slide Again","Summary":""},{"Date":"Sep. 7, 2020 at 11:22 a.m. ET","Headline":"Another warning from the 1918 flu for COVID-19: \u2018Survival does not mean that individuals fully recovered\u2019","Summary":""},{"Date":"Sep. 7, 2020 at 7:48 a.m. ET","Headline":"Think twice before wearing a face shield to protect against COVID-19 instead of a cloth face mask \u2014 here\u2019s why","Summary":""},{"Date":"Sep. 6, 2020 at 3:23 p.m. ET","Headline":"Sweden embraced herd immunity, while the U.K. abandoned the idea \u2014 so why do they both have high COVID-19 fatality rates?","Summary":""},{"Date":"Sep. 9, 2020 at 7:28 p.m. ET","Headline":"Report: TikTok Talking With U.S. About Ways to Avoid a Sale","Summary":"Specialized health-care exchange-traded funds outperformed the broader stock market Wednesday even as stocks rebounded from a sell-off that left the Nasdaq Composite Index  in correction territory. The Invesco DWA Health C..."},{"Date":"Sep. 9, 2020 at 2:58 p.m. ET","Headline":"Coronavirus update: Global death toll edges toward 900,000 as AstraZeneca halts vaccine trial after patient struck by illness","Summary":"Specialized health-care exchange-traded funds outperformed the broader stock market Wednesday even as stocks rebounded from a sell-off that left the Nasdaq Composite Index  in correction territory. The Invesco DWA Health C..."},{"Date":"Sep. 9, 2020 at 2:02 p.m. ET","Headline":"Specialty biotech funds jump on promising coronavirus, funding news","Summary":"Specialized health-care exchange-traded funds outperformed the broader stock market Wednesday even as stocks rebounded from a sell-off that left the Nasdaq Composite Index  in correction territory. The Invesco DWA Health C..."},{"Date":"Sep. 9, 2020 at 9:18 a.m. ET","Headline":"AstraZeneca\u2019s Vaccine-Trial Pause Won\u2019t Slow Its Rivals","Summary":"BioNTech  and Pfizer Inc. , which are developing a COVID-19 vaccine candidate, said in a news release on Wednesday that they plan to pursue regulatory review for BNT162b2 in October, depending on the success of the vaccine..."},{"Date":"Sep. 9, 2020 at 8:52 a.m. ET","Headline":"Why an approved coronavirus vaccine may not end the pandemic quickly","Summary":"BioNTech  and Pfizer Inc. , which are developing a COVID-19 vaccine candidate, said in a news release on Wednesday that they plan to pursue regulatory review for BNT162b2 in October, depending on the success of the vaccine..."},{"Date":"Sep. 9, 2020 at 8:33 a.m. ET","Headline":"BioNTech, Pfizer expect clinical 'answer' on coronavirus vaccine in late October","Summary":"BioNTech  and Pfizer Inc. , which are developing a COVID-19 vaccine candidate, said in a news release on Wednesday that they plan to pursue regulatory review for BNT162b2 in October, depending on the success of the vaccine..."},{"Date":"Sep. 9, 2020 at 7:47 a.m. ET","Headline":"Moderna, BioNTech, Pfizer stocks rally after AstraZeneca COVID-19 vaccine trial is reportedly halted","Summary":"Shares of several companies that are developing COVID-19 vaccines rallied on Wednesday morning before the market opened  published Tuesday that said AstraZeneca  [ halted a Phase 3 clinical trial for its coronavirus vaccin..."},{"Date":"Sep. 9, 2020 at 7:43 a.m. ET","Headline":"Tech Stocks Are Bouncing Back. It Doesn\u2019t Mean Anything Yet.","Summary":"Shares of BioNTech SE  rallied 5.0% in premarket trading Wednesday, and Pfizer Inc. shares  rose 1.8%, after the drug makers said it had concluded exploratory talks with the European Commission (EU) for a proposed deal to ..."},{"Date":"Sep. 9, 2020 at 6:25 a.m. ET","Headline":"Pfizer, BioNTech conclude talks over supplying EU with SARS-CoV-2 vaccine candidate","Summary":"Shares of BioNTech SE  rallied 5.0% in premarket trading Wednesday, and Pfizer Inc. shares  rose 1.8%, after the drug makers said it had concluded exploratory talks with the European Commission (EU) for a proposed deal to ..."},{"Date":"Sep. 8, 2020 at 7:17 p.m. ET","Headline":"AstraZeneca Pauses Coronavirus Vaccine Study","Summary":"Analysts at SVB Leerink downgraded shares of Moderna Inc.  to underperform from market perform, citing growing \"competitive pressure\" from other developers of COVID-19 vaccines. Shares of Moderna were down 7.3% in premarke..."},{"Date":"Sep. 8, 2020 at 12:05 p.m. ET","Headline":"Under Pressure to Deliver, 9 Covid-19 Vaccine Developers Promise Safety First","Summary":"Analysts at SVB Leerink downgraded shares of Moderna Inc.  to underperform from market perform, citing growing \"competitive pressure\" from other developers of COVID-19 vaccines. Shares of Moderna were down 7.3% in premarke..."},{"Date":"Sep. 8, 2020 at 10:59 a.m. ET","Headline":"Buy Pfizer Stock, Analyst Says. A Strong Drug Pipeline Will Outshine a Covid Vaccine.","Summary":"Analysts at SVB Leerink downgraded shares of Moderna Inc.  to underperform from market perform, citing growing \"competitive pressure\" from other developers of COVID-19 vaccines. Shares of Moderna were down 7.3% in premarke..."},{"Date":"Sep. 8, 2020 at 9:11 a.m. ET","Headline":"Sell Moderna Stock, Analyst Says, Because Covid Vaccine Competition Is Fierce","Summary":"Analysts at SVB Leerink downgraded shares of Moderna Inc.  to underperform from market perform, citing growing \"competitive pressure\" from other developers of COVID-19 vaccines. Shares of Moderna were down 7.3% in premarke..."},{"Date":"Sep. 8, 2020 at 8:20 a.m. ET","Headline":"SVB analysts downgrade Moderna's stock, citing 'competitive pressure' from other COVID vaccine developers","Summary":"Analysts at SVB Leerink downgraded shares of Moderna Inc.  to underperform from market perform, citing growing \"competitive pressure\" from other developers of COVID-19 vaccines. Shares of Moderna were down 7.3% in premarke..."},{"Date":"Sep. 8, 2020 at 6:44 a.m. ET","Headline":"Group of 9 drug company CEOs pledge to make sure COVID-19 vaccine follows full regulatory path","Summary":"A group of nine drug company chief executives said Tuesday they have signed a pledge to make the safety and well-being of vaccinated individuals the top priority in developing the first COVID-19 vaccine. The CEOs of AstraZ..."},{"Date":"Sep. 11, 2020 at 7:45 p.m. ET","Headline":"How Facebook Could Build a Billion-Dollar Videogame Business","Summary":"Shares of Sarepta Therapeutics Inc.  were down 0.7% in premarket trading on Thursday, the day after the company said it had submitted a written response to the Food and Drug Administration for its investigational Duchenne ..."},{"Date":"Sep. 11, 2020 at 2:22 p.m. ET","Headline":"These 3 Funds Balance Safety and Return","Summary":"Shares of Sarepta Therapeutics Inc.  were down 0.7% in premarket trading on Thursday, the day after the company said it had submitted a written response to the Food and Drug Administration for its investigational Duchenne ..."},{"Date":"Sep. 11, 2020 at 10:00 a.m. ET","Headline":"It\u2019s Likely Too Late for Regeneron\u2019s Virus Treatment","Summary":"Shares of Sarepta Therapeutics Inc.  were down 0.7% in premarket trading on Thursday, the day after the company said it had submitted a written response to the Food and Drug Administration for its investigational Duchenne ..."},{"Date":"Sep. 10, 2020 at 10:19 a.m. ET","Headline":"FDA Delays Start of Sarepta\u2019s Gene Therapy Trial. That Doesn\u2019t Faze the Stock\u2019s Bulls.","Summary":"Shares of Sarepta Therapeutics Inc.  were down 0.7% in premarket trading on Thursday, the day after the company said it had submitted a written response to the Food and Drug Administration for its investigational Duchenne ..."},{"Date":"Sep. 10, 2020 at 8:21 a.m. ET","Headline":"AstraZeneca\u2019s coronavirus vaccine setback shows why Big Pharma prefers to be safe than sorry. Which is good news","Summary":"Shares of Sarepta Therapeutics Inc.  were down 0.7% in premarket trading on Thursday, the day after the company said it had submitted a written response to the Food and Drug Administration for its investigational Duchenne ..."},{"Date":"Sep. 10, 2020 at 7:38 a.m. ET","Headline":"Sarepta shares fall on potential regulatory delay for experimental Duchenne drug","Summary":"Shares of Sarepta Therapeutics Inc.  were down 0.7% in premarket trading on Thursday, the day after the company said it had submitted a written response to the Food and Drug Administration for its investigational Duchenne ..."},{"Date":"Sep. 13, 2020 at 8:11 p.m. ET","Headline":"Oracle Chosen as Winner in TikTok Sale","Summary":""},{"Date":"Sep. 10, 2020 at 7:25 a.m. ET","Headline":"Own Tesla, Apple, Beyond Meat? You\u2019d better believe in them, says this top-performing fund house","Summary":""},{"Date":"Sep. 15, 2020 at 4:32 p.m. ET","Headline":"Dow erases early climb, S&P 500 notches third straight gain as tech stocks extend rebound from last week\u2019s rout","Summary":"BioNTech SE shares  soared 4% in premarket trade Tuesday, after the drug company said it will receive up to 375 million euros ($445.9 million) in funding from the German Federal Ministry of Education and Research to suppor..."},{"Date":"Sep. 15, 2020 at 1:47 p.m. ET","Headline":"Bill Gates questions FDA, says only one drugmaker has a chance to deliver a coronavirus vaccine by next month","Summary":"BioNTech SE shares  soared 4% in premarket trade Tuesday, after the drug company said it will receive up to 375 million euros ($445.9 million) in funding from the German Federal Ministry of Education and Research to suppor..."},{"Date":"Sep. 15, 2020 at 11:10 a.m. ET","Headline":"Pfizer, Novavax, and Other Covid-19 Vaccine Rivals Race Down the Home Stretch. What to Know.","Summary":"BioNTech SE shares  soared 4% in premarket trade Tuesday, after the drug company said it will receive up to 375 million euros ($445.9 million) in funding from the German Federal Ministry of Education and Research to suppor..."},{"Date":"Sep. 15, 2020 at 9:25 a.m. ET","Headline":"Pfizer Highlights Dozens of Drugs in Its Pipeline. Here\u2019s What It Means for the Stock.","Summary":"BioNTech SE shares  soared 4% in premarket trade Tuesday, after the drug company said it will receive up to 375 million euros ($445.9 million) in funding from the German Federal Ministry of Education and Research to suppor..."},{"Date":"Sep. 15, 2020 at 8:19 a.m. ET","Headline":"Steve Cohen Finally Buys the Mets. You Can Buy the Braves.","Summary":"BioNTech SE shares  soared 4% in premarket trade Tuesday, after the drug company said it will receive up to 375 million euros ($445.9 million) in funding from the German Federal Ministry of Education and Research to suppor..."},{"Date":"Sep. 15, 2020 at 6:40 a.m. ET","Headline":"BioNTech shares jump premarket on news of 375 million euros in German funding for COVID-19 vaccine","Summary":"BioNTech SE shares  soared 4% in premarket trade Tuesday, after the drug company said it will receive up to 375 million euros ($445.9 million) in funding from the German Federal Ministry of Education and Research to suppor..."},{"Date":"Sep. 15, 2020 at 6:13 a.m. ET","Headline":"Here\u2019s what you need to know about clinical trials as drug makers push forward with coronavirus vaccine studies","Summary":"U.S. stocks on Monday closed sharply higher, amid fresh hope for a coronavirus vaccine, a flurry of initial public offerings and potential corporate deals, including reports that Oracle  may be forging a partnership with T..."},{"Date":"Sep. 14, 2020 at 4:42 p.m. ET","Headline":"Dow ends 327 points higher as stocks rebound amid vaccine hopes, IPO rush and corporate deal-making","Summary":"U.S. stocks on Monday closed sharply higher, amid fresh hope for a coronavirus vaccine, a flurry of initial public offerings and potential corporate deals, including reports that Oracle  may be forging a partnership with T..."},{"Date":"Sep. 14, 2020 at 4:25 p.m. ET","Headline":"Stocks Rise Ahead of Apple Event, Tech IPOs","Summary":"U.S. stocks on Monday closed sharply higher, amid fresh hope for a coronavirus vaccine, a flurry of initial public offerings and potential corporate deals, including reports that Oracle  may be forging a partnership with T..."},{"Date":"Sep. 14, 2020 at 4:04 p.m. ET","Headline":"Dow posts roughly 330-point gain as IPO rush, deal-making fervor and vaccine hopes reignite stock buying","Summary":"U.S. stocks on Monday closed sharply higher, amid fresh hope for a coronavirus vaccine, a flurry of initial public offerings and potential corporate deals, including reports that Oracle  may be forging a partnership with T..."},{"Date":"Sep. 14, 2020 at 1:31 p.m. ET","Headline":"Coronavirus update: WHO says record number of new cases \u2014 307,930 \u2014 counted worldwide on Sunday","Summary":""},{"Date":"Sep. 14, 2020 at 12:48 p.m. ET","Headline":"U.K. stocks fall as BP warns oil demand may have peaked but the pound climbs","Summary":""},{"Date":"Sep. 14, 2020 at 12:18 p.m. ET","Headline":"European stock rally fades despite M&A surge and Wall Street gains","Summary":""},{"Date":"Sep. 14, 2020 at 8:26 a.m. ET","Headline":"The Dow Is Set to Open Higher as Oracle, Nvidia, Delta Stock Soar","Summary":""},{"Date":"Sep. 14, 2020 at 7:40 a.m. ET","Headline":"Adobe, FedEx, Lennar and Other Stocks to Watch This Week","Summary":""},{"Date":"Sep. 14, 2020 at 2:02 a.m. ET","Headline":"Pfizer CEO: Coronavirus vaccine could be distributed in U.S. by end of year","Summary":""},{"Date":"Sep. 16, 2020 at 1:57 p.m. ET","Headline":"Lilly and Pfizer Are Testing Treatments for Hospitalized Covid Patients","Summary":""},{"Date":"Sep. 16, 2020 at 10:29 a.m. ET","Headline":"How Pfizer Plans to Lead the Industry in Gene Therapies","Summary":""},{"Date":"Sep. 16, 2020 at 8:00 a.m. ET","Headline":"Pfizer Says Its Covid Vaccine Is Just the First in a New Wave of Preventives","Summary":""},{"Date":"Sep. 18, 2020 at 8:25 a.m. ET","Headline":"Get Ready for \u2018Quadruple Witching\u2019 Day","Summary":""},{"Date":"Sep. 17, 2020 at 5:23 p.m. ET","Headline":"Moderna Shares the Latest on its Coronavirus Vaccine Trial and Other Research Advances","Summary":""},{"Date":"Sep. 21, 2020 at 10:42 a.m. ET","Headline":"Anticancer Drug Team-Ups Show Promise. 4 Stocks That Stand to Gain.","Summary":""},{"Date":"Sep. 21, 2020 at 7:30 a.m. ET","Headline":"Philadelphia pediatrician Paul Offit: Prepare to wear masks and socially distance even after getting COVID-19 vaccine","Summary":""},{"Date":"Sep. 21, 2020 at 3:57 a.m. ET","Headline":"Dr. Fauci: \u2018We may be able to put this coronavirus outbreak behind us\u2019 \u2014 but he says Americans must play a critical role","Summary":""},{"Date":"Sep. 23, 2020 at 8:33 p.m. ET","Headline":"Trump Says Kentucky Attorney General Is Handling Breonna Taylor Situation \u2018Very Well\u2019","Summary":"Drug makers developing COVID-19 vaccines will decide  to seek full approval from the Food and Drug Administration or the less rigorous emergency use authorization (EUA), according to remarks made by FDA commissioner Dr. St..."},{"Date":"Sep. 23, 2020 at 3:42 p.m. ET","Headline":"Coronavirus update: U.S. death toll tops 201,000, as daily tally more than doubles","Summary":"Drug makers developing COVID-19 vaccines will decide  to seek full approval from the Food and Drug Administration or the less rigorous emergency use authorization (EUA), according to remarks made by FDA commissioner Dr. St..."},{"Date":"Sep. 23, 2020 at 11:06 a.m. ET","Headline":"FDA commissioner: It's up to drug makers developing vaccines to seek approval or EUA","Summary":"Drug makers developing COVID-19 vaccines will decide  to seek full approval from the Food and Drug Administration or the less rigorous emergency use authorization (EUA), according to remarks made by FDA commissioner Dr. St..."},{"Date":"Sep. 23, 2020 at 10:52 a.m. ET","Headline":"Fauci predicts U.S. will know if COVID-19 vaccines are effective by \"November or December\"","Summary":"Dr. Anthony Fauci, director of National Institute of Allergy and Infectious Diseases, expects to see data from the Phase 3 clinical trials of some COVID-19 vaccine candidates indicating whether the vaccines are safe and ef..."},{"Date":"Sep. 23, 2020 at 10:51 a.m. ET","Headline":"J&J Launches Trial of Single-Dose Covid Vaccine. Results Could Come Quicker Than You Think.","Summary":""},{"Date":"Sep. 22, 2020 at 12:55 p.m. ET","Headline":"Scientists examine how adults and children fight off COVID-19 \u2014 and say it may have implications for vaccine research","Summary":""},{"Date":"Sep. 25, 2020 at 3:16 p.m. ET","Headline":"Everything you need to know about what it would take for the FDA to approve a COVID-19 vaccine","Summary":""},{"Date":"Sep. 25, 2020 at 1:30 p.m. ET","Headline":"Why Covid-19 Vaccine Prices May Be Unexpectedly Low","Summary":""},{"Date":"Sep. 25, 2020 at 9:07 a.m. ET","Headline":"Another Covid-19 Vaccine Candidate Is in the Final Stage of Testing","Summary":""},{"Date":"Sep. 25, 2020 at 5:34 a.m. ET","Headline":"Just 4 in 10 Americans now say they would get the first coronavirus vaccine","Summary":""},{"Date":"Sep. 24, 2020 at 6:45 p.m. ET","Headline":"All the Covid-19 Vaccine Candidates That Are Now in Final Trials","Summary":""},{"Date":"Sep. 24, 2020 at 4:14 p.m. ET","Headline":"Moderna Stock Can\u2019t Go Much Higher\u2014Even If It Makes a Covid-19 Vaccine","Summary":""},{"Date":"Sep. 24, 2020 at 7:54 a.m. ET","Headline":"The Stock Market Is Having a September to Forget","Summary":""},{"Date":"Sep. 24, 2020 at 1:42 a.m. ET","Headline":"As Trump continues to press for coronavirus vaccine by Election Day, public health officials vow \u2018no cutting corners\u2019","Summary":""},{"Date":"Sep. 26, 2020 at 11:33 a.m. ET","Headline":"Novavax stock soars after start of late-stage COVID-19 vaccine trial","Summary":""},{"Date":"Sep. 26, 2020 at 7:30 a.m. ET","Headline":"Honeywell and General Mills Boost Their Dividends This Week","Summary":""},{"Date":"Sep. 28, 2020 at 5:06 p.m. ET","Headline":"Sarepta\u2019s First Gene-Therapy Test Patients Look Good, Two Years Out","Summary":""},{"Date":"Sep. 28, 2020 at 3:46 p.m. ET","Headline":"Inovio Stock Tumbles After Covid-19 Vaccine Trial Is Halted","Summary":""},{"Date":"Sep. 28, 2020 at 7:27 a.m. ET","Headline":"There are four coronavirus vaccines in late-stage studies \u2014 here\u2019s how they differ","Summary":""},{"Date":"Oct. 1, 2020 at 3:18 p.m. ET","Headline":"In These Election Scenarios, Managed Care Wins, Biotech Loses","Summary":""},{"Date":"Oct. 1, 2020 at 2:56 p.m. ET","Headline":"Why Solid Biosciences Stock Has Doubled Today","Summary":""},{"Date":"Sep. 30, 2020 at 10:19 a.m. ET","Headline":"Moderna\u2019s Covid Vaccine Generated Strong Antibodies in the Elderly. What It Means for the Stock.","Summary":""},{"Date":"Sep. 30, 2020 at 9:13 a.m. ET","Headline":"Regeneron\u2019s Good News on Covid Antibodies Is Positive for Vaccines, Too","Summary":""},{"Date":"Oct. 3, 2020 at 3:08 p.m. ET","Headline":"Here are the biggest winners in a solid third quarter for U.S. stocks","Summary":"Shares of Pfizer Inc.  were down 0.1% in premarket trading on Friday, the day after  that CEO Albert Bourla had reportedly told employees that development for its COVID-19 vaccine would move \"at the speed of science\" rathe..."},{"Date":"Oct. 2, 2020 at 3:32 p.m. ET","Headline":"Coronavirus update: Lawmakers rush to express hope Trump\u2019s positive coronavirus test will change views of the illness and improve compliance with safety measures","Summary":"Shares of Pfizer Inc.  were down 0.1% in premarket trading on Friday, the day after  that CEO Albert Bourla had reportedly told employees that development for its COVID-19 vaccine would move \"at the speed of science\" rathe..."},{"Date":"Oct. 2, 2020 at 10:23 a.m. ET","Headline":"Trump\u2019s Covid Case Brings New Urgency to Treatments and Vaccines","Summary":"Shares of Pfizer Inc.  were down 0.1% in premarket trading on Friday, the day after  that CEO Albert Bourla had reportedly told employees that development for its COVID-19 vaccine would move \"at the speed of science\" rathe..."},{"Date":"Oct. 2, 2020 at 9:50 a.m. ET","Headline":"President Trump Tests Positive for Coronavirus. Where the Covid-19 Vaccines Stand Now.","Summary":"Shares of Pfizer Inc.  were down 0.1% in premarket trading on Friday, the day after  that CEO Albert Bourla had reportedly told employees that development for its COVID-19 vaccine would move \"at the speed of science\" rathe..."},{"Date":"Oct. 2, 2020 at 9:15 a.m. ET","Headline":"Report: Pfizer CEO tell employees COVID-19 vaccine will move only at 'speed of science'","Summary":"Shares of Pfizer Inc.  were down 0.1% in premarket trading on Friday, the day after  that CEO Albert Bourla had reportedly told employees that development for its COVID-19 vaccine would move \"at the speed of science\" rathe..."},{"Date":"Oct. 5, 2020 at 10:33 a.m. ET","Headline":"Here\u2019s what doctors are saying about Trump\u2019s motorcade outside Walter Reed to wave at supporters","Summary":""},{"Date":"Oct. 5, 2020 at 8:18 a.m. ET","Headline":"How to Build the Best Bond Portfolio for Crazy Times","Summary":""},{"Date":"Oct. 5, 2020 at 6:56 a.m. ET","Headline":"\u2018We\u2019re getting great reports from the doctors\u2019: Trump tweets second video from Walter Reed \u2014 and later gives thumbs-up to supporters from motorcade","Summary":""},{"Date":"Oct. 4, 2020 at 4:57 p.m. ET","Headline":"\u2018I wasn\u2019t feeling so well. I feel much better now\u2019: Full transcript of Trump\u2019s video address from Walter Reed","Summary":""},{"Date":"Oct. 4, 2020 at 4:51 p.m. ET","Headline":"Why Trump is at higher risk of more severe illness from unpredictable COVID-19","Summary":""},{"Date":"Oct. 4, 2020 at 2:54 p.m. ET","Headline":"Coronavirus update: Expert calls for \u2018radical transparency\u2019 on Trump\u2019s coronavirus treatment and progress as more in president\u2019s circle test positive","Summary":""},{"Date":"Oct. 7, 2020 at 1:44 p.m. ET","Headline":"Lilly Serves Up an Anti-Covid Cocktail, Like Regeneron\u2019s. The Stock Is Rising.","Summary":"Pharmaceutical companies developing COVID-19 vaccines should wait two months after late-stage studies conclude to submit an application for an emergency use authorization to the Food and Drug Administration, the regulator ..."},{"Date":"Oct. 7, 2020 at 10:30 a.m. ET","Headline":"The Stock Market Is Bouncing Back Because Trump Still Wants Stimulus","Summary":"Pharmaceutical companies developing COVID-19 vaccines should wait two months after late-stage studies conclude to submit an application for an emergency use authorization to the Food and Drug Administration, the regulator ..."},{"Date":"Oct. 7, 2020 at 2:26 a.m. ET","Headline":"\u2018Don\u2019t ever, ever underestimate the potential of the pandemic\u2019: 5 reasons scientists say you should be afraid of COVID-19","Summary":"Pharmaceutical companies developing COVID-19 vaccines should wait two months after late-stage studies conclude to submit an application for an emergency use authorization to the Food and Drug Administration, the regulator ..."},{"Date":"Oct. 6, 2020 at 7:15 p.m. ET","Headline":"FDA Is Looking for More Clinical Trial Data. Why That Makes a Pre-Election Covid Vaccine Unlikely.","Summary":"Pharmaceutical companies developing COVID-19 vaccines should wait two months after late-stage studies conclude to submit an application for an emergency use authorization to the Food and Drug Administration, the regulator ..."},{"Date":"Oct. 6, 2020 at 6:11 p.m. ET","Headline":"Coronavirus update: U.S. death toll tops 210,000 as doctors say Trump\u2019s comments on COVID-19 are sending the wrong message","Summary":"Pharmaceutical companies developing COVID-19 vaccines should wait two months after late-stage studies conclude to submit an application for an emergency use authorization to the Food and Drug Administration, the regulator ..."},{"Date":"Oct. 6, 2020 at 4:15 p.m. ET","Headline":"Markets Drop as Trump Ends Stimulus Talks","Summary":"Pharmaceutical companies developing COVID-19 vaccines should wait two months after late-stage studies conclude to submit an application for an emergency use authorization to the Food and Drug Administration, the regulator ..."},{"Date":"Oct. 6, 2020 at 1:20 p.m. ET","Headline":"FDA to require 2-month follow-up period for COVID-19 vaccines before authorization","Summary":"Pharmaceutical companies developing COVID-19 vaccines should wait two months after late-stage studies conclude to submit an application for an emergency use authorization to the Food and Drug Administration, the regulator ..."},{"Date":"Oct. 6, 2020 at 12:44 p.m. ET","Headline":"Pfizer and BioNTech Start Filing for Covid-19 Vaccine Approval in Europe. That Doesn\u2019t Mean a Vaccine Is Coming Sooner Than Expected.","Summary":"Pfizer Inc.  and BioNTech SE  said the European Medicines Agency has decided to review data from their COVID-19 vaccine candidate on a rolling basis and has already started to evaluate data from pre-clinical trials. The de..."},{"Date":"Oct. 6, 2020 at 9:24 a.m. ET","Headline":"The Dow Is Rising on Stimulus Hopes, Costco Stock Is Gaining and BioNTech Is Jumping","Summary":"Pfizer Inc.  and BioNTech SE  said the European Medicines Agency has decided to review data from their COVID-19 vaccine candidate on a rolling basis and has already started to evaluate data from pre-clinical trials. The de..."},{"Date":"Oct. 6, 2020 at 6:54 a.m. ET","Headline":"Trump White House blocks FDA\u2019s new guidelines for vaccine approval","Summary":"Pfizer Inc.  and BioNTech SE  said the European Medicines Agency has decided to review data from their COVID-19 vaccine candidate on a rolling basis and has already started to evaluate data from pre-clinical trials. The de..."},{"Date":"Oct. 6, 2020 at 6:34 a.m. ET","Headline":"Pfizer and BioNTech says European Medicines Agency to review data from COVID-19 vaccine trial on rolling basis","Summary":"Pfizer Inc.  and BioNTech SE  said the European Medicines Agency has decided to review data from their COVID-19 vaccine candidate on a rolling basis and has already started to evaluate data from pre-clinical trials. The de..."},{"Date":"Sep. 28, 2020 at 8:56 a.m. ET","Headline":"10 Stocks to Buy as the Health-Care Revolution Races Ahead, According to Experts","Summary":""},{"Date":"Oct. 8, 2020 at 12:58 p.m. ET","Headline":"How the EU will speed up approval of eventual COVID-19 vaccine, in contrast to what has happened in U.S.","Summary":""},{"Date":"Oct. 8, 2020 at 10:06 a.m. ET","Headline":"Regeneron Wants FDA Approval for Trump\u2019s Covid-19 Treatment. What Could Come Next.","Summary":""},{"Date":"Oct. 12, 2020 at 5:23 p.m. ET","Headline":"Pfizer Suit Could Be an \u2018Earthquake\u2019 for Drug Pricing","Summary":""},{"Date":"Oct. 11, 2020 at 2:20 p.m. ET","Headline":"Why This Value Fund Likes UPS, Walmart, and Home Depot Stock","Summary":""},{"Date":"Oct. 14, 2020 at 11:14 a.m. ET","Headline":"How to Invest In Covid-19 Vaccines and Treatments When Trials Keep Getting Paused","Summary":""},{"Date":"Oct. 14, 2020 at 8:38 a.m. ET","Headline":"There are seven coronavirus vaccine candidates being tested in the U.S. \u2014 here\u2019s where they stand","Summary":""},{"Date":"Oct. 17, 2020 at 6:29 p.m. ET","Headline":"Coronavirus update: Global COVID-19 cases top 39 million as trial of promising therapy finds it does not stop patients dying","Summary":"Biotech exchange-traded funds got a bounce Friday from bullish news on coronavirus treatments. The ALPS Medical Breakthroughs ETF , the ARK Genomic Revolution ETF , and the First Trust NYSE Arca Biotechnology Index Fund  w..."},{"Date":"Oct. 17, 2020 at 10:29 a.m. ET","Headline":"Pfizer could know if COVID-19 vaccine candidate is effective by end of October","Summary":"Biotech exchange-traded funds got a bounce Friday from bullish news on coronavirus treatments. The ALPS Medical Breakthroughs ETF , the ARK Genomic Revolution ETF , and the First Trust NYSE Arca Biotechnology Index Fund  w..."},{"Date":"Oct. 16, 2020 at 4:30 p.m. ET","Headline":"The Dow Gains as Retail Sales Come in Strong","Summary":"Biotech exchange-traded funds got a bounce Friday from bullish news on coronavirus treatments. The ALPS Medical Breakthroughs ETF , the ARK Genomic Revolution ETF , and the First Trust NYSE Arca Biotechnology Index Fund  w..."},{"Date":"Oct. 16, 2020 at 4:22 p.m. ET","Headline":"Dow adds 100 points, stocks manage weekly gains as retail sales, consumer sentiment rise","Summary":"Biotech exchange-traded funds got a bounce Friday from bullish news on coronavirus treatments. The ALPS Medical Breakthroughs ETF , the ARK Genomic Revolution ETF , and the First Trust NYSE Arca Biotechnology Index Fund  w..."},{"Date":"Oct. 16, 2020 at 3:01 p.m. ET","Headline":"Trump reports September fundraising haul that lags Biden\u2019s, as the candidates campaign in Florida, Georgia, Michigan","Summary":"Biotech exchange-traded funds got a bounce Friday from bullish news on coronavirus treatments. The ALPS Medical Breakthroughs ETF , the ARK Genomic Revolution ETF , and the First Trust NYSE Arca Biotechnology Index Fund  w..."},{"Date":"Oct. 16, 2020 at 1:25 p.m. ET","Headline":"WHO Questions Effectiveness of Remdesivir on Covid-19 Death Rates","Summary":"Biotech exchange-traded funds got a bounce Friday from bullish news on coronavirus treatments. The ALPS Medical Breakthroughs ETF , the ARK Genomic Revolution ETF , and the First Trust NYSE Arca Biotechnology Index Fund  w..."},{"Date":"Oct. 16, 2020 at 11:49 a.m. ET","Headline":"The Latest Bad News on the Industrial Economy, and Why Investors Are Shrugging It Off","Summary":"Biotech exchange-traded funds got a bounce Friday from bullish news on coronavirus treatments. The ALPS Medical Breakthroughs ETF , the ARK Genomic Revolution ETF , and the First Trust NYSE Arca Biotechnology Index Fund  w..."},{"Date":"Oct. 16, 2020 at 11:34 a.m. ET","Headline":"Biotech ETFs at two-week highs on upbeat vaccine news","Summary":"Biotech exchange-traded funds got a bounce Friday from bullish news on coronavirus treatments. The ALPS Medical Breakthroughs ETF , the ARK Genomic Revolution ETF , and the First Trust NYSE Arca Biotechnology Index Fund  w..."},{"Date":"Oct. 16, 2020 at 11:03 a.m. ET","Headline":"Autos and apparel makers boost European stocks","Summary":"U.S. stock futures moved higher Friday after Pfizer  said it could file for emergency use authorization from the Food and Drug Administration for the COVID-19 vaccine it's created with BioNTech  in late November. Futures o..."},{"Date":"Oct. 16, 2020 at 8:24 a.m. ET","Headline":"Boeing Jumps, Pfizer Rises as the Dow Edges Up","Summary":"U.S. stock futures moved higher Friday after Pfizer  said it could file for emergency use authorization from the Food and Drug Administration for the COVID-19 vaccine it's created with BioNTech  in late November. Futures o..."},{"Date":"Oct. 16, 2020 at 7:55 a.m. ET","Headline":"Pfizer and BioNTech Vaccine Could Be Ready By the End of November. We\u2019re All Winners.","Summary":"U.S. stock futures moved higher Friday after Pfizer  said it could file for emergency use authorization from the Food and Drug Administration for the COVID-19 vaccine it's created with BioNTech  in late November. Futures o..."},{"Date":"Oct. 16, 2020 at 7:11 a.m. ET","Headline":"Here\u2019s how to play the 3 big uncertainties hanging over the market, according to one hedge fund","Summary":"U.S. stock futures moved higher Friday after Pfizer  said it could file for emergency use authorization from the Food and Drug Administration for the COVID-19 vaccine it's created with BioNTech  in late November. Futures o..."},{"Date":"Oct. 16, 2020 at 6:48 a.m. ET","Headline":"U.S. stock futures get a lift from Pfizer vaccine news","Summary":"U.S. stock futures moved higher Friday after Pfizer  said it could file for emergency use authorization from the Food and Drug Administration for the COVID-19 vaccine it's created with BioNTech  in late November. Futures o..."},{"Date":"Oct. 19, 2020 at 2:13 p.m. ET","Headline":"GE Stock Is in a Stealth Bull Market. Here\u2019s Why.","Summary":""},{"Date":"Oct. 19, 2020 at 7:57 a.m. ET","Headline":"Dr. Fauci urges Americans to make sacrifices: \u2018Thanksgiving is going to look very different this year\u2019","Summary":""},{"Date":"Oct. 18, 2020 at 9:08 a.m. ET","Headline":"People of color shouldn\u2019t be treated equally in COVID-19 vaccine trials, ER doctor says: They should be over-represented","Summary":""},{"Date":"Oct. 18, 2020 at 7:27 a.m. ET","Headline":"\u2018COVID-19 remains a serious public-health threat\u2019: New Yorkers don\u2019t have hope that their city will recover anytime soon","Summary":""},{"Date":"Oct. 18, 2020 at 7:21 a.m. ET","Headline":"Dr. Fauci: \u2018This is an outbreak of historic proportions, the likes of which we\u2019ve not seen in 102 years\u2019","Summary":""},{"Date":"Oct. 21, 2020 at 2:16 p.m. ET","Headline":"Participant in AstraZeneca Vaccine Trial Dies","Summary":"U.S. stock benchmarks on Tuesday kicked off trade modestly higher, as stocks attempted to recover from the worst daily percentage decline in about a month. House Speaker Nancy Pelosi and Treasury Secretary Steven Mnuchin h..."},{"Date":"Oct. 21, 2020 at 12:00 p.m. ET","Headline":"Fauci Tells Doctors Covid is Worse in the U.S. Because of a Failure to Avoid Crowds","Summary":"U.S. stock benchmarks on Tuesday kicked off trade modestly higher, as stocks attempted to recover from the worst daily percentage decline in about a month. House Speaker Nancy Pelosi and Treasury Secretary Steven Mnuchin h..."},{"Date":"Oct. 20, 2020 at 3:28 p.m. ET","Headline":"Gold scores back-to-back gains, settles at highest in over a week","Summary":"U.S. stock benchmarks on Tuesday kicked off trade modestly higher, as stocks attempted to recover from the worst daily percentage decline in about a month. House Speaker Nancy Pelosi and Treasury Secretary Steven Mnuchin h..."},{"Date":"Oct. 20, 2020 at 2:38 p.m. ET","Headline":"Coronavirus update: Global case tally climbs to 40.6 million and WHO expert urges governments to look to regions that have succeeded in containing spread","Summary":"U.S. stock benchmarks on Tuesday kicked off trade modestly higher, as stocks attempted to recover from the worst daily percentage decline in about a month. House Speaker Nancy Pelosi and Treasury Secretary Steven Mnuchin h..."},{"Date":"Oct. 20, 2020 at 2:11 p.m. ET","Headline":"Covid-19 Vaccines Could Take a Critical Next Step in November \u2014 Just Not In Time for the Election","Summary":"U.S. stock benchmarks on Tuesday kicked off trade modestly higher, as stocks attempted to recover from the worst daily percentage decline in about a month. House Speaker Nancy Pelosi and Treasury Secretary Steven Mnuchin h..."},{"Date":"Oct. 20, 2020 at 9:36 a.m. ET","Headline":"Dow gains at Tuesday's open as coronavirus relief package deadline and vaccines come into focus","Summary":"U.S. stock benchmarks on Tuesday kicked off trade modestly higher, as stocks attempted to recover from the worst daily percentage decline in about a month. House Speaker Nancy Pelosi and Treasury Secretary Steven Mnuchin h..."},{"Date":"Oct. 20, 2020 at 9:25 a.m. ET","Headline":"Trump calls Dr. Fauci a \u2018disaster\u2019 \u2014 Fauci tells Americans: \u2018Stay away from the politics\u2019","Summary":""},{"Date":"Oct. 19, 2020 at 4:17 p.m. ET","Headline":"The Spike in Covid Cases Could Speed Vaccine Trial Readouts","Summary":""},{"Date":"Oct. 23, 2020 at 7:17 p.m. ET","Headline":"Remdesivir Gets FDA Approval. What It Means for Gilead Stock and Vaccine Makers.","Summary":""},{"Date":"Oct. 23, 2020 at 5:51 p.m. ET","Headline":"Why Snap\u2019s Surge Is Good News for Social Media","Summary":""},{"Date":"Oct. 23, 2020 at 8:06 a.m. ET","Headline":"Intel and the Risks of Being Left Behind","Summary":""},{"Date":"Oct. 22, 2020 at 11:11 p.m. ET","Headline":"Stock Futures Flat After Final Presidential Debate Ends","Summary":""},{"Date":"Oct. 22, 2020 at 1:59 p.m. ET","Headline":"FDA Covid Meeting Shows the Companies Behind the Vaccines","Summary":""},{"Date":"Oct. 22, 2020 at 12:04 p.m. ET","Headline":"Glaxo Vaccines Target Another Viral Threat","Summary":""},{"Date":"Oct. 22, 2020 at 8:30 a.m. ET","Headline":"The Stock Market Is Preparing for a Blue Wave. That Could Be Premature, Researcher Says.","Summary":""},{"Date":"Oct. 27, 2020 at 4:31 p.m. ET","Headline":"Dow books back-to-back loss as Wall Street struggles to rebound from Monday selloff","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Tuesday after the drug maker missed sales expectations for the quarter. Pfizer had earnings of $2.2 billion, or 39 cents per share, in the third quarter of 2020, ..."},{"Date":"Oct. 27, 2020 at 10:05 a.m. ET","Headline":"Pfizer Stock Is Lower Because the Covid-19 Vaccine Looms Over Earnings","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Tuesday after the drug maker missed sales expectations for the quarter. Pfizer had earnings of $2.2 billion, or 39 cents per share, in the third quarter of 2020, ..."},{"Date":"Oct. 27, 2020 at 7:29 a.m. ET","Headline":"As markets gyrate over second-wave fears, here are 2 consumer staple stocks to ride for the long run, from Barclays","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Tuesday after the drug maker missed sales expectations for the quarter. Pfizer had earnings of $2.2 billion, or 39 cents per share, in the third quarter of 2020, ..."},{"Date":"Oct. 27, 2020 at 7:24 a.m. ET","Headline":"Pfizer cites $500 million impact in the third quarter as a result of the COVID-19 pandemic","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Tuesday after the drug maker missed sales expectations for the quarter. Pfizer had earnings of $2.2 billion, or 39 cents per share, in the third quarter of 2020, ..."},{"Date":"Oct. 26, 2020 at 12:04 p.m. ET","Headline":"After Restarting Covid Vaccine Trial, AstraZeneca Has Good News for Older Adults","Summary":""},{"Date":"Oct. 26, 2020 at 11:36 a.m. ET","Headline":"Bayer Is the Latest Drug Giant Betting on Gene Therapy With a $4 Billion U.S. Acquisition","Summary":""},{"Date":"Oct. 26, 2020 at 11:07 a.m. ET","Headline":"Fauci and Biden advocate a federal mask mandate, as new COVID-19 infections surge","Summary":""},{"Date":"Oct. 26, 2020 at 9:45 a.m. ET","Headline":"9 Promising Stocks From Emerging Markets","Summary":""},{"Date":"Oct. 26, 2020 at 7:31 a.m. ET","Headline":"Apple, Amazon, Boeing, Visa, Pfizer, and Other Stocks to Watch This Week","Summary":""},{"Date":"Oct. 29, 2020 at 10:55 a.m. ET","Headline":"Moderna Stock Jumps as Biotech Rakes in Revenue for Covid Vaccine","Summary":""},{"Date":"Oct. 28, 2020 at 6:51 p.m. ET","Headline":"Amgen\u2019s Earnings and Sales Climb, Driven by Its Biosimilars","Summary":""},{"Date":"Oct. 28, 2020 at 9:19 a.m. ET","Headline":"Covid-19 Couldn\u2019t Stop the Dodgers\u2014and It Won\u2019t Stop the Stock Market","Summary":""},{"Date":"Oct. 28, 2020 at 6:17 a.m. ET","Headline":"Coronavirus update: U.S. case tally tops 8.7 million and marks seven-day record, with more than 20 states seeing most new cases since start of the outbreak","Summary":""},{"Date":"Oct. 31, 2020 at 3:23 p.m. ET","Headline":"These are the 3 best dividend yield investments for 2021","Summary":""},{"Date":"Oct. 30, 2020 at 6:18 p.m. ET","Headline":"Overconfident Predictions for Stocks, the Election, and a Covid-19 Vaccine","Summary":""},{"Date":"Oct. 30, 2020 at 3:01 p.m. ET","Headline":"U.K. regulator is accelerating reviews of COVID-19 vaccines from Pfizer and AstraZeneca, according to a report","Summary":""},{"Date":"Nov. 2, 2020 at 12:26 p.m. ET","Headline":"CureVac\u2019s COVID-19 vaccine shows immune response in Phase 1 trial","Summary":""},{"Date":"Nov. 2, 2020 at 8:58 a.m. ET","Headline":"Here\u2019s What a Covid-19 Vaccine Could Be Worth to Pfizer Stock","Summary":""},{"Date":"Nov. 4, 2020 at 1:44 p.m. ET","Headline":"Oxford vaccine-trial chief sees \u2018small chance\u2019 of COVID-19 inoculations being ready by Christmas","Summary":""},{"Date":"Nov. 3, 2020 at 10:48 a.m. ET","Headline":"Bristol Myers Says Its Psoriasis Drug Outperformed Amgen\u2019s Otezla","Summary":""},{"Date":"Nov. 5, 2020 at 3:04 p.m. ET","Headline":"These 7 \u2018deeply out of favor stocks\u2019 are worth a look right now, says contrarian manager","Summary":""},{"Date":"Nov. 7, 2020 at 9:11 p.m. ET","Headline":"Biden Has Won the Most Extraordinary Election of Our Time. What Comes Next.","Summary":""},{"Date":"Jul. 13, 2020 at 2:12 p.m. ET","Headline":"37 Stocks Poised to Emerge Even Stronger After the Crisis, According to Barron\u2019s Investing Experts","Summary":""},{"Date":"Nov. 10, 2020 at 6:26 p.m. ET","Headline":"The U.S. has already had more than 1 million new coronavirus cases in November","Summary":"U.S. stocks on Tuesday finished on a mixed note, with the Dow Jones Industrial Average, outperforming its benchmarks counterparts and small-capitalization and value-oriented stocks performing best of all. Meanwhile, the Na..."},{"Date":"Nov. 10, 2020 at 5:51 p.m. ET","Headline":"The Dow Rose 263 Points Because Investors Are Feeling Confident","Summary":"U.S. stocks on Tuesday finished on a mixed note, with the Dow Jones Industrial Average, outperforming its benchmarks counterparts and small-capitalization and value-oriented stocks performing best of all. Meanwhile, the Na..."},{"Date":"Nov. 10, 2020 at 5:28 p.m. ET","Headline":"These are the non-pharma winners and losers from the Pfizer vaccine results","Summary":"U.S. stocks on Tuesday finished on a mixed note, with the Dow Jones Industrial Average, outperforming its benchmarks counterparts and small-capitalization and value-oriented stocks performing best of all. Meanwhile, the Na..."},{"Date":"Nov. 10, 2020 at 4:48 p.m. ET","Headline":"Microsoft and Other Tech Stocks Got Crushed. Why the Dow Jones Industrial Average Rose Today.","Summary":"U.S. stocks on Tuesday finished on a mixed note, with the Dow Jones Industrial Average, outperforming its benchmarks counterparts and small-capitalization and value-oriented stocks performing best of all. Meanwhile, the Na..."},{"Date":"Nov. 10, 2020 at 4:22 p.m. ET","Headline":"Dow gains 260 points, while Nasdaq slides as vaccine hopes spark rotation away from tech highfliers","Summary":"U.S. stocks on Tuesday finished on a mixed note, with the Dow Jones Industrial Average, outperforming its benchmarks counterparts and small-capitalization and value-oriented stocks performing best of all. Meanwhile, the Na..."},{"Date":"Nov. 10, 2020 at 4:09 p.m. ET","Headline":"Dow industrials book second straight gain to end about 0.5% from record high but tech selloff sends Nasdaq skidding to 3% weekly loss","Summary":"U.S. stocks on Tuesday finished on a mixed note, with the Dow Jones Industrial Average, outperforming its benchmarks counterparts and small-capitalization and value-oriented stocks performing best of all. Meanwhile, the Na..."},{"Date":"Nov. 10, 2020 at 4:05 p.m. ET","Headline":"Lyft\u2019s Revenues Top Estimates. It Still Expects a Profit in 2021.","Summary":""},{"Date":"Nov. 10, 2020 at 3:21 p.m. ET","Headline":"Oil prices tally back-to-back gains on optimism over vaccine","Summary":""},{"Date":"Nov. 10, 2020 at 2:34 p.m. ET","Headline":"3 Retail Stocks With Covid Vaccine Upside \u2014 and 3 to Avoid","Summary":""},{"Date":"Nov. 10, 2020 at 2:34 p.m. ET","Headline":"Cruise stocks pull back, led by Carnival\u2019s tumble after plans for another large stock offering","Summary":""},{"Date":"Nov. 10, 2020 at 2:25 p.m. ET","Headline":"He bought Tesla and Apple in 2013 \u2014 now he\u2019s got $5.4 million and is asking the internet what to do with it","Summary":""},{"Date":"Nov. 10, 2020 at 2:22 p.m. ET","Headline":"Coronavirus update: U.S. adds another 130,000 cases in a day: \u2018This is what exponential math looks like,\u2019 says expert","Summary":""},{"Date":"Nov. 10, 2020 at 2:03 p.m. ET","Headline":"Gold prices end higher a day after sharpest daily drop in 7 years","Summary":""},{"Date":"Nov. 10, 2020 at 1:48 p.m. ET","Headline":"EU Hits Amazon With Antitrust Charges and Opens New Probe on E-Commerce Practices","Summary":""},{"Date":"Nov. 10, 2020 at 1:07 p.m. ET","Headline":"Investors need to brace for a \u2018violent rotation into\u2019 cyclicals, value stocks, says Lee","Summary":""},{"Date":"Nov. 10, 2020 at 1:06 p.m. ET","Headline":"Buy Raytheon, Spirit Because of Pfizer\u2019s Vaccine News, Analyst Says. Here\u2019s How Far Those Stocks Can Run.","Summary":""},{"Date":"Nov. 10, 2020 at 12:51 p.m. ET","Headline":"10 Hidden Gems in the Rush for Covid-Vaccine Stocks","Summary":""},{"Date":"Nov. 10, 2020 at 12:44 p.m. ET","Headline":"Why the Small-Cap Rally Is Just Getting Started","Summary":""},{"Date":"Nov. 12, 2020 at 4:36 p.m. ET","Headline":"Dow ends day with 300-point loss as COVID-19 fears spook stock market","Summary":""},{"Date":"Nov. 12, 2020 at 3:13 p.m. ET","Headline":"Moderna Raises the Stakes in Vaccine Race With Pfizer. Differences Could Matter.","Summary":""},{"Date":"Nov. 12, 2020 at 3:05 p.m. ET","Headline":"Oil prices settle lower after  surprise climb in U.S. crude supplies, rise in coronavirus cases","Summary":""},{"Date":"Nov. 12, 2020 at 2:01 p.m. ET","Headline":"Gold settles higher on risk-off trade, fall in bond yields","Summary":""},{"Date":"Nov. 12, 2020 at 11:50 a.m. ET","Headline":"Rising Covid Cases Leave Markets Mixed Despite Vaccine Hopes","Summary":""},{"Date":"Nov. 12, 2020 at 11:32 a.m. ET","Headline":"Here\u2019s One U.K. Play on Pfizer\u2019s Covid-19 Vaccine That May Be Overdone","Summary":""},{"Date":"Nov. 12, 2020 at 11:27 a.m. ET","Headline":"Beware a nasty reversal if the S&P 500 doesn\u2019t reach a fresh all-time closing high","Summary":""},{"Date":"Nov. 12, 2020 at 10:47 a.m. ET","Headline":"Mortgage rates rise from record lows on vaccine news, election results","Summary":""},{"Date":"Nov. 12, 2020 at 10:10 a.m. ET","Headline":"Why stock-market bulls can\u2019t ignore rising COVID cases despite vaccine optimism","Summary":""},{"Date":"Nov. 12, 2020 at 8:33 a.m. ET","Headline":"U.S. Covid-19 Cases, Hospitalizations Hit More New Highs. Where Things Are Getting Worse.","Summary":""},{"Date":"Nov. 12, 2020 at 8:05 a.m. ET","Headline":"EV Stocks Can\u2019t Be Stopped","Summary":""},{"Date":"Nov. 12, 2020 at 7:39 a.m. ET","Headline":"Short sellers lost $5.5 billion so far in November. Here are the trades that hurt the most","Summary":""},{"Date":"Nov. 12, 2020 at 6:00 a.m. ET","Headline":"Delta CEO on the Recovery in Air Travel: \u2018We\u2019re Seeing Light at the End of the Tunnel\u2019","Summary":""},{"Date":"Nov. 12, 2020 at 5:13 a.m. ET","Headline":"Goldman Sachs has just boosted its S&P 500 target. Here\u2019s why","Summary":""},{"Date":"Nov. 11, 2020 at 8:39 p.m. ET","Headline":"How stock-market sectors have reacted to bullish coronavirus vaccine news","Summary":""},{"Date":"Nov. 11, 2020 at 4:45 p.m. ET","Headline":"Dow snaps 2-day win streak, Nasdaq gains as rotation fades with surging coronavirus cases","Summary":""},{"Date":"Nov. 11, 2020 at 4:39 p.m. ET","Headline":"Nervous about tech stocks as investors rotate to value? This chart won\u2019t help","Summary":""},{"Date":"Nov. 11, 2020 at 4:24 p.m. ET","Headline":"The Dow Ended Lower But Tech Stocks Bounced Back","Summary":""},{"Date":"Nov. 14, 2020 at 4:57 p.m. ET","Headline":"Weekend reads: Stocks for the Biden presidency","Summary":"The small-capitalization Russell 2000 index just logged its first closing high in over two years, boosted by the prospects of a remedies and cures for the deadly COVID-19 pandemic that has hobbled economies and disproporti..."},{"Date":"Nov. 14, 2020 at 12:27 p.m. ET","Headline":"J&J and U.S. Government Earmark $1 Billion for Covid-19 Vaccine Trials","Summary":"The small-capitalization Russell 2000 index just logged its first closing high in over two years, boosted by the prospects of a remedies and cures for the deadly COVID-19 pandemic that has hobbled economies and disproporti..."},{"Date":"Nov. 14, 2020 at 11:58 a.m. ET","Headline":"COVID-19: U.S. sees new daily high for positive tests above 184,500","Summary":"The small-capitalization Russell 2000 index just logged its first closing high in over two years, boosted by the prospects of a remedies and cures for the deadly COVID-19 pandemic that has hobbled economies and disproporti..."},{"Date":"Nov. 14, 2020 at 11:57 a.m. ET","Headline":"Europe may have a merrier Christmas than the U.S., according to JPMorgan. Here\u2019s why","Summary":"The small-capitalization Russell 2000 index just logged its first closing high in over two years, boosted by the prospects of a remedies and cures for the deadly COVID-19 pandemic that has hobbled economies and disproporti..."},{"Date":"Nov. 14, 2020 at 3:32 a.m. ET","Headline":"Unemployment figures rise as Europe\u2019s COVID-19 jobs crisis deepens","Summary":"The small-capitalization Russell 2000 index just logged its first closing high in over two years, boosted by the prospects of a remedies and cures for the deadly COVID-19 pandemic that has hobbled economies and disproporti..."},{"Date":"Nov. 13, 2020 at 9:01 p.m. ET","Headline":"Why the Good News on Vaccines Could Be Bad News for Stocks","Summary":"The small-capitalization Russell 2000 index just logged its first closing high in over two years, boosted by the prospects of a remedies and cures for the deadly COVID-19 pandemic that has hobbled economies and disproporti..."},{"Date":"Nov. 13, 2020 at 8:39 p.m. ET","Headline":"Mary Barra on General Motors\u2019 All-Electric Future","Summary":"The small-capitalization Russell 2000 index just logged its first closing high in over two years, boosted by the prospects of a remedies and cures for the deadly COVID-19 pandemic that has hobbled economies and disproporti..."},{"Date":"Nov. 13, 2020 at 8:00 p.m. ET","Headline":"Mergers Have Bounced Back. But Will Biden See an M&A Boom?","Summary":"The small-capitalization Russell 2000 index just logged its first closing high in over two years, boosted by the prospects of a remedies and cures for the deadly COVID-19 pandemic that has hobbled economies and disproporti..."},{"Date":"Nov. 13, 2020 at 8:00 p.m. ET","Headline":"Here\u2019s What the Rise in Long-Term Interest Rates Means","Summary":"The small-capitalization Russell 2000 index just logged its first closing high in over two years, boosted by the prospects of a remedies and cures for the deadly COVID-19 pandemic that has hobbled economies and disproporti..."},{"Date":"Nov. 13, 2020 at 6:28 p.m. ET","Headline":"Pandemic or Not, Visa Remains a Growth Stock Stalking Its Biggest Rival, Cash","Summary":"The small-capitalization Russell 2000 index just logged its first closing high in over two years, boosted by the prospects of a remedies and cures for the deadly COVID-19 pandemic that has hobbled economies and disproporti..."},{"Date":"Nov. 13, 2020 at 5:38 p.m. ET","Headline":"Trump says \u2018time will tell\u2019 if he stays in power and threatens to withhold coronavirus vaccine from New York","Summary":"The small-capitalization Russell 2000 index just logged its first closing high in over two years, boosted by the prospects of a remedies and cures for the deadly COVID-19 pandemic that has hobbled economies and disproporti..."},{"Date":"Nov. 13, 2020 at 4:43 p.m. ET","Headline":"The Stock Market Finished the Week at a Record High\u2014No Tech Needed","Summary":"The small-capitalization Russell 2000 index just logged its first closing high in over two years, boosted by the prospects of a remedies and cures for the deadly COVID-19 pandemic that has hobbled economies and disproporti..."},{"Date":"Nov. 13, 2020 at 4:43 p.m. ET","Headline":"Pfizer vaccine news sparks $44.5 billion flood into the stock market\u2014its biggest weekly inflow ever, says BofA","Summary":"The small-capitalization Russell 2000 index just logged its first closing high in over two years, boosted by the prospects of a remedies and cures for the deadly COVID-19 pandemic that has hobbled economies and disproporti..."},{"Date":"Nov. 13, 2020 at 4:29 p.m. ET","Headline":"U.S. stocks surge to close the week, with S&P 500 at record high","Summary":"The small-capitalization Russell 2000 index just logged its first closing high in over two years, boosted by the prospects of a remedies and cures for the deadly COVID-19 pandemic that has hobbled economies and disproporti..."},{"Date":"Nov. 13, 2020 at 4:24 p.m. ET","Headline":"The Russell 2000 index just ended its longest record drought in nine years as vaccine hopes buoy small-cap stocks","Summary":"The small-capitalization Russell 2000 index just logged its first closing high in over two years, boosted by the prospects of a remedies and cures for the deadly COVID-19 pandemic that has hobbled economies and disproporti..."},{"Date":"Nov. 13, 2020 at 4:11 p.m. ET","Headline":"S&P 500 ends at record as stocks rally amid vaccine hopes","Summary":"Stocks scored gains Friday, with the S&P 500 closing at a record as investors cheered progress toward a COVID-19 vaccine, while seeming to look past a continued rise in new cases of the ilness. The Dow Jones Industrial Ave..."},{"Date":"Nov. 13, 2020 at 3:35 p.m. ET","Headline":"Trump to speak from Rose Garden about vaccine efforts as COVID cases and hospitalizations surge across country","Summary":""},{"Date":"Nov. 13, 2020 at 3:07 p.m. ET","Headline":"Oil falls for the session, but scores an 8% weekly rise","Summary":""},{"Date":"Nov. 16, 2020 at 5:57 p.m. ET","Headline":"Warren Buffett\u2019s Berkshire Hathaway Confirms Apple Stock Sale, Buys of Pfizer, Merck","Summary":"U.S. Treasury yields rise Monday as Moderna announces its COVID-19 vaccine candidate is 94.5% effective, bolstering sentiment in risk assets and away from havens like government bonds."},{"Date":"Nov. 16, 2020 at 5:54 p.m. ET","Headline":"Not again! Economy faces another stiff test from record coronavirus surge","Summary":"U.S. Treasury yields rise Monday as Moderna announces its COVID-19 vaccine candidate is 94.5% effective, bolstering sentiment in risk assets and away from havens like government bonds."},{"Date":"Nov. 16, 2020 at 5:51 p.m. ET","Headline":"Folks share their new Thanksgiving traditions on Twitter: Muting relatives on Zoom and being thankful for toilet paper","Summary":"U.S. Treasury yields rise Monday as Moderna announces its COVID-19 vaccine candidate is 94.5% effective, bolstering sentiment in risk assets and away from havens like government bonds."},{"Date":"Nov. 16, 2020 at 5:05 p.m. ET","Headline":"The Dow Rose 471 Points Because Moderna\u2019s Vaccine Data Look Good","Summary":"U.S. Treasury yields rise Monday as Moderna announces its COVID-19 vaccine candidate is 94.5% effective, bolstering sentiment in risk assets and away from havens like government bonds."},{"Date":"Nov. 16, 2020 at 4:54 p.m. ET","Headline":"Dow, S&P 500 end at record highs Monday as stock market rallies amid further vaccine progress","Summary":"U.S. Treasury yields rise Monday as Moderna announces its COVID-19 vaccine candidate is 94.5% effective, bolstering sentiment in risk assets and away from havens like government bonds."},{"Date":"Nov. 16, 2020 at 4:45 p.m. ET","Headline":"Dow, S&P 500 Soar to Records on More Positive Vaccine News","Summary":"U.S. Treasury yields rise Monday as Moderna announces its COVID-19 vaccine candidate is 94.5% effective, bolstering sentiment in risk assets and away from havens like government bonds."},{"Date":"Nov. 16, 2020 at 4:44 p.m. ET","Headline":"Treasury yields tick higher after Moderna announces positive vaccine news","Summary":"U.S. Treasury yields rise Monday as Moderna announces its COVID-19 vaccine candidate is 94.5% effective, bolstering sentiment in risk assets and away from havens like government bonds."},{"Date":"Nov. 16, 2020 at 4:21 p.m. ET","Headline":"Biden says \u2018more people may die\u2019 if Trump administration doesn\u2019t cooperate with transition","Summary":"Exchange-traded funds tracking energy surged higher Monday after Moderna Inc.  said its COVID-19 vaccine was more effective, and more easily deployed, than one announced last week from Pfizer Inc. . The Energy Select Secto..."},{"Date":"Nov. 16, 2020 at 4:05 p.m. ET","Headline":"The Dow just clinched its fastest bear-market recovery in 30 years","Summary":"Exchange-traded funds tracking energy surged higher Monday after Moderna Inc.  said its COVID-19 vaccine was more effective, and more easily deployed, than one announced last week from Pfizer Inc. . The Energy Select Secto..."},{"Date":"Nov. 16, 2020 at 3:54 p.m. ET","Headline":"Moderna\u2019s Covid-19 Vaccine Appears to Work. What It Means for Its Stock \u2014 and Pfizer\u2019s.","Summary":"Exchange-traded funds tracking energy surged higher Monday after Moderna Inc.  said its COVID-19 vaccine was more effective, and more easily deployed, than one announced last week from Pfizer Inc. . The Energy Select Secto..."},{"Date":"Nov. 16, 2020 at 3:24 p.m. ET","Headline":"Oil rallies, with U.S. prices up 3% after positive Moderna vaccine results","Summary":"Exchange-traded funds tracking energy surged higher Monday after Moderna Inc.  said its COVID-19 vaccine was more effective, and more easily deployed, than one announced last week from Pfizer Inc. . The Energy Select Secto..."},{"Date":"Nov. 16, 2020 at 3:11 p.m. ET","Headline":"Why \u2018seriously underloved\u2019 small-cap stocks have room to rise as vaccine progress sparks rotation","Summary":"Exchange-traded funds tracking energy surged higher Monday after Moderna Inc.  said its COVID-19 vaccine was more effective, and more easily deployed, than one announced last week from Pfizer Inc. . The Energy Select Secto..."},{"Date":"Nov. 16, 2020 at 3:08 p.m. ET","Headline":"Airline stocks surge on a double dose of upbeat COVID vaccine news and a bullish chart pattern","Summary":"Exchange-traded funds tracking energy surged higher Monday after Moderna Inc.  said its COVID-19 vaccine was more effective, and more easily deployed, than one announced last week from Pfizer Inc. . The Energy Select Secto..."},{"Date":"Nov. 16, 2020 at 2:22 p.m. ET","Headline":"Gold tallies a third straight gain, buoyed by virus-related economic restrictions","Summary":"Exchange-traded funds tracking energy surged higher Monday after Moderna Inc.  said its COVID-19 vaccine was more effective, and more easily deployed, than one announced last week from Pfizer Inc. . The Energy Select Secto..."},{"Date":"Nov. 16, 2020 at 1:59 p.m. ET","Headline":"Trump isn\u2019t going quietly and fiscal stimulus won\u2019t come easily, but investors have bigger things to worry about","Summary":"Exchange-traded funds tracking energy surged higher Monday after Moderna Inc.  said its COVID-19 vaccine was more effective, and more easily deployed, than one announced last week from Pfizer Inc. . The Energy Select Secto..."},{"Date":"Nov. 16, 2020 at 1:52 p.m. ET","Headline":"10-Year Treasury Yields Will Rise Into 2021, Citi Says. This \u2018Aggressive\u2019 Equity Strategy Can Outperform.","Summary":"Exchange-traded funds tracking energy surged higher Monday after Moderna Inc.  said its COVID-19 vaccine was more effective, and more easily deployed, than one announced last week from Pfizer Inc. . The Energy Select Secto..."},{"Date":"Nov. 16, 2020 at 11:53 a.m. ET","Headline":"Energy ETFs power higher on Moderna news, on pace for best month since April","Summary":"Exchange-traded funds tracking energy surged higher Monday after Moderna Inc.  said its COVID-19 vaccine was more effective, and more easily deployed, than one announced last week from Pfizer Inc. . The Energy Select Secto..."},{"Date":"Nov. 16, 2020 at 11:45 a.m. ET","Headline":"Airline Stocks Are Rising Because Just the Hope for a Vaccine Is Lifting the Outlook","Summary":""},{"Date":"Nov. 18, 2020 at 10:58 p.m. ET","Headline":"Asian markets sag on potential economic losses from latest COVID surge","Summary":"Treasury yields came off their lows on Wednesday, largely unchanged from the previous day's levels after tepid demand for a key bond sale erased an overnight rally in Treasurys."},{"Date":"Nov. 18, 2020 at 5:06 p.m. ET","Headline":"The Dow Fell 375 Points Because More Good Vaccine Data Was Already Priced In","Summary":"Treasury yields came off their lows on Wednesday, largely unchanged from the previous day's levels after tepid demand for a key bond sale erased an overnight rally in Treasurys."},{"Date":"Nov. 18, 2020 at 4:53 p.m. ET","Headline":"Dow falls 345 points as New York City says public schools will close amid rising COVID-19 cases","Summary":"Treasury yields came off their lows on Wednesday, largely unchanged from the previous day's levels after tepid demand for a key bond sale erased an overnight rally in Treasurys."},{"Date":"Nov. 18, 2020 at 4:32 p.m. ET","Headline":"U.S. Stock Indexes Close Lower on Virus Fears Despite Vaccine News","Summary":"Treasury yields came off their lows on Wednesday, largely unchanged from the previous day's levels after tepid demand for a key bond sale erased an overnight rally in Treasurys."},{"Date":"Nov. 18, 2020 at 3:56 p.m. ET","Headline":"Treasury yields end mostly flat after weak debt sale","Summary":"Treasury yields came off their lows on Wednesday, largely unchanged from the previous day's levels after tepid demand for a key bond sale erased an overnight rally in Treasurys."},{"Date":"Nov. 18, 2020 at 3:47 p.m. ET","Headline":"Biden says Trump administration\u2019s failure to recognize his election win may delay rollout of coronavirus vaccine","Summary":"U.S. stocks opened near break-even levels on Wednesday amid signs of progress by vaccine-makers in developing a viable weapon against the COVID-19 pandemic's unchecked spread. The S&P 500  was down a point to 3,608. The Do..."},{"Date":"Nov. 18, 2020 at 3:44 p.m. ET","Headline":"Stocks Are on Hold. 3 Factors That Could Send Them Higher.","Summary":"U.S. stocks opened near break-even levels on Wednesday amid signs of progress by vaccine-makers in developing a viable weapon against the COVID-19 pandemic's unchecked spread. The S&P 500  was down a point to 3,608. The Do..."},{"Date":"Nov. 18, 2020 at 3:32 p.m. ET","Headline":"Oil prices tally highest finish since early September on latest vaccine prospects","Summary":"U.S. stocks opened near break-even levels on Wednesday amid signs of progress by vaccine-makers in developing a viable weapon against the COVID-19 pandemic's unchecked spread. The S&P 500  was down a point to 3,608. The Do..."},{"Date":"Nov. 18, 2020 at 3:31 p.m. ET","Headline":"Here\u2019s why stocks can climb 15% next year, according to JPMorgan\u2019s strategists","Summary":"U.S. stocks opened near break-even levels on Wednesday amid signs of progress by vaccine-makers in developing a viable weapon against the COVID-19 pandemic's unchecked spread. The S&P 500  was down a point to 3,608. The Do..."},{"Date":"Nov. 18, 2020 at 2:24 p.m. ET","Headline":"Coronavirus update: U.S. death toll tops 1,500 in a day, as Pfizer provides glimmer of hope for a vaccine with plans to seek emergency approval","Summary":"U.S. stocks opened near break-even levels on Wednesday amid signs of progress by vaccine-makers in developing a viable weapon against the COVID-19 pandemic's unchecked spread. The S&P 500  was down a point to 3,608. The Do..."},{"Date":"Nov. 18, 2020 at 2:20 p.m. ET","Headline":"Gold prices suffer first back-to-back loss in 3 weeks","Summary":"U.S. stocks opened near break-even levels on Wednesday amid signs of progress by vaccine-makers in developing a viable weapon against the COVID-19 pandemic's unchecked spread. The S&P 500  was down a point to 3,608. The Do..."},{"Date":"Nov. 18, 2020 at 2:11 p.m. ET","Headline":"A Rush of Good News Is Lifting Airline Stocks. But the Virus Hasn\u2019t Been Subdued Yet.","Summary":"U.S. stocks opened near break-even levels on Wednesday amid signs of progress by vaccine-makers in developing a viable weapon against the COVID-19 pandemic's unchecked spread. The S&P 500  was down a point to 3,608. The Do..."},{"Date":"Nov. 18, 2020 at 12:05 p.m. ET","Headline":"The Dow Is Up 91 Points Because More Upbeat Vaccine News Is In","Summary":"U.S. stocks opened near break-even levels on Wednesday amid signs of progress by vaccine-makers in developing a viable weapon against the COVID-19 pandemic's unchecked spread. The S&P 500  was down a point to 3,608. The Do..."},{"Date":"Nov. 18, 2020 at 11:55 a.m. ET","Headline":"German vaccine maker CureVac ramps up capacity to 300 million COVID-19 doses in 2021","Summary":"U.S. stocks opened near break-even levels on Wednesday amid signs of progress by vaccine-makers in developing a viable weapon against the COVID-19 pandemic's unchecked spread. The S&P 500  was down a point to 3,608. The Do..."},{"Date":"Nov. 18, 2020 at 10:41 a.m. ET","Headline":"RSA Insurance is a top gainer in London after $9.54 billion buyout deal","Summary":"U.S. stocks opened near break-even levels on Wednesday amid signs of progress by vaccine-makers in developing a viable weapon against the COVID-19 pandemic's unchecked spread. The S&P 500  was down a point to 3,608. The Do..."},{"Date":"Nov. 18, 2020 at 9:37 a.m. ET","Headline":"Stocks open mixed as investors eye signs of vaccine progress","Summary":"U.S. stocks opened near break-even levels on Wednesday amid signs of progress by vaccine-makers in developing a viable weapon against the COVID-19 pandemic's unchecked spread. The S&P 500  was down a point to 3,608. The Do..."},{"Date":"Nov. 18, 2020 at 9:12 a.m. ET","Headline":"Pfizer\u2019s Final Analysis Shows  Covid Vaccine is 95% Effective, Matching Moderna","Summary":""},{"Date":"Nov. 18, 2020 at 9:02 a.m. ET","Headline":"Pfizer Jumps on Vaccine News, Boeing Flies on Max, and Target Is Rising","Summary":""},{"Date":"Nov. 20, 2020 at 9:07 p.m. ET","Headline":"Bitcoin Rushes Toward New Highs, But the Debate Over Viability Continues","Summary":"Pfizer Inc.  and BioNTech  on Friday submitted an application for an emergency use authorization for their trial COVID-19 vaccine candidate, making their vaccine candidate the first in line with U.S. regulators. The two co..."},{"Date":"Nov. 20, 2020 at 5:25 p.m. ET","Headline":"Pfizer, BioNTech make it official: COVID-19 vaccine EUA submitted","Summary":"Pfizer Inc.  and BioNTech  on Friday submitted an application for an emergency use authorization for their trial COVID-19 vaccine candidate, making their vaccine candidate the first in line with U.S. regulators. The two co..."},{"Date":"Nov. 20, 2020 at 5:00 p.m. ET","Headline":"The Dow Fell 220 Points Because the Rise in Covid-19 Cases Is Unchecked","Summary":"U.S. stocks opened modestly lower as market participants focused on the likely expiration of several federal emergency loan programs established at the beginning of the coronavirus crisis. The Dow Jones Industrial Average ..."},{"Date":"Nov. 20, 2020 at 4:27 p.m. ET","Headline":"Stocks end the week on a downbeat as rising COVID cases weigh","Summary":"U.S. stocks opened modestly lower as market participants focused on the likely expiration of several federal emergency loan programs established at the beginning of the coronavirus crisis. The Dow Jones Industrial Average ..."},{"Date":"Nov. 20, 2020 at 4:04 p.m. ET","Headline":"Trump announces rules to lower drug prices","Summary":"U.S. stocks opened modestly lower as market participants focused on the likely expiration of several federal emergency loan programs established at the beginning of the coronavirus crisis. The Dow Jones Industrial Average ..."},{"Date":"Nov. 20, 2020 at 3:08 p.m. ET","Headline":"Gold ends higher after a 3-session skid, but posts a 2nd weekly slide in a row","Summary":"U.S. stocks opened modestly lower as market participants focused on the likely expiration of several federal emergency loan programs established at the beginning of the coronavirus crisis. The Dow Jones Industrial Average ..."},{"Date":"Nov. 20, 2020 at 1:43 p.m. ET","Headline":"There\u2019s Still Time to Buy Regional Banks. 5 Stocks to Grab Now.","Summary":"U.S. stocks opened modestly lower as market participants focused on the likely expiration of several federal emergency loan programs established at the beginning of the coronavirus crisis. The Dow Jones Industrial Average ..."},{"Date":"Nov. 20, 2020 at 1:33 p.m. ET","Headline":"Maravai LifeSciences Jumps Nearly 19% in IPO, While Sotera Pops 17%","Summary":"U.S. stocks opened modestly lower as market participants focused on the likely expiration of several federal emergency loan programs established at the beginning of the coronavirus crisis. The Dow Jones Industrial Average ..."},{"Date":"Nov. 20, 2020 at 1:22 p.m. ET","Headline":"What\u2019s next for markets after Treasury Secretary Steven Mnuchin pulls the $455 billion plug","Summary":"U.S. stocks opened modestly lower as market participants focused on the likely expiration of several federal emergency loan programs established at the beginning of the coronavirus crisis. The Dow Jones Industrial Average ..."},{"Date":"Nov. 20, 2020 at 12:06 p.m. ET","Headline":"The Dow Is Falling 157 Points Because Vaccine Hopes Can\u2019t Fight Covid-19","Summary":"U.S. stocks opened modestly lower as market participants focused on the likely expiration of several federal emergency loan programs established at the beginning of the coronavirus crisis. The Dow Jones Industrial Average ..."},{"Date":"Nov. 20, 2020 at 10:33 a.m. ET","Headline":"Pfizer and partner BioNTech to seek emergency-use authorization for COVID-19 vaccine Friday","Summary":"U.S. stocks opened modestly lower as market participants focused on the likely expiration of several federal emergency loan programs established at the beginning of the coronavirus crisis. The Dow Jones Industrial Average ..."},{"Date":"Nov. 20, 2020 at 10:28 a.m. ET","Headline":"European stocks rise as investors weigh up virus updates","Summary":"U.S. stocks opened modestly lower as market participants focused on the likely expiration of several federal emergency loan programs established at the beginning of the coronavirus crisis. The Dow Jones Industrial Average ..."},{"Date":"Nov. 20, 2020 at 9:36 a.m. ET","Headline":"Stocks lower at the open as Treasury, Fed spar over financial market backstops","Summary":"U.S. stocks opened modestly lower as market participants focused on the likely expiration of several federal emergency loan programs established at the beginning of the coronavirus crisis. The Dow Jones Industrial Average ..."},{"Date":"Nov. 20, 2020 at 9:22 a.m. ET","Headline":"Pfizer and BioNTech Are Filing Today to Distribute Their Covid-19 Vaccine","Summary":"Shares of Pfizer Inc.  gained 1.4% in premarket trading on Friday after it announced plans with BioNTech  to submit an application later in the day for an emergency use authorization for their experimental COVID-19 vaccine..."},{"Date":"Nov. 20, 2020 at 9:13 a.m. ET","Headline":"Pfizer Rises, FireEye Soars, and the Dow Is Going Nowhere","Summary":"Shares of Pfizer Inc.  gained 1.4% in premarket trading on Friday after it announced plans with BioNTech  to submit an application later in the day for an emergency use authorization for their experimental COVID-19 vaccine..."},{"Date":"Nov. 20, 2020 at 8:46 a.m. ET","Headline":"California to Begin Overnight Lockdown","Summary":"Shares of Pfizer Inc.  gained 1.4% in premarket trading on Friday after it announced plans with BioNTech  to submit an application later in the day for an emergency use authorization for their experimental COVID-19 vaccine..."},{"Date":"Nov. 20, 2020 at 7:58 a.m. ET","Headline":"Pfizer Asked the FDA to Approve Its Covid Vaccine. What Comes Next.","Summary":"Shares of Pfizer Inc.  gained 1.4% in premarket trading on Friday after it announced plans with BioNTech  to submit an application later in the day for an emergency use authorization for their experimental COVID-19 vaccine..."},{"Date":"Nov. 20, 2020 at 7:19 a.m. ET","Headline":"BioNTech, Pfizer say they plan to submit COVID-19 vaccine application on Friday","Summary":"Shares of Pfizer Inc.  gained 1.4% in premarket trading on Friday after it announced plans with BioNTech  to submit an application later in the day for an emergency use authorization for their experimental COVID-19 vaccine..."},{"Date":"Nov. 22, 2020 at 5:50 p.m. ET","Headline":"Dr. Fauci on Biden\u2019s scientific credentials \u2014 and the delay in the transfer of power","Summary":""},{"Date":"Nov. 22, 2020 at 12:57 p.m. ET","Headline":"First coronavirus immunizations could come Dec. 12, says head of federal vaccine-development program","Summary":""},{"Date":"Nov. 22, 2020 at 6:56 a.m. ET","Headline":"As nation awaits transition of power, Fauci issues timely warning to his fellow scientists","Summary":""},{"Date":"Nov. 21, 2020 at 1:25 p.m. ET","Headline":"Mortgage rates drop to new record low as coronavirus cases climb","Summary":""},{"Date":"Nov. 21, 2020 at 12:15 p.m. ET","Headline":"The Stock Market Is Getting Support From a \u2018Vaccine Put.\u2019 Here\u2019s What That Means.","Summary":""},{"Date":"Nov. 21, 2020 at 11:32 a.m. ET","Headline":"U.S. moves closer to 200,000 daily COVID cases; Birx and Fauci urge Americans to follow safety measures over Thanksgiving","Summary":""},{"Date":"Nov. 21, 2020 at 8:01 a.m. ET","Headline":"Here are 20 stocks that may benefit as investors rotate money into cyclical sectors","Summary":""},{"Date":"Nov. 21, 2020 at 7:30 a.m. ET","Headline":"How the Vaccine Era Could Be a Sweet Spot for Stocks","Summary":""},{"Date":"Nov. 24, 2020 at 4:27 p.m. ET","Headline":"Dow, S&P 500 Set New Records on Vaccine Optimism","Summary":"U.S. government bonds see rates climb to start a holiday-shortened week, after the sharpest weekly yield drop for long-dated debt in months."},{"Date":"Nov. 24, 2020 at 3:37 p.m. ET","Headline":"Profits at the World\u2019s Largest Caterer Fell 82%. Why the Stock Is Rising.","Summary":"U.S. government bonds see rates climb to start a holiday-shortened week, after the sharpest weekly yield drop for long-dated debt in months."},{"Date":"Nov. 24, 2020 at 3:10 p.m. ET","Headline":"U.S. is \u2018in the middle of the Fight of the Century,\u2019 says former CDC head as cases rise in 45 states, hospitalizations set record","Summary":"U.S. government bonds see rates climb to start a holiday-shortened week, after the sharpest weekly yield drop for long-dated debt in months."},{"Date":"Nov. 24, 2020 at 11:20 a.m. ET","Headline":"Shoppers. Shoppers. Shoppers. Wall Street is watching you","Summary":"U.S. government bonds see rates climb to start a holiday-shortened week, after the sharpest weekly yield drop for long-dated debt in months."},{"Date":"Nov. 24, 2020 at 11:06 a.m. ET","Headline":"The Price of Oil Is Ripping Higher. Here\u2019s What Could Stop It.","Summary":"U.S. government bonds see rates climb to start a holiday-shortened week, after the sharpest weekly yield drop for long-dated debt in months."},{"Date":"Nov. 24, 2020 at 10:14 a.m. ET","Headline":"Be Like Buffett and Wager on Pfizer. Here\u2019s How to Do It With Options.","Summary":"U.S. government bonds see rates climb to start a holiday-shortened week, after the sharpest weekly yield drop for long-dated debt in months."},{"Date":"Nov. 24, 2020 at 9:48 a.m. ET","Headline":"Is upbeat COVID-vaccine news priced into the market?","Summary":"U.S. government bonds see rates climb to start a holiday-shortened week, after the sharpest weekly yield drop for long-dated debt in months."},{"Date":"Nov. 24, 2020 at 7:30 a.m. ET","Headline":"Why Now May Be the Time to Buy Health Care Stocks","Summary":"U.S. government bonds see rates climb to start a holiday-shortened week, after the sharpest weekly yield drop for long-dated debt in months."},{"Date":"Nov. 24, 2020 at 6:58 a.m. ET","Headline":"AstraZeneca\u2019s COVID-19 vaccine data fails to impress Wall Street analysts with its effectiveness in clinical trials","Summary":"U.S. government bonds see rates climb to start a holiday-shortened week, after the sharpest weekly yield drop for long-dated debt in months."},{"Date":"Nov. 23, 2020 at 5:17 p.m. ET","Headline":"Fears of a COVID-inspired crude oil glut? Fading \u2018contango\u2019 tells a different story","Summary":"U.S. government bonds see rates climb to start a holiday-shortened week, after the sharpest weekly yield drop for long-dated debt in months."},{"Date":"Nov. 23, 2020 at 5:11 p.m. ET","Headline":"The Dow Rose 328 Points Because Vaccine and Economic Data Were Great","Summary":"U.S. government bonds see rates climb to start a holiday-shortened week, after the sharpest weekly yield drop for long-dated debt in months."},{"Date":"Nov. 23, 2020 at 4:50 p.m. ET","Headline":"Stocks Climb on AstraZeneca  Vaccine Results","Summary":"U.S. government bonds see rates climb to start a holiday-shortened week, after the sharpest weekly yield drop for long-dated debt in months."},{"Date":"Nov. 23, 2020 at 4:30 p.m. ET","Headline":"Dow ends 327 point higher after Janet Yellen reported as Biden\u2019s Treasury Secretary pick","Summary":"U.S. government bonds see rates climb to start a holiday-shortened week, after the sharpest weekly yield drop for long-dated debt in months."},{"Date":"Nov. 23, 2020 at 4:30 p.m. ET","Headline":"Treasury rates climb amid COVID vaccine, treatment updates","Summary":"U.S. government bonds see rates climb to start a holiday-shortened week, after the sharpest weekly yield drop for long-dated debt in months."},{"Date":"Nov. 23, 2020 at 3:41 p.m. ET","Headline":"AstraZeneca\u2019s Covid-19 Vaccine Can Be Up to 90% Effective. Why That\u2019s Good News.","Summary":""},{"Date":"Nov. 23, 2020 at 3:37 p.m. ET","Headline":"Brent crude oil sees highest finish since March as positive vaccine news mounts","Summary":""},{"Date":"Nov. 23, 2020 at 2:58 p.m. ET","Headline":"U.S. coronavirus case tally tops 12 million amid growing fears that Thanksgiving travel will spark another surge of infections","Summary":""},{"Date":"Nov. 23, 2020 at 12:56 p.m. ET","Headline":"Manufacturing and Consumer Services Stocks Soar on Economic Data","Summary":""},{"Date":"Nov. 26, 2020 at 6:55 a.m. ET","Headline":"Global Stocks Struggle for Traction as Virus Worries and U.S. Thanksgiving Holiday Sidelines Investors","Summary":"Shares of Equillium Inc.  tumbled 12.6% in premarket trading Wednesday, after the biotechnology company said it decided not to initiate a Phase 3 trial its itolizumab for the treatment of hospitalized COVID-19 patients \"at..."},{"Date":"Nov. 26, 2020 at 3:45 a.m. ET","Headline":"Dr. Fauci on Cuomo\u2019s decision to review vaccines for New Yorkers after FDA approval: \u2018Trust the process\u2019","Summary":"Shares of Equillium Inc.  tumbled 12.6% in premarket trading Wednesday, after the biotechnology company said it decided not to initiate a Phase 3 trial its itolizumab for the treatment of hospitalized COVID-19 patients \"at..."},{"Date":"Nov. 25, 2020 at 9:26 p.m. ET","Headline":"How Georgia\u2019s Sen. David Perdue cashed in with coronavirus stock trades","Summary":"Shares of Equillium Inc.  tumbled 12.6% in premarket trading Wednesday, after the biotechnology company said it decided not to initiate a Phase 3 trial its itolizumab for the treatment of hospitalized COVID-19 patients \"at..."},{"Date":"Nov. 25, 2020 at 5:31 p.m. ET","Headline":"How a Restructured Pfizer Will Pay Out Its Dividend","Summary":"Shares of Equillium Inc.  tumbled 12.6% in premarket trading Wednesday, after the biotechnology company said it decided not to initiate a Phase 3 trial its itolizumab for the treatment of hospitalized COVID-19 patients \"at..."},{"Date":"Nov. 25, 2020 at 3:31 p.m. ET","Headline":"Durable-goods orders jump 1.3% in October as manufacturers lead U.S. economic recovery","Summary":"Shares of Equillium Inc.  tumbled 12.6% in premarket trading Wednesday, after the biotechnology company said it decided not to initiate a Phase 3 trial its itolizumab for the treatment of hospitalized COVID-19 patients \"at..."},{"Date":"Nov. 25, 2020 at 2:55 p.m. ET","Headline":"Hospital workers called exhausted as U.S. records highest number of COVID deaths since May","Summary":"Shares of Equillium Inc.  tumbled 12.6% in premarket trading Wednesday, after the biotechnology company said it decided not to initiate a Phase 3 trial its itolizumab for the treatment of hospitalized COVID-19 patients \"at..."},{"Date":"Nov. 25, 2020 at 1:58 p.m. ET","Headline":"Banks and oil companies weigh on FTSE 100 as investors pause ahead of U.S. holiday","Summary":"Shares of Equillium Inc.  tumbled 12.6% in premarket trading Wednesday, after the biotechnology company said it decided not to initiate a Phase 3 trial its itolizumab for the treatment of hospitalized COVID-19 patients \"at..."},{"Date":"Nov. 25, 2020 at 12:48 p.m. ET","Headline":"Moderna\u2019s Final Covid Vaccine Results Are Imminent. Billions in Revenue Will Follow, Goldman Says.","Summary":"Shares of Equillium Inc.  tumbled 12.6% in premarket trading Wednesday, after the biotechnology company said it decided not to initiate a Phase 3 trial its itolizumab for the treatment of hospitalized COVID-19 patients \"at..."},{"Date":"Nov. 25, 2020 at 8:46 a.m. ET","Headline":"Equillium's stock tumbles after decision to not initiate late-stage trial of COVID-19 treatment","Summary":"Shares of Equillium Inc.  tumbled 12.6% in premarket trading Wednesday, after the biotechnology company said it decided not to initiate a Phase 3 trial its itolizumab for the treatment of hospitalized COVID-19 patients \"at..."},{"Date":"Nov. 20, 2020 at 4:21 p.m. ET","Headline":"Stocks Slip as Fed and Treasury Clash Over Emergency Spending","Summary":""},{"Date":"Nov. 16, 2020 at 2:23 p.m. ET","Headline":"Peloton Stock Has Staying Power, Even After the Pandemic, Analyst Argues","Summary":""},{"Date":"Nov. 28, 2020 at 6:27 p.m. ET","Headline":"What a COVID-19 vaccine would mean for mortgage rates and the housing market","Summary":"United Airlines Holdings Inc.  on Friday started operating charter flights to get doses of Pfizer Inc.'s  and BioNTech SE's  COVID-19 vaccine ready for quick distribution if the vaccine candidate is approved by regulators,..."},{"Date":"Nov. 28, 2020 at 1:25 p.m. ET","Headline":"7 reasons why energy stocks will be 60% higher a year from now","Summary":"United Airlines Holdings Inc.  on Friday started operating charter flights to get doses of Pfizer Inc.'s  and BioNTech SE's  COVID-19 vaccine ready for quick distribution if the vaccine candidate is approved by regulators,..."},{"Date":"Nov. 27, 2020 at 4:38 p.m. ET","Headline":"United Airlines starts charter flights to distribute Pfizer's COVID-19 vaccine: WSJ","Summary":"United Airlines Holdings Inc.  on Friday started operating charter flights to get doses of Pfizer Inc.'s  and BioNTech SE's  COVID-19 vaccine ready for quick distribution if the vaccine candidate is approved by regulators,..."},{"Date":"Nov. 27, 2020 at 2:52 p.m. ET","Headline":"Bank Stocks Had a Great Month. Here Are the Top 5.","Summary":""},{"Date":"Nov. 27, 2020 at 10:05 a.m. ET","Headline":"AstraZeneca\u2019s Vaccine Test Mistake Is a Buying Opportunity, Citi Says","Summary":""},{"Date":"Nov. 27, 2020 at 8:39 a.m. ET","Headline":"U.K. Pushes for AstraZeneca Vaccine Approval Amid Questions Over Trial Data","Summary":""},{"Date":"Nov. 27, 2020 at 8:08 a.m. ET","Headline":"It\u2019s Black Friday\u2014and the Election Is Almost Over","Summary":""},{"Date":"Nov. 27, 2020 at 8:00 a.m. ET","Headline":"Covid Vaccines Look Promising. How Emerging Markets Could Benefit.","Summary":""},{"Date":"Nov. 27, 2020 at 8:00 a.m. ET","Headline":"How the pandemic presented a stock-market opportunity to Sen. David Perdue of Georgia","Summary":""},{"Date":"Nov. 26, 2020 at 8:48 a.m. ET","Headline":"Here\u2019s How Many People Flew for Thanksgiving, and What It Means for Airline Stocks","Summary":""},{"Date":"Nov. 30, 2020 at 11:03 p.m. ET","Headline":"\u2018100% of Americans that want the vaccine will have had the vaccine\u2019 by June, says Operation Warp Speed official","Summary":""},{"Date":"Nov. 30, 2020 at 8:34 p.m. ET","Headline":"U.K. Could Become First Country to Roll Out Covid-19 Vaccine as Pfizer-BioNTech Approval Likely \u2018Within Days\u2019","Summary":""},{"Date":"Nov. 30, 2020 at 6:44 p.m. ET","Headline":"Dow sinks 272 points, but books best November since 1928, and best month since \u201987","Summary":""},{"Date":"Nov. 30, 2020 at 4:28 p.m. ET","Headline":"Stocks End Record-Breaking November on a Down Note","Summary":""},{"Date":"Nov. 30, 2020 at 4:08 p.m. ET","Headline":"Coronavirus update: U.S. cases slip again, but deaths are rising in 39 states and hospitalizations break another record","Summary":""},{"Date":"Nov. 30, 2020 at 3:49 p.m. ET","Headline":"Vaccination Plans Are Under Way at Pfizer and Moderna. Who Will Be First in Line?","Summary":""},{"Date":"Nov. 30, 2020 at 3:13 p.m. ET","Headline":"Arizona Certifies Joe Biden\u2019s Narrow Win in State","Summary":""},{"Date":"Nov. 30, 2020 at 1:26 p.m. ET","Headline":"This is what it\u2019s like being in a COVID-19 vaccine trial","Summary":""},{"Date":"Nov. 30, 2020 at 1:10 p.m. ET","Headline":"Pfizer\u2019s CEO sold $5.6 million worth of shares on the day of its big vaccine news. So what?","Summary":""},{"Date":"Nov. 30, 2020 at 12:24 p.m. ET","Headline":"FTSE 100 rounds off bumper November with losses as BP and Shell fall during OPEC meeting","Summary":""},{"Date":"Nov. 30, 2020 at 12:20 p.m. ET","Headline":"Almost a third of the U.S. could be infected by the coronavirus within a month, former FDA chief warns","Summary":""},{"Date":"Nov. 30, 2020 at 12:15 p.m. ET","Headline":"Airline Stocks Face Short-Term Struggles, but Analysts Expect a Strong Rebound","Summary":""},{"Date":"Nov. 30, 2020 at 12:13 p.m. ET","Headline":"European stocks struggle as blockbuster November comes to a close","Summary":""},{"Date":"Nov. 30, 2020 at 11:51 a.m. ET","Headline":"Moderna asking U.S., European regulators to authorize COVID-19 vaccine for emergency use","Summary":""},{"Date":"Nov. 30, 2020 at 8:51 a.m. ET","Headline":"Moderna Soars, IHS Markit Jumps, and the Dow Sags","Summary":""},{"Date":"Nov. 30, 2020 at 8:06 a.m. ET","Headline":"IPO Roadshows for Airbnb and DoorDash","Summary":""},{"Date":"Nov. 30, 2020 at 8:06 a.m. ET","Headline":"The Russell 2000 has had a powerful November \u2014 and the gains aren\u2019t over","Summary":""},{"Date":"Nov. 30, 2020 at 7:34 a.m. ET","Headline":"Only these five dividend stocks made the cut in a \u2018safer and better\u2019 screen","Summary":""},{"Date":"Dec. 2, 2020 at 11:09 p.m. ET","Headline":"Asian markets rise on optimism over vaccine, U.S. stimulus","Summary":"Becton Dickinson & Co.  said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the..."},{"Date":"Dec. 2, 2020 at 4:20 p.m. ET","Headline":"Stocks close mostly higher as S&P 500 notches new record","Summary":"Becton Dickinson & Co.  said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the..."},{"Date":"Dec. 2, 2020 at 4:17 p.m. ET","Headline":"S&P 500 Notches Fresh Record Despite Tech Stocks\u2019 Fall","Summary":"Becton Dickinson & Co.  said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the..."},{"Date":"Dec. 2, 2020 at 2:48 p.m. ET","Headline":"U.S. COVID-19 death toll tops 272,000 as CDC pushes ahead with plans for expected vaccine rollout","Summary":"Becton Dickinson & Co.  said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the..."},{"Date":"Dec. 2, 2020 at 2:21 p.m. ET","Headline":"Treasury Yields Have Soared This Week. What Investors Should Expect Now.","Summary":"Becton Dickinson & Co.  said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the..."},{"Date":"Dec. 2, 2020 at 2:12 p.m. ET","Headline":"\u2018Cytokine Storm\u2019 \u2014 the \u2018intriguing\u2019 similarity between COVID-19 and the 1918 influenza","Summary":"Becton Dickinson & Co.  said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the..."},{"Date":"Dec. 2, 2020 at 2:00 p.m. ET","Headline":"As holidays loom, Dr. Fauci warns of \u2018a surge that has really surpassed the others\u2019","Summary":"Becton Dickinson & Co.  said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the..."},{"Date":"Dec. 2, 2020 at 12:24 p.m. ET","Headline":"Democrats and Republicans Trade Stimulus Offers","Summary":"Becton Dickinson & Co.  said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the..."},{"Date":"Dec. 2, 2020 at 11:14 a.m. ET","Headline":"Restaurants gain in London on vaccine news, but Brexit worries overshadow pound","Summary":"Becton Dickinson & Co.  said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the..."},{"Date":"Dec. 2, 2020 at 9:45 a.m. ET","Headline":"COVID-19 vaccines should be designed for people, not for profits","Summary":"Becton Dickinson & Co.  said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the..."},{"Date":"Dec. 2, 2020 at 9:17 a.m. ET","Headline":"Moderna Stock Dips After Merck Announces It Sold Its Stake","Summary":"Becton Dickinson & Co.  said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the..."},{"Date":"Dec. 2, 2020 at 9:10 a.m. ET","Headline":"Salesforce Stock Falls, Hiring Slows, and the Dow Is Dropping","Summary":"Becton Dickinson & Co.  said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the..."},{"Date":"Dec. 2, 2020 at 9:05 a.m. ET","Headline":"Investors are overlooking this one thing, major bank says as it sets 4,000 target on S&P 500","Summary":"Becton Dickinson & Co.  said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the..."},{"Date":"Dec. 2, 2020 at 7:58 a.m. ET","Headline":"A Hard Lesson in Green Energy Stocks","Summary":"Becton Dickinson & Co.  said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the..."},{"Date":"Dec. 2, 2020 at 7:56 a.m. ET","Headline":"European stocks mostly lower as investors pause after rally","Summary":"Becton Dickinson & Co.  said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the..."},{"Date":"Dec. 2, 2020 at 7:08 a.m. ET","Headline":"Becton Dickinson to invest $1.2 billion to expand pre-fillable syringe manufacturing capacity for COVID vaccination","Summary":"Becton Dickinson & Co.  said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the..."},{"Date":"Dec. 2, 2020 at 7:01 a.m. ET","Headline":"Health-care workers and nursing-home residents should be the first to get COVID-19 vaccine, CDC committee says","Summary":"The global tally for confirmed cases of the coronavirus that causes COVID-19 rose above 63.9 million on Wednesday, , while the death toll rose above 1.48 million. The U.S. has the highest case tally in the world at 13.7 mi..."},{"Date":"Dec. 2, 2020 at 6:18 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 63.9 million and U.S. death toll passes 270,000","Summary":"The global tally for confirmed cases of the coronavirus that causes COVID-19 rose above 63.9 million on Wednesday, , while the death toll rose above 1.48 million. The U.S. has the highest case tally in the world at 13.7 mi..."},{"Date":"Dec. 4, 2020 at 11:01 p.m. ET","Headline":"Bahrain becomes second country to grant the Pfizer-BioNTech vaccine emergency-use authorization","Summary":""},{"Date":"Dec. 4, 2020 at 9:14 p.m. ET","Headline":"Mexico, Thailand, and Other Countries Have Been Hit Hard by Covid-19. How to Invest in Their Recovery.","Summary":""},{"Date":"Dec. 4, 2020 at 8:30 p.m. ET","Headline":"November\u2019s Jobs Report Was Disappointing. December\u2019s Could Be Worse","Summary":""},{"Date":"Dec. 4, 2020 at 8:00 p.m. ET","Headline":"In a Pandemic Year, Online Seems to Own Holiday Shopping","Summary":""},{"Date":"Dec. 4, 2020 at 5:34 p.m. ET","Headline":"U.K. authorized COVID-19 vaccine so fast because it\u2019s a \u2018much better country\u2019 than America, concludes member of Boris Johnson cabinet","Summary":""},{"Date":"Dec. 4, 2020 at 4:35 p.m. ET","Headline":"Stocks Climb to New Records Despite Weakening Jobs Growth","Summary":""},{"Date":"Dec. 4, 2020 at 4:22 p.m. ET","Headline":"The Boeing MAX 737 Jet Is Carrying Passengers Again. What It Means for the Stock.","Summary":""},{"Date":"Dec. 4, 2020 at 12:46 p.m. ET","Headline":"What we still don\u2019t know about COVID vaccines after the U.K.\u2019s emergency-use authorization of the Pfizer-BioNTech candidate","Summary":""},{"Date":"Dec. 4, 2020 at 12:14 p.m. ET","Headline":"Pelosi Says There\u2019s Momentum in Stimulus Negotiations","Summary":""},{"Date":"Dec. 4, 2020 at 11:53 a.m. ET","Headline":"Where\u2019s the stock market going next? Look at the 1960s for an answer, says a Fidelity strategist","Summary":""},{"Date":"Dec. 4, 2020 at 11:17 a.m. ET","Headline":"Cruise Stocks Are Hot as the Pandemic Worsens. Here\u2019s Why.","Summary":""},{"Date":"Dec. 4, 2020 at 11:14 a.m. ET","Headline":"Why Bond Investors Are Taking On More Risk","Summary":""},{"Date":"Dec. 4, 2020 at 10:11 a.m. ET","Headline":"Vaccines and Approved Antibodies Dim Vir Biotechnology\u2019s Covid Opportunity, Analyst Says","Summary":""},{"Date":"Dec. 4, 2020 at 8:54 a.m. ET","Headline":"European stocks hold modest gains, with drug and energy shares gaining","Summary":""},{"Date":"Dec. 4, 2020 at 8:00 a.m. ET","Headline":"New Results on Blood Disorder Treatments Are Coming. Watch These Stocks.","Summary":""},{"Date":"Dec. 4, 2020 at 6:31 a.m. ET","Headline":"How to protect your mental health and fight \u2018COVID fatigue\u2019 this winter","Summary":""},{"Date":"Dec. 4, 2020 at 6:30 a.m. ET","Headline":"Best Bet in a Down Year: The Dividend Aristocrats","Summary":""},{"Date":"Dec. 4, 2020 at 6:00 a.m. ET","Headline":"Value Stock Rally Buoys Dividend Payers\u2019 Returns. Can the Gains Go On?","Summary":""},{"Date":"Dec. 6, 2020 at 9:30 p.m. ET","Headline":"U.K. gears up for huge coronavirus vaccination program","Summary":""},{"Date":"Dec. 5, 2020 at 3:17 p.m. ET","Headline":"The U.S. economy is going to get worse before it gets better","Summary":""},{"Date":"Dec. 5, 2020 at 1:12 p.m. ET","Headline":"Thanksgiving is over. Christmas is coming. What now?","Summary":""},{"Date":"Dec. 5, 2020 at 1:11 p.m. ET","Headline":"\u2018Surge upon a surge\u2019: Dr. Fauci warns of COVID-19 infections that are worse than any previous surge","Summary":""},{"Date":"Dec. 5, 2020 at 8:43 a.m. ET","Headline":"U.S. stock indexes sweep to records as hope for fiscal relief overshadows weak jobs data","Summary":""},{"Date":"Dec. 8, 2020 at 11:31 p.m. ET","Headline":"Asian markets rally after Wall Street\u2019s latest record highs","Summary":"Shares of Pfizer Inc.  rose 0.5% in the extended session Tuesday after the company said the U.S. Food and Drug Administration has accepted for priority review the company's vaccine candidate against bacteria causing pneumo..."},{"Date":"Dec. 8, 2020 at 8:36 p.m. ET","Headline":"U.S. suffers deadliest week from coronavirus since pandemic broke out","Summary":"Shares of Pfizer Inc.  rose 0.5% in the extended session Tuesday after the company said the U.S. Food and Drug Administration has accepted for priority review the company's vaccine candidate against bacteria causing pneumo..."},{"Date":"Dec. 8, 2020 at 7:50 p.m. ET","Headline":"Johnson & Johnson Expects Vaccine Trial Results in January","Summary":"Shares of Pfizer Inc.  rose 0.5% in the extended session Tuesday after the company said the U.S. Food and Drug Administration has accepted for priority review the company's vaccine candidate against bacteria causing pneumo..."},{"Date":"Dec. 8, 2020 at 4:48 p.m. ET","Headline":"Pfizer's pneumonia vaccine candidate gets FDA review","Summary":"Shares of Pfizer Inc.  rose 0.5% in the extended session Tuesday after the company said the U.S. Food and Drug Administration has accepted for priority review the company's vaccine candidate against bacteria causing pneumo..."},{"Date":"Dec. 8, 2020 at 4:40 p.m. ET","Headline":"The Dow Rose Only 104 Points Because Stocks Have Run Hot Lately","Summary":"Stocks ended slightly higher Tuesday, enough to push the S&P 500 and Nasdaq Composite to record finishes as investors tracked progress toward another round of aid spending and Pfizer Inc.  and BioNTech SE  began the rollou..."},{"Date":"Dec. 8, 2020 at 4:26 p.m. ET","Headline":"S&P 500, Nasdaq carve out new records as vaccine outlook outweighs COVID hospitalizations and deaths","Summary":"Stocks ended slightly higher Tuesday, enough to push the S&P 500 and Nasdaq Composite to record finishes as investors tracked progress toward another round of aid spending and Pfizer Inc.  and BioNTech SE  began the rollou..."},{"Date":"Dec. 8, 2020 at 4:24 p.m. ET","Headline":"S&P Has Record Close on Vaccine News","Summary":"Stocks ended slightly higher Tuesday, enough to push the S&P 500 and Nasdaq Composite to record finishes as investors tracked progress toward another round of aid spending and Pfizer Inc.  and BioNTech SE  began the rollou..."},{"Date":"Dec. 8, 2020 at 4:06 p.m. ET","Headline":"S&P 500, Nasdaq close at records as stocks post modest gains","Summary":"Stocks ended slightly higher Tuesday, enough to push the S&P 500 and Nasdaq Composite to record finishes as investors tracked progress toward another round of aid spending and Pfizer Inc.  and BioNTech SE  began the rollou..."},{"Date":"Dec. 8, 2020 at 3:24 p.m. ET","Headline":"Watch this signal to see if the rally can continue, strategist says","Summary":"The COVID-19 vaccine candidate developed by BioNTech  and Pfizer Inc.  likely has a \"favorable safety profile,\" according to  published Tuesday by the Food and Drug Administration. In premarket trading on Tuesday, BioNTech..."},{"Date":"Dec. 8, 2020 at 3:02 p.m. ET","Headline":"Oil prices end mixed as spread of COVID-19 dulls demand prospects, but vaccine offers hope","Summary":"The COVID-19 vaccine candidate developed by BioNTech  and Pfizer Inc.  likely has a \"favorable safety profile,\" according to  published Tuesday by the Food and Drug Administration. In premarket trading on Tuesday, BioNTech..."},{"Date":"Dec. 8, 2020 at 1:59 p.m. ET","Headline":"FDA highlights safety profile of BioNTech\/Pfizer vaccine in advance of advisory committee meeting","Summary":"The COVID-19 vaccine candidate developed by BioNTech  and Pfizer Inc.  likely has a \"favorable safety profile,\" according to  published Tuesday by the Food and Drug Administration. In premarket trading on Tuesday, BioNTech..."},{"Date":"Dec. 8, 2020 at 11:53 a.m. ET","Headline":"FDA Calls Pfizer\/BioNTech Covid Vaccine Effective and Safe","Summary":""},{"Date":"Dec. 8, 2020 at 11:32 a.m. ET","Headline":"European stocks struggle for direction as Brexit fears overshadow COVID-19 vaccine milestone","Summary":""},{"Date":"Dec. 8, 2020 at 11:19 a.m. ET","Headline":"This is why I volunteered for the Novavax COVID-19 vaccine trial, and am still cheering for the underdog","Summary":""},{"Date":"Dec. 8, 2020 at 11:10 a.m. ET","Headline":"FTSE 100 and sterling recover despite Boris Johnson warning Brexit trade deal looks \u2018very, very difficult\u2019","Summary":""},{"Date":"Dec. 8, 2020 at 11:03 a.m. ET","Headline":"Morocco to use Chinese vaccine that hasn\u2019t yet completed advanced trials to kick off mass vaccinations","Summary":""},{"Date":"Dec. 8, 2020 at 10:09 a.m. ET","Headline":"Here are 5 things to know about BioNTech and the married couple behind the COVID-19 vaccine developed with Pfizer","Summary":""},{"Date":"Dec. 8, 2020 at 8:47 a.m. ET","Headline":"Stitch Fix Stock Soars, Coty Slides, and the Stock Market Dips as Stimulus Talks Stall","Summary":""},{"Date":"Dec. 10, 2020 at 6:15 p.m. ET","Headline":"FDA Advisory Committee Recommends Authorization of Pfizer\u2019s Covid Vaccine","Summary":""},{"Date":"Dec. 10, 2020 at 5:55 p.m. ET","Headline":"Medical experts vote in favor of FDA authorization of BioNTech\/Pfizer COVID-19 vaccine candidate","Summary":""},{"Date":"Dec. 10, 2020 at 4:18 p.m. ET","Headline":"Dow slips, Nasdaq gains as surge in jobless claims reinforces need for financial aid before year end","Summary":""},{"Date":"Dec. 10, 2020 at 4:11 p.m. ET","Headline":"U.S. Stocks End Mixed as Jobless Claims Rise and Stimulus Talks Continue","Summary":""},{"Date":"Dec. 10, 2020 at 3:10 p.m. ET","Headline":"Global oil prices settle above $50 for the first time since March on vaccine optimism","Summary":""},{"Date":"Dec. 10, 2020 at 2:22 p.m. ET","Headline":"U.S. sets record one-day death toll from coronavirus as FDA committee meets to review Pfizer\u2013BioNTech vaccine","Summary":""},{"Date":"Dec. 10, 2020 at 2:06 p.m. ET","Headline":"Gold ends lower for a second session on expectations for a U.S. vaccine rollout","Summary":""},{"Date":"Dec. 10, 2020 at 12:01 p.m. ET","Headline":"Here\u2019s What Is Happening Today as Pfizer-BioNTech Covid Vaccine Gets First U.S. Review","Summary":""},{"Date":"Dec. 10, 2020 at 8:57 a.m. ET","Headline":"Economic forecasts haven\u2019t accelerated after good vaccine news. That\u2019s puzzling, experts say","Summary":""},{"Date":"Dec. 10, 2020 at 8:43 a.m. ET","Headline":"What the FDA and Pfizer Need From Each Other","Summary":""},{"Date":"Dec. 10, 2020 at 7:54 a.m. ET","Headline":"European stocks edge lower as ECB meets bond-buying expectations, with FTSE 100 boosted by lack of progress on trade talks","Summary":""},{"Date":"Dec. 10, 2020 at 7:21 a.m. ET","Headline":"What to expect from the FDA\u2019s important COVID-19 vaccine meeting Thursday","Summary":""},{"Date":"Dec. 10, 2020 at 6:30 a.m. ET","Headline":"A Vaccine Snag Could Slam the Economy and Lift These Stocks","Summary":""},{"Date":"Dec. 10, 2020 at 5:46 a.m. ET","Headline":"The perils of transporting millions of COVID-19 vaccines with dry ice across the U.S.","Summary":""},{"Date":"Dec. 9, 2020 at 11:49 p.m. ET","Headline":"Asian markets slip after Nasdaq\u2019s bad day","Summary":""},{"Date":"Dec. 9, 2020 at 11:10 p.m. ET","Headline":"More Americans died from coronavirus Wednesday than died on 9\/11","Summary":""},{"Date":"Dec. 9, 2020 at 8:15 p.m. ET","Headline":"GE Reaches $200M Settlement With the SEC. Why That\u2019s a Win for the Stock.","Summary":""},{"Date":"Dec. 8, 2020 at 11:34 a.m. ET","Headline":"Here\u2019s the timeline for vaccine approval around the world, as U.K. authorizes COVID-19 shot","Summary":""},{"Date":"Dec. 12, 2020 at 7:33 p.m. ET","Headline":"Weekend reads: Hot IPOs for DoorDash and Airbnb point to an overheated stock market","Summary":"Biotech company Moderna Inc.  said late Friday the U.S. government has exercised its option to purchase an additional 100 million doses of Moderna's COVID-19 vaccine candidate, which brings the confirmed order commitment t..."},{"Date":"Dec. 12, 2020 at 2:19 p.m. ET","Headline":"Despite stock-market rally, investors aren\u2019t fully convinced vaccines will tame COVID in 2021, survey finds","Summary":"Biotech company Moderna Inc.  said late Friday the U.S. government has exercised its option to purchase an additional 100 million doses of Moderna's COVID-19 vaccine candidate, which brings the confirmed order commitment t..."},{"Date":"Dec. 12, 2020 at 12:38 p.m. ET","Headline":"COVID-19 vaccine to start arriving in U.S. states Monday","Summary":"Biotech company Moderna Inc.  said late Friday the U.S. government has exercised its option to purchase an additional 100 million doses of Moderna's COVID-19 vaccine candidate, which brings the confirmed order commitment t..."},{"Date":"Dec. 12, 2020 at 8:43 a.m. ET","Headline":"30 stocks of companies expected to increase sales the most in 2021","Summary":"Biotech company Moderna Inc.  said late Friday the U.S. government has exercised its option to purchase an additional 100 million doses of Moderna's COVID-19 vaccine candidate, which brings the confirmed order commitment t..."},{"Date":"Dec. 12, 2020 at 7:00 a.m. ET","Headline":"Campbell Soup, Pfizer, Mastercard, and Other Companies That Raised Their Dividends This Week","Summary":"Biotech company Moderna Inc.  said late Friday the U.S. government has exercised its option to purchase an additional 100 million doses of Moderna's COVID-19 vaccine candidate, which brings the confirmed order commitment t..."},{"Date":"Dec. 11, 2020 at 10:00 p.m. ET","Headline":"First COVID-19 vaccine receives emergency-use authorization from U.S. FDA","Summary":"Biotech company Moderna Inc.  said late Friday the U.S. government has exercised its option to purchase an additional 100 million doses of Moderna's COVID-19 vaccine candidate, which brings the confirmed order commitment t..."},{"Date":"Dec. 11, 2020 at 8:16 p.m. ET","Headline":"Will the FTC\u2019s Suit Against Facebook Stifle M&A? Probably Not.","Summary":"Biotech company Moderna Inc.  said late Friday the U.S. government has exercised its option to purchase an additional 100 million doses of Moderna's COVID-19 vaccine candidate, which brings the confirmed order commitment t..."},{"Date":"Dec. 11, 2020 at 6:00 p.m. ET","Headline":"U.S. Suffer Worst Week for Covid-19 Cases, Deaths, and Hospitalizations","Summary":"Biotech company Moderna Inc.  said late Friday the U.S. government has exercised its option to purchase an additional 100 million doses of Moderna's COVID-19 vaccine candidate, which brings the confirmed order commitment t..."},{"Date":"Dec. 11, 2020 at 5:45 p.m. ET","Headline":"Government Asks Moderna for More Covid-19 Shots","Summary":"Biotech company Moderna Inc.  said late Friday the U.S. government has exercised its option to purchase an additional 100 million doses of Moderna's COVID-19 vaccine candidate, which brings the confirmed order commitment t..."},{"Date":"Dec. 11, 2020 at 5:39 p.m. ET","Headline":"Certara IPO Soars 66%. Employees Will Get Shares.","Summary":"Biotech company Moderna Inc.  said late Friday the U.S. government has exercised its option to purchase an additional 100 million doses of Moderna's COVID-19 vaccine candidate, which brings the confirmed order commitment t..."},{"Date":"Dec. 11, 2020 at 4:41 p.m. ET","Headline":"U.S. buys another 100 million COVID-19 vaccine candidate doses: Moderna","Summary":"Biotech company Moderna Inc.  said late Friday the U.S. government has exercised its option to purchase an additional 100 million doses of Moderna's COVID-19 vaccine candidate, which brings the confirmed order commitment t..."},{"Date":"Dec. 11, 2020 at 4:33 p.m. ET","Headline":"Stocks Close With Losses for the Week","Summary":"Stocks saw a mixed finish Friday, leaving major benchmarks modestly lower for the week as talks toward another round of pandemic relief spending remained stalled on Capitol Hill. The Dow Jones Industrial Average  ended aro..."},{"Date":"Dec. 11, 2020 at 4:23 p.m. ET","Headline":"Stocks end mostly lower Friday amid setbacks on U.S. fiscal stimulus and Brexit","Summary":"Stocks saw a mixed finish Friday, leaving major benchmarks modestly lower for the week as talks toward another round of pandemic relief spending remained stalled on Capitol Hill. The Dow Jones Industrial Average  ended aro..."},{"Date":"Dec. 11, 2020 at 4:07 p.m. ET","Headline":"Stocks log modest weekly declines as stimulus talks stall","Summary":"Stocks saw a mixed finish Friday, leaving major benchmarks modestly lower for the week as talks toward another round of pandemic relief spending remained stalled on Capitol Hill. The Dow Jones Industrial Average  ended aro..."},{"Date":"Dec. 11, 2020 at 4:03 p.m. ET","Headline":"Treasury yields edge lower as stalled U.S. stimulus talks, Brexit worries spark demand for safe assets","Summary":"Treasury prices rise Friday, dragging down yields, as investors show interest in safe assets as prospects for another round of U.S. aid spending fade and the potential for a \u201cno-deal Brexit\u201d looms larger."},{"Date":"Dec. 11, 2020 at 3:44 p.m. ET","Headline":"COVID vaccine from Sanofi and GSK is delayed, triggering uncertainty ahead of Europe\u2019s mass inoculation campaigns","Summary":""},{"Date":"Dec. 11, 2020 at 3:42 p.m. ET","Headline":"It\u2019s Vaccine Time. Industries Jostle in the Line for Shots.","Summary":""},{"Date":"Dec. 11, 2020 at 3:01 p.m. ET","Headline":"Oil ends lower, but notches a weekly gain, lifted by vaccine optimism","Summary":""},{"Date":"Dec. 14, 2020 at 5:10 p.m. ET","Headline":"Treasury yields erase early rise on threat of renewed lockdowns","Summary":"Treasury prices erase early losses, leaving yields little changed, as worries that rising COVID-19 cases could curtail economic activity and spark renewed lockdowns put a damper on a stock-market rally."},{"Date":"Dec. 14, 2020 at 4:43 p.m. ET","Headline":"Dow books worst day in two weeks as COVID lockdowns intensify amid U.S. vaccine rollout","Summary":"A Food and Drug Administration advisory committee will meet for the second time in a week to discuss whether the regulator should authorize Moderna Inc.'s  COVID-19 vaccine candidate. The same committee, the Vaccines and R..."},{"Date":"Dec. 14, 2020 at 4:21 p.m. ET","Headline":"Stocks Fell as U.S. Covid Deaths Surpass 300,000","Summary":"A Food and Drug Administration advisory committee will meet for the second time in a week to discuss whether the regulator should authorize Moderna Inc.'s  COVID-19 vaccine candidate. The same committee, the Vaccines and R..."},{"Date":"Dec. 14, 2020 at 3:59 p.m. ET","Headline":"U.S. tops 300,000 COVID-19 deaths on the same day vaccinations begin","Summary":"A Food and Drug Administration advisory committee will meet for the second time in a week to discuss whether the regulator should authorize Moderna Inc.'s  COVID-19 vaccine candidate. The same committee, the Vaccines and R..."},{"Date":"Dec. 14, 2020 at 3:44 p.m. ET","Headline":"As some hospitals near 90% capacity due to COVID-19, this map can tell you if your local hospital is almost full","Summary":"A Food and Drug Administration advisory committee will meet for the second time in a week to discuss whether the regulator should authorize Moderna Inc.'s  COVID-19 vaccine candidate. The same committee, the Vaccines and R..."},{"Date":"Dec. 14, 2020 at 3:40 p.m. ET","Headline":"Americans prepare to travel again for Christmas, while hospitals brace for post-Thanksgiving surge","Summary":"A Food and Drug Administration advisory committee will meet for the second time in a week to discuss whether the regulator should authorize Moderna Inc.'s  COVID-19 vaccine candidate. The same committee, the Vaccines and R..."},{"Date":"Dec. 14, 2020 at 3:23 p.m. ET","Headline":"This Is How Vaccines Are Distributed and Which Stocks Benefit","Summary":"A Food and Drug Administration advisory committee will meet for the second time in a week to discuss whether the regulator should authorize Moderna Inc.'s  COVID-19 vaccine candidate. The same committee, the Vaccines and R..."},{"Date":"Dec. 14, 2020 at 3:23 p.m. ET","Headline":"Oil climbs to a 9-month high on U.S. vaccine rollout, but OPEC\u2019s lower demand forecast tempers the rise","Summary":"A Food and Drug Administration advisory committee will meet for the second time in a week to discuss whether the regulator should authorize Moderna Inc.'s  COVID-19 vaccine candidate. The same committee, the Vaccines and R..."},{"Date":"Dec. 14, 2020 at 2:12 p.m. ET","Headline":"Gold prices settle at a nearly 2-week low on U.S. coronavirus vaccine rollout","Summary":"A Food and Drug Administration advisory committee will meet for the second time in a week to discuss whether the regulator should authorize Moderna Inc.'s  COVID-19 vaccine candidate. The same committee, the Vaccines and R..."},{"Date":"Dec. 14, 2020 at 1:55 p.m. ET","Headline":"CureVac starts Phase 3 clinical trial of its COVID-19 vaccine candidate","Summary":"A Food and Drug Administration advisory committee will meet for the second time in a week to discuss whether the regulator should authorize Moderna Inc.'s  COVID-19 vaccine candidate. The same committee, the Vaccines and R..."},{"Date":"Dec. 14, 2020 at 12:57 p.m. ET","Headline":"WATCH: Relieved Americans applaud as the Pfizer-BioNTech COVID-19 vaccine rolls out across the country","Summary":"A Food and Drug Administration advisory committee will meet for the second time in a week to discuss whether the regulator should authorize Moderna Inc.'s  COVID-19 vaccine candidate. The same committee, the Vaccines and R..."},{"Date":"Dec. 14, 2020 at 10:59 a.m. ET","Headline":"FDA committee to meet again Thursday for Moderna's COVID-19 vaccine","Summary":"A Food and Drug Administration advisory committee will meet for the second time in a week to discuss whether the regulator should authorize Moderna Inc.'s  COVID-19 vaccine candidate. The same committee, the Vaccines and R..."},{"Date":"Dec. 14, 2020 at 10:46 a.m. ET","Headline":"Pound surges as U.K. and EU set to go \u2018the extra mile\u2019 on Brexit deal","Summary":""},{"Date":"Dec. 14, 2020 at 10:45 a.m. ET","Headline":"European stocks climb on COVID-19 vaccine optimism and stimulus-deal hopes","Summary":""},{"Date":"Dec. 14, 2020 at 10:16 a.m. ET","Headline":"Queens, N.Y., critical-care nurse becomes first person in U.S. to receive COVID-19 vaccine","Summary":""},{"Date":"Dec. 14, 2020 at 9:55 a.m. ET","Headline":"Critical Care Nurse Receives First Vaccine in New York","Summary":""},{"Date":"Dec. 14, 2020 at 8:49 a.m. ET","Headline":"Americans Will Start Getting the Pfizer Vaccine This Week","Summary":""},{"Date":"Dec. 14, 2020 at 8:30 a.m. ET","Headline":"Airbnb and DoorDash Weren\u2019t the Last Big IPOs of 2020. Burger King India Is Next.","Summary":""},{"Date":"Dec. 16, 2020 at 11:40 p.m. ET","Headline":"California reports record coronavirus deaths as new cases spiral","Summary":""},{"Date":"Dec. 16, 2020 at 11:10 p.m. ET","Headline":"U.S. negotiating to buy more doses of Pfizer\u2019s coronavirus vaccine","Summary":""},{"Date":"Dec. 16, 2020 at 7:18 p.m. ET","Headline":"Extra doses in vials could significantly stretch nation\u2019s COVID-19 vaccine supply","Summary":""},{"Date":"Dec. 16, 2020 at 4:52 p.m. ET","Headline":"BioAtla Is the Latest Biotech IPO to Pop","Summary":""},{"Date":"Dec. 16, 2020 at 4:25 p.m. ET","Headline":"S&P 500, Nasdaq end higher after Fed vows to buy bonds until economy heals","Summary":""},{"Date":"Dec. 16, 2020 at 4:14 p.m. ET","Headline":"Why Pfizer\u2019s Stock Has Reached Its Limit, According to One Analyst","Summary":""},{"Date":"Dec. 16, 2020 at 3:26 p.m. ET","Headline":"COVID-19 hospitalizations rise to a 10th-straight daily record, as nearly 3,000 die in the past day","Summary":""},{"Date":"Dec. 16, 2020 at 3:26 p.m. ET","Headline":"Florida Gov. DeSantis reveals delay in delivery of Pfizer vaccine as hospital network seeks to inoculate 20,000 employees","Summary":""},{"Date":"Dec. 16, 2020 at 3:05 p.m. ET","Headline":"Oil prices end higher on stimulus hopes, EIA supply decline, but demand outlook remains dim","Summary":""},{"Date":"Dec. 16, 2020 at 2:33 p.m. ET","Headline":"Focus Shifts to Europe as Gilead Backs Away From Arthritis-Drug Partnership","Summary":""},{"Date":"Dec. 16, 2020 at 11:04 a.m. ET","Headline":"Moderna nears its first-ever FDA authorization, for its COVID-19 vaccine","Summary":""},{"Date":"Dec. 16, 2020 at 8:46 a.m. ET","Headline":"Twitter Stock Is Up, United Airlines Drops, as the Dow Edges Higher","Summary":""},{"Date":"Dec. 16, 2020 at 8:41 a.m. ET","Headline":"Retail sales sink 1.1% in November as COVID-19 buffets restaurants and economy","Summary":""},{"Date":"Dec. 16, 2020 at 6:52 a.m. ET","Headline":"Dr. Fauci: \u2018For the first time in more than 30 years, I\u2019m not spending the Christmas holidays with my daughters\u2019","Summary":""},{"Date":"Dec. 16, 2020 at 6:51 a.m. ET","Headline":"Dr. Fauci: For security reasons, Biden and Harris should receive COVID-19 vaccine \u2018as soon as we possibly can\u2019","Summary":""},{"Date":"Dec. 15, 2020 at 10:58 p.m. ET","Headline":"Asian markets rise after stimulus talks lift Wall Street","Summary":""},{"Date":"Dec. 15, 2020 at 8:57 p.m. ET","Headline":"California distributes 5,000 body bags, has makeshift morgues on standby as COVID toll worsens","Summary":""},{"Date":"Dec. 15, 2020 at 6:17 p.m. ET","Headline":"There\u2019s More Juice in the IPO Pipeline. Wish Prices at the Top of Its Range.","Summary":""},{"Date":"Dec. 18, 2020 at 9:24 p.m. ET","Headline":"RingCentral Takes on Zoom\u2019s and Slack\u2019s Hold Over Meeting Culture","Summary":"Treasury yields edge higher Friday, with the rate on the 10-year benchmark logging a weekly rise as investors tracked talks on Capitol Hill toward a $900 billion package of economic relief and vaccine developments as COVID..."},{"Date":"Dec. 18, 2020 at 8:02 p.m. ET","Headline":"FDA grants Moderna authorization for a second COVID-19 vaccine","Summary":"Treasury yields edge higher Friday, with the rate on the 10-year benchmark logging a weekly rise as investors tracked talks on Capitol Hill toward a $900 billion package of economic relief and vaccine developments as COVID..."},{"Date":"Dec. 18, 2020 at 4:33 p.m. ET","Headline":"Dow ends 124 points lower as Congress races to avert government shutdown, pass economic relief package","Summary":"Treasury yields edge higher Friday, with the rate on the 10-year benchmark logging a weekly rise as investors tracked talks on Capitol Hill toward a $900 billion package of economic relief and vaccine developments as COVID..."},{"Date":"Dec. 18, 2020 at 4:27 p.m. ET","Headline":"Treasury yields see weekly rise as investors await fiscal stimulus from Congress","Summary":"Treasury yields edge higher Friday, with the rate on the 10-year benchmark logging a weekly rise as investors tracked talks on Capitol Hill toward a $900 billion package of economic relief and vaccine developments as COVID..."},{"Date":"Dec. 18, 2020 at 3:17 p.m. ET","Headline":"Vaccines Could Be Available to the U.S. Public in March, Fauci Says","Summary":"Walgreens Boots Alliance Inc.  said Friday it has begun administering Pfizer Inc.'s  and BioNTech SE's  COVID-19 vaccine to residents and staff at long-term care facilities, starting with Connecticut and Ohio. Starting Dec..."},{"Date":"Dec. 18, 2020 at 3:15 p.m. ET","Headline":"Oil prices settle at highest since February, up a 7th week in a row","Summary":"Walgreens Boots Alliance Inc.  said Friday it has begun administering Pfizer Inc.'s  and BioNTech SE's  COVID-19 vaccine to residents and staff at long-term care facilities, starting with Connecticut and Ohio. Starting Dec..."},{"Date":"Dec. 18, 2020 at 2:39 p.m. ET","Headline":"U.S. COVID-19 daily death toll slips, but stays above 3,000 for 3rd-straight day","Summary":"Walgreens Boots Alliance Inc.  said Friday it has begun administering Pfizer Inc.'s  and BioNTech SE's  COVID-19 vaccine to residents and staff at long-term care facilities, starting with Connecticut and Ohio. Starting Dec..."},{"Date":"Dec. 18, 2020 at 10:28 a.m. ET","Headline":"Moderna\u2019s Vaccine Is Close to Getting a Thumbs-Up. Its Stock Is Taking a Hit.","Summary":"Walgreens Boots Alliance Inc.  said Friday it has begun administering Pfizer Inc.'s  and BioNTech SE's  COVID-19 vaccine to residents and staff at long-term care facilities, starting with Connecticut and Ohio. Starting Dec..."},{"Date":"Dec. 18, 2020 at 9:54 a.m. ET","Headline":"Walgreens and CVS are on a hiring spree looking to fill 35,000 jobs for COVID-19 vaccine rollout","Summary":"Walgreens Boots Alliance Inc.  said Friday it has begun administering Pfizer Inc.'s  and BioNTech SE's  COVID-19 vaccine to residents and staff at long-term care facilities, starting with Connecticut and Ohio. Starting Dec..."},{"Date":"Dec. 18, 2020 at 8:56 a.m. ET","Headline":"Watch These Transport Stocks as Europe Rebounds","Summary":"Walgreens Boots Alliance Inc.  said Friday it has begun administering Pfizer Inc.'s  and BioNTech SE's  COVID-19 vaccine to residents and staff at long-term care facilities, starting with Connecticut and Ohio. Starting Dec..."},{"Date":"Dec. 18, 2020 at 8:49 a.m. ET","Headline":"Palantir Stock Drops, FedEx Falls, and the Stock Market Is Looking for a Reason to Move","Summary":"Walgreens Boots Alliance Inc.  said Friday it has begun administering Pfizer Inc.'s  and BioNTech SE's  COVID-19 vaccine to residents and staff at long-term care facilities, starting with Connecticut and Ohio. Starting Dec..."},{"Date":"Dec. 18, 2020 at 8:26 a.m. ET","Headline":"Bitcoin Is Surging. Coinbase\u2019s IPO Will Be Another Way to Play the Hot Cryptocurrency.","Summary":"Walgreens Boots Alliance Inc.  said Friday it has begun administering Pfizer Inc.'s  and BioNTech SE's  COVID-19 vaccine to residents and staff at long-term care facilities, starting with Connecticut and Ohio. Starting Dec..."},{"Date":"Dec. 18, 2020 at 8:24 a.m. ET","Headline":"FDA committee supports authorization of Moderna\u2019s COVID-19 vaccine","Summary":"Walgreens Boots Alliance Inc.  said Friday it has begun administering Pfizer Inc.'s  and BioNTech SE's  COVID-19 vaccine to residents and staff at long-term care facilities, starting with Connecticut and Ohio. Starting Dec..."},{"Date":"Dec. 18, 2020 at 7:49 a.m. ET","Headline":"Walgreens plans to administer COVID-19 vaccine to 3 million people at 35,000 long-term care facilities","Summary":"Walgreens Boots Alliance Inc.  said Friday it has begun administering Pfizer Inc.'s  and BioNTech SE's  COVID-19 vaccine to residents and staff at long-term care facilities, starting with Connecticut and Ohio. Starting Dec..."},{"Date":"Dec. 17, 2020 at 11:51 p.m. ET","Headline":"Some states complain their allotments of Pfizer\u2019s coronavirus vaccine will be cut next week","Summary":""},{"Date":"Dec. 17, 2020 at 6:13 p.m. ET","Headline":"Moderna\u2019s Covid-19 Vaccine Is Backed by FDA Advisory Panel","Summary":""},{"Date":"Dec. 17, 2020 at 3:27 p.m. ET","Headline":"Moderna\u2019s Covid Vaccine Gets FDA Panel Review Today. What to Expect.","Summary":""},{"Date":"Dec. 17, 2020 at 3:22 p.m. ET","Headline":"Vaccine Push at Nursing Homes Meets Resistance","Summary":""},{"Date":"Dec. 20, 2020 at 6:27 p.m. ET","Headline":"People over 75, essential workers should be next in line for vaccine, panel says","Summary":""},{"Date":"Dec. 20, 2020 at 5:01 p.m. ET","Headline":"Those who\u2019ve had coronavirus should also get vaccinated, top official says","Summary":""},{"Date":"Dec. 20, 2020 at 4:09 p.m. ET","Headline":"Moderna starts shipping its COVID-19 vaccine in U.S.","Summary":""},{"Date":"Dec. 19, 2020 at 9:06 a.m. ET","Headline":"Trust is the secret sauce that Warren Buffett and others value highly in companies","Summary":""},{"Date":"Dec. 19, 2020 at 4:00 a.m. ET","Headline":"\u2018Wear masks when seeing family over Christmas,\u2019 WHO urges Europeans, as regulator accelerates COVID vaccine timeline","Summary":""},{"Date":"Dec. 22, 2020 at 8:31 p.m. ET","Headline":"Stock Futures Fall Slightly After Trump Calls for Major Changes to Stimulus Bill","Summary":""},{"Date":"Dec. 22, 2020 at 8:00 p.m. ET","Headline":"U.S. close to deal with Pfizer to buy millions more vaccine doses","Summary":""},{"Date":"Dec. 22, 2020 at 7:20 p.m. ET","Headline":"Oil prices end sharply lower, threatening to snap 7-week streak of gains","Summary":""},{"Date":"Dec. 22, 2020 at 4:52 p.m. ET","Headline":"Bank debt leads corporate bond rally sparked by COVID-19 vaccine rollout","Summary":""},{"Date":"Dec. 22, 2020 at 4:11 p.m. ET","Headline":"Stocks Wavered as Investors Weighed Stimulus, New Covid-19 Strain","Summary":""},{"Date":"Dec. 22, 2020 at 3:02 p.m. ET","Headline":"U.S. tops 18 million COVID-19 cases, as daily new cases and deaths are back on the rise","Summary":""},{"Date":"Dec. 22, 2020 at 1:53 p.m. ET","Headline":"\u2018How can we become trustworthy?\u2019 Doctors and community leaders are working to counter vaccine hesitancy in Black and Latino Americans","Summary":""},{"Date":"Dec. 22, 2020 at 11:52 a.m. ET","Headline":"BioNTech boss says more tests needed to see if vaccine protects against new COVID-19 strain","Summary":""},{"Date":"Dec. 22, 2020 at 11:41 a.m. ET","Headline":"A Vaccine Doesn\u2019t Solve Everything for Europe\u2019s Economy. Here Are the Hurdles in 2021.","Summary":""},{"Date":"Dec. 22, 2020 at 11:38 a.m. ET","Headline":"Watch: Dr. Fauci gets Moderna\u2019s COVID-19 vaccine on camera \u2018as a symbol to the rest of the country\u2019 to get vaccinated","Summary":""},{"Date":"Dec. 22, 2020 at 10:15 a.m. ET","Headline":"Fauci suggests all Americans who want to be vaccinated will have gotten shots by midsummer","Summary":""},{"Date":"Dec. 22, 2020 at 9:02 a.m. ET","Headline":"Europe Pushes Ahead With Vaccine Rollout as New Coronavirus Variant Closes Borders","Summary":""},{"Date":"Dec. 22, 2020 at 8:35 a.m. ET","Headline":"Europe is pushing ahead with COVID-19 vaccine rollout as a new and more infectious coronavirus strain closes borders","Summary":""},{"Date":"Dec. 22, 2020 at 8:09 a.m. ET","Headline":"Joint Chiefs chairman and vice chairman receive Pfizer vaccination","Summary":""},{"Date":"Dec. 22, 2020 at 8:07 a.m. ET","Headline":"Apple and Others Are Coming for Tesla","Summary":""},{"Date":"Dec. 21, 2020 at 6:47 p.m. ET","Headline":"California COVID restrictions likely to be extended; nearly 100,000 hospitalizations possible in next month","Summary":""},{"Date":"Dec. 21, 2020 at 6:41 p.m. ET","Headline":"Former congressman suggests adding $300 or $400 to stimulus checks \u2014 for people who get the COVID-19 vaccine","Summary":""},{"Date":"Dec. 21, 2020 at 3:57 p.m. ET","Headline":"Biden urges Americans to take coronavirus vaccine as he gets first dose","Summary":""},{"Date":"Dec. 24, 2020 at 5:47 p.m. ET","Headline":"Small-Caps Have Been Too Hot. Here\u2019s What It Means for the Stock Market.","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to..."},{"Date":"Dec. 24, 2020 at 12:42 p.m. ET","Headline":"House Republicans Block Bid for $2,000 Stimulus Checks. Democrats Will Try Again Monday.","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to..."},{"Date":"Dec. 24, 2020 at 12:14 p.m. ET","Headline":"Daily death toll from COVID-19 climbs to more than 3,400, the same day vaccinations top 1 million","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to..."},{"Date":"Dec. 24, 2020 at 7:41 a.m. ET","Headline":"Dr. James Hildreth: Here\u2019s how to instill vaccine confidence among people of color","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to..."},{"Date":"Dec. 23, 2020 at 4:39 p.m. ET","Headline":"U.S. stocks eke out gains as investors monitor vaccination push, tumult in Washington","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to..."},{"Date":"Dec. 23, 2020 at 4:29 p.m. ET","Headline":"President Trump Vetoes Defense Bill","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to..."},{"Date":"Dec. 23, 2020 at 2:37 p.m. ET","Headline":"U.S. COVID-19 deaths surge back to more than 3,000 a day as hospitalizations spike to another record","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to..."},{"Date":"Dec. 23, 2020 at 12:11 p.m. ET","Headline":"European stocks rise on reports of imminent Brexit trade deal","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to..."},{"Date":"Dec. 23, 2020 at 12:05 p.m. ET","Headline":"More U.K. lockdowns as second more contagious new strain of COVID-19 detected from South Africa","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to..."},{"Date":"Dec. 23, 2020 at 11:05 a.m. ET","Headline":"New U.S. Covid-19 Vaccine Deal Gives Pfizer $2 Billion More in Sales","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to..."},{"Date":"Dec. 23, 2020 at 10:32 a.m. ET","Headline":"AstraZeneca\u2019s COVID-19 vaccine could be approved in U.K. \u2018shortly after Christmas\u2019 \u2013 top Oxford scientist says","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to..."},{"Date":"Dec. 23, 2020 at 8:56 a.m. ET","Headline":"3 Stock Market Risks That Aren\u2019t a Covid Stimulus Package","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to..."},{"Date":"Dec. 23, 2020 at 8:32 a.m. ET","Headline":"Coronavirus Mutation May Already Be in the U.S.","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to..."},{"Date":"Dec. 23, 2020 at 7:51 a.m. ET","Headline":"Trump Doesn\u2019t Like the Stimulus Plan. Why the Stock Market Doesn\u2019t Care.","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to..."},{"Date":"Dec. 23, 2020 at 7:24 a.m. ET","Headline":"Investors are getting too bullish, say Jefferies global strategists \u2014 they see it as a 2019 rerun","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to..."},{"Date":"Dec. 23, 2020 at 7:16 a.m. ET","Headline":"Pfizer, BioNTech to supply U.S. with an additional 100 million doses of COVID-19 vaccine for about $2 billion","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to..."},{"Date":"Dec. 23, 2020 at 6:43 a.m. ET","Headline":"Coronavirus tally: Daily death toll spikes back above 3,000 as hospitalizations jumps to another record","Summary":"It was a bad day on the COVID-19 front. While the number of daily new cases slipped to 201,674 on Tuesday from 201,723 on Monday, the number of deaths spiked up to 3,239 on Tuesday, the third-highest daily total ever, from..."},{"Date":"Dec. 22, 2020 at 2:17 p.m. ET","Headline":"Lufthansa airlifting food to U.K. as border chaos continues \u2014 thousands of trucks bound for France stranded","Summary":""},{"Date":"Dec. 26, 2020 at 1:46 p.m. ET","Headline":"Germany, Hungary give 1st vaccine shots ahead of EU rollout","Summary":""},{"Date":"Dec. 26, 2020 at 10:03 a.m. ET","Headline":"What could rattle markets in 2021, even as vaccines are rolling out","Summary":""},{"Date":"Dec. 26, 2020 at 9:26 a.m. ET","Headline":"Here\u2019s what we know so far about the new strain of COVID-19","Summary":""},{"Date":"Dec. 28, 2020 at 4:37 p.m. ET","Headline":"Dow, S&P 500, Nasdaq end at record highs as Trump signs COVID aid package","Summary":"Shares of Myovant Sciences  soared 20% in premarket trade Monday, after its parent Sumitovant Biopharma said Myovant will work with Pfizer Inc.  to jointly develop a treatment for prostate cancer and women's health in a de..."},{"Date":"Dec. 28, 2020 at 2:01 p.m. ET","Headline":"U.S. has had more than 19 million COVID-19 cases, and Fauci is getting worried about a post-holiday surge","Summary":"Shares of Myovant Sciences  soared 20% in premarket trade Monday, after its parent Sumitovant Biopharma said Myovant will work with Pfizer Inc.  to jointly develop a treatment for prostate cancer and women's health in a de..."},{"Date":"Dec. 28, 2020 at 10:19 a.m. ET","Headline":"\u2018Santa Claus\u2019 rally has begun. Why few 7-session stretches are better for the stock market.","Summary":"Shares of Myovant Sciences  soared 20% in premarket trade Monday, after its parent Sumitovant Biopharma said Myovant will work with Pfizer Inc.  to jointly develop a treatment for prostate cancer and women's health in a de..."},{"Date":"Dec. 28, 2020 at 9:53 a.m. ET","Headline":"European stocks trade higher as investors welcome U.S. stimulus package and Brexit deal","Summary":"Shares of Myovant Sciences  soared 20% in premarket trade Monday, after its parent Sumitovant Biopharma said Myovant will work with Pfizer Inc.  to jointly develop a treatment for prostate cancer and women's health in a de..."},{"Date":"Dec. 28, 2020 at 9:39 a.m. ET","Headline":"McKesson Stock May Be the Real Covid Vaccine Winner. Here\u2019s Why.","Summary":"Shares of Myovant Sciences  soared 20% in premarket trade Monday, after its parent Sumitovant Biopharma said Myovant will work with Pfizer Inc.  to jointly develop a treatment for prostate cancer and women's health in a de..."},{"Date":"Dec. 28, 2020 at 8:33 a.m. ET","Headline":"UPDATE: Myovant shares soar 20% premarket on news of Pfizer cancer drug deal worth up to $4.2 billion","Summary":"Shares of Myovant Sciences  soared 20% in premarket trade Monday, after its parent Sumitovant Biopharma said Myovant will work with Pfizer Inc.  to jointly develop a treatment for prostate cancer and women's health in a de..."},{"Date":"Dec. 27, 2020 at 6:19 p.m. ET","Headline":"First shots given as EU rolls out its COVID-19 vaccine campaign","Summary":""},{"Date":"Dec. 27, 2020 at 10:42 a.m. ET","Headline":"Will COVID-19 push more employees to work remotely after the pandemic? This economist says yes","Summary":""},{"Date":"Dec. 30, 2020 at 11:37 p.m. ET","Headline":"Asian markets mixed in last trading day of 2020","Summary":"The global tally for confirmed cases of the coronavirus that causes COVID-19 rose above 82 million on Wednesday,  while the death toll rose above 1.79 million. The U.S. has the highest case tally in the world at 19.5 milli..."},{"Date":"Dec. 30, 2020 at 3:52 p.m. ET","Headline":"AstraZeneca and Oxford University\u2019s Covid-19 Vaccine Is Approved in the U.K.","Summary":"The global tally for confirmed cases of the coronavirus that causes COVID-19 rose above 82 million on Wednesday,  while the death toll rose above 1.79 million. The U.S. has the highest case tally in the world at 19.5 milli..."},{"Date":"Dec. 30, 2020 at 2:23 p.m. ET","Headline":"U.S. sets record for COVID-19 hospitalizations, as country\u2019s first case of new U.K. variant is found in Colorado","Summary":"The global tally for confirmed cases of the coronavirus that causes COVID-19 rose above 82 million on Wednesday,  while the death toll rose above 1.79 million. The U.S. has the highest case tally in the world at 19.5 milli..."},{"Date":"Dec. 30, 2020 at 1:03 p.m. ET","Headline":"How many people have to get vaccinated against COVID-19 to reach herd immunity? \u2018The faster we do it, the faster we get back to life\u2019","Summary":"The global tally for confirmed cases of the coronavirus that causes COVID-19 rose above 82 million on Wednesday,  while the death toll rose above 1.79 million. The U.S. has the highest case tally in the world at 19.5 milli..."},{"Date":"Dec. 30, 2020 at 12:04 p.m. ET","Headline":"Merck Had a Disappointing 2020. Why Its Strategy Could Pay Off in 2021.","Summary":"The global tally for confirmed cases of the coronavirus that causes COVID-19 rose above 82 million on Wednesday,  while the death toll rose above 1.79 million. The U.S. has the highest case tally in the world at 19.5 milli..."},{"Date":"Dec. 30, 2020 at 8:00 a.m. ET","Headline":"AstraZeneca\u2019s Covid-19 Vaccine Just Got U.K. Approval. Why the Stock Market Shrugged.","Summary":"The global tally for confirmed cases of the coronavirus that causes COVID-19 rose above 82 million on Wednesday,  while the death toll rose above 1.79 million. The U.S. has the highest case tally in the world at 19.5 milli..."},{"Date":"Dec. 30, 2020 at 7:59 a.m. ET","Headline":"Germany accused of grabbing too much vaccine \u2014 citizens also injected with five times the recommended dosage","Summary":"The global tally for confirmed cases of the coronavirus that causes COVID-19 rose above 82 million on Wednesday,  while the death toll rose above 1.79 million. The U.S. has the highest case tally in the world at 19.5 milli..."},{"Date":"Dec. 30, 2020 at 6:47 a.m. ET","Headline":"U.K. approves coronavirus vaccine AstraZeneca made with Oxford","Summary":"The global tally for confirmed cases of the coronavirus that causes COVID-19 rose above 82 million on Wednesday,  while the death toll rose above 1.79 million. The U.S. has the highest case tally in the world at 19.5 milli..."},{"Date":"Dec. 30, 2020 at 6:37 a.m. ET","Headline":"UPDATE: Coronavirus tally: Global cases of COVID-19 top 82 million as U.K. authorizes third vaccine","Summary":"The global tally for confirmed cases of the coronavirus that causes COVID-19 rose above 82 million on Wednesday,  while the death toll rose above 1.79 million. The U.S. has the highest case tally in the world at 19.5 milli..."},{"Date":"Dec. 30, 2020 at 6:35 a.m. ET","Headline":"Biden joins public health experts in expressing dismay as early days of COVID vaccine rollout in U.S. fall far short of expectations","Summary":"Pfizer Inc.  and its German partner BioNTech SE  will supply an additional 100 million doses of their COVID-19 vaccine to the 27 member states of the European Union, the companies said in a joint statement. The move comes ..."},{"Date":"Dec. 30, 2020 at 5:06 a.m. ET","Headline":"European markets inch higher as U.K. approves AstraZeneca\u2019s COVID-19 vaccine","Summary":"Pfizer Inc.  and its German partner BioNTech SE  will supply an additional 100 million doses of their COVID-19 vaccine to the 27 member states of the European Union, the companies said in a joint statement. The move comes ..."},{"Date":"Dec. 29, 2020 at 8:34 p.m. ET","Headline":"Americans who will get COVID-19 vaccine will do it for one reason more important than country, economy or community","Summary":"Pfizer Inc.  and its German partner BioNTech SE  will supply an additional 100 million doses of their COVID-19 vaccine to the 27 member states of the European Union, the companies said in a joint statement. The move comes ..."},{"Date":"Dec. 29, 2020 at 5:24 p.m. ET","Headline":"Stocks Slip Into Red After Rally to Record Highs","Summary":"Pfizer Inc.  and its German partner BioNTech SE  will supply an additional 100 million doses of their COVID-19 vaccine to the 27 member states of the European Union, the companies said in a joint statement. The move comes ..."},{"Date":"Dec. 29, 2020 at 5:11 p.m. ET","Headline":"Novavax Starts a Phase 3 Trial for Its Covid Vaccine, While Arcturus Gets 5 Downgrades for Its Stock","Summary":"Pfizer Inc.  and its German partner BioNTech SE  will supply an additional 100 million doses of their COVID-19 vaccine to the 27 member states of the European Union, the companies said in a joint statement. The move comes ..."},{"Date":"Dec. 29, 2020 at 1:44 p.m. ET","Headline":"WHO says coronavirus pandemic is \u2018not the big one\u2019 the world needs to brace for","Summary":"Pfizer Inc.  and its German partner BioNTech SE  will supply an additional 100 million doses of their COVID-19 vaccine to the 27 member states of the European Union, the companies said in a joint statement. The move comes ..."},{"Date":"Dec. 29, 2020 at 1:31 p.m. ET","Headline":"Pfizer and BioNTech to supply additional 100 million COVID vaccine doses to EU in 2021","Summary":"Pfizer Inc.  and its German partner BioNTech SE  will supply an additional 100 million doses of their COVID-19 vaccine to the 27 member states of the European Union, the companies said in a joint statement. The move comes ..."},{"Date":"Dec. 29, 2020 at 10:23 a.m. ET","Headline":"Arcturus Therapeutics shares slide 55% after COVID vaccine data are deemed \u2018underwhelming\u2019","Summary":""},{"Date":"Dec. 29, 2020 at 9:33 a.m. ET","Headline":"Three More Coronavirus Vaccines Expected by Early 2021","Summary":""},{"Date":"Jan. 1, 2021 at 6:44 p.m. ET","Headline":"U.K. is in the \u2018eye of the storm\u2019 as coronavirus cases surge","Summary":"CNN is reporting Friday afternoon that Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, has ruled out an extension of the recommended interval between doses of the coronavirus vacci..."},{"Date":"Jan. 1, 2021 at 3:38 p.m. ET","Headline":"Fauci reportedly says U.S. will not extend interval between vaccine doses","Summary":"CNN is reporting Friday afternoon that Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, has ruled out an extension of the recommended interval between doses of the coronavirus vacci..."},{"Date":"Jan. 1, 2021 at 3:08 p.m. ET","Headline":"Fauci says U.S. will not extend interval between vaccine doses: CNN","Summary":"CNN is reporting Friday afternoon that Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, has ruled out an extension of the recommended interval between doses of the coronavirus vacci..."},{"Date":"Jan. 1, 2021 at 1:24 p.m. ET","Headline":"University of Michigan football stadium becomes giant vaccination site","Summary":""},{"Date":"Jan. 1, 2021 at 8:17 a.m. ET","Headline":"CDC issues COVID-19 vaccine guidance for Americans with HIV, Guillain-Barr\u00e9 and other underlying conditions","Summary":""},{"Date":"Jan. 1, 2021 at 4:00 a.m. ET","Headline":"Merck Is One of Barron\u2019s Top Stock Picks for the New Year. Here\u2019s Why.","Summary":""},{"Date":"Dec. 31, 2020 at 7:01 p.m. ET","Headline":"The Nikkei Nears a High. Is That Good News or Bad News for Japan?","Summary":""},{"Date":"Dec. 31, 2020 at 3:14 p.m. ET","Headline":"U.K. health service pushes back interval for delivering second Pfizer coronavirus vaccine to a duration company says is untested","Summary":""},{"Date":"Dec. 31, 2020 at 1:35 p.m. ET","Headline":"Is the stock market open? Here are the trading hours on New Year\u2019s Eve and Day","Summary":""},{"Date":"Dec. 31, 2020 at 11:44 a.m. ET","Headline":"U.S. sets record for COVID deaths, and California confirms second case of highly infectious new strain","Summary":""},{"Date":"Dec. 31, 2020 at 9:37 a.m. ET","Headline":"U.K. now has enough vaccine \u2018to cover the entire population\u2019 after authorization of AstraZeneca\u2013Oxford COVID-19 vaccine","Summary":""},{"Date":"Jan. 3, 2021 at 8:57 p.m. ET","Headline":"India authorizes coronavirus vaccines from AstraZeneca and Bharat Biotech","Summary":""},{"Date":"Jan. 3, 2021 at 8:48 a.m. ET","Headline":"COVID-19 has created a \u2018flight to safety\u2019 for American job hunters","Summary":""},{"Date":"Jan. 3, 2021 at 8:35 a.m. ET","Headline":"I earned $100,000 in 2019, but far less in 2020. Why did I not get a stimulus check? How is that fair?","Summary":""},{"Date":"Jan. 2, 2021 at 1:42 p.m. ET","Headline":"U.K. hits daily coronavirus record, unions urge keeping schools closed","Summary":""},{"Date":"Jan. 2, 2021 at 11:42 a.m. ET","Headline":"Slow COVID-19 vaccine rollout in U.S. could portend more problems","Summary":""},{"Date":"Jan. 2, 2021 at 9:54 a.m. ET","Headline":"Drugmakers raise prices 3.3% in New Year","Summary":""},{"Date":"Jan. 2, 2021 at 8:17 a.m. ET","Headline":"These are the best performing Nasdaq and S&P 500 stocks of 2020","Summary":""},{"Date":"Jan. 2, 2021 at 6:30 a.m. ET","Headline":"The Dow Trailed the S&P 500 in 2020. It Was the Blue Chips\u2019 Worst Relative Performance Since 1998.","Summary":""},{"Date":"Jan. 1, 2021 at 4:30 a.m. ET","Headline":"Honeywell Had Quite a 2020. This Year Could Be Better.","Summary":""},{"Date":"Jan. 5, 2021 at 2:52 p.m. ET","Headline":"If 2020 was a year \u2018to buy the rumor,\u2019 maybe 2021 is time to \u2018sell the news,\u2019 veteran newsletter writer says","Summary":""},{"Date":"Jan. 5, 2021 at 2:19 p.m. ET","Headline":"January will be worst month for U.S. pandemic so far with post-holiday travel cases seen surging","Summary":""},{"Date":"Jan. 5, 2021 at 2:06 p.m. ET","Headline":"Pressed about vaccine delays, Florida Gov. DeSantis criticizes CNN reporter\u2018s questioning","Summary":""},{"Date":"Jan. 5, 2021 at 10:42 a.m. ET","Headline":"Pfizer Drops the Big Blue Pill to Highlight Shift in Strategy","Summary":""},{"Date":"Jan. 5, 2021 at 7:25 a.m. ET","Headline":"Slaoui proposes half-doses of Moderna\u2019s COVID-19 vaccine to speed vaccinations","Summary":""},{"Date":"Jan. 4, 2021 at 6:03 p.m. ET","Headline":"The Stock Market Got Hit Hard by Covid Fears. Why the Concerns May Be Overblown.","Summary":""},{"Date":"Jan. 4, 2021 at 5:42 p.m. ET","Headline":"Wisconsin pharmacist arrested and fired over spoiled vaccine doses is an admitted conspiracy theorist","Summary":""},{"Date":"Jan. 4, 2021 at 2:56 p.m. ET","Headline":"U.S. heads toward 21 million COVID-19 cases and 353,000 deaths as vaccine program continues to lag all targets","Summary":""},{"Date":"Jan. 4, 2021 at 12:50 p.m. ET","Headline":"U.K. becomes first country to roll out AstraZeneca-Oxford vaccine as tighter lockdowns imminent","Summary":""},{"Date":"Jan. 4, 2021 at 8:12 a.m. ET","Headline":"Getting COVID-19 vaccines to rural America will be difficult \u2014 here\u2019s what it will take to overcome that","Summary":""},{"Date":"Jan. 4, 2021 at 7:41 a.m. ET","Headline":"Here Are Barron\u2019s 10 Top Stocks for the New Year","Summary":""},{"Date":"Jan. 7, 2021 at 3:52 p.m. ET","Headline":"CureVac Forms Covid-19 Vaccine Alliance With Bayer. The Stock Is Surging.","Summary":""},{"Date":"Jan. 7, 2021 at 3:28 p.m. ET","Headline":"Third vaccine could be authorized for U.K. within weeks, boosting mass immunization drive, top scientist says","Summary":""},{"Date":"Jan. 7, 2021 at 5:11 a.m. ET","Headline":"European stocks and U.S. futures extend rally on hopes over fiscal stimulus and vaccine","Summary":""},{"Date":"Jan. 6, 2021 at 8:33 p.m. ET","Headline":"Debate Over Electoral Votes Resumes; Twitter Suspends Trump Account","Summary":""},{"Date":"Jan. 6, 2021 at 1:00 p.m. ET","Headline":"Long-Term Treasury Yields Are Climbing as Investors Bet on Democratic Senate Wins","Summary":""},{"Date":"Jan. 6, 2021 at 12:09 p.m. ET","Headline":"5 reasons musicians like Bob Dylan, Neil Young and Stevie Nicks are selling their song catalogs right now","Summary":""},{"Date":"Jan. 6, 2021 at 9:15 a.m. ET","Headline":"Novavax Has Covid-19 Vaccine News Coming Out Soon. That Could Be Good for the Stock.","Summary":""},{"Date":"Jan. 6, 2021 at 8:34 a.m. ET","Headline":"Hundreds of CEOs urge Congress to uphold principles of democracy and certify Biden\u2019s win","Summary":""},{"Date":"Jan. 9, 2021 at 1:39 p.m. ET","Headline":"After one hell of a year \u2014 10 New Year\u2019s resolutions to stay on top of the world in 2021","Summary":"Biotech Moderna's  COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regula..."},{"Date":"Jan. 9, 2021 at 12:57 p.m. ET","Headline":"Dr. Fauci on COVID-19 infections: \u2018Things will get worse as we get into January\u2019","Summary":"Biotech Moderna's  COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regula..."},{"Date":"Jan. 9, 2021 at 8:44 a.m. ET","Headline":"If you\u2019re thinking of rotating into value stocks, these are top newsletters\u2019 most-recommended industries","Summary":"Biotech Moderna's  COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regula..."},{"Date":"Jan. 8, 2021 at 7:23 p.m. ET","Headline":"Sarepta Stock Dropped 50% After Gene-Therapy Setback. What to Do Now.","Summary":"Biotech Moderna's  COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regula..."},{"Date":"Jan. 8, 2021 at 5:24 p.m. ET","Headline":"U.S. stocks close at all-time highs after Biden promise of more aid offsets worst jobs report since April","Summary":"Biotech Moderna's  COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regula..."},{"Date":"Jan. 8, 2021 at 4:13 p.m. ET","Headline":"More Travel Restrictions in Europe as Pandemic Keeps Spreading","Summary":"Biotech Moderna's  COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regula..."},{"Date":"Jan. 8, 2021 at 4:11 p.m. ET","Headline":"Travel restrictions tighten further in Europe as COVID-19 is spreading faster","Summary":"Biotech Moderna's  COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regula..."},{"Date":"Jan. 8, 2021 at 3:51 p.m. ET","Headline":"Pfizer-BioNTech Vaccine Effective Against Mutation in New Covid-19 Variants, Study Finds","Summary":"Biotech Moderna's  COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regula..."},{"Date":"Jan. 8, 2021 at 3:24 p.m. ET","Headline":"Bigger stimulus? Here\u2019s why now may be seen as the \u2018peak of this bubble,\u2019 warns strategist","Summary":"Biotech Moderna's  COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regula..."},{"Date":"Jan. 8, 2021 at 3:23 p.m. ET","Headline":"Pfizer\u2013BioNTech vaccine appears to protect against U.K. and South African COVID-19 strains in lab, study finds","Summary":"Biotech Moderna's  COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regula..."},{"Date":"Jan. 8, 2021 at 3:21 p.m. ET","Headline":"Moderna\u2019s COVID-19 vaccine becomes third shot authorized for use in U.K.","Summary":"Biotech Moderna's  COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regula..."},{"Date":"Jan. 8, 2021 at 2:37 p.m. ET","Headline":"More than 4,000 U.S. lives lost to COVID in single day, exceeding death toll from 9\/11 attacks","Summary":"Biotech Moderna's  COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regula..."},{"Date":"Jan. 8, 2021 at 1:55 p.m. ET","Headline":"Where\u2019s mine? Anxious New Yorkers getting jumpy about slow vaccines","Summary":"Biotech Moderna's  COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regula..."},{"Date":"Jan. 8, 2021 at 1:33 p.m. ET","Headline":"Biden Plans to Release Nearly All Available Covid-19 Vaccine Doses","Summary":"Biotech Moderna's  COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regula..."},{"Date":"Jan. 8, 2021 at 10:55 a.m. ET","Headline":"FDA Commissioner Says States Should Expand Covid-19 Vaccine Eligibility","Summary":"Biotech Moderna's  COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regula..."},{"Date":"Jan. 8, 2021 at 8:29 a.m. ET","Headline":"Moderna's COVID-19 vaccine becomes third to be authorized by U.K. regulator","Summary":"Biotech Moderna's  COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regula..."},{"Date":"Jan. 8, 2021 at 8:28 a.m. ET","Headline":"Europe's drug regulator says there is an extra dose in BioNTech\/Pfizer's COVID-19 vaccine vials","Summary":"The European Medicines Agency  that the product information for BioNTech SE  and Pfizer Inc.'s  COVID-19 vaccine should be updated to say there are six doses in each vial. The authorization granted to the vaccine, which is..."},{"Date":"Jan. 8, 2021 at 8:23 a.m. ET","Headline":"Tesla\u2019s Elon Musk and How to Become the Richest Person in the World","Summary":""},{"Date":"Jan. 11, 2021 at 5:30 p.m. ET","Headline":"U.S. tops 22 million cases of COVID-19 after adding record of more than 300,000 in a day","Summary":"Germany's BioNTech SE  said Monday it is aiming to supply up to 2 billion doses of its COVID-19 vaccine in 2021, after receiving emergency use authorization in both the U.S. and EU.  the company said it has committed to su..."},{"Date":"Jan. 11, 2021 at 3:22 p.m. ET","Headline":"EasyJet lands $1.87 billion state-backed loan as it looks to ease COVID cash crunch","Summary":"Germany's BioNTech SE  said Monday it is aiming to supply up to 2 billion doses of its COVID-19 vaccine in 2021, after receiving emergency use authorization in both the U.S. and EU.  the company said it has committed to su..."},{"Date":"Jan. 11, 2021 at 3:14 p.m. ET","Headline":"Biden says he\u2019s unafraid of taking oath of office outside after Capitol riot","Summary":"Germany's BioNTech SE  said Monday it is aiming to supply up to 2 billion doses of its COVID-19 vaccine in 2021, after receiving emergency use authorization in both the U.S. and EU.  the company said it has committed to su..."},{"Date":"Jan. 11, 2021 at 3:11 p.m. ET","Headline":"Report: FBI Warns of Armed Protests Ahead of Inauguration Day","Summary":"Germany's BioNTech SE  said Monday it is aiming to supply up to 2 billion doses of its COVID-19 vaccine in 2021, after receiving emergency use authorization in both the U.S. and EU.  the company said it has committed to su..."},{"Date":"Jan. 11, 2021 at 3:11 p.m. ET","Headline":"Sarepta Stock Gains as CEO Explains What Went Wrong With Gene-Therapy Trial","Summary":"Germany's BioNTech SE  said Monday it is aiming to supply up to 2 billion doses of its COVID-19 vaccine in 2021, after receiving emergency use authorization in both the U.S. and EU.  the company said it has committed to su..."},{"Date":"Jan. 11, 2021 at 3:08 p.m. ET","Headline":"Stock market exuberance is here to stay, Credit Suisse says. Here\u2019s why investors can be positive","Summary":"Germany's BioNTech SE  said Monday it is aiming to supply up to 2 billion doses of its COVID-19 vaccine in 2021, after receiving emergency use authorization in both the U.S. and EU.  the company said it has committed to su..."},{"Date":"Jan. 11, 2021 at 12:29 p.m. ET","Headline":"BioNTech CEO Says a Version of Its Covid Vaccine With Less Stringent Storage Requirements Could Come This Year","Summary":"Germany's BioNTech SE  said Monday it is aiming to supply up to 2 billion doses of its COVID-19 vaccine in 2021, after receiving emergency use authorization in both the U.S. and EU.  the company said it has committed to su..."},{"Date":"Jan. 11, 2021 at 9:38 a.m. ET","Headline":"Biden plans to distribute COVID-19 vaccine doses immediately","Summary":"Germany's BioNTech SE  said Monday it is aiming to supply up to 2 billion doses of its COVID-19 vaccine in 2021, after receiving emergency use authorization in both the U.S. and EU.  the company said it has committed to su..."},{"Date":"Jan. 11, 2021 at 8:42 a.m. ET","Headline":"BioNTech to target supply of up to 2 billion doses of COVID-19 vaccine in 2021","Summary":"Germany's BioNTech SE  said Monday it is aiming to supply up to 2 billion doses of its COVID-19 vaccine in 2021, after receiving emergency use authorization in both the U.S. and EU.  the company said it has committed to su..."},{"Date":"Jan. 11, 2021 at 7:49 a.m. ET","Headline":"CDC officials say people with history of allergic reactions should be monitored after receiving a COVID-19 shot","Summary":""},{"Date":"Jan. 11, 2021 at 6:25 a.m. ET","Headline":"America\u2019s 1% will be pulling out all the stops to get their hands on COVID-19 vaccine","Summary":""},{"Date":"Jan. 10, 2021 at 5:54 p.m. ET","Headline":"What side effects, if any, can you expect from a COVID-19 vaccine shot?","Summary":""},{"Date":"Jan. 13, 2021 at 12:06 p.m. ET","Headline":"Here are the 10 best places to work in 2021, according to employees","Summary":"Shares of Pfizer Inc.  dropped 2.1% in morning trading Tuesday, even after the drug maker provided an upbeat earnings outlook for this year. Speaking at the J.P. Morgan Health Care Conference, Chief Executive Albert Bourla..."},{"Date":"Jan. 13, 2021 at 10:39 a.m. ET","Headline":"Johnson & Johnson Hits Vaccine Production Snags, New York Times Reports","Summary":"Shares of Pfizer Inc.  dropped 2.1% in morning trading Tuesday, even after the drug maker provided an upbeat earnings outlook for this year. Speaking at the J.P. Morgan Health Care Conference, Chief Executive Albert Bourla..."},{"Date":"Jan. 13, 2021 at 8:14 a.m. ET","Headline":"The Apple Car Chatter Is Back\u2014and It\u2019s Helping Everyone Except Apple","Summary":"Shares of Pfizer Inc.  dropped 2.1% in morning trading Tuesday, even after the drug maker provided an upbeat earnings outlook for this year. Speaking at the J.P. Morgan Health Care Conference, Chief Executive Albert Bourla..."},{"Date":"Jan. 12, 2021 at 4:56 p.m. ET","Headline":"Bristol Myers Looks to Its Drug Pipeline to Turbocharge Growth","Summary":"Shares of Pfizer Inc.  dropped 2.1% in morning trading Tuesday, even after the drug maker provided an upbeat earnings outlook for this year. Speaking at the J.P. Morgan Health Care Conference, Chief Executive Albert Bourla..."},{"Date":"Jan. 12, 2021 at 4:33 p.m. ET","Headline":"Dow misses out on record high as Wall Street avoids back-to-back losses","Summary":"Shares of Pfizer Inc.  dropped 2.1% in morning trading Tuesday, even after the drug maker provided an upbeat earnings outlook for this year. Speaking at the J.P. Morgan Health Care Conference, Chief Executive Albert Bourla..."},{"Date":"Jan. 12, 2021 at 3:18 p.m. ET","Headline":"AstraZeneca\u2013Oxford COVID-19 shot could be authorized Jan. 29, says EU medical regulator","Summary":"Shares of Pfizer Inc.  dropped 2.1% in morning trading Tuesday, even after the drug maker provided an upbeat earnings outlook for this year. Speaking at the J.P. Morgan Health Care Conference, Chief Executive Albert Bourla..."},{"Date":"Jan. 12, 2021 at 2:15 p.m. ET","Headline":"U.S. heads toward 23 million COVID-19 cases as three lawmakers test positive after Capitol lockdown","Summary":"Shares of Pfizer Inc.  dropped 2.1% in morning trading Tuesday, even after the drug maker provided an upbeat earnings outlook for this year. Speaking at the J.P. Morgan Health Care Conference, Chief Executive Albert Bourla..."},{"Date":"Jan. 12, 2021 at 1:51 p.m. ET","Headline":"HHS announces unexpected shift to speed vaccinations; won\u2019t hold back 2nd doses","Summary":"Shares of Pfizer Inc.  dropped 2.1% in morning trading Tuesday, even after the drug maker provided an upbeat earnings outlook for this year. Speaking at the J.P. Morgan Health Care Conference, Chief Executive Albert Bourla..."},{"Date":"Jan. 12, 2021 at 1:02 p.m. ET","Headline":"Pfizer Says It Can Quickly Develop Vaccines for Future Covid-19 Variants","Summary":"Shares of Pfizer Inc.  dropped 2.1% in morning trading Tuesday, even after the drug maker provided an upbeat earnings outlook for this year. Speaking at the J.P. Morgan Health Care Conference, Chief Executive Albert Bourla..."},{"Date":"Jan. 12, 2021 at 11:28 a.m. ET","Headline":"Pfizer's earnings outlook for 2021 tops expectations, but stock falls","Summary":"Shares of Pfizer Inc.  dropped 2.1% in morning trading Tuesday, even after the drug maker provided an upbeat earnings outlook for this year. Speaking at the J.P. Morgan Health Care Conference, Chief Executive Albert Bourla..."},{"Date":"Jan. 12, 2021 at 9:27 a.m. ET","Headline":"Moderna Executives Say Covid-19 Vaccine Should Offer a Year of Protection","Summary":"Uber Technologies Inc.  and Moderna Inc.  said Tuesday they will collaborate to explore ways to support the uptake of COVID-19 vaccines. The ridesharing and delivery company and the biotech said they will work together to ..."},{"Date":"Jan. 12, 2021 at 8:49 a.m. ET","Headline":"Johnson & Johnson\u2019s Covid-19 Vaccine Could Alter the Course of the Pandemic. Investors Will Soon Know if It Works.","Summary":"Uber Technologies Inc.  and Moderna Inc.  said Tuesday they will collaborate to explore ways to support the uptake of COVID-19 vaccines. The ridesharing and delivery company and the biotech said they will work together to ..."},{"Date":"Jan. 12, 2021 at 8:16 a.m. ET","Headline":"Uber, Moderna to collaborate on supporting COVID-19 vaccine uptake","Summary":"Uber Technologies Inc.  and Moderna Inc.  said Tuesday they will collaborate to explore ways to support the uptake of COVID-19 vaccines. The ridesharing and delivery company and the biotech said they will work together to ..."},{"Date":"Jan. 12, 2021 at 1:45 a.m. ET","Headline":"Democratic lawmakers test positive for COVID and believe they were exposed in secure location during Capitol siege","Summary":""},{"Date":"Jan. 15, 2021 at 4:20 p.m. ET","Headline":"U.S. stocks close lower for the week after release of big bank quarterly results, Biden aid plan","Summary":"U.S. stock market indexes Friday morning were trading at or near sessions lows after a report indicated some delays in the distribution of vaccines from Pfizer in Europe.  that the European Union's Pfizer  vaccine deliveri..."},{"Date":"Jan. 15, 2021 at 3:02 p.m. ET","Headline":"Global deaths from COVID-19 top 2 million as U.S. suffers most weekly fatalities since start of the pandemic","Summary":"U.S. stock market indexes Friday morning were trading at or near sessions lows after a report indicated some delays in the distribution of vaccines from Pfizer in Europe.  that the European Union's Pfizer  vaccine deliveri..."},{"Date":"Jan. 15, 2021 at 12:11 p.m. ET","Headline":"Pharma industry warns against interfering with COVID vaccine shot intervals","Summary":"U.S. stock market indexes Friday morning were trading at or near sessions lows after a report indicated some delays in the distribution of vaccines from Pfizer in Europe.  that the European Union's Pfizer  vaccine deliveri..."},{"Date":"Jan. 15, 2021 at 11:23 a.m. ET","Headline":"Pfizer temporarily reduces European deliveries of vaccine while upgrading production capacity","Summary":"U.S. stock market indexes Friday morning were trading at or near sessions lows after a report indicated some delays in the distribution of vaccines from Pfizer in Europe.  that the European Union's Pfizer  vaccine deliveri..."},{"Date":"Jan. 15, 2021 at 10:29 a.m. ET","Headline":"Dow skids to session low Friday morning amid report that Pfizer vaccines in EU may face delays","Summary":"U.S. stock market indexes Friday morning were trading at or near sessions lows after a report indicated some delays in the distribution of vaccines from Pfizer in Europe.  that the European Union's Pfizer  vaccine deliveri..."},{"Date":"Jan. 14, 2021 at 3:31 p.m. ET","Headline":"Covid-19 Infection Likely to Provide Immunity for at Least Five Months, Study Finds. What That Might Mean.","Summary":""},{"Date":"Jan. 14, 2021 at 3:24 p.m. ET","Headline":"COVID-19 infection likely to provide immunity for at least 5 months, but people may still transmit virus, study finds","Summary":""},{"Date":"Jan. 14, 2021 at 3:11 p.m. ET","Headline":"With Rare Speed, Gene Editing Emerges as Biotech\u2019s New Cutting Edge","Summary":""},{"Date":"Jan. 14, 2021 at 2:54 p.m. ET","Headline":"U.S. case tally climbs to 23 million \u2014 or a quarter of the global tally \u2014 amid surge in new infections","Summary":""},{"Date":"Jan. 14, 2021 at 10:54 a.m. ET","Headline":"Why Indonesia is vaccinating its working-age adults before the elderly","Summary":""},{"Date":"Jan. 14, 2021 at 8:09 a.m. ET","Headline":"New Data Boosts Confidence In J&J Vaccine","Summary":""},{"Date":"Jan. 17, 2021 at 1:41 p.m. ET","Headline":"Biden Is Planning a Blitz of Executive Orders as Soon as He Takes Office","Summary":""},{"Date":"Jan. 17, 2021 at 9:39 a.m. ET","Headline":"Biden\u2019s $1.9-trillion COVID-19 rescue plan is a \u2018lifeline\u2019 for millions of Americans","Summary":""},{"Date":"Jan. 16, 2021 at 4:59 p.m. ET","Headline":"\u2018Deaths of despair\u2019 during COVID-19 have risen significantly in 2020, new research says","Summary":""},{"Date":"Jan. 16, 2021 at 12:16 p.m. ET","Headline":"West Virginia is vaccinating people faster than California \u2014 here\u2019s why","Summary":""},{"Date":"Jan. 16, 2021 at 9:16 a.m. ET","Headline":"I didn\u2019t receive a $1,200 stimulus check during the first surge of COVID-19. Will I get a payment this time around?","Summary":""},{"Date":"Jan. 19, 2021 at 4:27 p.m. ET","Headline":"How to get a vaccine for someone who is homebound","Summary":""},{"Date":"Jan. 19, 2021 at 3:31 p.m. ET","Headline":"Open all hours: Round-the-clock vaccination sites to be piloted in England in COVID-19 drive","Summary":""},{"Date":"Jan. 19, 2021 at 2:50 p.m. ET","Headline":"U.S. climbs above 400,000 COVID-19 fatalities as California becomes first state with 3 million confirmed cases","Summary":""},{"Date":"Jan. 19, 2021 at 2:00 p.m. ET","Headline":"Schwab Stock Gains Because Retail Investors Are Trading. State Street Did Pretty Well, Too.","Summary":""},{"Date":"Jan. 19, 2021 at 1:14 p.m. ET","Headline":"McConnell Says Trump Provoked Mob That Attacked Capitol","Summary":""},{"Date":"Jan. 19, 2021 at 8:05 a.m. ET","Headline":"Eli Lilly Stock Is Still Pricey. Why It Might Be a Buy.","Summary":""},{"Date":"Jan. 18, 2021 at 10:02 p.m. ET","Headline":"Frustrated by slow rollout, Cuomo mulls buying coronavirus vaccine directly from Pfizer","Summary":""},{"Date":"Jan. 18, 2021 at 8:42 p.m. ET","Headline":"Barron\u2019s Investing Experts See \u2018Low-Level Civil War,\u2019 Hyper Stimulus, and Risks That Haven\u2019t Yet Materialized for the Stock Market","Summary":""},{"Date":"Jan. 18, 2021 at 3:13 p.m. ET","Headline":"Big Tech Stocks Are Struggling. Small Tech Stocks Could Be Next.","Summary":""},{"Date":"Jan. 18, 2021 at 11:03 a.m. ET","Headline":"Who gets the COVID-19 vaccination first? Only 12 states follow CDC guidelines on the order or priority","Summary":""},{"Date":"Jan. 18, 2021 at 2:49 a.m. ET","Headline":"Fauci says two more COVID-19 vaccines could be approved within \u2018weeks\u2019","Summary":""},{"Date":"Jan. 15, 2021 at 7:30 a.m. ET","Headline":"Global Dividends Will Rise 7% in 2021, IHS Markit Says, but U.S. Payouts Seen Falling 0.7%","Summary":""},{"Date":"Jan. 21, 2021 at 3:44 p.m. ET","Headline":"Inequitable vaccine distribution could lead to \u2018a catastrophic moral failure\u2019","Summary":""},{"Date":"Jan. 21, 2021 at 9:59 a.m. ET","Headline":"Hungary Approves Russia\u2019s Covid-19 Vaccine","Summary":""},{"Date":"Jan. 21, 2021 at 8:04 a.m. ET","Headline":"Amazon, Honeywell, and Other Big Businesses Want to Help You Get Vaccinated. Here\u2019s Why.","Summary":""},{"Date":"Jan. 21, 2021 at 6:30 a.m. ET","Headline":"4 Retail Winners to Buy for the Recovery","Summary":""},{"Date":"Jan. 20, 2021 at 6:14 p.m. ET","Headline":"Some COVID-19 variants may reduce effectiveness of vaccines","Summary":""},{"Date":"Jan. 20, 2021 at 5:22 p.m. ET","Headline":"Biden logs best stock-market rally from Election to Inauguration Day in history","Summary":""},{"Date":"Jan. 20, 2021 at 4:49 p.m. ET","Headline":"What to know about getting the COVID-19 vaccine in New York City","Summary":""},{"Date":"Jan. 20, 2021 at 12:36 p.m. ET","Headline":"Crypto tech vs. COVID-19: How hospitals are using blockchain in the vaccine rollout","Summary":""},{"Date":"Jan. 20, 2021 at 7:48 a.m. ET","Headline":"Another Paper From Pfizer and BioNTech Shows Vaccine Will Protect Against U.K. Strain","Summary":""},{"Date":"Jan. 16, 2021 at 12:29 p.m. ET","Headline":"Criminals come out of the woodwork as countries roll out COVID-19 vaccines","Summary":""},{"Date":"Jan. 23, 2021 at 12:18 p.m. ET","Headline":"\u2018When older people are upset, you fix it\u2019 \u2014 this Florida journalist has helped hundreds book COVID-19 vaccinations","Summary":"BioNTech SE  and Pfizer Inc.  said Friday that they plan to sell 40 million doses of their COVID-19 vaccine this year to Covax, a group that aims to ensure 92 lower-income countries have access to coronavirus vaccines. Bio..."},{"Date":"Jan. 22, 2021 at 8:30 p.m. ET","Headline":"MGM Stock Is Still a Good Bet, Despite Failure to Buy Entain","Summary":"BioNTech SE  and Pfizer Inc.  said Friday that they plan to sell 40 million doses of their COVID-19 vaccine this year to Covax, a group that aims to ensure 92 lower-income countries have access to coronavirus vaccines. Bio..."},{"Date":"Jan. 22, 2021 at 1:55 p.m. ET","Headline":"Barron\u2019s Stock Picks Beat the Market Again Last Year. Here\u2019s How We Did It.","Summary":"BioNTech SE  and Pfizer Inc.  said Friday that they plan to sell 40 million doses of their COVID-19 vaccine this year to Covax, a group that aims to ensure 92 lower-income countries have access to coronavirus vaccines. Bio..."},{"Date":"Jan. 22, 2021 at 12:15 p.m. ET","Headline":"BioNTech, Pfizer to sell 40 million doses to lower-income countries","Summary":"BioNTech SE  and Pfizer Inc.  said Friday that they plan to sell 40 million doses of their COVID-19 vaccine this year to Covax, a group that aims to ensure 92 lower-income countries have access to coronavirus vaccines. Bio..."},{"Date":"Jan. 22, 2021 at 9:26 a.m. ET","Headline":"Johnson & Johnson Aims for 100 Million Vaccine Doses by Spring. The Stock Market Is Counting on It.","Summary":""},{"Date":"Jan. 22, 2021 at 8:06 a.m. ET","Headline":"New Covid-19 Strains May Make Vaccines Less Effective, Fauci Warns","Summary":""},{"Date":"Jan. 20, 2021 at 10:29 p.m. ET","Headline":"Black Americans are dying from COVID-19 at higher rates than others \u2014 but they are also getting vaccinated at lower rates","Summary":""},{"Date":"Jan. 25, 2021 at 3:16 p.m. ET","Headline":"When can younger, healthy people get vaccinated? A former Biden COVID-19 adviser says it will be months","Summary":"Shares of Johnson & Johnson  were up 0.9% in trading on Monday, as the company nears the anticipated disclosure of interim results from a late-stage clinical trial evaluating its single-dose COVID-19 vaccine candidate. J&J..."},{"Date":"Jan. 25, 2021 at 2:33 p.m. ET","Headline":"Biden to reinstate travel bans amid fears about new variants as global case tally heads toward 100 million","Summary":"Shares of Johnson & Johnson  were up 0.9% in trading on Monday, as the company nears the anticipated disclosure of interim results from a late-stage clinical trial evaluating its single-dose COVID-19 vaccine candidate. J&J..."},{"Date":"Jan. 25, 2021 at 12:37 p.m. ET","Headline":"J&J may share findings from Phase 3 vaccine trial this week","Summary":"Shares of Johnson & Johnson  were up 0.9% in trading on Monday, as the company nears the anticipated disclosure of interim results from a late-stage clinical trial evaluating its single-dose COVID-19 vaccine candidate. J&J..."},{"Date":"Jan. 25, 2021 at 10:31 a.m. ET","Headline":"Moderna Making Vaccine Booster Shot to Protect Against South African Covid-19 Strain","Summary":"The Centers for Disease Control and Prevention updated  for vaccine administration to say that it's okay to space out the first and second doses of the currently available COVID-19 vaccines by up to 42 days, if necessary. ..."},{"Date":"Jan. 25, 2021 at 8:26 a.m. ET","Headline":"Merck Scraps Covid-19 Vaccine Programs","Summary":"The Centers for Disease Control and Prevention updated  for vaccine administration to say that it's okay to space out the first and second doses of the currently available COVID-19 vaccines by up to 42 days, if necessary. ..."},{"Date":"Jan. 25, 2021 at 8:24 a.m. ET","Headline":"CDC says doses of COVID-19 vaccines can be spaced out by up to 42 days","Summary":"The Centers for Disease Control and Prevention updated  for vaccine administration to say that it's okay to space out the first and second doses of the currently available COVID-19 vaccines by up to 42 days, if necessary. ..."},{"Date":"Jan. 25, 2021 at 8:20 a.m. ET","Headline":"CDC: Moderna's COVID-19 vaccine can cause allergic reaction in some people","Summary":"The Centers for Disease Control and Prevention said Friday that Moderna Inc.'s  COVID-19 vaccine produces an allergic reaction in a small percentage of people, similar to the agency's findings about the coronavirus vaccine..."},{"Date":"Jan. 24, 2021 at 12:15 p.m. ET","Headline":"Fauci suggests Johnson & Johnson COVID-19 vaccine could win emergency-use authorization in just two weeks","Summary":""},{"Date":"Jan. 27, 2021 at 11:33 p.m. ET","Headline":"Asian markets sink after Wall Street\u2019s worst day in months","Summary":"Shares of Moderna Inc.  were down 2.1% in premarket trading on Wednesday after the company said it was in talks with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine. The delivery, whic..."},{"Date":"Jan. 27, 2021 at 3:55 p.m. ET","Headline":"EU demands access to U.K.-made AstraZeneca vaccine shots as row over shortages intensifies","Summary":"Shares of Moderna Inc.  were down 2.1% in premarket trading on Wednesday after the company said it was in talks with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine. The delivery, whic..."},{"Date":"Jan. 27, 2021 at 3:33 p.m. ET","Headline":"Sanofi teams up with BioNTech and Pfizer to help fix Europe\u2019s vaccine shortage","Summary":"Shares of Moderna Inc.  were down 2.1% in premarket trading on Wednesday after the company said it was in talks with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine. The delivery, whic..."},{"Date":"Jan. 27, 2021 at 3:20 p.m. ET","Headline":"Boris Johnson \u2018deeply sorry for every life lost\u2019 as U.K. passes 100,000 COVID-19 deaths","Summary":"Shares of Moderna Inc.  were down 2.1% in premarket trading on Wednesday after the company said it was in talks with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine. The delivery, whic..."},{"Date":"Jan. 27, 2021 at 2:57 p.m. ET","Headline":"Biden pledges to speed vaccine program as U.S. sees another 4,000 COVID deaths in a single day","Summary":"Shares of Moderna Inc.  were down 2.1% in premarket trading on Wednesday after the company said it was in talks with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine. The delivery, whic..."},{"Date":"Jan. 27, 2021 at 11:26 a.m. ET","Headline":"CDC Director: \u2018I can\u2019t tell you how much vaccine we have and, if I can\u2019t tell it to you, then I can\u2019t tell it to the governors\u2019","Summary":"Shares of Moderna Inc.  were down 2.1% in premarket trading on Wednesday after the company said it was in talks with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine. The delivery, whic..."},{"Date":"Jan. 27, 2021 at 10:27 a.m. ET","Headline":"European stocks track Wall Street lower with investors focused on Fed and big tech earnings","Summary":"Shares of Moderna Inc.  were down 2.1% in premarket trading on Wednesday after the company said it was in talks with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine. The delivery, whic..."},{"Date":"Jan. 27, 2021 at 10:15 a.m. ET","Headline":"AstraZeneca Denies Pulling Out of Meeting With EU on Vaccine Deliveries","Summary":"Shares of Moderna Inc.  were down 2.1% in premarket trading on Wednesday after the company said it was in talks with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine. The delivery, whic..."},{"Date":"Jan. 27, 2021 at 8:36 a.m. ET","Headline":"Moderna: U.S. gov plans to order an additional 100 million doses of its COVID-19 vaccine","Summary":"Shares of Moderna Inc.  were down 2.1% in premarket trading on Wednesday after the company said it was in talks with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine. The delivery, whic..."},{"Date":"Jan. 27, 2021 at 8:05 a.m. ET","Headline":"Governments Are Scrambling for Vaccine Doses. More Supplies Seem Imminent.","Summary":"Shares of Regeneron Pharmaceuticals Inc.  gained 1.2% in premarket trading on Wednesday after the company said its COVID-19 antibody cocktail still works against two new more infectious strains of the virus: the B.1.1.7 an..."},{"Date":"Jan. 27, 2021 at 7:51 a.m. ET","Headline":"Regeneron says its COVID-19 antibody cocktail still works against new strains in lab test","Summary":"Shares of Regeneron Pharmaceuticals Inc.  gained 1.2% in premarket trading on Wednesday after the company said its COVID-19 antibody cocktail still works against two new more infectious strains of the virus: the B.1.1.7 an..."},{"Date":"Jan. 27, 2021 at 7:39 a.m. ET","Headline":"Tensions Rise in Europe on AstraZeneca Covid-19 Vaccine Woes","Summary":"Johnson & Johnson  expects to share details from the Phase 3 clinical trial for its COVID-19 vaccine candidate \"early next week,\" according to remarks made by CEO Alex Gorsky on Tuesday during an earnings call. J&J's stock..."},{"Date":"Jan. 27, 2021 at 7:36 a.m. ET","Headline":"Vaccine nationalism: Germany suggests EU should restrict the export of Pfizer\u2019s vaccine","Summary":"Johnson & Johnson  expects to share details from the Phase 3 clinical trial for its COVID-19 vaccine candidate \"early next week,\" according to remarks made by CEO Alex Gorsky on Tuesday during an earnings call. J&J's stock..."},{"Date":"Jan. 27, 2021 at 6:02 a.m. ET","Headline":"Only 49% of frontline workers say they\u2019ll get vaccinated, poll shows","Summary":"Johnson & Johnson  expects to share details from the Phase 3 clinical trial for its COVID-19 vaccine candidate \"early next week,\" according to remarks made by CEO Alex Gorsky on Tuesday during an earnings call. J&J's stock..."},{"Date":"Jan. 26, 2021 at 9:05 p.m. ET","Headline":"Biden Announces Plans for U.S. to Buy 200 Million More Covid Vaccine Doses","Summary":"Johnson & Johnson  expects to share details from the Phase 3 clinical trial for its COVID-19 vaccine candidate \"early next week,\" according to remarks made by CEO Alex Gorsky on Tuesday during an earnings call. J&J's stock..."},{"Date":"Jan. 26, 2021 at 5:20 p.m. ET","Headline":"Biden announces plans for U.S. to buy 200 million more COVID vaccine doses","Summary":"Johnson & Johnson  expects to share details from the Phase 3 clinical trial for its COVID-19 vaccine candidate \"early next week,\" according to remarks made by CEO Alex Gorsky on Tuesday during an earnings call. J&J's stock..."},{"Date":"Jan. 26, 2021 at 2:54 p.m. ET","Headline":"U.S. COVID-19 death toll tops 423,000 as Biden prepares to boost daily vaccination targets","Summary":"Johnson & Johnson  expects to share details from the Phase 3 clinical trial for its COVID-19 vaccine candidate \"early next week,\" according to remarks made by CEO Alex Gorsky on Tuesday during an earnings call. J&J's stock..."},{"Date":"Jan. 26, 2021 at 12:39 p.m. ET","Headline":"J&J CEO: Expect Phase 3 results for its COVID-19 vaccine candidate early next week","Summary":"Johnson & Johnson  expects to share details from the Phase 3 clinical trial for its COVID-19 vaccine candidate \"early next week,\" according to remarks made by CEO Alex Gorsky on Tuesday during an earnings call. J&J's stock..."},{"Date":"Jan. 29, 2021 at 8:27 p.m. ET","Headline":"Inverters Are Critical to Solar Power. Tesla Wants to Own It, But That Won\u2019t Be Easy.","Summary":"Johnson & Johnson  said Friday a Phase 3 trial of its one-dose COVID-19 vaccine proved to be 66% effective overall in preventing moderate-to-severe disease 28 days after vaccination, raising hopes it may receive emergency ..."},{"Date":"Jan. 29, 2021 at 8:00 p.m. ET","Headline":"Tackling the Wealth Gap Isn\u2019t a Single Challenge, But Many Interconnected Ones","Summary":"Johnson & Johnson  said Friday a Phase 3 trial of its one-dose COVID-19 vaccine proved to be 66% effective overall in preventing moderate-to-severe disease 28 days after vaccination, raising hopes it may receive emergency ..."},{"Date":"Jan. 29, 2021 at 7:06 p.m. ET","Headline":"Fauci says kids will be vaccinated against COVID-19 as soon as late spring","Summary":"Johnson & Johnson  said Friday a Phase 3 trial of its one-dose COVID-19 vaccine proved to be 66% effective overall in preventing moderate-to-severe disease 28 days after vaccination, raising hopes it may receive emergency ..."},{"Date":"Jan. 29, 2021 at 3:56 p.m. ET","Headline":"EU\u2019s drug regulator authorizes AstraZeneca COVID-19 vaccine for all ages over 18","Summary":"Johnson & Johnson  said Friday a Phase 3 trial of its one-dose COVID-19 vaccine proved to be 66% effective overall in preventing moderate-to-severe disease 28 days after vaccination, raising hopes it may receive emergency ..."},{"Date":"Jan. 29, 2021 at 3:50 p.m. ET","Headline":"European Cities Forced to Halt Vaccinations as Supply Issues Reach Crisis Point","Summary":"Johnson & Johnson  said Friday a Phase 3 trial of its one-dose COVID-19 vaccine proved to be 66% effective overall in preventing moderate-to-severe disease 28 days after vaccination, raising hopes it may receive emergency ..."},{"Date":"Jan. 29, 2021 at 3:13 p.m. ET","Headline":"EU threatens legal action to secure more doses as vaccine shortage reaches crisis point","Summary":"Johnson & Johnson  said Friday a Phase 3 trial of its one-dose COVID-19 vaccine proved to be 66% effective overall in preventing moderate-to-severe disease 28 days after vaccination, raising hopes it may receive emergency ..."},{"Date":"Jan. 29, 2021 at 3:10 p.m. ET","Headline":"Don\u2019t be a pig \u2014 GameStop advice as Robinhood reopens the spigot","Summary":"Johnson & Johnson  said Friday a Phase 3 trial of its one-dose COVID-19 vaccine proved to be 66% effective overall in preventing moderate-to-severe disease 28 days after vaccination, raising hopes it may receive emergency ..."},{"Date":"Jan. 29, 2021 at 12:11 p.m. ET","Headline":"Novavax Stock Soars as Its Covid-19 Vaccine Outperforms J&J\u2019s","Summary":"Johnson & Johnson  said Friday a Phase 3 trial of its one-dose COVID-19 vaccine proved to be 66% effective overall in preventing moderate-to-severe disease 28 days after vaccination, raising hopes it may receive emergency ..."},{"Date":"Jan. 29, 2021 at 12:11 p.m. ET","Headline":"Vaccine hopes boosted by data from Novavax and J&J, but fears over new variants remain","Summary":"Johnson & Johnson  said Friday a Phase 3 trial of its one-dose COVID-19 vaccine proved to be 66% effective overall in preventing moderate-to-severe disease 28 days after vaccination, raising hopes it may receive emergency ..."},{"Date":"Jan. 29, 2021 at 10:54 a.m. ET","Headline":"Fear of new virus variant pushes U.S. toward more genomic sequencing","Summary":"Johnson & Johnson  said Friday a Phase 3 trial of its one-dose COVID-19 vaccine proved to be 66% effective overall in preventing moderate-to-severe disease 28 days after vaccination, raising hopes it may receive emergency ..."},{"Date":"Jan. 29, 2021 at 10:20 a.m. ET","Headline":"Does wearing two masks help prevent COVID-19 transmission? Dr. Fauci has an answer","Summary":"Johnson & Johnson  said Friday a Phase 3 trial of its one-dose COVID-19 vaccine proved to be 66% effective overall in preventing moderate-to-severe disease 28 days after vaccination, raising hopes it may receive emergency ..."},{"Date":"Jan. 29, 2021 at 9:43 a.m. ET","Headline":"J&J Vaccine Prevents Serious Illness, but Falls Short of Competitors","Summary":"Johnson & Johnson  said Friday a Phase 3 trial of its one-dose COVID-19 vaccine proved to be 66% effective overall in preventing moderate-to-severe disease 28 days after vaccination, raising hopes it may receive emergency ..."},{"Date":"Jan. 29, 2021 at 8:58 a.m. ET","Headline":"The GameStop Frenzy Won\u2019t Die. What It Means for the Stock Market.","Summary":"Johnson & Johnson  said Friday a Phase 3 trial of its one-dose COVID-19 vaccine proved to be 66% effective overall in preventing moderate-to-severe disease 28 days after vaccination, raising hopes it may receive emergency ..."},{"Date":"Jan. 29, 2021 at 8:41 a.m. ET","Headline":"UPDATE: Johnson & Johnson says COVID vaccine was 66% effective in Phase 3 trial","Summary":"Johnson & Johnson  said Friday a Phase 3 trial of its one-dose COVID-19 vaccine proved to be 66% effective overall in preventing moderate-to-severe disease 28 days after vaccination, raising hopes it may receive emergency ..."},{"Date":"Jan. 29, 2021 at 8:17 a.m. ET","Headline":"Covid-19 Vaccine Trial Data Is Good News for Novavax","Summary":""},{"Date":"Jan. 29, 2021 at 4:50 a.m. ET","Headline":"European stocks and U.S. futures drop as GameStop-fueled volatility and COVID-19 worries drag on markets","Summary":""},{"Date":"Jan. 28, 2021 at 9:32 p.m. ET","Headline":"Novavax Says Its Vaccine Is 89% Effective in Britain\u2013but Not as Effective Against the South African Variant","Summary":""},{"Date":"Jan. 28, 2021 at 3:01 p.m. ET","Headline":"Oil ends lower as demand concerns undermine support from supply decline","Summary":""},{"Date":"Jan. 31, 2021 at 6:51 p.m. ET","Headline":"Futures Slide as Variant Worries Rattle Investors","Summary":""},{"Date":"Jan. 31, 2021 at 2:11 p.m. ET","Headline":"As vaccinations continue, 45% of millennials say they\u2019re OK with socializing in public places","Summary":""},{"Date":"Jan. 31, 2021 at 2:04 p.m. ET","Headline":"Here\u2019s the best way to double mask in 30 seconds flat (only one mask required)","Summary":""},{"Date":"Jan. 30, 2021 at 3:41 p.m. ET","Headline":"Here\u2019s what the robot fund that\u2019s beating the S&P 500 is investing in now","Summary":""},{"Date":"Jan. 30, 2021 at 12:18 p.m. ET","Headline":"Sanofi Will Make Pfizer\u2019s Covid-19 Vaccine. Are More Manufacturing Partnerships Coming?","Summary":""},{"Date":"Jan. 30, 2021 at 11:18 a.m. ET","Headline":"The new B.1.1.7 is a \u2018super-spreader\u2019 strain. Here\u2019s how the U.S. can control it, says Dr. Eric Topol","Summary":""},{"Date":"Feb. 2, 2021 at 10:51 p.m. ET","Headline":"Australia places no upper age limit on Pfizer coronavirus vaccine","Summary":"The Biden administration said Tuesday it plans to ship an additional 1 million COVID-19 vaccine doses to pharmacies as part of its strategy to expand access to vaccinations. Those vaccine doses are expected to be made avai..."},{"Date":"Feb. 2, 2021 at 4:32 p.m. ET","Headline":"Dow stages biggest daily gain in 3-months as investors focus on fiscal stimulus, vaccine and earnings","Summary":"The Biden administration said Tuesday it plans to ship an additional 1 million COVID-19 vaccine doses to pharmacies as part of its strategy to expand access to vaccinations. Those vaccine doses are expected to be made avai..."},{"Date":"Feb. 2, 2021 at 4:27 p.m. ET","Headline":"Stocks Rally to Close Higher as Stimulus Expectations Grow","Summary":"The Biden administration said Tuesday it plans to ship an additional 1 million COVID-19 vaccine doses to pharmacies as part of its strategy to expand access to vaccinations. Those vaccine doses are expected to be made avai..."},{"Date":"Feb. 2, 2021 at 3:32 p.m. ET","Headline":"Russia\u2019s Sputnik V COVID-19 vaccine shows 91.6% efficacy in late-stage trial","Summary":"The Biden administration said Tuesday it plans to ship an additional 1 million COVID-19 vaccine doses to pharmacies as part of its strategy to expand access to vaccinations. Those vaccine doses are expected to be made avai..."},{"Date":"Feb. 2, 2021 at 2:49 p.m. ET","Headline":"Pfizer Increased Vaccine Sales Estimate After AstraZeneca and J&J Stumbles","Summary":"The Biden administration said Tuesday it plans to ship an additional 1 million COVID-19 vaccine doses to pharmacies as part of its strategy to expand access to vaccinations. Those vaccine doses are expected to be made avai..."},{"Date":"Feb. 2, 2021 at 12:53 p.m. ET","Headline":"Americans in priority groups can start getting vaccinated at some pharmacies starting Feb. 11","Summary":"The Biden administration said Tuesday it plans to ship an additional 1 million COVID-19 vaccine doses to pharmacies as part of its strategy to expand access to vaccinations. Those vaccine doses are expected to be made avai..."},{"Date":"Feb. 2, 2021 at 12:43 p.m. ET","Headline":"Why the WallStreetBets crowd isn\u2019t scaring JPMorgan or Goldman away from stocks","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Tuesday after the drugmaker said the COVID-19 vaccine it developed with BioNTech SE  is expected to generate about $15 billion in sales in 2021. BioNTech's shares..."},{"Date":"Feb. 2, 2021 at 11:07 a.m. ET","Headline":"U.S. has administered at least one coronavirus vaccine dose to nearly 8% of the population","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Tuesday after the drugmaker said the COVID-19 vaccine it developed with BioNTech SE  is expected to generate about $15 billion in sales in 2021. BioNTech's shares..."},{"Date":"Feb. 2, 2021 at 9:46 a.m. ET","Headline":"Moderna Wants to Put More Vaccine in Each Vial as Supply Challenge Changes","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Tuesday after the drugmaker said the COVID-19 vaccine it developed with BioNTech SE  is expected to generate about $15 billion in sales in 2021. BioNTech's shares..."},{"Date":"Feb. 2, 2021 at 8:08 a.m. ET","Headline":"Pfizer expects its COVID-19 vaccine to bring in about $15 billion in revenue this year","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Tuesday after the drugmaker said the COVID-19 vaccine it developed with BioNTech SE  is expected to generate about $15 billion in sales in 2021. BioNTech's shares..."},{"Date":"Feb. 2, 2021 at 8:04 a.m. ET","Headline":"The GameStop Trade Is Over. It\u2019s Time to Think About Investing.","Summary":"Shares of Pfizer Inc.  slipped 0.6% in premarket trading Tuesday, after the drug maker reported fourth-quarter profit that missed expectations, but revenue that beat forecasts and provided an upbeat full-year outlook. The ..."},{"Date":"Feb. 2, 2021 at 7:59 a.m. ET","Headline":"Pfizer Just Reported Earnings. Here\u2019s the One Number to Notice.","Summary":"Shares of Pfizer Inc.  slipped 0.6% in premarket trading Tuesday, after the drug maker reported fourth-quarter profit that missed expectations, but revenue that beat forecasts and provided an upbeat full-year outlook. The ..."},{"Date":"Feb. 2, 2021 at 7:00 a.m. ET","Headline":"Pfizer stock slips after profit misses expectations, while revenue beats","Summary":"Shares of Pfizer Inc.  slipped 0.6% in premarket trading Tuesday, after the drug maker reported fourth-quarter profit that missed expectations, but revenue that beat forecasts and provided an upbeat full-year outlook. The ..."},{"Date":"Feb. 1, 2021 at 5:06 p.m. ET","Headline":"The Dow Rose 229 Points Because Everything Went Right for Stocks","Summary":"Shares of Moderna Inc.  tumbled 8.2% in trading on Monday after Bank of America analysts downgraded the company's stock to underperform from neutral, citing valuation concerns. Until December, Moderna was a clinical-stage ..."},{"Date":"Feb. 1, 2021 at 3:04 p.m. ET","Headline":"Bank of America downgrades Moderna stock over concerns about valuation","Summary":"Shares of Moderna Inc.  tumbled 8.2% in trading on Monday after Bank of America analysts downgraded the company's stock to underperform from neutral, citing valuation concerns. Until December, Moderna was a clinical-stage ..."},{"Date":"Feb. 1, 2021 at 2:01 p.m. ET","Headline":"BioNTech Now Plans to Produce 2 Billion Vaccine Doses in 2021","Summary":""},{"Date":"Feb. 1, 2021 at 1:19 p.m. ET","Headline":"Pfizer\u2013BioNTech partnership pledges 75 million more vaccine doses to help ease the EU bloc\u2019s shortage","Summary":""},{"Date":"Feb. 1, 2021 at 1:11 p.m. ET","Headline":"Time for more record earnings reports from Big Tech, led by Amazon\u2019s first $100 billion quarter","Summary":""},{"Date":"Feb. 4, 2021 at 6:09 p.m. ET","Headline":"The new South African strain is more infectious, and it\u2019s also making COVID-19 vaccines less effective","Summary":"Shares of Johnson & Johnson  gained 1.2% in after-hours trading on Thursday after the company announced that it had submitted an application for an emergency use authorization to the Food and Drug Administration for its CO..."},{"Date":"Feb. 4, 2021 at 5:57 p.m. ET","Headline":"J&J submits application for its COVID-19 shot to the FDA","Summary":"Shares of Johnson & Johnson  gained 1.2% in after-hours trading on Thursday after the company announced that it had submitted an application for an emergency use authorization to the Food and Drug Administration for its CO..."},{"Date":"Feb. 4, 2021 at 12:47 p.m. ET","Headline":"Merrick Garland Pledges to Sell Stocks After Confirmation as Attorney General","Summary":"Pfizer\u2019s Covid-19 vaccine is big business. Amazon has a $126 billion quarter, and other big news. And Impossible Foods drops its prices by 20%."},{"Date":"Feb. 4, 2021 at 11:16 a.m. ET","Headline":"U.S. death toll tops 450,000 but hospitalizations decline for a 23rd straight day","Summary":"Pfizer\u2019s Covid-19 vaccine is big business. Amazon has a $126 billion quarter, and other big news. And Impossible Foods drops its prices by 20%."},{"Date":"Feb. 4, 2021 at 8:28 a.m. ET","Headline":"U.S. COVID cases continue to fall, even with one-day death rate still above 3,000","Summary":"Pfizer\u2019s Covid-19 vaccine is big business. Amazon has a $126 billion quarter, and other big news. And Impossible Foods drops its prices by 20%."},{"Date":"Feb. 3, 2021 at 8:45 p.m. ET","Headline":"U.K. to test mixing and matching of COVID-19 vaccines","Summary":"Pfizer\u2019s Covid-19 vaccine is big business. Amazon has a $126 billion quarter, and other big news. And Impossible Foods drops its prices by 20%."},{"Date":"Feb. 3, 2021 at 7:22 p.m. ET","Headline":"A straightforward explanation why more COVID-19 vaccines can\u2019t be produced with help from \u2018dozens\u2019 of companies","Summary":"Pfizer\u2019s Covid-19 vaccine is big business. Amazon has a $126 billion quarter, and other big news. And Impossible Foods drops its prices by 20%."},{"Date":"Feb. 3, 2021 at 3:35 p.m. ET","Headline":"AstraZeneca vaccine may reduce spread by 67% \u2014 and protection remains over 3-month dosage gap","Summary":"Pfizer\u2019s Covid-19 vaccine is big business. Amazon has a $126 billion quarter, and other big news. And Impossible Foods drops its prices by 20%."},{"Date":"Feb. 3, 2021 at 3:22 p.m. ET","Headline":"Glaxo and CureVac join forces to develop vaccines targeting new COVID-19 variants","Summary":"Pfizer\u2019s Covid-19 vaccine is big business. Amazon has a $126 billion quarter, and other big news. And Impossible Foods drops its prices by 20%."},{"Date":"Feb. 3, 2021 at 1:43 p.m. ET","Headline":"As new coronavirus strains raise questions about mask quality, the N95 market in the U.S. is still facing supply issues","Summary":"Pfizer\u2019s Covid-19 vaccine is big business. Amazon has a $126 billion quarter, and other big news. And Impossible Foods drops its prices by 20%."},{"Date":"Feb. 3, 2021 at 11:28 a.m. ET","Headline":"Lifted by a Short Squeeze, Vaxart Stock Sinks on Lackluster Vaccine News","Summary":"Pfizer\u2019s Covid-19 vaccine is big business. Amazon has a $126 billion quarter, and other big news. And Impossible Foods drops its prices by 20%."},{"Date":"Feb. 3, 2021 at 9:11 a.m. ET","Headline":"The U.S. Scrambles to Overcome Its Vaccine Shortage","Summary":"Pfizer\u2019s Covid-19 vaccine is big business. Amazon has a $126 billion quarter, and other big news. And Impossible Foods drops its prices by 20%."},{"Date":"Feb. 3, 2021 at 9:02 a.m. ET","Headline":"GlaxoSmithKline Will Develop Next-Generation Vaccine With Biotech CureVac","Summary":"Pfizer\u2019s Covid-19 vaccine is big business. Amazon has a $126 billion quarter, and other big news. And Impossible Foods drops its prices by 20%."},{"Date":"Feb. 3, 2021 at 8:16 a.m. ET","Headline":"Bezos Is Stepping Down as Amazon CEO. Here\u2019s What He Achieved Over 26 Years.","Summary":"Pfizer\u2019s Covid-19 vaccine is big business. Amazon has a $126 billion quarter, and other big news. And Impossible Foods drops its prices by 20%."},{"Date":"Feb. 3, 2021 at 5:00 a.m. ET","Headline":"Amazon Had a $126 Billion Quarter, and Two More Numbers to Know","Summary":"Pfizer\u2019s Covid-19 vaccine is big business. Amazon has a $126 billion quarter, and other big news. And Impossible Foods drops its prices by 20%."},{"Date":"Jan. 23, 2021 at 10:52 a.m. ET","Headline":"\u2018Just because we\u2019re undocumented does not mean we\u2019re worth less than other people\u2019: Will undocumented immigrants get COVID-19 vaccines under Biden?","Summary":""},{"Date":"Dec. 18, 2020 at 12:01 a.m. ET","Headline":"The Stock Market Could Gain Another 10% Next Year, Experts Say","Summary":""},{"Date":"Feb. 5, 2021 at 3:55 p.m. ET","Headline":"COVID-19 hotel quarantine from high-risk countries to start in U.K. from Feb. 15","Summary":"A Food and Drug Administration advisory committee is now scheduled to meet Feb. 26 for an all-day meeting to discuss Johnson & Johnson's  COVID-19 vaccine candidate. This is the next step in the regulatory process after J&..."},{"Date":"Feb. 5, 2021 at 3:42 p.m. ET","Headline":"These early BioNTech investors just saw their faith rewarded with a $719 million payday","Summary":"A Food and Drug Administration advisory committee is now scheduled to meet Feb. 26 for an all-day meeting to discuss Johnson & Johnson's  COVID-19 vaccine candidate. This is the next step in the regulatory process after J&..."},{"Date":"Feb. 5, 2021 at 3:33 p.m. ET","Headline":"Sanofi Ramps Up Cost-Cutting to Fund Drug Pipeline as Earnings Beat Estimates. The Stock Is Rising.","Summary":"A Food and Drug Administration advisory committee is now scheduled to meet Feb. 26 for an all-day meeting to discuss Johnson & Johnson's  COVID-19 vaccine candidate. This is the next step in the regulatory process after J&..."},{"Date":"Feb. 5, 2021 at 2:39 p.m. ET","Headline":"J&J\u2019s COVID-19 vaccine candidate sparks hopes for faster recovery, just as daily deaths spike above 5,000 in the U.S.","Summary":"A Food and Drug Administration advisory committee is now scheduled to meet Feb. 26 for an all-day meeting to discuss Johnson & Johnson's  COVID-19 vaccine candidate. This is the next step in the regulatory process after J&..."},{"Date":"Feb. 5, 2021 at 1:29 p.m. ET","Headline":"How soon will New York vaccinate its prisoners?","Summary":"A Food and Drug Administration advisory committee is now scheduled to meet Feb. 26 for an all-day meeting to discuss Johnson & Johnson's  COVID-19 vaccine candidate. This is the next step in the regulatory process after J&..."},{"Date":"Feb. 5, 2021 at 12:55 p.m. ET","Headline":"U.S. aims to spur development of 61 million at-home COVID-19 tests","Summary":"A Food and Drug Administration advisory committee is now scheduled to meet Feb. 26 for an all-day meeting to discuss Johnson & Johnson's  COVID-19 vaccine candidate. This is the next step in the regulatory process after J&..."},{"Date":"Feb. 5, 2021 at 7:31 a.m. ET","Headline":"FDA schedules advisory committee for J&J's COVID-19 vaccine candidate for Feb. 26","Summary":"A Food and Drug Administration advisory committee is now scheduled to meet Feb. 26 for an all-day meeting to discuss Johnson & Johnson's  COVID-19 vaccine candidate. This is the next step in the regulatory process after J&..."},{"Date":"Feb. 8, 2021 at 2:32 p.m. ET","Headline":"U.S. COVID case tally tops 27 million, while South Africa abandons AstraZeneca vaccine","Summary":""},{"Date":"Feb. 8, 2021 at 12:30 p.m. ET","Headline":"The 30-Year Treasury Just Hit 2%. When Will Yields Start Hurting the Stock Market?","Summary":""},{"Date":"Feb. 8, 2021 at 12:10 p.m. ET","Headline":"Despite \u2018positive trend\u2019 of fewer COVID-19 cases, health officials urge patience","Summary":""},{"Date":"Feb. 8, 2021 at 8:19 a.m. ET","Headline":"Another EV Stock Is Coming to Market. What It Means for Oil Investors.","Summary":""},{"Date":"Feb. 10, 2021 at 2:34 p.m. ET","Headline":"WHO team member hits back at criticism of Wuhan mission as global COVID tally tops 107 million","Summary":"COVID-19 vaccine maker BioNTech  has started production at a new site in Germany, in a move that will help alleviate a shortage of supplies of the shot it has developed with Pfizer . The factory will produce mRNA, the acti..."},{"Date":"Feb. 10, 2021 at 2:18 p.m. ET","Headline":"CDC: Double masking is more likely to protect against the coronavirus","Summary":"COVID-19 vaccine maker BioNTech  has started production at a new site in Germany, in a move that will help alleviate a shortage of supplies of the shot it has developed with Pfizer . The factory will produce mRNA, the acti..."},{"Date":"Feb. 10, 2021 at 1:52 p.m. ET","Headline":"This chart shows stock-market investors are dashing to trash","Summary":"COVID-19 vaccine maker BioNTech  has started production at a new site in Germany, in a move that will help alleviate a shortage of supplies of the shot it has developed with Pfizer . The factory will produce mRNA, the acti..."},{"Date":"Feb. 10, 2021 at 9:41 a.m. ET","Headline":"BioNTech starts COVID vaccine production at new German site, boosting EU supplies","Summary":"COVID-19 vaccine maker BioNTech  has started production at a new site in Germany, in a move that will help alleviate a shortage of supplies of the shot it has developed with Pfizer . The factory will produce mRNA, the acti..."},{"Date":"Feb. 10, 2021 at 8:23 a.m. ET","Headline":"Twitter Earnings Show There Is Life After Trump","Summary":""},{"Date":"Feb. 10, 2021 at 8:05 a.m. ET","Headline":"Annual Covid-19 Boosters May Be Needed, J&J CEO Says","Summary":""},{"Date":"Feb. 9, 2021 at 1:51 p.m. ET","Headline":"WHO team says coronavirus jumped to humans from an animal, as global case tally tops 106.5 million","Summary":""},{"Date":"Feb. 9, 2021 at 1:33 p.m. ET","Headline":"Sanofi CEO on the Future of Messenger RNA Vaccines \u2014 and His Company","Summary":""},{"Date":"Feb. 9, 2021 at 12:38 p.m. ET","Headline":"Travel giant TUI bets on summer vacations as COVID-19 vaccines boost a surge in bookings","Summary":""},{"Date":"Feb. 9, 2021 at 11:49 a.m. ET","Headline":"AstraZeneca COVID-19 vaccine concerns shrugged off by U.K. and Australia","Summary":""},{"Date":"Feb. 9, 2021 at 7:00 a.m. ET","Headline":"Large-Cap Value Stocks Could Be Long-Term Winners. Think MetLife and Coca-Cola.","Summary":""},{"Date":"Feb. 12, 2021 at 4:24 p.m. ET","Headline":"Trump Defense Rests Case at Senate Impeachment Trial","Summary":"BioNTech SE's  stock was down 0.3% and shares of Pfizer Inc.  were up 0.1% in premarket trading on Friday after the companies said the U.S. now plans to purchase an additional 100 million doses of its COVID-19 vaccine for ..."},{"Date":"Feb. 12, 2021 at 2:59 p.m. ET","Headline":"A majority in the U.S. personally know somebody who has been vaccinated against COVID-19","Summary":"BioNTech SE's  stock was down 0.3% and shares of Pfizer Inc.  were up 0.1% in premarket trading on Friday after the companies said the U.S. now plans to purchase an additional 100 million doses of its COVID-19 vaccine for ..."},{"Date":"Feb. 12, 2021 at 2:50 p.m. ET","Headline":"U.S. COVID vaccine program enters new phase as feds deliver jabs directly to drug store chains","Summary":"BioNTech SE's  stock was down 0.3% and shares of Pfizer Inc.  were up 0.1% in premarket trading on Friday after the companies said the U.S. now plans to purchase an additional 100 million doses of its COVID-19 vaccine for ..."},{"Date":"Feb. 12, 2021 at 8:56 a.m. ET","Headline":"U.S. orders another 100 million doses of the BioNTech\/Pfizer COVID-19 vaccine","Summary":"BioNTech SE's  stock was down 0.3% and shares of Pfizer Inc.  were up 0.1% in premarket trading on Friday after the companies said the U.S. now plans to purchase an additional 100 million doses of its COVID-19 vaccine for ..."},{"Date":"Feb. 12, 2021 at 8:10 a.m. ET","Headline":"The U.S. Will Be Swimming in Covid-19 Vaccines by Midsummer","Summary":"President Joe Biden on Thursday said the U.S. is on track to have enough COVID-19 vaccines for 300 million Americans by the end of July. Speaking at the National Institutes of Health, Biden said the U.S. has signed contrac..."},{"Date":"Feb. 12, 2021 at 8:08 a.m. ET","Headline":"The SEC Finally Says Enough to One Social Media-Fueled Trade","Summary":"President Joe Biden on Thursday said the U.S. is on track to have enough COVID-19 vaccines for 300 million Americans by the end of July. Speaking at the National Institutes of Health, Biden said the U.S. has signed contrac..."},{"Date":"Feb. 11, 2021 at 6:34 p.m. ET","Headline":"Biden says U.S. is ahead of pace, will have vaccines for 300 million Americans by end of July","Summary":"President Joe Biden on Thursday said the U.S. is on track to have enough COVID-19 vaccines for 300 million Americans by the end of July. Speaking at the National Institutes of Health, Biden said the U.S. has signed contrac..."},{"Date":"Feb. 11, 2021 at 4:59 p.m. ET","Headline":"Biden says U.S. on track to have enough vaccines for 300 million Americans by end of July","Summary":"President Joe Biden on Thursday said the U.S. is on track to have enough COVID-19 vaccines for 300 million Americans by the end of July. Speaking at the National Institutes of Health, Biden said the U.S. has signed contrac..."},{"Date":"Feb. 11, 2021 at 3:59 p.m. ET","Headline":"Here\u2019s the formula for spotting genuinely undervalued companies, claims this investment house","Summary":""},{"Date":"Feb. 11, 2021 at 3:52 p.m. ET","Headline":"The \u2018Growth vs. Value\u2019 Stock Dichotomy Is False, According to This Investment House. But Here\u2019s How to Pick Undervalued Stocks.","Summary":""},{"Date":"Feb. 11, 2021 at 10:25 a.m. ET","Headline":"When Will Israel\u2019s Vaccination Campaign Boost the Nation\u2019s Economy?","Summary":""},{"Date":"Feb. 11, 2021 at 8:26 a.m. ET","Headline":"Pot Stocks Are the Next GameStop. It Won\u2019t End Well.","Summary":""},{"Date":"Feb. 11, 2021 at 5:35 a.m. ET","Headline":"Promising vaccination results raise prospects for swifter economic recovery","Summary":""},{"Date":"Jan. 13, 2021 at 1:03 p.m. ET","Headline":"Want family members to get COVID-19 vaccination? Try Apple\u2019s tactic for selling AirPods \u2014 and these other psychological approaches","Summary":""},{"Date":"Feb. 13, 2021 at 1:02 p.m. ET","Headline":"How the Pandemic Is Changing the Vaccine Industry","Summary":""},{"Date":"Feb. 13, 2021 at 7:00 a.m. ET","Headline":"A Top Pension Bought More GE, Zoom, and Pfizer Stock. Here\u2019s What It Sold.","Summary":""},{"Date":"Feb. 16, 2021 at 7:41 p.m. ET","Headline":"Japan begins COVID-19 vaccinations amid supply worries","Summary":""},{"Date":"Feb. 16, 2021 at 6:26 p.m. ET","Headline":"Warren Buffett\u2019s Berkshire Hathaway Bought Verizon and Chevron. Here\u2019s What Else It Traded.","Summary":""},{"Date":"Feb. 16, 2021 at 1:24 p.m. ET","Headline":"Winter storm disrupts COVID-19 vaccine program as snow and ice force sites to temporarily close","Summary":""},{"Date":"Feb. 16, 2021 at 10:38 a.m. ET","Headline":"Biden to Push Stimulus Package in Town Hall","Summary":""},{"Date":"Feb. 16, 2021 at 8:22 a.m. ET","Headline":"A Polar Vortex Is Roiling Power Markets","Summary":""},{"Date":"Feb. 16, 2021 at 8:05 a.m. ET","Headline":"World Health Organization Authorizes AstraZeneca\u2019s Covid-19 Vaccine","Summary":""},{"Date":"Feb. 16, 2021 at 1:23 a.m. ET","Headline":"World Health Organization grants emergency authorization to AstraZeneca\u2019s COVID-19 vaccine","Summary":""},{"Date":"Feb. 15, 2021 at 12:52 p.m. ET","Headline":"Welcome home: U.K. arrivals from high-risk countries start checking in at quarantine hotels","Summary":""},{"Date":"Feb. 15, 2021 at 9:48 a.m. ET","Headline":"To speed up COVID-19 shots, Massachusetts is testing a student vaccine corps","Summary":""},{"Date":"Feb. 15, 2021 at 9:47 a.m. ET","Headline":"The U.S. is getting plenty of COVID-19 vaccines, but you still won\u2019t have a normal summer","Summary":""},{"Date":"Feb. 18, 2021 at 3:40 p.m. ET","Headline":"Yes, your employer can require you to get a COVID-19 vaccine, the EEOC says","Summary":"Pfizer Inc.  and partner BioNTech SE  said Thursday that they have commenced a clinical trial to evaluate their COVID-19 vaccine in pregnant women. The companies said the Phase 2\/3 trial will enroll 4,000 health pregnant w..."},{"Date":"Feb. 18, 2021 at 1:45 p.m. ET","Headline":"Pfizer, BioNTech have started trial to evaluate their COVID-19 vaccine in pregnant women","Summary":"Pfizer Inc.  and partner BioNTech SE  said Thursday that they have commenced a clinical trial to evaluate their COVID-19 vaccine in pregnant women. The companies said the Phase 2\/3 trial will enroll 4,000 health pregnant w..."},{"Date":"Feb. 18, 2021 at 12:07 p.m. ET","Headline":"Young, healthy adults will be paid \u00a34,500 to be deliberately infected with COVID-19 in new trial","Summary":"Retractable Technologies Inc.  said in a securities filing on Feb. 16 that it was awarded a $54.2 million contract from the federal government. to supply low dead space safety syringes. These types of syringes are used to ..."},{"Date":"Feb. 18, 2021 at 11:07 a.m. ET","Headline":"UN chief joins WHO in slamming rich countries for hogging COVID vaccines","Summary":"Retractable Technologies Inc.  said in a securities filing on Feb. 16 that it was awarded a $54.2 million contract from the federal government. to supply low dead space safety syringes. These types of syringes are used to ..."},{"Date":"Feb. 18, 2021 at 10:52 a.m. ET","Headline":"Retractable Technologies gets $54 million to supply syringes to the U.S. for COVID-19 vaccination","Summary":"Retractable Technologies Inc.  said in a securities filing on Feb. 16 that it was awarded a $54.2 million contract from the federal government. to supply low dead space safety syringes. These types of syringes are used to ..."},{"Date":"Feb. 18, 2021 at 10:18 a.m. ET","Headline":"Don\u2019t Count on an Early Surge of J&J Covid-19 Vaccines: White House","Summary":"Pfizer Inc.  and BioNTech SE  said late Wednesday its COVID-19 vaccine provided protection against the South African variant of the novel coranovirus in a lab study. The study, conducted by Pfizer and the University of Tex..."},{"Date":"Feb. 18, 2021 at 9:25 a.m. ET","Headline":"Vaccine Boosters for South African Strain Look More Likely to Be Needed","Summary":"Pfizer Inc.  and BioNTech SE  said late Wednesday its COVID-19 vaccine provided protection against the South African variant of the novel coranovirus in a lab study. The study, conducted by Pfizer and the University of Tex..."},{"Date":"Feb. 17, 2021 at 5:34 p.m. ET","Headline":"Pfizer, BioNTech COVID-19 vaccine likely to protect against South Africa strain","Summary":"Pfizer Inc.  and BioNTech SE  said late Wednesday its COVID-19 vaccine provided protection against the South African variant of the novel coranovirus in a lab study. The study, conducted by Pfizer and the University of Tex..."},{"Date":"Feb. 17, 2021 at 3:15 p.m. ET","Headline":"Looking to avoid an obscenely overpriced U.S. stock market? Here\u2019s one strategist\u2019s advice on how to ride the inflation wave","Summary":""},{"Date":"Feb. 17, 2021 at 2:34 p.m. ET","Headline":"President Joe Biden seeks to assuage concerns about pace of vaccination","Summary":""},{"Date":"Feb. 17, 2021 at 12:06 p.m. ET","Headline":"5 Affordable Biopharma Stocks With Growth Potential","Summary":""},{"Date":"Feb. 17, 2021 at 10:52 a.m. ET","Headline":"Biden to Meet With Union Leaders to Discuss Infrastructure Spending","Summary":""},{"Date":"Feb. 17, 2021 at 8:20 a.m. ET","Headline":"Bitcoin Hits $51,000. The Run Doesn\u2019t Make Sense.","Summary":""},{"Date":"Feb. 17, 2021 at 5:55 a.m. ET","Headline":"WHO and Australian approvals lift hopes for AstraZeneca vaccine","Summary":""},{"Date":"Feb. 17, 2021 at 4:59 a.m. ET","Headline":"Pfizer-BioNTech to get EU 200 million more COVID-19 shots","Summary":""},{"Date":"Feb. 20, 2021 at 5:02 p.m. ET","Headline":"Vaccine trials have underrepresented people of color for the past decade \u2014 and many failed to even report demographic data","Summary":"Both of the authorized COVID-19 vaccines in the U.S. are nearly as effective at preventing infections with SARS-CoV-2 in the real world as they were in clinical trials, according to  conducted by the Mayo Clinic and Nferen..."},{"Date":"Feb. 20, 2021 at 9:25 a.m. ET","Headline":"22 additional dividend stocks that Warren Buffett might consider buying","Summary":"Both of the authorized COVID-19 vaccines in the U.S. are nearly as effective at preventing infections with SARS-CoV-2 in the real world as they were in clinical trials, according to  conducted by the Mayo Clinic and Nferen..."},{"Date":"Feb. 19, 2021 at 5:42 p.m. ET","Headline":"Biden Says He\u2019s Open to Making His $1.9 Trillion Aid Plan \u2018Cheaper\u2019","Summary":"Both of the authorized COVID-19 vaccines in the U.S. are nearly as effective at preventing infections with SARS-CoV-2 in the real world as they were in clinical trials, according to  conducted by the Mayo Clinic and Nferen..."},{"Date":"Feb. 19, 2021 at 5:32 p.m. ET","Headline":"Blackstone Has Quietly Invested in Life Sciences for Years. Now Its Bet Could Pay Off.","Summary":"Both of the authorized COVID-19 vaccines in the U.S. are nearly as effective at preventing infections with SARS-CoV-2 in the real world as they were in clinical trials, according to  conducted by the Mayo Clinic and Nferen..."},{"Date":"Feb. 19, 2021 at 4:54 p.m. ET","Headline":"Biden says he\u2019s open to making his $1.9 trillion aid plan \u2018cheaper\u2019","Summary":"Both of the authorized COVID-19 vaccines in the U.S. are nearly as effective at preventing infections with SARS-CoV-2 in the real world as they were in clinical trials, according to  conducted by the Mayo Clinic and Nferen..."},{"Date":"Feb. 19, 2021 at 4:30 p.m. ET","Headline":"Small-Cap Stocks Rally as Bond Yields Remain Elevated","Summary":"Both of the authorized COVID-19 vaccines in the U.S. are nearly as effective at preventing infections with SARS-CoV-2 in the real world as they were in clinical trials, according to  conducted by the Mayo Clinic and Nferen..."},{"Date":"Feb. 19, 2021 at 3:33 p.m. ET","Headline":"Mayo Clinic: COVID-19 vaccines are 88.7% effective in the 'real world'","Summary":"Both of the authorized COVID-19 vaccines in the U.S. are nearly as effective at preventing infections with SARS-CoV-2 in the real world as they were in clinical trials, according to  conducted by the Mayo Clinic and Nferen..."},{"Date":"Feb. 19, 2021 at 2:53 p.m. ET","Headline":"Global case tally for COVID climbs above 110.4 million as G-7 gathers to discuss vaccine equity","Summary":"Federal health officials on Friday downplayed the real-world application of  in Israel that said one dose of BioNTech SE  and Pfizer Inc.'s  COVID-19 vaccine was 85% effective. Their vaccine, which requires two doses space..."},{"Date":"Feb. 19, 2021 at 1:58 p.m. ET","Headline":"Fauci says U.S. is sticking to two doses of the BioNTech\/Pfizer vaccine","Summary":"Federal health officials on Friday downplayed the real-world application of  in Israel that said one dose of BioNTech SE  and Pfizer Inc.'s  COVID-19 vaccine was 85% effective. Their vaccine, which requires two doses space..."},{"Date":"Feb. 19, 2021 at 10:45 a.m. ET","Headline":"Pfizer, Seeking Big Sales Of Covid-19 Vaccine, Adds to Its Lead","Summary":"Both of the authorized COVID-19 vaccines in the U.S. are nearly as effective at preventing infections with SARS-CoV-2 in the real world as they were in clinical trials, according to  conducted by the Mayo Clinic. The study..."},{"Date":"Feb. 19, 2021 at 8:59 a.m. ET","Headline":"Uber Stock Drops, Applied Materials Jumps, and Stocks Are Rising Once Again","Summary":"Both of the authorized COVID-19 vaccines in the U.S. are nearly as effective at preventing infections with SARS-CoV-2 in the real world as they were in clinical trials, according to  conducted by the Mayo Clinic. The study..."},{"Date":"Feb. 19, 2021 at 8:22 a.m. ET","Headline":"Mayo Clinic: COVID-19 vaccines are 88.7% effective in the 'real world'","Summary":"Both of the authorized COVID-19 vaccines in the U.S. are nearly as effective at preventing infections with SARS-CoV-2 in the real world as they were in clinical trials, according to  conducted by the Mayo Clinic. The study..."},{"Date":"Feb. 19, 2021 at 7:28 a.m. ET","Headline":"BioNTech, Pfizer say their COVID-19 vaccine can be stored at higher temperatures than previously thought","Summary":"Shares of Pfizer Inc.  gained 0.1% in premarket trading on Friday after the drugmaker said it is requesting a regulatory change to the storage requirements for the COVID-19 vaccine it developed with BioNTech SE . BioNTech'..."},{"Date":"Feb. 22, 2021 at 4:01 p.m. ET","Headline":"Even one dose of Pfizer vaccine reduces coronavirus-infection risk, Public Health England says","Summary":"U.S. Treasury yields rose sharply Monday, kicking off the week with a further selloff in government bonds that appeared to undercut broader risk assets."},{"Date":"Feb. 22, 2021 at 3:55 p.m. ET","Headline":"Good  Vaccine News Help Boris Johnson Lift England out of Covid Restrictions","Summary":"U.S. Treasury yields rose sharply Monday, kicking off the week with a further selloff in government bonds that appeared to undercut broader risk assets."},{"Date":"Feb. 22, 2021 at 3:53 p.m. ET","Headline":"10-year Treasury nears one-year high of 1.40% as bond selloff gathers steam","Summary":"U.S. Treasury yields rose sharply Monday, kicking off the week with a further selloff in government bonds that appeared to undercut broader risk assets."},{"Date":"Feb. 22, 2021 at 3:15 p.m. ET","Headline":"7 reasons to buy the dip in stocks as bond yields climb, strategist says","Summary":"Shares of Viatris Inc.  tumbled 11.0% in premarket trading, to pace all of the S&P 500's  decliners ahead of the open, after the pharmaceutical and health care services company provided a downbeat 2021 revenue outlook, whi..."},{"Date":"Feb. 22, 2021 at 11:37 a.m. ET","Headline":"Airline Stocks Are Surging as Another Analyst Turns Bullish","Summary":"Shares of Viatris Inc.  tumbled 11.0% in premarket trading, to pace all of the S&P 500's  decliners ahead of the open, after the pharmaceutical and health care services company provided a downbeat 2021 revenue outlook, whi..."},{"Date":"Feb. 22, 2021 at 10:34 a.m. ET","Headline":"Boris Johnson outlines road map to take England out of lockdown","Summary":"Shares of Viatris Inc.  tumbled 11.0% in premarket trading, to pace all of the S&P 500's  decliners ahead of the open, after the pharmaceutical and health care services company provided a downbeat 2021 revenue outlook, whi..."},{"Date":"Feb. 22, 2021 at 8:49 a.m. ET","Headline":"Viatris stock tumbles to pace S&P 500 losers after downbeat revenue, free cash flow outlooks","Summary":"Shares of Viatris Inc.  tumbled 11.0% in premarket trading, to pace all of the S&P 500's  decliners ahead of the open, after the pharmaceutical and health care services company provided a downbeat 2021 revenue outlook, whi..."},{"Date":"Feb. 22, 2021 at 8:17 a.m. ET","Headline":"COVID-19 is on the run \u2014 expect the pandemic to be under control by Memorial Day","Summary":"A Food and Drug Administration advisory committee is set to meet Friday to vote on whether the regulator should authorize Johnson & Johnson's  experimental single-dose COVID-19 vaccine. Shares of J&J were up 0.5% in premar..."},{"Date":"Feb. 22, 2021 at 8:13 a.m. ET","Headline":"Why Rising Inflation Expectations Are Hitting the Stock Market","Summary":"A Food and Drug Administration advisory committee is set to meet Friday to vote on whether the regulator should authorize Johnson & Johnson's  experimental single-dose COVID-19 vaccine. Shares of J&J were up 0.5% in premar..."},{"Date":"Feb. 22, 2021 at 8:01 a.m. ET","Headline":"Sanofi and GlaxoSmithKline Start Phase 2 Trial of Delayed Covid-19 Vaccine","Summary":"A Food and Drug Administration advisory committee is set to meet Friday to vote on whether the regulator should authorize Johnson & Johnson's  experimental single-dose COVID-19 vaccine. Shares of J&J were up 0.5% in premar..."},{"Date":"Feb. 22, 2021 at 7:46 a.m. ET","Headline":"FDA committee to review J&J's COVID-19 vaccine candidate this week","Summary":"A Food and Drug Administration advisory committee is set to meet Friday to vote on whether the regulator should authorize Johnson & Johnson's  experimental single-dose COVID-19 vaccine. Shares of J&J were up 0.5% in premar..."},{"Date":"Feb. 22, 2021 at 5:29 a.m. ET","Headline":"Scottish study finds up to 94% drop in COVID-19 hospitalization from vaccine use: reports","Summary":"A new study in Scotland finds a drop in hospital admissions from the use of vaccines, according to U.K. media reports.  reported that after the fourth week of getting the initial dose, the risk of hospitalization from usin..."},{"Date":"Feb. 21, 2021 at 4:57 p.m. ET","Headline":"Biden administration poised to dramatically ramp up coronavirus vaccinations","Summary":""},{"Date":"Feb. 21, 2021 at 4:27 p.m. ET","Headline":"U.K. says all adults will get first COVID-19 vaccination by July 31","Summary":""},{"Date":"Feb. 21, 2021 at 9:00 a.m. ET","Headline":"Join Us For Barron\u2019s Healthcare Investing Roundtable on Feb. 24","Summary":""},{"Date":"Feb. 24, 2021 at 6:06 p.m. ET","Headline":"How Pfizer Plans to Combat Covid-19 Variants","Summary":"Shares of Johnson & Johnson  were down 0.1% in premarket trading on Tuesday after the company said in  released in advance of a congressional hearing that it plans to deliver about 20 million doses of its COVID-19 vaccine ..."},{"Date":"Feb. 24, 2021 at 4:43 p.m. ET","Headline":"Dow Hits Record High After Powell Testifies Again","Summary":"Shares of Johnson & Johnson  were down 0.1% in premarket trading on Tuesday after the company said in  released in advance of a congressional hearing that it plans to deliver about 20 million doses of its COVID-19 vaccine ..."},{"Date":"Feb. 24, 2021 at 4:12 p.m. ET","Headline":"Moderna Ships Updated Covid-19 Vaccine to NIH for Testing","Summary":"Shares of Johnson & Johnson  were down 0.1% in premarket trading on Tuesday after the company said in  released in advance of a congressional hearing that it plans to deliver about 20 million doses of its COVID-19 vaccine ..."},{"Date":"Feb. 24, 2021 at 12:04 p.m. ET","Headline":"Global COVID cases fall for a sixth straight week as hopes for J&J vaccine are bolstered by FDA data","Summary":"Shares of Johnson & Johnson  were down 0.1% in premarket trading on Tuesday after the company said in  released in advance of a congressional hearing that it plans to deliver about 20 million doses of its COVID-19 vaccine ..."},{"Date":"Feb. 24, 2021 at 8:37 a.m. ET","Headline":"Here\u2019s One Way the GameStop Speculation Could End","Summary":"Shares of Johnson & Johnson  were down 0.1% in premarket trading on Tuesday after the company said in  released in advance of a congressional hearing that it plans to deliver about 20 million doses of its COVID-19 vaccine ..."},{"Date":"Feb. 24, 2021 at 8:25 a.m. ET","Headline":"Half of Israelis Have at Least One Dose. It\u2019s an Economic Test Case.","Summary":"Shares of Johnson & Johnson  were down 0.1% in premarket trading on Tuesday after the company said in  released in advance of a congressional hearing that it plans to deliver about 20 million doses of its COVID-19 vaccine ..."},{"Date":"Feb. 23, 2021 at 8:22 p.m. ET","Headline":"Biden focuses on climate and COVID in meeting with Canada\u2019s Trudeau","Summary":"Shares of Johnson & Johnson  were down 0.1% in premarket trading on Tuesday after the company said in  released in advance of a congressional hearing that it plans to deliver about 20 million doses of its COVID-19 vaccine ..."},{"Date":"Feb. 23, 2021 at 3:28 p.m. ET","Headline":"Airlines and travel stocks surge as U.K. sets out lockdown exit plans","Summary":"Shares of Johnson & Johnson  were down 0.1% in premarket trading on Tuesday after the company said in  released in advance of a congressional hearing that it plans to deliver about 20 million doses of its COVID-19 vaccine ..."},{"Date":"Feb. 23, 2021 at 2:25 p.m. ET","Headline":"Mutual Funds Have Gotten Off to a Strong Start. Small Caps and Value Stocks Are Leading the Way.","Summary":"Shares of Johnson & Johnson  were down 0.1% in premarket trading on Tuesday after the company said in  released in advance of a congressional hearing that it plans to deliver about 20 million doses of its COVID-19 vaccine ..."},{"Date":"Feb. 23, 2021 at 2:05 p.m. ET","Headline":"U.S. death toll atop 501,000 as Biden calls for unity, face masks and vaccination \u2018when it\u2019s your turn\u2019","Summary":"Shares of Johnson & Johnson  were down 0.1% in premarket trading on Tuesday after the company said in  released in advance of a congressional hearing that it plans to deliver about 20 million doses of its COVID-19 vaccine ..."},{"Date":"Feb. 23, 2021 at 10:55 a.m. ET","Headline":"Vaccine Makers Promise More Supply as FDA Clears Path for Faster Updates","Summary":"Shares of Johnson & Johnson  were down 0.1% in premarket trading on Tuesday after the company said in  released in advance of a congressional hearing that it plans to deliver about 20 million doses of its COVID-19 vaccine ..."},{"Date":"Feb. 23, 2021 at 10:14 a.m. ET","Headline":"Biden Marks \u2018Heartbreaking Milestone\u2019 of More Than 500,000 U.S. Coronavirus Deaths","Summary":"Shares of Johnson & Johnson  were down 0.1% in premarket trading on Tuesday after the company said in  released in advance of a congressional hearing that it plans to deliver about 20 million doses of its COVID-19 vaccine ..."},{"Date":"Feb. 23, 2021 at 8:56 a.m. ET","Headline":"J&J plans to deliver 20 million doses of its COVID-19 vaccine in the U.S. in March","Summary":"Shares of Johnson & Johnson  were down 0.1% in premarket trading on Tuesday after the company said in  released in advance of a congressional hearing that it plans to deliver about 20 million doses of its COVID-19 vaccine ..."},{"Date":"Feb. 23, 2021 at 7:30 a.m. ET","Headline":"U.S. COVID deaths top 500,000 as experts look to FDA meeting on J&J\u2019s one-dose vaccine","Summary":""},{"Date":"Feb. 23, 2021 at 7:08 a.m. ET","Headline":"COVID-19 fatalities hit 500K in the U.S. When will life return to normal? Dr. Fauci cautions, \u2018It really depends on what you mean by normality\u2019","Summary":""},{"Date":"Feb. 21, 2021 at 7:29 p.m. ET","Headline":"Futures Mostly Flat as U.S. Virus Deaths Near 500,000","Summary":""},{"Date":"Feb. 26, 2021 at 7:24 p.m. ET","Headline":"The Pandemic Tested Healthcare R&D. Now the Future Looks Bright.","Summary":"Shares of Johnson & Johnson  were up 1.3% in after-hours trading on Friday after a Food and Drug Administration advisory committee vote 22-0 in favor of the regulator authorizing the company's COVID-19 vaccine candidate. T..."},{"Date":"Feb. 26, 2021 at 5:54 p.m. ET","Headline":"FDA Committee Votes in Favor Of Johnson &  Johnson\u2019s Covid-19 Vaccine","Summary":"Shares of Johnson & Johnson  were up 1.3% in after-hours trading on Friday after a Food and Drug Administration advisory committee vote 22-0 in favor of the regulator authorizing the company's COVID-19 vaccine candidate. T..."},{"Date":"Feb. 26, 2021 at 5:08 p.m. ET","Headline":"FDA committee votes unanimously, says benefits of J&J's COVID-19 vaccine outweigh the risks","Summary":"Shares of Johnson & Johnson  were up 1.3% in after-hours trading on Friday after a Food and Drug Administration advisory committee vote 22-0 in favor of the regulator authorizing the company's COVID-19 vaccine candidate. T..."},{"Date":"Feb. 26, 2021 at 4:44 p.m. ET","Headline":"Pro wrestlers, ski instructors and Zoom shrinks: If they can get the COVID vaccine, where\u2019s mine?","Summary":"The global tally for confirmed cases of the coronavirus that causes COVID-19 climbed above 113 million on Friday,  while the death toll rose above 2.50 million. The U.S. has the highest case tally in the world at 28.4 mill..."},{"Date":"Feb. 26, 2021 at 12:45 p.m. ET","Headline":"Global COVID cases top 113 million as FDA committee meets to vote on J&J vaccine","Summary":"The global tally for confirmed cases of the coronavirus that causes COVID-19 climbed above 113 million on Friday,  while the death toll rose above 2.50 million. The U.S. has the highest case tally in the world at 28.4 mill..."},{"Date":"Feb. 26, 2021 at 8:47 a.m. ET","Headline":"An FDA Committee Meets Today to Discuss Johnson & Johnson\u2019s Vaccine. Here\u2019s What to Expect.","Summary":"The global tally for confirmed cases of the coronavirus that causes COVID-19 climbed above 113 million on Friday,  while the death toll rose above 2.50 million. The U.S. has the highest case tally in the world at 28.4 mill..."},{"Date":"Feb. 26, 2021 at 8:21 a.m. ET","Headline":"J&J\u2019s one-shot COVID-19 vaccine nears authorization as FDA has no \u2018specific safety concerns\u2019","Summary":"The global tally for confirmed cases of the coronavirus that causes COVID-19 climbed above 113 million on Friday,  while the death toll rose above 2.50 million. The U.S. has the highest case tally in the world at 28.4 mill..."},{"Date":"Feb. 26, 2021 at 6:30 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 113 million and U.S. death toll atop 508,000","Summary":"The global tally for confirmed cases of the coronavirus that causes COVID-19 climbed above 113 million on Friday,  while the death toll rose above 2.50 million. The U.S. has the highest case tally in the world at 28.4 mill..."},{"Date":"Feb. 26, 2021 at 5:00 a.m. ET","Headline":"Crude Oil Prices Rally 30% in 2021, and Two More Numbers to Know","Summary":"Pfizer and BioNTech stage a new trial to test booster Covid-19 dose. Oil producers will meet to discuss production levels. And the number of millionaires in London is on the rise."},{"Date":"Feb. 25, 2021 at 4:42 p.m. ET","Headline":"Pfizer: FDA eases ultra-low temperature requirements for COVID-19 vaccine","Summary":"Pfizer Inc.  said late Thursday the U.S. Food and Drug Administration is allowing the company \"more flexible\" storage and transportation conditions for its and BioNTech's [s:bntx] COVID-19 vaccine. The FDA will allow undil..."},{"Date":"Feb. 25, 2021 at 1:50 p.m. ET","Headline":"Positive news on COVID vaccines weighs against concerns over new variants","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday they have initiated the evaluation of a third dose of their COVID-19 vaccine, to study the effect of a booster on new SARS-CoV-2 variants. The study will draw on participants of ..."},{"Date":"Feb. 25, 2021 at 12:40 p.m. ET","Headline":"Pfizer Will Test Third Dose of Vaccine to Protect Against Variants","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday they have initiated the evaluation of a third dose of their COVID-19 vaccine, to study the effect of a booster on new SARS-CoV-2 variants. The study will draw on participants of ..."},{"Date":"Feb. 25, 2021 at 11:38 a.m. ET","Headline":"Only 50 people are known to have contracted COVID-19 more than once \u2014 but new strains have medical experts on high alert","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday they have initiated the evaluation of a third dose of their COVID-19 vaccine, to study the effect of a booster on new SARS-CoV-2 variants. The study will draw on participants of ..."},{"Date":"Feb. 25, 2021 at 10:33 a.m. ET","Headline":"Pfizer Vaccine 94% Effective Across Age Groups in Israeli Study","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday they have initiated the evaluation of a third dose of their COVID-19 vaccine, to study the effect of a booster on new SARS-CoV-2 variants. The study will draw on participants of ..."},{"Date":"Feb. 25, 2021 at 8:49 a.m. ET","Headline":"Nvidia Drops, Moderna Pops, and Stocks Are Dented By Higher Rates","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday they have initiated the evaluation of a third dose of their COVID-19 vaccine, to study the effect of a booster on new SARS-CoV-2 variants. The study will draw on participants of ..."},{"Date":"Feb. 25, 2021 at 8:13 a.m. ET","Headline":"The GameStop Music Is Playing Again. Don\u2019t Be Left Standing When It Stops.","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday they have initiated the evaluation of a third dose of their COVID-19 vaccine, to study the effect of a booster on new SARS-CoV-2 variants. The study will draw on participants of ..."},{"Date":"Feb. 25, 2021 at 7:03 a.m. ET","Headline":"Pfizer, BioNTech to test a COVID-19 vaccine booster against new SARS-CoV-2 variants","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday they have initiated the evaluation of a third dose of their COVID-19 vaccine, to study the effect of a booster on new SARS-CoV-2 variants. The study will draw on participants of ..."},{"Date":"Feb. 25, 2021 at 4:58 a.m. ET","Headline":"Ghana becomes first country to receive COVID-19 vaccine through Covax program","Summary":""},{"Date":"Feb. 28, 2021 at 6:27 p.m. ET","Headline":"CDC panel joins FDA in endorsing Johnson & Johnson COVID-19 vaccine","Summary":""},{"Date":"Feb. 27, 2021 at 8:30 p.m. ET","Headline":"FDA Issues Emergency Use Authorization for J&J Covid-19 Vaccine","Summary":""},{"Date":"Feb. 27, 2021 at 6:51 p.m. ET","Headline":"Pfizer vaccine can reduce transmission after 1 dose, new study finds","Summary":""},{"Date":"Feb. 27, 2021 at 6:46 p.m. ET","Headline":"How does the Johnson & Johnson COVID-19 vaccine compare with the Pfizer and Moderna shots?","Summary":""},{"Date":"Mar. 2, 2021 at 9:25 p.m. ET","Headline":"Biden moves up timeline for when enough vaccine doses will be available for all adults: now end of May","Summary":""},{"Date":"Mar. 2, 2021 at 3:52 p.m. ET","Headline":"Renishaw shares soar 18% as engineer puts itself up for sale","Summary":""},{"Date":"Mar. 2, 2021 at 2:36 p.m. ET","Headline":"U.S. COVID vaccine supply to be boosted by Merck helping make J&J vaccine","Summary":""},{"Date":"Mar. 2, 2021 at 10:58 a.m. ET","Headline":"Merck Will Help Make J&J\u2019s Covid-19 Vaccine, Washington Post Reports","Summary":""},{"Date":"Mar. 2, 2021 at 10:36 a.m. ET","Headline":"AstraZeneca\u2019s Vaccine Works in Older Adults, UK Says","Summary":""},{"Date":"Mar. 1, 2021 at 7:17 p.m. ET","Headline":"Novavax Hopes to Start Supplying Covid Shots This Spring","Summary":""},{"Date":"Mar. 1, 2021 at 4:38 p.m. ET","Headline":"FDA authorizes the first single-dose COVID-19 vaccine","Summary":""},{"Date":"Mar. 1, 2021 at 3:53 p.m. ET","Headline":"AstraZeneca Sold Its Stake in Rival Covid-19 Vaccine Maker Moderna for More Than $1 Billion","Summary":""},{"Date":"Mar. 1, 2021 at 3:41 p.m. ET","Headline":"AstraZeneca sold its stake in Moderna for more than $1 billion, as it looks to develop its own pipeline of drugs","Summary":""},{"Date":"Mar. 1, 2021 at 2:19 p.m. ET","Headline":"J&J CEO says Americans should start getting single-dose COVID vaccine within 48 hours","Summary":""},{"Date":"Mar. 1, 2021 at 10:33 a.m. ET","Headline":"These people have gotten their vaccine. Here are their tips on how to book yours","Summary":""},{"Date":"Mar. 1, 2021 at 10:27 a.m. ET","Headline":"Johnson & Johnson\u2019s Vaccine Will Start Arriving on Tuesday","Summary":""},{"Date":"Mar. 1, 2021 at 8:38 a.m. ET","Headline":"Fauci Urges Americans to Take Johnson & Johnson Vaccine Despite Concerns","Summary":""},{"Date":"Mar. 1, 2021 at 8:21 a.m. ET","Headline":"J&J\u2019s Covid-19 Vaccine Is Authorized. Here\u2019s What It Means for the Stock.","Summary":""},{"Date":"Mar. 1, 2021 at 8:09 a.m. ET","Headline":"Dr. Fauci on J&J\u2019s COVID-19 vaccine: \u2018I would have no hesitancy whatsoever to take it\u2019","Summary":""},{"Date":"Mar. 4, 2021 at 11:33 a.m. ET","Headline":"Moderna, IBM explore blockchain tech, AI to support 'smarter' management of COVID-19 vaccines","Summary":"Moderna Inc.  and International Business Machines Corp.  announced Thursday plans to work together to find technologies to support \"smarter COVID-19 vaccine management.\" The technologies the companies will explore include ..."},{"Date":"Mar. 4, 2021 at 11:20 a.m. ET","Headline":"House Passes Voting-Rights Bill in Rescheduled Vote","Summary":""},{"Date":"Mar. 4, 2021 at 10:17 a.m. ET","Headline":"Novartis Will Help Manufacture CureVac\u2019s Covid-19 Vaccine","Summary":""},{"Date":"Mar. 3, 2021 at 1:05 p.m. ET","Headline":"Single dose of AstraZeneca or Pfizer COVID-19 vaccine cuts hospitalization risk by more than 80%, study shows","Summary":""},{"Date":"Mar. 3, 2021 at 8:53 a.m. ET","Headline":"U.S. Vaccine Shortage Could Soon End With Oversupply","Summary":""},{"Date":"Mar. 3, 2021 at 8:46 a.m. ET","Headline":"Biden Says U.S. Could Have Enough Vaccine Doses for Every American in May","Summary":""},{"Date":"Mar. 5, 2021 at 9:54 a.m. ET","Headline":"In Reversal, Germany Will Give AstraZeneca\u2019s Covid-19 Vaccine to Older Adults","Summary":""},{"Date":"Mar. 8, 2021 at 5:08 p.m. ET","Headline":"Russian disinformation has a new target: vaccines made by Pfizer and other Western companies","Summary":"Federal health officials said Monday that fully vaccinated people can socialize together indoors in small groups without taking any preventative measures such as wearing a mask or social distancing if it takes place at lea..."},{"Date":"Mar. 8, 2021 at 3:54 p.m. ET","Headline":"Italy approves AstraZeneca\u2019s COVID-19 vaccine for over 65s","Summary":"Federal health officials said Monday that fully vaccinated people can socialize together indoors in small groups without taking any preventative measures such as wearing a mask or social distancing if it takes place at lea..."},{"Date":"Mar. 8, 2021 at 2:30 p.m. ET","Headline":"Russian Intelligence Services Are Meddling in the Vaccine Market, WSJ Reports","Summary":"Federal health officials said Monday that fully vaccinated people can socialize together indoors in small groups without taking any preventative measures such as wearing a mask or social distancing if it takes place at lea..."},{"Date":"Mar. 8, 2021 at 11:37 a.m. ET","Headline":"CDC says vaccinated people can gather indoors in small groups without masks","Summary":"Federal health officials said Monday that fully vaccinated people can socialize together indoors in small groups without taking any preventative measures such as wearing a mask or social distancing if it takes place at lea..."},{"Date":"Mar. 8, 2021 at 7:21 a.m. ET","Headline":"25 stocks of companies backed by rapid earnings growth as the economy reopens","Summary":""},{"Date":"Mar. 7, 2021 at 2:32 p.m. ET","Headline":"\u2018I\u2019ve been ready for this since this was declared a pandemic\u2019: J&J\u2019s one-shot COVID-19 vaccine is enticing for people who hate needles","Summary":""},{"Date":"Mar. 10, 2021 at 4:22 p.m. ET","Headline":"\u2018We want to be oversupplied\u2019: U.S. buying additional 100 million doses of J&J vaccine","Summary":"The European Commission said Wednesday that Pfizer  and BioNTech  will provide 4 million more doses of their coronavirus vaccine in the next two weeks. European Commission President Ursula von der Leyen said the doses are ..."},{"Date":"Mar. 10, 2021 at 3:36 p.m. ET","Headline":"Pfizer and BioNTech Agree to Provide 4 Million More Vaccine Doses to Europe","Summary":"The European Commission said Wednesday that Pfizer  and BioNTech  will provide 4 million more doses of their coronavirus vaccine in the next two weeks. European Commission President Ursula von der Leyen said the doses are ..."},{"Date":"Mar. 10, 2021 at 2:24 p.m. ET","Headline":"Biden to buy another 100 million doses of J&J vaccine as Alaska becomes first state to open eligibility to everyone aged 16 and over","Summary":"The European Commission said Wednesday that Pfizer  and BioNTech  will provide 4 million more doses of their coronavirus vaccine in the next two weeks. European Commission President Ursula von der Leyen said the doses are ..."},{"Date":"Mar. 10, 2021 at 8:29 a.m. ET","Headline":"BioNTech Says It Could Supply 3 Billion Doses of Its Covid-19 Vaccine Next Year","Summary":"The European Commission said Wednesday that Pfizer  and BioNTech  will provide 4 million more doses of their coronavirus vaccine in the next two weeks. European Commission President Ursula von der Leyen said the doses are ..."},{"Date":"Mar. 10, 2021 at 4:57 a.m. ET","Headline":"European Commission says Pfizer and BioNTech to supply 4 million more coronavirus vaccine doses","Summary":"The European Commission said Wednesday that Pfizer  and BioNTech  will provide 4 million more doses of their coronavirus vaccine in the next two weeks. European Commission President Ursula von der Leyen said the doses are ..."},{"Date":"Mar. 9, 2021 at 11:40 p.m. ET","Headline":"Mexico to rely heavily on Chinese COVID-19 vaccines","Summary":""},{"Date":"Mar. 9, 2021 at 3:15 p.m. ET","Headline":"This clear signal says the big tech unwind isn\u2019t done yet, according to strategist","Summary":""},{"Date":"Mar. 9, 2021 at 11:46 a.m. ET","Headline":"Why VanEck\u2019s New Meme Stocks ETF Might Not Be Reddit-Worthy","Summary":""},{"Date":"Mar. 9, 2021 at 11:42 a.m. ET","Headline":"Global tally of COVID cases tops 117 million as study finds Pfizer-BioNTech vaccine works against Brazil variant","Summary":""},{"Date":"Mar. 9, 2021 at 10:55 a.m. ET","Headline":"What can you do after you are fully vaccinated? The CDC finally has an answer","Summary":""},{"Date":"Mar. 9, 2021 at 2:19 a.m. ET","Headline":"Pfizer-BioNTech vaccine neutralizes Brazil COVID-19 variant, study shows","Summary":""},{"Date":"Mar. 12, 2021 at 2:31 p.m. ET","Headline":"Pfizer CEO compensation jumped 17% in 2020, as COVID-19 vaccine was developed but stock fell","Summary":"Pfizer Inc.'s stock  may have lost ground last year, and so far this year, while its peer group gained ground, but 2020 could still be considered a good year for the health care company, as it developed, along with its par..."},{"Date":"Mar. 12, 2021 at 11:25 a.m. ET","Headline":"World Health Organization grants emergency use authorization to Johnson & Johnson vaccine","Summary":"The World Health Organization on Friday granted emergency use authorization to the COVID-19 vaccine developed by Johnson & Johnson  and added it to its Covax program, which aims to ensure vaccine equity for lower income co..."},{"Date":"Mar. 12, 2021 at 10:32 a.m. ET","Headline":"Women account for almost 69% of side effects from Covid vaccines in Switzerland","Summary":"Pfizer Inc.  and BioNTech SE , along with the Israel Ministry of Health, said a real-world study showed \"dramatically lower\" rates of COVID-19 cases in people vaccinated with the companies' BNT162b2 vaccine. The data also ..."},{"Date":"Mar. 12, 2021 at 8:14 a.m. ET","Headline":"Biden\u2019s Message of Hope Is Hitting Tech Stocks","Summary":"Pfizer Inc.  and BioNTech SE , along with the Israel Ministry of Health, said a real-world study showed \"dramatically lower\" rates of COVID-19 cases in people vaccinated with the companies' BNT162b2 vaccine. The data also ..."},{"Date":"Mar. 12, 2021 at 8:12 a.m. ET","Headline":"Sanofi and Translate Bio Begin Clinical Trials of mRNA-Based Covid-19 Vaccine","Summary":"Pfizer Inc.  and BioNTech SE , along with the Israel Ministry of Health, said a real-world study showed \"dramatically lower\" rates of COVID-19 cases in people vaccinated with the companies' BNT162b2 vaccine. The data also ..."},{"Date":"Mar. 12, 2021 at 7:28 a.m. ET","Headline":"Americans debate what COVID-19 vaccine they want, but Fauci says to take what\u2019s available to you","Summary":"Pfizer Inc.  and BioNTech SE , along with the Israel Ministry of Health, said a real-world study showed \"dramatically lower\" rates of COVID-19 cases in people vaccinated with the companies' BNT162b2 vaccine. The data also ..."},{"Date":"Mar. 12, 2021 at 6:59 a.m. ET","Headline":"WHO declared a pandemic one year ago today","Summary":"Pfizer Inc.  and BioNTech SE , along with the Israel Ministry of Health, said a real-world study showed \"dramatically lower\" rates of COVID-19 cases in people vaccinated with the companies' BNT162b2 vaccine. The data also ..."},{"Date":"Mar. 12, 2021 at 1:13 a.m. ET","Headline":"Flower shows and soccer matches will be the hottest post-pandemic events this summer","Summary":"Pfizer Inc.  and BioNTech SE , along with the Israel Ministry of Health, said a real-world study showed \"dramatically lower\" rates of COVID-19 cases in people vaccinated with the companies' BNT162b2 vaccine. The data also ..."},{"Date":"Mar. 11, 2021 at 8:32 p.m. ET","Headline":"\u2018Mask up, America!\u2019 Texas abandons COVID-19 mask mandate \u2014 health experts say that\u2019s a really, really bad idea","Summary":"Pfizer Inc.  and BioNTech SE , along with the Israel Ministry of Health, said a real-world study showed \"dramatically lower\" rates of COVID-19 cases in people vaccinated with the companies' BNT162b2 vaccine. The data also ..."},{"Date":"Mar. 11, 2021 at 8:30 p.m. ET","Headline":"India Wants to Copy American Vaccines. Biden Shouldn\u2019t Fall For It.","Summary":"Pfizer Inc.  and BioNTech SE , along with the Israel Ministry of Health, said a real-world study showed \"dramatically lower\" rates of COVID-19 cases in people vaccinated with the companies' BNT162b2 vaccine. The data also ..."},{"Date":"Mar. 11, 2021 at 12:58 p.m. ET","Headline":"Brazil\u2019s Covid-19 Crisis Could Pose Trouble for a Global Travel Recovery. Here\u2019s Why.","Summary":"Pfizer Inc.  and BioNTech SE , along with the Israel Ministry of Health, said a real-world study showed \"dramatically lower\" rates of COVID-19 cases in people vaccinated with the companies' BNT162b2 vaccine. The data also ..."},{"Date":"Mar. 11, 2021 at 10:21 a.m. ET","Headline":"Moderna Doses First Subject in Covid-19 Booster Vaccine Trial, and Its Stock Is Rising","Summary":"Pfizer Inc.  and BioNTech SE , along with the Israel Ministry of Health, said a real-world study showed \"dramatically lower\" rates of COVID-19 cases in people vaccinated with the companies' BNT162b2 vaccine. The data also ..."},{"Date":"Mar. 11, 2021 at 6:56 a.m. ET","Headline":"Pfizer, BioNTech real-world study shows COVID-19 vaccine 'dramatically' lowers cases, hospitalizations and deaths","Summary":"Pfizer Inc.  and BioNTech SE , along with the Israel Ministry of Health, said a real-world study showed \"dramatically lower\" rates of COVID-19 cases in people vaccinated with the companies' BNT162b2 vaccine. The data also ..."},{"Date":"Mar. 13, 2021 at 5:26 p.m. ET","Headline":"\u2018We are weary\u2019: Life in Italy, one year after national lockdown to stop the spread of COVID-19","Summary":""},{"Date":"Mar. 13, 2021 at 2:26 p.m. ET","Headline":"The backlash against Johnson & Johnson\u2019s COVID-19 vaccine is real and risky \u2014 here\u2019s exactly how to make the rollout a success","Summary":""},{"Date":"Mar. 13, 2021 at 1:02 p.m. ET","Headline":"Biotech stocks are a buy \u2014 especially these 18 picks","Summary":""},{"Date":"Mar. 12, 2021 at 8:43 a.m. ET","Headline":"Novavax Stock Jumps on Final Data From U.K. Vaccine Trial","Summary":""},{"Date":"Mar. 16, 2021 at 2:05 p.m. ET","Headline":"Moderna starts COVID-19 vaccine candidate testing on children, as U.S. cases and deaths tick up","Summary":"The European Commission said it's agreed to accelerate the delivery of 10 million doses from BioNTech  and Pfizer , bringing the total doses from the drugmakers to over 200 million for the second quarter. The European Comm..."},{"Date":"Mar. 16, 2021 at 7:40 a.m. ET","Headline":"Moderna Begins Testing Covid-19 Vaccine In Children","Summary":"The European Commission said it's agreed to accelerate the delivery of 10 million doses from BioNTech  and Pfizer , bringing the total doses from the drugmakers to over 200 million for the second quarter. The European Comm..."},{"Date":"Mar. 16, 2021 at 6:55 a.m. ET","Headline":"AstraZeneca Trial Data May Set Up A Buying Opportunity, Says Jefferies","Summary":"The European Commission said it's agreed to accelerate the delivery of 10 million doses from BioNTech  and Pfizer , bringing the total doses from the drugmakers to over 200 million for the second quarter. The European Comm..."},{"Date":"Mar. 16, 2021 at 6:21 a.m. ET","Headline":"European Commission to accelerate delivery of 10 million doses from Pfizer and BioNTech","Summary":"The European Commission said it's agreed to accelerate the delivery of 10 million doses from BioNTech  and Pfizer , bringing the total doses from the drugmakers to over 200 million for the second quarter. The European Comm..."},{"Date":"Mar. 15, 2021 at 4:55 p.m. ET","Headline":"AstraZeneca Defends Vaccine After More Countries Suspend Its Use Over Blood Clot Concerns","Summary":""},{"Date":"Mar. 15, 2021 at 2:58 p.m. ET","Headline":"COVID-19 cases top 120 million globally, and U.S. accounts for one-quarter of the total","Summary":""},{"Date":"Mar. 15, 2021 at 1:49 p.m. ET","Headline":"Germany and France become latest countries to halt use of AstraZeneca COVID-19 vaccine over blood clot concerns","Summary":""},{"Date":"Mar. 15, 2021 at 10:20 a.m. ET","Headline":"Is it better to just get vaccines in as many arms as possible, regardless of age or health status?","Summary":""},{"Date":"Mar. 15, 2021 at 8:43 a.m. ET","Headline":"Big Pharma Battled the Pandemic. The Stocks Are Cheap.","Summary":""},{"Date":"Mar. 18, 2021 at 2:34 p.m. ET","Headline":"U.S. in a race between vaccinations and the potential next surge, Dr. Fauci says","Summary":""},{"Date":"Mar. 18, 2021 at 11:33 a.m. ET","Headline":"Why Goldman says the AstraZeneca vaccine suspension isn\u2019t a game changer for growth","Summary":""},{"Date":"Mar. 18, 2021 at 9:38 a.m. ET","Headline":"No, an AstraZeneca Suspension Won\u2019t Derail Europe\u2019s Rebound. Here\u2019s Why.","Summary":""},{"Date":"Mar. 17, 2021 at 4:01 p.m. ET","Headline":"Amid vaccine hurdles, EU battles to save summer vacations with COVID travel pass","Summary":""},{"Date":"Mar. 17, 2021 at 3:29 p.m. ET","Headline":"COVID-19 vaccines get an endorsement from Trump, as daily U.S. deaths rise back above 1,000","Summary":""},{"Date":"Mar. 17, 2021 at 1:48 p.m. ET","Headline":"Biopharma Stocks Aren\u2019t Getting a Lot of Credit. Here Are 5 of the Most Undervalued.","Summary":""},{"Date":"Mar. 17, 2021 at 8:30 a.m. ET","Headline":"More States Open Vaccinations to All","Summary":""},{"Date":"Mar. 17, 2021 at 8:23 a.m. ET","Headline":"It\u2019s Fed Day\u2014and Tech Stocks Are Terrified","Summary":""},{"Date":"Mar. 19, 2021 at 3:05 p.m. ET","Headline":"Daily COVID-19 cases rise back above 60,000 as President Biden hails vaccination efforts","Summary":""},{"Date":"Mar. 19, 2021 at 9:52 a.m. ET","Headline":"Why Tensions on Vaccine Supplies Are Unlikely to Subside","Summary":""},{"Date":"Mar. 22, 2021 at 3:51 p.m. ET","Headline":"AstraZeneca Vaccine Found to Be Safe and 79% Effective in U.S. Trial. The Stock Is Rising.","Summary":""},{"Date":"Mar. 22, 2021 at 2:22 p.m. ET","Headline":"U.S. on track to almost triple vaccine output in March, as new variants pressure Europe and Brazil","Summary":""},{"Date":"Mar. 22, 2021 at 1:48 p.m. ET","Headline":"\u2018My pulse rate had shot up to 120 as I gasped my way into the ER\u2019: Italy resumes AstraZeneca vaccine, and tightens lockdown","Summary":""},{"Date":"Mar. 22, 2021 at 8:03 a.m. ET","Headline":"Fewer people take a \u2018wait and see\u2019 approach to COVID-19 vaccine \u2014 here\u2019s what changed their minds","Summary":""},{"Date":"Mar. 21, 2021 at 7:31 p.m. ET","Headline":"U.S. production of COVID-19 vaccine dramatically speeds up","Summary":""},{"Date":"Mar. 24, 2021 at 3:53 p.m. ET","Headline":"EU Proposes Tougher Controls on Covid-19 Vaccine Exports as Supply Dispute Deepens","Summary":"The global tally for the coronavirus-borne illness rose above 124 million on Wednesday, according to , while the death toll rose above 2.73 million. The U.S. has the highest case tally in the world at 29.9 million and the ..."},{"Date":"Mar. 24, 2021 at 1:57 p.m. ET","Headline":"EU proposes tougher controls on COVID-19 vaccine exports as supply row deepens","Summary":"The global tally for the coronavirus-borne illness rose above 124 million on Wednesday, according to , while the death toll rose above 2.73 million. The U.S. has the highest case tally in the world at 29.9 million and the ..."},{"Date":"Mar. 24, 2021 at 1:57 p.m. ET","Headline":"Global tally of COVID-19 cases tops 124 million as EU curbs vaccine exports","Summary":"The global tally for the coronavirus-borne illness rose above 124 million on Wednesday, according to , while the death toll rose above 2.73 million. The U.S. has the highest case tally in the world at 29.9 million and the ..."},{"Date":"Mar. 24, 2021 at 1:29 p.m. ET","Headline":"Fauci insists that AstraZeneca\u2019s COVID-19 vaccine candidate is \u2018good\u2019 after issue with information in company\u2019s press release","Summary":"The global tally for the coronavirus-borne illness rose above 124 million on Wednesday, according to , while the death toll rose above 2.73 million. The U.S. has the highest case tally in the world at 29.9 million and the ..."},{"Date":"Mar. 24, 2021 at 8:42 a.m. ET","Headline":"Hong Kong Halts Use of BioNTech Vaccine Over Packaging Issues","Summary":"The global tally for the coronavirus-borne illness rose above 124 million on Wednesday, according to , while the death toll rose above 2.73 million. The U.S. has the highest case tally in the world at 29.9 million and the ..."},{"Date":"Mar. 24, 2021 at 8:28 a.m. ET","Headline":"Elon Musk Says You Can Buy a Tesla With Bitcoin Now. What That Means for Investors.","Summary":"The global tally for the coronavirus-borne illness rose above 124 million on Wednesday, according to , while the death toll rose above 2.73 million. The U.S. has the highest case tally in the world at 29.9 million and the ..."},{"Date":"Mar. 24, 2021 at 6:40 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 124 million and U.S. nears 544,000 fatalities","Summary":"The global tally for the coronavirus-borne illness rose above 124 million on Wednesday, according to , while the death toll rose above 2.73 million. The U.S. has the highest case tally in the world at 29.9 million and the ..."},{"Date":"Mar. 23, 2021 at 11:08 p.m. ET","Headline":"Hong Kong suspends use of Pfizer vaccine over defective bottle lids","Summary":"Shares of Pfizer Inc.  were down 1.1% in trading on Tuesday after the drug maker said it initiated a Phase 1 clinical trial testing its experimental oral antiviral as a COVID-19 treatment. The early-stage study, which is b..."},{"Date":"Mar. 23, 2021 at 3:55 p.m. ET","Headline":"AstraZeneca May Have Included \u2018Outdated Information\u2019 in Vaccine Trial, U.S. Health Agency Says","Summary":"Shares of Pfizer Inc.  were down 1.1% in trading on Tuesday after the drug maker said it initiated a Phase 1 clinical trial testing its experimental oral antiviral as a COVID-19 treatment. The early-stage study, which is b..."},{"Date":"Mar. 23, 2021 at 3:35 p.m. ET","Headline":"U.S. health agency says AstraZeneca may have included \u2018outdated information\u2019 when it released COVID-19 vaccine trial data","Summary":"Shares of Pfizer Inc.  were down 1.1% in trading on Tuesday after the drug maker said it initiated a Phase 1 clinical trial testing its experimental oral antiviral as a COVID-19 treatment. The early-stage study, which is b..."},{"Date":"Mar. 23, 2021 at 2:23 p.m. ET","Headline":"Global case tally for COVID-19 nears 124 million as U.S. health experts question AstraZeneca trial data","Summary":"Shares of Pfizer Inc.  were down 1.1% in trading on Tuesday after the drug maker said it initiated a Phase 1 clinical trial testing its experimental oral antiviral as a COVID-19 treatment. The early-stage study, which is b..."},{"Date":"Mar. 23, 2021 at 2:16 p.m. ET","Headline":"Citigroup and 5 More Lenders Poised for Gains in \u2018Bank Renaissance\u2019","Summary":"Shares of Pfizer Inc.  were down 1.1% in trading on Tuesday after the drug maker said it initiated a Phase 1 clinical trial testing its experimental oral antiviral as a COVID-19 treatment. The early-stage study, which is b..."},{"Date":"Mar. 23, 2021 at 12:42 p.m. ET","Headline":"Pfizer Will Test a Pill to Kill the Covid-19 Virus","Summary":"Shares of Pfizer Inc.  were down 1.1% in trading on Tuesday after the drug maker said it initiated a Phase 1 clinical trial testing its experimental oral antiviral as a COVID-19 treatment. The early-stage study, which is b..."},{"Date":"Mar. 23, 2021 at 12:30 p.m. ET","Headline":"Pfizer starts early-stage study of oral COVID-19 treatment","Summary":"Shares of Pfizer Inc.  were down 1.1% in trading on Tuesday after the drug maker said it initiated a Phase 1 clinical trial testing its experimental oral antiviral as a COVID-19 treatment. The early-stage study, which is b..."},{"Date":"Mar. 26, 2021 at 10:04 a.m. ET","Headline":"BioNTech's Marburg facility gets EMA approval, boosting COVID-19 vaccine production capacity by a billion doses a year","Summary":"BioNTech SE  said Friday that the European Medicines Agency (EMA) has approved its Marburg facility in Germany for the manufacture of the COVID-19 vaccine drug substance, which would boost annual vaccine production capacit..."},{"Date":"Mar. 26, 2021 at 8:38 a.m. ET","Headline":"WeWork Is Back \u2014 With a SPAC","Summary":"Corning Inc.  is planning to increase production of glass vials for COVID-19 vaccines by 50% from prior targets, after receiving more federal funding, the Wall Street Journal reported on Friday. The glass maker is now expe..."},{"Date":"Mar. 26, 2021 at 8:13 a.m. ET","Headline":"FDA Advisory Panel Says Risks Outweigh Benefits of Pfizer and Lilly\u2019s Pain Drug","Summary":"Corning Inc.  is planning to increase production of glass vials for COVID-19 vaccines by 50% from prior targets, after receiving more federal funding, the Wall Street Journal reported on Friday. The glass maker is now expe..."},{"Date":"Mar. 26, 2021 at 7:08 a.m. ET","Headline":"Corning to double production of glass vials for COVID vaccines to 150 million this year, holding 1.2 billion doses: WSJ","Summary":"Corning Inc.  is planning to increase production of glass vials for COVID-19 vaccines by 50% from prior targets, after receiving more federal funding, the Wall Street Journal reported on Friday. The glass maker is now expe..."},{"Date":"Mar. 25, 2021 at 7:49 p.m. ET","Headline":"AstraZeneca Now Says Covid-19 Vaccine Is 76% Effective in Updated Trial Data and It Plans to Seek U.S. Approval","Summary":"Pfizer Inc.  and Eli Lilly and Co.  said Thursday that a joint advisory committee of the U.S. Food and Drug Administration has voted against  their investigational tanezumab drug for the treatment of certain types of arthr..."},{"Date":"Mar. 25, 2021 at 4:12 p.m. ET","Headline":"Pfizer, Eli Lilly say experimental arthritis drug tanezumab hits FDA snag","Summary":"Pfizer Inc.  and Eli Lilly and Co.  said Thursday that a joint advisory committee of the U.S. Food and Drug Administration has voted against  their investigational tanezumab drug for the treatment of certain types of arthr..."},{"Date":"Mar. 25, 2021 at 2:45 p.m. ET","Headline":"U.S. tops 30 million confirmed cases of COVID-19 as Biden pledges $10 billion investment to expand vaccine access","Summary":"Shares of Pfizer Inc.  gained 0.2% in premarket trading on Thursday after the company said peer-reviewed research shows that Ibrance improved survival among about 1,400 breast-cancer patients when used as a first-line ther..."},{"Date":"Mar. 25, 2021 at 7:32 a.m. ET","Headline":"Pfizer says Ibrance gives more survival time to some breast-cancer patients","Summary":"Shares of Pfizer Inc.  gained 0.2% in premarket trading on Thursday after the company said peer-reviewed research shows that Ibrance improved survival among about 1,400 breast-cancer patients when used as a first-line ther..."},{"Date":"Mar. 27, 2021 at 12:07 p.m. ET","Headline":"Am I a jerk for getting a COVID-19 vaccine if I feel healthy and work from home?","Summary":""},{"Date":"Mar. 27, 2021 at 11:03 a.m. ET","Headline":"90% of CEOs say they\u2019ll want to know if employees are vaccinated \u2014 before they return to the office","Summary":""},{"Date":"Mar. 27, 2021 at 8:00 a.m. ET","Headline":"The Global Vaccine Rollout Means Heightened Corruption Risk. Here\u2019s What to Know.","Summary":""},{"Date":"Mar. 30, 2021 at 11:39 p.m. ET","Headline":"Pfizer working on freeze-dried version of COVID-19 vaccine that doesn\u2019t need ultracold storage","Summary":""},{"Date":"Mar. 30, 2021 at 2:15 p.m. ET","Headline":"Here\u2019s why Wall Street and investors aren\u2019t giddy enough, says top strategist","Summary":""},{"Date":"Mar. 30, 2021 at 1:30 p.m. ET","Headline":"50 Stocks to Trade on Rising Inflation Expectations","Summary":""},{"Date":"Mar. 30, 2021 at 11:06 a.m. ET","Headline":"CDC\u2019s Dr. Walensky makes emotional plea to Americans as COVID cases rise again","Summary":""},{"Date":"Mar. 30, 2021 at 10:41 a.m. ET","Headline":"Stocks Are Lower as Treasury Yields Rise","Summary":""},{"Date":"Mar. 30, 2021 at 10:40 a.m. ET","Headline":"After I get my COVID-19 vaccination, can I travel and socialize? Do I still need to wear my mask?","Summary":""},{"Date":"Mar. 30, 2021 at 8:11 a.m. ET","Headline":"Investing Lessons From the Archegos Saga","Summary":""},{"Date":"Mar. 30, 2021 at 7:58 a.m. ET","Headline":"BioNTech Expects $11.5 Billion in Covid-19 Vaccine Revenue","Summary":""},{"Date":"Mar. 29, 2021 at 8:15 p.m. ET","Headline":"More than a dozen states to open COVID-19 vaccines to all adults this week","Summary":""},{"Date":"Mar. 29, 2021 at 2:42 p.m. ET","Headline":"U.S. COVID death toll nears 550,000 as Dr. Birx says most could have been avoided","Summary":""},{"Date":"Mar. 29, 2021 at 10:24 a.m. ET","Headline":"New coronavirus wave threatens to overwhelm Paris hospitals","Summary":""},{"Date":"Mar. 29, 2021 at 7:25 a.m. ET","Headline":"The Value Stock Rotation Isn\u2019t Over\u2014Not by a Long Shot","Summary":""},{"Date":"Apr. 1, 2021 at 8:42 p.m. ET","Headline":"Fauci says U.S. may not even need AstraZeneca\u2019s COVID-19 vaccine: report","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a study of COVID-19 patients six months after receiving a second dose of their vaccine BNT162b2 confirmed its high efficacy and lack of serious safety concerns. Th..."},{"Date":"Apr. 1, 2021 at 3:45 p.m. ET","Headline":"Pfizer Warns EU Bureaucracy Is Holding Back Worldwide Vaccine Efforts","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a study of COVID-19 patients six months after receiving a second dose of their vaccine BNT162b2 confirmed its high efficacy and lack of serious safety concerns. Th..."},{"Date":"Apr. 1, 2021 at 2:29 p.m. ET","Headline":"Pfizer and BioNTech say their COVID-19 vaccine is safe and highly effective \u2014 including against South Africa variant","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a study of COVID-19 patients six months after receiving a second dose of their vaccine BNT162b2 confirmed its high efficacy and lack of serious safety concerns. Th..."},{"Date":"Apr. 1, 2021 at 1:24 p.m. ET","Headline":"Pfizer Trials Show Vaccine Is Effective for At Least Six Months","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a study of COVID-19 patients six months after receiving a second dose of their vaccine BNT162b2 confirmed its high efficacy and lack of serious safety concerns. Th..."},{"Date":"Apr. 1, 2021 at 8:26 a.m. ET","Headline":"Taiwan Semi Is Throwing Billions at the Chip Shortage","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a study of COVID-19 patients six months after receiving a second dose of their vaccine BNT162b2 confirmed its high efficacy and lack of serious safety concerns. Th..."},{"Date":"Apr. 1, 2021 at 7:02 a.m. ET","Headline":"Pfizer, BioNTech say study of COVID-19 patients six months after second vaccine dose proved it is safe and effective","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a study of COVID-19 patients six months after receiving a second dose of their vaccine BNT162b2 confirmed its high efficacy and lack of serious safety concerns. Th..."},{"Date":"Mar. 31, 2021 at 6:00 p.m. ET","Headline":"This simple change would eliminate much of the COVID-19 vaccination chaos","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Wednesday that a Phase 3 trial of its COVID-19 vaccine in adolescents aged 12 to 15 showed 100% efficacy and robust antibody responses, an even better result than seen in a..."},{"Date":"Mar. 31, 2021 at 4:44 p.m. ET","Headline":"S&P 500 ends at record, stocks book 4th straight quarter of gains as Biden readies $2.3 trillion infrastructure pitch","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Wednesday that a Phase 3 trial of its COVID-19 vaccine in adolescents aged 12 to 15 showed 100% efficacy and robust antibody responses, an even better result than seen in a..."},{"Date":"Mar. 31, 2021 at 1:55 p.m. ET","Headline":"Global COVID case tally climbs for fifth straight week, highlighting need to ensure vaccine equity","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Wednesday that a Phase 3 trial of its COVID-19 vaccine in adolescents aged 12 to 15 showed 100% efficacy and robust antibody responses, an even better result than seen in a..."},{"Date":"Mar. 31, 2021 at 7:56 a.m. ET","Headline":"Half of England\u2019s population has antibodies against coronavirus, says statistics agency","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Wednesday that a Phase 3 trial of its COVID-19 vaccine in adolescents aged 12 to 15 showed 100% efficacy and robust antibody responses, an even better result than seen in a..."},{"Date":"Mar. 31, 2021 at 7:53 a.m. ET","Headline":"Pfizer\u2019s Covid-19 Vaccine Is 100% Effective in Adolescents, Company Says","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Wednesday that a Phase 3 trial of its COVID-19 vaccine in adolescents aged 12 to 15 showed 100% efficacy and robust antibody responses, an even better result than seen in a..."},{"Date":"Mar. 31, 2021 at 7:35 a.m. ET","Headline":"Pfizer and BioNTech say COVID-19 vaccine was 100% effective in Phase 3 trial in adolescents","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Wednesday that a Phase 3 trial of its COVID-19 vaccine in adolescents aged 12 to 15 showed 100% efficacy and robust antibody responses, an even better result than seen in a..."},{"Date":"Mar. 31, 2021 at 7:18 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 128.3 million and U.S. death toll near 551,000","Summary":"The global tally for the coronavirus-borne illness rose above 128.3 million on Wednesday, according to , with the U.S. accounting for a quarter of that number at more than 30.3 million. The death toll rose above 2.8 millio..."},{"Date":"Apr. 2, 2021 at 6:38 p.m. ET","Headline":"\u2018It could take more than a year to dig out of the total jobs shortfall\u2019","Summary":""},{"Date":"Apr. 2, 2021 at 1:57 p.m. ET","Headline":"Global tally of COVID cases edges closer to 130 million, as Fauci says U.S. may not need AstraZeneca vaccine","Summary":""},{"Date":"Apr. 2, 2021 at 12:35 p.m. ET","Headline":"Pfizer warns EU bureaucracy is holding back worldwide vaccine efforts","Summary":""},{"Date":"Apr. 2, 2021 at 9:44 a.m. ET","Headline":"FDA Eases Storage Restrictions for Moderna\u2019s Covid-19 Vaccine","Summary":""},{"Date":"Apr. 2, 2021 at 8:14 a.m. ET","Headline":"U.S. May Not Need AstraZeneca Vaccine, Fauci Tells Reuters","Summary":""},{"Date":"Apr. 2, 2021 at 5:00 a.m. ET","Headline":"Susan Huang","Summary":""},{"Date":"Apr. 5, 2021 at 2:58 p.m. ET","Headline":"\u2018If a student chooses to come to an institution, they agree to abide by the rules\u2019: Can colleges force students to get COVID-19 vaccines?","Summary":""},{"Date":"Apr. 5, 2021 at 2:50 p.m. ET","Headline":"U.S. COVID vaccine program speeds up to about 3 million doses a day in the past week","Summary":""},{"Date":"Apr. 5, 2021 at 1:37 p.m. ET","Headline":"Pfizer Negotiating Deal to Sell More Covid-19 Vaccines to Israel","Summary":""},{"Date":"Apr. 5, 2021 at 11:53 a.m. ET","Headline":"Corporations gave over $50 million to voting restriction backers, despite executives\u2019 recent activism","Summary":""},{"Date":"Apr. 5, 2021 at 8:16 a.m. ET","Headline":"BioNTech Stock Has Surged on Covid Vaccine. Its Next Big Hit Might Take a While.","Summary":""},{"Date":"Apr. 5, 2021 at 8:06 a.m. ET","Headline":"The Stock Market Gets Delayed Gratification from Jobs and Tesla","Summary":""},{"Date":"Apr. 5, 2021 at 7:42 a.m. ET","Headline":"CDC offers travel advice to vaccinated Americans \u2014 but stops short of saying it\u2019s OK to get on a plane","Summary":""},{"Date":"Apr. 4, 2021 at 6:27 p.m. ET","Headline":"Futures Rise on Strong Jobs Report, Amazon Apologizes for Tweet","Summary":""},{"Date":"Apr. 7, 2021 at 1:50 p.m. ET","Headline":"CDC says now-dominant variant poses risk even with nearly 20% of U.S. fully vaccinated","Summary":"The National Institutes of Health said Wednesday that it started a  assessing allergic reactions to the mRNA COVID-19 vaccines developed by Moderna Inc.  and BioNTech SE \/Pfizer Inc. . The aim is to understand who is at in..."},{"Date":"Apr. 7, 2021 at 11:48 a.m. ET","Headline":"EU and U.K. regulators say AstraZeneca vaccine is safe, but Brits under 30 to be offered alternative shot","Summary":"The National Institutes of Health said Wednesday that it started a  assessing allergic reactions to the mRNA COVID-19 vaccines developed by Moderna Inc.  and BioNTech SE \/Pfizer Inc. . The aim is to understand who is at in..."},{"Date":"Apr. 7, 2021 at 10:14 a.m. ET","Headline":"Pfizer\u2019s Xeljanz Faces Canadian Review Amid More Scrutiny of JAK Inhibitors","Summary":"The National Institutes of Health said Wednesday that it started a  assessing allergic reactions to the mRNA COVID-19 vaccines developed by Moderna Inc.  and BioNTech SE \/Pfizer Inc. . The aim is to understand who is at in..."},{"Date":"Apr. 7, 2021 at 10:06 a.m. ET","Headline":"U.S. government to study allergic reactions to COVID-19 vaccines","Summary":"The National Institutes of Health said Wednesday that it started a  assessing allergic reactions to the mRNA COVID-19 vaccines developed by Moderna Inc.  and BioNTech SE \/Pfizer Inc. . The aim is to understand who is at in..."},{"Date":"Apr. 7, 2021 at 8:32 a.m. ET","Headline":"Anthem to provide employees with an incentive to be fully vaccinated against COVID-19","Summary":"Anthem Inc.  said Wednesday it will provide an incentive to any of its employees who are fully vaccinated against COVID-19. The health insurer said the incentive will be in the form of a one-time credit toward medical prem..."},{"Date":"Apr. 7, 2021 at 8:01 a.m. ET","Headline":"Pfizer says FDA review time for dermatitis drug candidate has been extended","Summary":"Shares of Pfizer Inc.  were up 0.1% after the drug maker said regulators in the U.S. extended the priority review time for three months for two therapies: abrocitinib, a new treatment candidate for severe atopic dermatitis..."},{"Date":"Apr. 7, 2021 at 6:33 a.m. ET","Headline":"U.K. rollout of Moderna COVID-19 vaccine begins in Wales","Summary":"Initial doses of Moderna's  COVID-19 vaccine were being administered in Wales on Wednesday. The vaccine is the U.K.'s third to be approved for use, after the one developed jointly by BioNTech  and Pfizer  , and the one fro..."},{"Date":"Apr. 6, 2021 at 5:53 p.m. ET","Headline":"Reneo Pharmaceuticals and VectivBio Plan IPOs This Week","Summary":"Shares of Moderna Inc.  gained 5.9% in trading on Tuesday after  published in The New England Journal of Medicine indicates that the company's COVID-19 vaccine generated antibodies that extend at least six months after the..."},{"Date":"Apr. 6, 2021 at 3:02 p.m. ET","Headline":"Biden advances timeline for COVID vaccine eligibility as experts warn Americans, \u2018the war is not yet won\u2019","Summary":"Shares of Moderna Inc.  gained 5.9% in trading on Tuesday after  published in The New England Journal of Medicine indicates that the company's COVID-19 vaccine generated antibodies that extend at least six months after the..."},{"Date":"Apr. 6, 2021 at 1:14 p.m. ET","Headline":"Research letter indicates that Moderna's COVID-19 vaccine has efficacy past 6 months","Summary":"Shares of Moderna Inc.  gained 5.9% in trading on Tuesday after  published in The New England Journal of Medicine indicates that the company's COVID-19 vaccine generated antibodies that extend at least six months after the..."},{"Date":"Apr. 6, 2021 at 11:47 a.m. ET","Headline":"Planning to take a cruise this year? You may not be allowed on board without a COVID-19 vaccination","Summary":""},{"Date":"Apr. 6, 2021 at 8:28 a.m. ET","Headline":"What you need to know about COVID-19 vaccine passports \u2014 and the \u2018double privilege\u2019 dilemma they raise for society","Summary":""},{"Date":"Apr. 6, 2021 at 7:36 a.m. ET","Headline":"Should the U.S. donate COVID vaccine doses to less-wealthy countries? Some want to wait until all willing Americans can be vaccinated","Summary":""},{"Date":"Apr. 9, 2021 at 4:58 p.m. ET","Headline":"2 More Biotechs Hit the Market Today. Here\u2019s How They Did.","Summary":"Shares of Pfizer Inc.  gained 1% in trading on Friday after the drug maker said it requested that the emergency-use authorization for its COVID-19 vaccine be amended to include teens between the ages of 12 and 15. The vacc..."},{"Date":"Apr. 9, 2021 at 4:31 p.m. ET","Headline":"Dow, S&P 500 end at record highs, extend win streak to 3 weeks in a row despite inflation concerns","Summary":"Shares of Pfizer Inc.  gained 1% in trading on Friday after the drug maker said it requested that the emergency-use authorization for its COVID-19 vaccine be amended to include teens between the ages of 12 and 15. The vacc..."},{"Date":"Apr. 9, 2021 at 4:14 p.m. ET","Headline":"Will you vaccinate your kids against COVID-19 once they\u2019re eligible? Only half of U.S. parents say yes","Summary":"Shares of Pfizer Inc.  gained 1% in trading on Friday after the drug maker said it requested that the emergency-use authorization for its COVID-19 vaccine be amended to include teens between the ages of 12 and 15. The vacc..."},{"Date":"Apr. 9, 2021 at 2:28 p.m. ET","Headline":"Global COVID-19 case tally above 134 million as more countries impose restrictions on AstraZeneca vaccine","Summary":"Shares of Pfizer Inc.  gained 1% in trading on Friday after the drug maker said it requested that the emergency-use authorization for its COVID-19 vaccine be amended to include teens between the ages of 12 and 15. The vacc..."},{"Date":"Apr. 9, 2021 at 1:59 p.m. ET","Headline":"Pfizer asks FDA to expand COVID-19 vaccine authorization to include 12- to 15-year-olds","Summary":"Shares of Pfizer Inc.  gained 1% in trading on Friday after the drug maker said it requested that the emergency-use authorization for its COVID-19 vaccine be amended to include teens between the ages of 12 and 15. The vacc..."},{"Date":"Apr. 9, 2021 at 1:05 p.m. ET","Headline":"Wanna meet? Here\u2019s your QR badge\u2026Here\u2019s your temperature scan","Summary":""},{"Date":"Apr. 9, 2021 at 9:11 a.m. ET","Headline":"J&J Vaccine Dose Allocations Will Drop Next Week. It Won\u2019t Have an Immediate Effect on Availability.","Summary":""},{"Date":"Apr. 8, 2021 at 3:55 p.m. ET","Headline":"Europe\u2019s vaccine woes continue as Spain and Italy halt use of AstraZeneca shot for under-60s","Summary":""},{"Date":"Apr. 8, 2021 at 12:54 p.m. ET","Headline":"Covid-19 Vaccines Are Ramping Up. That Could Fuel Gains For Danaher Stock.","Summary":""},{"Date":"Apr. 8, 2021 at 5:49 a.m. ET","Headline":"European regulator to probe whether Russians were forced to participate in Sputnik vaccine trials: report","Summary":""},{"Date":"Apr. 10, 2021 at 10:02 a.m. ET","Headline":"There\u2019s more money to be made in stocks than in ETFs today \u2014 here\u2019s why","Summary":""},{"Date":"Apr. 13, 2021 at 7:20 p.m. ET","Headline":"J&J debt trades lower after pause of one-shot COVID-19 vaccine","Summary":"Moderna Inc.  said late Tuesday that its COVID-19 vaccine continued to show \"strong efficacy,\" including greater than 90% efficacy against cases of COVID-19 and greater than 95% against severe cases of COVID-19 in a median..."},{"Date":"Apr. 13, 2021 at 5:01 p.m. ET","Headline":"S&P 500 ends at record as stocks shake off JNJ vaccine pause and bond-yield slide","Summary":"Moderna Inc.  said late Tuesday that its COVID-19 vaccine continued to show \"strong efficacy,\" including greater than 90% efficacy against cases of COVID-19 and greater than 95% against severe cases of COVID-19 in a median..."},{"Date":"Apr. 13, 2021 at 4:59 p.m. ET","Headline":"Moderna says that it COVID-19 vaccine continues to show 'strong efficacy'","Summary":"Moderna Inc.  said late Tuesday that its COVID-19 vaccine continued to show \"strong efficacy,\" including greater than 90% efficacy against cases of COVID-19 and greater than 95% against severe cases of COVID-19 in a median..."},{"Date":"Apr. 13, 2021 at 4:00 p.m. ET","Headline":"Moderna COVID-19 vaccine rollout begins in England, giving under 30s alternative to AstraZeneca","Summary":"President Joe Biden said Tuesday the U.S. has enough vaccine \"for every single solitary American,\" in the wake of U.S. health authorities' recommendation of a pause in use of the Johnson & Johnson  COVID-19 vaccine. Regula..."},{"Date":"Apr. 13, 2021 at 3:21 p.m. ET","Headline":"Johnson & Johnson pause \u2018will not have a significant impact on our vaccination plan,\u2019 White House says","Summary":"President Joe Biden said Tuesday the U.S. has enough vaccine \"for every single solitary American,\" in the wake of U.S. health authorities' recommendation of a pause in use of the Johnson & Johnson  COVID-19 vaccine. Regula..."},{"Date":"Apr. 13, 2021 at 3:11 p.m. ET","Headline":"Biden says U.S. has enough vaccines for 'every single' American","Summary":"President Joe Biden said Tuesday the U.S. has enough vaccine \"for every single solitary American,\" in the wake of U.S. health authorities' recommendation of a pause in use of the Johnson & Johnson  COVID-19 vaccine. Regula..."},{"Date":"Apr. 13, 2021 at 11:41 a.m. ET","Headline":"The J&J Vaccine Just Got Paused. \u2018These Adverse Events Appear to Be Extremely Rare.\u2019","Summary":"Shares of Moderna Inc.  shot up 8.6% in morning trading, BioNTech SE  ran up 5.7% toward a 4-month high and Pfizer Inc.  climbed 1.1% toward a 3-month high, after U.S. health regulators paused the use of Johnson & Johnson'..."},{"Date":"Apr. 13, 2021 at 10:56 a.m. ET","Headline":"U.S. recommends pausing use of J&J\u2019s COVID-19 vaccine after reports of rare blood clots","Summary":"Shares of Moderna Inc.  shot up 8.6% in morning trading, BioNTech SE  ran up 5.7% toward a 4-month high and Pfizer Inc.  climbed 1.1% toward a 3-month high, after U.S. health regulators paused the use of Johnson & Johnson'..."},{"Date":"Apr. 13, 2021 at 10:06 a.m. ET","Headline":"Moderna, BioNTech stocks surge after regulators halt use of J&J vaccine","Summary":"Shares of Moderna Inc.  shot up 8.6% in morning trading, BioNTech SE  ran up 5.7% toward a 4-month high and Pfizer Inc.  climbed 1.1% toward a 3-month high, after U.S. health regulators paused the use of Johnson & Johnson'..."},{"Date":"Apr. 13, 2021 at 8:22 a.m. ET","Headline":"Johnson & Johnson Vaccine Paused on Blood Clot Concerns. What to Know.","Summary":""},{"Date":"Apr. 12, 2021 at 11:41 p.m. ET","Headline":"Australia has its second likely AstraZeneca vaccine blood-clot case","Summary":""},{"Date":"Apr. 12, 2021 at 10:35 p.m. ET","Headline":"Australia won\u2019t be buying Johnson & Johnson COVID-19 vaccine","Summary":""},{"Date":"Apr. 12, 2021 at 3:21 p.m. ET","Headline":"COVID-19 cases keep surging in some U.S. states, and Michigan governor continues plea for more vaccines as shots in arms hits daily record","Summary":""},{"Date":"Apr. 12, 2021 at 9:55 a.m. ET","Headline":"One Strain Better Than Others at Infecting People Dosed With Pfizer Vaccine, Study Shows","Summary":""},{"Date":"Apr. 12, 2021 at 8:50 a.m. ET","Headline":"Top official admits China\u2019s COVID-19 vaccines have low effectiveness","Summary":""},{"Date":"Apr. 15, 2021 at 5:43 p.m. ET","Headline":"Pfizer\u2019s CEO believes people will need COVID-19 vaccination shots every year","Summary":"A  found the number of people who receive blood clots after getting vaccinated with a coronavirus vaccine are about the same for those who get Pfizer  and Moderna  vaccines as they are for the AstraZeneca  vaccine that was..."},{"Date":"Apr. 15, 2021 at 5:29 p.m. ET","Headline":"Pfizer CEO Says a Covid Booster Shot Will Likely Be Needed","Summary":"A  found the number of people who receive blood clots after getting vaccinated with a coronavirus vaccine are about the same for those who get Pfizer  and Moderna  vaccines as they are for the AstraZeneca  vaccine that was..."},{"Date":"Apr. 15, 2021 at 4:31 p.m. ET","Headline":"Dow ends at record above 34,000 as U.S. recovery picks up speed","Summary":"A  found the number of people who receive blood clots after getting vaccinated with a coronavirus vaccine are about the same for those who get Pfizer  and Moderna  vaccines as they are for the AstraZeneca  vaccine that was..."},{"Date":"Apr. 15, 2021 at 2:57 p.m. ET","Headline":"Global tally of COVID-19 cases tops 138 million as CDC committee opts to extend pause on J&J vaccine","Summary":"A  found the number of people who receive blood clots after getting vaccinated with a coronavirus vaccine are about the same for those who get Pfizer  and Moderna  vaccines as they are for the AstraZeneca  vaccine that was..."},{"Date":"Apr. 15, 2021 at 12:43 p.m. ET","Headline":"When COVID hit home for NYC\u2019s health commissioner Dr. Dave Chokshi","Summary":"A  found the number of people who receive blood clots after getting vaccinated with a coronavirus vaccine are about the same for those who get Pfizer  and Moderna  vaccines as they are for the AstraZeneca  vaccine that was..."},{"Date":"Apr. 15, 2021 at 8:20 a.m. ET","Headline":"This Quarter\u2019s Earnings Were Supposed to Disappoint. They\u2019re Beating Expectations\u2014So Far.","Summary":"A  found the number of people who receive blood clots after getting vaccinated with a coronavirus vaccine are about the same for those who get Pfizer  and Moderna  vaccines as they are for the AstraZeneca  vaccine that was..."},{"Date":"Apr. 15, 2021 at 6:05 a.m. ET","Headline":"Blood clots as prevalent with Pfizer and Moderna vaccine as with AstraZeneca's: study","Summary":"A  found the number of people who receive blood clots after getting vaccinated with a coronavirus vaccine are about the same for those who get Pfizer  and Moderna  vaccines as they are for the AstraZeneca  vaccine that was..."},{"Date":"Apr. 15, 2021 at 4:50 a.m. ET","Headline":"Denmark Is First Country to Permanently Stop Use of AstraZeneca Vaccine","Summary":"The European Union has reached an agreement to speed up delivery of 50 million more doses of the BioNTech-Pfizer  COVID-19 vaccines to boost the continent's vaccination program. \"Those 50 million doses were initially fores..."},{"Date":"Apr. 15, 2021 at 4:49 a.m. ET","Headline":"Denmark becomes first country to permanently stop use of AstraZeneca vaccine","Summary":"The European Union has reached an agreement to speed up delivery of 50 million more doses of the BioNTech-Pfizer  COVID-19 vaccines to boost the continent's vaccination program. \"Those 50 million doses were initially fores..."},{"Date":"Apr. 14, 2021 at 5:43 p.m. ET","Headline":"CDC committee votes to extend the \u2018pause\u2019 for J&J\u2019s COVID-19 shot","Summary":"The European Union has reached an agreement to speed up delivery of 50 million more doses of the BioNTech-Pfizer  COVID-19 vaccines to boost the continent's vaccination program. \"Those 50 million doses were initially fores..."},{"Date":"Apr. 14, 2021 at 4:01 p.m. ET","Headline":"Moderna and Novavax added to \u2018mix and match\u2019 COVID-19 vaccine trial","Summary":"The European Union has reached an agreement to speed up delivery of 50 million more doses of the BioNTech-Pfizer  COVID-19 vaccines to boost the continent's vaccination program. \"Those 50 million doses were initially fores..."},{"Date":"Apr. 14, 2021 at 2:21 p.m. ET","Headline":"Rare blood-clotting issue dominates COVID news as Denmark scraps AstraZeneca vaccine","Summary":"The European Union has reached an agreement to speed up delivery of 50 million more doses of the BioNTech-Pfizer  COVID-19 vaccines to boost the continent's vaccination program. \"Those 50 million doses were initially fores..."},{"Date":"Apr. 14, 2021 at 11:47 a.m. ET","Headline":"Rare blood clots tied to J&J\u2019s COVID-19 shot are similar to issues with AstraZeneca\u2019s vaccine, FDA official says","Summary":"The European Union has reached an agreement to speed up delivery of 50 million more doses of the BioNTech-Pfizer  COVID-19 vaccines to boost the continent's vaccination program. \"Those 50 million doses were initially fores..."},{"Date":"Apr. 14, 2021 at 11:00 a.m. ET","Headline":"Pfizer Will Send More Vaccine Doses After J&J Pause","Summary":"The European Union has reached an agreement to speed up delivery of 50 million more doses of the BioNTech-Pfizer  COVID-19 vaccines to boost the continent's vaccination program. \"Those 50 million doses were initially fores..."},{"Date":"Apr. 14, 2021 at 8:46 a.m. ET","Headline":"EU moves up delivery for 50 million BioNTech and Pfizer COVID-19 vaccine doses","Summary":"The European Union has reached an agreement to speed up delivery of 50 million more doses of the BioNTech-Pfizer  COVID-19 vaccines to boost the continent's vaccination program. \"Those 50 million doses were initially fores..."},{"Date":"Apr. 14, 2021 at 8:24 a.m. ET","Headline":"It\u2019s a Coinbase World. JPMorgan Is Just Living in It.","Summary":""},{"Date":"Apr. 14, 2021 at 7:18 a.m. ET","Headline":"An Israeli study says a COVID-19 variant can still infect vaccinated people \u2014 here\u2019s what Fauci says the research means","Summary":""},{"Date":"Apr. 14, 2021 at 7:11 a.m. ET","Headline":"U.S. COVID vaccine program faces setback with J&J jab, as experts say there is no cause for alarm","Summary":""},{"Date":"Apr. 17, 2021 at 9:34 a.m. ET","Headline":"More than 3 million people have died of COVID-19 and more than 140 million have been infected","Summary":"The global tally for the coronavirus-borne illness rose above 139 million on Friday, according to , as the death toll climbed above 2.98 million. The U.S. leads the world in cases and deaths by wide margins, with 31.5 mill..."},{"Date":"Apr. 17, 2021 at 9:03 a.m. ET","Headline":"Getting COVID creates far higher risk of rare blood clots than vaccines, Oxford study finds","Summary":"The global tally for the coronavirus-borne illness rose above 139 million on Friday, according to , as the death toll climbed above 2.98 million. The U.S. leads the world in cases and deaths by wide margins, with 31.5 mill..."},{"Date":"Apr. 16, 2021 at 8:39 p.m. ET","Headline":"Visteon Looks Good, but Its Shares Are Too Pricey","Summary":"The global tally for the coronavirus-borne illness rose above 139 million on Friday, according to , as the death toll climbed above 2.98 million. The U.S. leads the world in cases and deaths by wide margins, with 31.5 mill..."},{"Date":"Apr. 16, 2021 at 4:44 p.m. ET","Headline":"The Dow Rose 165 Points Because Everything Came Up Roses","Summary":"The global tally for the coronavirus-borne illness rose above 139 million on Friday, according to , as the death toll climbed above 2.98 million. The U.S. leads the world in cases and deaths by wide margins, with 31.5 mill..."},{"Date":"Apr. 16, 2021 at 3:55 p.m. ET","Headline":"Norway delays decision to ditch AstraZeneca vaccine, warning it could impact J&J rollout","Summary":"The global tally for the coronavirus-borne illness rose above 139 million on Friday, according to , as the death toll climbed above 2.98 million. The U.S. leads the world in cases and deaths by wide margins, with 31.5 mill..."},{"Date":"Apr. 16, 2021 at 10:25 a.m. ET","Headline":"Moderna, Pfizer Rebuffed J&J Proposal for Joint Vaccine Safety Exam, WSJ Reports","Summary":"The global tally for the coronavirus-borne illness rose above 139 million on Friday, according to , as the death toll climbed above 2.98 million. The U.S. leads the world in cases and deaths by wide margins, with 31.5 mill..."},{"Date":"Apr. 16, 2021 at 9:23 a.m. ET","Headline":"Splunk Slips, Sunrun Rises, and Stocks Are Up","Summary":"The global tally for the coronavirus-borne illness rose above 139 million on Friday, according to , as the death toll climbed above 2.98 million. The U.S. leads the world in cases and deaths by wide margins, with 31.5 mill..."},{"Date":"Apr. 16, 2021 at 9:22 a.m. ET","Headline":"Buy Novavax Because It Could Be About to Score With J&J\u2019s Covid-19 Vaccine on the Sidelines","Summary":"The global tally for the coronavirus-borne illness rose above 139 million on Friday, according to , as the death toll climbed above 2.98 million. The U.S. leads the world in cases and deaths by wide margins, with 31.5 mill..."},{"Date":"Apr. 16, 2021 at 8:44 a.m. ET","Headline":"J&J privately asked rival COVID-19 vaccine makers to probe clotting risks","Summary":"The global tally for the coronavirus-borne illness rose above 139 million on Friday, according to , as the death toll climbed above 2.98 million. The U.S. leads the world in cases and deaths by wide margins, with 31.5 mill..."},{"Date":"Apr. 16, 2021 at 8:36 a.m. ET","Headline":"Hedge Fund Billionaire Who Shorted Lehman Brothers Says the Fed and SEC Aren\u2019t Doing Their Jobs","Summary":"The global tally for the coronavirus-borne illness rose above 139 million on Friday, according to , as the death toll climbed above 2.98 million. The U.S. leads the world in cases and deaths by wide margins, with 31.5 mill..."},{"Date":"Apr. 16, 2021 at 6:20 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 139 million and U.S. death toll is above 565,000","Summary":"The global tally for the coronavirus-borne illness rose above 139 million on Friday, according to , as the death toll climbed above 2.98 million. The U.S. leads the world in cases and deaths by wide margins, with 31.5 mill..."},{"Date":"Apr. 15, 2021 at 3:42 p.m. ET","Headline":"Covid-19 Disease Triggers More Ultra-Rare Blood Clots Than Vaccines, Study Finds","Summary":""},{"Date":"Apr. 15, 2021 at 10:06 a.m. ET","Headline":"J&J Vaccine Pause Could Boost Pfizer, Moderna Stock","Summary":""},{"Date":"Apr. 19, 2021 at 3:05 p.m. ET","Headline":"U.S. COVID-19 vaccine program meets key goal, but India cases and Brazil deaths worry experts","Summary":""},{"Date":"Apr. 19, 2021 at 1:21 p.m. ET","Headline":"Nearly 40% of Americans Have Received at Least One Covid-19 Vaccine Shot","Summary":""},{"Date":"Apr. 19, 2021 at 10:03 a.m. ET","Headline":"Biogen Stock Could Rise 85%. Two Drugs Are Critical.","Summary":""},{"Date":"Apr. 19, 2021 at 8:22 a.m. ET","Headline":"What to Know About Bitcoin\u2019s Terrible Weekend\u2014and Dogecoin\u2019s Wicked Rally","Summary":""},{"Date":"Apr. 19, 2021 at 7:54 a.m. ET","Headline":"J&J\u2019s Vaccine Pause Could Have Ripple Effects for the World","Summary":""},{"Date":"Apr. 19, 2021 at 7:23 a.m. ET","Headline":"Here\u2019s how the \u2018pause\u2019 on J&J\u2019s COVID-19 shot may or may not affect the company\u2019s earnings","Summary":""},{"Date":"Apr. 19, 2021 at 1:36 a.m. ET","Headline":"Fauci warns of COVID-19 spread in youth sports \u2014 and parents call for better enforcement of virus protocols","Summary":""},{"Date":"Apr. 19, 2021 at 1:33 a.m. ET","Headline":"What determines when Americans reclaim their \u2018liberty\u2019? Here is Dr. Fauci\u2019s answer","Summary":""},{"Date":"Apr. 19, 2021 at 1:28 a.m. ET","Headline":"The public\u2019s expectation of perfection: Risk of blood clot from Johnson & Johnson COVID-19 vaccine is 0.00009%","Summary":""},{"Date":"Apr. 18, 2021 at 6:21 p.m. ET","Headline":"Futures Fall After Bitcoin Plunge","Summary":""},{"Date":"Apr. 18, 2021 at 4:30 p.m. ET","Headline":"Half of all adults in U.S. have received at least one COVID-19 shot","Summary":""},{"Date":"Apr. 18, 2021 at 8:30 a.m. ET","Headline":"2 Biotech Start-Ups Are Searching for Cancer\u2019s Hidden Weaknesses. What to Know.","Summary":""},{"Date":"Apr. 21, 2021 at 11:55 p.m. ET","Headline":"China says it\u2019s administered 200 million COVID-19 vaccine doses so far","Summary":""},{"Date":"Apr. 21, 2021 at 5:39 p.m. ET","Headline":"Regeneron and 4 More Biopharma Stocks That Look Cheap","Summary":""},{"Date":"Apr. 21, 2021 at 2:54 p.m. ET","Headline":"India records more than 200,000 COVID cases for seventh straight day as hospitals run low on oxygen","Summary":""},{"Date":"Apr. 21, 2021 at 8:24 a.m. ET","Headline":"Pfizer says it has uncovered counterfeit COVID vaccine distribution in Poland and Mexico","Summary":""},{"Date":"Apr. 20, 2021 at 4:19 p.m. ET","Headline":"Young, healthy adults will be deliberately reinfected with COVID-19 to boost vaccine development","Summary":""},{"Date":"Apr. 20, 2021 at 2:48 p.m. ET","Headline":"Johnson & Johnson vaccine \u2018pause\u2019 isn\u2019t crimping confidence in the vaccination process, survey says","Summary":""},{"Date":"Apr. 20, 2021 at 1:31 p.m. ET","Headline":"Global tally of COVID-19 cases top 142 million as India\u2019s surge raises the alarm","Summary":""},{"Date":"Apr. 23, 2021 at 7:22 p.m. ET","Headline":"U.S. Ends Pause on Johnson & Johnson\u2019s Covid Vaccine. What to Know.","Summary":""},{"Date":"Apr. 23, 2021 at 5:38 p.m. ET","Headline":"Johnson & Johnson vaccine pause: What to know if you got or scheduled the shot","Summary":""},{"Date":"Apr. 23, 2021 at 5:06 p.m. ET","Headline":"CDC committee votes to lift pause on Johnson & Johnson COVID-19 vaccine","Summary":""},{"Date":"Apr. 23, 2021 at 1:43 p.m. ET","Headline":"CDC committee to meet on J&J COVID vaccine as India sets record case number for second straight day","Summary":""},{"Date":"Apr. 23, 2021 at 11:38 a.m. ET","Headline":"Johnson & Johnson\u2019s Covid Vaccine Faces a Make-or-Break Vote Today","Summary":""},{"Date":"Apr. 23, 2021 at 9:37 a.m. ET","Headline":"Inovio Shares Tumble After Government Pulls Funding for Covid Vaccine Trial","Summary":""},{"Date":"Apr. 22, 2021 at 7:35 p.m. ET","Headline":"California state universities to require COVID-19 vaccinations for fall","Summary":""},{"Date":"Apr. 22, 2021 at 4:00 p.m. ET","Headline":"French vaccine maker Valneva launches Phase 3 trial of its COVID-19 shot after snubbing EU","Summary":""},{"Date":"Apr. 22, 2021 at 2:47 p.m. ET","Headline":"Global COVID cases top 144 million as India breaks U.S.\u2019s daily case record","Summary":""},{"Date":"Apr. 22, 2021 at 9:23 a.m. ET","Headline":"Treating COVID-19 at home could soon be a reality in the U.K. as government steps up efforts","Summary":""},{"Date":"Apr. 22, 2021 at 8:42 a.m. ET","Headline":"Bank of America, Boeing, Pfizer, Qualcomm among companies that gave $1 million to Biden\u2019s inauguration","Summary":""},{"Date":"Apr. 21, 2021 at 3:23 p.m. ET","Headline":"Earth Day Climate Summit Starts on Thursday. Here\u2019s What to Expect.","Summary":""},{"Date":"Apr. 25, 2021 at 7:54 p.m. ET","Headline":"EU set to welcome fully vaccinated U.S. tourists this summer: report","Summary":""},{"Date":"Apr. 25, 2021 at 12:28 p.m. ET","Headline":"Ireland surpassed China in confirmed COVID-19 deaths \u2014 how on Earth did that happen?","Summary":""},{"Date":"Apr. 24, 2021 at 1:28 p.m. ET","Headline":"What we know about COVID vaccine side effects in women","Summary":""},{"Date":"Apr. 24, 2021 at 1:23 p.m. ET","Headline":"CDC and FDA lift pause, allowing Johnson & Johnson COVID-19 vaccinations to resume","Summary":""},{"Date":"Apr. 24, 2021 at 11:52 a.m. ET","Headline":"What does a strong reaction to a COVID-19 vaccine mean?","Summary":""},{"Date":"Apr. 27, 2021 at 4:49 p.m. ET","Headline":"Brazil\u2019s Senate launches probe into Bolsonaro\u2019s mismanagement of COVID-19","Summary":"The Centers for Disease Control and Prevention said Tuesday that people who are fully vaccinated no longer need to wear a mask at small outdoor gatherings with both vaccinated and unvaccinated people or when dining outdoor..."},{"Date":"Apr. 27, 2021 at 2:38 p.m. ET","Headline":"No mask required \u2018if you\u2019re fully vaccinated, and you\u2019re outdoors, and not in a big crowd,\u2019 Biden says","Summary":"The Centers for Disease Control and Prevention said Tuesday that people who are fully vaccinated no longer need to wear a mask at small outdoor gatherings with both vaccinated and unvaccinated people or when dining outdoor..."},{"Date":"Apr. 27, 2021 at 1:34 p.m. ET","Headline":"India\u2019s COVID surge is \u2018beyond heartbreaking,\u2019 says WHO director-general, as first relief supplies arrive","Summary":"The Centers for Disease Control and Prevention said Tuesday that people who are fully vaccinated no longer need to wear a mask at small outdoor gatherings with both vaccinated and unvaccinated people or when dining outdoor..."},{"Date":"Apr. 27, 2021 at 12:41 p.m. ET","Headline":"CDC: Small groups of people can gather outside without masks","Summary":"The Centers for Disease Control and Prevention said Tuesday that people who are fully vaccinated no longer need to wear a mask at small outdoor gatherings with both vaccinated and unvaccinated people or when dining outdoor..."},{"Date":"Apr. 27, 2021 at 11:10 a.m. ET","Headline":"These 5 biotech \u2018busted IPOs\u2019 look attractive now that the sectorwide selloff seems over","Summary":"Adobe Inc.  on Monday said it has inked deals with Pfizer Inc. , Walgreens Boots Alliance Inc. , Mercy Health, and others in healthcare to leverage Adobe Experience Cloud to transform their customer operations. The compani..."},{"Date":"Apr. 26, 2021 at 1:51 p.m. ET","Headline":"Biden administration to share access to U.S.\u2019s pipeline of AstraZeneca vaccine to help close global gap","Summary":"Adobe Inc.  on Monday said it has inked deals with Pfizer Inc. , Walgreens Boots Alliance Inc. , Mercy Health, and others in healthcare to leverage Adobe Experience Cloud to transform their customer operations. The compani..."},{"Date":"Apr. 26, 2021 at 1:49 p.m. ET","Headline":"India sets fresh global case record, and U.S. gears up to send oxygen, tests, treatments and PPE","Summary":"Adobe Inc.  on Monday said it has inked deals with Pfizer Inc. , Walgreens Boots Alliance Inc. , Mercy Health, and others in healthcare to leverage Adobe Experience Cloud to transform their customer operations. The compani..."},{"Date":"Apr. 26, 2021 at 12:22 p.m. ET","Headline":"Johnson & Johnson Vaccinations Resume Amid Declining U.S. Infections","Summary":"Adobe Inc.  on Monday said it has inked deals with Pfizer Inc. , Walgreens Boots Alliance Inc. , Mercy Health, and others in healthcare to leverage Adobe Experience Cloud to transform their customer operations. The compani..."},{"Date":"Apr. 26, 2021 at 10:14 a.m. ET","Headline":"Why There\u2019s Room for More Players in the Covid-19 Vaccine Market","Summary":"Adobe Inc.  on Monday said it has inked deals with Pfizer Inc. , Walgreens Boots Alliance Inc. , Mercy Health, and others in healthcare to leverage Adobe Experience Cloud to transform their customer operations. The compani..."},{"Date":"Apr. 26, 2021 at 10:03 a.m. ET","Headline":"Adobe inks cloud deals with Pfizer, Walgreens, other healthcare companies","Summary":"Adobe Inc.  on Monday said it has inked deals with Pfizer Inc. , Walgreens Boots Alliance Inc. , Mercy Health, and others in healthcare to leverage Adobe Experience Cloud to transform their customer operations. The compani..."},{"Date":"Apr. 26, 2021 at 8:52 a.m. ET","Headline":"Here\u2019s a Key Player in Covid Vaccines Whose Shares You Can\u2019t Trade\u2014Yet","Summary":"French drug maker Sanofi S.A.  has agreed to make Moderna Inc.'s  COVID-19 vaccine at its site in Ridgefield, New Jersey, and will fill and finish up to 200 million doses starting in September. Chief Executive Paul Hudson ..."},{"Date":"Apr. 26, 2021 at 8:36 a.m. ET","Headline":"Apple, Microsoft, and Exxon Report Earnings This Week. Why It\u2019s Make-or-Break for the Stock Market.","Summary":"French drug maker Sanofi S.A.  has agreed to make Moderna Inc.'s  COVID-19 vaccine at its site in Ridgefield, New Jersey, and will fill and finish up to 200 million doses starting in September. Chief Executive Paul Hudson ..."},{"Date":"Apr. 26, 2021 at 7:13 a.m. ET","Headline":"Sanofi agrees to make Moderna COVID-19 vaccine in the U.S. starting in September","Summary":"French drug maker Sanofi S.A.  has agreed to make Moderna Inc.'s  COVID-19 vaccine at its site in Ridgefield, New Jersey, and will fill and finish up to 200 million doses starting in September. Chief Executive Paul Hudson ..."},{"Date":"Apr. 26, 2021 at 6:55 a.m. ET","Headline":"Moderna Is More Than Its Covid Vaccine. Why It\u2019s Time to Buy the Stock.","Summary":""},{"Date":"Apr. 26, 2021 at 5:35 a.m. ET","Headline":"These Real Estate Stocks Still Have Room to Run","Summary":""},{"Date":"Apr. 29, 2021 at 3:51 p.m. ET","Headline":"Moderna in bid to double COVID-19 vaccine production to up to 3 billion doses in 2022","Summary":"Adults of 65 years and older are 94% less likely to be hospitalized with COVID-19 if they have been fully vaccinated with either of the two mRNA vaccines that have received emergency use authorization in the U.S.,  compare..."},{"Date":"Apr. 29, 2021 at 1:26 p.m. ET","Headline":"Moderna in Bid to Double Covid-19 Vaccine Production to up to 3 Billion Doses in 2022","Summary":"Adults of 65 years and older are 94% less likely to be hospitalized with COVID-19 if they have been fully vaccinated with either of the two mRNA vaccines that have received emergency use authorization in the U.S.,  compare..."},{"Date":"Apr. 29, 2021 at 1:12 p.m. ET","Headline":"BioNTech thinks it can submit data from coronavirus vaccine trials in 5- to 12-year-olds by July","Summary":"Adults of 65 years and older are 94% less likely to be hospitalized with COVID-19 if they have been fully vaccinated with either of the two mRNA vaccines that have received emergency use authorization in the U.S.,  compare..."},{"Date":"Apr. 29, 2021 at 12:58 p.m. ET","Headline":"India\u2019s COVID-19 crisis is a \u2018crime against humanity,\u2019 says prize-winning author as nation sets new case record","Summary":"Adults of 65 years and older are 94% less likely to be hospitalized with COVID-19 if they have been fully vaccinated with either of the two mRNA vaccines that have received emergency use authorization in the U.S.,  compare..."},{"Date":"Apr. 29, 2021 at 8:40 a.m. ET","Headline":"What Caterpillar Earnings Mean for Ford and the Chip Shortage","Summary":"Adults of 65 years and older are 94% less likely to be hospitalized with COVID-19 if they have been fully vaccinated with either of the two mRNA vaccines that have received emergency use authorization in the U.S.,  compare..."},{"Date":"Apr. 28, 2021 at 3:49 p.m. ET","Headline":"EU legal complaint against AstraZeneca heard in Brussels court","Summary":"Adults of 65 years and older are 94% less likely to be hospitalized with COVID-19 if they have been fully vaccinated with either of the two mRNA vaccines that have received emergency use authorization in the U.S.,  compare..."},{"Date":"Apr. 28, 2021 at 1:57 p.m. ET","Headline":"Fauci says world shares blame for India\u2019s COVID crisis by failing to coordinate global pandemic response","Summary":"Adults of 65 years and older are 94% less likely to be hospitalized with COVID-19 if they have been fully vaccinated with either of the two mRNA vaccines that have received emergency use authorization in the U.S.,  compare..."},{"Date":"Apr. 28, 2021 at 12:08 p.m. ET","Headline":"Older adults 94% less likely to be hospitalized with COVID after receiving Pfizer or Moderna vaccines: CDC","Summary":"Adults of 65 years and older are 94% less likely to be hospitalized with COVID-19 if they have been fully vaccinated with either of the two mRNA vaccines that have received emergency use authorization in the U.S.,  compare..."},{"Date":"Apr. 28, 2021 at 8:20 a.m. ET","Headline":"Forget the Fed. Biden\u2019s $1.8 Trillion Plan Is What Matters.","Summary":""},{"Date":"Apr. 25, 2021 at 8:28 p.m. ET","Headline":"The Big Tech Stocks Could Fall, if History Is Any Guide","Summary":""},{"Date":"May. 1, 2021 at 3:01 p.m. ET","Headline":"1 in 5 of these essential workers say they will \u2018definitely not\u2019 get the COVID vaccine","Summary":"Canada had been getting the vaccine from a Belgium site."},{"Date":"May. 1, 2021 at 2:56 p.m. ET","Headline":"Do you still need to wear a mask if you\u2019re fully vaccinated? The CDC has new advice","Summary":"Canada had been getting the vaccine from a Belgium site."},{"Date":"Apr. 30, 2021 at 3:59 p.m. ET","Headline":"\u2018Drugs from bugs\u2019 \u2014 biotech companies are mining the gut microbiome to treat difficult diseases","Summary":"Canada had been getting the vaccine from a Belgium site."},{"Date":"Apr. 30, 2021 at 2:34 p.m. ET","Headline":"India sets another COVID case record, and Brazil\u2019s health minister makes plea for vaccines","Summary":"Canada had been getting the vaccine from a Belgium site."},{"Date":"Apr. 30, 2021 at 1:57 p.m. ET","Headline":"Canada to begin getting doses of Pfizer-BioNTech vaccine from U.S. next week","Summary":"Canada had been getting the vaccine from a Belgium site."},{"Date":"Apr. 30, 2021 at 1:31 p.m. ET","Headline":"AstraZeneca reveals COVID-19 vaccine sales but that isn\u2019t why the stock is rising","Summary":""},{"Date":"Apr. 30, 2021 at 1:25 p.m. ET","Headline":"AstraZeneca Reveals Covid-19 Vaccine Sales. That Isn\u2019t Why the Stock Is Rising.","Summary":""},{"Date":"Apr. 30, 2021 at 8:57 a.m. ET","Headline":"Pfizer and BioNTech Ask EU for Covid-19 Vaccine Authorization in Adolescents","Summary":""},{"Date":"Apr. 30, 2021 at 8:24 a.m. ET","Headline":"Apple and the Rest of Big Tech Reported Blockbuster Earnings. Why Their Stocks Went Nowhere.","Summary":""},{"Date":"Apr. 30, 2021 at 8:18 a.m. ET","Headline":"Pfizer to Export U.S.-Made Vaccine Doses, Report Says","Summary":""},{"Date":"Apr. 30, 2021 at 7:58 a.m. ET","Headline":"BioNTech and Pfizer seek regulatory OK in Europe to extend vaccine authorization to 12- to 15-year-olds","Summary":""},{"Date":"May. 3, 2021 at 6:22 p.m. ET","Headline":"Pfizer COVID-19 vaccine to be approved for 12- to 15-year olds: report","Summary":""},{"Date":"May. 3, 2021 at 2:09 p.m. ET","Headline":"New Delhi court threatens to punish Indian government officials if they fail to deliver oxygen to hospitals overwhelmed by COVID cases","Summary":"Denmark, which recently discontinued use of the AstraZeneca PLC  COVID-19 vaccine over rare blood-clotting issues, said Monday it has also decided it will not use the vaccine developed by Johnson & Johnson, also due to wor..."},{"Date":"May. 3, 2021 at 1:19 p.m. ET","Headline":"Pfizer\u2019s Earnings Are Tuesday. Here\u2019s What to Expect.","Summary":"Denmark, which recently discontinued use of the AstraZeneca PLC  COVID-19 vaccine over rare blood-clotting issues, said Monday it has also decided it will not use the vaccine developed by Johnson & Johnson, also due to wor..."},{"Date":"May. 3, 2021 at 12:48 p.m. ET","Headline":"With earnings on track for best growth in more than a decade, here come Uber, Lyft and the vaccine makers","Summary":"Denmark, which recently discontinued use of the AstraZeneca PLC  COVID-19 vaccine over rare blood-clotting issues, said Monday it has also decided it will not use the vaccine developed by Johnson & Johnson, also due to wor..."},{"Date":"May. 3, 2021 at 12:24 p.m. ET","Headline":"Denmark says it won't use J&J COVID vaccine due to blood-clotting concerns","Summary":"Denmark, which recently discontinued use of the AstraZeneca PLC  COVID-19 vaccine over rare blood-clotting issues, said Monday it has also decided it will not use the vaccine developed by Johnson & Johnson, also due to wor..."},{"Date":"May. 3, 2021 at 11:13 a.m. ET","Headline":"Pfizer says it submitted application for COVID-19 vaccine to Indian regulators 'months ago'","Summary":"Shares of Pfizer Inc.  gained 2.2% in trading on Monday after the pharmaceutical company said it will donate $70 million in medicine to India, which is facing the worst surge in COVID-19 cases worldwide during the pandemic..."},{"Date":"May. 3, 2021 at 11:08 a.m. ET","Headline":"Vaccinated Tourists Can Visit Europe This Summer","Summary":""},{"Date":"May. 3, 2021 at 9:35 a.m. ET","Headline":"Uber, Pfizer, ViacomCBS, General Motors, and Other Stocks to Watch This Week","Summary":""},{"Date":"May. 3, 2021 at 8:04 a.m. ET","Headline":"Berkshire Hathaway\u2019s Munger Hates Bitcoin. Bitcoin Doesn\u2019t Care.","Summary":""},{"Date":"May. 2, 2021 at 6:39 p.m. ET","Headline":"Nearly Two-Thirds of Americans Are Optimistic About the Future Under Biden","Summary":""},{"Date":"Apr. 30, 2021 at 7:55 p.m. ET","Headline":"Spotify Has Big Growth Expectations. So Far It\u2019s Short of Proof.","Summary":""},{"Date":"May. 5, 2021 at 4:34 p.m. ET","Headline":"Dow books 22nd record close of 2021, but tech stocks slip for 4th day","Summary":"Shares of Pfizer Inc.  gained 2.5% in trading on Wednesday after Canadian regulators said they authorized using the company's COVID-19 vaccine for children between the ages of 12 and 15 years old. Pfizer developed the vacc..."},{"Date":"May. 5, 2021 at 3:35 p.m. ET","Headline":"Global COVID-19 caseload at pandemic high for second straight week, says WHO","Summary":"Shares of Pfizer Inc.  gained 2.5% in trading on Wednesday after Canadian regulators said they authorized using the company's COVID-19 vaccine for children between the ages of 12 and 15 years old. Pfizer developed the vacc..."},{"Date":"May. 5, 2021 at 3:30 p.m. ET","Headline":"Blackfeet tribe in Montana gifts surplus vaccines to neighbors in Canada","Summary":"Shares of Pfizer Inc.  gained 2.5% in trading on Wednesday after Canadian regulators said they authorized using the company's COVID-19 vaccine for children between the ages of 12 and 15 years old. Pfizer developed the vacc..."},{"Date":"May. 5, 2021 at 2:08 p.m. ET","Headline":"U.S. Birthrate Dropped 4% in 2020, Hurt By the Pandemic","Summary":"Shares of Pfizer Inc.  gained 2.5% in trading on Wednesday after Canadian regulators said they authorized using the company's COVID-19 vaccine for children between the ages of 12 and 15 years old. Pfizer developed the vacc..."},{"Date":"May. 5, 2021 at 11:42 a.m. ET","Headline":"Pfizer Will Meet Growth Goals Even Without Vaccine Sales, CFO Says","Summary":"Shares of Pfizer Inc.  gained 2.5% in trading on Wednesday after Canadian regulators said they authorized using the company's COVID-19 vaccine for children between the ages of 12 and 15 years old. Pfizer developed the vacc..."},{"Date":"May. 5, 2021 at 10:42 a.m. ET","Headline":"Canada authorizes Pfizer's COVID-19 vaccine for kids between the ages of 12 and 15 years old","Summary":"Shares of Pfizer Inc.  gained 2.5% in trading on Wednesday after Canadian regulators said they authorized using the company's COVID-19 vaccine for children between the ages of 12 and 15 years old. Pfizer developed the vacc..."},{"Date":"May. 5, 2021 at 9:12 a.m. ET","Headline":"Moderna Reports Earnings on Thursday. Here\u2019s What to Expect.","Summary":""},{"Date":"May. 5, 2021 at 8:25 a.m. ET","Headline":"General Motors Just Reported Earnings. Everything Will Be Ok.","Summary":""},{"Date":"May. 5, 2021 at 7:26 a.m. ET","Headline":"CVS banks on future gains from pediatric vaccines as hesitant adults drive recent COVID vaccination decline","Summary":""},{"Date":"May. 4, 2021 at 5:03 p.m. ET","Headline":"What happened in the stock market today? Tech sees worst day since March, Dow ekes out gain","Summary":""},{"Date":"May. 4, 2021 at 3:55 p.m. ET","Headline":"EU regulator starts \u2018rolling review\u2019 of China\u2019s Sinovac COVID-19 vaccine","Summary":""},{"Date":"May. 4, 2021 at 3:15 p.m. ET","Headline":"Sweating over stock picks? Get rid of the losers and watch your portfolio fly, says this index manager","Summary":""},{"Date":"May. 4, 2021 at 2:41 p.m. ET","Headline":"India\u2019s COVID-19 case tally tops 20 million after nearly doubling in three months","Summary":""},{"Date":"May. 4, 2021 at 1:26 p.m. ET","Headline":"EU Regulator Starts \u2018Rolling Review\u2019 of China\u2019s Sinovac Covid-19 Vaccine","Summary":""},{"Date":"May. 4, 2021 at 1:01 p.m. ET","Headline":"A Tech Rout for the Nasdaq, a Slim Gain for the Dow. What\u2019s Next.","Summary":""},{"Date":"May. 4, 2021 at 11:39 a.m. ET","Headline":"Pfizer\u2019s Covid-19 Vaccine Could Be Approved for 12- to 15-Year-Olds By Next Week","Summary":""},{"Date":"May. 4, 2021 at 10:24 a.m. ET","Headline":"Pfizer\u2019s Vaccine Drove a Big Earnings Beat. What It Means for the Stock.","Summary":""},{"Date":"May. 4, 2021 at 9:02 a.m. ET","Headline":"FTSE 100 outpaces European indexes, lifted by airlines, commodity stocks and manufacturing data","Summary":""},{"Date":"May. 7, 2021 at 7:40 p.m. ET","Headline":"The Tussle Over Covid Vaccine Patents Looks Overblown. Why Moderna and BioNTech Can Weather the Jolts.","Summary":"The World Health Organization said Friday it has listed the COVID-19 vaccine developed by China's Sinopharm for emergency use, allowing it to be rolled out across the world. The vaccine, which is made by Beijing Bio-Instit..."},{"Date":"May. 7, 2021 at 5:10 p.m. ET","Headline":"How the Dow Jones Industrial Average Performed Over the Last 100 Years","Summary":"The World Health Organization said Friday it has listed the COVID-19 vaccine developed by China's Sinopharm for emergency use, allowing it to be rolled out across the world. The vaccine, which is made by Beijing Bio-Instit..."},{"Date":"May. 7, 2021 at 4:45 p.m. ET","Headline":"Dow, S&P 500 both log new records despite weak April  jobs report","Summary":"The World Health Organization said Friday it has listed the COVID-19 vaccine developed by China's Sinopharm for emergency use, allowing it to be rolled out across the world. The vaccine, which is made by Beijing Bio-Instit..."},{"Date":"May. 7, 2021 at 3:56 p.m. ET","Headline":"Under-40s to be offered alternative COVID-19 vaccines to AstraZeneca\u2019s","Summary":"The World Health Organization said Friday it has listed the COVID-19 vaccine developed by China's Sinopharm for emergency use, allowing it to be rolled out across the world. The vaccine, which is made by Beijing Bio-Instit..."},{"Date":"May. 7, 2021 at 1:21 p.m. ET","Headline":"India sets grim record of more than 414,000 new COVID cases a single day as pressure builds on Modi for nationwide lockdown","Summary":"The World Health Organization said Friday it has listed the COVID-19 vaccine developed by China's Sinopharm for emergency use, allowing it to be rolled out across the world. The vaccine, which is made by Beijing Bio-Instit..."},{"Date":"May. 7, 2021 at 11:53 a.m. ET","Headline":"WHO grants emergency use to COVID-19 vaccine developed by China's Sinopharm","Summary":"The World Health Organization said Friday it has listed the COVID-19 vaccine developed by China's Sinopharm for emergency use, allowing it to be rolled out across the world. The vaccine, which is made by Beijing Bio-Instit..."},{"Date":"May. 7, 2021 at 9:20 a.m. ET","Headline":"Pfizer and BioNTech Ask FDA for Full Approval of Covid-19 Vaccine","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday they have initiated rolling submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration for full approval of their COVID-19 vaccin..."},{"Date":"May. 7, 2021 at 7:34 a.m. ET","Headline":"Is herd immunity a realistic concept? Fauci calls it \u2018elusive\u2019 and \u2018mystical\u2019","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday they have initiated rolling submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration for full approval of their COVID-19 vaccin..."},{"Date":"May. 7, 2021 at 7:32 a.m. ET","Headline":"Moderna\u2019s first-ever profit and billion-dollar quarter is dampened by COVID-19 vaccine patent proposal","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday they have initiated rolling submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration for full approval of their COVID-19 vaccin..."},{"Date":"May. 7, 2021 at 6:56 a.m. ET","Headline":"Pfizer and BioNTech start process of seeking full FDA approval of their COVID-19 vaccine","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday they have initiated rolling submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration for full approval of their COVID-19 vaccin..."},{"Date":"May. 7, 2021 at 4:55 a.m. ET","Headline":"Planning a Vacation This Summer? European Vaccinations Are Picking Up, Says Goldman Sachs.","Summary":""},{"Date":"May. 6, 2021 at 6:17 p.m. ET","Headline":"Pfizer and BioNTech to donate vaccine doses for athletes ahead of Tokyo Olympics in July","Summary":""},{"Date":"May. 6, 2021 at 4:32 p.m. ET","Headline":"Valneva Gains in Nasdaq  Debut as Rival Vaccine Makers Fall","Summary":""},{"Date":"May. 6, 2021 at 4:29 p.m. ET","Headline":"Dow climbs to new record ahead of monthly U.S. jobs report","Summary":""},{"Date":"May. 6, 2021 at 3:51 p.m. ET","Headline":"Pfizer beat earnings but here\u2019s why this analyst downgraded the stock to neutral","Summary":""},{"Date":"May. 6, 2021 at 2:50 p.m. ET","Headline":"Will corporate greed prolong the COVID-19 pandemic?","Summary":""},{"Date":"May. 6, 2021 at 1:15 p.m. ET","Headline":"Pfizer Beat Earnings. But Here\u2019s Why This Analyst Downgraded the Stock to Neutral.","Summary":""},{"Date":"May. 6, 2021 at 11:57 a.m. ET","Headline":"Stocks Lack Direction Despite Drop in Jobless Claims","Summary":""},{"Date":"May. 9, 2021 at 6:29 p.m. ET","Headline":"The Number of U.S. Covid-19 Deaths Are \u201cNo Doubt\u201d an Undercount, Dr. Fauci Says","Summary":""},{"Date":"May. 9, 2021 at 12:30 p.m. ET","Headline":"Biden administration set to ramp up vaccine diplomacy in drive to inoculate world against COVID-19","Summary":""},{"Date":"May. 9, 2021 at 12:23 p.m. ET","Headline":"Can you be fired for refusing to get a COVID-19 vaccine? America is about to find out","Summary":""},{"Date":"May. 8, 2021 at 6:04 p.m. ET","Headline":"COVID-19 was never going to have a tidy Hollywood ending","Summary":""},{"Date":"May. 8, 2021 at 1:46 p.m. ET","Headline":"EU agrees potential 1.8 billion-dose purchase of Pfizer jab","Summary":""},{"Date":"May. 8, 2021 at 10:43 a.m. ET","Headline":"Biden\u2019s move on vaccine patents represents blow for the second-biggest spender on Washington lobbying","Summary":""},{"Date":"May. 11, 2021 at 4:24 p.m. ET","Headline":"Tech Stocks Are Getting Hammered. Here\u2019s the Logic Behind the Rout.","Summary":"The global tally for the coronavirus-borne illness edged close to 159 million on Tuesday, according to , while the death toll rose above 3.3 million. The U.S. continues to lead the world in cases and deaths by wide margins..."},{"Date":"May. 11, 2021 at 2:48 p.m. ET","Headline":"Global cases and deaths from COVID-19 are plateauing but India\u2019s crisis continues to deepen","Summary":"The global tally for the coronavirus-borne illness edged close to 159 million on Tuesday, according to , while the death toll rose above 3.3 million. The U.S. continues to lead the world in cases and deaths by wide margins..."},{"Date":"May. 11, 2021 at 11:30 a.m. ET","Headline":"Wall Street Is Changing Its Mind on Covid Vaccine Revenues. It Now Expects Big Sales Next Year.","Summary":"The global tally for the coronavirus-borne illness edged close to 159 million on Tuesday, according to , while the death toll rose above 3.3 million. The U.S. continues to lead the world in cases and deaths by wide margins..."},{"Date":"May. 11, 2021 at 9:56 a.m. ET","Headline":"Can schools require teens to get a COVID-19 vaccine?","Summary":"The global tally for the coronavirus-borne illness edged close to 159 million on Tuesday, according to , while the death toll rose above 3.3 million. The U.S. continues to lead the world in cases and deaths by wide margins..."},{"Date":"May. 11, 2021 at 6:23 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 near 159 million and death toll above 3.3 million","Summary":"The global tally for the coronavirus-borne illness edged close to 159 million on Tuesday, according to , while the death toll rose above 3.3 million. The U.S. continues to lead the world in cases and deaths by wide margins..."},{"Date":"May. 10, 2021 at 6:21 p.m. ET","Headline":"FDA Clears Way for Use of Pfizer-BioNTech\u2019s Covid Vaccine in Adolescents","Summary":"The U.S. Food and Drug Administration late Monday authorized the emergency use of Pfizer Inc.  and BioNTech SE  COVID-19 vacccine for children between the ages of 12 and 15. Acting FDA commissioner Janet Woodcock called th..."},{"Date":"May. 10, 2021 at 5:24 p.m. ET","Headline":"FDA authorizes emergency use of Pfizer, BioNTech COVID vaccine to kids 12-15","Summary":"The U.S. Food and Drug Administration late Monday authorized the emergency use of Pfizer Inc.  and BioNTech SE  COVID-19 vacccine for children between the ages of 12 and 15. Acting FDA commissioner Janet Woodcock called th..."},{"Date":"May. 10, 2021 at 5:18 p.m. ET","Headline":"Dow ends lower for first time in 6 sessions after topping 35,000 milestone, and social-media stocks weigh on Nasdaq","Summary":"The Food and Drug Administration advisory committee plans to hold a  on June 10 to discuss authorizing COVID-19 vaccines for use in pediatric populations. Pfizer Inc.'s  is the only authorized vaccine that is available to ..."},{"Date":"May. 10, 2021 at 3:56 p.m. ET","Headline":"EU won\u2019t renew AstraZeneca COVID-19 vaccine; Pfizer shot will take precedence","Summary":"The Food and Drug Administration advisory committee plans to hold a  on June 10 to discuss authorizing COVID-19 vaccines for use in pediatric populations. Pfizer Inc.'s  is the only authorized vaccine that is available to ..."},{"Date":"May. 10, 2021 at 3:55 p.m. ET","Headline":"AstraZeneca CEO\u2019s pay package contested by investors","Summary":"The Food and Drug Administration advisory committee plans to hold a  on June 10 to discuss authorizing COVID-19 vaccines for use in pediatric populations. Pfizer Inc.'s  is the only authorized vaccine that is available to ..."},{"Date":"May. 10, 2021 at 3:30 p.m. ET","Headline":"BioNTech shares soar 7% as COVID-19 vaccines help revenues smash estimates","Summary":"The Food and Drug Administration advisory committee plans to hold a  on June 10 to discuss authorizing COVID-19 vaccines for use in pediatric populations. Pfizer Inc.'s  is the only authorized vaccine that is available to ..."},{"Date":"May. 10, 2021 at 2:43 p.m. ET","Headline":"India\u2019s COVID crisis deepens, as BioNTech says there\u2019s no evidence its vaccine needs adapting to cope with new variants","Summary":"The Food and Drug Administration advisory committee plans to hold a  on June 10 to discuss authorizing COVID-19 vaccines for use in pediatric populations. Pfizer Inc.'s  is the only authorized vaccine that is available to ..."},{"Date":"May. 10, 2021 at 1:31 p.m. ET","Headline":"FDA committee to hold meeting about COVID-19 vaccines for children in June","Summary":"The Food and Drug Administration advisory committee plans to hold a  on June 10 to discuss authorizing COVID-19 vaccines for use in pediatric populations. Pfizer Inc.'s  is the only authorized vaccine that is available to ..."},{"Date":"May. 10, 2021 at 10:12 a.m. ET","Headline":"What BioNTech\u2019s Earnings Mean for the Drug Makers","Summary":"Norway should exclude the COVID-19 vaccines made by AstraZeneca  and Johnson & Johnson  from its immunization program, due to a small risk of rare but serious side effects, a panel of health experts commissioned by the gov..."},{"Date":"May. 10, 2021 at 8:26 a.m. ET","Headline":"Copper and Other Metals Are the New Bitcoin. Here\u2019s Why.","Summary":"Norway should exclude the COVID-19 vaccines made by AstraZeneca  and Johnson & Johnson  from its immunization program, due to a small risk of rare but serious side effects, a panel of health experts commissioned by the gov..."},{"Date":"May. 10, 2021 at 8:21 a.m. ET","Headline":"EU Ditches AstraZeneca Vaccine. It\u2019s Pivoting to Pfizer.","Summary":"Norway should exclude the COVID-19 vaccines made by AstraZeneca  and Johnson & Johnson  from its immunization program, due to a small risk of rare but serious side effects, a panel of health experts commissioned by the gov..."},{"Date":"May. 10, 2021 at 8:14 a.m. ET","Headline":"Norway may drop AstraZeneca, J&J vaccines; EU will not take AstraZeneca one after June","Summary":"Norway should exclude the COVID-19 vaccines made by AstraZeneca  and Johnson & Johnson  from its immunization program, due to a small risk of rare but serious side effects, a panel of health experts commissioned by the gov..."},{"Date":"May. 10, 2021 at 7:50 a.m. ET","Headline":"BioNTech shares soar 8% as COVID-19 vaccines drive revenue surge","Summary":"Shares in BioNTech  surged 8% in premarket trading on Monday, after the German biotechnology group reported first-quarter earnings. Jointly with Pfizer , BioNTech co-developed the first COVID-19 vaccine to receive the gree..."},{"Date":"May. 13, 2021 at 5:38 p.m. ET","Headline":"\u2018A great day for America\u2019: CDC says fully vaccinated can largely ditch masks","Summary":"A Centers for Disease Control and Prevention committee voted 14-0-1 in favor of recommending that Pfizer Inc.'s  COVID-19 vaccine can be safely used in 12- to 15-year-olds. The recommendation, made Wednesday by the CDC's A..."},{"Date":"May. 13, 2021 at 3:59 p.m. ET","Headline":"Mixing Pfizer and AstraZeneca COVID-19 vaccines increases mild side effects but is safe, study shows","Summary":"A Centers for Disease Control and Prevention committee voted 14-0-1 in favor of recommending that Pfizer Inc.'s  COVID-19 vaccine can be safely used in 12- to 15-year-olds. The recommendation, made Wednesday by the CDC's A..."},{"Date":"May. 13, 2021 at 2:25 p.m. ET","Headline":"Global tally of COVID-19 cases tops 160 million as U.S. gears up to vaccinate 12- to 15-year-olds","Summary":"A Centers for Disease Control and Prevention committee voted 14-0-1 in favor of recommending that Pfizer Inc.'s  COVID-19 vaccine can be safely used in 12- to 15-year-olds. The recommendation, made Wednesday by the CDC's A..."},{"Date":"May. 13, 2021 at 1:08 p.m. ET","Headline":"Mixing Pfizer and AstraZeneca Vaccines Increases Mild Side Effects but Is Safe, Study Shows","Summary":"A Centers for Disease Control and Prevention committee voted 14-0-1 in favor of recommending that Pfizer Inc.'s  COVID-19 vaccine can be safely used in 12- to 15-year-olds. The recommendation, made Wednesday by the CDC's A..."},{"Date":"May. 13, 2021 at 9:19 a.m. ET","Headline":"CDC Panel Recommends Pfizer\u2019s Covid-19 Vaccine in Younger Teens. What Comes Next.","Summary":"A Centers for Disease Control and Prevention committee voted 14-0-1 in favor of recommending that Pfizer Inc.'s  COVID-19 vaccine can be safely used in 12- to 15-year-olds. The recommendation, made Wednesday by the CDC's A..."},{"Date":"May. 13, 2021 at 7:14 a.m. ET","Headline":"Cannabis company executives saw double-digit salary gains in first quarter amid shortage of experienced workers","Summary":"A Centers for Disease Control and Prevention committee voted 14-0-1 in favor of recommending that Pfizer Inc.'s  COVID-19 vaccine can be safely used in 12- to 15-year-olds. The recommendation, made Wednesday by the CDC's A..."},{"Date":"May. 13, 2021 at 7:13 a.m. ET","Headline":"CDC committee recommends that Pfizer's COVID-19 shot be used in 12- to 15-year-olds","Summary":"A Centers for Disease Control and Prevention committee voted 14-0-1 in favor of recommending that Pfizer Inc.'s  COVID-19 vaccine can be safely used in 12- to 15-year-olds. The recommendation, made Wednesday by the CDC's A..."},{"Date":"May. 13, 2021 at 6:28 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 160 million and India nears 24 million cases","Summary":"The global tally for the coronavirus-borne illness climbed above 160.4 million on Thursday, according to , while the death toll rose above 3.3 million. The U.S. continues to lead the world in cases and deaths by wide margi..."},{"Date":"May. 12, 2021 at 2:00 p.m. ET","Headline":"Global tally of COVID-19 cases nears 160 million and variant first found in India is now in 44 countries","Summary":""},{"Date":"May. 12, 2021 at 10:50 a.m. ET","Headline":"Novavax\u2019s Manufacturing Issues May Be Its Top Vaccine Struggle, Analyst Says","Summary":""},{"Date":"May. 12, 2021 at 9:12 a.m. ET","Headline":"Americans are increasingly going out to eat, visiting friends and warming to \u2018normal\u2019 life amid the pandemic","Summary":""},{"Date":"May. 12, 2021 at 4:25 a.m. ET","Headline":"AstraZeneca CEO Pascal Soriot narrowly wins vote on pay raise","Summary":""},{"Date":"May. 15, 2021 at 11:24 a.m. ET","Headline":"Do breakthrough COVID-19 infections seen in the Yankees and Bill Maher mean vaccinated people should still wear masks?","Summary":""},{"Date":"May. 14, 2021 at 3:59 p.m. ET","Headline":"Delaying second Pfizer COVID-19 shot boosts immune response in over-80s, study finds","Summary":""},{"Date":"May. 14, 2021 at 3:15 p.m. ET","Headline":"Rather than \u2018Will cryptos drop to zero?\u2019, investors should be asking this question instead, says strategist","Summary":""},{"Date":"May. 14, 2021 at 3:10 p.m. ET","Headline":"The COVID-19 pandemic isn\u2019t over, but \u2018the great end point\u2019 is in site as more than 120 million Americans are fully vaccinated","Summary":""},{"Date":"May. 14, 2021 at 10:23 a.m. ET","Headline":"U.S. Will Send No New J&J Vaccines Doses to States Next Week","Summary":""},{"Date":"May. 14, 2021 at 7:54 a.m. ET","Headline":"The U.S. will begin giving COVID-19 shots to 12- to 15-year-olds as Pfizer\u2019s vaccine gets expanded authorization","Summary":""},{"Date":"May. 17, 2021 at 10:17 p.m. ET","Headline":"Infectious Diseases Society of America: \u2018CDC recommendations should not send the message that the pandemic is over\u2019","Summary":"The U.S. plans to send 20 million COVID-19 vaccine doses authorized for use in the U.S. to other countries battling the pandemic by the end of June, White House press secretary Jen Psaki said Monday, as she said President ..."},{"Date":"May. 17, 2021 at 6:01 p.m. ET","Headline":"What this Cleveland Clinic pediatrician and vaccine expert is telling teens and their parents about getting COVID-19 shots","Summary":"The U.S. plans to send 20 million COVID-19 vaccine doses authorized for use in the U.S. to other countries battling the pandemic by the end of June, White House press secretary Jen Psaki said Monday, as she said President ..."},{"Date":"May. 17, 2021 at 2:34 p.m. ET","Headline":"Almost half U.S. population is partially vaccinated against COVID-19 \u2014 while Asia remains a virus hot spot","Summary":"The U.S. plans to send 20 million COVID-19 vaccine doses authorized for use in the U.S. to other countries battling the pandemic by the end of June, White House press secretary Jen Psaki said Monday, as she said President ..."},{"Date":"May. 17, 2021 at 2:16 p.m. ET","Headline":"Biden sees U.S. as \u2018arsenal of vaccines\u2019 as he plans to send 20 million more doses overseas","Summary":"The U.S. plans to send 20 million COVID-19 vaccine doses authorized for use in the U.S. to other countries battling the pandemic by the end of June, White House press secretary Jen Psaki said Monday, as she said President ..."},{"Date":"May. 17, 2021 at 12:33 p.m. ET","Headline":"U.S. plans to send 20 million more COVID vaccine doses overseas: White House","Summary":"The U.S. plans to send 20 million COVID-19 vaccine doses authorized for use in the U.S. to other countries battling the pandemic by the end of June, White House press secretary Jen Psaki said Monday, as she said President ..."},{"Date":"May. 17, 2021 at 10:59 a.m. ET","Headline":"Sanofi Executives Say Covid Vaccine Could Be \u2018Universal Booster\u2019","Summary":"More than 3 million teens between the ages of 12 and 17 years old have gotten at least one COVID-19 shot, as of Monday, . The public health agency does not break out more specific age categories on its COVID Data Tracker p..."},{"Date":"May. 17, 2021 at 9:01 a.m. ET","Headline":"CDC: 3 million teens between ages of 12 and 17 have received at least one COVID-19 shot","Summary":"More than 3 million teens between the ages of 12 and 17 years old have gotten at least one COVID-19 shot, as of Monday, . The public health agency does not break out more specific age categories on its COVID Data Tracker p..."},{"Date":"May. 17, 2021 at 1:30 a.m. ET","Headline":"Sanofi and Glaxo Are Back With a  Covid-19 Vaccine","Summary":""},{"Date":"May. 16, 2021 at 4:31 p.m. ET","Headline":"U.K. yet to decide on Pfizer offer to vaccinate Olympians","Summary":""},{"Date":"May. 16, 2021 at 12:42 p.m. ET","Headline":"Companies and employees appear to have starkly different ideas about where they\u2019ll work post-COVID","Summary":""},{"Date":"May. 16, 2021 at 12:26 p.m. ET","Headline":"Is it ethical for cruise lines, venues, schools or Broadway to restrict entry to people not vaccinated against COVID-19?","Summary":""},{"Date":"May. 19, 2021 at 8:06 p.m. ET","Headline":"What bitcoin\u2019s collapse could mean for your retirement","Summary":"BioNTech SE , the German biotech that partnered with Pfizer Inc.  to develop a COVID-19 vaccine that is authorized for use in the U.S., said Tuesday it has named Jens Holstein as chief financial officer. Holstein will repl..."},{"Date":"May. 19, 2021 at 4:39 p.m. ET","Headline":"10 countries where vaccinated Americans are allowed to travel \u2014 but it won\u2019t come cheap","Summary":"BioNTech SE , the German biotech that partnered with Pfizer Inc.  to develop a COVID-19 vaccine that is authorized for use in the U.S., said Tuesday it has named Jens Holstein as chief financial officer. Holstein will repl..."},{"Date":"May. 19, 2021 at 2:54 p.m. ET","Headline":"As Europe relaxes COVID-19 restrictions and U.S. cases fall, India suffers deadliest single day of the pandemic","Summary":"BioNTech SE , the German biotech that partnered with Pfizer Inc.  to develop a COVID-19 vaccine that is authorized for use in the U.S., said Tuesday it has named Jens Holstein as chief financial officer. Holstein will repl..."},{"Date":"May. 19, 2021 at 11:16 a.m. ET","Headline":"EU Set to Welcome Vaccinated Tourists This Summer","Summary":"BioNTech SE , the German biotech that partnered with Pfizer Inc.  to develop a COVID-19 vaccine that is authorized for use in the U.S., said Tuesday it has named Jens Holstein as chief financial officer. Holstein will repl..."},{"Date":"May. 19, 2021 at 10:21 a.m. ET","Headline":"Big step taken toward relaxing travel restrictions in Europe","Summary":"BioNTech SE , the German biotech that partnered with Pfizer Inc.  to develop a COVID-19 vaccine that is authorized for use in the U.S., said Tuesday it has named Jens Holstein as chief financial officer. Holstein will repl..."},{"Date":"May. 19, 2021 at 9:16 a.m. ET","Headline":"Waiving COVID-19 vaccine patents would be disastrous","Summary":"BioNTech SE , the German biotech that partnered with Pfizer Inc.  to develop a COVID-19 vaccine that is authorized for use in the U.S., said Tuesday it has named Jens Holstein as chief financial officer. Holstein will repl..."},{"Date":"May. 19, 2021 at 9:12 a.m. ET","Headline":"How the Global  Virus Disaster Could Cut Short the U.S. Recovery","Summary":"BioNTech SE , the German biotech that partnered with Pfizer Inc.  to develop a COVID-19 vaccine that is authorized for use in the U.S., said Tuesday it has named Jens Holstein as chief financial officer. Holstein will repl..."},{"Date":"May. 19, 2021 at 8:14 a.m. ET","Headline":"The Bitcoin Bubble Is Popping. Why There\u2019s No Telling Where the Selling Stops.","Summary":"BioNTech SE , the German biotech that partnered with Pfizer Inc.  to develop a COVID-19 vaccine that is authorized for use in the U.S., said Tuesday it has named Jens Holstein as chief financial officer. Holstein will repl..."},{"Date":"May. 19, 2021 at 7:26 a.m. ET","Headline":"Red Cross calls on wealthier countries to end \u2018glaring inequity\u2019 in COVID-19 vaccine access as global case tally nears 164 million","Summary":"BioNTech SE , the German biotech that partnered with Pfizer Inc.  to develop a COVID-19 vaccine that is authorized for use in the U.S., said Tuesday it has named Jens Holstein as chief financial officer. Holstein will repl..."},{"Date":"May. 18, 2021 at 9:21 p.m. ET","Headline":"Divorce attorneys are bracing for exes battling over giving kids the COVID-19 vaccine","Summary":"BioNTech SE , the German biotech that partnered with Pfizer Inc.  to develop a COVID-19 vaccine that is authorized for use in the U.S., said Tuesday it has named Jens Holstein as chief financial officer. Holstein will repl..."},{"Date":"May. 18, 2021 at 6:05 p.m. ET","Headline":"Glaxo Has Promising News On Another Covid-19 Vaccine. Can It Compete?","Summary":"BioNTech SE , the German biotech that partnered with Pfizer Inc.  to develop a COVID-19 vaccine that is authorized for use in the U.S., said Tuesday it has named Jens Holstein as chief financial officer. Holstein will repl..."},{"Date":"May. 18, 2021 at 4:56 p.m. ET","Headline":"U.S. stocks close lower after weaker-than-expected housing data","Summary":"BioNTech SE , the German biotech that partnered with Pfizer Inc.  to develop a COVID-19 vaccine that is authorized for use in the U.S., said Tuesday it has named Jens Holstein as chief financial officer. Holstein will repl..."},{"Date":"May. 18, 2021 at 2:38 p.m. ET","Headline":"How Sarepta Revived Confidence in Its Gene Therapy","Summary":"BioNTech SE , the German biotech that partnered with Pfizer Inc.  to develop a COVID-19 vaccine that is authorized for use in the U.S., said Tuesday it has named Jens Holstein as chief financial officer. Holstein will repl..."},{"Date":"May. 18, 2021 at 8:21 a.m. ET","Headline":"AMC Entertainment Stock Is Soaring Again \u2014 and the Meme Trade Won\u2019t Die","Summary":"BioNTech SE , the German biotech that partnered with Pfizer Inc.  to develop a COVID-19 vaccine that is authorized for use in the U.S., said Tuesday it has named Jens Holstein as chief financial officer. Holstein will repl..."},{"Date":"May. 18, 2021 at 6:12 a.m. ET","Headline":"BioNTech names Jens Holstein CFO","Summary":"BioNTech SE , the German biotech that partnered with Pfizer Inc.  to develop a COVID-19 vaccine that is authorized for use in the U.S., said Tuesday it has named Jens Holstein as chief financial officer. Holstein will repl..."},{"Date":"May. 21, 2021 at 7:10 p.m. ET","Headline":"White House Proposes $1.7 Trillion Infrastructure Counteroffer to Republicans","Summary":"BioNTech's  chief executive has said that the COVID-19 vaccine it developed with U.S. pharmaceutical group Pfizer  is likely to be effective against the Indian variant of coronavirus. The German biotechnology company's CEO..."},{"Date":"May. 21, 2021 at 4:52 p.m. ET","Headline":"Dow closes higher, but posts another weekly loss in choppy market","Summary":"BioNTech's  chief executive has said that the COVID-19 vaccine it developed with U.S. pharmaceutical group Pfizer  is likely to be effective against the Indian variant of coronavirus. The German biotechnology company's CEO..."},{"Date":"May. 21, 2021 at 3:56 p.m. ET","Headline":"Booster dose of COVID vaccines to be given to U.K. volunteers in new trial","Summary":"BioNTech's  chief executive has said that the COVID-19 vaccine it developed with U.S. pharmaceutical group Pfizer  is likely to be effective against the Indian variant of coronavirus. The German biotechnology company's CEO..."},{"Date":"May. 21, 2021 at 2:16 p.m. ET","Headline":"COVID vaccination success in U.S. and other wealthy countries contrasts with shortages elsewhere as G-20 promises to step up","Summary":"BioNTech's  chief executive has said that the COVID-19 vaccine it developed with U.S. pharmaceutical group Pfizer  is likely to be effective against the Indian variant of coronavirus. The German biotechnology company's CEO..."},{"Date":"May. 21, 2021 at 1:20 p.m. ET","Headline":"BioNTech Says Covid-19 Vaccine Likely to Be Effective Against Indian Coronavirus Variant","Summary":"BioNTech's  chief executive has said that the COVID-19 vaccine it developed with U.S. pharmaceutical group Pfizer  is likely to be effective against the Indian variant of coronavirus. The German biotechnology company's CEO..."},{"Date":"May. 21, 2021 at 10:49 a.m. ET","Headline":"Merck Battles Pfizer in Lucrative Pediatric Vaccine Market","Summary":"BioNTech's  chief executive has said that the COVID-19 vaccine it developed with U.S. pharmaceutical group Pfizer  is likely to be effective against the Indian variant of coronavirus. The German biotechnology company's CEO..."},{"Date":"May. 21, 2021 at 6:24 a.m. ET","Headline":"BioNTech says COVID-19 vaccine likely to be effective against Indian coronavirus variant","Summary":"BioNTech's  chief executive has said that the COVID-19 vaccine it developed with U.S. pharmaceutical group Pfizer  is likely to be effective against the Indian variant of coronavirus. The German biotechnology company's CEO..."},{"Date":"May. 20, 2021 at 5:25 p.m. ET","Headline":"U.S. Treasury Proposes Global Minimum Corporate Tax of At Least 15%","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday they have reached a new agreement with the European Commission to supply up to 1.8 billion additional doses of their COVID-19 vaccine. The partners said the agreem..."},{"Date":"May. 20, 2021 at 5:00 p.m. ET","Headline":"Dow ends up nearly 200 points, stocks snap 3-day skid on brighter economic data","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday they have reached a new agreement with the European Commission to supply up to 1.8 billion additional doses of their COVID-19 vaccine. The partners said the agreem..."},{"Date":"May. 20, 2021 at 2:21 p.m. ET","Headline":"WHO Europe advises avoiding international travel for now as concern about vaccine inequity grows","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday they have reached a new agreement with the European Commission to supply up to 1.8 billion additional doses of their COVID-19 vaccine. The partners said the agreem..."},{"Date":"May. 20, 2021 at 7:00 a.m. ET","Headline":"5 Biopharma Stocks That Are Cheap and Growing","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday they have reached a new agreement with the European Commission to supply up to 1.8 billion additional doses of their COVID-19 vaccine. The partners said the agreem..."},{"Date":"May. 20, 2021 at 6:09 a.m. ET","Headline":"UPDATE: Pfizer and BioNTech to supply EU with up to 1.8 billion additional COVID vaccine doses","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday they have reached a new agreement with the European Commission to supply up to 1.8 billion additional doses of their COVID-19 vaccine. The partners said the agreem..."},{"Date":"May. 19, 2021 at 8:45 p.m. ET","Headline":"Shareholders fight to rein in risk by demanding transparency into public companies\u2019 political spending","Summary":""},{"Date":"May. 23, 2021 at 11:29 p.m. ET","Headline":"With Olympics approaching, Japan speeds up vaccination rollout","Summary":""},{"Date":"May. 23, 2021 at 4:25 p.m. ET","Headline":"COVID-19 vaccines effective against Indian variant, U.K. health officials say","Summary":""},{"Date":"May. 25, 2021 at 1:16 p.m. ET","Headline":"EU expects to take delivery of 1 billion COVID-19 vaccine doses by the end of September, agrees on digital certificate for travelers","Summary":"Shares of Pfizer Inc.  gained 0.1% in premarket trading on Monday after the company said it is testing its experimental 20-valent pneumococcal conjugate vaccine in combination with a booster dose of its COVID-19 vaccine in..."},{"Date":"May. 25, 2021 at 8:17 a.m. ET","Headline":"Moderna to Seek Approval for  Covid-19 Vaccine for Adolescents","Summary":"Shares of Pfizer Inc.  gained 0.1% in premarket trading on Monday after the company said it is testing its experimental 20-valent pneumococcal conjugate vaccine in combination with a booster dose of its COVID-19 vaccine in..."},{"Date":"May. 24, 2021 at 3:06 p.m. ET","Headline":"WHO head slams \u2018scandalous inequity\u2019 in COVID vaccines with 10 countries accounting for 75% of doses administered","Summary":"Shares of Pfizer Inc.  gained 0.1% in premarket trading on Monday after the company said it is testing its experimental 20-valent pneumococcal conjugate vaccine in combination with a booster dose of its COVID-19 vaccine in..."},{"Date":"May. 24, 2021 at 10:48 a.m. ET","Headline":"Big Drug Stocks Have Rallied. Why an Analyst Says They Have More Room to Run.","Summary":"Shares of Pfizer Inc.  gained 0.1% in premarket trading on Monday after the company said it is testing its experimental 20-valent pneumococcal conjugate vaccine in combination with a booster dose of its COVID-19 vaccine in..."},{"Date":"May. 24, 2021 at 10:02 a.m. ET","Headline":"Pfizer Starts Another Covid-19 Booster Trial","Summary":"Shares of Pfizer Inc.  gained 0.1% in premarket trading on Monday after the company said it is testing its experimental 20-valent pneumococcal conjugate vaccine in combination with a booster dose of its COVID-19 vaccine in..."},{"Date":"May. 24, 2021 at 8:21 a.m. ET","Headline":"Virgin Galactic Stock Is Soaring. Just Like That, SPACs Are Back.","Summary":"Shares of Pfizer Inc.  gained 0.1% in premarket trading on Monday after the company said it is testing its experimental 20-valent pneumococcal conjugate vaccine in combination with a booster dose of its COVID-19 vaccine in..."},{"Date":"May. 24, 2021 at 7:35 a.m. ET","Headline":"Pfizer is testing a COVID-19 booster shot in combination with new pneumococcal conjugate vaccine candidate","Summary":"Shares of Pfizer Inc.  gained 0.1% in premarket trading on Monday after the company said it is testing its experimental 20-valent pneumococcal conjugate vaccine in combination with a booster dose of its COVID-19 vaccine in..."},{"Date":"May. 24, 2021 at 6:23 a.m. ET","Headline":"When was the last time you saw Paris? EU ambassadors will ease travel restrictions, but Americans still face hurdles","Summary":""},{"Date":"May. 27, 2021 at 12:56 p.m. ET","Headline":"Activist Fund Elliott Management Could Give GSK Some Space: Report","Summary":""},{"Date":"May. 26, 2021 at 3:56 p.m. ET","Headline":"CureVac\u2019s COVID vaccine has important role to play in fighting variants, CEO says","Summary":""},{"Date":"May. 26, 2021 at 3:05 p.m. ET","Headline":"Taiwan criticizes China over Pfizer vaccine deal, and Wuhan lab theory irks Beijing","Summary":""},{"Date":"May. 26, 2021 at 2:41 p.m. ET","Headline":"CureVac\u2019s Covid-19 Vaccine Has Important Role to Play in Fighting Variants, CEO Says","Summary":""},{"Date":"May. 26, 2021 at 2:13 p.m. ET","Headline":"Nick Offerman urges everyone to get vaccinated against COVID: \u2018Medicine doesn\u2019t care who you voted for\u2019","Summary":""},{"Date":"May. 26, 2021 at 8:34 a.m. ET","Headline":"Breakthrough infections in people who have gotten their COVID-19 shots are very rare. But here\u2019s why Rick Bright wants the CDC to restart the sequencing of all viral strains.","Summary":""},{"Date":"May. 29, 2021 at 5:24 p.m. ET","Headline":"Weekend reads: AMC and GameStop rocket again","Summary":""},{"Date":"May. 29, 2021 at 1:30 p.m. ET","Headline":"Do Americans trust others to be honest about their COVID-19 vaccine? It all depends on where you are","Summary":""},{"Date":"May. 28, 2021 at 3:51 p.m. ET","Headline":"Johnson & Johnson COVID-19 vaccine authorized for use in the U.K.","Summary":""},{"Date":"May. 28, 2021 at 3:49 p.m. ET","Headline":"European regulator approves Pfizer\u2013BioNTech vaccine for children aged 12-15","Summary":""},{"Date":"May. 28, 2021 at 3:18 p.m. ET","Headline":"Babydog the bulldog is begging people to enter West Virginia\u2019s vaccine lottery","Summary":""},{"Date":"May. 28, 2021 at 2:22 p.m. ET","Headline":"U.S. heads into holiday weekend with 51% of adults fully vaccinated and COVID cases down 35% from two weeks ago","Summary":""},{"Date":"May. 28, 2021 at 1:40 p.m. ET","Headline":"Johnson & Johnson Covid-19 Vaccine Authorized for Use in U.K.","Summary":""},{"Date":"May. 28, 2021 at 6:39 a.m. ET","Headline":"Germany to offer COVID-19 vaccine to children as young as 12 from June","Summary":""},{"Date":"May. 27, 2021 at 10:30 a.m. ET","Headline":"Run a Quality Check to Limit Chances of a Dividend Stock Shock","Summary":""},{"Date":"May. 31, 2021 at 11:49 a.m. ET","Headline":"Vietnam says new virus variant is a hybrid of strains first identified in the U.K. and India","Summary":""},{"Date":"May. 30, 2021 at 7:00 a.m. ET","Headline":"Giant Pension Slashed Intel, Tesla Stakes. It Scooped Up Covid-Vaccine Makers.","Summary":""},{"Date":"Jun. 2, 2021 at 3:52 p.m. ET","Headline":"Zero U.K. COVID-19 deaths recorded for first time since start of pandemic","Summary":"Shares of Johnson & Johnson  rose 0.4% in morning trading, in the wake of the a Missouri court verdict regarding various talc cases against the consumer products and drug maker. As a result of the Supreme Court decision, J..."},{"Date":"Jun. 2, 2021 at 3:02 p.m. ET","Headline":"New COVID-19 cases, deaths and hospitalizations keep falling in U.S., as vaccinations keep increasing","Summary":"Shares of Johnson & Johnson  rose 0.4% in morning trading, in the wake of the a Missouri court verdict regarding various talc cases against the consumer products and drug maker. As a result of the Supreme Court decision, J..."},{"Date":"Jun. 2, 2021 at 10:58 a.m. ET","Headline":"J&J stock gains after Moody's says $2.5 billion payment for talc claims doesn't affect Aaa rating","Summary":"Shares of Johnson & Johnson  rose 0.4% in morning trading, in the wake of the a Missouri court verdict regarding various talc cases against the consumer products and drug maker. As a result of the Supreme Court decision, J..."},{"Date":"Jun. 2, 2021 at 10:41 a.m. ET","Headline":"Moderna seeks full FDA approval for COVID vaccine \u2014 will it move the needle on vaccine hesitancy?","Summary":"The National Institutes of Health said Tuesday it plans to test booster shots from different vaccines in a fully vaccinated population as part of a \"mix-and-match\" clinical trial. The  is being funded by the National Insti..."},{"Date":"Jun. 2, 2021 at 9:47 a.m. ET","Headline":"The U.K. Hits a Major Covid-19 Milestone","Summary":"The National Institutes of Health said Tuesday it plans to test booster shots from different vaccines in a fully vaccinated population as part of a \"mix-and-match\" clinical trial. The  is being funded by the National Insti..."},{"Date":"Jun. 2, 2021 at 9:41 a.m. ET","Headline":"Novavax Says Data From Its U.S. Phase 3 Trial Is Coming Soon","Summary":"The National Institutes of Health said Tuesday it plans to test booster shots from different vaccines in a fully vaccinated population as part of a \"mix-and-match\" clinical trial. The  is being funded by the National Insti..."},{"Date":"Jun. 2, 2021 at 8:48 a.m. ET","Headline":"U.S. to run 'mix-and-match' clinical trial testing Moderna's vaccine as booster shot","Summary":"The National Institutes of Health said Tuesday it plans to test booster shots from different vaccines in a fully vaccinated population as part of a \"mix-and-match\" clinical trial. The  is being funded by the National Insti..."},{"Date":"Jun. 2, 2021 at 8:25 a.m. ET","Headline":"Amazon Prime Day Is Good For Shoppers. Just Don\u2019t Expect It to Move the Stock.","Summary":"Shares of Moderna Inc.  gained 0.1% in premarket on Tuesday after the company said it is formally seeking full approval from the Food and Drug Administration for its COVID-19 vaccine. Moderna said it has initiated a rollin..."},{"Date":"Jun. 1, 2021 at 2:50 p.m. ET","Headline":"More than half of U.S. adults are fully vaccinated, as Memorial Day air travel reaches pre-pandemic levels","Summary":"Shares of Moderna Inc.  gained 0.1% in premarket on Tuesday after the company said it is formally seeking full approval from the Food and Drug Administration for its COVID-19 vaccine. Moderna said it has initiated a rollin..."},{"Date":"Jun. 1, 2021 at 7:59 a.m. ET","Headline":"Moderna submits 'rolling' application as part of process to obtain full FDA approval for its COVID-19 shot","Summary":"Shares of Moderna Inc.  gained 0.1% in premarket on Tuesday after the company said it is formally seeking full approval from the Food and Drug Administration for its COVID-19 vaccine. Moderna said it has initiated a rollin..."},{"Date":"Jun. 1, 2021 at 7:27 a.m. ET","Headline":"Stocks to buy and those to avoid as U.S. economy runs faster than the Indy 500","Summary":""},{"Date":"Jun. 1, 2021 at 7:25 a.m. ET","Headline":"Moderna and Pfizer are already developing COVID-19 vaccine boosters. Do we need a third shot?","Summary":""},{"Date":"Jun. 4, 2021 at 8:41 p.m. ET","Headline":"The Top-Returning IPOs of the Pandemic","Summary":"The Centers for Disease Control and Prevention is urging teens who are at least 12 years old to get vaccinated over concerns about the number of adolescents who are being hospitalized for COVID-19. The Pfizer Inc.  and Bio..."},{"Date":"Jun. 4, 2021 at 4:22 p.m. ET","Headline":"U.S. stocks end higher as May jobs report invokes bullish \u2018Goldilocks\u2019 scenario","Summary":"The Centers for Disease Control and Prevention is urging teens who are at least 12 years old to get vaccinated over concerns about the number of adolescents who are being hospitalized for COVID-19. The Pfizer Inc.  and Bio..."},{"Date":"Jun. 4, 2021 at 12:50 p.m. ET","Headline":"Don\u2019t laminate your COVID vaccination card before doing these 5 things","Summary":"The Centers for Disease Control and Prevention is urging teens who are at least 12 years old to get vaccinated over concerns about the number of adolescents who are being hospitalized for COVID-19. The Pfizer Inc.  and Bio..."},{"Date":"Jun. 4, 2021 at 11:40 a.m. ET","Headline":"CDC director is 'concerned' about teens hospitalized for COVID-19, urges vaccination","Summary":"The Centers for Disease Control and Prevention is urging teens who are at least 12 years old to get vaccinated over concerns about the number of adolescents who are being hospitalized for COVID-19. The Pfizer Inc.  and Bio..."},{"Date":"Jun. 4, 2021 at 11:22 a.m. ET","Headline":"Global COVID-19 cases top 172 million as WHO warns of possible third wave in Africa after 20% increase in infections in two weeks","Summary":"The COVID-19 vaccine developed jointly by Pfizer and BioNTech  has been approved for 12 to 15-year-olds in the U.K, the Medicines and Healthcare products Regulatory Agency (MHRA) . More than 2,000 children were involved in..."},{"Date":"Jun. 4, 2021 at 10:53 a.m. ET","Headline":"I\u2019m fully vaccinated but feel sick \u2013 should I get tested for COVID-19?","Summary":"The COVID-19 vaccine developed jointly by Pfizer and BioNTech  has been approved for 12 to 15-year-olds in the U.K, the Medicines and Healthcare products Regulatory Agency (MHRA) . More than 2,000 children were involved in..."},{"Date":"Jun. 4, 2021 at 8:03 a.m. ET","Headline":"National Doughnut Day: Get 2 free Krispy Kreme treats \u2014 if you\u2019re vaccinated against COVID","Summary":"The COVID-19 vaccine developed jointly by Pfizer and BioNTech  has been approved for 12 to 15-year-olds in the U.K, the Medicines and Healthcare products Regulatory Agency (MHRA) . More than 2,000 children were involved in..."},{"Date":"Jun. 4, 2021 at 7:11 a.m. ET","Headline":"Pfizer-BioNTech Covid-19 vaccine approved for 12 to 15-year-olds in the U.K.","Summary":"The COVID-19 vaccine developed jointly by Pfizer and BioNTech  has been approved for 12 to 15-year-olds in the U.K, the Medicines and Healthcare products Regulatory Agency (MHRA) . More than 2,000 children were involved in..."},{"Date":"Jun. 4, 2021 at 1:33 a.m. ET","Headline":"Heart inflammation probed as possible rare side effect of COVID-19 vaccine for teens","Summary":"The White House said Thursday that it removed a requirement that is part of the Defense Production Act that gives the U.S. preferential orders for the COVID-19 vaccines developed by AstraZeneca , Novavax Inc. , and Sanofi ..."},{"Date":"Jun. 3, 2021 at 3:55 p.m. ET","Headline":"Ohio\u2019s second million-dollar vaccine lottery winner is an Amazon delivery driver from Toledo","Summary":"The White House said Thursday that it removed a requirement that is part of the Defense Production Act that gives the U.S. preferential orders for the COVID-19 vaccines developed by AstraZeneca , Novavax Inc. , and Sanofi ..."},{"Date":"Jun. 3, 2021 at 1:56 p.m. ET","Headline":"Covax gets $2.4 billion in COVID vaccine supply commitments for world\u2019s poorest countries as experts warn on variants","Summary":"The White House said Thursday that it removed a requirement that is part of the Defense Production Act that gives the U.S. preferential orders for the COVID-19 vaccines developed by AstraZeneca , Novavax Inc. , and Sanofi ..."},{"Date":"Jun. 3, 2021 at 11:30 a.m. ET","Headline":"White House to allow AstraZeneca, Novavax, Sanofi to distribute COVID-19 shots how they see fit","Summary":"The White House said Thursday that it removed a requirement that is part of the Defense Production Act that gives the U.S. preferential orders for the COVID-19 vaccines developed by AstraZeneca , Novavax Inc. , and Sanofi ..."},{"Date":"Jun. 3, 2021 at 1:47 a.m. ET","Headline":"China aims to vaccinate 80% of its 1.4 billion people by the end of 2021","Summary":""},{"Date":"Jun. 6, 2021 at 8:59 p.m. ET","Headline":"Senators say U.S. will give Taiwan 750,000 doses of COVID-19 vaccine","Summary":""},{"Date":"Jun. 6, 2021 at 12:09 p.m. ET","Headline":"Here\u2019s what employers are NOT allowed to do to entice workers to get COVID-19 vaccinations","Summary":""},{"Date":"Jun. 6, 2021 at 12:03 p.m. ET","Headline":"If it\u2019s not enhanced unemployment benefits, why are people turning down jobs?","Summary":""},{"Date":"Jun. 5, 2021 at 2:12 p.m. ET","Headline":"Two signs of COVID-19 that predict higher mortality are \u2018easily measured\u2019 at home","Summary":""},{"Date":"Jun. 5, 2021 at 2:08 p.m. ET","Headline":"Stimulus checks played a major role in nationwide decline in anxiety and depression, new analysis says","Summary":""},{"Date":"Jun. 5, 2021 at 12:50 p.m. ET","Headline":"Winner of Ohio vaccine lottery says $1 million prize \u2018pushed me over the edge\u2019 to get a COVID shot","Summary":""},{"Date":"Jun. 4, 2021 at 12:11 p.m. ET","Headline":"The Dangerous Politicization of American Science","Summary":""},{"Date":"Jun. 8, 2021 at 4:34 p.m. ET","Headline":"Retirees stuck in the middle of debate over drug-price reform","Summary":""},{"Date":"Jun. 8, 2021 at 2:04 p.m. ET","Headline":"New U.S. COVID-19 cases and deaths tick higher, while CDC\u2019s \u2018real world\u2019 study shows Pfizer, Moderna vaccines reduce infection risk by 91%","Summary":""},{"Date":"Jun. 7, 2021 at 2:40 p.m. ET","Headline":"COVID-19 vaccines administered tops 300 million, as cases, deaths and hospitalizations keep falling","Summary":""},{"Date":"Jun. 7, 2021 at 12:49 p.m. ET","Headline":"U.K. may delay final lockdown easing as COVID-19 infections rise","Summary":""},{"Date":"Jun. 7, 2021 at 9:53 a.m. ET","Headline":"The Delta Virus Variant Has the World on Edge. What to Know.","Summary":""},{"Date":"Jun. 7, 2021 at 8:13 a.m. ET","Headline":"Amazon\u2019s Jeff Bezos Is Going to Space\u2014and You Can Too","Summary":""},{"Date":"Jun. 10, 2021 at 6:46 p.m. ET","Headline":"U.S. global vaccine donation plan draws cheers, questions","Summary":"Moderna Inc.  said Thursday that it has filed for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration for use of its COVID-19 vaccine in adolescents. Moderna's stock slipped 0.2% in premarket tradi..."},{"Date":"Jun. 10, 2021 at 3:06 p.m. ET","Headline":"France\u2019s Macron labels Biden vaccine-sharing plan \u2018great news\u2019","Summary":"Moderna Inc.  said Thursday that it has filed for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration for use of its COVID-19 vaccine in adolescents. Moderna's stock slipped 0.2% in premarket tradi..."},{"Date":"Jun. 10, 2021 at 2:47 p.m. ET","Headline":"New daily COVID-19 cases rise back above 20,000, as cases and deaths increase for 3rd straight day","Summary":"Moderna Inc.  said Thursday that it has filed for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration for use of its COVID-19 vaccine in adolescents. Moderna's stock slipped 0.2% in premarket tradi..."},{"Date":"Jun. 10, 2021 at 2:20 p.m. ET","Headline":"Biden calls big U.S. donation of vaccines foundation for contributions by other G-7 nations","Summary":"Moderna Inc.  said Thursday that it has filed for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration for use of its COVID-19 vaccine in adolescents. Moderna's stock slipped 0.2% in premarket tradi..."},{"Date":"Jun. 10, 2021 at 11:33 a.m. ET","Headline":"JBS Paid $11 Million Ransom After Cyberattack Shut Down Meat Plants","Summary":"Moderna Inc.  said Thursday that it has filed for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration for use of its COVID-19 vaccine in adolescents. Moderna's stock slipped 0.2% in premarket tradi..."},{"Date":"Jun. 10, 2021 at 9:17 a.m. ET","Headline":"Inflation Is Here. But It Won\u2019t Doom Stocks.","Summary":"Moderna Inc.  said Thursday that it has filed for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration for use of its COVID-19 vaccine in adolescents. Moderna's stock slipped 0.2% in premarket tradi..."},{"Date":"Jun. 10, 2021 at 8:40 a.m. ET","Headline":"Pfizer and BioNTech Will Sell 500 Million Covid Vaccine Doses to the U.S. for Global Distribution","Summary":"Moderna Inc.  said Thursday that it has filed for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration for use of its COVID-19 vaccine in adolescents. Moderna's stock slipped 0.2% in premarket tradi..."},{"Date":"Jun. 10, 2021 at 8:14 a.m. ET","Headline":"Moderna files for its COVID-19 vaccine to be granted emergency use in adolescents","Summary":"Moderna Inc.  said Thursday that it has filed for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration for use of its COVID-19 vaccine in adolescents. Moderna's stock slipped 0.2% in premarket tradi..."},{"Date":"Jun. 9, 2021 at 3:38 p.m. ET","Headline":"New daily COVID-19 cases and deaths rise again as concerns over delta variant and Biden vaccination target for July 4 increase","Summary":"The Biden administration is buying 500\u2009million doses of Pfizer's  COVID-19 vaccine to donate to the world as part of its effort to boost vaccination rates in other countries, according to a  citing people familiar with the..."},{"Date":"Jun. 9, 2021 at 2:14 p.m. ET","Headline":"Biden administration to buy 500 million Pfizer shots for other countries: report","Summary":"The Biden administration is buying 500\u2009million doses of Pfizer's  COVID-19 vaccine to donate to the world as part of its effort to boost vaccination rates in other countries, according to a  citing people familiar with the..."},{"Date":"Jun. 9, 2021 at 8:36 a.m. ET","Headline":"FDA Approves Pfizer\u2019s New Pneumococcal Vaccine, Setting Up Clash With Merck","Summary":""},{"Date":"Jun. 8, 2021 at 5:08 p.m. ET","Headline":"Oil Crosses $70. These Stocks Are Seeing Big Gains.","Summary":""},{"Date":"Jun. 12, 2021 at 9:41 a.m. ET","Headline":"New U.S. COVID-19 cases and deaths jump to two weeks highs","Summary":""},{"Date":"Jun. 11, 2021 at 10:10 p.m. ET","Headline":"Houston hospital workers were told to get vaccinated \u2014 or be fired. Now their case is being heard in federal court","Summary":""},{"Date":"Jun. 11, 2021 at 5:35 p.m. ET","Headline":"Johnson & Johnson Can\u2019t Use 60 Million Covid Doses Because of Possible Contamination, FDA Rules","Summary":""},{"Date":"Jun. 11, 2021 at 3:03 p.m. ET","Headline":"New daily COVID-19 cases and deaths fall for first time in 4 days, while vaccine concerns grow with reports of side effects","Summary":""},{"Date":"Jun. 11, 2021 at 12:06 p.m. ET","Headline":"G-7 summit\u2019s first order of business is commitment to global billion-dose vaccine donation","Summary":""},{"Date":"Jun. 11, 2021 at 11:23 a.m. ET","Headline":"CureVac Stock Drops on Worries Over Vaccine Trial Delay","Summary":""},{"Date":"Jun. 11, 2021 at 8:19 a.m. ET","Headline":"The S&P 500 Is Hitting New Highs Again. Bad News Doesn\u2019t Seem to Matter.","Summary":""},{"Date":"Jun. 14, 2021 at 10:20 p.m. ET","Headline":"U.K. data show COVID-19 vaccines provide significant protection from delta variant","Summary":""},{"Date":"Jun. 14, 2021 at 4:46 p.m. ET","Headline":"S&P 500, Nasdaq Hit New Records as Bond Yields Remain Contained","Summary":""},{"Date":"Jun. 14, 2021 at 2:44 p.m. ET","Headline":"U.K. to delay reopening as Delta variant accounts for 90% of cases and U.S. court upholds mandatory vaccination","Summary":""},{"Date":"Jun. 14, 2021 at 12:19 p.m. ET","Headline":"\u2018We will all be incredibly rusty\u2019: The softball field replaces the water cooler as company sports teams reunite","Summary":""},{"Date":"Jun. 14, 2021 at 9:53 a.m. ET","Headline":"Novavax\u2019s Study Showed Its Covid-19 Vaccine Works. Why Moderna Stock Is Down.","Summary":""},{"Date":"Jun. 14, 2021 at 9:20 a.m. ET","Headline":"Court upholds Houston hospital\u2019s mandatory COVID-19 vaccine policy: \u2018Every employment includes limits on the worker\u2019s behavior\u2019","Summary":""},{"Date":"Aug. 31, 2020 at 7:44 a.m. ET","Headline":"It\u2019s Crunch Time for Vaccine News. Brace Yourself.","Summary":""},{"Date":"Jun. 16, 2021 at 7:35 p.m. ET","Headline":"CDC aligns with WHO on delta COVID variant; experts warn of higher risks of infection and serious illness","Summary":"Most remaining COVID restrictions in New York will be lifted as 70% of state residents aged 18 years-and-older have received at least a first dose of a coronavirus vaccine, Gov. Andrew Cuomo announced Tuesday. The lifting ..."},{"Date":"Jun. 16, 2021 at 7:31 p.m. ET","Headline":"CureVac Started the Day Worth More Than Novavax. Then Its Vaccine News Hit.","Summary":"Most remaining COVID restrictions in New York will be lifted as 70% of state residents aged 18 years-and-older have received at least a first dose of a coronavirus vaccine, Gov. Andrew Cuomo announced Tuesday. The lifting ..."},{"Date":"Jun. 16, 2021 at 10:53 a.m. ET","Headline":"The U.K. Reopening Trade Has Run Out of Steam. Here\u2019s Where It Hasn\u2019t.","Summary":"Most remaining COVID restrictions in New York will be lifted as 70% of state residents aged 18 years-and-older have received at least a first dose of a coronavirus vaccine, Gov. Andrew Cuomo announced Tuesday. The lifting ..."},{"Date":"Jun. 15, 2021 at 2:38 p.m. ET","Headline":"Fear grows that delta variant will become dominant COVID strain worldwide as WHO says it\u2019s now in 74 countries","Summary":"Most remaining COVID restrictions in New York will be lifted as 70% of state residents aged 18 years-and-older have received at least a first dose of a coronavirus vaccine, Gov. Andrew Cuomo announced Tuesday. The lifting ..."},{"Date":"Jun. 15, 2021 at 12:38 p.m. ET","Headline":"New York lifts most remaining COVID restrictions as 70% of adults have received at least one vaccine dose","Summary":"Most remaining COVID restrictions in New York will be lifted as 70% of state residents aged 18 years-and-older have received at least a first dose of a coronavirus vaccine, Gov. Andrew Cuomo announced Tuesday. The lifting ..."},{"Date":"Jun. 15, 2021 at 11:34 a.m. ET","Headline":"Novavax Fell After Vaccine News. Rivals\u2019 Stocks Tell the Real Story.","Summary":""},{"Date":"Jun. 15, 2021 at 10:59 a.m. ET","Headline":"Novavax\u2019s Covid Vaccine Is Real Competition for Pfizer and Moderna","Summary":""},{"Date":"Jun. 15, 2021 at 8:21 a.m. ET","Headline":"AstraZeneca, Pfizer Vaccines Offer Strong Protection From Delta Variant","Summary":""},{"Date":"Jun. 15, 2021 at 7:51 a.m. ET","Headline":"Inflation Fears Have Faded. JPMorgan\u2019s Jamie Dimon Is Betting They\u2019ll Return.","Summary":""},{"Date":"Jun. 18, 2021 at 10:54 a.m. ET","Headline":"CureVac Shares Are Soaring Because the Company Won\u2019t Give Up on a Covid-19 Vaccine","Summary":"Shares of Curevac  rose 10% in premarket trading on Friday. Shares of the German biotech have lost 48% this week after the company said a late-stage clinical trial of its COVID-19 vaccine . But Curevac's chief financial of..."},{"Date":"Jun. 18, 2021 at 6:18 a.m. ET","Headline":"Curevac shares climb 10%; CFO says not giving up on COVID-19 vaccine","Summary":"Shares of Curevac  rose 10% in premarket trading on Friday. Shares of the German biotech have lost 48% this week after the company said a late-stage clinical trial of its COVID-19 vaccine . But Curevac's chief financial of..."},{"Date":"Jun. 17, 2021 at 4:49 p.m. ET","Headline":"BioNTech CEO Warns Delta Variant Could Lead to a Covid-19 Resurgence","Summary":"Shares of Curevac NV plunged more than 50% in the extended session Wednesday after the pharma company said its trial COVID-19 vaccine showed an efficacy of 47% against the illness."},{"Date":"Jun. 17, 2021 at 4:46 p.m. ET","Headline":"CureVac Stock Fell 39% After Its Vaccine Failure. The Pain May Just Be Getting Started.","Summary":"Shares of Curevac NV plunged more than 50% in the extended session Wednesday after the pharma company said its trial COVID-19 vaccine showed an efficacy of 47% against the illness."},{"Date":"Jun. 17, 2021 at 1:42 p.m. ET","Headline":"CureVac says its COVID vaccine was poor match against 29 COVID variants, as global case tally tops 177 million","Summary":"Shares of Curevac NV plunged more than 50% in the extended session Wednesday after the pharma company said its trial COVID-19 vaccine showed an efficacy of 47% against the illness."},{"Date":"Jun. 17, 2021 at 10:19 a.m. ET","Headline":"Pfizer Covid-19 Vaccine Could See Blockbuster Sales for Years","Summary":"Shares of Curevac NV plunged more than 50% in the extended session Wednesday after the pharma company said its trial COVID-19 vaccine showed an efficacy of 47% against the illness."},{"Date":"Jun. 17, 2021 at 7:25 a.m. ET","Headline":"CureVac\u2019s COVID vaccine candidate 47% effective, stock tanks","Summary":"Shares of Curevac NV plunged more than 50% in the extended session Wednesday after the pharma company said its trial COVID-19 vaccine showed an efficacy of 47% against the illness."},{"Date":"Jun. 17, 2021 at 7:20 a.m. ET","Headline":"Looking for hedges against inflation? Try Apple, Nike, Verizon and stocks with this in common, strategists say","Summary":"Shares of CureVac  fell 42% in premarket trading on Thurdsay, a day after  its COVID-19 vaccine was 47% effective in preventing the disease. CureVac's study, conducted in 10 countries and involving 40,000 people, showed th..."},{"Date":"Jun. 17, 2021 at 6:44 a.m. ET","Headline":"CureVac tumbles 41% in premarket on COVID-19 vaccine disappointment","Summary":"Shares of CureVac  fell 42% in premarket trading on Thurdsay, a day after  its COVID-19 vaccine was 47% effective in preventing the disease. CureVac's study, conducted in 10 countries and involving 40,000 people, showed th..."},{"Date":"Jun. 17, 2021 at 6:25 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 177 million and CureVac vaccine is just 47% effective","Summary":"The global tally for the coronavirus-borne illness headed above 177 million on Thursday, , while deaths climbed above 3.8 million. The U.S. continues to lead the world in total cases at 33.49 million, while deaths total 60..."},{"Date":"Jun. 16, 2021 at 2:00 a.m. ET","Headline":"Join Barron\u2019s Investing in Tech Conference to Hear From the CEOs of Palantir, BioNTech, and Others","Summary":""},{"Date":"Jun. 20, 2021 at 4:33 p.m. ET","Headline":"U.S. sends Taiwan 2.5 million doses of COVID vaccine, tripling pledge","Summary":""},{"Date":"Jun. 19, 2021 at 12:12 p.m. ET","Headline":"U.S. moves to fill gap in treatments for COVID, as Delta variant creates worrying spike in new cases in the U.K.","Summary":""},{"Date":"Jun. 19, 2021 at 11:57 a.m. ET","Headline":"The U.K. has vaccinated 80% of adults but Delta variant cases are surging. What it means for the U.S.","Summary":""},{"Date":"Jun. 22, 2021 at 1:41 p.m. ET","Headline":"WHO warns poorer countries are not getting fair share of COVID vaccine supply, as Colombia passes 100,000 deaths","Summary":"New  published in JAMA found there was no difference in sperm parameters in 45 men who received mRNA vaccines against COVID-19. The two authorized mRNA vaccines, which were developed by Pfizer Inc.  and Moderna Inc. , are ..."},{"Date":"Jun. 22, 2021 at 9:01 a.m. ET","Headline":"Covid-19 Showed mRNA Vaccines Work. Translate Bio, Sanofi, Are Testing One for Flu.","Summary":"New  published in JAMA found there was no difference in sperm parameters in 45 men who received mRNA vaccines against COVID-19. The two authorized mRNA vaccines, which were developed by Pfizer Inc.  and Moderna Inc. , are ..."},{"Date":"Jun. 22, 2021 at 8:40 a.m. ET","Headline":"New research says Pfizer and Moderna's mRNA vaccines don't affect sperm parameters","Summary":"New  published in JAMA found there was no difference in sperm parameters in 45 men who received mRNA vaccines against COVID-19. The two authorized mRNA vaccines, which were developed by Pfizer Inc.  and Moderna Inc. , are ..."},{"Date":"Jun. 22, 2021 at 8:14 a.m. ET","Headline":"CDC committee to discuss rare cases of myocarditis occurring in people who have gotten their COVID-19 shots","Summary":"Federal health experts plan to meet on Wednesday and Thursday  rare but serious cases of myocarditis and pericarditis - inflammation of the heart - reported in about 800 people who have been vaccinated against COVID-19 wit..."},{"Date":"Jun. 21, 2021 at 3:10 p.m. ET","Headline":"American Airlines Cuts Flights to Relieve Strains of Travel Surge","Summary":""},{"Date":"Jun. 21, 2021 at 12:53 p.m. ET","Headline":"30 states likely to miss President Biden\u2019s July 4 vaccination goal, and Brazil\u2019s death toll has topped 500,000","Summary":""},{"Date":"Jun. 21, 2021 at 8:59 a.m. ET","Headline":"The U.K. Has Vaccinated 80% of Adults, But Delta Variant Cases Are Rising. What\u2019s Going On?","Summary":""},{"Date":"Jun. 21, 2021 at 8:29 a.m. ET","Headline":"Why This Market-Beating Investor Sold Apple Stock to Buy Berkshire Hathaway","Summary":""},{"Date":"Jun. 21, 2021 at 8:16 a.m. ET","Headline":"Theravance Stock Drops on Covid-19 Therapy Disappointment","Summary":""},{"Date":"Jun. 24, 2021 at 2:37 p.m. ET","Headline":"Brazil and Russia see fresh wave of COVID cases, showing pandemic is far from over in many places","Summary":"The global tally for the coronavirus-borne illness headed above 179.6 million on Thursday, , while deaths climbed above 3.89 million. The U.S. continues to lead the world in total cases at 33.6 million, and by deaths that ..."},{"Date":"Jun. 24, 2021 at 9:27 a.m. ET","Headline":"The CDC Isn\u2019t Convinced Yet That Covid-19 Boosters Are Required. What It Means for Vaccine Stocks.","Summary":"The global tally for the coronavirus-borne illness headed above 179.6 million on Thursday, , while deaths climbed above 3.89 million. The U.S. continues to lead the world in total cases at 33.6 million, and by deaths that ..."},{"Date":"Jun. 24, 2021 at 7:56 a.m. ET","Headline":"Tesla Stock Is Soaring Again. What\u2019s Behind the Big Gains.","Summary":"The global tally for the coronavirus-borne illness headed above 179.6 million on Thursday, , while deaths climbed above 3.89 million. The U.S. continues to lead the world in total cases at 33.6 million, and by deaths that ..."},{"Date":"Jun. 24, 2021 at 6:37 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 head toward 180 million and  death toll edges closer to 4 million","Summary":"The global tally for the coronavirus-borne illness headed above 179.6 million on Thursday, , while deaths climbed above 3.89 million. The U.S. continues to lead the world in total cases at 33.6 million, and by deaths that ..."},{"Date":"Jun. 23, 2021 at 11:07 p.m. ET","Headline":"Ohio ends incentive lottery, but still can\u2019t crack 50% vaccination rate","Summary":""},{"Date":"Jun. 23, 2021 at 3:55 p.m. ET","Headline":"Moderna and Other Vaccine Makers Dropped Wednesday. Here\u2019s Why.","Summary":""},{"Date":"Jun. 23, 2021 at 2:23 p.m. ET","Headline":"Delta variant of SARS-CoV-2 is now in 85 countries and accounts for 20% of U.S. infections in past two weeks","Summary":""},{"Date":"Jun. 23, 2021 at 11:23 a.m. ET","Headline":"Warren Buffett Donating $4.1 Billion of Berkshire Stock to Five Foundations","Summary":""},{"Date":"Jun. 23, 2021 at 11:16 a.m. ET","Headline":"Pfizer argues its case in federal court for helping seniors meet drug copays","Summary":""},{"Date":"Jun. 23, 2021 at 10:53 a.m. ET","Headline":"GlaxoSmithKline Just Announced a Dividend Cut. Why Its Stock Is Rising.","Summary":""},{"Date":"Jun. 23, 2021 at 8:36 a.m. ET","Headline":"Fauci Calls Delta Variant the \u201cGreatest Threat\u201d to Defeating Coronavirus","Summary":""},{"Date":"Jun. 23, 2021 at 7:52 a.m. ET","Headline":"From \u2018Death Cross\u2019 to a Near Bull Market: Bitcoin\u2019s Wild Ride","Summary":""},{"Date":"Jun. 21, 2021 at 10:28 a.m. ET","Headline":"Investors: Prepare for a Volatile Summer.","Summary":""},{"Date":"Jun. 26, 2021 at 10:18 a.m. ET","Headline":"Senate Republican Ron Johnson of Wisconsin is planning an event to publicize adverse vaccine experiences","Summary":""},{"Date":"Jun. 25, 2021 at 8:37 p.m. ET","Headline":"Pfizer Developed a Vaccine in Less Than a Year. There\u2019s More to Come.","Summary":""},{"Date":"Jun. 25, 2021 at 3:09 p.m. ET","Headline":"Global tally of COVID cases top 180 million as fast-spreading delta variant continues to alarm experts","Summary":""},{"Date":"Jun. 25, 2021 at 4:45 a.m. ET","Headline":"This Biotech Is Editing Genes Inside the Body. What It Means for the Stock.","Summary":""},{"Date":"Jun. 28, 2021 at 4:42 p.m. ET","Headline":"S&P 500, Nasdaq Composite book closing records, but Dow loses ground","Summary":""},{"Date":"Jun. 28, 2021 at 9:03 a.m. ET","Headline":"Will We Need Booster Vaccines for Covid-19? Study Raises Doubts.","Summary":""},{"Date":"Jun. 28, 2021 at 8:58 a.m. ET","Headline":"Third dose of AstraZeneca COVID-19 vaccine boosts immune response, Oxford study finds","Summary":""},{"Date":"Jun. 28, 2021 at 8:39 a.m. ET","Headline":"Gene Editing Data Look Good for Intellia. How It Made History.","Summary":""},{"Date":"Jun. 28, 2021 at 8:15 a.m. ET","Headline":"The 20 best-performing IPOs of the past three years have returned up to 1,477%","Summary":""},{"Date":"Jun. 28, 2021 at 8:06 a.m. ET","Headline":"The Covid-19 Booster Market Just Keeps Getting Bigger, Moderna\u2019s CEO Says","Summary":""},{"Date":"Jun. 30, 2021 at 2:36 p.m. ET","Headline":"More than 3 billion COVID vaccine shots administered globally, but unevenly. Delta variant now in 96 countries","Summary":"Shares of Moderna Inc.  were up 2.3% in premarket trading on Wednesday, the day after the company's stock price hit an all-time high of $234.60 when the market closed on Tuesday. Moderna has one authorized product, its two..."},{"Date":"Jun. 30, 2021 at 1:38 p.m. ET","Headline":"When can children get the the COVID-19 vaccine? Here\u2019s a timeline.","Summary":"Shares of Moderna Inc.  were up 2.3% in premarket trading on Wednesday, the day after the company's stock price hit an all-time high of $234.60 when the market closed on Tuesday. Moderna has one authorized product, its two..."},{"Date":"Jun. 30, 2021 at 11:32 a.m. ET","Headline":"Here Are the Best and Worst Biopharma Stock Performers So Far This Year","Summary":"Shares of Moderna Inc.  were up 2.3% in premarket trading on Wednesday, the day after the company's stock price hit an all-time high of $234.60 when the market closed on Tuesday. Moderna has one authorized product, its two..."},{"Date":"Jun. 30, 2021 at 8:20 a.m. ET","Headline":"Moderna's stock hits record price on Tuesday","Summary":"Shares of Moderna Inc.  were up 2.3% in premarket trading on Wednesday, the day after the company's stock price hit an all-time high of $234.60 when the market closed on Tuesday. Moderna has one authorized product, its two..."},{"Date":"Jun. 30, 2021 at 8:18 a.m. ET","Headline":"Cerevel Test Data Scrambles Schizophrenia Stocks","Summary":""},{"Date":"Jun. 30, 2021 at 3:43 a.m. ET","Headline":"The Delta variant is now surging in Germany as concern grows in Europe","Summary":""},{"Date":"Jun. 29, 2021 at 1:43 p.m. ET","Headline":"WHO says delta variant of COVID means even vaccinated people should keep wearing face masks, as more Asian cities lock down","Summary":""},{"Date":"Jun. 29, 2021 at 5:09 a.m. ET","Headline":"Australia offers AstraZeneca COVID-19 vaccine to all adults to speed up rollout","Summary":""},{"Date":"Jun. 28, 2021 at 10:39 a.m. ET","Headline":"Intellia Stock Is Rocketing Because of a Gene-Editing Breakthrough","Summary":""},{"Date":"Jul. 2, 2021 at 2:02 p.m. ET","Headline":"Rising COVID-19 cases in California highlight risks of delta variant, as WHO head warns world in dangerous period of pandemic","Summary":""},{"Date":"Jul. 2, 2021 at 10:01 a.m. ET","Headline":"J&J Covid-19 Vaccine Protects Against Delta Variant, Study Says","Summary":""},{"Date":"Jul. 1, 2021 at 2:10 p.m. ET","Headline":"Delta variant of COVID-19 creates surges in Europe and Asia, as Euro 2020 soccer tournament sparks outbreak","Summary":""},{"Date":"Jul. 1, 2021 at 9:03 a.m. ET","Headline":"Vaccine Makers\u2019 Stocks Are  Moving as Also-Rans Fight for Spots in the Market","Summary":""},{"Date":"Jul. 1, 2021 at 2:35 a.m. ET","Headline":"Those who get infected by COVID-19 after vaccines carry less viral load, study finds","Summary":""},{"Date":"Jun. 28, 2021 at 8:51 a.m. ET","Headline":"Our Top CEOs: Meet 30 Leaders Who Turned Crisis Into Opportunity","Summary":""},{"Date":"Jul. 3, 2021 at 8:48 a.m. ET","Headline":"Study finds Pfizer and Moderna vaccines may offer COVID protection for years, as Australia struggles to contain delta variant","Summary":""},{"Date":"Jul. 6, 2021 at 11:38 p.m. ET","Headline":"New Zealand approves use of J&J coronavirus vaccine","Summary":"Israel's health ministry said Monday the effectiveness of the COVID-19 shot developed by BioNTech SE  and Pfizer Inc.  is now thought to be 64% at preventing symptomatic infections in that country. The vaccine had an effic..."},{"Date":"Jul. 6, 2021 at 6:28 p.m. ET","Headline":"Campaign-finance experts unsurprised as U.S. companies resume political contributions paused after Jan. 6 insurrection","Summary":"Israel's health ministry said Monday the effectiveness of the COVID-19 shot developed by BioNTech SE  and Pfizer Inc.  is now thought to be 64% at preventing symptomatic infections in that country. The vaccine had an effic..."},{"Date":"Jul. 6, 2021 at 4:49 p.m. ET","Headline":"Stocks Close Down on Oil Drop and China Crackdown","Summary":"Israel's health ministry said Monday the effectiveness of the COVID-19 shot developed by BioNTech SE  and Pfizer Inc.  is now thought to be 64% at preventing symptomatic infections in that country. The vaccine had an effic..."},{"Date":"Jul. 6, 2021 at 3:45 p.m. ET","Headline":"Biden says COVID\u2019s delta variant should make you \u2018think twice\u2019 if you haven\u2019t gotten vaccinated","Summary":"Israel's health ministry said Monday the effectiveness of the COVID-19 shot developed by BioNTech SE  and Pfizer Inc.  is now thought to be 64% at preventing symptomatic infections in that country. The vaccine had an effic..."},{"Date":"Jul. 6, 2021 at 3:09 p.m. ET","Headline":"Israel says Pfizer vaccine just 64% effective in real world as delta variant continues to spread rapidly","Summary":"Israel's health ministry said Monday the effectiveness of the COVID-19 shot developed by BioNTech SE  and Pfizer Inc.  is now thought to be 64% at preventing symptomatic infections in that country. The vaccine had an effic..."},{"Date":"Jul. 6, 2021 at 11:43 a.m. ET","Headline":"Dr. Fauci advises vaccinated Americans to wear masks in areas with low COVID-19 immunization rates","Summary":"Israel's health ministry said Monday the effectiveness of the COVID-19 shot developed by BioNTech SE  and Pfizer Inc.  is now thought to be 64% at preventing symptomatic infections in that country. The vaccine had an effic..."},{"Date":"Jul. 6, 2021 at 10:47 a.m. ET","Headline":"Weibo Stock Is Soaring, Didi Is Tumbling, and the Dow Has Dropped 285 Points","Summary":"Israel's health ministry said Monday the effectiveness of the COVID-19 shot developed by BioNTech SE  and Pfizer Inc.  is now thought to be 64% at preventing symptomatic infections in that country. The vaccine had an effic..."},{"Date":"Jul. 6, 2021 at 10:15 a.m. ET","Headline":"Israel Says Covid-19 Vaccine Less Effective at Preventing Delta Variant Infections, but Data Is Mixed","Summary":"Israel's health ministry said Monday the effectiveness of the COVID-19 shot developed by BioNTech SE  and Pfizer Inc.  is now thought to be 64% at preventing symptomatic infections in that country. The vaccine had an effic..."},{"Date":"Jul. 6, 2021 at 8:55 a.m. ET","Headline":"Israel says Pfizer's COVID-19 shot is 64% effective against the infections from the delta variant","Summary":"Israel's health ministry said Monday the effectiveness of the COVID-19 shot developed by BioNTech SE  and Pfizer Inc.  is now thought to be 64% at preventing symptomatic infections in that country. The vaccine had an effic..."},{"Date":"Jul. 6, 2021 at 7:30 a.m. ET","Headline":"Full FDA approval of Pfizer\u2019s and Moderna\u2019s COVID-19 shots would reinvigorate the U.S. vaccination push \u2014 but it could still be months away","Summary":""},{"Date":"Jul. 6, 2021 at 7:26 a.m. ET","Headline":"Here\u2019s what could turn a \u2018breather\u2019 for stocks into a bigger correction","Summary":""},{"Date":"Jul. 8, 2021 at 2:44 p.m. ET","Headline":"Delta variant of COVID-19  could reverse trend of declining cases and deaths in the U.S., report warns","Summary":""},{"Date":"Jul. 8, 2021 at 6:48 a.m. ET","Headline":"Minneapolis Fed requiring COVID-19 vaccinations by next month \u2014 or employees will lose their jobs","Summary":""},{"Date":"Jul. 8, 2021 at 4:15 a.m. ET","Headline":"Vaccine Maker AstraZeneca\u2019s Strong Drug Pipeline Could Lift the Stock Higher for Years","Summary":""},{"Date":"Jul. 7, 2021 at 2:25 p.m. ET","Headline":"New daily COVID-19 cases and deaths spike to 6-week highs as delta variant spreads rapidly","Summary":""},{"Date":"Jul. 7, 2021 at 8:25 a.m. ET","Headline":"As worries emerge about the delta variant and the J&J shot, health officials \u2014 and, so far, the research \u2014 say the vaccinated are still protected","Summary":""},{"Date":"Jul. 7, 2021 at 7:54 a.m. ET","Headline":"Amazon\u2019s Jeff Bezos Is Getting Richer\u2014and You Can Too","Summary":""},{"Date":"Jul. 10, 2021 at 8:59 a.m. ET","Headline":"Weekend reads: Can you find a beautiful retirement spot for $250,000?","Summary":"Shares of Pfizer Inc.  gained 1.9% in trading on Friday, the day after the company put out a statement saying it plans to share clinical data for its experimental COVID-19 booster shot in August. Pfizer  it would share tha..."},{"Date":"Jul. 10, 2021 at 8:54 a.m. ET","Headline":"U.S. stocks recover to end Friday at record highs, advancing for a third straight week","Summary":"Shares of Pfizer Inc.  gained 1.9% in trading on Friday, the day after the company put out a statement saying it plans to share clinical data for its experimental COVID-19 booster shot in August. Pfizer  it would share tha..."},{"Date":"Jul. 9, 2021 at 8:53 p.m. ET","Headline":"Ohio, California, New York and Michigan are dangling million-dollar lotteries to get people vaccinated \u2014 but will it work?","Summary":"Shares of Pfizer Inc.  gained 1.9% in trading on Friday, the day after the company put out a statement saying it plans to share clinical data for its experimental COVID-19 booster shot in August. Pfizer  it would share tha..."},{"Date":"Jul. 9, 2021 at 5:26 p.m. ET","Headline":"Dow, S&P 500, and Nasdaq Close at New Records as Bond Yields Stabilize","Summary":"Shares of Pfizer Inc.  gained 1.9% in trading on Friday, the day after the company put out a statement saying it plans to share clinical data for its experimental COVID-19 booster shot in August. Pfizer  it would share tha..."},{"Date":"Jul. 9, 2021 at 2:55 p.m. ET","Headline":"Delta variant of COVID-19  is forcing Asian countries to lock down, while Africa suffers its worst week a year and a half into the pandemic","Summary":"Shares of Pfizer Inc.  gained 1.9% in trading on Friday, the day after the company put out a statement saying it plans to share clinical data for its experimental COVID-19 booster shot in August. Pfizer  it would share tha..."},{"Date":"Jul. 9, 2021 at 10:20 a.m. ET","Headline":"Pfizer says COVID-19 booster shot data coming in August, not July","Summary":"Shares of Pfizer Inc.  gained 1.9% in trading on Friday, the day after the company put out a statement saying it plans to share clinical data for its experimental COVID-19 booster shot in August. Pfizer  it would share tha..."},{"Date":"Jul. 9, 2021 at 9:02 a.m. ET","Headline":"CDC and FDA Signal They Won\u2019t Let Vaccine Makers Dictate Booster Timeline","Summary":"The global tally for the coronavirus-borne illness rose above 185.5 million on Friday, while the death toll climbed further above 4.01 million, according to . The U.S. leads the world with a total of 33.79 million cases an..."},{"Date":"Jul. 9, 2021 at 8:44 a.m. ET","Headline":"Pfizer and BioNTech to develop booster vaccine for delta variant","Summary":"The global tally for the coronavirus-borne illness rose above 185.5 million on Friday, while the death toll climbed further above 4.01 million, according to . The U.S. leads the world with a total of 33.79 million cases an..."},{"Date":"Jul. 9, 2021 at 8:26 a.m. ET","Headline":"U.S. drug regulators unmoved by Pfizer plan to seek Covid booster authorization","Summary":"The global tally for the coronavirus-borne illness rose above 185.5 million on Friday, while the death toll climbed further above 4.01 million, according to . The U.S. leads the world with a total of 33.79 million cases an..."},{"Date":"Jul. 9, 2021 at 8:18 a.m. ET","Headline":"Earnings Season Is Coming. It Could Make or Break the Stock Market.","Summary":"The global tally for the coronavirus-borne illness rose above 185.5 million on Friday, while the death toll climbed further above 4.01 million, according to . The U.S. leads the world with a total of 33.79 million cases an..."},{"Date":"Jul. 9, 2021 at 7:00 a.m. ET","Headline":"Here\u2019s what a megadrought in North America means for investors \u2014 and, possibly, the Fed","Summary":"The global tally for the coronavirus-borne illness rose above 185.5 million on Friday, while the death toll climbed further above 4.01 million, according to . The U.S. leads the world with a total of 33.79 million cases an..."},{"Date":"Jul. 9, 2021 at 6:19 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 185.5 million and Pfizer to develop booster against delta variant","Summary":"The global tally for the coronavirus-borne illness rose above 185.5 million on Friday, while the death toll climbed further above 4.01 million, according to . The U.S. leads the world with a total of 33.79 million cases an..."},{"Date":"Jul. 9, 2021 at 5:00 a.m. ET","Headline":"Here Are the Cheapest Stocks in Each Sector. Some Deserve the Discount, Others Look Like Bargains.","Summary":""},{"Date":"Jul. 8, 2021 at 7:20 p.m. ET","Headline":"Pfizer and BioNTech Plan to Seek FDA Approval for Covid-19 Booster","Summary":""},{"Date":"Jul. 12, 2021 at 2:01 p.m. ET","Headline":"Fauci says COVID-19 vaccine boosters not needed for now, with delta variant mostly infecting the unvaccinated","Summary":""},{"Date":"Jul. 12, 2021 at 8:16 a.m. ET","Headline":"Pfizer Will Make the Case for Booster Dose to Federal Regulators","Summary":""},{"Date":"Jul. 12, 2021 at 7:44 a.m. ET","Headline":"Pfizer, citing Israeli data that says the delta variant is making its COVID-19 shot less effective, calls for boosters. Medical experts say it\u2019s too soon to worry.","Summary":""},{"Date":"Jul. 11, 2021 at 4:25 p.m. ET","Headline":"Pfizer to discuss vaccine booster with U.S. officials Monday","Summary":""},{"Date":"Jul. 14, 2021 at 2:10 p.m. ET","Headline":"Delta variant drove COVID-19 cases higher across the globe last week \u2014 including in the U.S.","Summary":"The global tally for the coronavirus-borne illness climbed above 187 million on Tuesday, while the death toll climbed further above 4.03 million, according to . The U.S. leads the world with a total of 33.88 million cases ..."},{"Date":"Jul. 14, 2021 at 9:20 a.m. ET","Headline":"Should schools and employers mandate COVID vaccination? Americans come down on one side \u2014 by a whisker","Summary":"The global tally for the coronavirus-borne illness climbed above 187 million on Tuesday, while the death toll climbed further above 4.03 million, according to . The U.S. leads the world with a total of 33.88 million cases ..."},{"Date":"Jul. 13, 2021 at 5:44 p.m. ET","Headline":"FDA Warns of New Rare Side Effect of J&J Vaccine","Summary":"The global tally for the coronavirus-borne illness climbed above 187 million on Tuesday, while the death toll climbed further above 4.03 million, according to . The U.S. leads the world with a total of 33.88 million cases ..."},{"Date":"Jul. 13, 2021 at 2:56 p.m. ET","Headline":"WHO head slams countries for ordering millions of COVID booster shots, when much of the world has not even vaccinated the most vulnerable","Summary":"The global tally for the coronavirus-borne illness climbed above 187 million on Tuesday, while the death toll climbed further above 4.03 million, according to . The U.S. leads the world with a total of 33.88 million cases ..."},{"Date":"Jul. 13, 2021 at 1:04 p.m. ET","Headline":"The EU won\u2019t let travelers in who got certain versions of these COVID-19 vaccines","Summary":"The global tally for the coronavirus-borne illness climbed above 187 million on Tuesday, while the death toll climbed further above 4.03 million, according to . The U.S. leads the world with a total of 33.88 million cases ..."},{"Date":"Jul. 13, 2021 at 12:54 p.m. ET","Headline":"Here\u2019s why just allowing an \u2018exit wave\u2019 of COVID-19 cases carries huge risks for countries","Summary":"The global tally for the coronavirus-borne illness climbed above 187 million on Tuesday, while the death toll climbed further above 4.03 million, according to . The U.S. leads the world with a total of 33.88 million cases ..."},{"Date":"Jul. 13, 2021 at 10:16 a.m. ET","Headline":"Pfizer Met With Government Scientists. Approval of a Booster Dose Is No Closer.","Summary":"The global tally for the coronavirus-borne illness climbed above 187 million on Tuesday, while the death toll climbed further above 4.03 million, according to . The U.S. leads the world with a total of 33.88 million cases ..."},{"Date":"Jul. 13, 2021 at 7:50 a.m. ET","Headline":"Earnings Season Is Here. Look Beyond the Numbers.","Summary":"The global tally for the coronavirus-borne illness climbed above 187 million on Tuesday, while the death toll climbed further above 4.03 million, according to . The U.S. leads the world with a total of 33.88 million cases ..."},{"Date":"Jul. 13, 2021 at 6:27 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 187 million as FDA tells Pfizer no boosters needed for now","Summary":"The global tally for the coronavirus-borne illness climbed above 187 million on Tuesday, while the death toll climbed further above 4.03 million, according to . The U.S. leads the world with a total of 33.88 million cases ..."},{"Date":"Jul. 16, 2021 at 10:40 p.m. ET","Headline":"Zoetis Stock Soared During the Pandemic. This Analyst Says the Run Is Over.","Summary":"The global tally for the coronavirus-borne illness climbed above 188.9 million on Friday, while the death toll climbed further above 4.06 million, according to . The U.S. leads the world with a total of 33.9 million cases ..."},{"Date":"Jul. 16, 2021 at 4:39 p.m. ET","Headline":"7 Companies Opened for Trading. Here\u2019s How They Did.","Summary":"The global tally for the coronavirus-borne illness climbed above 188.9 million on Friday, while the death toll climbed further above 4.06 million, according to . The U.S. leads the world with a total of 33.9 million cases ..."},{"Date":"Jul. 16, 2021 at 2:06 p.m. ET","Headline":"COVID-19 cases now rising in all 50 states, as global tally tops 189 million","Summary":"The global tally for the coronavirus-borne illness climbed above 188.9 million on Friday, while the death toll climbed further above 4.06 million, according to . The U.S. leads the world with a total of 33.9 million cases ..."},{"Date":"Jul. 16, 2021 at 9:07 a.m. ET","Headline":"A COVID hiccup as New York Yankees open second half of season against archrival Boston Red Sox","Summary":"The global tally for the coronavirus-borne illness climbed above 188.9 million on Friday, while the death toll climbed further above 4.06 million, according to . The U.S. leads the world with a total of 33.9 million cases ..."},{"Date":"Jul. 16, 2021 at 7:37 a.m. ET","Headline":"Moderna set to join S&P 500, stock rallies 8% after hours","Summary":"The global tally for the coronavirus-borne illness climbed above 188.9 million on Friday, while the death toll climbed further above 4.06 million, according to . The U.S. leads the world with a total of 33.9 million cases ..."},{"Date":"Jul. 16, 2021 at 6:44 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 near 189 million; BioNTech vaccine sees 10 times more antibodies than Sinovac one in study","Summary":"The global tally for the coronavirus-borne illness climbed above 188.9 million on Friday, while the death toll climbed further above 4.06 million, according to . The U.S. leads the world with a total of 33.9 million cases ..."},{"Date":"Jul. 15, 2021 at 6:22 p.m. ET","Headline":"Los Angeles County to restore indoor mask mandate for all","Summary":""},{"Date":"Jul. 15, 2021 at 2:53 p.m. ET","Headline":"U.S. COVID-19 cases more than double in two weeks as delta variant spreads fast, and WHO warns \u2018pandemic nowhere near finished\u2019","Summary":""},{"Date":"Jul. 15, 2021 at 11:04 a.m. ET","Headline":"What are the symptoms of Guillain-Barr\u00e9 syndrome? Should I still get the J&J vaccine?","Summary":""},{"Date":"Jul. 20, 2021 at 7:10 p.m. ET","Headline":"Drug Distributors Reach $1.2 Billion Opioid Settlement with New York State","Summary":"Pfizer Inc.  said Friday that the Food and Drug Administration accepted its application for  of the COVID-19 vaccine it developed with BioNTech SE . As part of the application process, the FDA sets a decision date based on..."},{"Date":"Jul. 20, 2021 at 4:27 p.m. ET","Headline":"American Academy of Pediatrics urges universal masking in schools for everyone ages 2 and up \u2014 whether vaccinated or not","Summary":"Pfizer Inc.  said Friday that the Food and Drug Administration accepted its application for  of the COVID-19 vaccine it developed with BioNTech SE . As part of the application process, the FDA sets a decision date based on..."},{"Date":"Jul. 20, 2021 at 1:55 p.m. ET","Headline":"U.S. warns travelers to avoid U.K. as long as delta variant of COVID is rampant, and study finds India death toll likely 10 times higher than official count","Summary":"Pfizer Inc.  said Friday that the Food and Drug Administration accepted its application for  of the COVID-19 vaccine it developed with BioNTech SE . As part of the application process, the FDA sets a decision date based on..."},{"Date":"Jul. 19, 2021 at 4:09 p.m. ET","Headline":"The Stock Market Had Its Worst Day in Months as Covid-19 Fears Sent Investors Fleeing to Bonds","Summary":"Pfizer Inc.  said Friday that the Food and Drug Administration accepted its application for  of the COVID-19 vaccine it developed with BioNTech SE . As part of the application process, the FDA sets a decision date based on..."},{"Date":"Jul. 19, 2021 at 3:13 p.m. ET","Headline":"Covid Cases Are Rising. Why This Wave May Be Different.","Summary":"Pfizer Inc.  said Friday that the Food and Drug Administration accepted its application for  of the COVID-19 vaccine it developed with BioNTech SE . As part of the application process, the FDA sets a decision date based on..."},{"Date":"Jul. 19, 2021 at 1:02 p.m. ET","Headline":"U.K. drops COVID restrictions against advice of experts, and delta variant drives cases higher across the U.S.","Summary":"Pfizer Inc.  said Friday that the Food and Drug Administration accepted its application for  of the COVID-19 vaccine it developed with BioNTech SE . As part of the application process, the FDA sets a decision date based on..."},{"Date":"Jul. 19, 2021 at 11:34 a.m. ET","Headline":"Pfizer is making the case for COVID-19 booster shots, but Fauci says we don\u2019t need a third dose yet","Summary":"Pfizer Inc.  said Friday that the Food and Drug Administration accepted its application for  of the COVID-19 vaccine it developed with BioNTech SE . As part of the application process, the FDA sets a decision date based on..."},{"Date":"Jul. 19, 2021 at 8:57 a.m. ET","Headline":"Pfizer says FDA's decision to approve its COVID-19 vaccine is expected by January","Summary":"Pfizer Inc.  said Friday that the Food and Drug Administration accepted its application for  of the COVID-19 vaccine it developed with BioNTech SE . As part of the application process, the FDA sets a decision date based on..."},{"Date":"Jul. 19, 2021 at 8:50 a.m. ET","Headline":"BioNTech to buy T-cell receptor facility and platform from Gilead Sciences","Summary":"Shares of BioNTech SE  were down 2.4% in premarket trading on Monday after the company said it plans to buy one of Gilead Sciences Inc.'s  clinical manufacturing facilities and its platform for T-cell receptor therapies. T..."},{"Date":"Jul. 19, 2021 at 8:47 a.m. ET","Headline":"Big Contrarian Investor Sold Apple, Microsoft Stock, Bought Pfizer and Merck","Summary":""},{"Date":"Jul. 22, 2021 at 3:11 p.m. ET","Headline":"Biden says COVID-19 fast becoming pandemic of unvaccinated, hopes children under 12 can join program \u2018within months\u2019","Summary":"Shares of Arvinas Inc.  were up 6.0% in premarket trading on Thursday after the company announced a billion-dollar deal with Pfizer Inc.  to develop and commercialize its experimental breast-cancer treatment. Pfizer will m..."},{"Date":"Jul. 22, 2021 at 1:19 p.m. ET","Headline":"Mask Wearing Is Back. Going Back to the Office Might Be Delayed. The Covid Crisis Isn\u2019t Over.","Summary":"Shares of Arvinas Inc.  were up 6.0% in premarket trading on Thursday after the company announced a billion-dollar deal with Pfizer Inc.  to develop and commercialize its experimental breast-cancer treatment. Pfizer will m..."},{"Date":"Jul. 22, 2021 at 8:06 a.m. ET","Headline":"Pfizer to pay at least $1 billion to develop, commercialize Arvinas' investigational breast-cancer therapy","Summary":"Shares of Arvinas Inc.  were up 6.0% in premarket trading on Thursday after the company announced a billion-dollar deal with Pfizer Inc.  to develop and commercialize its experimental breast-cancer treatment. Pfizer will m..."},{"Date":"Jul. 22, 2021 at 7:08 a.m. ET","Headline":"An \u2018above-average growth story\u2019 is about to unfold. 3 stocks to play it from a top-performing fund manager.","Summary":"Shares of Pfizer Inc.  gained 0.5% in premarket trading on Wednesday after the company and its COVID-19 partner BioNTech SE  signed a deal with a South African drug maker to produce and distribute their shot in the African..."},{"Date":"Jul. 21, 2021 at 7:48 p.m. ET","Headline":"South African company to start making Pfizer vaccine","Summary":"Shares of Pfizer Inc.  gained 0.5% in premarket trading on Wednesday after the company and its COVID-19 partner BioNTech SE  signed a deal with a South African drug maker to produce and distribute their shot in the African..."},{"Date":"Jul. 21, 2021 at 1:21 p.m. ET","Headline":"Delta variant of SARS-CoV-2 will likely be dominant strain globally within months after spreading to 124 countries, says WHO","Summary":"Shares of Pfizer Inc.  gained 0.5% in premarket trading on Wednesday after the company and its COVID-19 partner BioNTech SE  signed a deal with a South African drug maker to produce and distribute their shot in the African..."},{"Date":"Jul. 21, 2021 at 9:55 a.m. ET","Headline":"J&J Earnings Beat Expectations as Study Raises Doubts Over Vaccine\u2019s Efficacy","Summary":"Shares of Pfizer Inc.  gained 0.5% in premarket trading on Wednesday after the company and its COVID-19 partner BioNTech SE  signed a deal with a South African drug maker to produce and distribute their shot in the African..."},{"Date":"Jul. 21, 2021 at 9:54 a.m. ET","Headline":"The World Is Squandering Vaccines as New Wave Starts, WHO Chief Says","Summary":"Shares of Pfizer Inc.  gained 0.5% in premarket trading on Wednesday after the company and its COVID-19 partner BioNTech SE  signed a deal with a South African drug maker to produce and distribute their shot in the African..."},{"Date":"Jul. 21, 2021 at 9:25 a.m. ET","Headline":"Delta variant will be the \u2018most serious virus\u2019 the unvaccinated ever get, says ex-FDA head Gottlieb","Summary":"Shares of Pfizer Inc.  gained 0.5% in premarket trading on Wednesday after the company and its COVID-19 partner BioNTech SE  signed a deal with a South African drug maker to produce and distribute their shot in the African..."},{"Date":"Jul. 21, 2021 at 7:47 a.m. ET","Headline":"Pfizer, BioNTech partner with South African drug maker to make and distribute COVID-19 shot in Africa","Summary":"Shares of Pfizer Inc.  gained 0.5% in premarket trading on Wednesday after the company and its COVID-19 partner BioNTech SE  signed a deal with a South African drug maker to produce and distribute their shot in the African..."},{"Date":"Jul. 21, 2021 at 7:17 a.m. ET","Headline":"Immunity provided by COVID-19 vaccines likely to \u2018wane, not plummet,\u2019 CDC director tells Congress","Summary":""},{"Date":"Jul. 21, 2021 at 2:10 a.m. ET","Headline":"Johnson & Johnson COVID-19 vaccine may not perform as well against delta variant, says study","Summary":""},{"Date":"Jul. 23, 2021 at 10:03 p.m. ET","Headline":"Musk Tweets That Tesla Will Share Its Charging Network. Why That\u2019s a Savvy Move.","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday the U.S. government has purchased an additional 200 million doses of their COVID-19 vaccine. The partners said the new doses will be delivered from Oct. 2021 through..."},{"Date":"Jul. 23, 2021 at 2:19 p.m. ET","Headline":"With COVID cases rising in all 50 states, CDC head  urges unvaccinated to get their shots; U.S. \u2018not out of the woods yet\u2019","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday the U.S. government has purchased an additional 200 million doses of their COVID-19 vaccine. The partners said the new doses will be delivered from Oct. 2021 through..."},{"Date":"Jul. 23, 2021 at 1:34 p.m. ET","Headline":"This is the tipping point for when people vaccinated against COVID-19 should mask up again indoors","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday the U.S. government has purchased an additional 200 million doses of their COVID-19 vaccine. The partners said the new doses will be delivered from Oct. 2021 through..."},{"Date":"Jul. 23, 2021 at 11:31 a.m. ET","Headline":"Booster Shots Seem More Likely. Israeli Data Show Delta Variant\u2019s Risks.","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday the U.S. government has purchased an additional 200 million doses of their COVID-19 vaccine. The partners said the new doses will be delivered from Oct. 2021 through..."},{"Date":"Jul. 23, 2021 at 7:34 a.m. ET","Headline":"The FDA may not fully approve a COVID-19 vaccine until January. Here\u2019s why.","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday the U.S. government has purchased an additional 200 million doses of their COVID-19 vaccine. The partners said the new doses will be delivered from Oct. 2021 through..."},{"Date":"Jul. 23, 2021 at 7:29 a.m. ET","Headline":"Chip Stocks Can\u2019t Win Right Now. Investors Can.","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday the U.S. government has purchased an additional 200 million doses of their COVID-19 vaccine. The partners said the new doses will be delivered from Oct. 2021 through..."},{"Date":"Jul. 23, 2021 at 6:54 a.m. ET","Headline":"Pfizer and BioNTech to supply U.S. govt with additional 200 million doses of COVID-19 vaccine","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday the U.S. government has purchased an additional 200 million doses of their COVID-19 vaccine. The partners said the new doses will be delivered from Oct. 2021 through..."},{"Date":"Jul. 26, 2021 at 9:44 p.m. ET","Headline":"BioNTech CEO Says Vaccine Is Growing Less Effective, but Still Prevents Severe Disease","Summary":""},{"Date":"Jul. 26, 2021 at 5:44 p.m. ET","Headline":"Moderna expanding children\u2019s COVID-19 vaccine study to better assess safety","Summary":""},{"Date":"Jul. 26, 2021 at 5:15 p.m. ET","Headline":"VA to require COVID-19 vaccination for health care workers","Summary":""},{"Date":"Jul. 26, 2021 at 1:02 p.m. ET","Headline":"Fauci confirms U.S. health officials are taking a fresh look at face masks, as COVID-19 cases continue to spread","Summary":""},{"Date":"Jul. 26, 2021 at 12:00 p.m. ET","Headline":"Covid Boosters Are Coming This Year for People 50 and Older, Citi Analyst Predicts","Summary":""},{"Date":"Jul. 26, 2021 at 10:44 a.m. ET","Headline":"100 American athletes at the Tokyo Olympics are unvaccinated, team doctor says","Summary":""},{"Date":"Jul. 25, 2021 at 6:47 p.m. ET","Headline":"Bipartisan Senators Group is Close to an Infrastructure Deal","Summary":""},{"Date":"Jul. 25, 2021 at 5:31 p.m. ET","Headline":"Rising Covid Cases Put the Economic Recovery at Risk. What You Need to Know.","Summary":""},{"Date":"Jul. 28, 2021 at 4:23 p.m. ET","Headline":"Dow ends slightly lower after Fed leaves easy-monetary policies unchanged","Summary":"Shares of Pfizer Inc.  were down 0.6% in premarket trading on Wednesday after the company clocked another nearly $8 billion in revenue for the COVID-19 vaccine it developed with BioNTech SE . Pfizer now expects that the va..."},{"Date":"Jul. 28, 2021 at 4:07 p.m. ET","Headline":"GOP Senators Say Agreement Reached on Infrastructure Plan","Summary":"Shares of Pfizer Inc.  were down 0.6% in premarket trading on Wednesday after the company clocked another nearly $8 billion in revenue for the COVID-19 vaccine it developed with BioNTech SE . Pfizer now expects that the va..."},{"Date":"Jul. 28, 2021 at 2:08 p.m. ET","Headline":"No, you\u2019re not crazy. Yes, the CDC\u2019s mask guidelines are confusing \u2014 should you wear a mask indoors even if you\u2019re vaccinated?","Summary":"Shares of Pfizer Inc.  were down 0.6% in premarket trading on Wednesday after the company clocked another nearly $8 billion in revenue for the COVID-19 vaccine it developed with BioNTech SE . Pfizer now expects that the va..."},{"Date":"Jul. 28, 2021 at 1:54 p.m. ET","Headline":"CDC head takes to the airwaves to sell change on face masks, as delta variant of SARS-CoV-2 spreads to 132 countries","Summary":"Shares of Pfizer Inc.  were down 0.6% in premarket trading on Wednesday after the company clocked another nearly $8 billion in revenue for the COVID-19 vaccine it developed with BioNTech SE . Pfizer now expects that the va..."},{"Date":"Jul. 28, 2021 at 10:52 a.m. ET","Headline":"CDC: Vaccinated Americans should start wearing masks again indoors in areas with high COVID-19 transmission rates","Summary":"Shares of Pfizer Inc.  were down 0.6% in premarket trading on Wednesday after the company clocked another nearly $8 billion in revenue for the COVID-19 vaccine it developed with BioNTech SE . Pfizer now expects that the va..."},{"Date":"Jul. 28, 2021 at 10:08 a.m. ET","Headline":"Bristol Myers Squibb Stock Rises After Modest Earnings Beat","Summary":"Shares of Pfizer Inc.  were down 0.6% in premarket trading on Wednesday after the company clocked another nearly $8 billion in revenue for the COVID-19 vaccine it developed with BioNTech SE . Pfizer now expects that the va..."},{"Date":"Jul. 28, 2021 at 9:37 a.m. ET","Headline":"Pfizer Covid Vaccine Sales Are Booming \u2014 and Should Keep on Booming","Summary":"Shares of Pfizer Inc.  were down 0.6% in premarket trading on Wednesday after the company clocked another nearly $8 billion in revenue for the COVID-19 vaccine it developed with BioNTech SE . Pfizer now expects that the va..."},{"Date":"Jul. 28, 2021 at 8:43 a.m. ET","Headline":"Pfizer's COVID-19 vaccine generated $7.8 billion in revenue in the second quarter","Summary":"Shares of Pfizer Inc.  were down 0.6% in premarket trading on Wednesday after the company clocked another nearly $8 billion in revenue for the COVID-19 vaccine it developed with BioNTech SE . Pfizer now expects that the va..."},{"Date":"Jul. 28, 2021 at 8:01 a.m. ET","Headline":"Pfizer shares limited data about its COVID-19 booster candidate, says it ups protection against the delta variant","Summary":"Pfizer Inc.  said Wednesday that a third dose of its COVID-19 vaccine likely provides further protection against the delta variant, which is more infectious and thought to be driving the recent surge in cases, hospitalizat..."},{"Date":"Jul. 28, 2021 at 6:07 a.m. ET","Headline":"CDC reverses policy on face masks, amid reports of breakthrough infections with delta variant of COVID-19","Summary":""},{"Date":"Jul. 27, 2021 at 6:05 p.m. ET","Headline":"CDC Recommends That Vaccinated People Resume Wearing Masks Indoors","Summary":""},{"Date":"Jul. 27, 2021 at 8:50 a.m. ET","Headline":"Covid Cases Are Dropping in the U.K. What It Means for the U.S.","Summary":""},{"Date":"Jul. 27, 2021 at 7:51 a.m. ET","Headline":"Chinese Stocks Were Crushed Again. The Pain Is Spreading.","Summary":""},{"Date":"Jul. 27, 2021 at 6:00 a.m. ET","Headline":"Why It\u2019s Hard to Go Wrong With Bristol Myers Stock","Summary":""},{"Date":"Jul. 27, 2021 at 4:12 a.m. ET","Headline":"China and Hong Kong stocks remain under pressure for a third day. Other Asian stocks rise amid Wall St records","Summary":""},{"Date":"Jul. 26, 2021 at 8:23 a.m. ET","Headline":"Apple, Tesla, Amazon, Pfizer, and Other Stocks to Watch This Week","Summary":""},{"Date":"Jul. 30, 2021 at 3:08 p.m. ET","Headline":"How Contagious Is the Delta Variant? CDC Study Sheds Light.","Summary":""},{"Date":"Jul. 30, 2021 at 2:08 p.m. ET","Headline":"CDC releases data that informed reconsideration of face masks, says delta variant of COVID means the \u2018war has changed\u2019","Summary":""},{"Date":"Jul. 29, 2021 at 6:01 p.m. ET","Headline":"What It Will Take to Get America Vaccinated, According to Biden","Summary":""},{"Date":"Jul. 29, 2021 at 4:44 p.m. ET","Headline":"Israel to offer Pfizer vaccine booster shots to those over 60","Summary":""},{"Date":"Jul. 29, 2021 at 11:18 a.m. ET","Headline":"AstraZeneca Covid Vaccine Sales Surge. The Drugmaker Has a Dilemma.","Summary":""},{"Date":"Jul. 29, 2021 at 11:14 a.m. ET","Headline":"Biden expected to outline requirement for federal workers to get vaccinated or face regular tests in latest push for U.S. vaccine program","Summary":""},{"Date":"Jul. 29, 2021 at 10:16 a.m. ET","Headline":"Latest Covid Spike Means You May Want a Booster Shot","Summary":""},{"Date":"Aug. 1, 2021 at 3:25 p.m. ET","Headline":"Vaccine Mandates Could Be Good News for Vaccine Makers","Summary":""},{"Date":"Jul. 31, 2021 at 2:53 p.m. ET","Headline":"Are teachers next in line for vaccine mandates? \u2018It\u2019s going be a very difficult school year\u2019","Summary":""},{"Date":"Aug. 3, 2021 at 8:10 p.m. ET","Headline":"FDA aims for full approval of Pfizer COVID-19 vaccine by Labor Day: report","Summary":"Shares of Translate Bio Inc.  soared 29.8% in premarket trading on Tuesday after Sanofi  said it will spend $3.2 billion to buy the developer of messenger RNA (mRNA) technologies. The U.S.-listed shares of Sanofi were down..."},{"Date":"Aug. 3, 2021 at 2:45 p.m. ET","Headline":"The Race Is On to Vaccinate School Kids This Year","Summary":"Shares of Translate Bio Inc.  soared 29.8% in premarket trading on Tuesday after Sanofi  said it will spend $3.2 billion to buy the developer of messenger RNA (mRNA) technologies. The U.S.-listed shares of Sanofi were down..."},{"Date":"Aug. 3, 2021 at 2:14 p.m. ET","Headline":"Biden to make fresh plea for the unvaccinated to get their shots after CDC raises alarm on delta variant of COVID-19","Summary":"Shares of Translate Bio Inc.  soared 29.8% in premarket trading on Tuesday after Sanofi  said it will spend $3.2 billion to buy the developer of messenger RNA (mRNA) technologies. The U.S.-listed shares of Sanofi were down..."},{"Date":"Aug. 3, 2021 at 1:16 p.m. ET","Headline":"Translate Bio Stock Jumps After Agreeing to Be Bought by Sanofi. Why It\u2019s a Smart Deal.","Summary":"Shares of Translate Bio Inc.  soared 29.8% in premarket trading on Tuesday after Sanofi  said it will spend $3.2 billion to buy the developer of messenger RNA (mRNA) technologies. The U.S.-listed shares of Sanofi were down..."},{"Date":"Aug. 3, 2021 at 10:43 a.m. ET","Headline":"New York City mandates vaccination for access to restaurants, gyms and other indoor venues","Summary":"Shares of Translate Bio Inc.  soared 29.8% in premarket trading on Tuesday after Sanofi  said it will spend $3.2 billion to buy the developer of messenger RNA (mRNA) technologies. The U.S.-listed shares of Sanofi were down..."},{"Date":"Aug. 3, 2021 at 10:03 a.m. ET","Headline":"\u2018I don\u2019t want to lose you\u2019: How families approached their loved ones about the importance of getting the COVID-19 vaccination","Summary":"Shares of Translate Bio Inc.  soared 29.8% in premarket trading on Tuesday after Sanofi  said it will spend $3.2 billion to buy the developer of messenger RNA (mRNA) technologies. The U.S.-listed shares of Sanofi were down..."},{"Date":"Aug. 3, 2021 at 8:15 a.m. ET","Headline":"Sanofi to buy mRNA developer for $3.2 billion","Summary":"Shares of Translate Bio Inc.  soared 29.8% in premarket trading on Tuesday after Sanofi  said it will spend $3.2 billion to buy the developer of messenger RNA (mRNA) technologies. The U.S.-listed shares of Sanofi were down..."},{"Date":"Aug. 3, 2021 at 6:37 a.m. ET","Headline":"Chinese Stocks Feel the Pain Again. This Time It\u2019s the Gaming Sector.","Summary":"The U.S. reached a COVID-19 milestone on Monday by having 70% of American adults receive at least one dose of a vaccine,  from Cyrus Shahpar, White House COVID-19 data director, emergency physician and epidemiologist. Pres..."},{"Date":"Aug. 2, 2021 at 3:55 p.m. ET","Headline":"Germany set to begin vaccinating teens 12 and over and offering COVID booster shots to older and at-risk people","Summary":"The U.S. reached a COVID-19 milestone on Monday by having 70% of American adults receive at least one dose of a vaccine,  from Cyrus Shahpar, White House COVID-19 data director, emergency physician and epidemiologist. Pres..."},{"Date":"Aug. 2, 2021 at 2:46 p.m. ET","Headline":"Videogames entered the mainstream for good in the pandemic, but the industry faces a rough transition","Summary":"The U.S. reached a COVID-19 milestone on Monday by having 70% of American adults receive at least one dose of a vaccine,  from Cyrus Shahpar, White House COVID-19 data director, emergency physician and epidemiologist. Pres..."},{"Date":"Aug. 2, 2021 at 1:29 p.m. ET","Headline":"U.S. COVID-19 daily case tally back at February levels, and patients are getting younger as Florida records highest hospitalizations yet","Summary":"The U.S. reached a COVID-19 milestone on Monday by having 70% of American adults receive at least one dose of a vaccine,  from Cyrus Shahpar, White House COVID-19 data director, emergency physician and epidemiologist. Pres..."},{"Date":"Aug. 2, 2021 at 1:24 p.m. ET","Headline":"U.S. reaches COVID-19 milestone of 70% of adults receiving at least one vaccine dose: White House","Summary":"The U.S. reached a COVID-19 milestone on Monday by having 70% of American adults receive at least one dose of a vaccine,  from Cyrus Shahpar, White House COVID-19 data director, emergency physician and epidemiologist. Pres..."},{"Date":"Aug. 2, 2021 at 12:05 p.m. ET","Headline":"Countries Are Preparing to Offer Booster Shots. What It Means for Vaccine Makers.","Summary":""},{"Date":"Aug. 2, 2021 at 8:20 a.m. ET","Headline":"Covid Has Boosted the Healthcare Sector. This Stock Is a Prime Example.","Summary":""},{"Date":"Aug. 2, 2021 at 8:08 a.m. ET","Headline":"Buy This Drugmaker Stock Because Its Turnaround Could Be Accelerated","Summary":""},{"Date":"Aug. 2, 2021 at 7:16 a.m. ET","Headline":"No deaths, few hospitalizations, but 74% of those testing positive for COVID-19 in Massachusetts outbreak were vaccinated","Summary":""},{"Date":"Aug. 5, 2021 at 2:39 p.m. ET","Headline":"Global tally of COVID-19 cases tops 200 million as U.S., Germany and France push back against WHO call on boosters","Summary":"Moderna Inc.'s  said Thursday that its COVID-19 vaccine is 93% efficacious six months after the second dose as part of its . This is different than what Pfizer Inc.  said last week about its COVID-19 shot, which is that % ..."},{"Date":"Aug. 5, 2021 at 11:35 a.m. ET","Headline":"Biden White House minimizes WHO call for booster-shot moratorium as \u2018false choice\u2019","Summary":"Moderna Inc.'s  said Thursday that its COVID-19 vaccine is 93% efficacious six months after the second dose as part of its . This is different than what Pfizer Inc.  said last week about its COVID-19 shot, which is that % ..."},{"Date":"Aug. 5, 2021 at 7:29 a.m. ET","Headline":"Pfizer says immunity can drop to 83% within four months in people who got its COVID-19 shot, further bolstering the company case for a booster","Summary":"Moderna Inc.'s  said Thursday that its COVID-19 vaccine is 93% efficacious six months after the second dose as part of its . This is different than what Pfizer Inc.  said last week about its COVID-19 shot, which is that % ..."},{"Date":"Aug. 5, 2021 at 7:27 a.m. ET","Headline":"Moderna says its COVID-19 shot provides 93% immunity after six months","Summary":"Moderna Inc.'s  said Thursday that its COVID-19 vaccine is 93% efficacious six months after the second dose as part of its . This is different than what Pfizer Inc.  said last week about its COVID-19 shot, which is that % ..."},{"Date":"Aug. 5, 2021 at 7:05 a.m. ET","Headline":"The brief history of meme stocks like GameStop suggests betting against Robinhood is foolhardy","Summary":"The global tally for the coronavirus-borne illness headed above 199.6 million on Wednesday, while the death toll climbed above 4.24 million according to . The U.S. leads the world with a total of 35.2 million cases and in ..."},{"Date":"Aug. 5, 2021 at 6:33 a.m. ET","Headline":"Biden Just Changed the EV Game. Big Gains May Be Ahead.","Summary":"The global tally for the coronavirus-borne illness headed above 199.6 million on Wednesday, while the death toll climbed above 4.24 million according to . The U.S. leads the world with a total of 35.2 million cases and in ..."},{"Date":"Aug. 4, 2021 at 5:27 p.m. ET","Headline":"New York International Auto Show Canceled Over Coronavirus Concerns","Summary":"The global tally for the coronavirus-borne illness headed above 199.6 million on Wednesday, while the death toll climbed above 4.24 million according to . The U.S. leads the world with a total of 35.2 million cases and in ..."},{"Date":"Aug. 4, 2021 at 2:58 p.m. ET","Headline":"Delta variant is now in 135 countries, says WHO, as director-general calls for moratorium on boosters to allow poorer countries get first doses","Summary":"The global tally for the coronavirus-borne illness headed above 199.6 million on Wednesday, while the death toll climbed above 4.24 million according to . The U.S. leads the world with a total of 35.2 million cases and in ..."},{"Date":"Aug. 4, 2021 at 1:18 p.m. ET","Headline":"Should the Lambda Variant Worry You? Not if You\u2019re Vaccinated.","Summary":"The global tally for the coronavirus-borne illness headed above 199.6 million on Wednesday, while the death toll climbed above 4.24 million according to . The U.S. leads the world with a total of 35.2 million cases and in ..."},{"Date":"Aug. 4, 2021 at 11:33 a.m. ET","Headline":"Novavax Is Set to Provide Europe With Up to 200 Million Covid-19 Vaccines. The Stock Is Soaring.","Summary":"The global tally for the coronavirus-borne illness headed above 199.6 million on Wednesday, while the death toll climbed above 4.24 million according to . The U.S. leads the world with a total of 35.2 million cases and in ..."},{"Date":"Aug. 4, 2021 at 10:11 a.m. ET","Headline":"The way to fight Lyme disease might be an annual antibody shot, not a vaccine","Summary":"The global tally for the coronavirus-borne illness headed above 199.6 million on Wednesday, while the death toll climbed above 4.24 million according to . The U.S. leads the world with a total of 35.2 million cases and in ..."},{"Date":"Aug. 4, 2021 at 8:19 a.m. ET","Headline":"Citi strategist fears stock-market pullback may emerge in September despite no obvious catalyst","Summary":"The global tally for the coronavirus-borne illness headed above 199.6 million on Wednesday, while the death toll climbed above 4.24 million according to . The U.S. leads the world with a total of 35.2 million cases and in ..."},{"Date":"Aug. 4, 2021 at 7:16 a.m. ET","Headline":"The delta variant is more than twice as contagious as previous strains of the virus, CDC says, as health officials urge vaccinations","Summary":"The global tally for the coronavirus-borne illness headed above 199.6 million on Wednesday, while the death toll climbed above 4.24 million according to . The U.S. leads the world with a total of 35.2 million cases and in ..."},{"Date":"Aug. 4, 2021 at 6:33 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 near 200 million and FDA seeks full approval of Pfizer vaccine by Labor Day","Summary":"The global tally for the coronavirus-borne illness headed above 199.6 million on Wednesday, while the death toll climbed above 4.24 million according to . The U.S. leads the world with a total of 35.2 million cases and in ..."},{"Date":"Aug. 7, 2021 at 7:11 p.m. ET","Headline":"Pilots to United Airlines: Not So Fast on Vaccine Mandate","Summary":""},{"Date":"Aug. 7, 2021 at 4:26 p.m. ET","Headline":"Here\u2019s how to get the Excelsior Pass now that NYC will soon require proof of vaccination","Summary":""},{"Date":"Aug. 6, 2021 at 8:26 p.m. ET","Headline":"Plastics Are Still in Demand. This Stock Stands to Profit\u2014but Beware the Risks.","Summary":""},{"Date":"Aug. 6, 2021 at 2:57 p.m. ET","Headline":"More states and companies take a stand on vaccination against COVID-19 in latest push to get unvaccinated to get their shots","Summary":""},{"Date":"Aug. 6, 2021 at 1:08 p.m. ET","Headline":"Moderna Has Admirers. Still, the Stock Gets Hit With Downgrades.","Summary":""},{"Date":"Aug. 6, 2021 at 8:34 a.m. ET","Headline":"A glimmer of hope that more unvaccinated Americans are willing to get the COVID-19 shot","Summary":""},{"Date":"Aug. 6, 2021 at 7:58 a.m. ET","Headline":"United Airlines to require vaccination of all 67,000 employees in U.S.","Summary":""},{"Date":"Aug. 6, 2021 at 6:43 a.m. ET","Headline":"Novavax Readies Its Vaccine to Fight Covid Worldwide","Summary":""},{"Date":"Aug. 6, 2021 at 6:37 a.m. ET","Headline":"Booster Shots Look Inevitable. The Market May Have Priced That In.","Summary":""},{"Date":"Aug. 9, 2021 at 2:59 p.m. ET","Headline":"Pentagon to Require Covid  Vaccines For Military by Sept. 15","Summary":""},{"Date":"Aug. 9, 2021 at 2:17 p.m. ET","Headline":"Austin, Texas is running out of ICU beds as U.S. daily average of COVID cases tops 100,000 to mark highest level since February","Summary":""},{"Date":"Aug. 9, 2021 at 11:23 a.m. ET","Headline":"Moderna presses for COVID-19 boosters as federal health officials warm to an extra dose for some people","Summary":""},{"Date":"Aug. 9, 2021 at 10:41 a.m. ET","Headline":"BioNTech Stock Climbs. Earnings Blew Past Expectations.","Summary":""},{"Date":"Aug. 9, 2021 at 8:14 a.m. ET","Headline":"Covid Cases Are Still Rising, but the Vaccine News Is Promising","Summary":""},{"Date":"Aug. 9, 2021 at 7:46 a.m. ET","Headline":"If the S&P 500 breaks above this key level, it could set off an \u2018epic emotional squeeze\u2019 not unlike 1999, strategists warn","Summary":""},{"Date":"Aug. 8, 2021 at 4:10 p.m. ET","Headline":"Fauci hopeful COVID-19 vaccine will get FDA\u2019s full approval within weeks","Summary":""},{"Date":"Aug. 8, 2021 at 6:00 a.m. ET","Headline":"Third-Largest U.S. Pension Scooped Up EV Stocks, Covid-Vaccine Makers","Summary":""},{"Date":"Aug. 11, 2021 at 11:53 p.m. ET","Headline":"COVID-free New Zealand won\u2019t reopen borders until early 2022","Summary":""},{"Date":"Aug. 11, 2021 at 10:54 p.m. ET","Headline":"FDA set to approve third COVID-vaccine dose for those with weakened immune systems: report","Summary":""},{"Date":"Aug. 11, 2021 at 3:22 p.m. ET","Headline":"Drug Companies Are Putting Profits First While the Delta Variant Spreads. That Needs to Change.","Summary":""},{"Date":"Aug. 11, 2021 at 1:28 p.m. ET","Headline":"Sen. Rand Paul suspended from YouTube for spreading mask misinformation","Summary":""},{"Date":"Aug. 11, 2021 at 9:10 a.m. ET","Headline":"Booster Doses for the Elderly Are Coming, Analyst Says. Friday Is a Key Date.","Summary":""},{"Date":"Aug. 11, 2021 at 8:25 a.m. ET","Headline":"Moderna\u2019s stock price is \u2018ridiculous,\u2019 says BofA analyst","Summary":""},{"Date":"Aug. 10, 2021 at 6:57 p.m. ET","Headline":"Keep New Zealand\u2019s tight COVID restrictions in effect, experts say","Summary":""},{"Date":"Aug. 10, 2021 at 5:59 p.m. ET","Headline":"Rep. Marjorie Taylor Greene suspended again from Twitter; ban looms","Summary":""},{"Date":"Aug. 10, 2021 at 2:01 p.m. ET","Headline":"Louisiana leads U.S. by new COVID cases, while Arkansas has record hospitalizations as delta variant continues to spread","Summary":""},{"Date":"Aug. 10, 2021 at 1:20 p.m. ET","Headline":"Divided on COVID-19 vaccines, Republicans and Democrats do agree on this healthcare issue","Summary":""},{"Date":"Aug. 10, 2021 at 11:17 a.m. ET","Headline":"When the Delta Surge Could End, and What Comes Next","Summary":""},{"Date":"Aug. 10, 2021 at 6:38 a.m. ET","Headline":"Earnings Slump at Softbank but It Shrugs Off the Chinese Crackdown\u2013for Now","Summary":""},{"Date":"Aug. 13, 2021 at 4:40 p.m. ET","Headline":"Dow, S&P 500 end at records Friday, finish week with longest streak of closing records since March","Summary":"Shares of Moderna Inc.  ran up 3.4% in premarket trading Friday, after the Food and Drug Administration authorized a third shot of COVID-19 vaccines from Moderna and Pfizer-BioNTech for immunocompromised adults. The booste..."},{"Date":"Aug. 13, 2021 at 2:45 p.m. ET","Headline":"U.S. Authorizes Third Dose of Covid Vaccines. Don\u2019t Call Them Booster Shots.","Summary":"Shares of Moderna Inc.  ran up 3.4% in premarket trading Friday, after the Food and Drug Administration authorized a third shot of COVID-19 vaccines from Moderna and Pfizer-BioNTech for immunocompromised adults. The booste..."},{"Date":"Aug. 13, 2021 at 9:38 a.m. ET","Headline":"The S&P 500 is nearly 99% above its March 2020 low. These 3 big-tech charts will tell you if things are about to unravel","Summary":"Shares of Moderna Inc.  ran up 3.4% in premarket trading Friday, after the Food and Drug Administration authorized a third shot of COVID-19 vaccines from Moderna and Pfizer-BioNTech for immunocompromised adults. The booste..."},{"Date":"Aug. 13, 2021 at 9:21 a.m. ET","Headline":"Moderna stock rallies after FDA OKs booster shot of COVID-19 vaccine for most at-risk adults","Summary":"Shares of Moderna Inc.  ran up 3.4% in premarket trading Friday, after the Food and Drug Administration authorized a third shot of COVID-19 vaccines from Moderna and Pfizer-BioNTech for immunocompromised adults. The booste..."},{"Date":"Aug. 13, 2021 at 8:22 a.m. ET","Headline":"Rocket Rises, Virgin Galactic Slumps\u2060\u2014and What Else Is Happening in the Stock Market Today","Summary":"The global tally for the coronavirus-borne illness headed above 205.4  million on Friday, while the death toll climbed above 4.33 million according to . The U.S. leads the world with a total of 36.3 million cases and in de..."},{"Date":"Aug. 13, 2021 at 7:00 a.m. ET","Headline":"Chinese Port Closure Offers Glimpse of Autumn Headwinds for Markets","Summary":"The global tally for the coronavirus-borne illness headed above 205.4  million on Friday, while the death toll climbed above 4.33 million according to . The U.S. leads the world with a total of 36.3 million cases and in de..."},{"Date":"Aug. 13, 2021 at 6:27 a.m. ET","Headline":"FDA authorizes booster vaccine dose for people with weak immune systems, and WHO to test 3 drugs as possible treatments for hospitalized COVID patients","Summary":"The global tally for the coronavirus-borne illness headed above 205.4  million on Friday, while the death toll climbed above 4.33 million according to . The U.S. leads the world with a total of 36.3 million cases and in de..."},{"Date":"Aug. 13, 2021 at 6:19 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 205.4 million as FDA authorizes vaccine booster for those with weak immune systems","Summary":"The global tally for the coronavirus-borne illness headed above 205.4  million on Friday, while the death toll climbed above 4.33 million according to . The U.S. leads the world with a total of 36.3 million cases and in de..."},{"Date":"Aug. 12, 2021 at 4:24 p.m. ET","Headline":"Dow, S&P 500 creep up to close at new record for third straight day as investors assess economic data","Summary":"An influential group of advisors to the Centers for Disease Control and Prevention is scheduled to meet Friday to discuss whether people who are immunocompromised should receive COVID-19 booster shots. This is the main ite..."},{"Date":"Aug. 12, 2021 at 12:37 p.m. ET","Headline":"Merck Spinoff Organon Is Supercheap\u2014and It Just Set a 3.7% Dividend Yield","Summary":"An influential group of advisors to the Centers for Disease Control and Prevention is scheduled to meet Friday to discuss whether people who are immunocompromised should receive COVID-19 booster shots. This is the main ite..."},{"Date":"Aug. 12, 2021 at 11:19 a.m. ET","Headline":"FDA Could Authorize Covid Booster Shots for Immunocompromised. What to Know.","Summary":"An influential group of advisors to the Centers for Disease Control and Prevention is scheduled to meet Friday to discuss whether people who are immunocompromised should receive COVID-19 booster shots. This is the main ite..."},{"Date":"Aug. 12, 2021 at 10:45 a.m. ET","Headline":"Mask Mandates Are Spreading Across the U.S. The Delta Wave Is Still Rising.","Summary":"An influential group of advisors to the Centers for Disease Control and Prevention is scheduled to meet Friday to discuss whether people who are immunocompromised should receive COVID-19 booster shots. This is the main ite..."},{"Date":"Aug. 12, 2021 at 7:52 a.m. ET","Headline":"California, New York, Texas, Florida, and other states weigh in on mask mandates for schoolchildren \u2014 here\u2019s where they stand","Summary":"An influential group of advisors to the Centers for Disease Control and Prevention is scheduled to meet Friday to discuss whether people who are immunocompromised should receive COVID-19 booster shots. This is the main ite..."},{"Date":"Aug. 12, 2021 at 7:23 a.m. ET","Headline":"CDC advisory committee to meet Friday, discuss COVID-19 booster shots","Summary":"An influential group of advisors to the Centers for Disease Control and Prevention is scheduled to meet Friday to discuss whether people who are immunocompromised should receive COVID-19 booster shots. This is the main ite..."},{"Date":"Aug. 12, 2021 at 6:54 a.m. ET","Headline":"U.S. COVID-19 case tally passes 36 million as more states seek face-mask mandates and plead with unvaccinated to get shots","Summary":"The global tally for the coronavirus-borne illness headed above 204.8  million on Thursday, while the death toll climbed above 4.32 million according to . The U.S. leads the world with a total of 36.2 million cases and in ..."},{"Date":"Aug. 12, 2021 at 6:39 a.m. ET","Headline":"Markets Remain Unfazed After Biden\u2019s Push for More Oil","Summary":"The global tally for the coronavirus-borne illness headed above 204.8  million on Thursday, while the death toll climbed above 4.32 million according to . The U.S. leads the world with a total of 36.2 million cases and in ..."},{"Date":"Aug. 12, 2021 at 6:26 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 head toward 205 million and FDA reportedly read to authorize boosters for some","Summary":"The global tally for the coronavirus-borne illness headed above 204.8  million on Thursday, while the death toll climbed above 4.32 million according to . The U.S. leads the world with a total of 36.2 million cases and in ..."},{"Date":"Aug. 15, 2021 at 4:12 p.m. ET","Headline":"U.S. could offer COVID vaccine boosters for elderly as soon as this fall","Summary":""},{"Date":"Aug. 14, 2021 at 1:08 p.m. ET","Headline":"Face mask fights escalate in Texas and Florida as delta variant of COVID forces Louisiana to send ambulances to other states","Summary":""},{"Date":"Aug. 14, 2021 at 10:58 a.m. ET","Headline":"Covid-19 Cases Are Surging. When Will This Wave Peak?","Summary":""},{"Date":"Aug. 14, 2021 at 10:55 a.m. ET","Headline":"Moderna\u2019s Stock Crumbled This Week. Investors Are Questioning Its Spectacular Surge.","Summary":""},{"Date":"Aug. 10, 2021 at 12:57 p.m. ET","Headline":"Dow Industrials and S&P 500 Pushed to New Highs After Senate OKs Infrastructure Bill","Summary":""},{"Date":"Aug. 17, 2021 at 1:44 p.m. ET","Headline":"Booster Doses Could Come Soon as Delta Spreads Across U.S.","Summary":"Pfizer Inc.  and partner BioNTech SE  announced Monday that data from a Phase 1 study has been submitted to the U.S. Food and Drug Administration, for the evaluation of a third, booster dose of their COVID-19 vaccine. The ..."},{"Date":"Aug. 17, 2021 at 9:58 a.m. ET","Headline":"CureVac Says Second Covid-19 Vaccine Was Better in Preclinical Test","Summary":"Pfizer Inc.  and partner BioNTech SE  announced Monday that data from a Phase 1 study has been submitted to the U.S. Food and Drug Administration, for the evaluation of a third, booster dose of their COVID-19 vaccine. The ..."},{"Date":"Aug. 17, 2021 at 6:31 a.m. ET","Headline":"Booster Shots Are Coming. Biotech Valuations Are Already Injected.","Summary":"Pfizer Inc.  and partner BioNTech SE  announced Monday that data from a Phase 1 study has been submitted to the U.S. Food and Drug Administration, for the evaluation of a third, booster dose of their COVID-19 vaccine. The ..."},{"Date":"Aug. 16, 2021 at 11:12 p.m. ET","Headline":"U.S. to recommend COVID booster for most people 8 months after vaccination: reports","Summary":"Pfizer Inc.  and partner BioNTech SE  announced Monday that data from a Phase 1 study has been submitted to the U.S. Food and Drug Administration, for the evaluation of a third, booster dose of their COVID-19 vaccine. The ..."},{"Date":"Aug. 16, 2021 at 4:48 p.m. ET","Headline":"Dow, S&P 500 end at records, shake off earlier losses from weak China data and Afghanistan turmoil","Summary":"Pfizer Inc.  and partner BioNTech SE  announced Monday that data from a Phase 1 study has been submitted to the U.S. Food and Drug Administration, for the evaluation of a third, booster dose of their COVID-19 vaccine. The ..."},{"Date":"Aug. 16, 2021 at 1:56 p.m. ET","Headline":"Pfizer and BioNTech Submit Covid Booster Vaccine Data to FDA","Summary":"Pfizer Inc.  and partner BioNTech SE  announced Monday that data from a Phase 1 study has been submitted to the U.S. Food and Drug Administration, for the evaluation of a third, booster dose of their COVID-19 vaccine. The ..."},{"Date":"Aug. 16, 2021 at 12:26 p.m. ET","Headline":"Cities begin to roll out COVID-19 vaccination rules as cases in the U.S. hit a six-month high","Summary":"Pfizer Inc.  and partner BioNTech SE  announced Monday that data from a Phase 1 study has been submitted to the U.S. Food and Drug Administration, for the evaluation of a third, booster dose of their COVID-19 vaccine. The ..."},{"Date":"Aug. 16, 2021 at 11:49 a.m. ET","Headline":"Pfizer, BioNTech submit trial data on COVID-19 booster shot to FDA","Summary":"Pfizer Inc.  and partner BioNTech SE  announced Monday that data from a Phase 1 study has been submitted to the U.S. Food and Drug Administration, for the evaluation of a third, booster dose of their COVID-19 vaccine. The ..."},{"Date":"Aug. 16, 2021 at 11:15 a.m. ET","Headline":"CureVac stock gains after upbeat preclinical data on COVID-19 vaccine candidate on primates","Summary":"Shares of CureVac N.V.  gained 0.4% in morning trading Monday, but bucked the selloff in the biotechnology sector and the broader stock market, after the Germany-based company revealed upbeat preclinical data regarding its..."},{"Date":"Aug. 16, 2021 at 9:04 a.m. ET","Headline":"U.S. \u2018Absolutely Prepared\u2019 to Offer Third Covid-19 Shot, and Surges Are \u2018Entirely Preventable,\u2019 Says Fauci","Summary":""},{"Date":"Aug. 16, 2021 at 8:45 a.m. ET","Headline":"As Covid Cases Spread, Vaccines Won\u2019t Be Enough","Summary":""},{"Date":"Aug. 19, 2021 at 4:32 p.m. ET","Headline":"U.S. stocks end mostly higher but Dow slips for third day with coronavirus delta variant a concern","Summary":"The global tally for the coronavirus-borne illness climbed above 209.3 million as of early Thursday, while death toll rose to 4,393,138, according to . The U.S. led the world with a total of 37.16 million cases and 624,253..."},{"Date":"Aug. 19, 2021 at 9:08 a.m. ET","Headline":"Biden mandates COVID vaccines for nursing-home workers, promises booster shots will be \u2018easy\u2019","Summary":"The global tally for the coronavirus-borne illness climbed above 209.3 million as of early Thursday, while death toll rose to 4,393,138, according to . The U.S. led the world with a total of 37.16 million cases and 624,253..."},{"Date":"Aug. 19, 2021 at 8:38 a.m. ET","Headline":"The Fed\u2019s not boring anyone into submission after all. The dollar might be to blame.","Summary":"The global tally for the coronavirus-borne illness climbed above 209.3 million as of early Thursday, while death toll rose to 4,393,138, according to . The U.S. led the world with a total of 37.16 million cases and 624,253..."},{"Date":"Aug. 19, 2021 at 6:37 a.m. ET","Headline":"Robinhood Enjoys Crypto Boom. Why the Stock Is Tumbling.","Summary":"The global tally for the coronavirus-borne illness climbed above 209.3 million as of early Thursday, while death toll rose to 4,393,138, according to . The U.S. led the world with a total of 37.16 million cases and 624,253..."},{"Date":"Aug. 19, 2021 at 6:36 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 tops 209 million, U.S. daily average of deaths rises to 4-month high","Summary":"The global tally for the coronavirus-borne illness climbed above 209.3 million as of early Thursday, while death toll rose to 4,393,138, according to . The U.S. led the world with a total of 37.16 million cases and 624,253..."},{"Date":"Aug. 19, 2021 at 3:55 a.m. ET","Headline":"U.K. study finds vaccines less effective against delta variant of coronavirus","Summary":"A new study finds that vaccines are less effective against the delta variant of coronavirus. The U.K. study, , found that there were similar peak levels of virus after two vaccine doses to those in unvaccinated people. The..."},{"Date":"Aug. 18, 2021 at 11:57 a.m. ET","Headline":"Covid-19 Booster Shots Recommended for Americans","Summary":""},{"Date":"Aug. 18, 2021 at 11:29 a.m. ET","Headline":"The White House Just Announced Its Covid Booster Plan. What to Know.","Summary":""},{"Date":"Aug. 18, 2021 at 7:24 a.m. ET","Headline":"The U.S. is reportedly preparing to give COVID-19 booster shots for everyone who qualifies","Summary":""},{"Date":"Aug. 18, 2021 at 6:33 a.m. ET","Headline":"The Fed Has a Minor Problem\u2014It Has No Idea Where Economy\u2019s Headed","Summary":""},{"Date":"Aug. 17, 2021 at 11:09 a.m. ET","Headline":"Can my employer make me get vaccinated?","Summary":""},{"Date":"Aug. 14, 2021 at 11:47 a.m. ET","Headline":"Meeting vaccine hesitancy, one calm answer at a time","Summary":""},{"Date":"Aug. 21, 2021 at 3:16 p.m. ET","Headline":"U.S. prepares to administer 100 million booster shots as Biden tells Americans it will \u2018help us end the pandemic faster\u2019","Summary":""},{"Date":"Aug. 21, 2021 at 11:53 a.m. ET","Headline":"FDA is expected to give full approval of Pfizer COVID-19 vaccine next week","Summary":""},{"Date":"Aug. 21, 2021 at 10:30 a.m. ET","Headline":"People in the U.S. who received Moderna\u2019s or Pfizer\u2019s COVID-19 vaccine will be eligible for a booster dose in September","Summary":""},{"Date":"Aug. 20, 2021 at 7:43 p.m. ET","Headline":"Pfizer Covid-19 Vaccine Expected to Get Full FDA Approval Next Week","Summary":""},{"Date":"Aug. 20, 2021 at 7:26 p.m. ET","Headline":"Shopping for a Solid Stock? Consider Walmart.","Summary":""},{"Date":"Aug. 20, 2021 at 7:01 p.m. ET","Headline":"Pfizer, BioNTech stocks rise on report FDA could fully approve COVID-19 vaccine","Summary":""},{"Date":"Aug. 20, 2021 at 6:54 p.m. ET","Headline":"Pfizer and BioNTech shares rise on report FDA could fully approve COVID-19 vaccine next week","Summary":"Pfizer Inc.  and U.S.-listed shares of BioNTech SE  rose in the extended session Friday following a report that the drug makers will likely get full Food and Drug Administration approval for their COVID-19 vaccine sometime..."},{"Date":"Aug. 20, 2021 at 12:48 p.m. ET","Headline":"U.S. Officials Examine Reports Rare Vaccine Side Effect Is More Common With Moderna Than Pfizer","Summary":""},{"Date":"Aug. 20, 2021 at 8:19 a.m. ET","Headline":"J&J\u2019s CEO Plans to Step Down. Analysts Expect a Smooth Transition.","Summary":""},{"Date":"Aug. 19, 2021 at 9:14 a.m. ET","Headline":"Pfizer Vaccine\u2019s Efficacy Against Delta Variant Drops After Three Months: Study","Summary":""},{"Date":"Aug. 23, 2021 at 6:09 p.m. ET","Headline":"The Nasdaq Closes at a Record as Stocks Make a Comeback","Summary":"Shares of cruise operators rallied Monday, as the Food and Drug Administration's full approval of the COVID-19 vaccine developed by Pfizer Inc.  and partner BioNTech SE  boosted hopes for increased vaccination rates. Carni..."},{"Date":"Aug. 23, 2021 at 4:35 p.m. ET","Headline":"Nasdaq ends at record, stocks score best day in a month on bullish tone ahead of Jackson Hole","Summary":"Shares of cruise operators rallied Monday, as the Food and Drug Administration's full approval of the COVID-19 vaccine developed by Pfizer Inc.  and partner BioNTech SE  boosted hopes for increased vaccination rates. Carni..."},{"Date":"Aug. 23, 2021 at 2:50 p.m. ET","Headline":"Biden urges more companies to require COVID vaccines as Pfizer shot wins full approval","Summary":"Shares of cruise operators rallied Monday, as the Food and Drug Administration's full approval of the COVID-19 vaccine developed by Pfizer Inc.  and partner BioNTech SE  boosted hopes for increased vaccination rates. Carni..."},{"Date":"Aug. 23, 2021 at 2:50 p.m. ET","Headline":"AMC\u2019s stock shoots up after FDA approval of COVID vaccine","Summary":"Shares of cruise operators rallied Monday, as the Food and Drug Administration's full approval of the COVID-19 vaccine developed by Pfizer Inc.  and partner BioNTech SE  boosted hopes for increased vaccination rates. Carni..."},{"Date":"Aug. 23, 2021 at 1:20 p.m. ET","Headline":"Americans are creating their own vaccine mandates by cutting ties with the unvaccinated","Summary":"Shares of cruise operators rallied Monday, as the Food and Drug Administration's full approval of the COVID-19 vaccine developed by Pfizer Inc.  and partner BioNTech SE  boosted hopes for increased vaccination rates. Carni..."},{"Date":"Aug. 23, 2021 at 12:55 p.m. ET","Headline":"Unvaccinated Americans hospitalized with COVID-19 cost the U.S. health care system $2.3 billion in June and July: report","Summary":"Shares of cruise operators rallied Monday, as the Food and Drug Administration's full approval of the COVID-19 vaccine developed by Pfizer Inc.  and partner BioNTech SE  boosted hopes for increased vaccination rates. Carni..."},{"Date":"Aug. 23, 2021 at 12:03 p.m. ET","Headline":"A Licensed Vaccine Demolishes the Arguments Against Mandates","Summary":"Shares of cruise operators rallied Monday, as the Food and Drug Administration's full approval of the COVID-19 vaccine developed by Pfizer Inc.  and partner BioNTech SE  boosted hopes for increased vaccination rates. Carni..."},{"Date":"Aug. 23, 2021 at 11:15 a.m. ET","Headline":"Will vaccine skeptics accept the safety of the COVID shot now that the FDA has granted full approval?","Summary":"Shares of cruise operators rallied Monday, as the Food and Drug Administration's full approval of the COVID-19 vaccine developed by Pfizer Inc.  and partner BioNTech SE  boosted hopes for increased vaccination rates. Carni..."},{"Date":"Aug. 23, 2021 at 11:09 a.m. ET","Headline":"Cruise stocks rally after FDA approval of Pfizer COVID-19 vaccine","Summary":"Shares of cruise operators rallied Monday, as the Food and Drug Administration's full approval of the COVID-19 vaccine developed by Pfizer Inc.  and partner BioNTech SE  boosted hopes for increased vaccination rates. Carni..."},{"Date":"Aug. 23, 2021 at 10:34 a.m. ET","Headline":"Home sales rise as the limited number of properties on the market improves","Summary":"Shares of Trillium Therapeutics Inc.  nearly tripled in premarket trading Monday, skyrocketing 189.3%, after the immuno-oncology company announced an agreement to be acquired by Pfizer Inc.  in a cash deal valued $2.26 bil..."},{"Date":"Aug. 23, 2021 at 10:19 a.m. ET","Headline":"Pfizer Vaccine Gets FDA Full Approval, Opening Door for Widespread Mandates","Summary":"Shares of Trillium Therapeutics Inc.  nearly tripled in premarket trading Monday, skyrocketing 189.3%, after the immuno-oncology company announced an agreement to be acquired by Pfizer Inc.  in a cash deal valued $2.26 bil..."},{"Date":"Aug. 23, 2021 at 9:57 a.m. ET","Headline":"Pfizer Agrees to Buy Cancer Biotech Trillium Therapeutics at a 200% Premium","Summary":"Shares of Trillium Therapeutics Inc.  nearly tripled in premarket trading Monday, skyrocketing 189.3%, after the immuno-oncology company announced an agreement to be acquired by Pfizer Inc.  in a cash deal valued $2.26 bil..."},{"Date":"Aug. 23, 2021 at 9:56 a.m. ET","Headline":"Pfizer Climbs, Exxon Jumps \u2014 And What Else Is Happening in the Stock Market Monday","Summary":"Shares of Trillium Therapeutics Inc.  nearly tripled in premarket trading Monday, skyrocketing 189.3%, after the immuno-oncology company announced an agreement to be acquired by Pfizer Inc.  in a cash deal valued $2.26 bil..."},{"Date":"Aug. 23, 2021 at 8:46 a.m. ET","Headline":"Facebook\u2019s been one of the strongest FAANGs this year. Here\u2019s why it\u2019s just been downgraded.","Summary":"Shares of Trillium Therapeutics Inc.  nearly tripled in premarket trading Monday, skyrocketing 189.3%, after the immuno-oncology company announced an agreement to be acquired by Pfizer Inc.  in a cash deal valued $2.26 bil..."},{"Date":"Aug. 23, 2021 at 7:58 a.m. ET","Headline":"Bitcoin Roars Above $50,000. Strap In for the Ride.","Summary":"Shares of Trillium Therapeutics Inc.  nearly tripled in premarket trading Monday, skyrocketing 189.3%, after the immuno-oncology company announced an agreement to be acquired by Pfizer Inc.  in a cash deal valued $2.26 bil..."},{"Date":"Aug. 23, 2021 at 7:04 a.m. ET","Headline":"Trillium Therapeutics' stock nearly triples after buyout deal with Pfizer valued at $2.26 billion","Summary":"Shares of Trillium Therapeutics Inc.  nearly tripled in premarket trading Monday, skyrocketing 189.3%, after the immuno-oncology company announced an agreement to be acquired by Pfizer Inc.  in a cash deal valued $2.26 bil..."},{"Date":"Aug. 23, 2021 at 6:51 a.m. ET","Headline":"Coronavirus tally: Average daily U.S. death toll tops 1,000 for first time in 5 months, FDA set to approve Pfizer vaccine","Summary":"The global tally for the coronavirus-borne illness climbed to 211.9 million as of early Monday, while death toll rose to 4,432,694, according to . The U.S. led the world with a total of 37.71 million cases and 628,503 deat..."},{"Date":"Aug. 23, 2021 at 4:00 a.m. ET","Headline":"The Covid Threat Is Here to Stay. What That Means for Drugmakers.","Summary":""},{"Date":"Aug. 25, 2021 at 8:56 p.m. ET","Headline":"U.S. likely to approve COVID-19 boosters at 6 months after vaccination","Summary":"BioNTech SE  and Pfizer Inc.  said Wednesday that they initiated an application to U.S. regulators for a third dose of Comirnaty, their COVID-19 vaccine. BioNTech's stock was down 0.2% in trading on Wednesday, while Pfizer..."},{"Date":"Aug. 25, 2021 at 6:54 p.m. ET","Headline":"Texas governor issues new order banning local vaccine mandates","Summary":"BioNTech SE  and Pfizer Inc.  said Wednesday that they initiated an application to U.S. regulators for a third dose of Comirnaty, their COVID-19 vaccine. BioNTech's stock was down 0.2% in trading on Wednesday, while Pfizer..."},{"Date":"Aug. 25, 2021 at 12:49 p.m. ET","Headline":"BioNTech, Pfizer initiate application for approval of a third dose of their COVID-19 vaccine","Summary":"BioNTech SE  and Pfizer Inc.  said Wednesday that they initiated an application to U.S. regulators for a third dose of Comirnaty, their COVID-19 vaccine. BioNTech's stock was down 0.2% in trading on Wednesday, while Pfizer..."},{"Date":"Aug. 25, 2021 at 12:41 p.m. ET","Headline":"Covid-19 Vaccine Makers Rush to Keep Up After Pfizer Gets FDA Approval","Summary":"Shares of Johnson & Johnson  gained 0.8% in premarket trading on Wednesday after the company shared interim clinical data that indicates Americans who have received its single-dose COVID-19 vaccine could get a second dose...."},{"Date":"Aug. 25, 2021 at 11:01 a.m. ET","Headline":"Delta Air Lines Tells Workers to Get Vaccinated or Pay $200 a Month","Summary":"Shares of Johnson & Johnson  gained 0.8% in premarket trading on Wednesday after the company shared interim clinical data that indicates Americans who have received its single-dose COVID-19 vaccine could get a second dose...."},{"Date":"Aug. 25, 2021 at 10:41 a.m. ET","Headline":"Covid Could Evolve to Evade Pfizer Vaccine, CEO Says","Summary":"Shares of Johnson & Johnson  gained 0.8% in premarket trading on Wednesday after the company shared interim clinical data that indicates Americans who have received its single-dose COVID-19 vaccine could get a second dose...."},{"Date":"Aug. 25, 2021 at 10:07 a.m. ET","Headline":"Who can get a COVID booster shot, and where do you get one? Here\u2019s what we know so far.","Summary":"Shares of Johnson & Johnson  gained 0.8% in premarket trading on Wednesday after the company shared interim clinical data that indicates Americans who have received its single-dose COVID-19 vaccine could get a second dose...."},{"Date":"Aug. 25, 2021 at 10:03 a.m. ET","Headline":"J&J says new data indicates an extra dose of its COVID-19 vaccine can boost antibody levels","Summary":"Shares of Johnson & Johnson  gained 0.8% in premarket trading on Wednesday after the company shared interim clinical data that indicates Americans who have received its single-dose COVID-19 vaccine could get a second dose...."},{"Date":"Aug. 25, 2021 at 9:58 a.m. ET","Headline":"Moderna completes BLA submission for full approval of COVID-19 vaccine","Summary":"Shares of Moderna Inc.  rallied 4.0% in morning trading Wednesday after the biotechnology company said it has completed the submission to the Food and Drug Administration for its Biologics License Application (BLA) for the..."},{"Date":"Aug. 25, 2021 at 7:52 a.m. ET","Headline":"J&J\u2019s Covid Vaccine Booster Shot Increased Antibodies in Early Trials. What Comes Next.","Summary":""},{"Date":"Aug. 25, 2021 at 7:34 a.m. ET","Headline":"Now that a COVID-19 shot is fully approved, employer mandates are rolling in. But will vaccination rates in the U.S. go up?","Summary":""},{"Date":"Aug. 25, 2021 at 6:46 a.m. ET","Headline":"There Are Tentative Signs the Out-of-Control Housing Market Is Healing","Summary":""},{"Date":"Aug. 24, 2021 at 4:40 p.m. ET","Headline":"U.S. stocks end higher  with S&P 500, Nasdaq notching all-time highs","Summary":""},{"Date":"Aug. 24, 2021 at 4:06 p.m. ET","Headline":"Over half of Americans are more likely to shop at businesses with vaccine mandates: poll","Summary":""},{"Date":"Aug. 24, 2021 at 1:41 p.m. ET","Headline":"Minnesota and Louisiana public universities to enact campus vaccine mandates","Summary":""},{"Date":"Aug. 24, 2021 at 10:59 a.m. ET","Headline":"The S&P 500 Has Been Soaring. These 10 Stocks Are Still Cheap.","Summary":""},{"Date":"Aug. 24, 2021 at 9:01 a.m. ET","Headline":"Covid-19 Vaccine Mandates Spread After FDA Approval of Pfizer\u2019s Vaccine","Summary":""},{"Date":"Aug. 24, 2021 at 7:40 a.m. ET","Headline":"Biden Urges More Employers to Enact Vaccine Mandates Following FDA\u2019s Full Approval","Summary":""},{"Date":"Aug. 27, 2021 at 11:46 a.m. ET","Headline":"U.S. is averaging more than 1,000 COVID-19 deaths a day for first time since March","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday that they have signed a letter of intent (LOI) with Brazil-based biopharmaceutical company Eurofarma Laborat\u00f3rios SA to make COVID-19 vaccines for distribution in Latin America. ..."},{"Date":"Aug. 27, 2021 at 10:51 a.m. ET","Headline":"BioNTech Says It Will Make Its Malaria, TB Vaccines in Africa","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday that they have signed a letter of intent (LOI) with Brazil-based biopharmaceutical company Eurofarma Laborat\u00f3rios SA to make COVID-19 vaccines for distribution in Latin America. ..."},{"Date":"Aug. 27, 2021 at 8:32 a.m. ET","Headline":"Risk of Blood Clots \u2018Much Higher\u2019 With Covid-19 Than Vaccines","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday that they have signed a letter of intent (LOI) with Brazil-based biopharmaceutical company Eurofarma Laborat\u00f3rios SA to make COVID-19 vaccines for distribution in Latin America. ..."},{"Date":"Aug. 27, 2021 at 7:52 a.m. ET","Headline":"Doctors question the optics and the scientific rationale behind the plan for COVID-19 booster shots in the U.S.","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday that they have signed a letter of intent (LOI) with Brazil-based biopharmaceutical company Eurofarma Laborat\u00f3rios SA to make COVID-19 vaccines for distribution in Latin America. ..."},{"Date":"Aug. 26, 2021 at 5:23 p.m. ET","Headline":"As Delta\u2019s $200 staff surcharge shows, employers face a dilemma: keeping workers safe \u2014 and holding onto their employees","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday that they have signed a letter of intent (LOI) with Brazil-based biopharmaceutical company Eurofarma Laborat\u00f3rios SA to make COVID-19 vaccines for distribution in Latin America. ..."},{"Date":"Aug. 26, 2021 at 5:09 p.m. ET","Headline":"FDA urges people to stop taking ivermectin to treat COVID as overdoses continue to rise","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday that they have signed a letter of intent (LOI) with Brazil-based biopharmaceutical company Eurofarma Laborat\u00f3rios SA to make COVID-19 vaccines for distribution in Latin America. ..."},{"Date":"Aug. 26, 2021 at 11:23 a.m. ET","Headline":"Texas Governor Abbott Banned State and Local Governments From ImposingVaccine Mandates. What to Know.","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday that they have signed a letter of intent (LOI) with Brazil-based biopharmaceutical company Eurofarma Laborat\u00f3rios SA to make COVID-19 vaccines for distribution in Latin America. ..."},{"Date":"Aug. 26, 2021 at 9:59 a.m. ET","Headline":"U.S. COVID-19 hospitalizations hit 100,000 to mark highest level since January","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday that they have signed a letter of intent (LOI) with Brazil-based biopharmaceutical company Eurofarma Laborat\u00f3rios SA to make COVID-19 vaccines for distribution in Latin America. ..."},{"Date":"Aug. 26, 2021 at 7:55 a.m. ET","Headline":"Covid Infections Among Young Children Are Surging. When a Vaccine Could Be Ready.","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday that they have signed a letter of intent (LOI) with Brazil-based biopharmaceutical company Eurofarma Laborat\u00f3rios SA to make COVID-19 vaccines for distribution in Latin America. ..."},{"Date":"Aug. 26, 2021 at 7:53 a.m. ET","Headline":"J&J says an extra dose of its COVID-19 vaccine can boost antibody levels","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday that they have signed a letter of intent (LOI) with Brazil-based biopharmaceutical company Eurofarma Laborat\u00f3rios SA to make COVID-19 vaccines for distribution in Latin America. ..."},{"Date":"Aug. 26, 2021 at 7:01 a.m. ET","Headline":"Pfizer, BioNTech sign LOI with Brazil's Eurofarma to make COVID-19 vaccines for use in Latin America","Summary":"Pfizer Inc.  and BioNTech SE  said Thursday that they have signed a letter of intent (LOI) with Brazil-based biopharmaceutical company Eurofarma Laborat\u00f3rios SA to make COVID-19 vaccines for distribution in Latin America. ..."},{"Date":"Aug. 26, 2021 at 6:59 a.m. ET","Headline":"Fed Tightening Unlikely as Europe Discusses U.S. Travel Ban","Summary":""},{"Date":"Aug. 25, 2021 at 2:30 p.m. ET","Headline":"Uber, Lyft Dealt Setback in Prop 22 Driver Classification Case. Here\u2019s What\u2019s Next.","Summary":""},{"Date":"Aug. 28, 2021 at 1:29 p.m. ET","Headline":"Should unvaccinated employees pay more for health insurance? American workers give their verdict","Summary":""},{"Date":"Aug. 28, 2021 at 1:21 p.m. ET","Headline":"Gen Z students overwhelmingly support strict COVID-19 policies as they return to school","Summary":""},{"Date":"Aug. 31, 2021 at 4:21 p.m. ET","Headline":"U.S. Booster Plans Are Frontrunning the Science","Summary":"The global tally for the coronavirus-borne illness climbed above 217 million on Tuesday, while the death toll rose to 4.51 million, according to . The U.S. leads the world with a total of 39 million cases and 638,715 death..."},{"Date":"Aug. 31, 2021 at 2:47 p.m. ET","Headline":"U.S. Education Department opens civil-rights probe of school face-mask bans in latest clash between Republican governors and Biden administration","Summary":"The global tally for the coronavirus-borne illness climbed above 217 million on Tuesday, while the death toll rose to 4.51 million, according to . The U.S. leads the world with a total of 39 million cases and 638,715 death..."},{"Date":"Aug. 31, 2021 at 12:01 p.m. ET","Headline":"Moderna\u2019s Covid Vaccine Produces More Antibodies Than Pfizer\u2019s, Study Shows","Summary":"The global tally for the coronavirus-borne illness climbed above 217 million on Tuesday, while the death toll rose to 4.51 million, according to . The U.S. leads the world with a total of 39 million cases and 638,715 death..."},{"Date":"Aug. 31, 2021 at 8:36 a.m. ET","Headline":"Covid-19 Booster-Shot Access May Be More Limited, CDC Committee Signals","Summary":"The global tally for the coronavirus-borne illness climbed above 217 million on Tuesday, while the death toll rose to 4.51 million, according to . The U.S. leads the world with a total of 39 million cases and 638,715 death..."},{"Date":"Aug. 31, 2021 at 6:58 a.m. ET","Headline":"The S&P 500 is headed for 5,000, says UBS. Here\u2019s the when and how.","Summary":"The global tally for the coronavirus-borne illness climbed above 217 million on Tuesday, while the death toll rose to 4.51 million, according to . The U.S. leads the world with a total of 39 million cases and 638,715 death..."},{"Date":"Aug. 31, 2021 at 6:23 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 217 million as study finds Moderna vaccine produced more antibodies than Pfizer's","Summary":"The global tally for the coronavirus-borne illness climbed above 217 million on Tuesday, while the death toll rose to 4.51 million, according to . The U.S. leads the world with a total of 39 million cases and 638,715 death..."},{"Date":"Aug. 31, 2021 at 2:34 a.m. ET","Headline":"Moderna\u2019s COVID-19 vaccine created more antibodies than Pfizer\/BioNTech\u2019s in study of vaccinated Belgian health-care workers","Summary":""},{"Date":"Aug. 30, 2021 at 9:37 p.m. ET","Headline":"In reversal, judge allows Chicago mother to see her son even if she doesn\u2019t have COVID-19 vaccine","Summary":""},{"Date":"Aug. 30, 2021 at 9:13 p.m. ET","Headline":"\u2018It almost feels like Groundhog Day\u2019: Colleges welcome students back to campus amid delta-variant surge","Summary":""},{"Date":"Aug. 30, 2021 at 2:23 p.m. ET","Headline":"WHO warns of possible 236,000 new COVID-19 deaths in Europe by December, and Fauci says U.S. could see another 100,000","Summary":""},{"Date":"Aug. 30, 2021 at 9:23 a.m. ET","Headline":"The Stock Market Got the Green Light From Powell. Why It Keeps Hitting Record Highs.","Summary":""},{"Date":"Aug. 30, 2021 at 8:52 a.m. ET","Headline":"Covid-19 Vaccine Maker Shares Drop on Reports of Ultrarare Deaths","Summary":""},{"Date":"Aug. 30, 2021 at 8:15 a.m. ET","Headline":"Fauci: COVID-19 vaccine mandate for schoolchildren \u2018is a good idea\u2019","Summary":""},{"Date":"Aug. 30, 2021 at 7:36 a.m. ET","Headline":"Starting today, get 2 free Krispy Kreme doughnuts for getting a COVID vaccine","Summary":""},{"Date":"Aug. 29, 2021 at 11:45 p.m. ET","Headline":"It Was a Big Week for Covid Vaccine News. What Stocks Came Out on Top.","Summary":""},{"Date":"Sep. 2, 2021 at 3:46 p.m. ET","Headline":"FDA committee to discuss COVID-19 booster shots","Summary":"An influential Food and Drug Administration advisory committee plans to meet Sept. 17 to discuss extra doses of the COVID-19 vaccines, including the application filed by BioNTech SE  and Pfizer Inc.  for a third dose of th..."},{"Date":"Sep. 2, 2021 at 3:04 p.m. ET","Headline":"AbbVie Stock Dropped After FDA Warning. Analysts Say Selloff Is Overblown.","Summary":"Moderna Inc.  said late Wednesday it is submitting documents to the U.S. Food and Drug Administration (FDA) for the evaluation of a booster dose of its COVID-19 vaccine as a 50-microgram dose. The biotech company said it e..."},{"Date":"Sep. 2, 2021 at 2:58 p.m. ET","Headline":"\u2018Vaccine mandates actually further civil liberties,\u2019 the ACLU writes in an op-ed","Summary":"Moderna Inc.  said late Wednesday it is submitting documents to the U.S. Food and Drug Administration (FDA) for the evaluation of a booster dose of its COVID-19 vaccine as a 50-microgram dose. The biotech company said it e..."},{"Date":"Sep. 2, 2021 at 2:28 p.m. ET","Headline":"European regulator sees \u2018no urgent need\u2019 for COVID-19 boosters, aligning with WHO view and not the U.S.","Summary":"Moderna Inc.  said late Wednesday it is submitting documents to the U.S. Food and Drug Administration (FDA) for the evaluation of a booster dose of its COVID-19 vaccine as a 50-microgram dose. The biotech company said it e..."},{"Date":"Sep. 2, 2021 at 12:41 p.m. ET","Headline":"Goldman Sachs, McDonald\u2019s, tell employees to get vaccinated before coming back to work","Summary":"Moderna Inc.  said late Wednesday it is submitting documents to the U.S. Food and Drug Administration (FDA) for the evaluation of a booster dose of its COVID-19 vaccine as a 50-microgram dose. The biotech company said it e..."},{"Date":"Sep. 2, 2021 at 11:15 a.m. ET","Headline":"FDA Will Convene Advisory Committee to Consider Pfizer Covid-19 Booster","Summary":"Moderna Inc.  said late Wednesday it is submitting documents to the U.S. Food and Drug Administration (FDA) for the evaluation of a booster dose of its COVID-19 vaccine as a 50-microgram dose. The biotech company said it e..."},{"Date":"Sep. 2, 2021 at 7:42 a.m. ET","Headline":"Moderna Begins Submission Process for FDA Approval of Its Covid Booster Shot","Summary":"Moderna Inc.  said late Wednesday it is submitting documents to the U.S. Food and Drug Administration (FDA) for the evaluation of a booster dose of its COVID-19 vaccine as a 50-microgram dose. The biotech company said it e..."},{"Date":"Sep. 2, 2021 at 6:48 a.m. ET","Headline":"Heading Into Jobs Report, It\u2019s Back to a Bad News Is Good News Market","Summary":"Moderna Inc.  said late Wednesday it is submitting documents to the U.S. Food and Drug Administration (FDA) for the evaluation of a booster dose of its COVID-19 vaccine as a 50-microgram dose. The biotech company said it e..."},{"Date":"Sep. 2, 2021 at 3:28 a.m. ET","Headline":"Long COVID risks halved by dual vaccination, study finds","Summary":"Moderna Inc.  said late Wednesday it is submitting documents to the U.S. Food and Drug Administration (FDA) for the evaluation of a booster dose of its COVID-19 vaccine as a 50-microgram dose. The biotech company said it e..."},{"Date":"Sep. 1, 2021 at 11:44 p.m. ET","Headline":"Taiwan gets first batch of Pfizer-BioNTech vaccines after long delay","Summary":"Moderna Inc.  said late Wednesday it is submitting documents to the U.S. Food and Drug Administration (FDA) for the evaluation of a booster dose of its COVID-19 vaccine as a 50-microgram dose. The biotech company said it e..."},{"Date":"Sep. 1, 2021 at 5:03 p.m. ET","Headline":"Moderna asks FDA to evaluate COVID-19 vaccine booster candidate","Summary":"Moderna Inc.  said late Wednesday it is submitting documents to the U.S. Food and Drug Administration (FDA) for the evaluation of a booster dose of its COVID-19 vaccine as a 50-microgram dose. The biotech company said it e..."},{"Date":"Sep. 1, 2021 at 2:29 p.m. ET","Headline":"Vaccine hesitancy falls to lowest level since start of coronavirus pandemic in new poll, but more Americans still need to be persuaded","Summary":""},{"Date":"Sep. 1, 2021 at 11:21 a.m. ET","Headline":"WHO identifies new coronavirus \u2018variant of interest\u2019 and experts urge caution on boosters","Summary":""},{"Date":"Sep. 1, 2021 at 10:27 a.m. ET","Headline":"Merck and Pfizer Are Testing Antiviral Pills. The Covid Battle Is Moving Beyond Vaccines.","Summary":""},{"Date":"Sep. 4, 2021 at 5:39 p.m. ET","Headline":"More U.S. companies are considering surcharges for unvaccinated employees","Summary":"Government health officials have advised the White House to scale back President Joe Biden's promise to offer boosters to vaccinated Americans beginning later this month, because available data are insufficient to determin..."},{"Date":"Sep. 4, 2021 at 9:34 a.m. ET","Headline":"14 dividend stocks from a winning value manager as the broader market hits record highs","Summary":"Government health officials have advised the White House to scale back President Joe Biden's promise to offer boosters to vaccinated Americans beginning later this month, because available data are insufficient to determin..."},{"Date":"Sep. 4, 2021 at 8:35 a.m. ET","Headline":"COVID-19 vaccine booster shots are more complicated than they appear. Here\u2019s why.","Summary":"Government health officials have advised the White House to scale back President Joe Biden's promise to offer boosters to vaccinated Americans beginning later this month, because available data are insufficient to determin..."},{"Date":"Sep. 3, 2021 at 7:39 p.m. ET","Headline":"Why Caterpillar Stock Is Likely to Keep Plowing Ahead","Summary":"Government health officials have advised the White House to scale back President Joe Biden's promise to offer boosters to vaccinated Americans beginning later this month, because available data are insufficient to determin..."},{"Date":"Sep. 3, 2021 at 1:49 p.m. ET","Headline":"Fauci says mu variant isn\u2019t an \u2018immediate threat\u2019 to U.S. as delta remains dominant coronavirus strain","Summary":"Government health officials have advised the White House to scale back President Joe Biden's promise to offer boosters to vaccinated Americans beginning later this month, because available data are insufficient to determin..."},{"Date":"Sep. 3, 2021 at 12:30 p.m. ET","Headline":"Government health officials tell White House to scale back booster plan: report","Summary":"Government health officials have advised the White House to scale back President Joe Biden's promise to offer boosters to vaccinated Americans beginning later this month, because available data are insufficient to determin..."},{"Date":"Sep. 6, 2021 at 6:29 p.m. ET","Headline":"Millions Losing Federal Unemployment Benefits as Aid Expires","Summary":""},{"Date":"Sep. 6, 2021 at 2:03 p.m. ET","Headline":"Biotech Is Due for a Comeback. 5 Stocks That Could Lead a Revival.","Summary":""},{"Date":"Sep. 6, 2021 at 5:00 a.m. ET","Headline":"Bangladesh Is Still a Frontier Market. But Its Economy Is Expanding and There Are Even Some Stocks to Buy.","Summary":""},{"Date":"Sep. 8, 2021 at 11:10 a.m. ET","Headline":"U.S. Deaths From Coronavirus Surpass 650,000","Summary":""},{"Date":"Sep. 8, 2021 at 7:19 a.m. ET","Headline":"Moderna stock extends rally after price target gets a 77% boost at Morgan Stanley","Summary":""},{"Date":"Sep. 7, 2021 at 7:32 p.m. ET","Headline":"Fauci on COVID-19 vaccines: \u2018The optimal regimen will ultimately be that third shot\u2019","Summary":""},{"Date":"Sep. 7, 2021 at 11:11 a.m. ET","Headline":"Vaccine Booster Will Be Ready for FDA Approval, Fauci Says","Summary":""},{"Date":"Sep. 7, 2021 at 8:17 a.m. ET","Headline":"Pfizer booster likely to be OK\u2019d by Sept. 20, but Moderna\u2019s may lag, Fauci says","Summary":""},{"Date":"Sep. 7, 2021 at 6:32 a.m. ET","Headline":"Boeing Now Has an Airbus Problem to Add to the List","Summary":""},{"Date":"Sep. 7, 2021 at 5:37 a.m. ET","Headline":"Strategists Say the Stock Market Could Struggle This Fall. What to Buy Now.","Summary":""},{"Date":"Sep. 4, 2021 at 10:31 a.m. ET","Headline":"Investors care more about fair wages for workers than environmental issues, ESG survey shows","Summary":""},{"Date":"Sep. 10, 2021 at 5:57 p.m. ET","Headline":"Unvaccinated are 11 times likelier to die of COVID-19, says CDC","Summary":"Shares of Marriott International Inc.  rose 1.0% in afternoon trading Thursday after the hotel operator indicated that business has stabilized following some weakness in August as a results of . Speaking at the Bank of Ame..."},{"Date":"Sep. 10, 2021 at 2:36 p.m. ET","Headline":"Daily COVID-19 deaths rise to 6-month high, and Biden\u2019s \u2018patience is wearing thin\u2019 for the unvaccinated","Summary":"Shares of Marriott International Inc.  rose 1.0% in afternoon trading Thursday after the hotel operator indicated that business has stabilized following some weakness in August as a results of . Speaking at the Bank of Ame..."},{"Date":"Sep. 10, 2021 at 9:28 a.m. ET","Headline":"Biden Vaccination Plan Could Be a Boon for Covid Test Makers","Summary":"Shares of Marriott International Inc.  rose 1.0% in afternoon trading Thursday after the hotel operator indicated that business has stabilized following some weakness in August as a results of . Speaking at the Bank of Ame..."},{"Date":"Sep. 9, 2021 at 5:57 p.m. ET","Headline":"Biden announces sweeping COVID vaccine mandates for millions of U.S. workers as he warns of \u2018tough stretch\u2019","Summary":"Shares of Marriott International Inc.  rose 1.0% in afternoon trading Thursday after the hotel operator indicated that business has stabilized following some weakness in August as a results of . Speaking at the Bank of Ame..."},{"Date":"Sep. 9, 2021 at 2:40 p.m. ET","Headline":"Marriott stock gains after CEO sees 'stabilization' in RevPAR in September","Summary":"Shares of Marriott International Inc.  rose 1.0% in afternoon trading Thursday after the hotel operator indicated that business has stabilized following some weakness in August as a results of . Speaking at the Bank of Ame..."},{"Date":"Sep. 9, 2021 at 11:51 a.m. ET","Headline":"Why the U.K. Drug Regulator Approved Booster Shots\u2014but the U.S. Is Still Deciding","Summary":""},{"Date":"Sep. 9, 2021 at 11:07 a.m. ET","Headline":"Biden\u2019s new pandemic approach to include vaccine mandates for federal workers, as U.S. averages 1,500 COVID deaths a day","Summary":""},{"Date":"Sep. 9, 2021 at 10:55 a.m. ET","Headline":"Why Atea Could Be the Frontrunner in the Covid Antiviral Race","Summary":""},{"Date":"Sep. 9, 2021 at 9:55 a.m. ET","Headline":"White House to Announce Drug-Pricing Plan. Pharma Stocks Are Down.","Summary":""},{"Date":"Sep. 9, 2021 at 6:34 a.m. ET","Headline":"Chinese Tech Stocks Are Tumbling Again. Cathie Wood Has an Idea.","Summary":""},{"Date":"Sep. 11, 2021 at 9:51 a.m. ET","Headline":"Biden on prospect of legal challenges to his vaccine mandate from Republican governors: \u2018Have at it\u2019","Summary":""},{"Date":"Sep. 14, 2021 at 1:58 p.m. ET","Headline":"Biden seeks to have 70% of world vaccinated within a year, as unvaccinated Americans continue to account for most COVID cases and deaths","Summary":"Israel is considering a fourth round of coronavirus vaccines, Bloomberg News reported, citing an interview a health ministry official gave to a local radio station. \"We don't know when it will happen; I hope very much that..."},{"Date":"Sep. 14, 2021 at 11:19 a.m. ET","Headline":"When can kids under 12 get a COVID-19 vaccine? CDC Director Rochelle Walensky has an answer","Summary":"Israel is considering a fourth round of coronavirus vaccines, Bloomberg News reported, citing an interview a health ministry official gave to a local radio station. \"We don't know when it will happen; I hope very much that..."},{"Date":"Sep. 14, 2021 at 9:54 a.m. ET","Headline":"CureVac Stock Falls as Company Cancels Vaccine Manufacturing Contracts","Summary":"Israel is considering a fourth round of coronavirus vaccines, Bloomberg News reported, citing an interview a health ministry official gave to a local radio station. \"We don't know when it will happen; I hope very much that..."},{"Date":"Sep. 14, 2021 at 8:25 a.m. ET","Headline":"It\u2019s Crunch Time for Biden\u2019s Booster Plan. The Debate is Growing.","Summary":"Israel is considering a fourth round of coronavirus vaccines, Bloomberg News reported, citing an interview a health ministry official gave to a local radio station. \"We don't know when it will happen; I hope very much that..."},{"Date":"Sep. 14, 2021 at 6:42 a.m. ET","Headline":"It\u2019s Showtime for Apple After Spyware Flaw and Court Ruling","Summary":"Israel is considering a fourth round of coronavirus vaccines, Bloomberg News reported, citing an interview a health ministry official gave to a local radio station. \"We don't know when it will happen; I hope very much that..."},{"Date":"Sep. 13, 2021 at 3:33 p.m. ET","Headline":"Moderna Stock Is Tanking After a Review Arguing That Covid Vaccine Boosters Aren\u2019t Needed","Summary":"Israel is considering a fourth round of coronavirus vaccines, Bloomberg News reported, citing an interview a health ministry official gave to a local radio station. \"We don't know when it will happen; I hope very much that..."},{"Date":"Sep. 13, 2021 at 9:32 a.m. ET","Headline":"The U.K. Canceled a Vaccine Deal. Here\u2019s the Fallout for Valneva and 3 Other Stocks.","Summary":"Israel is considering a fourth round of coronavirus vaccines, Bloomberg News reported, citing an interview a health ministry official gave to a local radio station. \"We don't know when it will happen; I hope very much that..."},{"Date":"Sep. 13, 2021 at 8:26 a.m. ET","Headline":"The U.S. Is Debating a Third Vaccine Dose. Israel Is Talking About a Fourth.","Summary":"Israel is considering a fourth round of coronavirus vaccines, Bloomberg News reported, citing an interview a health ministry official gave to a local radio station. \"We don't know when it will happen; I hope very much that..."},{"Date":"Sep. 13, 2021 at 3:52 a.m. ET","Headline":"Israel weighing fourth round of coronavirus vaccines: report","Summary":"Israel is considering a fourth round of coronavirus vaccines, Bloomberg News reported, citing an interview a health ministry official gave to a local radio station. \"We don't know when it will happen; I hope very much that..."},{"Date":"Sep. 16, 2021 at 6:05 p.m. ET","Headline":"Florida surpasses 50,000 coronavirus deaths; a quarter have come this summer","Summary":"The Food and Drug Administration said Wednesday that observational studies have had mixed findings assessing whether the efficacy for BioNTech SE  and Pfizer Inc.'s  COVID-19 vaccine is declining as a result of time or the..."},{"Date":"Sep. 16, 2021 at 2:40 p.m. ET","Headline":"U.S. passes grim milestone as 1 person in every 500 has now died of COVID, as a debate about the need for booster shots heats up","Summary":"The Food and Drug Administration said Wednesday that observational studies have had mixed findings assessing whether the efficacy for BioNTech SE  and Pfizer Inc.'s  COVID-19 vaccine is declining as a result of time or the..."},{"Date":"Sep. 16, 2021 at 12:10 p.m. ET","Headline":"Moderna Says Higher Infection Risk After One Year Supports Covid Boosters","Summary":"The Food and Drug Administration said Wednesday that observational studies have had mixed findings assessing whether the efficacy for BioNTech SE  and Pfizer Inc.'s  COVID-19 vaccine is declining as a result of time or the..."},{"Date":"Sep. 16, 2021 at 7:06 a.m. ET","Headline":"Emotional AI and other \u2018moonshot\u2019 technologies could grow to $6 trillion market by 2030, says Bank of America","Summary":"The Food and Drug Administration said Wednesday that observational studies have had mixed findings assessing whether the efficacy for BioNTech SE  and Pfizer Inc.'s  COVID-19 vaccine is declining as a result of time or the..."},{"Date":"Sep. 16, 2021 at 6:40 a.m. ET","Headline":"Ignore the Billionaire Space Race. What SpaceX\u2019s Historic Flight Really Means.","Summary":"The Food and Drug Administration said Wednesday that observational studies have had mixed findings assessing whether the efficacy for BioNTech SE  and Pfizer Inc.'s  COVID-19 vaccine is declining as a result of time or the..."},{"Date":"Sep. 15, 2021 at 5:20 p.m. ET","Headline":"FDA says COVID-19 vaccines continue to protect people in the U.S. from severe disease","Summary":"The Food and Drug Administration said Wednesday that observational studies have had mixed findings assessing whether the efficacy for BioNTech SE  and Pfizer Inc.'s  COVID-19 vaccine is declining as a result of time or the..."},{"Date":"Sep. 15, 2021 at 2:30 p.m. ET","Headline":"Exact stock surges as changes to Pfizer's sales agreement a 'positive,' analyst says","Summary":"Shares of Exact Sciences Corp.  rallied 8.0% in afternoon trading Wednesday, after the molecular diagnostics company said it taking over the selling of its Cologuard at-home colon cancer screening test from Pfizer Inc. , a..."},{"Date":"Sep. 15, 2021 at 1:20 p.m. ET","Headline":"FDA Stays Neutral on Covid Boosters. A Showdown Is Brewing.","Summary":"Shares of Pfizer Inc.  gained 0.1% in premarket trading on Wednesday after the drug maker said the \"totality\" of clinical data indicates that people who are at least 16 years old and were vaccinated with the COVID-19 shot ..."},{"Date":"Sep. 15, 2021 at 12:14 p.m. ET","Headline":"\u2018Shoulda Got the Shot\u2019: New PSAs employ real people rather than science and data to encourage unvaccinated Americans to change their minds","Summary":"Shares of Pfizer Inc.  gained 0.1% in premarket trading on Wednesday after the drug maker said the \"totality\" of clinical data indicates that people who are at least 16 years old and were vaccinated with the COVID-19 shot ..."},{"Date":"Sep. 15, 2021 at 10:32 a.m. ET","Headline":"Companies say they want to close the gender-pay gap. So why are they trying to block relevant disclosures to investors?","Summary":"Shares of Pfizer Inc.  gained 0.1% in premarket trading on Wednesday after the drug maker said the \"totality\" of clinical data indicates that people who are at least 16 years old and were vaccinated with the COVID-19 shot ..."},{"Date":"Sep. 15, 2021 at 9:29 a.m. ET","Headline":"Pfizer cites 'totality' of clinical data in bid for COVID-19 booster approval","Summary":"Shares of Pfizer Inc.  gained 0.1% in premarket trading on Wednesday after the drug maker said the \"totality\" of clinical data indicates that people who are at least 16 years old and were vaccinated with the COVID-19 shot ..."},{"Date":"Sep. 15, 2021 at 8:57 a.m. ET","Headline":"Enough Hand-Wringing Over the Science. Bring on the Boosters.","Summary":"Pfizer Inc.  expects to share data about the safety and efficacy of the COVID-19 vaccine it developed with BioNTech SE  for children between the ages of 5 and 11 years old by the end of September, with plans to file for em..."},{"Date":"Sep. 15, 2021 at 8:43 a.m. ET","Headline":"Vaccines for Children Are Moving Closer. Pfizer Will Seek FDA Go-Ahead Next Month.","Summary":"Pfizer Inc.  expects to share data about the safety and efficacy of the COVID-19 vaccine it developed with BioNTech SE  for children between the ages of 5 and 11 years old by the end of September, with plans to file for em..."},{"Date":"Sep. 15, 2021 at 7:47 a.m. ET","Headline":"Pfizer expects to have safety and efficacy data for its COVID-19 vaccine in children in late September","Summary":"Pfizer Inc.  expects to share data about the safety and efficacy of the COVID-19 vaccine it developed with BioNTech SE  for children between the ages of 5 and 11 years old by the end of September, with plans to file for em..."},{"Date":"Sep. 18, 2021 at 3:29 p.m. ET","Headline":"WHO warns lack of COVID-19 vaccine supply in Africa could make it breeding ground for new variants and \u2018send the whole world back to square one\u2019","Summary":""},{"Date":"Sep. 18, 2021 at 7:00 a.m. ET","Headline":"Modern Portfolio Theory Ignores Crucial Systemic Risk, Author Says","Summary":""},{"Date":"Sep. 17, 2021 at 8:02 p.m. ET","Headline":"Cisco Stock Should Get a Boost From a Coming Wave of Equipment Buying","Summary":""},{"Date":"Sep. 17, 2021 at 6:04 p.m. ET","Headline":"FDA Committee Vote Is a Rebuff to Biden. Impact on Vaccine Makers Is Less Clear.","Summary":""},{"Date":"Sep. 17, 2021 at 5:57 p.m. ET","Headline":"Dow, S&P 500, Nasdaq close lower in weekly slump on \u2018quad witching\u2019 and weak consumer sentiment","Summary":""},{"Date":"Sep. 17, 2021 at 4:40 p.m. ET","Headline":"FDA Panel Votes No on Biden\u2019s Booster Shot Plan. Drug Stocks Fall.","Summary":""},{"Date":"Sep. 17, 2021 at 9:10 a.m. ET","Headline":"Scientists continue to say there isn\u2019t enough evidence to make COVID-19 boosters available to all Americans","Summary":""},{"Date":"Sep. 17, 2021 at 8:43 a.m. ET","Headline":"Investors are in a historically rotten mood. Their three biggest fears are overblown, strategist says.","Summary":""},{"Date":"Sep. 17, 2021 at 8:13 a.m. ET","Headline":"China\u2019s Billionaires Are Losing Billions Fast","Summary":""},{"Date":"Sep. 17, 2021 at 7:58 a.m. ET","Headline":"Sanofi Is Finally Catching Up. How a Covid Vaccine Could Lift the Stock.","Summary":""},{"Date":"Sep. 17, 2021 at 6:21 a.m. ET","Headline":"Alaska joins Idaho in rationing health care as hospitals are packed with COVID patients, and WHO says Africa is being left behind in vaccine push","Summary":""},{"Date":"Sep. 16, 2021 at 3:08 p.m. ET","Headline":"FDA Advisors to Weigh In on Covid Booster Shots Friday. Investors Expect a Yes.","Summary":""},{"Date":"Sep. 20, 2021 at 5:46 p.m. ET","Headline":"Pfizer and BioNTech Say Covid-19 Vaccine Has Positive Results in Children. What to Know.","Summary":"U.S. Treasury yields fall, as the potential collapse of a Chinese property development company rattled investors, raising the prospect of a spillover into other global markets."},{"Date":"Sep. 20, 2021 at 5:44 p.m. ET","Headline":"Stocks Notch Worst Day in Months on Evergrande Fears","Summary":"U.S. Treasury yields fall, as the potential collapse of a Chinese property development company rattled investors, raising the prospect of a spillover into other global markets."},{"Date":"Sep. 20, 2021 at 4:59 p.m. ET","Headline":"Dow books worst day in 9 weeks as debt woes for China\u2019s Evergrande rattle stock market","Summary":"U.S. Treasury yields fall, as the potential collapse of a Chinese property development company rattled investors, raising the prospect of a spillover into other global markets."},{"Date":"Sep. 20, 2021 at 4:17 p.m. ET","Headline":"COVID-19 has killed about as many Americans as the 1918\u201319 flu pandemic","Summary":"U.S. Treasury yields fall, as the potential collapse of a Chinese property development company rattled investors, raising the prospect of a spillover into other global markets."},{"Date":"Sep. 20, 2021 at 3:46 p.m. ET","Headline":"Treasury yields post biggest daily drop since August amid worries of potential spillover from China\u2019s Evergrande","Summary":"U.S. Treasury yields fall, as the potential collapse of a Chinese property development company rattled investors, raising the prospect of a spillover into other global markets."},{"Date":"Sep. 20, 2021 at 2:09 p.m. ET","Headline":"Upbeat result of COVID-19 vaccine trial in 5- to 11-year-olds tempered as U.S. daily death rate tops 2,000 for first time since March 1","Summary":"Pfizer Inc.  and German partner BioNTech SE  on Monday announced positive results in a Phase 2\/3 trial of their COVID-19 vaccine in children aged 5 to 11, and said the vaccine was safe, well tolerated and produced \"robust\"..."},{"Date":"Sep. 20, 2021 at 2:07 p.m. ET","Headline":"A New Aspirin From PLX Has Investors\u2019 Hearts Pounding","Summary":"Pfizer Inc.  and German partner BioNTech SE  on Monday announced positive results in a Phase 2\/3 trial of their COVID-19 vaccine in children aged 5 to 11, and said the vaccine was safe, well tolerated and produced \"robust\"..."},{"Date":"Sep. 20, 2021 at 9:48 a.m. ET","Headline":"FDA Panel Is a Win for Pfizer, Despite Mixed Result, Analyst Says","Summary":"Pfizer Inc.  and German partner BioNTech SE  on Monday announced positive results in a Phase 2\/3 trial of their COVID-19 vaccine in children aged 5 to 11, and said the vaccine was safe, well tolerated and produced \"robust\"..."},{"Date":"Sep. 20, 2021 at 8:25 a.m. ET","Headline":"Buy the dip shopping? Four growth stocks that are bucking a down market","Summary":"Pfizer Inc.  and German partner BioNTech SE  on Monday announced positive results in a Phase 2\/3 trial of their COVID-19 vaccine in children aged 5 to 11, and said the vaccine was safe, well tolerated and produced \"robust\"..."},{"Date":"Sep. 20, 2021 at 7:51 a.m. ET","Headline":"Pills to Battle Covid Are Coming. These Companies Stand to Gain.","Summary":"Pfizer Inc.  and German partner BioNTech SE  on Monday announced positive results in a Phase 2\/3 trial of their COVID-19 vaccine in children aged 5 to 11, and said the vaccine was safe, well tolerated and produced \"robust\"..."},{"Date":"Sep. 20, 2021 at 7:47 a.m. ET","Headline":"FDA panel recommends Pfizer\u2019s COVID-19 booster for 65 and older, but not for the general public","Summary":"Pfizer Inc.  and German partner BioNTech SE  on Monday announced positive results in a Phase 2\/3 trial of their COVID-19 vaccine in children aged 5 to 11, and said the vaccine was safe, well tolerated and produced \"robust\"..."},{"Date":"Sep. 20, 2021 at 7:15 a.m. ET","Headline":"Pfizer and BioNTech say COVID-19 vaccine safe and effective in children aged 5 to 11","Summary":"Pfizer Inc.  and German partner BioNTech SE  on Monday announced positive results in a Phase 2\/3 trial of their COVID-19 vaccine in children aged 5 to 11, and said the vaccine was safe, well tolerated and produced \"robust\"..."},{"Date":"Sep. 20, 2021 at 6:39 a.m. ET","Headline":"It\u2019s Crunchtime for Evergrande. The Market Is Worried.","Summary":""},{"Date":"Sep. 22, 2021 at 7:57 p.m. ET","Headline":"FDA backs Pfizer COVID-19 boosters for seniors and those at high risk","Summary":"A Centers for Disease Control and Prevention committee is  Wednesday and Thursday to again discuss the science and possible administration plan for BioNTech SE  and Pfizer Inc.'s  COVID-19 booster shot. The CDC's Advisory ..."},{"Date":"Sep. 22, 2021 at 2:48 p.m. ET","Headline":"Global tally of COVID-19 cases nears 230 million, as Biden convenes virtual pandemic summit and doubles U.S. purchase of Pfizer vaccine","Summary":"A Centers for Disease Control and Prevention committee is  Wednesday and Thursday to again discuss the science and possible administration plan for BioNTech SE  and Pfizer Inc.'s  COVID-19 booster shot. The CDC's Advisory ..."},{"Date":"Sep. 22, 2021 at 9:09 a.m. ET","Headline":"CDC Committee Will Consider Pfizer Booster. What to Know.","Summary":"A Centers for Disease Control and Prevention committee is  Wednesday and Thursday to again discuss the science and possible administration plan for BioNTech SE  and Pfizer Inc.'s  COVID-19 booster shot. The CDC's Advisory ..."},{"Date":"Sep. 22, 2021 at 8:34 a.m. ET","Headline":"J&J says booster shot greatly improves its COVID-19 vaccine\u2019s efficacy as experts await FDA decision","Summary":"A Centers for Disease Control and Prevention committee is  Wednesday and Thursday to again discuss the science and possible administration plan for BioNTech SE  and Pfizer Inc.'s  COVID-19 booster shot. The CDC's Advisory ..."},{"Date":"Sep. 22, 2021 at 7:34 a.m. ET","Headline":"CDC committee to meet today and Thursday to again discuss BioNTech and Pfizer's COVID-19 booster","Summary":"A Centers for Disease Control and Prevention committee is  Wednesday and Thursday to again discuss the science and possible administration plan for BioNTech SE  and Pfizer Inc.'s  COVID-19 booster shot. The CDC's Advisory ..."},{"Date":"Sep. 22, 2021 at 7:06 a.m. ET","Headline":"Biden doubling vaccine purchase, calls for more global shots","Summary":"The global tally for the coronavirus-borne illness climbed above 229.5 million on Wednesday, while the death toll rose to 4.71 million, according to . The U.S. continues to lead the world with a total of 42.4 million cases..."},{"Date":"Sep. 22, 2021 at 6:30 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 229.5 million and CDC advisers to meet to discuss boosters","Summary":"The global tally for the coronavirus-borne illness climbed above 229.5 million on Wednesday, while the death toll rose to 4.71 million, according to . The U.S. continues to lead the world with a total of 42.4 million cases..."},{"Date":"Sep. 22, 2021 at 6:12 a.m. ET","Headline":"Pfizer, BioNTech to provide additional 500 million COVID-19 vaccine doses to U.S. government for donation","Summary":"Pfizer Inc.  and BioNTech SE  announced Wednesday plans to provide an additional 500 million doses of their COVID-19 vaccine to the U.S. government. The additional doses will be sold at \"not-for-profit\" prices, for donatio..."},{"Date":"Sep. 21, 2021 at 11:42 a.m. ET","Headline":"\u2018I\u2019m a firm believer in science, but I\u2019d still like to wait\u2019: Pfizer\u2019s vaccine results for kids might not lead to quick vaccinations","Summary":""},{"Date":"Sep. 21, 2021 at 10:09 a.m. ET","Headline":"J&J Says Its Booster Shot Works, but Its Vaccine Remains Effective Without a Second Dose","Summary":""},{"Date":"Sep. 24, 2021 at 8:11 p.m. ET","Headline":"PLx Pharma Aims to Fix What Ails Aspirin","Summary":"The Centers for Disease Control and Prevention does not plan to change the definition of what it means to be \"fully vaccinated\" right now that BioNTech SE  and Pfizer Inc.'s  COVID-19 booster shots are available for a larg..."},{"Date":"Sep. 24, 2021 at 2:26 p.m. ET","Headline":"Telemedicine, like remote learning, finds its place in COVID-era schools","Summary":"The Centers for Disease Control and Prevention does not plan to change the definition of what it means to be \"fully vaccinated\" right now that BioNTech SE  and Pfizer Inc.'s  COVID-19 booster shots are available for a larg..."},{"Date":"Sep. 24, 2021 at 2:15 p.m. ET","Headline":"CDC head overrules advisers to allow COVID-19 boosters for at-risk workers, and Biden urges those eligible to act fast","Summary":"The Centers for Disease Control and Prevention does not plan to change the definition of what it means to be \"fully vaccinated\" right now that BioNTech SE  and Pfizer Inc.'s  COVID-19 booster shots are available for a larg..."},{"Date":"Sep. 24, 2021 at 1:16 p.m. ET","Headline":"CDC: We are not changing the definition of 'fully vaccinated' now that COVID-19 boosters are available","Summary":"The Centers for Disease Control and Prevention does not plan to change the definition of what it means to be \"fully vaccinated\" right now that BioNTech SE  and Pfizer Inc.'s  COVID-19 booster shots are available for a larg..."},{"Date":"Sep. 24, 2021 at 10:46 a.m. ET","Headline":"'Go get the booster,' Biden says to eligible U.S. residents","Summary":"President Joe Biden on Friday addressed top U.S. health officials' , saying \"the majority of Americans who were fully vaccinated with the Pfizer  vaccine are now able to receive the booster shot six months after they've re..."},{"Date":"Sep. 24, 2021 at 9:46 a.m. ET","Headline":"Pfizer Vaccine Boosters Officially Approved. What to Know.","Summary":""},{"Date":"Sep. 24, 2021 at 8:16 a.m. ET","Headline":"Whether COVID-19 boosters get approved or not, Pfizer and Moderna have already made their money","Summary":""},{"Date":"Sep. 24, 2021 at 7:16 a.m. ET","Headline":"The S&P 500 has to hold this line in the sand or risk a terrifying plunge, says strategist","Summary":""},{"Date":"Sep. 24, 2021 at 6:48 a.m. ET","Headline":"It May Be Time to Start Worrying About Bond Yields Again","Summary":""},{"Date":"Sep. 23, 2021 at 5:51 p.m. ET","Headline":"CDC Advisors Recommend Pfizer Booster Shots for Older Americans. What to Know.","Summary":""},{"Date":"Sep. 23, 2021 at 5:03 p.m. ET","Headline":"CDC panel backs Pfizer\u2019s COVID-19 booster for seniors, high-risk adults","Summary":""},{"Date":"Sep. 23, 2021 at 4:32 p.m. ET","Headline":"Stocks Are Past the September Doldrums\u2014for Now","Summary":""},{"Date":"Sep. 23, 2021 at 2:22 p.m. ET","Headline":"Another Hedge Fund Joins in Criticism of GlaxoSmithKline CEO. What Investors Need to Know.","Summary":""},{"Date":"Sep. 23, 2021 at 1:58 p.m. ET","Headline":"CDC to meet on boosters just hours after FDA authorized their use for seniors and high-risk individuals, as Africa slams U.K.\u2019s travel rules","Summary":""},{"Date":"Sep. 23, 2021 at 9:26 a.m. ET","Headline":"\u2018I decided I\u2019d jump the gun\u2019: What to consider before getting a third shot if you\u2019re not eligible yet","Summary":""},{"Date":"Sep. 23, 2021 at 8:16 a.m. ET","Headline":"FDA Authorizes Pfizer Booster for Some Americans. The CDC\u2019s Call on the Rollout Could Come Today.","Summary":""},{"Date":"Sep. 23, 2021 at 6:31 a.m. ET","Headline":"Markets Defy Fed\u2019s Hawkish Shift. Here\u2019s Why.","Summary":""},{"Date":"Sep. 22, 2021 at 12:02 p.m. ET","Headline":"4 Midsize Biotech Stocks That Have Breakout Potential","Summary":""},{"Date":"Sep. 26, 2021 at 4:17 p.m. ET","Headline":"U.S. confident it has enough COVID-19 vaccines for boosters, kids\u2019 shots","Summary":""},{"Date":"Sep. 28, 2021 at 5:25 p.m. ET","Headline":"Pfizer\u2019s COVID vaccine for kids might not get FDA approval until November","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Tuesday they have submitted initial data from the late-stage trial of their COVID-19 vaccine in children aged 5 to 12 to the U.S. Food and Drug Administration, and are seek..."},{"Date":"Sep. 28, 2021 at 6:55 a.m. ET","Headline":"Pfizer and BioNTech submit initial data to FDA from trial of COVID-19 vaccine in children aged 5 to 12","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Tuesday they have submitted initial data from the late-stage trial of their COVID-19 vaccine in children aged 5 to 12 to the U.S. Food and Drug Administration, and are seek..."},{"Date":"Sep. 28, 2021 at 6:46 a.m. ET","Headline":"Is energy sector now so cheap that investors will put their green preferences on a back burner?","Summary":"President Joe Biden on Monday d a booster shot for the Pfizer  and BioNTech  COVID-19 vaccine, with the jab coming after top U.S. health officials  for people over age 65 and certain other groups. \"Boosters are important, ..."},{"Date":"Sep. 28, 2021 at 6:36 a.m. ET","Headline":"The Value Rotation Is Back. But for How Long?","Summary":"President Joe Biden on Monday d a booster shot for the Pfizer  and BioNTech  COVID-19 vaccine, with the jab coming after top U.S. health officials  for people over age 65 and certain other groups. \"Boosters are important, ..."},{"Date":"Sep. 27, 2021 at 4:17 p.m. ET","Headline":"Dow books 4-day winning streak, but S&P 500, Nasdaq end lower as tech shares stumble","Summary":"President Joe Biden on Monday d a booster shot for the Pfizer  and BioNTech  COVID-19 vaccine, with the jab coming after top U.S. health officials  for people over age 65 and certain other groups. \"Boosters are important, ..."},{"Date":"Sep. 27, 2021 at 1:54 p.m. ET","Headline":"CEO says Pfizer will submit data on COVID-19 vaccine trial in 5- to 11-year-olds within days, with U.S. daily death toll still above 2,000","Summary":"President Joe Biden on Monday d a booster shot for the Pfizer  and BioNTech  COVID-19 vaccine, with the jab coming after top U.S. health officials  for people over age 65 and certain other groups. \"Boosters are important, ..."},{"Date":"Sep. 27, 2021 at 1:25 p.m. ET","Headline":"Biden says 'boosters are important' as he receives his 3rd COVID vaccine shot","Summary":"President Joe Biden on Monday d a booster shot for the Pfizer  and BioNTech  COVID-19 vaccine, with the jab coming after top U.S. health officials  for people over age 65 and certain other groups. \"Boosters are important, ..."},{"Date":"Sep. 27, 2021 at 11:31 a.m. ET","Headline":"Biden to get COVID booster shot Monday, White House says","Summary":"President Joe Biden on Monday will receive his COVID-19 booster shot and deliver remarks, the White House said. Biden got his second dose of the Pfizer  and BioNTech  vaccine on Jan. 11, and said last week he'd get a boost..."},{"Date":"Sep. 27, 2021 at 10:10 a.m. ET","Headline":"There\u2019s a Global Energy Crisis \u2014 and It\u2019s Bad News for Apple and Tesla","Summary":"Pfizer Inc.  said Monday it is starting a Phase 2\/3 trial of its investigational novel oral antiviral candidate to treat adults living in a household with someone who has tested positive for and has symptoms of the coronav..."},{"Date":"Sep. 27, 2021 at 9:03 a.m. ET","Headline":"Pfizer CEO Says Vaccine Data in Children Due Soon, Starts Trial of Pill to Protect Against Covid-19","Summary":"Pfizer Inc.  said Monday it is starting a Phase 2\/3 trial of its investigational novel oral antiviral candidate to treat adults living in a household with someone who has tested positive for and has symptoms of the coronav..."},{"Date":"Sep. 27, 2021 at 7:53 a.m. ET","Headline":"Medicine\u2019s Golden Age Is Dawning. 10 Stocks to Play the Latest Innovations.","Summary":"Pfizer Inc.  said Monday it is starting a Phase 2\/3 trial of its investigational novel oral antiviral candidate to treat adults living in a household with someone who has tested positive for and has symptoms of the coronav..."},{"Date":"Sep. 27, 2021 at 7:14 a.m. ET","Headline":"Get ready for growth stocks to come roaring back to life says this top-performing manager. Here are his picks.","Summary":"Pfizer Inc.  said Monday it is starting a Phase 2\/3 trial of its investigational novel oral antiviral candidate to treat adults living in a household with someone who has tested positive for and has symptoms of the coronav..."},{"Date":"Sep. 27, 2021 at 6:53 a.m. ET","Headline":"Pfizer starts Phase 2\/3 study of COVID-19 oral antiviral candidate for  adults exposed to virus","Summary":"Pfizer Inc.  said Monday it is starting a Phase 2\/3 trial of its investigational novel oral antiviral candidate to treat adults living in a household with someone who has tested positive for and has symptoms of the coronav..."},{"Date":"Sep. 30, 2021 at 2:22 p.m. ET","Headline":"AstraZeneca vaccine shows 74% efficacy in large U.S.-backed trial, and BioNTech co-founder says COVID will become manageable","Summary":"Shares of Pfizer Inc.  gained 0.3% in premarket trading on Wednesday after the drugmaker said its combination pneumococcal and flu vaccine is safe and effective when administered at the same time. The Phase 3 study is eval..."},{"Date":"Sep. 30, 2021 at 1:29 p.m. ET","Headline":"A growing number of parents want to have their young children vaccinated as soon as possible","Summary":"Shares of Pfizer Inc.  gained 0.3% in premarket trading on Wednesday after the drugmaker said its combination pneumococcal and flu vaccine is safe and effective when administered at the same time. The Phase 3 study is eval..."},{"Date":"Sep. 30, 2021 at 9:57 a.m. ET","Headline":"There\u2019s a Fight Over Pneumococcal Vaccines. Pfizer May Be Winning.","Summary":"Shares of Pfizer Inc.  gained 0.3% in premarket trading on Wednesday after the drugmaker said its combination pneumococcal and flu vaccine is safe and effective when administered at the same time. The Phase 3 study is eval..."},{"Date":"Sep. 30, 2021 at 8:03 a.m. ET","Headline":"Moderna Is Likely to Get FDA Approval for Smaller Booster,  Report Says","Summary":"Shares of Pfizer Inc.  gained 0.3% in premarket trading on Wednesday after the drugmaker said its combination pneumococcal and flu vaccine is safe and effective when administered at the same time. The Phase 3 study is eval..."},{"Date":"Sep. 30, 2021 at 7:33 a.m. ET","Headline":"BioNTech Co-Founder Says Covid Will \u2018Become Manageable\u2019 and Be With Us for Years","Summary":"Shares of Pfizer Inc.  gained 0.3% in premarket trading on Wednesday after the drugmaker said its combination pneumococcal and flu vaccine is safe and effective when administered at the same time. The Phase 3 study is eval..."},{"Date":"Sep. 30, 2021 at 7:10 a.m. ET","Headline":"CDC study finds side effects from COVID-19 vaccine booster are the same as after second shot, as experts urge unvaccinated to get their first shots","Summary":"Shares of Pfizer Inc.  gained 0.3% in premarket trading on Wednesday after the drugmaker said its combination pneumococcal and flu vaccine is safe and effective when administered at the same time. The Phase 3 study is eval..."},{"Date":"Sep. 29, 2021 at 9:29 a.m. ET","Headline":"Pfizer Says Its Pneumococcal and Flu Vaccines Work Just as Well Given Together","Summary":"Shares of Pfizer Inc.  gained 0.3% in premarket trading on Wednesday after the drugmaker said its combination pneumococcal and flu vaccine is safe and effective when administered at the same time. The Phase 3 study is eval..."},{"Date":"Sep. 29, 2021 at 8:57 a.m. ET","Headline":"Pfizer says administering pneumococcal and flu shots at the same time is safe and effective","Summary":"Shares of Pfizer Inc.  gained 0.3% in premarket trading on Wednesday after the drugmaker said its combination pneumococcal and flu vaccine is safe and effective when administered at the same time. The Phase 3 study is eval..."},{"Date":"Sep. 29, 2021 at 8:33 a.m. ET","Headline":"Merck Says Its Covid-19  Antiviral Pill Looks Good Against Variants","Summary":"The global tally for the coronavirus-borne illness climbed above 232.8 million on Wednesday, while the death toll rose above 4.76 million, according to . The U.S. continues to lead the world with a total of 43.2 million ca..."},{"Date":"Sep. 29, 2021 at 7:25 a.m. ET","Headline":"Hopes rise that Pfizer  COVID-19 vaccine will be authorized for use in children aged 5 to 11 by late October, and Russia suffers worst one-day death toll","Summary":"The global tally for the coronavirus-borne illness climbed above 232.8 million on Wednesday, while the death toll rose above 4.76 million, according to . The U.S. continues to lead the world with a total of 43.2 million ca..."},{"Date":"Sep. 29, 2021 at 6:38 a.m. ET","Headline":"Pfizer Kids\u2019 Covid Vaccine May Not Be Authorized Before November","Summary":"The global tally for the coronavirus-borne illness climbed above 232.8 million on Wednesday, while the death toll rose above 4.76 million, according to . The U.S. continues to lead the world with a total of 43.2 million ca..."},{"Date":"Sep. 29, 2021 at 6:38 a.m. ET","Headline":"If Taper Tantrum 2.0 Is Like the First One, Prepare for Months of Instability","Summary":"The global tally for the coronavirus-borne illness climbed above 232.8 million on Wednesday, while the death toll rose above 4.76 million, according to . The U.S. continues to lead the world with a total of 43.2 million ca..."},{"Date":"Sep. 29, 2021 at 6:25 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 232.8 million and Pfizer vaccine may not get authorization for children until Nov.","Summary":"The global tally for the coronavirus-borne illness climbed above 232.8 million on Wednesday, while the death toll rose above 4.76 million, according to . The U.S. continues to lead the world with a total of 43.2 million ca..."},{"Date":"Oct. 2, 2021 at 1:43 p.m. ET","Headline":"Does your job make you eligible for a COVID-19 booster shot?","Summary":""},{"Date":"Oct. 1, 2021 at 2:27 p.m. ET","Headline":"Pfizer loses legal battle with big implications for drug pricing","Summary":""},{"Date":"Oct. 1, 2021 at 12:40 p.m. ET","Headline":"Merck Covid Pill Cuts Covid Hospitalization in Half. Its Stock Is Surging.","Summary":""},{"Date":"Oct. 1, 2021 at 10:08 a.m. ET","Headline":"BioNTech Starts New Cancer Vaccine Trial","Summary":""},{"Date":"Oct. 1, 2021 at 6:49 a.m. ET","Headline":"History Says Expect a Strong Fourth Quarter. History Can Be Wrong.","Summary":""},{"Date":"Oct. 4, 2021 at 11:17 a.m. ET","Headline":"New Vaccines Might Be Needed in 2022, BioNTech CEO Says. Vaccine Stocks Are Still Getting Crushed.","Summary":""},{"Date":"Oct. 4, 2021 at 8:41 a.m. ET","Headline":"Johnson & Johnson Data on RSV Vaccines Raises the Bar in Industrywide Race","Summary":""},{"Date":"Oct. 4, 2021 at 7:15 a.m. ET","Headline":"Here\u2019s why COVID-19 booster shots are good for business","Summary":""},{"Date":"Oct. 4, 2021 at 6:38 a.m. ET","Headline":"Facebook Whistleblower Fires More Shots. Will Its Valuation Suffer?","Summary":""},{"Date":"Oct. 3, 2021 at 6:51 p.m. ET","Headline":"Democrats Still Negotiating $3.5 Trillion Reconciliation Bill","Summary":""},{"Date":"Oct. 3, 2021 at 4:47 p.m. ET","Headline":"Moderna Stock Tumbled Because Good News on a Covid Pill Is Bad News for Vaccines","Summary":""},{"Date":"Oct. 6, 2021 at 4:55 p.m. ET","Headline":"Dow scores best comeback since December, S&P 500 and Nasdaq end higher as tech stocks find a footing","Summary":"Shares of Voyager Therapeutics Inc.  rocketed 38.9% in premarket trading Wednesday, after closing at a record low in the previous session, after the gene therapy company announced a license option agreement with Pfizer Inc..."},{"Date":"Oct. 6, 2021 at 11:42 a.m. ET","Headline":"Vaccine Stocks Slip Fourth Day in a Row. Here\u2019s Why.","Summary":"Shares of Voyager Therapeutics Inc.  rocketed 38.9% in premarket trading Wednesday, after closing at a record low in the previous session, after the gene therapy company announced a license option agreement with Pfizer Inc..."},{"Date":"Oct. 6, 2021 at 10:36 a.m. ET","Headline":"COVID-19 vaccines have saved more than 39,000 lives in Medicare population, government study concludes, while WHO warns that \u2018we are not out of the woods yet\u2019","Summary":"Shares of Voyager Therapeutics Inc.  rocketed 38.9% in premarket trading Wednesday, after closing at a record low in the previous session, after the gene therapy company announced a license option agreement with Pfizer Inc..."},{"Date":"Oct. 6, 2021 at 10:18 a.m. ET","Headline":"Voyager Therapeutics Stock Had Been Beaten Down. Here\u2019s Why It\u2019s Soaring.","Summary":"Shares of Voyager Therapeutics Inc.  rocketed 38.9% in premarket trading Wednesday, after closing at a record low in the previous session, after the gene therapy company announced a license option agreement with Pfizer Inc..."},{"Date":"Oct. 6, 2021 at 7:32 a.m. ET","Headline":"Voyager Therapeutics stock rockets after license option deal with Pfizer that could be valued at $630 million","Summary":"Shares of Voyager Therapeutics Inc.  rocketed 38.9% in premarket trading Wednesday, after closing at a record low in the previous session, after the gene therapy company announced a license option agreement with Pfizer Inc..."},{"Date":"Oct. 6, 2021 at 6:35 a.m. ET","Headline":"The Energy Price Surge Is Spiraling Into Other Markets","Summary":"Shares of Moderna Inc.  gained 1.2% in trading on Tuesday after the company announced that the European Medicines Agency authorized a third dose of its COVID-19 vaccine for people who are severely immunocompromised. The au..."},{"Date":"Oct. 5, 2021 at 11:22 a.m. ET","Headline":"E.U. authorizes third dose of Moderna's COVID-19 vaccine for the immunocompromised","Summary":"Shares of Moderna Inc.  gained 1.2% in trading on Tuesday after the company announced that the European Medicines Agency authorized a third dose of its COVID-19 vaccine for people who are severely immunocompromised. The au..."},{"Date":"Oct. 5, 2021 at 10:34 a.m. ET","Headline":"Pfizer\u2019s Covid Vaccine Loses Effectiveness Against Infection Over Time. What To Know.","Summary":""},{"Date":"Oct. 5, 2021 at 8:59 a.m. ET","Headline":"Johnson & Johnson Sends Booster Data to FDA. Here\u2019s What Comes Next.","Summary":""},{"Date":"Oct. 5, 2021 at 6:59 a.m. ET","Headline":"U.S. COVID-19 cases and hospitalizations continue to decline, but experts lament preventable deaths that have pushed toll above 700,000","Summary":""},{"Date":"Oct. 8, 2021 at 5:50 p.m. ET","Headline":"3 Biotechs Made Their Market Debut Today. Only 1 Rose Above Its Offer Price.","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Thursday after the company and BioNTech SE  announced they submitted an application for emergency use authorization for their COVID-19 vaccine in children between..."},{"Date":"Oct. 8, 2021 at 2:10 p.m. ET","Headline":"U.N. head says vaccine inequity is not just immoral but also \u2018stupid,\u2019 as U.S. daily case tally falls below 100,000 for first time since early August","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Thursday after the company and BioNTech SE  announced they submitted an application for emergency use authorization for their COVID-19 vaccine in children between..."},{"Date":"Oct. 8, 2021 at 11:01 a.m. ET","Headline":"A Lyme Disease Vaccine From Pfizer and Valneva Will Have to Avoid the Pitfalls of the Past","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Thursday after the company and BioNTech SE  announced they submitted an application for emergency use authorization for their COVID-19 vaccine in children between..."},{"Date":"Oct. 8, 2021 at 10:07 a.m. ET","Headline":"Covid-19 Vaccine Boosters Are Outpacing First Doses. What Vaccine Stocks Are Doing.","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Thursday after the company and BioNTech SE  announced they submitted an application for emergency use authorization for their COVID-19 vaccine in children between..."},{"Date":"Oct. 8, 2021 at 6:30 a.m. ET","Headline":"Jobs Day Is Here. Only a Huge Surprise Will Change Anything.","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Thursday after the company and BioNTech SE  announced they submitted an application for emergency use authorization for their COVID-19 vaccine in children between..."},{"Date":"Oct. 8, 2021 at 6:22 a.m. ET","Headline":"Finland joins other Nordic nations in curbing Moderna shots","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Thursday after the company and BioNTech SE  announced they submitted an application for emergency use authorization for their COVID-19 vaccine in children between..."},{"Date":"Oct. 7, 2021 at 2:32 p.m. ET","Headline":"News that children could soon be eligible for Pfizer-BioNTech vaccine cheers parents, as Biden pushes vaccine requirements in Chicago","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Thursday after the company and BioNTech SE  announced they submitted an application for emergency use authorization for their COVID-19 vaccine in children between..."},{"Date":"Oct. 7, 2021 at 10:01 a.m. ET","Headline":"Pfizer and BioNTech Asked FDA to Authorize Vaccine for Children","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Thursday after the company and BioNTech SE  announced they submitted an application for emergency use authorization for their COVID-19 vaccine in children between..."},{"Date":"Oct. 7, 2021 at 8:46 a.m. ET","Headline":"Pfizer, BioNTech file for FDA authorization for their COVID-19 vaccine in children","Summary":"Shares of Pfizer Inc.  were up 0.1% in premarket trading on Thursday after the company and BioNTech SE  announced they submitted an application for emergency use authorization for their COVID-19 vaccine in children between..."},{"Date":"Oct. 7, 2021 at 8:46 a.m. ET","Headline":"Bristol\u2019s Ulcerative Colitis Trial Disappoints. The Stock Is Falling.","Summary":""},{"Date":"Oct. 12, 2021 at 10:29 p.m. ET","Headline":"FDA staff takes no position on Moderna\u2019s COVID booster","Summary":""},{"Date":"Oct. 12, 2021 at 12:37 p.m. ET","Headline":"FDA Scientists Decline to Take Stance on Moderna Covid Booster Shot","Summary":""},{"Date":"Oct. 12, 2021 at 10:37 a.m. ET","Headline":"Sanofi\u2019s Covid Vaccine Inches Closer to the Market, Analyst Says","Summary":""},{"Date":"Oct. 12, 2021 at 8:49 a.m. ET","Headline":"Glaxo Stock Jumps as Private-Equity Firms Reportedly Circle Consumer Unit","Summary":""},{"Date":"Oct. 12, 2021 at 8:43 a.m. ET","Headline":"CureVac Halts Its First mRNA-Based Covid Vaccine. The Stock Is Tumbling.","Summary":""},{"Date":"Oct. 12, 2021 at 7:12 a.m. ET","Headline":"These 10 innovative trends will be \u2018game changers\u2019 for society. Here are the stocks that will benefit.","Summary":""},{"Date":"Oct. 12, 2021 at 6:35 a.m. ET","Headline":"Musk Taunts Bezos Over World\u2019s Richest Crown. But Who Will Make You Richer?","Summary":""},{"Date":"Oct. 12, 2021 at 6:14 a.m. ET","Headline":"Merck seeks authorization for what would be first pill to treat COVID-19, and AstraZeneca reports positive results for antibody treatment","Summary":""},{"Date":"Oct. 12, 2021 at 5:00 a.m. ET","Headline":"What\u2019s Behind the Tax Deal of the Century","Summary":""},{"Date":"Oct. 11, 2021 at 8:27 a.m. ET","Headline":"Merck Submits Covid Pill to FDA for Emergency Approval","Summary":""},{"Date":"Oct. 11, 2021 at 8:07 a.m. ET","Headline":"Allowing people to mix COVID-19 vaccines could cut into Pfizer and Moderna\u2019s revenue next year","Summary":""},{"Date":"Oct. 11, 2021 at 6:30 a.m. ET","Headline":"Sentiment Toward China Is Changing, as Tech Names Rally After Major Fine","Summary":""},{"Date":"Oct. 11, 2021 at 6:23 a.m. ET","Headline":"Merck asks U.S. FDA to authorize promising anti-COVID pill","Summary":""},{"Date":"Oct. 4, 2021 at 2:58 a.m. ET","Headline":"BioNTech CEO reportedly says a different COVID vaccine may be needed by next year","Summary":""},{"Date":"Oct. 14, 2021 at 5:00 p.m. ET","Headline":"Moderna Booster Is Recommended by FDA Advisory Panel. Here\u2019s Who Can Get Another Shot.","Summary":"Giving people a different COVID-19 booster than the vaccine series that they originally received is safe and generates an immune response that is stronger, according to a  conducted by the National Institutes of Health. (A..."},{"Date":"Oct. 14, 2021 at 4:14 p.m. ET","Headline":"Biden\u2019s approval ratings on the pandemic drop as vaccination push continues","Summary":"Giving people a different COVID-19 booster than the vaccine series that they originally received is safe and generates an immune response that is stronger, according to a  conducted by the National Institutes of Health. (A..."},{"Date":"Oct. 14, 2021 at 3:52 p.m. ET","Headline":"FDA panel endorses a lower dose of Moderna\u2019s COVID-19 vaccine for booster shot","Summary":"Giving people a different COVID-19 booster than the vaccine series that they originally received is safe and generates an immune response that is stronger, according to a  conducted by the National Institutes of Health. (A..."},{"Date":"Oct. 14, 2021 at 10:39 a.m. ET","Headline":"FDA Will Consider Regeneron\u2019s Covid-19 Antibody for Full Approval","Summary":"Giving people a different COVID-19 booster than the vaccine series that they originally received is safe and generates an immune response that is stronger, according to a  conducted by the National Institutes of Health. (A..."},{"Date":"Oct. 14, 2021 at 6:54 a.m. ET","Headline":"Wall Street Stays Serene in Face of Surging Prices. What to Watch.","Summary":"Giving people a different COVID-19 booster than the vaccine series that they originally received is safe and generates an immune response that is stronger, according to a  conducted by the National Institutes of Health. (A..."},{"Date":"Oct. 13, 2021 at 4:24 p.m. ET","Headline":"'Mixing' COVID-19 vaccines triggers a stronger immune response, preliminary NIH study says","Summary":"Giving people a different COVID-19 booster than the vaccine series that they originally received is safe and generates an immune response that is stronger, according to a  conducted by the National Institutes of Health. (A..."},{"Date":"Oct. 13, 2021 at 4:08 p.m. ET","Headline":"Johnson & Johnson Booster Shot May Bolster Immune Response, FDA Staff Says","Summary":"The number of people in the U.S who are eligible to get a COVID-19 but have not been vaccinated has decreased to 66 million individuals, compared with 97 million people who met these criteria back in late July, according t..."},{"Date":"Oct. 13, 2021 at 11:32 a.m. ET","Headline":"White House says an estimated 7 million people have received a COVID-19 booster","Summary":"The number of people in the U.S who are eligible to get a COVID-19 but have not been vaccinated has decreased to 66 million individuals, compared with 97 million people who met these criteria back in late July, according t..."},{"Date":"Oct. 13, 2021 at 9:11 a.m. ET","Headline":"Merck\u2019s Covid-19 Antiviral Can Still Get FDA Authorization, Despite Safety Concerns, Analyst Says","Summary":""},{"Date":"Oct. 13, 2021 at 6:36 a.m. ET","Headline":"Supply-Chain Issues Are the Focus of Earnings Season. Don\u2019t Overlook the Response.","Summary":""},{"Date":"Oct. 13, 2021 at 6:32 a.m. ET","Headline":"An FDA Advisory Panel Will Debate Moderna and J&J Boosters This Week","Summary":""},{"Date":"Sep. 15, 2021 at 12:24 p.m. ET","Headline":"Pope Francis expresses bewilderment over vaccine holdouts, including in the College of Cardinals","Summary":""},{"Date":"Oct. 15, 2021 at 5:41 p.m. ET","Headline":"FDA Vaccines Committee Seems Open to Mix-and-Match Boosters. What That Could Look Like.","Summary":""},{"Date":"Oct. 15, 2021 at 3:49 p.m. ET","Headline":"J&J Booster Backed by FDA Advisory Committee. Here\u2019s What Comes Next.","Summary":""},{"Date":"Oct. 15, 2021 at 1:50 p.m. ET","Headline":"Moderna Stock Tumbles on Report FDA Delays Clearing Its Vaccine for Adolescents","Summary":""},{"Date":"Oct. 15, 2021 at 11:04 a.m. ET","Headline":"Don\u2019t Count Out Covid-19 Monoclonal Antibody Treatments, Analyst Says. These Are the Stocks to Watch.","Summary":""},{"Date":"Oct. 15, 2021 at 7:45 a.m. ET","Headline":"Why a pill you take at home could change the direction of the pandemic","Summary":""},{"Date":"Oct. 15, 2021 at 6:37 a.m. ET","Headline":"Bitcoin Is Jumping. A Futures ETF May Finally Be Here.","Summary":""},{"Date":"Oct. 15, 2021 at 4:00 a.m. ET","Headline":"The FDA Is About to Make Some Major Drug Decisions. What Investors Need to Know.","Summary":""},{"Date":"Oct. 18, 2021 at 7:44 p.m. ET","Headline":"FDA may soon approve mixing and matching COVID booster shots","Summary":"The global tally for the coronavirus-borne illness climbed above 240 million on Monday, while the death toll edged above 4.9 million, according to . The U.S. continues to lead the world with a total of 44.9 million cases a..."},{"Date":"Oct. 18, 2021 at 3:00 p.m. ET","Headline":"U.S. may soon authorize boosters for all 3 in-use vaccines, as experts renew plea for unvaccinated to get their shots","Summary":"The global tally for the coronavirus-borne illness climbed above 240 million on Monday, while the death toll edged above 4.9 million, according to . The U.S. continues to lead the world with a total of 44.9 million cases a..."},{"Date":"Oct. 18, 2021 at 2:40 p.m. ET","Headline":"Colin Powell\u2019s death is a reminder that we desperately need herd immunity against COVID-19","Summary":"The global tally for the coronavirus-borne illness climbed above 240 million on Monday, while the death toll edged above 4.9 million, according to . The U.S. continues to lead the world with a total of 44.9 million cases a..."},{"Date":"Oct. 18, 2021 at 1:05 p.m. ET","Headline":"Pfizer Vaccine for Kids Aged 5 to 11 to Be Evaluated by EMA. Vaccine Makers\u2019 Stocks Are Mixed.","Summary":"The global tally for the coronavirus-borne illness climbed above 240 million on Monday, while the death toll edged above 4.9 million, according to . The U.S. continues to lead the world with a total of 44.9 million cases a..."},{"Date":"Oct. 18, 2021 at 11:03 a.m. ET","Headline":"Fauci Expects Regulators to Approve Mixing Vaccine Doses","Summary":"The global tally for the coronavirus-borne illness climbed above 240 million on Monday, while the death toll edged above 4.9 million, according to . The U.S. continues to lead the world with a total of 44.9 million cases a..."},{"Date":"Oct. 18, 2021 at 10:03 a.m. ET","Headline":"Valneva Says Its Covid Vaccine Beats AstraZeneca\u2019s. Shares Are Surging.","Summary":"The global tally for the coronavirus-borne illness climbed above 240 million on Monday, while the death toll edged above 4.9 million, according to . The U.S. continues to lead the world with a total of 44.9 million cases a..."},{"Date":"Oct. 18, 2021 at 7:04 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 240 million and U.S. edges toward 725,000 fatalities","Summary":"The global tally for the coronavirus-borne illness climbed above 240 million on Monday, while the death toll edged above 4.9 million, according to . The U.S. continues to lead the world with a total of 44.9 million cases a..."},{"Date":"Oct. 18, 2021 at 7:00 a.m. ET","Headline":"Annovis Bio Stock Tumbled, and CEO Maria L. Maccecchini Bought Shares","Summary":"Two doses of either the vaccine made by Pfizer  and BioNTech  or Oxford-AstraZeneca  vaccines provided a similar level of protection to prior natural infection when the Delta variant was dominant, the . Vaccination signifi..."},{"Date":"Oct. 18, 2021 at 5:16 a.m. ET","Headline":"Pfizer and AstraZeneca vaccines were as effective as prior infection, U.K. study finds","Summary":"Two doses of either the vaccine made by Pfizer  and BioNTech  or Oxford-AstraZeneca  vaccines provided a similar level of protection to prior natural infection when the Delta variant was dominant, the . Vaccination signifi..."},{"Date":"Oct. 18, 2021 at 12:19 a.m. ET","Headline":"\u2018I\u2019m getting compassion fatigue\u2019: My parents said they\u2019d rather quit their jobs and lose everything than get the COVID-19 vaccine","Summary":""},{"Date":"Oct. 17, 2021 at 7:06 p.m. ET","Headline":"Paid Family Leave is Still in Biden\u2019s Build Back Better Plan, Buttigieg Says","Summary":""},{"Date":"Oct. 17, 2021 at 4:55 p.m. ET","Headline":"Fauci: Texas ban on vaccine mandates is \u2018really unfortunate\u2019","Summary":""},{"Date":"Oct. 20, 2021 at 8:37 p.m. ET","Headline":"19 states offered million-dollar lotteries to increase COVID vaccination rates \u2014 this research says they didn\u2019t work","Summary":"The White House on Wednesday announced a plan detailing how the U.S. plans to roll out COVID-19 vaccines for children between the ages of 5 and 11 years old if and when COVID-19 shots are authorized for this age group. Whi..."},{"Date":"Oct. 20, 2021 at 6:27 p.m. ET","Headline":"FDA backs Moderna and J&J boosters, authorizes mixing COVID vaccines","Summary":"The White House on Wednesday announced a plan detailing how the U.S. plans to roll out COVID-19 vaccines for children between the ages of 5 and 11 years old if and when COVID-19 shots are authorized for this age group. Whi..."},{"Date":"Oct. 20, 2021 at 3:04 p.m. ET","Headline":"White House unveils plan to get COVID vaccine to 5- to 11-year-olds once it\u2019s authorized, and Europe is the only region with rising cases in latest week","Summary":"The White House on Wednesday announced a plan detailing how the U.S. plans to roll out COVID-19 vaccines for children between the ages of 5 and 11 years old if and when COVID-19 shots are authorized for this age group. Whi..."},{"Date":"Oct. 20, 2021 at 1:23 p.m. ET","Headline":"4 Healthcare Stocks Selling for Way Less Than Analysts Think They\u2019re Worth","Summary":"The White House on Wednesday announced a plan detailing how the U.S. plans to roll out COVID-19 vaccines for children between the ages of 5 and 11 years old if and when COVID-19 shots are authorized for this age group. Whi..."},{"Date":"Oct. 20, 2021 at 10:46 a.m. ET","Headline":"White House Lays Out Vaccine Rollout Plan for Kids Aged 5 to 11","Summary":"The White House on Wednesday announced a plan detailing how the U.S. plans to roll out COVID-19 vaccines for children between the ages of 5 and 11 years old if and when COVID-19 shots are authorized for this age group. Whi..."},{"Date":"Oct. 20, 2021 at 8:48 a.m. ET","Headline":"White House: Children will be able to get COVID-19 shots from their pediatricians","Summary":"The White House on Wednesday announced a plan detailing how the U.S. plans to roll out COVID-19 vaccines for children between the ages of 5 and 11 years old if and when COVID-19 shots are authorized for this age group. Whi..."},{"Date":"Oct. 20, 2021 at 7:20 a.m. ET","Headline":"U.S. COVID-19 death toll tops 726,000 amid report FDA is set to allow mix-and-match vaccine booster shots","Summary":""},{"Date":"Oct. 19, 2021 at 4:57 p.m. ET","Headline":"Atea Pharma Stumbles in Race for a Covid Pill. The Stock Is Down 64%.","Summary":""},{"Date":"Oct. 19, 2021 at 9:46 a.m. ET","Headline":"Johnson & Johnson Stock Is Soaring Because Earnings Beat, Raised Guidance","Summary":""},{"Date":"Oct. 19, 2021 at 9:07 a.m. ET","Headline":"Pfizer CEO says he\u2019s gotten a COVID vaccine booster shot and most of us will, too","Summary":""},{"Date":"Oct. 19, 2021 at 7:34 a.m. ET","Headline":"Allison Williams leaves ESPN over vaccine mandate: \u2018I cannot put a paycheck over principle\u2019","Summary":""},{"Date":"Oct. 19, 2021 at 7:25 a.m. ET","Headline":"The success of Merck\u2019s antiviral \u2014 and other COVID-19 pills in development \u2014 may depend on how quickly people start taking them","Summary":""},{"Date":"Oct. 19, 2021 at 7:20 a.m. ET","Headline":"FDA committee says it\u2019s safe for all adults who got J&J\u2019s COVID-19 vaccine to get a booster","Summary":""},{"Date":"Oct. 19, 2021 at 6:47 a.m. ET","Headline":"The FDA May Approve \u2018Mix-and-Match\u2019 Booster Shots as Soon as This Week","Summary":""},{"Date":"Oct. 6, 2021 at 7:42 p.m. ET","Headline":"Former FDA Commissioner Scott Gottlieb on the Covid Pill, Vaccines for Kids","Summary":""},{"Date":"Oct. 22, 2021 at 1:53 p.m. ET","Headline":"Pfizer data boosts hopes children will soon be eligible for COVID-19 vaccine, and CDC expands booster program","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a late-stage trial of a 30 mg booster dose of their COVID-19 vaccine showed efficacy of 95.6% compared with those who received a placebo. The companies said the Ph..."},{"Date":"Oct. 22, 2021 at 10:32 a.m. ET","Headline":"Pfizer and BioNTech Covid Vaccine Is Nearly 91% Effective in Children","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a late-stage trial of a 30 mg booster dose of their COVID-19 vaccine showed efficacy of 95.6% compared with those who received a placebo. The companies said the Ph..."},{"Date":"Oct. 22, 2021 at 10:01 a.m. ET","Headline":"Pfizer says COVID-19 vaccine is more than 90% effective in kids 5 to 11","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a late-stage trial of a 30 mg booster dose of their COVID-19 vaccine showed efficacy of 95.6% compared with those who received a placebo. The companies said the Ph..."},{"Date":"Oct. 22, 2021 at 8:17 a.m. ET","Headline":"Mix-and-Match Booster Rollout Is Set to Start. Nearly 100 Million People Could Be Eligible.","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a late-stage trial of a 30 mg booster dose of their COVID-19 vaccine showed efficacy of 95.6% compared with those who received a placebo. The companies said the Ph..."},{"Date":"Oct. 22, 2021 at 7:40 a.m. ET","Headline":"People who got J&J\u2019s COVID-19 shot can get a booster. Which one should they get?","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a late-stage trial of a 30 mg booster dose of their COVID-19 vaccine showed efficacy of 95.6% compared with those who received a placebo. The companies said the Ph..."},{"Date":"Oct. 22, 2021 at 7:01 a.m. ET","Headline":"Snap\u2019s Apple Ads Warning Is a Wake-Up Call for Tech Investors. What to Watch Next.","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a late-stage trial of a 30 mg booster dose of their COVID-19 vaccine showed efficacy of 95.6% compared with those who received a placebo. The companies said the Ph..."},{"Date":"Oct. 21, 2021 at 9:05 p.m. ET","Headline":"CDC approves expanded rollout of COVID-19 boosters","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a late-stage trial of a 30 mg booster dose of their COVID-19 vaccine showed efficacy of 95.6% compared with those who received a placebo. The companies said the Ph..."},{"Date":"Oct. 21, 2021 at 6:12 p.m. ET","Headline":"CDC Advisors Unanimously Back Mixing Covid-19 Vaccine Boosters","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a late-stage trial of a 30 mg booster dose of their COVID-19 vaccine showed efficacy of 95.6% compared with those who received a placebo. The companies said the Ph..."},{"Date":"Oct. 21, 2021 at 4:37 p.m. ET","Headline":"S&P 500 closes at record high as investors assess strong earnings, tax battle in Congress","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a late-stage trial of a 30 mg booster dose of their COVID-19 vaccine showed efficacy of 95.6% compared with those who received a placebo. The companies said the Ph..."},{"Date":"Oct. 21, 2021 at 2:07 p.m. ET","Headline":"CDC gathers to discuss which patient groups should get Moderna and J&J COVID-19 vaccine boosters, and Pfizer reports positive results from booster trial","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a late-stage trial of a 30 mg booster dose of their COVID-19 vaccine showed efficacy of 95.6% compared with those who received a placebo. The companies said the Ph..."},{"Date":"Oct. 21, 2021 at 11:39 a.m. ET","Headline":"Merck Scores Unexpectedly in Pneumococcal Vaccine Fight With Pfizer. What It Means for the Stocks.","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a late-stage trial of a 30 mg booster dose of their COVID-19 vaccine showed efficacy of 95.6% compared with those who received a placebo. The companies said the Ph..."},{"Date":"Oct. 21, 2021 at 9:30 a.m. ET","Headline":"Pfizer Covid-19 Booster Found to Restore Efficacy Back to Near 96%","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a late-stage trial of a 30 mg booster dose of their COVID-19 vaccine showed efficacy of 95.6% compared with those who received a placebo. The companies said the Ph..."},{"Date":"Oct. 21, 2021 at 8:45 a.m. ET","Headline":"Moderna Stock Is Rising After FDA Authorization of Mix-and-Match Boosters","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a late-stage trial of a 30 mg booster dose of their COVID-19 vaccine showed efficacy of 95.6% compared with those who received a placebo. The companies said the Ph..."},{"Date":"Oct. 21, 2021 at 7:19 a.m. ET","Headline":"Next year will be \u2018tricky\u2019 for stockholders, so follow this road map, says RBC\u2019s top strategist Lori Calvasina","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a late-stage trial of a 30 mg booster dose of their COVID-19 vaccine showed efficacy of 95.6% compared with those who received a placebo. The companies said the Ph..."},{"Date":"Oct. 21, 2021 at 6:57 a.m. ET","Headline":"Pfizer and BioNTech say Phase 3 trial found booster dose of COVID vaccine had 95.6% efficacy against disease","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a late-stage trial of a 30 mg booster dose of their COVID-19 vaccine showed efficacy of 95.6% compared with those who received a placebo. The companies said the Ph..."},{"Date":"Oct. 21, 2021 at 6:18 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 242 million and FDA backs Moderna, J&J boosters and mix-and-match","Summary":"The global tally for the coronavirus-borne illness climbed above 242 million on Wednesday, while the death toll edged above 4.92 million, according to . The U.S. continues to lead the world with a total of 45.2 million cas..."},{"Date":"Oct. 20, 2021 at 5:40 p.m. ET","Headline":"FDA Authorizes Mix-and-Match, J&J, and Moderna Boosters","Summary":""},{"Date":"Oct. 24, 2021 at 7:14 p.m. ET","Headline":"Florida\u2019s top health official refuses to wear mask, is told to leave meeting","Summary":""},{"Date":"Oct. 26, 2021 at 7:09 p.m. ET","Headline":"FDA Panel Backs Pfizer\u2019s Covid Vaccine for Children 5 to 11","Summary":"Shares of Moderna Inc.  gained 0.9% in premarket trading on Monday after the company shared interim data from a Phase 2\/3 clinical study evaluating its COVID-19 vaccine in children between the ages of 6 and 11 years old. T..."},{"Date":"Oct. 26, 2021 at 2:49 p.m. ET","Headline":"FDA committee meets on COVID-19 vaccines for young children, and White House outlines new rules for travelers to U.S.","Summary":"Shares of Moderna Inc.  gained 0.9% in premarket trading on Monday after the company shared interim data from a Phase 2\/3 clinical study evaluating its COVID-19 vaccine in children between the ages of 6 and 11 years old. T..."},{"Date":"Oct. 26, 2021 at 8:26 a.m. ET","Headline":"Fauci says U.S. is on track to start vaccinating kids aged 5 to 11 by November, as FDA advisers prepare to meet on the matter","Summary":"Shares of Moderna Inc.  gained 0.9% in premarket trading on Monday after the company shared interim data from a Phase 2\/3 clinical study evaluating its COVID-19 vaccine in children between the ages of 6 and 11 years old. T..."},{"Date":"Oct. 26, 2021 at 6:30 a.m. ET","Headline":"Facebook\u2019s Swimming in Profit as Much as It\u2019s Mired in Controversy","Summary":"Shares of Moderna Inc.  gained 0.9% in premarket trading on Monday after the company shared interim data from a Phase 2\/3 clinical study evaluating its COVID-19 vaccine in children between the ages of 6 and 11 years old. T..."},{"Date":"Oct. 26, 2021 at 12:01 a.m. ET","Headline":"FDA Advisors to Discuss Covid-19 Vaccines for Children Today. What Comes Next.","Summary":"Shares of Moderna Inc.  gained 0.9% in premarket trading on Monday after the company shared interim data from a Phase 2\/3 clinical study evaluating its COVID-19 vaccine in children between the ages of 6 and 11 years old. T..."},{"Date":"Oct. 25, 2021 at 11:06 p.m. ET","Headline":"Most international travelers to U.S. will need to be vaxed under new rules","Summary":"Shares of Moderna Inc.  gained 0.9% in premarket trading on Monday after the company shared interim data from a Phase 2\/3 clinical study evaluating its COVID-19 vaccine in children between the ages of 6 and 11 years old. T..."},{"Date":"Oct. 25, 2021 at 10:17 a.m. ET","Headline":"Moderna Announces Positive Data on Covid-19 Vaccine in Children","Summary":"Shares of Moderna Inc.  gained 0.9% in premarket trading on Monday after the company shared interim data from a Phase 2\/3 clinical study evaluating its COVID-19 vaccine in children between the ages of 6 and 11 years old. T..."},{"Date":"Oct. 25, 2021 at 8:52 a.m. ET","Headline":"Moderna says its COVID-19 shot generates 'robust' response in children 6 to 11","Summary":"Shares of Moderna Inc.  gained 0.9% in premarket trading on Monday after the company shared interim data from a Phase 2\/3 clinical study evaluating its COVID-19 vaccine in children between the ages of 6 and 11 years old. T..."},{"Date":"Oct. 25, 2021 at 8:09 a.m. ET","Headline":"FDA committee to discuss BioNTech\/Pfizer's COVID-19 shot in children 5 to 11","Summary":"A Food and Drug Administration advisory committee  to discuss and then recommend whether the benefits outweigh the risks of BioNTech SE  and Pfizer Inc.'s  COVID-19 vaccine in children between the ages of 5 and 11 years ol..."},{"Date":"Oct. 28, 2021 at 10:16 a.m. ET","Headline":"U.S. Buys 50 Million Child-Sized Pfizer Doses","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday the U.S. government has purchased an additional 50 million pediatric doses of their COVID-19 vaccine, as it prepares to start dosing children. The additional order..."},{"Date":"Oct. 28, 2021 at 9:04 a.m. ET","Headline":"FDA advisors recommend BioNTech and Pfizer\u2019s COVID-19 shot for children","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday the U.S. government has purchased an additional 50 million pediatric doses of their COVID-19 vaccine, as it prepares to start dosing children. The additional order..."},{"Date":"Oct. 28, 2021 at 8:28 a.m. ET","Headline":"Merck Stock Is Gaining. Earnings Came in Strong.","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday the U.S. government has purchased an additional 50 million pediatric doses of their COVID-19 vaccine, as it prepares to start dosing children. The additional order..."},{"Date":"Oct. 28, 2021 at 8:20 a.m. ET","Headline":"U.S. moves closer to vaccinating young children, and WHO warns pandemic is \u2018far from finished\u2019","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday the U.S. government has purchased an additional 50 million pediatric doses of their COVID-19 vaccine, as it prepares to start dosing children. The additional order..."},{"Date":"Oct. 28, 2021 at 7:33 a.m. ET","Headline":"Pfizer and BioNTech say U.S. government has purchased additional 50 million pediatric doses of their COVID vaccine","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday the U.S. government has purchased an additional 50 million pediatric doses of their COVID-19 vaccine, as it prepares to start dosing children. The additional order..."},{"Date":"Oct. 27, 2021 at 10:26 p.m. ET","Headline":"Newsom touts boosters as California COVID cases stop falling","Summary":"Shares of Novavax Inc.  jumped 8.0% in premarket trading on Wednesday after the company said it began submitting its experimental COVID-19 vaccine for authorization in the U.K. Novavax's vaccine candidate is protein-based,..."},{"Date":"Oct. 27, 2021 at 3:47 p.m. ET","Headline":"Novavax Stock Is Rising. Its Long-Delayed Vaccine Is Moving Ahead.","Summary":"Shares of Novavax Inc.  jumped 8.0% in premarket trading on Wednesday after the company said it began submitting its experimental COVID-19 vaccine for authorization in the U.K. Novavax's vaccine candidate is protein-based,..."},{"Date":"Oct. 27, 2021 at 8:47 a.m. ET","Headline":"Novavax is seeking authorization in the U.K. for its COVID-19 vaccine","Summary":"Shares of Novavax Inc.  jumped 8.0% in premarket trading on Wednesday after the company said it began submitting its experimental COVID-19 vaccine for authorization in the U.K. Novavax's vaccine candidate is protein-based,..."},{"Date":"Oct. 27, 2021 at 6:42 a.m. ET","Headline":"Twitter and Alphabet Bat Away Fears Over Apple\u2019s Privacy Setting","Summary":"The global tally for the coronavirus-borne illness climbed above 244.6 million on Wednesday, while the death toll edged above 4.96 million, according to . The U.S. continues to lead the world with a total of 45.6 million c..."},{"Date":"Oct. 27, 2021 at 6:28 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 244.6 million and FDA advisors back Pfizer's COVID-19 shot for children","Summary":"The global tally for the coronavirus-borne illness climbed above 244.6 million on Wednesday, while the death toll edged above 4.96 million, according to . The U.S. continues to lead the world with a total of 45.6 million c..."},{"Date":"Oct. 30, 2021 at 9:10 a.m. ET","Headline":"Kid Vaccines Are Coming Soon. Why a Mandate Wouldn\u2019t Be Wise.","Summary":""},{"Date":"Oct. 29, 2021 at 4:22 p.m. ET","Headline":"FDA Authorizes  Covid-19 Vaccine for Children","Summary":""},{"Date":"Oct. 29, 2021 at 3:29 p.m. ET","Headline":"FDA authorizes the COVID-19 vaccine from Pfizer and BioNtech for kids 5 to 11","Summary":""},{"Date":"Nov. 1, 2021 at 4:37 p.m. ET","Headline":"Major U.S. stock indexes finish at records as investors await this week\u2019s Fed meeting","Summary":""},{"Date":"Nov. 1, 2021 at 4:15 p.m. ET","Headline":"The Dow Rises to a Record High\u2014and What Else Is Happening in the Stock Market Today","Summary":""},{"Date":"Nov. 1, 2021 at 11:35 a.m. ET","Headline":"How much is Big Pharma making from COVID-19 vaccines? We\u2019re about to find out","Summary":""},{"Date":"Nov. 1, 2021 at 10:49 a.m. ET","Headline":"Novavax\u2019s Covid Vaccine Gets Its First Authorization\u2014and More Could Come Soon","Summary":""},{"Date":"Nov. 1, 2021 at 8:13 a.m. ET","Headline":"Moderna to Delay Request for Approval of Covid Vaccine in Children After FDA Asks for More Time","Summary":""},{"Date":"Nov. 1, 2021 at 6:30 a.m. ET","Headline":"Biden Ends Trump-Era Trade War With EU Steel Deal. What It Means.","Summary":""},{"Date":"Nov. 1, 2021 at 1:00 a.m. ET","Headline":"Uber, T-Mobile, Pfizer, Ferrari, and Other Stocks to Watch This Week","Summary":""},{"Date":"Oct. 31, 2021 at 7:47 p.m. ET","Headline":"There Are Hundreds of Reasons to Sell the Stock Market. Don\u2019t.","Summary":""},{"Date":"Oct. 31, 2021 at 6:35 p.m. ET","Headline":"U.S. Stock Futures Poised to Open Slightly Higher Monday","Summary":""},{"Date":"Oct. 29, 2021 at 6:57 p.m. ET","Headline":"9 Potential Winners of Facebook\u2019s Big Spend","Summary":""},{"Date":"Nov. 3, 2021 at 11:30 p.m. ET","Headline":"Another grim milestone: U.S. tops 750,000 deaths from COVID-19","Summary":"President Joe Biden on Wednesday urged parents of young children to get them vaccinated, a day after the Centers for Disease Control and Prevention  to the COVID-19 vaccine developed by Pfizer  and BioNTech . The decision ..."},{"Date":"Nov. 3, 2021 at 5:37 p.m. ET","Headline":"COVID vaccinations for kids begin in California with toys and gifts","Summary":"President Joe Biden on Wednesday urged parents of young children to get them vaccinated, a day after the Centers for Disease Control and Prevention  to the COVID-19 vaccine developed by Pfizer  and BioNTech . The decision ..."},{"Date":"Nov. 3, 2021 at 4:24 p.m. ET","Headline":"'Get your children vaccinated,' Biden urges after shots for kids 5-11 approved","Summary":"President Joe Biden on Wednesday urged parents of young children to get them vaccinated, a day after the Centers for Disease Control and Prevention  to the COVID-19 vaccine developed by Pfizer  and BioNTech . The decision ..."},{"Date":"Nov. 3, 2021 at 8:56 a.m. ET","Headline":"Kids\u2019 Vaccination Campaign Is Starting in U.S., With 28 Million Eligible","Summary":"Pfizer Inc. shares  jumped 2.5% in premarket trade Tuesday, after the company beat earnings estimates for the third quarter and raised guidance, boosted by strong sales of its COVID-19 vaccine, Comirnaty. The company poste..."},{"Date":"Nov. 3, 2021 at 6:30 a.m. ET","Headline":"Powell Will Have a Tough Time Reeling in the Market\u2019s Rate-Hike Expectations","Summary":"Pfizer Inc. shares  jumped 2.5% in premarket trade Tuesday, after the company beat earnings estimates for the third quarter and raised guidance, boosted by strong sales of its COVID-19 vaccine, Comirnaty. The company poste..."},{"Date":"Nov. 2, 2021 at 8:39 p.m. ET","Headline":"CDC gives final approval for Pfizer\u2019s COVID shot for kids 5-11","Summary":"Pfizer Inc. shares  jumped 2.5% in premarket trade Tuesday, after the company beat earnings estimates for the third quarter and raised guidance, boosted by strong sales of its COVID-19 vaccine, Comirnaty. The company poste..."},{"Date":"Nov. 2, 2021 at 8:11 p.m. ET","Headline":"CDC Recommends Pfizer Covid Vaccine for Kids 5 to 11","Summary":"Pfizer Inc. shares  jumped 2.5% in premarket trade Tuesday, after the company beat earnings estimates for the third quarter and raised guidance, boosted by strong sales of its COVID-19 vaccine, Comirnaty. The company poste..."},{"Date":"Nov. 2, 2021 at 6:22 p.m. ET","Headline":"Democrats Reach Deal on Drug Prices, Schumer Says. Pharma Stocks Are Steady.","Summary":"Pfizer Inc. shares  jumped 2.5% in premarket trade Tuesday, after the company beat earnings estimates for the third quarter and raised guidance, boosted by strong sales of its COVID-19 vaccine, Comirnaty. The company poste..."},{"Date":"Nov. 2, 2021 at 4:39 p.m. ET","Headline":"Dow, S&P 500, Nasdaq end at all-time highs, extending win streak as traders wait for outcome of Federal Reserve policy meeting","Summary":"Pfizer Inc. shares  jumped 2.5% in premarket trade Tuesday, after the company beat earnings estimates for the third quarter and raised guidance, boosted by strong sales of its COVID-19 vaccine, Comirnaty. The company poste..."},{"Date":"Nov. 2, 2021 at 4:16 p.m. ET","Headline":"Pfizer CEO Says Poor Countries Need to Order Covid Vaccines Earlier","Summary":"Pfizer Inc. shares  jumped 2.5% in premarket trade Tuesday, after the company beat earnings estimates for the third quarter and raised guidance, boosted by strong sales of its COVID-19 vaccine, Comirnaty. The company poste..."},{"Date":"Nov. 2, 2021 at 9:46 a.m. ET","Headline":"Shipping of kid-sized doses of Pfizer-BioNTech vaccine under way ahead of CDC recommendation","Summary":"Pfizer Inc. shares  jumped 2.5% in premarket trade Tuesday, after the company beat earnings estimates for the third quarter and raised guidance, boosted by strong sales of its COVID-19 vaccine, Comirnaty. The company poste..."},{"Date":"Nov. 2, 2021 at 9:29 a.m. ET","Headline":"Pfizer Stock Charges Higher as Drug Maker Boosts 2021 Guidance","Summary":"Pfizer Inc. shares  jumped 2.5% in premarket trade Tuesday, after the company beat earnings estimates for the third quarter and raised guidance, boosted by strong sales of its COVID-19 vaccine, Comirnaty. The company poste..."},{"Date":"Nov. 2, 2021 at 7:53 a.m. ET","Headline":"What to expect from Tuesday\u2019s CDC meeting about BioNTech and Pfizer\u2019s COVID-19 shots for young children","Summary":"Pfizer Inc. shares  jumped 2.5% in premarket trade Tuesday, after the company beat earnings estimates for the third quarter and raised guidance, boosted by strong sales of its COVID-19 vaccine, Comirnaty. The company poste..."},{"Date":"Nov. 2, 2021 at 7:18 a.m. ET","Headline":"Here are the five dumbest ways you could have gotten rich in 2021","Summary":"Pfizer Inc. shares  jumped 2.5% in premarket trade Tuesday, after the company beat earnings estimates for the third quarter and raised guidance, boosted by strong sales of its COVID-19 vaccine, Comirnaty. The company poste..."},{"Date":"Nov. 2, 2021 at 7:00 a.m. ET","Headline":"Pfizer shares jump 2.5% premarket as earnings beat, company raises guidance","Summary":"Pfizer Inc. shares  jumped 2.5% in premarket trade Tuesday, after the company beat earnings estimates for the third quarter and raised guidance, boosted by strong sales of its COVID-19 vaccine, Comirnaty. The company poste..."},{"Date":"Nov. 2, 2021 at 6:24 a.m. ET","Headline":"Global death toll from COVID-19 tops 5 million, as parents in the U.S. await next moves on vaccines for children","Summary":""},{"Date":"Nov. 1, 2021 at 8:27 a.m. ET","Headline":"The CDC Meets Today on Kids\u2019 Covid Vaccines. What to Know.","Summary":""},{"Date":"Nov. 5, 2021 at 4:37 p.m. ET","Headline":"Dow, S&P 500, Nasdaq end at record highs, extending streak of weekly gains on Pfizer pill study, stronger-than-expected jobs report","Summary":"Shares of Merck & Co.  tumbled 9.5% in midday trading Friday, putting them on track to suffer the biggest one-day drop since January 2005, after Pfizer Inc.  released data on  that showed greater efficacy than Merck's. The..."},{"Date":"Nov. 5, 2021 at 4:27 p.m. ET","Headline":"Stocks Rallied to Records After Strong Jobs Report, Peloton Tumbled\u2014and What Else Happened in the Stock Market Today","Summary":"Shares of Merck & Co.  tumbled 9.5% in midday trading Friday, putting them on track to suffer the biggest one-day drop since January 2005, after Pfizer Inc.  released data on  that showed greater efficacy than Merck's. The..."},{"Date":"Nov. 5, 2021 at 1:16 p.m. ET","Headline":"Pfizer\u2019s positive antiviral news raises hopes for a new easy-to-take treatment for COVID-19, and cases start to rise again in California","Summary":"Shares of Merck & Co.  tumbled 9.5% in midday trading Friday, putting them on track to suffer the biggest one-day drop since January 2005, after Pfizer Inc.  released data on  that showed greater efficacy than Merck's. The..."},{"Date":"Nov. 5, 2021 at 11:58 a.m. ET","Headline":"Merck stock's biggest selloff in nearly 17 years is cutting close to 60 points off the Dow's price","Summary":"Shares of Merck & Co.  tumbled 9.5% in midday trading Friday, putting them on track to suffer the biggest one-day drop since January 2005, after Pfizer Inc.  released data on  that showed greater efficacy than Merck's. The..."},{"Date":"Nov. 5, 2021 at 11:33 a.m. ET","Headline":"U.S. has 'secured millions of doses' of Pfizer's promising new COVID antiviral, Biden says","Summary":"President Joe Biden on Friday indicated that his administration has pre-ordered Pfizer Inc.'s  oral antiviral Paxlovid. \"Last night, we received  about another potent potential COVID treatment, a pill developed by Pfizer t..."},{"Date":"Nov. 5, 2021 at 10:49 a.m. ET","Headline":"The Market Is Rallying. But Airline Stocks Are Taking Off.","Summary":"Merck & Co. Inc. shares  slid 10% in premarket trading Friday after Pfizer Inc.  said its oral antiviral treatment candidate for COVID-19 reduced the risk of hospitalization or death by 89% in non-hospitalized high-risk ad..."},{"Date":"Nov. 5, 2021 at 9:19 a.m. ET","Headline":"Pfizer Stock Is Soaring Because Its Covid Antiviral Appears to Work Really, Really Well","Summary":"Merck & Co. Inc. shares  slid 10% in premarket trading Friday after Pfizer Inc.  said its oral antiviral treatment candidate for COVID-19 reduced the risk of hospitalization or death by 89% in non-hospitalized high-risk ad..."},{"Date":"Nov. 5, 2021 at 8:40 a.m. ET","Headline":"Here\u2019s the factor that mattered most to driving stocks \u2014 and it sure wasn\u2019t interest rates","Summary":"Merck & Co. Inc. shares  slid 10% in premarket trading Friday after Pfizer Inc.  said its oral antiviral treatment candidate for COVID-19 reduced the risk of hospitalization or death by 89% in non-hospitalized high-risk ad..."},{"Date":"Nov. 5, 2021 at 7:49 a.m. ET","Headline":"WHO warns Europe could see 500,000 more COVID-19 deaths by February amid uneven vaccine take-up, and U.S. starts to give kids as young as 5 their shots","Summary":"Merck & Co. Inc. shares  slid 10% in premarket trading Friday after Pfizer Inc.  said its oral antiviral treatment candidate for COVID-19 reduced the risk of hospitalization or death by 89% in non-hospitalized high-risk ad..."},{"Date":"Nov. 5, 2021 at 7:28 a.m. ET","Headline":"Merck shares slide premarket as Pfizer soars on data from trial of rival COVID-19 antiviral treatment","Summary":"Merck & Co. Inc. shares  slid 10% in premarket trading Friday after Pfizer Inc.  said its oral antiviral treatment candidate for COVID-19 reduced the risk of hospitalization or death by 89% in non-hospitalized high-risk ad..."},{"Date":"Nov. 5, 2021 at 7:00 a.m. ET","Headline":"Pfizer shares soar after data finds COVID antiviral reduced risk of death or hospitalization by 89% in high-risk adults","Summary":"Pfizer Inc. shares  jumped 13% in premarket trade Friday, after the company said interim data from a Phase 2\/3 trial of its oral antiviral treatment for COVID-19 reduced the risk of hospitalization or death by 89% in non-h..."},{"Date":"Nov. 5, 2021 at 6:32 a.m. ET","Headline":"Peloton, Uber, and Airbnb Earnings All Tell Investors the Same Thing","Summary":""},{"Date":"Nov. 4, 2021 at 12:35 p.m. ET","Headline":"Kids age 5 to 11 can now get \nPfizer\u2019s COVID-19 vaccine \u2014 5 key questions parents should ask","Summary":""},{"Date":"Nov. 4, 2021 at 11:43 a.m. ET","Headline":"U.S. Covid-19 Vaccine Mandates Have a January Deadline. What to Know.","Summary":""},{"Date":"Nov. 4, 2021 at 11:12 a.m. ET","Headline":"Can kids 5-11 get a flu shot and Pfizer\u2019s COVID-19 vaccine at the same time? Here\u2019s what doctors say","Summary":""},{"Date":"Nov. 4, 2021 at 10:01 a.m. ET","Headline":"A Step in the Right Direction for Sharing Covid-19 Medicines","Summary":""},{"Date":"Nov. 4, 2021 at 8:10 a.m. ET","Headline":"CDC decision to vaccinate children cheered by parents, and Colorado hospitals are being forced to redirect patients","Summary":""},{"Date":"Nov. 4, 2021 at 8:03 a.m. ET","Headline":"Moderna\u2019s Sales Miss Forecasts by 20%. Pfizer Is Taking the U.S. Vaccine Market.","Summary":""},{"Date":"Nov. 7, 2021 at 2:00 p.m. ET","Headline":"Good Jobs Report Points to Continued Good Times for Stocks","Summary":""},{"Date":"Nov. 7, 2021 at 8:40 a.m. ET","Headline":"Moderna cites supply-chain \u2018complexity\u2019 as COVID-19 vaccine sales come in $1 billion short","Summary":""},{"Date":"Nov. 6, 2021 at 2:35 p.m. ET","Headline":"How Long Will the Stock Market Rally? At Least Until New Year\u2019s.","Summary":""},{"Date":"Nov. 9, 2021 at 9:32 p.m. ET","Headline":"Aaron Rodgers admits misleading people; NFL fines QB and Packers for violating vaccine protocol","Summary":"Pfizer Inc.  said Tuesday that it is asking the Food and Drug Administration to authorize its COVID-19 booster for all adults in the U.S. This is the second time that the company and BioNTech SE  have asked the regulator t..."},{"Date":"Nov. 9, 2021 at 3:17 p.m. ET","Headline":"Pfizer asks FDA to authorize COVID-19 booster shot for all adults","Summary":"Pfizer Inc.  said Tuesday that it is asking the Food and Drug Administration to authorize its COVID-19 booster for all adults in the U.S. This is the second time that the company and BioNTech SE  have asked the regulator t..."},{"Date":"Nov. 9, 2021 at 1:32 p.m. ET","Headline":"\u2018Red COVID\u2019? Coronavirus deaths are highest in counties with the largest share of Trump voters","Summary":"Shares of BioNTech SE  dropped 2.9% in morning trading Tuesday, reversing an earlier intraday gain of as much as 4.3%, in the wake of the Germany-based biotechnology company's better-than-expected third-quarter earnings re..."},{"Date":"Nov. 9, 2021 at 1:00 p.m. ET","Headline":"Terry Bradshaw blasts Aaron Rodgers over vaccine status: \u2018You lied to everyone\u2019","Summary":"Shares of BioNTech SE  dropped 2.9% in morning trading Tuesday, reversing an earlier intraday gain of as much as 4.3%, in the wake of the Germany-based biotechnology company's better-than-expected third-quarter earnings re..."},{"Date":"Nov. 9, 2021 at 11:12 a.m. ET","Headline":"BioNTech stock reverses lower after earnings report, in which profit and revenue beat expectations","Summary":"Shares of BioNTech SE  dropped 2.9% in morning trading Tuesday, reversing an earlier intraday gain of as much as 4.3%, in the wake of the Germany-based biotechnology company's better-than-expected third-quarter earnings re..."},{"Date":"Nov. 9, 2021 at 9:00 a.m. ET","Headline":"Pfizer to seek authorization of COVID-19 pill \u2018as soon as possible\u2019","Summary":"Shares of Biohaven Pharmaceutical Holding Company Ltd.   tumbled 15.2% in premarket trading on Tuesday after it announced a deal worth up to $1.2 billion with Pfizer Inc.  to commercialize the company's migraine treatment ..."},{"Date":"Nov. 9, 2021 at 8:44 a.m. ET","Headline":"BioNTech Stock Is Getting a Lift. Earnings Were Strong.","Summary":"Shares of Biohaven Pharmaceutical Holding Company Ltd.   tumbled 15.2% in premarket trading on Tuesday after it announced a deal worth up to $1.2 billion with Pfizer Inc.  to commercialize the company's migraine treatment ..."},{"Date":"Nov. 9, 2021 at 8:07 a.m. ET","Headline":"Biohaven's stock slides 15% on deal with Pfizer for its migraine drug","Summary":"Shares of Biohaven Pharmaceutical Holding Company Ltd.   tumbled 15.2% in premarket trading on Tuesday after it announced a deal worth up to $1.2 billion with Pfizer Inc.  to commercialize the company's migraine treatment ..."},{"Date":"Nov. 9, 2021 at 6:14 a.m. ET","Headline":"Merck stock rallies after U.S. plans to buy 1.4 million more COVID-19 pill courses for $1 billion if authorized","Summary":"Shares of Merck & Co. Inc.  rallied 1.9% in premarket trading Tuesday, after the drug maker and partner Ridgeback Biotherapeutics said the U.S. government will exercise options to buy 1.4 million additional courses of the ..."},{"Date":"Nov. 8, 2021 at 4:52 p.m. ET","Headline":"S&P 500 ends at record for 8th day in a row, the longest streak of records since 1997, on renewed optimism","Summary":"The benchmark 10-year Treasury yield climbs modestly on Monday, after putting in the sharpest weekly fall since June 2020, as investors pivot toward the potential for a \u201cglobal reopening\u201d trade and digest U.S. House approv..."},{"Date":"Nov. 8, 2021 at 4:07 p.m. ET","Headline":"Benchmark 10-year Treasury rate logs largest rise in 3 weeks but holds around 1.50%","Summary":"The benchmark 10-year Treasury yield climbs modestly on Monday, after putting in the sharpest weekly fall since June 2020, as investors pivot toward the potential for a \u201cglobal reopening\u201d trade and digest U.S. House approv..."},{"Date":"Nov. 8, 2021 at 10:49 a.m. ET","Headline":"Regeneron\u2019s Covid Drug Could Be an Alternative to Vaccines","Summary":""},{"Date":"Nov. 8, 2021 at 8:31 a.m. ET","Headline":"Airline Stocks Surge as U.S. Welcomes Travelers From Europe and Other Countries Again","Summary":""},{"Date":"Nov. 8, 2021 at 8:08 a.m. ET","Headline":"A Huge Fund Sold GameStop Stock. It Bought Moderna and Lyft.","Summary":""},{"Date":"Nov. 11, 2021 at 5:16 p.m. ET","Headline":"Moderna Stock Falls Back to Earth as Questions Mount","Summary":""},{"Date":"Nov. 11, 2021 at 9:59 a.m. ET","Headline":"Viewers of these news outlets are most likely to believe COVID-19 myths","Summary":""},{"Date":"Nov. 11, 2021 at 7:17 a.m. ET","Headline":"WHO highlights that Europe is only region with rising COVID cases and deaths, as Russia overtakes U.S. for most fatalities in a week","Summary":""},{"Date":"Nov. 11, 2021 at 6:28 a.m. ET","Headline":"Tesla and AMC Insiders Are Selling. And They\u2019re Not the Only Ones.","Summary":""},{"Date":"Nov. 10, 2021 at 10:31 a.m. ET","Headline":"White House says 900,000 5- to 11-year-olds were vaccinated during first week of eligibility for scaled-down dose","Summary":""},{"Date":"Nov. 10, 2021 at 7:20 a.m. ET","Headline":"Pfizer and BioNTech seek backing of COVID-19 booster for those 18 and over, as U.S. deaths continue to average 1,200 a day","Summary":""},{"Date":"Nov. 13, 2021 at 2:08 p.m. ET","Headline":"\u2018Now is not the time for happy talk\u2019: Experts warn the pandemic is far from over and urge people to combine vaccines with face masks and other measures","Summary":"Johnson & Johnson shares  jumped 3.6% in premarket trade Friday, after  that the company plans to split into two companies, splitting off the consumer group from the prescription drugs and medical devices business. The com..."},{"Date":"Nov. 13, 2021 at 10:27 a.m. ET","Headline":"Unvaccinated people will hear you out on the COVID-19 shot \u2014 as long as you don\u2019t work for the government","Summary":"Johnson & Johnson shares  jumped 3.6% in premarket trade Friday, after  that the company plans to split into two companies, splitting off the consumer group from the prescription drugs and medical devices business. The com..."},{"Date":"Nov. 13, 2021 at 9:55 a.m. ET","Headline":"Ten recommended stocks if you think value will beat growth as inflation surges","Summary":"Johnson & Johnson shares  jumped 3.6% in premarket trade Friday, after  that the company plans to split into two companies, splitting off the consumer group from the prescription drugs and medical devices business. The com..."},{"Date":"Nov. 13, 2021 at 7:00 a.m. ET","Headline":"Shell\u2019s Pension Dropped Alibaba, Sold Pfizer, J&J, and Merck Stock","Summary":"Johnson & Johnson shares  jumped 3.6% in premarket trade Friday, after  that the company plans to split into two companies, splitting off the consumer group from the prescription drugs and medical devices business. The com..."},{"Date":"Nov. 12, 2021 at 11:03 a.m. ET","Headline":"Johnson & Johnson Stock Is Gaining Because 2 Companies Might Make More Sense Than 1","Summary":"Johnson & Johnson shares  jumped 3.6% in premarket trade Friday, after  that the company plans to split into two companies, splitting off the consumer group from the prescription drugs and medical devices business. The com..."},{"Date":"Nov. 12, 2021 at 7:50 a.m. ET","Headline":"Johnson & Johnson to spin off consumer health unit from medical device and drug-making division","Summary":"Johnson & Johnson shares  jumped 3.6% in premarket trade Friday, after  that the company plans to split into two companies, splitting off the consumer group from the prescription drugs and medical devices business. The com..."},{"Date":"Nov. 12, 2021 at 6:32 a.m. ET","Headline":"J&J plans to split into two public companies and separate consumer and drug businesses","Summary":"Johnson & Johnson shares  jumped 3.6% in premarket trade Friday, after  that the company plans to split into two companies, splitting off the consumer group from the prescription drugs and medical devices business. The com..."},{"Date":"Nov. 15, 2021 at 12:05 p.m. ET","Headline":"Covid Cases Are Rising Again. Booster Rollout Could Expand as a Result.","Summary":""},{"Date":"Nov. 14, 2021 at 10:03 p.m. ET","Headline":"Pfizer\u2019s Big Gamble Is Paying Off. Its Stock Is a Good Long-Term Bet.","Summary":""},{"Date":"Nov. 14, 2021 at 9:36 p.m. ET","Headline":"Will Johnson & Johnson\u2019s Split Pay Off? History Says No.","Summary":""},{"Date":"Nov. 17, 2021 at 4:17 p.m. ET","Headline":"Dow ends 200 points lower, but large-cap tech stocks outperform as yields recede","Summary":"Pfizer Inc.  said Wednesday it's launching a search for a new chief financial officer because its current CFO Frank D'Amelio will retire. D'Amelio also held the position of executive vice president of global supply. The co..."},{"Date":"Nov. 17, 2021 at 2:27 p.m. ET","Headline":"Viatris\u2019s CEO Sees a Unique Drug Business. The Stock Fell 12.5% in Its First Year.","Summary":"Pfizer Inc.  said Wednesday it's launching a search for a new chief financial officer because its current CFO Frank D'Amelio will retire. D'Amelio also held the position of executive vice president of global supply. The co..."},{"Date":"Nov. 17, 2021 at 10:57 a.m. ET","Headline":"Pfizer launches search for new CFO as Frank D'Amelio announces his retirement","Summary":"Pfizer Inc.  said Wednesday it's launching a search for a new chief financial officer because its current CFO Frank D'Amelio will retire. D'Amelio also held the position of executive vice president of global supply. The co..."},{"Date":"Nov. 17, 2021 at 9:30 a.m. ET","Headline":"Glaxo and Vir Report $1 Billion Sale of Covid-19 Antibody. The U.S. Is Still Buying.","Summary":"The global tally for the coronavirus-borne illness climbed above 254.5 million on Wednesday, while the death toll edged above 5.11 million, according to . The U.S. continues to lead the world with a total of 47.3 million c..."},{"Date":"Nov. 17, 2021 at 8:23 a.m. ET","Headline":"Pfizer and Moderna announce moves to help get vital COVID medicines to low-income countries, and Arkansas joins U.S. states expanding booster program to all adults","Summary":"The global tally for the coronavirus-borne illness climbed above 254.5 million on Wednesday, while the death toll edged above 5.11 million, according to . The U.S. continues to lead the world with a total of 47.3 million c..."},{"Date":"Nov. 17, 2021 at 6:47 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 above 254.5 million and FDA may authorize boosters for all adults by Thursday","Summary":"The global tally for the coronavirus-borne illness climbed above 254.5 million on Wednesday, while the death toll edged above 5.11 million, according to . The U.S. continues to lead the world with a total of 47.3 million c..."},{"Date":"Nov. 16, 2021 at 6:44 p.m. ET","Headline":"Regulators closer to approving COVID booster for all adults","Summary":"Pfizer Inc.  said Tuesday it has signed a voluntary license agreement with United Nations-backed public health organization the Medicines Patent Pool that will allow generics makers to manufacture its COVID-19 oral antivir..."},{"Date":"Nov. 16, 2021 at 2:34 p.m. ET","Headline":"Pfizer files for U.S. regulatory authorization of its COVID pill","Summary":"Pfizer Inc.  said Tuesday it has signed a voluntary license agreement with United Nations-backed public health organization the Medicines Patent Pool that will allow generics makers to manufacture its COVID-19 oral antivir..."},{"Date":"Nov. 16, 2021 at 9:18 a.m. ET","Headline":"Pfizer Signs Royalty-Free Deal to Aid Poor Nations\u2019 Access to Its Covid Pill","Summary":"Pfizer Inc.  said Tuesday it has signed a voluntary license agreement with United Nations-backed public health organization the Medicines Patent Pool that will allow generics makers to manufacture its COVID-19 oral antivir..."},{"Date":"Nov. 16, 2021 at 7:20 a.m. ET","Headline":"UPDATE: Pfizer to allow generics companies to make its COVID-19 oral antiviral treatment, expand access to poorer countries","Summary":"Pfizer Inc.  said Tuesday it has signed a voluntary license agreement with United Nations-backed public health organization the Medicines Patent Pool that will allow generics makers to manufacture its COVID-19 oral antivir..."},{"Date":"Nov. 16, 2021 at 7:11 a.m. ET","Headline":"Here\u2019s why tech could be the sweet spot for next year, but this hot sector is a no, says Wells Fargo","Summary":""},{"Date":"Nov. 16, 2021 at 6:42 a.m. ET","Headline":"Biden\u2019s Inflation Solution May Be Staring Him in the Face\u2014China","Summary":""},{"Date":"Nov. 19, 2021 at 6:29 p.m. ET","Headline":"CDC recommends COVID-19 vaccine booster shots for all adults","Summary":"Shares of Pfizer Inc.  rose 2.1% and of Germany-based partner BioNTech SE  climbed 4.2% in morning trading Friday, after Health Canada authorized use of the companies' COVID-19 vaccine in children 5 to 11 years old. That's..."},{"Date":"Nov. 19, 2021 at 4:31 p.m. ET","Headline":"The Dow Slid, Tech Outperformed\u2014and What Else Happened in the Stock Market Today","Summary":"Shares of Pfizer Inc.  rose 2.1% and of Germany-based partner BioNTech SE  climbed 4.2% in morning trading Friday, after Health Canada authorized use of the companies' COVID-19 vaccine in children 5 to 11 years old. That's..."},{"Date":"Nov. 19, 2021 at 4:06 p.m. ET","Headline":"CDC Advisory Panel Backs Pfizer and Moderna Boosters for All Adults","Summary":"Shares of Pfizer Inc.  rose 2.1% and of Germany-based partner BioNTech SE  climbed 4.2% in morning trading Friday, after Health Canada authorized use of the companies' COVID-19 vaccine in children 5 to 11 years old. That's..."},{"Date":"Nov. 19, 2021 at 4:03 p.m. ET","Headline":"COVID-19 booster shots get FDA OK, as U.S.\u2019s daily death toll holds above 1,000 and cases rise to 6-week high","Summary":"Shares of Pfizer Inc.  rose 2.1% and of Germany-based partner BioNTech SE  climbed 4.2% in morning trading Friday, after Health Canada authorized use of the companies' COVID-19 vaccine in children 5 to 11 years old. That's..."},{"Date":"Nov. 19, 2021 at 10:42 a.m. ET","Headline":"J&J Says its Drug Pipeline Is Being Underestimated","Summary":"Shares of Pfizer Inc.  rose 2.1% and of Germany-based partner BioNTech SE  climbed 4.2% in morning trading Friday, after Health Canada authorized use of the companies' COVID-19 vaccine in children 5 to 11 years old. That's..."},{"Date":"Nov. 19, 2021 at 10:00 a.m. ET","Headline":"Pfizer, BioNTech COVID-19 vaccine authorized in Canada for children 5 to 11 years of age","Summary":"Shares of Pfizer Inc.  rose 2.1% and of Germany-based partner BioNTech SE  climbed 4.2% in morning trading Friday, after Health Canada authorized use of the companies' COVID-19 vaccine in children 5 to 11 years old. That's..."},{"Date":"Nov. 19, 2021 at 9:26 a.m. ET","Headline":"FDA Authorizes Pfizer and Moderna Covid-19 Vaccine Boosters for All Adults","Summary":"Pfizer  said Thursday it has agreed to supply the U.S. government with 10 million doses of its COVID-19 antiviral and will receive $5.29 billion assuming the treatment is authorized. Paxlovid would be the first oral antivi..."},{"Date":"Nov. 19, 2021 at 8:39 a.m. ET","Headline":"U.S. to make COVID-19 booster shots available to anyone 18 or older","Summary":"Pfizer  said Thursday it has agreed to supply the U.S. government with 10 million doses of its COVID-19 antiviral and will receive $5.29 billion assuming the treatment is authorized. Paxlovid would be the first oral antivi..."},{"Date":"Nov. 18, 2021 at 2:57 p.m. ET","Headline":"Face masks and distancing are most effective measures in reducing COVID-19 spread, study finds, as experts clamor for U.S. to expand booster program","Summary":"Pfizer  said Thursday it has agreed to supply the U.S. government with 10 million doses of its COVID-19 antiviral and will receive $5.29 billion assuming the treatment is authorized. Paxlovid would be the first oral antivi..."},{"Date":"Nov. 18, 2021 at 2:26 p.m. ET","Headline":"Pfizer CEO Talks About Covid Vaccines and What Comes Next: \u2018I Think We Are Undervalued.\u2019","Summary":"Pfizer  said Thursday it has agreed to supply the U.S. government with 10 million doses of its COVID-19 antiviral and will receive $5.29 billion assuming the treatment is authorized. Paxlovid would be the first oral antivi..."},{"Date":"Nov. 18, 2021 at 10:11 a.m. ET","Headline":"Pfizer to Be Paid $5.29 Billion From U.S. Government for Covid-19 Oral Pill","Summary":"Pfizer  said Thursday it has agreed to supply the U.S. government with 10 million doses of its COVID-19 antiviral and will receive $5.29 billion assuming the treatment is authorized. Paxlovid would be the first oral antivi..."},{"Date":"Nov. 18, 2021 at 9:08 a.m. ET","Headline":"Pfizer to supply U.S. government with 10 million doses of its antiviral for $5.29 billion","Summary":"Pfizer  said Thursday it has agreed to supply the U.S. government with 10 million doses of its COVID-19 antiviral and will receive $5.29 billion assuming the treatment is authorized. Paxlovid would be the first oral antivi..."},{"Date":"Nov. 18, 2021 at 8:20 a.m. ET","Headline":"CureVac Stock Climbs as Early Data Show Hope for Second Try at Covid Vaccine","Summary":""},{"Date":"Nov. 18, 2021 at 6:34 a.m. ET","Headline":"Nvidia Stock Keeps Rising. The Next Catalyst Is in the Balance.","Summary":""},{"Date":"Nov. 18, 2021 at 6:13 a.m. ET","Headline":"Europe is the only region where COVID-19 deaths rose in the latest week, as U.S. embarks on effort to greatly boost vaccine manufacturing","Summary":""},{"Date":"Nov. 18, 2021 at 5:38 a.m. ET","Headline":"AstraZeneca Says Preventive Covid Antibody Drug Reduces Risk by 83%","Summary":""},{"Date":"Nov. 17, 2021 at 6:30 a.m. ET","Headline":"Nvidia Earnings Are a Big Deal. But There\u2019s Something More Important.","Summary":""},{"Date":"Nov. 20, 2021 at 2:13 p.m. ET","Headline":"Casper Investors Have Endured Plenty of Lumps Leading Up to the Company\u2019s Buyout","Summary":""},{"Date":"Nov. 20, 2021 at 1:23 p.m. ET","Headline":"Pills to treat COVID-19 will be game-changers, but the best strategy remains prevention","Summary":""},{"Date":"Nov. 23, 2021 at 11:45 p.m. ET","Headline":"Elizabeth Holmes denies deception, but admits \u2018I wish I had done it differently\u2019","Summary":"Pfizer Inc.  and BioNTech SE  said Monday that topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in people 12 through 15 show that a two-dose series of the Pfizer-BioNTech COV..."},{"Date":"Nov. 23, 2021 at 9:13 a.m. ET","Headline":"Covid-19 Vaccine and Pills Will Push Pfizer\u2019s Revenue Above $100B Next Year, Analyst Says","Summary":"Pfizer Inc.  and BioNTech SE  said Monday that topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in people 12 through 15 show that a two-dose series of the Pfizer-BioNTech COV..."},{"Date":"Nov. 23, 2021 at 6:39 a.m. ET","Headline":"The Market Reaction to Powell\u2019s Nomination Might Seem Strange. It Isn\u2019t.","Summary":"Pfizer Inc.  and BioNTech SE  said Monday that topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in people 12 through 15 show that a two-dose series of the Pfizer-BioNTech COV..."},{"Date":"Nov. 22, 2021 at 11:03 p.m. ET","Headline":"Don\u2019t expect U.S. to follow Europe with new COVID lockdowns","Summary":"Pfizer Inc.  and BioNTech SE  said Monday that topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in people 12 through 15 show that a two-dose series of the Pfizer-BioNTech COV..."},{"Date":"Nov. 22, 2021 at 11:12 a.m. ET","Headline":"Moderna\u2019s patent dispute with the U.S. government gets at a crucial question:  control over how the drug is used","Summary":"Pfizer Inc.  and BioNTech SE  said Monday that topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in people 12 through 15 show that a two-dose series of the Pfizer-BioNTech COV..."},{"Date":"Nov. 22, 2021 at 11:04 a.m. ET","Headline":"How Scale Went Out of Fashion in Corporate America","Summary":"Pfizer Inc.  and BioNTech SE  said Monday that topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in people 12 through 15 show that a two-dose series of the Pfizer-BioNTech COV..."},{"Date":"Nov. 22, 2021 at 10:53 a.m. ET","Headline":"Busy Thanksgiving travel sparks U.S. COVID spread worries as Europe\u2019s crisis worsens","Summary":"Pfizer Inc.  and BioNTech SE  said Monday that topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in people 12 through 15 show that a two-dose series of the Pfizer-BioNTech COV..."},{"Date":"Nov. 22, 2021 at 7:13 a.m. ET","Headline":"Pfizer and BioNTech say late-stage trial shows vaccine effective for 12- to 15-year-olds","Summary":"Pfizer Inc.  and BioNTech SE  said Monday that topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in people 12 through 15 show that a two-dose series of the Pfizer-BioNTech COV..."},{"Date":"Nov. 22, 2021 at 5:02 a.m. ET","Headline":"Where to find the cheap airfares","Summary":""},{"Date":"Nov. 25, 2021 at 10:56 a.m. ET","Headline":"Fauci\u2019s guidance for Thanksgiving: \u2018Among vaccinated people, enjoy the holiday\u2019","Summary":"Johnson & Johnson  said Wednesday its one-dose COVID-19 vaccine has been granted full approval by Health Canada, marking its first major regulatory approval. The vaccine has been granted an emergency use authorization in t..."},{"Date":"Nov. 25, 2021 at 9:58 a.m. ET","Headline":"Europe Set to Authorize Covid Shot for Children Above 5 Years Old","Summary":"Johnson & Johnson  said Wednesday its one-dose COVID-19 vaccine has been granted full approval by Health Canada, marking its first major regulatory approval. The vaccine has been granted an emergency use authorization in t..."},{"Date":"Nov. 25, 2021 at 7:07 a.m. ET","Headline":"EU regulator authorizes Pfizer\u2019s COVID vaccine for kids 5-11 as infections sweep region","Summary":"Johnson & Johnson  said Wednesday its one-dose COVID-19 vaccine has been granted full approval by Health Canada, marking its first major regulatory approval. The vaccine has been granted an emergency use authorization in t..."},{"Date":"Nov. 24, 2021 at 12:48 p.m. ET","Headline":"U.S. has already seen more COVID deaths in 2021 than 2020 before vaccines were available, as experts again warn pandemic is not over","Summary":"Johnson & Johnson  said Wednesday its one-dose COVID-19 vaccine has been granted full approval by Health Canada, marking its first major regulatory approval. The vaccine has been granted an emergency use authorization in t..."},{"Date":"Nov. 24, 2021 at 8:51 a.m. ET","Headline":"Valneva Stock Is Jumping on European Vaccine Supply Deal","Summary":"Johnson & Johnson  said Wednesday its one-dose COVID-19 vaccine has been granted full approval by Health Canada, marking its first major regulatory approval. The vaccine has been granted an emergency use authorization in t..."},{"Date":"Nov. 24, 2021 at 8:03 a.m. ET","Headline":"Johnson & Johnson COVID vaccine wins full approval in Canada in first major regulatory nod","Summary":"Johnson & Johnson  said Wednesday its one-dose COVID-19 vaccine has been granted full approval by Health Canada, marking its first major regulatory approval. The vaccine has been granted an emergency use authorization in t..."},{"Date":"Nov. 24, 2021 at 6:32 a.m. ET","Headline":"WHO warns Europe COVID death toll could exceed 2.2 million by March, and U.S. warns against travel to Germany and Denmark","Summary":""},{"Date":"Nov. 23, 2021 at 8:16 a.m. ET","Headline":"The Dogs of the Dow Are Ending 2021 With a Whimper. Why Next Year Could Be Better.","Summary":""},{"Date":"Nov. 27, 2021 at 11:27 a.m. ET","Headline":"What to Know About Omicron, a New Covid Variant of Concern","Summary":"Moderna Inc.  said Friday it will \"rapidly advance\" an omicron-specific COVID-19 booster vaccine candidate and continue to work on booster candidates designed to anticipate mutations of the coronavirus and to study and tes..."},{"Date":"Nov. 26, 2021 at 5:32 p.m. ET","Headline":"Covid Testing Company Says PCR Tests Are Effective Against New Covid Variant","Summary":"Moderna Inc.  said Friday it will \"rapidly advance\" an omicron-specific COVID-19 booster vaccine candidate and continue to work on booster candidates designed to anticipate mutations of the coronavirus and to study and tes..."},{"Date":"Nov. 26, 2021 at 3:56 p.m. ET","Headline":"Moderna to 'rapidly advance' omicron-specific COVID-19 booster candidate","Summary":"Moderna Inc.  said Friday it will \"rapidly advance\" an omicron-specific COVID-19 booster vaccine candidate and continue to work on booster candidates designed to anticipate mutations of the coronavirus and to study and tes..."},{"Date":"Nov. 26, 2021 at 2:42 p.m. ET","Headline":"A New Covid Variant Is Triggering Travel Restrictions Worldwide. What to Know.","Summary":"Shares of airlines fell and drug makers rose in premarket trades on Friday as investors reacted to fresh travel bans related to a new variant of the coronavirus that causes COVID-19 called B.1.1.529 identified in South Afr..."},{"Date":"Nov. 26, 2021 at 2:39 p.m. ET","Headline":"Dow Sinks 900 Points, Oil and Bond Yields Plunge Amid New Covid Fears\u2014and What Else Happened in the Stock Market Today","Summary":"Shares of airlines fell and drug makers rose in premarket trades on Friday as investors reacted to fresh travel bans related to a new variant of the coronavirus that causes COVID-19 called B.1.1.529 identified in South Afr..."},{"Date":"Nov. 26, 2021 at 1:51 p.m. ET","Headline":"Dow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID \u2018variant of concern\u2019","Summary":"Shares of airlines fell and drug makers rose in premarket trades on Friday as investors reacted to fresh travel bans related to a new variant of the coronavirus that causes COVID-19 called B.1.1.529 identified in South Afr..."},{"Date":"Nov. 26, 2021 at 1:06 p.m. ET","Headline":"Zoom, Peloton and Moderna Stocks Surge. Why the Stay-at-Home Trade Is Back.","Summary":"Shares of airlines fell and drug makers rose in premarket trades on Friday as investors reacted to fresh travel bans related to a new variant of the coronavirus that causes COVID-19 called B.1.1.529 identified in South Afr..."},{"Date":"Nov. 26, 2021 at 12:21 p.m. ET","Headline":"Travel stocks slump and vaccine maker stocks rally as WHO names new \u2018variant of concern\u2019","Summary":"Shares of airlines fell and drug makers rose in premarket trades on Friday as investors reacted to fresh travel bans related to a new variant of the coronavirus that causes COVID-19 called B.1.1.529 identified in South Afr..."},{"Date":"Nov. 26, 2021 at 7:31 a.m. ET","Headline":"Drug maker stocks rise but travel stocks sink on new coronavirus variant","Summary":"Shares of airlines fell and drug makers rose in premarket trades on Friday as investors reacted to fresh travel bans related to a new variant of the coronavirus that causes COVID-19 called B.1.1.529 identified in South Afr..."},{"Date":"Nov. 26, 2021 at 7:04 a.m. ET","Headline":"On an ugly day for markets, here\u2019s the S&P 500 level investors need to watch closely, says this trader","Summary":""},{"Date":"Nov. 29, 2021 at 8:52 p.m. ET","Headline":"FDA may OK COVID boosters for 16- and 17-year-olds as soon as next week","Summary":""},{"Date":"Nov. 29, 2021 at 6:52 p.m. ET","Headline":"Confused about whether to get a COVID booster? Here\u2019s what to know","Summary":""},{"Date":"Nov. 29, 2021 at 4:57 p.m. ET","Headline":"3 Reasons the Stock Market Isn\u2019t That Worried About Omicron","Summary":""},{"Date":"Nov. 29, 2021 at 4:09 p.m. ET","Headline":"The Dow Is Rebounding, Moderna Is Flying\u2014and What Else Is Happening in the Stock Market Today","Summary":""},{"Date":"Nov. 29, 2021 at 3:08 p.m. ET","Headline":"Merck stock dives after Citi downgrades on \u2018high probability\u2019 that HIV treatment will be abandoned","Summary":""},{"Date":"Nov. 29, 2021 at 12:36 p.m. ET","Headline":"Visa and Mastercard Stocks Are Ailing as Omicron Hits Travel","Summary":""},{"Date":"Nov. 29, 2021 at 11:07 a.m. ET","Headline":"Vaccine Stocks Could Win Now, Lose Later, From the Omicron Variant","Summary":""},{"Date":"Nov. 29, 2021 at 10:02 a.m. ET","Headline":"Hedge-fund investor who made $2.6 billion on pandemic trades says omicron could be bullish for stock market","Summary":""},{"Date":"Nov. 29, 2021 at 8:24 a.m. ET","Headline":"Here\u2019s what the Black Friday carnage may mean for the stock market\u2019s trade Monday, analysts say","Summary":""},{"Date":"Nov. 29, 2021 at 6:40 a.m. ET","Headline":"WHO warns world leaders against knee-jerk reaction to coronavirus variant from South Africa as U.K. and EU impose travel bans","Summary":""},{"Date":"Nov. 29, 2021 at 3:08 a.m. ET","Headline":"\u2018Vaccine\u2019 chosen as word of the year by Merriam-Webster","Summary":""},{"Date":"Nov. 29, 2021 at 1:18 a.m. ET","Headline":"Asian stocks log more losses as omicron variant of COVID spreads","Summary":""},{"Date":"Nov. 28, 2021 at 11:38 p.m. ET","Headline":"More omicron cases pop up as world scrambles to learn more about latest COVID strain","Summary":""},{"Date":"Nov. 28, 2021 at 5:35 p.m. ET","Headline":"The U.S. stock market suffers ugly Black Friday selloff. Here are the biggest losers (and the winners).","Summary":""},{"Date":"Nov. 28, 2021 at 3:53 p.m. ET","Headline":"Vaccine Makers, Countries Rush to Fight Off New Covid Strain. The Latest News on Omicron.","Summary":""},{"Date":"Nov. 28, 2021 at 2:15 p.m. ET","Headline":"Why You Shouldn\u2019t Panic About the New Covid Variant","Summary":""},{"Date":"Nov. 26, 2021 at 6:44 p.m. ET","Headline":"Covid Shows It Can Still Rock Markets. What Has Changed for Investors.","Summary":""},{"Date":"Dec. 1, 2021 at 11:58 a.m. ET","Headline":"Moderna Stock Tanks After Losing a Patent Dispute. Here\u2019s What Comes Next.","Summary":""},{"Date":"Dec. 1, 2021 at 8:33 a.m. ET","Headline":"FDA Advisors Vote Narrowly in Favor of Merck Covid Pill","Summary":""},{"Date":"Dec. 1, 2021 at 8:31 a.m. ET","Headline":"The liquidity wave carrying stocks will continue even after the Powell Pivot, this analyst argues. Here\u2019s why.","Summary":""},{"Date":"Dec. 1, 2021 at 7:53 a.m. ET","Headline":"FDA advisers recommend Merck\u2019s COVID-19 pill in close vote","Summary":""},{"Date":"Dec. 1, 2021 at 6:31 a.m. ET","Headline":"A Volatile Fed Is the Last Thing Markets Need. Powell Has a Second Chance.","Summary":""},{"Date":"Dec. 1, 2021 at 5:00 a.m. ET","Headline":"No Nation Has Conquered Covid","Summary":""},{"Date":"Nov. 30, 2021 at 4:20 p.m. ET","Headline":"Stocks Had Another Ugly Day. They Couldn\u2019t Shake Off Omicron\u2014or Powell.","Summary":""},{"Date":"Nov. 30, 2021 at 1:35 p.m. ET","Headline":"Omicron Is a Real Risk. What Advisors Need to Know.","Summary":""},{"Date":"Nov. 30, 2021 at 11:00 a.m. ET","Headline":"Omicron variant unlikely to cause severe illness in vaccinated people, BioNTech founder says","Summary":""},{"Date":"Nov. 30, 2021 at 10:52 a.m. ET","Headline":"Pfizer and BioNTech to Seek Covid Booster Approval for 16- and 17-Year-Olds","Summary":""},{"Date":"Nov. 30, 2021 at 9:57 a.m. ET","Headline":"Stock Market Jitters Continue Over Omicron. Why It\u2019s Too Early to Panic.","Summary":""},{"Date":"Nov. 30, 2021 at 8:28 a.m. ET","Headline":"Merck\u2019s Covid Pill Gets an FDA Hearing. What\u2019s at Stake for the Stock.","Summary":""},{"Date":"Nov. 30, 2021 at 7:05 a.m. ET","Headline":"JPMorgan\u2019s S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here\u2019s the biggest risk it sees for stocks.","Summary":""},{"Date":"Nov. 30, 2021 at 6:32 a.m. ET","Headline":"Moderna\u2019s Omicron Warning Reignites Selloff. Get Used to Volatility.","Summary":""},{"Date":"Dec. 3, 2021 at 2:42 p.m. ET","Headline":"WHO has not seen any reports of deaths caused by omicron variant, urges people not to panic as delta still dominant","Summary":""},{"Date":"Dec. 2, 2021 at 3:42 p.m. ET","Headline":"Fauci says changing fully vaccinated definition to include boosters \u2018on the table\u2019","Summary":""},{"Date":"Dec. 2, 2021 at 9:53 a.m. ET","Headline":"Moderna\u2019s Patent Issues Highlight Uncertainty for a Vaccine Star","Summary":""},{"Date":"Dec. 2, 2021 at 8:42 a.m. ET","Headline":"Glaxo, Vir Antibody Drug Works Against Omicron, Tests Show. Vir Stock is Soaring.","Summary":""},{"Date":"Dec. 2, 2021 at 7:52 a.m. ET","Headline":"U.S. to tighten testing requirements for travelers in light of omicron variant, and analysts expected limited authorization of Merck antiviral","Summary":""},{"Date":"Dec. 2, 2021 at 6:35 a.m. ET","Headline":"The Stock Market Is Unhinged. Omicron Is Just One Factor.","Summary":""},{"Date":"Dec. 5, 2021 at 8:58 p.m. ET","Headline":"Omicron Is a Big Unknown. What\u2019s Ahead, According to a Key FDA Official.","Summary":""},{"Date":"Dec. 5, 2021 at 8:57 p.m. ET","Headline":"Bristol Stock Is Too Cheap. Why It Could Be Ready to Rally.","Summary":""},{"Date":"Dec. 5, 2021 at 10:40 a.m. ET","Headline":"After high hopes for Merck\u2019s COVID-19 pill, Wall Street now expects a \u2018tepid\u2019 authorization","Summary":""},{"Date":"Dec. 4, 2021 at 10:31 a.m. ET","Headline":"\u2018Don\u2019t freak out\u2019: Omicron is bound to disrupt supply chains. The question is, how bad will it be?","Summary":""},{"Date":"Dec. 4, 2021 at 10:17 a.m. ET","Headline":"Good Doge! Crypto fans are naming their dogs \u2018Doge\u2019 and cats \u2018Bitcoin\u2019 and \u2018Elon\u2019","Summary":""},{"Date":"Dec. 4, 2021 at 9:21 a.m. ET","Headline":"Insider buying says a Santa Claus rally is on the way \u2014 here are 10 stocks they favor","Summary":""},{"Date":"Dec. 7, 2021 at 8:16 p.m. ET","Headline":"Early lab tests show omicron may lessen effectiveness of vaccine","Summary":""},{"Date":"Dec. 7, 2021 at 8:22 a.m. ET","Headline":"Glaxo and Vir Stock Climb. New Data Show Antibody Drug Works on Omicron.","Summary":""},{"Date":"Dec. 7, 2021 at 6:47 a.m. ET","Headline":"Omicron Fears Are Easing. The Santa Rally Could Be Back On.","Summary":""},{"Date":"Dec. 6, 2021 at 6:50 p.m. ET","Headline":"Moderna Stock Dropped. The Omicron Picture Is Getting Slightly Less Hazy.","Summary":""},{"Date":"Dec. 6, 2021 at 4:54 p.m. ET","Headline":"The Dow Rose, Moderna Fell \u2014 and What Else Happened in the Stock Market Today","Summary":""},{"Date":"Dec. 6, 2021 at 1:18 p.m. ET","Headline":"New York becomes the first major city to require kids to show proof of vaccination for indoor activities","Summary":""},{"Date":"Dec. 6, 2021 at 7:08 a.m. ET","Headline":"A new study finds that most COVID-19 boosters strengthen immunity, though there is no winning shot","Summary":""},{"Date":"Dec. 6, 2021 at 6:42 a.m. ET","Headline":"Bitcoin Is Still Falling. The Dip-Buyers Are Staying Away.","Summary":""},{"Date":"Dec. 9, 2021 at 4:39 p.m. ET","Headline":"US stocks fall as nervous market awaits Friday\u2019s inflation data and anticipates Fed\u2019s response","Summary":"The Food and Drug Administration said 16- and 17-year-olds can now get booster doses of BioNTech SE  and Pfizer Inc.'s  COVID-19 vaccine. BioNTech's stock was down 0.1% in trading on Thursday, while Pfizer shares gained 1...."},{"Date":"Dec. 9, 2021 at 3:07 p.m. ET","Headline":"U.S. oil prices settle lower, ending a 3-session streak of gains","Summary":"The Food and Drug Administration said 16- and 17-year-olds can now get booster doses of BioNTech SE  and Pfizer Inc.'s  COVID-19 vaccine. BioNTech's stock was down 0.1% in trading on Thursday, while Pfizer shares gained 1...."},{"Date":"Dec. 9, 2021 at 2:54 p.m. ET","Headline":"FDA Authorizes Vaccine Boosters for 16- and 17-Year-Olds","Summary":"The Food and Drug Administration said 16- and 17-year-olds can now get booster doses of BioNTech SE  and Pfizer Inc.'s  COVID-19 vaccine. BioNTech's stock was down 0.1% in trading on Thursday, while Pfizer shares gained 1...."},{"Date":"Dec. 9, 2021 at 11:40 a.m. ET","Headline":"FDA authorizes BioNTech, Pfizer's COVID-19 booster for 16- and 17-year-olds","Summary":"The Food and Drug Administration said 16- and 17-year-olds can now get booster doses of BioNTech SE  and Pfizer Inc.'s  COVID-19 vaccine. BioNTech's stock was down 0.1% in trading on Thursday, while Pfizer shares gained 1...."},{"Date":"Dec. 9, 2021 at 9:57 a.m. ET","Headline":"FTSE 100 slumps as airlines and travel stocks struggle in U.K., amid talk of COVID restrictions","Summary":"A study in Japan has found that the omicron variant of COVID-19 is 4.2 times more contagious than the delta strain,  on Thursday. \"The omicron variant transmits more, and escapes immunity built naturally and through vaccin..."},{"Date":"Dec. 9, 2021 at 8:08 a.m. ET","Headline":"Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash","Summary":"A study in Japan has found that the omicron variant of COVID-19 is 4.2 times more contagious than the delta strain,  on Thursday. \"The omicron variant transmits more, and escapes immunity built naturally and through vaccin..."},{"Date":"Dec. 9, 2021 at 7:34 a.m. ET","Headline":"Early data indicates that boosters, at least for BioNTech and Pfizer\u2019s COVID-19 vaccine, further protect against omicron","Summary":"A study in Japan has found that the omicron variant of COVID-19 is 4.2 times more contagious than the delta strain,  on Thursday. \"The omicron variant transmits more, and escapes immunity built naturally and through vaccin..."},{"Date":"Dec. 9, 2021 at 6:42 a.m. ET","Headline":"Inflation Data Lie in Wait as the Stock Market\u2019s Next Nemesis","Summary":"A study in Japan has found that the omicron variant of COVID-19 is 4.2 times more contagious than the delta strain,  on Thursday. \"The omicron variant transmits more, and escapes immunity built naturally and through vaccin..."},{"Date":"Dec. 9, 2021 at 2:48 a.m. ET","Headline":"Japan study confirms omicron variant's high transmissibility: report","Summary":"A study in Japan has found that the omicron variant of COVID-19 is 4.2 times more contagious than the delta strain,  on Thursday. \"The omicron variant transmits more, and escapes immunity built naturally and through vaccin..."},{"Date":"Dec. 8, 2021 at 7:24 p.m. ET","Headline":"CDC chief says omicron cases have been mostly mild so far","Summary":"Long-dated yields for U.S. government debt ended higher Wednesday after posting the biggest three-day rise in three to four weeks as investors digested news suggesting the omicron variant of coronavirus may not impact the..."},{"Date":"Dec. 8, 2021 at 4:28 p.m. ET","Headline":"Stocks Gain as Pfizer Data Ease Omicron Fears","Summary":"Long-dated yields for U.S. government debt ended higher Wednesday after posting the biggest three-day rise in three to four weeks as investors digested news suggesting the omicron variant of coronavirus may not impact the..."},{"Date":"Dec. 8, 2021 at 3:51 p.m. ET","Headline":"Long-dated Treasury yields post biggest three-day rise in weeks after Pfizer\/BioNTech omicron report","Summary":"Long-dated yields for U.S. government debt ended higher Wednesday after posting the biggest three-day rise in three to four weeks as investors digested news suggesting the omicron variant of coronavirus may not impact the..."},{"Date":"Dec. 8, 2021 at 3:05 p.m. ET","Headline":"U.S. oil prices settle at 2-week high as omicron fears ease","Summary":""},{"Date":"Dec. 8, 2021 at 1:57 p.m. ET","Headline":"Gold futures inch higher, but finish below highest intraday level in past week","Summary":""},{"Date":"Dec. 8, 2021 at 1:39 p.m. ET","Headline":"It\u2019s a Third Dose Against Omicron, Not a Booster, BioNTech CEO Says","Summary":""},{"Date":"Dec. 8, 2021 at 1:02 p.m. ET","Headline":"A 10-year Treasury yield at or above 2% has been elusive. Here are the banks making it their 2022 call.","Summary":""},{"Date":"Dec. 8, 2021 at 11:03 a.m. ET","Headline":"Pound under pressure as U.K. markets mull further COVID restrictions","Summary":""},{"Date":"Dec. 8, 2021 at 10:28 a.m. ET","Headline":"Germany is getting a new chancellor. Here\u2019s how the DAX has performed under outgoing chancellor Angela Merkel.","Summary":""},{"Date":"Dec. 11, 2021 at 11:15 a.m. ET","Headline":"Fauci says omicron-specific vaccines may not be needed, while new research indicates T-cell protection may hold up against the variant","Summary":""},{"Date":"Dec. 10, 2021 at 11:16 a.m. ET","Headline":"Moderna Stock Drops as Flu Vaccine Data Disappoints","Summary":""},{"Date":"Dec. 10, 2021 at 8:58 a.m. ET","Headline":"Omicron-Specific Booster Shots May Not Be Needed, Fauci Says","Summary":""},{"Date":"Dec. 10, 2021 at 7:44 a.m. ET","Headline":"Omicron cases have been \u2018mild,\u2019 says CDC director, though majority so far are in the vaccinated","Summary":""},{"Date":"Dec. 10, 2021 at 6:45 a.m. ET","Headline":"Company Insiders Are Back in Buying Mode\u2014Even Tesla\u2019s Elon Musk","Summary":""},{"Date":"Dec. 13, 2021 at 11:51 p.m. ET","Headline":"Stocks move south in Asia after tech fuels a retreat on Wall Street","Summary":"Analysts are on board with Pfizer Inc.'s  plans to acquire Arena Pharmaceuticals Inc.  in a deal worth $6.7 billion and announced Monday morning. Pfizer's stock was up 1.2% in premarket trading on Monday, while shares of A..."},{"Date":"Dec. 13, 2021 at 5:17 p.m. ET","Headline":"The Dow Slid\u2014and What Else Happened in the Stock Market Today","Summary":"Analysts are on board with Pfizer Inc.'s  plans to acquire Arena Pharmaceuticals Inc.  in a deal worth $6.7 billion and announced Monday morning. Pfizer's stock was up 1.2% in premarket trading on Monday, while shares of A..."},{"Date":"Dec. 13, 2021 at 4:43 p.m. ET","Headline":"Dow and S&P 500 post biggest one-day declines in almost two weeks, with focus shifting to Fed and \u2018tidal wave\u2019 of omicron","Summary":"Analysts are on board with Pfizer Inc.'s  plans to acquire Arena Pharmaceuticals Inc.  in a deal worth $6.7 billion and announced Monday morning. Pfizer's stock was up 1.2% in premarket trading on Monday, while shares of A..."},{"Date":"Dec. 13, 2021 at 1:15 p.m. ET","Headline":"The Omicron Variant Won\u2019t Go Away That Easily. That\u2019s Good News for Vaccine Stocks.","Summary":"Analysts are on board with Pfizer Inc.'s  plans to acquire Arena Pharmaceuticals Inc.  in a deal worth $6.7 billion and announced Monday morning. Pfizer's stock was up 1.2% in premarket trading on Monday, while shares of A..."},{"Date":"Dec. 13, 2021 at 9:46 a.m. ET","Headline":"Buy Pfizer Stock Because Its Covid Pill Will Be a Big Seller, UBS Says","Summary":"Analysts are on board with Pfizer Inc.'s  plans to acquire Arena Pharmaceuticals Inc.  in a deal worth $6.7 billion and announced Monday morning. Pfizer's stock was up 1.2% in premarket trading on Monday, while shares of A..."},{"Date":"Dec. 13, 2021 at 9:46 a.m. ET","Headline":"Forklift races, drunken dips in hotel fountains \u2014 and COVID-19. Why companies need to think hard about throwing an office party this season","Summary":"Analysts are on board with Pfizer Inc.'s  plans to acquire Arena Pharmaceuticals Inc.  in a deal worth $6.7 billion and announced Monday morning. Pfizer's stock was up 1.2% in premarket trading on Monday, while shares of A..."},{"Date":"Dec. 13, 2021 at 8:44 a.m. ET","Headline":"Analysts: Pfizer to 'capitalize' on experimental colitis treatment in Arena deal","Summary":"Analysts are on board with Pfizer Inc.'s  plans to acquire Arena Pharmaceuticals Inc.  in a deal worth $6.7 billion and announced Monday morning. Pfizer's stock was up 1.2% in premarket trading on Monday, while shares of A..."},{"Date":"Dec. 13, 2021 at 8:40 a.m. ET","Headline":"Pfizer to Buy Arena Pharmaceuticals in $6.7 Billion Deal. Arena Stock  Soars.","Summary":"Pfizer Inc.  said Monday it has agreed to acquire Arena Pharmaceuticals Inc.  in a deal with a value of about $6.7 billion. The news sent Arena shares up 91% in premarket trading. Pfizer will pay $100 per Arena share, or d..."},{"Date":"Dec. 13, 2021 at 8:37 a.m. ET","Headline":"Fauci Says \u2018Tough to Tell\u2019 if Covid Boosters Will Be Needed Every Year","Summary":"Pfizer Inc.  said Monday it has agreed to acquire Arena Pharmaceuticals Inc.  in a deal with a value of about $6.7 billion. The news sent Arena shares up 91% in premarket trading. Pfizer will pay $100 per Arena share, or d..."},{"Date":"Dec. 13, 2021 at 7:27 a.m. ET","Headline":"A near-term pullback, then the third bubble in 100 years is coming, says strategist. Here\u2019s how to get ready.","Summary":"Pfizer Inc.  said Monday it has agreed to acquire Arena Pharmaceuticals Inc.  in a deal with a value of about $6.7 billion. The news sent Arena shares up 91% in premarket trading. Pfizer will pay $100 per Arena share, or d..."},{"Date":"Dec. 13, 2021 at 6:29 a.m. ET","Headline":"Pfizer to acquire Arena Pharmaceuticals in deal valued at about $6.7 billion","Summary":"Pfizer Inc.  said Monday it has agreed to acquire Arena Pharmaceuticals Inc.  in a deal with a value of about $6.7 billion. The news sent Arena shares up 91% in premarket trading. Pfizer will pay $100 per Arena share, or d..."},{"Date":"Dec. 13, 2021 at 5:32 a.m. ET","Headline":"Pfizer lifted to buy at UBS, which says COVID franchise sales could hit $50 billion next year","Summary":"Pfizer  was upgraded to buy from neutral at UBS, which also lifted its price target to $60 from $52. UBS said the oral antiviral paxlovid will generate at least $14 billion in sales next year, which it said was 40% above c..."},{"Date":"Dec. 13, 2021 at 4:44 a.m. ET","Headline":"\u2018The days you were considered fully vaccinated with two shots are going to be a thing of the past\u2019","Summary":""},{"Date":"Dec. 12, 2021 at 12:50 p.m. ET","Headline":"Here Are the Cheapest Stocks in Each Sector of the S&P 500","Summary":""},{"Date":"Dec. 12, 2021 at 11:23 a.m. ET","Headline":"Direct Listings Once Looked Like a Threat to Traditional IPOs. Now They\u2019re an Option for the Few.","Summary":""},{"Date":"Dec. 15, 2021 at 10:29 a.m. ET","Headline":"Cornell partially shuts down its campus due to more than 900 COVID-19 cases in possible omicron outbreak","Summary":"The European Medicines Agency said it will recommend Johnson & Johnson's  COVID-19 vaccine as a booster dose when administered at least two month after the first in those 18 years and older. That follows data showing that ..."},{"Date":"Dec. 15, 2021 at 9:48 a.m. ET","Headline":"Omicron Variant Spreading in the U.S. and Challenging Delta\u2019s Dominance, CDC Data Show","Summary":"The European Medicines Agency said it will recommend Johnson & Johnson's  COVID-19 vaccine as a booster dose when administered at least two month after the first in those 18 years and older. That follows data showing that ..."},{"Date":"Dec. 15, 2021 at 9:29 a.m. ET","Headline":"Vir and Glaxo\u2019s Drug Could Be the Last Antibody Treatment Standing Against Omicron","Summary":"The European Medicines Agency said it will recommend Johnson & Johnson's  COVID-19 vaccine as a booster dose when administered at least two month after the first in those 18 years and older. That follows data showing that ..."},{"Date":"Dec. 15, 2021 at 6:39 a.m. ET","Headline":"Inflation Is Hotter Than Ever as the Fed Makes Its Final Decision for 2021","Summary":"The European Medicines Agency said it will recommend Johnson & Johnson's  COVID-19 vaccine as a booster dose when administered at least two month after the first in those 18 years and older. That follows data showing that ..."},{"Date":"Dec. 15, 2021 at 6:32 a.m. ET","Headline":"Pfizer\u2019s COVID-19 antiviral proves almost 90% effective in latest trial data, as U.S. passes 50 million confirmed cases of the illness","Summary":"The European Medicines Agency said it will recommend Johnson & Johnson's  COVID-19 vaccine as a booster dose when administered at least two month after the first in those 18 years and older. That follows data showing that ..."},{"Date":"Dec. 15, 2021 at 5:57 a.m. ET","Headline":"European Medicines Agency to recommend Johnson & Johnson COVID booster","Summary":"The European Medicines Agency said it will recommend Johnson & Johnson's  COVID-19 vaccine as a booster dose when administered at least two month after the first in those 18 years and older. That follows data showing that ..."},{"Date":"Dec. 15, 2021 at 3:30 a.m. ET","Headline":"Why Wall Street Isn\u2019t Freaking Out Over Omicron","Summary":"Yields edge higher Tuesday as Federal Reserve policy makers meet in Washington and the latest producer price reading shows inflation getting worse."},{"Date":"Dec. 15, 2021 at 3:05 a.m. ET","Headline":"China\u2019s Sinovac vaccine \u2018inadequate\u2019 against omicron variant, study finds","Summary":"Yields edge higher Tuesday as Federal Reserve policy makers meet in Washington and the latest producer price reading shows inflation getting worse."},{"Date":"Dec. 15, 2021 at 12:19 a.m. ET","Headline":"Stocks fall in Asia as global markets shift attention to U.S. central-bank policy meeting","Summary":"Yields edge higher Tuesday as Federal Reserve policy makers meet in Washington and the latest producer price reading shows inflation getting worse."},{"Date":"Dec. 14, 2021 at 4:01 p.m. ET","Headline":"2- and 10-year Treasury yields see biggest gains in about a week as Fed meets and data highlight hot inflation","Summary":"Yields edge higher Tuesday as Federal Reserve policy makers meet in Washington and the latest producer price reading shows inflation getting worse."},{"Date":"Dec. 14, 2021 at 9:01 a.m. ET","Headline":"The Fed Meeting Could Be D-Day for Bitcoin and Other Cryptos","Summary":"Pfizer Inc.  said Tuesday that final data from a late-stage trial of its COVID-19 antiviral found it reduced the risk of hospitalization or death by 89% within three days of symptom onset by 89% and reduced it by 88% withi..."},{"Date":"Dec. 14, 2021 at 8:54 a.m. ET","Headline":"\u2018Zero Covid\u2019 Isn\u2019t Stopping Omicron. Here\u2019s What Will.","Summary":"Pfizer Inc.  said Tuesday that final data from a late-stage trial of its COVID-19 antiviral found it reduced the risk of hospitalization or death by 89% within three days of symptom onset by 89% and reduced it by 88% withi..."},{"Date":"Dec. 14, 2021 at 8:37 a.m. ET","Headline":"Here\u2019s why meme-stock madness and 99th percentile valuations will continue, according to this major bank.","Summary":"Pfizer Inc.  said Tuesday that final data from a late-stage trial of its COVID-19 antiviral found it reduced the risk of hospitalization or death by 89% within three days of symptom onset by 89% and reduced it by 88% withi..."},{"Date":"Dec. 14, 2021 at 8:32 a.m. ET","Headline":"Pfizer Confirms Its Covid Pill Reduces the Risk of Hospitalization or Death by Nearly 90%","Summary":"Pfizer Inc.  said Tuesday that final data from a late-stage trial of its COVID-19 antiviral found it reduced the risk of hospitalization or death by 89% within three days of symptom onset by 89% and reduced it by 88% withi..."},{"Date":"Dec. 14, 2021 at 7:00 a.m. ET","Headline":"Pfizer says final data from late-stage trial of COVID-19 antiviral shows it reduces risk of hospitalization or death by 89%","Summary":"Pfizer Inc.  said Tuesday that final data from a late-stage trial of its COVID-19 antiviral found it reduced the risk of hospitalization or death by 89% within three days of symptom onset by 89% and reduced it by 88% withi..."},{"Date":"Dec. 14, 2021 at 6:24 a.m. ET","Headline":"Pfizer stock closes at record after $6.7 billion takeover of Arena; deal \u2018makes strategic sense to us,\u2019 analyst says","Summary":"Two shots of the COVID vaccine produced by Pfizer  and BioNTech  may offer 70% protection against hospitalizations due to the omicron variant, a South African study showed Tuesday, . The study was released by Discovery Ltd..."},{"Date":"Dec. 14, 2021 at 5:14 a.m. ET","Headline":"South Africa study shows two Pfizer shots may halt 70% of omicron hospitalizations: report","Summary":"Two shots of the COVID vaccine produced by Pfizer  and BioNTech  may offer 70% protection against hospitalizations due to the omicron variant, a South African study showed Tuesday, . The study was released by Discovery Ltd..."},{"Date":"Dec. 13, 2021 at 4:48 p.m. ET","Headline":"U.S. Supreme Court Allows New York to Mandate Vaccines for Healthcare Workers","Summary":""},{"Date":"Dec. 17, 2021 at 8:36 p.m. ET","Headline":"Crypto Goes Briefly Haywire. That\u2019s No Joke.","Summary":"The global tally for the coronavirus-borne illness climbed above 273 million on Friday, while the death toll edged above 5.33 million, according to . The U.S. continues to lead the world with 50.5 million cases  and 803,65..."},{"Date":"Dec. 17, 2021 at 6:07 p.m. ET","Headline":"Pfizer Delays Authorization Request for Young Childrens\u2019 Covid Vaccine. Stock Slips.","Summary":"The global tally for the coronavirus-borne illness climbed above 273 million on Friday, while the death toll edged above 5.33 million, according to . The U.S. continues to lead the world with 50.5 million cases  and 803,65..."},{"Date":"Dec. 17, 2021 at 4:18 p.m. ET","Headline":"Pfizer pushes back plans to request authorization of COVID-19 vaccine in children ages 2 to 5","Summary":"The global tally for the coronavirus-borne illness climbed above 273 million on Friday, while the death toll edged above 5.33 million, according to . The U.S. continues to lead the world with 50.5 million cases  and 803,65..."},{"Date":"Dec. 17, 2021 at 2:42 p.m. ET","Headline":"Unvaccinated Americans facing \u2018winter of severe illness and death,\u2019 Biden warns, as omicron starts to spread across the U.S.","Summary":"The global tally for the coronavirus-borne illness climbed above 273 million on Friday, while the death toll edged above 5.33 million, according to . The U.S. continues to lead the world with 50.5 million cases  and 803,65..."},{"Date":"Dec. 17, 2021 at 12:09 p.m. ET","Headline":"Novavax Covid Vaccine Gets Emergency-Use Approval From WHO","Summary":"The global tally for the coronavirus-borne illness climbed above 273 million on Friday, while the death toll edged above 5.33 million, according to . The U.S. continues to lead the world with 50.5 million cases  and 803,65..."},{"Date":"Dec. 17, 2021 at 9:40 a.m. ET","Headline":"New COVID-19 booster candidates are still being developed as omicron spreads","Summary":"The global tally for the coronavirus-borne illness climbed above 273 million on Friday, while the death toll edged above 5.33 million, according to . The U.S. continues to lead the world with 50.5 million cases  and 803,65..."},{"Date":"Dec. 17, 2021 at 8:39 a.m. ET","Headline":"Biden Says Unvaccinated Face \u2018a Winter of Severe Illness and Death\u2019","Summary":"The global tally for the coronavirus-borne illness climbed above 273 million on Friday, while the death toll edged above 5.33 million, according to . The U.S. continues to lead the world with 50.5 million cases  and 803,65..."},{"Date":"Dec. 17, 2021 at 6:45 a.m. ET","Headline":"The Post-Fed Relief Rally Lasted a Day. What Next.","Summary":"The global tally for the coronavirus-borne illness climbed above 273 million on Friday, while the death toll edged above 5.33 million, according to . The U.S. continues to lead the world with 50.5 million cases  and 803,65..."},{"Date":"Dec. 17, 2021 at 6:23 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 273 million and CDC panel recommends Pfizer and Moderna vaccines over J&J's","Summary":"The global tally for the coronavirus-borne illness climbed above 273 million on Friday, while the death toll edged above 5.33 million, according to . The U.S. continues to lead the world with 50.5 million cases  and 803,65..."},{"Date":"Dec. 16, 2021 at 8:08 p.m. ET","Headline":"CDC Advisers Recommend Pfizer and Moderna\u2019s Vaccines Over J&J\u2019s","Summary":""},{"Date":"Dec. 16, 2021 at 4:11 p.m. ET","Headline":"CDC advisers recommend Pfizer, Moderna COVID-19 vaccines over J&J shot because of rare side effect","Summary":""},{"Date":"Dec. 16, 2021 at 3:49 p.m. ET","Headline":"A Biotech Unveils Its New Gene Control Technology","Summary":""},{"Date":"Dec. 16, 2021 at 6:41 a.m. ET","Headline":"The Fed May Have Kickstarted the Santa Claus Rally","Summary":""},{"Date":"Dec. 16, 2021 at 6:23 a.m. ET","Headline":"Omicron variant remains a \u2018very high\u2019 risk as it spreads fast and shows resistance to vaccines, but WHO says more data needed to know if it\u2019s more lethal","Summary":""},{"Date":"Dec. 16, 2021 at 2:09 a.m. ET","Headline":"\u2018The pandemic is not quite tired of us\u2019: Higher education moving classes and exams online and canceling events as campuses cope with a COVID resurgence","Summary":""},{"Date":"Dec. 19, 2021 at 5:26 p.m. ET","Headline":"Omicron may sideline two leading drugs used to treat COVID-19","Summary":""},{"Date":"Dec. 18, 2021 at 9:59 a.m. ET","Headline":"After a dazzling 2021, Apple and Tesla stocks are expected to be duds in 2022","Summary":""},{"Date":"Dec. 21, 2021 at 3:51 p.m. ET","Headline":"Treasury yields rise most in two weeks on optimism over Biden\u2019s COVID plan and vaccine prospects","Summary":"Treasury yields went higher on Tuesday, with government debt being sold and equities bought, a day after global stock markets sold off."},{"Date":"Dec. 21, 2021 at 11:31 a.m. ET","Headline":"Omicron Is Driving Up Demand for Rapid Tests","Summary":"The global tally for the coronavirus-borne illness climbed above 274.7 million on Monday, while the death toll edged above 5.35 million, according to . The U.S. continues to lead the world with 50.8 million cases  and 806,..."},{"Date":"Dec. 21, 2021 at 7:37 a.m. ET","Headline":"Data suggest boosters are essential to avoid omicron infection, and Fauci says the best way to protect kids is to make sure adults around them are fully vaccinated","Summary":"The global tally for the coronavirus-borne illness climbed above 274.7 million on Monday, while the death toll edged above 5.35 million, according to . The U.S. continues to lead the world with 50.8 million cases  and 806,..."},{"Date":"Dec. 20, 2021 at 8:14 p.m. ET","Headline":"\u2018Nobody was expecting omicron \u2014 this one really was a curveball\u2019: Francis Collins, National Institutes of Health\u2019s outgoing director, issues warning to Americans","Summary":"The global tally for the coronavirus-borne illness climbed above 274.7 million on Monday, while the death toll edged above 5.35 million, according to . The U.S. continues to lead the world with 50.8 million cases  and 806,..."},{"Date":"Dec. 20, 2021 at 5:27 p.m. ET","Headline":"Monday was an ugly one for the stock market headed to Christmas. Here\u2019s what history says about returns on the following Tuesday.","Summary":"The global tally for the coronavirus-borne illness climbed above 274.7 million on Monday, while the death toll edged above 5.35 million, according to . The U.S. continues to lead the world with 50.8 million cases  and 806,..."},{"Date":"Dec. 20, 2021 at 2:27 p.m. ET","Headline":"Moderna Covid Vaccine Booster Increases Antibodies Against Omicron 37-Fold","Summary":"The global tally for the coronavirus-borne illness climbed above 274.7 million on Monday, while the death toll edged above 5.35 million, according to . The U.S. continues to lead the world with 50.8 million cases  and 806,..."},{"Date":"Dec. 20, 2021 at 7:33 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 near 275 million and research shows only Pfizer\/Moderna vaccines with booster stop omicron","Summary":"The global tally for the coronavirus-borne illness climbed above 274.7 million on Monday, while the death toll edged above 5.35 million, according to . The U.S. continues to lead the world with 50.8 million cases  and 806,..."},{"Date":"Dec. 20, 2021 at 7:29 a.m. ET","Headline":"A COVID-19 recovery offers low protection against omicron variant but boosters are effective, London study finds","Summary":"Pfizer Inc.  and German partner BioNTEch SE  said Monday they have reached an agreement to provide an additional 200 million doses of their COVID-19 vaccine to the European Commission and its member states in 2022. The com..."},{"Date":"Dec. 20, 2021 at 7:19 a.m. ET","Headline":"Pfizer and BioNTech to provide more than 200 million additional COVID vaccine doses to EU in 2022","Summary":"Pfizer Inc.  and German partner BioNTEch SE  said Monday they have reached an agreement to provide an additional 200 million doses of their COVID-19 vaccine to the European Commission and its member states in 2022. The com..."},{"Date":"Dec. 17, 2021 at 7:38 p.m. ET","Headline":"Omicron Could Be the Start of a \u2018Viral Blizzard.\u2019 Brace for a Challenging Winter.","Summary":""},{"Date":"Dec. 9, 2021 at 7:22 a.m. ET","Headline":"Uncovering these \u2018hidden stories\u2019 has led this fund manager to stock gains that beat the S&P 500. Here are his picks","Summary":""},{"Date":"Dec. 23, 2021 at 9:04 p.m. ET","Headline":"The Meme Gang Cheers on Spidey for Saving the Movie Theaters","Summary":"U.S. Treasury yields edged up Thursday, posting gains for the abbreviated holiday week, as a gauge of U.S. inflation jumped and weekly initial jobless benefits came in unchanged."},{"Date":"Dec. 23, 2021 at 8:24 p.m. ET","Headline":"Omicron Is Surging. Inflation Is Rising. But Investors Are Dreaming of a Santa Claus Rally.","Summary":"U.S. Treasury yields edged up Thursday, posting gains for the abbreviated holiday week, as a gauge of U.S. inflation jumped and weekly initial jobless benefits came in unchanged."},{"Date":"Dec. 23, 2021 at 4:52 p.m. ET","Headline":"\u2018Get your booster shot\u2019: 3 ways to protect against omicron this holiday season","Summary":"U.S. Treasury yields edged up Thursday, posting gains for the abbreviated holiday week, as a gauge of U.S. inflation jumped and weekly initial jobless benefits came in unchanged."},{"Date":"Dec. 23, 2021 at 4:47 p.m. ET","Headline":"Is it time for you to cancel your holiday party?","Summary":"U.S. Treasury yields edged up Thursday, posting gains for the abbreviated holiday week, as a gauge of U.S. inflation jumped and weekly initial jobless benefits came in unchanged."},{"Date":"Dec. 23, 2021 at 3:34 p.m. ET","Headline":"Oil logs 4% weekly rise as omicron jitters fade","Summary":"U.S. Treasury yields edged up Thursday, posting gains for the abbreviated holiday week, as a gauge of U.S. inflation jumped and weekly initial jobless benefits came in unchanged."},{"Date":"Dec. 23, 2021 at 3:08 p.m. ET","Headline":"Treasury yields rise to highest level in weeks, post weekly gains, as U.S. inflation climbs and initial jobless claims come in unchanged","Summary":"U.S. Treasury yields edged up Thursday, posting gains for the abbreviated holiday week, as a gauge of U.S. inflation jumped and weekly initial jobless benefits came in unchanged."},{"Date":"Dec. 23, 2021 at 1:27 p.m. ET","Headline":"FDA adds Merck antiviral to COVID-19 tool kit for high-risk adults above 18 amid flurry of positive news on boosters","Summary":"Shares of Merck & Co. Inc.  were down 0.8% in trading on Thursday after the Food and Drug Administration authorized the company's COVID-19 antiviral for adults who have tested positive for the virus and are at high risk of..."},{"Date":"Dec. 23, 2021 at 12:49 p.m. ET","Headline":"The S&P 500 Celebrates the Holiday Early With a New High","Summary":"Shares of Merck & Co. Inc.  were down 0.8% in trading on Thursday after the Food and Drug Administration authorized the company's COVID-19 antiviral for adults who have tested positive for the virus and are at high risk of..."},{"Date":"Dec. 23, 2021 at 12:04 p.m. ET","Headline":"Merck\u2019s Antiviral Pill Gets Emergency Use OK for Some Covid Patients","Summary":"Shares of Merck & Co. Inc.  were down 0.8% in trading on Thursday after the Food and Drug Administration authorized the company's COVID-19 antiviral for adults who have tested positive for the virus and are at high risk of..."},{"Date":"Dec. 23, 2021 at 12:01 p.m. ET","Headline":"Pfizer\u2019s Arena Pharma deal may lead drug company to a cannabis-based treatment","Summary":"Shares of Merck & Co. Inc.  were down 0.8% in trading on Thursday after the Food and Drug Administration authorized the company's COVID-19 antiviral for adults who have tested positive for the virus and are at high risk of..."},{"Date":"Dec. 23, 2021 at 9:48 a.m. ET","Headline":"FDA authorizes Merck's COVID-19 antiviral but only when other treatments are 'not accessible' or 'appropriate'","Summary":"Shares of Merck & Co. Inc.  were down 0.8% in trading on Thursday after the Food and Drug Administration authorized the company's COVID-19 antiviral for adults who have tested positive for the virus and are at high risk of..."},{"Date":"Dec. 23, 2021 at 9:35 a.m. ET","Headline":"Technical trading signals in the stock market are on the verge of turning bullish","Summary":"The 10-year Treasury yield has its biggest drop in almost a week on Wednesday, despite data showing U.S. consumer confidence improved  this month, as markets continued to focus on the economic impact of the omicron variant..."},{"Date":"Dec. 23, 2021 at 8:27 a.m. ET","Headline":"South Africa offers grounds for cautious optimism on omicron variant, and Israel rolls out fourth vaccine dose to vulnerable groups","Summary":"The 10-year Treasury yield has its biggest drop in almost a week on Wednesday, despite data showing U.S. consumer confidence improved  this month, as markets continued to focus on the economic impact of the omicron variant..."},{"Date":"Dec. 23, 2021 at 6:47 a.m. ET","Headline":"Omicron Optimism Creeps In. Markets Are Still Cautious.","Summary":"The 10-year Treasury yield has its biggest drop in almost a week on Wednesday, despite data showing U.S. consumer confidence improved  this month, as markets continued to focus on the economic impact of the omicron variant..."},{"Date":"Dec. 22, 2021 at 4:24 p.m. ET","Headline":"Dow closes over 260 points higher Wednesday and stocks book 2nd straight gain as omicron fears subside","Summary":"The 10-year Treasury yield has its biggest drop in almost a week on Wednesday, despite data showing U.S. consumer confidence improved  this month, as markets continued to focus on the economic impact of the omicron variant..."},{"Date":"Dec. 22, 2021 at 3:49 p.m. ET","Headline":"Ten-year Treasury yield has biggest drop in almost a week as omicron variant remains front and center","Summary":"The 10-year Treasury yield has its biggest drop in almost a week on Wednesday, despite data showing U.S. consumer confidence improved  this month, as markets continued to focus on the economic impact of the omicron variant..."},{"Date":"Dec. 22, 2021 at 12:50 p.m. ET","Headline":"FDA Authorizes Pfizer Antiviral Pill to Fight Covid","Summary":"Shares of Pfizer Inc.  were up 1.6% in trading on Wednesday after the Food and Drug Administration authorized the company's COVID-19 antiviral, bringing to market the first at-home COVID-19 pill during the course of the pa..."},{"Date":"Dec. 22, 2021 at 12:23 p.m. ET","Headline":"FDA authorizes Pfizer's COVID-19 antiviral for high-risk teens and adults","Summary":"Shares of Pfizer Inc.  were up 1.6% in trading on Wednesday after the Food and Drug Administration authorized the company's COVID-19 antiviral, bringing to market the first at-home COVID-19 pill during the course of the pa..."},{"Date":"Dec. 25, 2021 at 9:30 a.m. ET","Headline":"Pfizer\u2019s Covid Pill Gets Green Light. Investors Are Starting to Pay Attention to the Stock.","Summary":""},{"Date":"Dec. 24, 2021 at 3:51 p.m. ET","Headline":"Is it safe to travel for Christmas as omicron spreads? Here are 5 steps to stay healthy during the holidays","Summary":""},{"Date":"Dec. 23, 2021 at 9:08 p.m. ET","Headline":"Omicron Who? S&P 500 Closes a Short Trading Week at a New High.","Summary":""},{"Date":"Dec. 27, 2021 at 10:20 p.m. ET","Headline":"CDC cuts recommended COVID-19 isolation time to 5 days if asymptomatic","Summary":""},{"Date":"Dec. 27, 2021 at 5:00 p.m. ET","Headline":"CDC halves recommended isolation period to 5 days from 10 for those who contract the coronavirus","Summary":""},{"Date":"Dec. 27, 2021 at 8:20 a.m. ET","Headline":"The FDA Has Braced for a Variant Like Omicron. Meet the Man Behind the Push.","Summary":""},{"Date":"Dec. 27, 2021 at 8:11 a.m. ET","Headline":"Omicron Is Wreaking Havoc. Why Investors Are Calm.","Summary":""},{"Date":"Dec. 26, 2021 at 4:35 p.m. ET","Headline":"New easy-to-use COVID-19 pills come with a catch","Summary":""},{"Date":"Dec. 26, 2021 at 2:16 p.m. ET","Headline":"Omicron\u2019s Surge Sparks New Wave of Restrictions in Europe","Summary":""},{"Date":"Dec. 29, 2021 at 4:26 p.m. ET","Headline":"Dow, S&P 500 end at records Wednesday as stocks rally in final week of 2021","Summary":""},{"Date":"Dec. 29, 2021 at 12:22 p.m. ET","Headline":"Some ETFs mix investing with charities \u2014 should you?","Summary":""},{"Date":"Dec. 29, 2021 at 10:52 a.m. ET","Headline":"Moderna and Other Vaccine Stocks Struggle to Shake Slump","Summary":""},{"Date":"Dec. 28, 2021 at 4:38 p.m. ET","Headline":"S&P 500 Falls From Record, Dow Extends Winning Streak\u2014and What Else Happened With the Stock Market Today","Summary":""},{"Date":"Dec. 28, 2021 at 11:25 a.m. ET","Headline":"The U.S. is rolling out Pfizer and Merck\u2019s COVID-19 antivirals to states but \u2018complex\u2019 manufacturing process may limit launch","Summary":""},{"Date":"Dec. 28, 2021 at 10:02 a.m. ET","Headline":"Moderna Stock Is Trying to End a Five-Day Losing Streak","Summary":""},{"Date":"Dec. 28, 2021 at 8:36 a.m. ET","Headline":"Covid Quarantine and Isolation Times Slashed as Worker Shortages Mount","Summary":""},{"Date":"Dec. 28, 2021 at 8:27 a.m. ET","Headline":"Scoping Out Bargains in Biotech? These 8 Stocks Trade for Less Than Their Cash.","Summary":""},{"Date":"Dec. 31, 2021 at 5:02 p.m. ET","Headline":"U.S. stocks end lower on New Year\u2019s Eve, but S&P 500, Dow, Nasdaq score big gains for 2021","Summary":"The U.K. Medicines and Healthcare products Regulatory Agency said it's approved Pfizer's  Paxlovid oral antiviral for people with mild to moderate COVID-19 and have at least one risk factor for developing severe illness. T..."},{"Date":"Dec. 31, 2021 at 12:02 p.m. ET","Headline":"Daily average of COVID hospitalizations rises above 80,000 for the first time in 3 months, while cases keep breaking daily records","Summary":"The U.K. Medicines and Healthcare products Regulatory Agency said it's approved Pfizer's  Paxlovid oral antiviral for people with mild to moderate COVID-19 and have at least one risk factor for developing severe illness. T..."},{"Date":"Dec. 31, 2021 at 11:26 a.m. ET","Headline":"U.K. Authorizes Pfizer\u2019s Antiviral Covid-19 Pill","Summary":"The U.K. Medicines and Healthcare products Regulatory Agency said it's approved Pfizer's  Paxlovid oral antiviral for people with mild to moderate COVID-19 and have at least one risk factor for developing severe illness. T..."},{"Date":"Dec. 31, 2021 at 7:18 a.m. ET","Headline":"These dividend-paying companies can help to fade big tech and play a broader economic recovery","Summary":"The U.K. Medicines and Healthcare products Regulatory Agency said it's approved Pfizer's  Paxlovid oral antiviral for people with mild to moderate COVID-19 and have at least one risk factor for developing severe illness. T..."},{"Date":"Dec. 31, 2021 at 6:41 a.m. ET","Headline":"U.K. approves Pfizer oral antiviral Paxlovid for COVID-19","Summary":"The U.K. Medicines and Healthcare products Regulatory Agency said it's approved Pfizer's  Paxlovid oral antiviral for people with mild to moderate COVID-19 and have at least one risk factor for developing severe illness. T..."},{"Date":"Dec. 31, 2021 at 4:06 a.m. ET","Headline":"Israel begins administering fourth coronavirus vaccine dose","Summary":""},{"Date":"Dec. 30, 2021 at 2:10 p.m. ET","Headline":"FDA Could Approve Covid Booster Shots for 12- to 15-Year-Olds Next Week","Summary":""},{"Date":"Dec. 30, 2021 at 6:30 a.m. ET","Headline":"The Great Supply-Chain Crisis Looks Like It Will Be a 2022 Story as Well","Summary":""},{"Date":"Dec. 17, 2021 at 7:42 p.m. ET","Headline":"Why a Wave of Mergers Next Year Could Lift Drug and Biotech Stocks","Summary":""},{"Date":"Jan. 2, 2022 at 10:37 a.m. ET","Headline":"Dr. Fauci and World Health Organization say omicron appears to be milder, but warn it\u2019s still early days","Summary":""},{"Date":"Jan. 1, 2022 at 1:11 p.m. ET","Headline":"As the S&P 500 hits records, keep an eye on these worrisome signals","Summary":""},{"Date":"Jan. 1, 2022 at 12:54 p.m. ET","Headline":"\u2018I thought that people would surely get vaccinated when threatened by actual illness. Nope.\u2019 Here\u2019s what else surprised people about the COVID-19 pandemic","Summary":""},{"Date":"Dec. 31, 2021 at 6:31 a.m. ET","Headline":"U.S. Covid Cases Hit Nearly 500,000 in New Daily Record","Summary":""},{"Date":"Jan. 4, 2022 at 12:11 p.m. ET","Headline":"Pfizer doubles sales of COVID-19 pill to U.S. government to 20 million treatment courses","Summary":"Pfizer Inc.  said it will sell an additional 10 million treatment courses of its  to the U.S. government this year. That doubles the total amount of courses contracted by the U.S. government to 20 million, with 10 million ..."},{"Date":"Jan. 4, 2022 at 10:09 a.m. ET","Headline":"Vaccine Stocks Tumble Even Though Covid-19 Cases Are Soaring","Summary":"Pfizer Inc.  and BioNTech SE  announced Monday that the U.S. Food and Drug Administration has granted Emergency Use Authorization of a booster dose of the companies' COVID-19 vaccine into people ages 12 years and older. Pr..."},{"Date":"Jan. 4, 2022 at 9:56 a.m. ET","Headline":"CDC Shortens Wait for Booster After Pfizer Doses, but No Action Yet on Boosters for Teens","Summary":"Pfizer Inc.  and BioNTech SE  announced Monday that the U.S. Food and Drug Administration has granted Emergency Use Authorization of a booster dose of the companies' COVID-19 vaccine into people ages 12 years and older. Pr..."},{"Date":"Jan. 4, 2022 at 9:07 a.m. ET","Headline":"Daily Covid Cases Top 1 Million in the U.S., Doubling the Previous Record","Summary":"Pfizer Inc.  and BioNTech SE  announced Monday that the U.S. Food and Drug Administration has granted Emergency Use Authorization of a booster dose of the companies' COVID-19 vaccine into people ages 12 years and older. Pr..."},{"Date":"Jan. 4, 2022 at 8:19 a.m. ET","Headline":"Following \u2018pushback,\u2019 Fauci says the CDC may require a negative COVID-19 test to end isolation","Summary":"Pfizer Inc.  and BioNTech SE  announced Monday that the U.S. Food and Drug Administration has granted Emergency Use Authorization of a booster dose of the companies' COVID-19 vaccine into people ages 12 years and older. Pr..."},{"Date":"Jan. 4, 2022 at 6:31 a.m. ET","Headline":"Apple\u2019s $3 Trillion Market Cap Is Still More Palatable Than Tesla\u2019s Valuation","Summary":"Pfizer Inc.  and BioNTech SE  announced Monday that the U.S. Food and Drug Administration has granted Emergency Use Authorization of a booster dose of the companies' COVID-19 vaccine into people ages 12 years and older. Pr..."},{"Date":"Jan. 3, 2022 at 5:03 p.m. ET","Headline":"Starbucks says employees must get COVID vaccine by Feb. 1 or get tested weekly","Summary":"Pfizer Inc.  and BioNTech SE  announced Monday that the U.S. Food and Drug Administration has granted Emergency Use Authorization of a booster dose of the companies' COVID-19 vaccine into people ages 12 years and older. Pr..."},{"Date":"Jan. 3, 2022 at 4:48 p.m. ET","Headline":"Dow, S&P 500 sweep to record closes in 2022\u2019s first session, while Nasdaq has biggest gain in a week","Summary":"Pfizer Inc.  and BioNTech SE  announced Monday that the U.S. Food and Drug Administration has granted Emergency Use Authorization of a booster dose of the companies' COVID-19 vaccine into people ages 12 years and older. Pr..."},{"Date":"Jan. 3, 2022 at 4:21 p.m. ET","Headline":"FDA Authorizes Boosters for Younger Teens as Omicron Spikes","Summary":"Pfizer Inc.  and BioNTech SE  announced Monday that the U.S. Food and Drug Administration has granted Emergency Use Authorization of a booster dose of the companies' COVID-19 vaccine into people ages 12 years and older. Pr..."},{"Date":"Jan. 3, 2022 at 10:02 a.m. ET","Headline":"Pfizer, BioNTech booster shot EUA expanded to include children 12 years old","Summary":"Pfizer Inc.  and BioNTech SE  announced Monday that the U.S. Food and Drug Administration has granted Emergency Use Authorization of a booster dose of the companies' COVID-19 vaccine into people ages 12 years and older. Pr..."},{"Date":"Jan. 3, 2022 at 7:53 a.m. ET","Headline":"Here Are Barron\u2019s Best Income Investments for the New Year","Summary":""},{"Date":"Jan. 6, 2022 at 11:15 a.m. ET","Headline":"This is the key support level for the S&P 500 \u2014 and it\u2019s not far from it","Summary":"Shares of Pfizer Inc.  rallied 2.5% in afternoon trading Wednesday, after BofA Securities analyst Geoff Meacham turned bullish on the drug maker, saying its COVID-19 pill Paxlovid could alleviate concerns over a \"cluster o..."},{"Date":"Jan. 6, 2022 at 10:05 a.m. ET","Headline":"Healthcare\u2019s Biggest Conference Is Next Week. What to Know.","Summary":"Shares of Pfizer Inc.  rallied 2.5% in afternoon trading Wednesday, after BofA Securities analyst Geoff Meacham turned bullish on the drug maker, saying its COVID-19 pill Paxlovid could alleviate concerns over a \"cluster o..."},{"Date":"Jan. 6, 2022 at 9:11 a.m. ET","Headline":"These Drug Companies Have Lots of Cash for Research and Product Buys","Summary":"Shares of Pfizer Inc.  rallied 2.5% in afternoon trading Wednesday, after BofA Securities analyst Geoff Meacham turned bullish on the drug maker, saying its COVID-19 pill Paxlovid could alleviate concerns over a \"cluster o..."},{"Date":"Jan. 6, 2022 at 7:33 a.m. ET","Headline":"The CDC sticks to new policy but tells people who want to test out of isolation after five days to use antigen tests","Summary":"Shares of Pfizer Inc.  rallied 2.5% in afternoon trading Wednesday, after BofA Securities analyst Geoff Meacham turned bullish on the drug maker, saying its COVID-19 pill Paxlovid could alleviate concerns over a \"cluster o..."},{"Date":"Jan. 6, 2022 at 7:23 a.m. ET","Headline":"The CDC Recommends Boosters for 12- to 15-Year-Olds. Here\u2019s What to Know.","Summary":"Shares of Pfizer Inc.  rallied 2.5% in afternoon trading Wednesday, after BofA Securities analyst Geoff Meacham turned bullish on the drug maker, saying its COVID-19 pill Paxlovid could alleviate concerns over a \"cluster o..."},{"Date":"Jan. 6, 2022 at 6:31 a.m. ET","Headline":"Fed Minutes Put Tech Bubble Under Pressure. Just Look at ARK\u2019s Flagship Fund.","Summary":"Shares of Pfizer Inc.  rallied 2.5% in afternoon trading Wednesday, after BofA Securities analyst Geoff Meacham turned bullish on the drug maker, saying its COVID-19 pill Paxlovid could alleviate concerns over a \"cluster o..."},{"Date":"Jan. 6, 2022 at 6:20 a.m. ET","Headline":"Covid Roundup: CDC Recommends Boosters for Kids 12 and Up, Hospitalizations for Children Rise","Summary":"Shares of Pfizer Inc.  rallied 2.5% in afternoon trading Wednesday, after BofA Securities analyst Geoff Meacham turned bullish on the drug maker, saying its COVID-19 pill Paxlovid could alleviate concerns over a \"cluster o..."},{"Date":"Jan. 5, 2022 at 9:00 p.m. ET","Headline":"CDC now urges everyone 12 and older to get Pfizer\u2019s COVID booster","Summary":"Shares of Pfizer Inc.  rallied 2.5% in afternoon trading Wednesday, after BofA Securities analyst Geoff Meacham turned bullish on the drug maker, saying its COVID-19 pill Paxlovid could alleviate concerns over a \"cluster o..."},{"Date":"Jan. 5, 2022 at 4:42 p.m. ET","Headline":"Stocks Tumble as Fed Minutes Confirm Rate Hikes Are Coming","Summary":"Shares of Pfizer Inc.  rallied 2.5% in afternoon trading Wednesday, after BofA Securities analyst Geoff Meacham turned bullish on the drug maker, saying its COVID-19 pill Paxlovid could alleviate concerns over a \"cluster o..."},{"Date":"Jan. 5, 2022 at 1:52 p.m. ET","Headline":"Pfizer upgraded to buy at BofA as Paxlovid likely to offset patent expiration concerns","Summary":"Shares of Pfizer Inc.  rallied 2.5% in afternoon trading Wednesday, after BofA Securities analyst Geoff Meacham turned bullish on the drug maker, saying its COVID-19 pill Paxlovid could alleviate concerns over a \"cluster o..."},{"Date":"Jan. 5, 2022 at 9:03 a.m. ET","Headline":"Wall Street is looking at Fed and the virus the wrong way, analyst says","Summary":"Shares of Pfizer Inc.  rose 1.6% in premarket trading Wednesday and BioNTech SE  gained 0.9%, after the drug makers said they will collaborate in developing a potential first mRNA-based shingles vaccine. The companies said..."},{"Date":"Jan. 5, 2022 at 8:19 a.m. ET","Headline":"These Are the Worst Income Investments for the New Year","Summary":"Shares of Pfizer Inc.  rose 1.6% in premarket trading Wednesday and BioNTech SE  gained 0.9%, after the drug makers said they will collaborate in developing a potential first mRNA-based shingles vaccine. The companies said..."},{"Date":"Jan. 5, 2022 at 7:13 a.m. ET","Headline":"Happy new year? Drug prices rising as 2022 begins","Summary":"Shares of Pfizer Inc.  rose 1.6% in premarket trading Wednesday and BioNTech SE  gained 0.9%, after the drug makers said they will collaborate in developing a potential first mRNA-based shingles vaccine. The companies said..."},{"Date":"Jan. 5, 2022 at 6:56 a.m. ET","Headline":"Pfizer, BioNTech to collaborate in developing mRNA-based shingles vaccine","Summary":"Shares of Pfizer Inc.  rose 1.6% in premarket trading Wednesday and BioNTech SE  gained 0.9%, after the drug makers said they will collaborate in developing a potential first mRNA-based shingles vaccine. The companies said..."},{"Date":"Jan. 5, 2022 at 6:41 a.m. ET","Headline":"The Auto Sector Is Electrified as GM, Ford, and Sony Join Tesla\u2019s Party","Summary":""},{"Date":"Jan. 8, 2022 at 10:35 a.m. ET","Headline":"Former Biden advisers lay out a new strategy to address endemic COVID-19","Summary":"The Food and Drug Administration said Friday that adults who have been vaccinated with Moderna Inc.'s  COVID-19 vaccine can get a booster dose five months after completing the primary series of shots. The previous recommen..."},{"Date":"Jan. 7, 2022 at 2:36 p.m. ET","Headline":"Child-Hospitalization Rates Highest of Covid Pandemic, CDC Director Says","Summary":"The Food and Drug Administration said Friday that adults who have been vaccinated with Moderna Inc.'s  COVID-19 vaccine can get a booster dose five months after completing the primary series of shots. The previous recommen..."},{"Date":"Jan. 7, 2022 at 12:52 p.m. ET","Headline":"Value has beaten growth by a huge margin \u2014 these are now top investment newsletters\u2019 best value-stock picks","Summary":"The Food and Drug Administration said Friday that adults who have been vaccinated with Moderna Inc.'s  COVID-19 vaccine can get a booster dose five months after completing the primary series of shots. The previous recommen..."},{"Date":"Jan. 7, 2022 at 10:41 a.m. ET","Headline":"FDA says adults can now get Moderna's COVID-19 booster five months after getting the first two shots","Summary":"The Food and Drug Administration said Friday that adults who have been vaccinated with Moderna Inc.'s  COVID-19 vaccine can get a booster dose five months after completing the primary series of shots. The previous recommen..."},{"Date":"Jan. 7, 2022 at 9:26 a.m. ET","Headline":"FDA Shortens Waiting Period for Moderna Covid Booster Shot to 5 Months","Summary":""},{"Date":"Jan. 7, 2022 at 9:19 a.m. ET","Headline":"Could the U.S. See a Fourth Covid-19 Vaccine Dose? Moderna, Pfizer Say Yes.","Summary":""},{"Date":"Jan. 7, 2022 at 8:52 a.m. ET","Headline":"Covid Cases Are Still Rising. Here\u2019s When They Could Peak.","Summary":""},{"Date":"Jan. 10, 2022 at 12:14 p.m. ET","Headline":"This \u2018cash cow\u2019 value-stock strategy can fatten your portfolio even if you fear the Fed","Summary":"Shares of Pfizer Inc.  gained 0.2% in premarket trading on Monday after the company announced a deal with Beam Therapeutics Inc.  worth up to $1.3 billion. Beam's stock was up 4.9% before the market opened. As part of the ..."},{"Date":"Jan. 10, 2022 at 10:48 a.m. ET","Headline":"Moderna CEO Resets Flu-Vaccine Expectations","Summary":"Shares of Pfizer Inc.  gained 0.2% in premarket trading on Monday after the company announced a deal with Beam Therapeutics Inc.  worth up to $1.3 billion. Beam's stock was up 4.9% before the market opened. As part of the ..."},{"Date":"Jan. 10, 2022 at 8:34 a.m. ET","Headline":"Lots of Deals, but No Blockbuster M&A, to Start Year\u2019s Biggest Healthcare Conference","Summary":"Shares of Pfizer Inc.  gained 0.2% in premarket trading on Monday after the company announced a deal with Beam Therapeutics Inc.  worth up to $1.3 billion. Beam's stock was up 4.9% before the market opened. As part of the ..."},{"Date":"Jan. 10, 2022 at 8:17 a.m. ET","Headline":"Pfizer and Beam Partner to Develop Treatments for 3 Genetic Diseases","Summary":"Shares of Pfizer Inc.  gained 0.2% in premarket trading on Monday after the company announced a deal with Beam Therapeutics Inc.  worth up to $1.3 billion. Beam's stock was up 4.9% before the market opened. As part of the ..."},{"Date":"Jan. 10, 2022 at 8:05 a.m. ET","Headline":"Covid Wave Likely Peaking on East Coast: Former FDA Commissioner","Summary":"Shares of Pfizer Inc.  gained 0.2% in premarket trading on Monday after the company announced a deal with Beam Therapeutics Inc.  worth up to $1.3 billion. Beam's stock was up 4.9% before the market opened. As part of the ..."},{"Date":"Jan. 10, 2022 at 7:44 a.m. ET","Headline":"Pfizer announces deal worth up to $1.3 billion with Beam; Beam's stock is up 4.9%","Summary":"Shares of Pfizer Inc.  gained 0.2% in premarket trading on Monday after the company announced a deal with Beam Therapeutics Inc.  worth up to $1.3 billion. Beam's stock was up 4.9% before the market opened. As part of the ..."},{"Date":"Jan. 10, 2022 at 6:45 a.m. ET","Headline":"Bond Yields Keep Rising. Goldman Sachs Now Sees 4 Rate Hikes in 2022.","Summary":""},{"Date":"Jan. 10, 2022 at 5:08 a.m. ET","Headline":"Novak Djokovic Reacts to Australian Court Win, FedEx Warns Omicron Hitting Staff","Summary":""},{"Date":"Jan. 8, 2022 at 1:17 p.m. ET","Headline":"Deere Goes Autonomous With Its Farmer-Free Tractor","Summary":""},{"Date":"Jan. 12, 2022 at 4:40 p.m. ET","Headline":"Dow, S&P 500 end second straight day higher as investors take inflation near 40-year high in stride","Summary":"Shares of Pfizer Inc.  were down 0.1% in premarket trading on Wednesday after the company said administering the Prevnar 20 pneumococcal disease shot at the same time as the COVID-19 vaccine and booster it developed with B..."},{"Date":"Jan. 12, 2022 at 7:29 a.m. ET","Headline":"Pfizer says its safe and effective to co-administer its Prevnar 20, COVID-19 shots","Summary":"Shares of Pfizer Inc.  were down 0.1% in premarket trading on Wednesday after the company said administering the Prevnar 20 pneumococcal disease shot at the same time as the COVID-19 vaccine and booster it developed with B..."},{"Date":"Jan. 12, 2022 at 6:49 a.m. ET","Headline":"Powell Said All the Right Things. But Inflation Has a Mind of Its Own.","Summary":"The number of Americans who are currently in hospitals with COVID-19 climbed to 142,388 on Sunday to exceed the peak of 142,315 reached last winter,  citing government data, highlighting the speed with which the highly tra..."},{"Date":"Jan. 12, 2022 at 6:04 a.m. ET","Headline":"China Blocks Some U.S. Flights After Passengers Get Covid-19, S. Korea OKs Novavax Vaccine","Summary":"The number of Americans who are currently in hospitals with COVID-19 climbed to 142,388 on Sunday to exceed the peak of 142,315 reached last winter,  citing government data, highlighting the speed with which the highly tra..."},{"Date":"Jan. 11, 2022 at 5:55 p.m. ET","Headline":"Pope Francis labels getting vaccinated a \u2018moral obligation\u2019","Summary":"The number of Americans who are currently in hospitals with COVID-19 climbed to 142,388 on Sunday to exceed the peak of 142,315 reached last winter,  citing government data, highlighting the speed with which the highly tra..."},{"Date":"Jan. 11, 2022 at 4:40 p.m. ET","Headline":"More Americans are in hospital with COVID-19 than in last winter peak, and WHO warns more than half of Europe could be infected by omicron within weeks","Summary":"The number of Americans who are currently in hospitals with COVID-19 climbed to 142,388 on Sunday to exceed the peak of 142,315 reached last winter,  citing government data, highlighting the speed with which the highly tra..."},{"Date":"Jan. 11, 2022 at 2:46 p.m. ET","Headline":"The Gene-Editing Industry Weighs In on Outlook at J.P. Morgan Conference","Summary":"The number of Americans who are currently in hospitals with COVID-19 climbed to 142,388 on Sunday to exceed the peak of 142,315 reached last winter,  citing government data, highlighting the speed with which the highly tra..."},{"Date":"Jan. 11, 2022 at 1:16 p.m. ET","Headline":"Stocks Needed a Little Boost From Powell. They Got It\u2014and Shot Up.","Summary":"The number of Americans who are currently in hospitals with COVID-19 climbed to 142,388 on Sunday to exceed the peak of 142,315 reached last winter,  citing government data, highlighting the speed with which the highly tra..."},{"Date":"Jan. 11, 2022 at 10:14 a.m. ET","Headline":"Covid Hospitalizations Hit a Record High. Pfizer\u2019s Omicron Vaccine Will Be Ready by March.","Summary":"The number of Americans who are currently in hospitals with COVID-19 climbed to 142,388 on Sunday to exceed the peak of 142,315 reached last winter,  citing government data, highlighting the speed with which the highly tra..."},{"Date":"Jan. 11, 2022 at 9:02 a.m. ET","Headline":"Vir Stock Jumps as U.S. Buys 600,000 More Glaxo Covid Antibody Doses","Summary":"The number of Americans who are currently in hospitals with COVID-19 climbed to 142,388 on Sunday to exceed the peak of 142,315 reached last winter,  citing government data, highlighting the speed with which the highly tra..."},{"Date":"Jan. 11, 2022 at 7:25 a.m. ET","Headline":"Coronavirus tally: U.S. hospitalizations exceed last winter's peak as omicron continues to spread rapidly","Summary":"The number of Americans who are currently in hospitals with COVID-19 climbed to 142,388 on Sunday to exceed the peak of 142,315 reached last winter,  citing government data, highlighting the speed with which the highly tra..."},{"Date":"Jan. 11, 2022 at 7:16 a.m. ET","Headline":"Here are dozens of \u2018cheap\u2019 stocks that could be poised to outperform as U.S. rates start to rise","Summary":""},{"Date":"Jan. 11, 2022 at 6:47 a.m. ET","Headline":"Powell\u2019s Senate Hearing Holds the Key for Markets. Expect the Unexpected.","Summary":""},{"Date":"Jan. 11, 2022 at 5:37 a.m. ET","Headline":"Pfizer plans to ready hybrid shot to protect against omicron by March, says CEO Bourla","Summary":""},{"Date":"Jan. 14, 2022 at 7:30 p.m. ET","Headline":"Las Vegas Sands Stock Could See Better Luck Ahead","Summary":""},{"Date":"Jan. 14, 2022 at 4:27 p.m. ET","Headline":"The Dow Slipped as Big Banks Reported Earnings, Dogecoin Soared\u2014and What Else Happened in the Stock Market Today","Summary":""},{"Date":"Jan. 14, 2022 at 1:39 p.m. ET","Headline":"Moderna, Novavax, and Other Vaccine Stocks Get Whacked by Supreme Court\u2019s Vaccine Decision","Summary":""},{"Date":"Jan. 14, 2022 at 2:35 a.m. ET","Headline":"Asian shares pressured following Wall Street retreat","Summary":""},{"Date":"Jan. 13, 2022 at 5:43 p.m. ET","Headline":"Barron\u2019s Stock Picks Fell Short in 2021\u2014Even With a Bunch of Winners","Summary":""},{"Date":"Jan. 13, 2022 at 11:12 a.m. ET","Headline":"Here\u2019s why you shouldn\u2019t be spooked by the S&P 500\u2019s pullback","Summary":""},{"Date":"Jan. 13, 2022 at 8:01 a.m. ET","Headline":"A Booster Vaccine Red Flag: Getting Too Many Could Backfire","Summary":""},{"Date":"Jan. 16, 2022 at 10:38 a.m. ET","Headline":"People of color have been less likely than their white counterparts to get a COVID-19 vaccine \u2014 but that is finally changing","Summary":""},{"Date":"Jan. 15, 2022 at 1:30 p.m. ET","Headline":"Unilever Strikes Out in Effort to Buy GlaxoSmithKline Consumer Health Business\u2014at Least So Far","Summary":""},{"Date":"Jan. 18, 2022 at 10:06 a.m. ET","Headline":"Brace for a volatile 2022, but cling to this tech stalwart when the storm comes, says investment adviser","Summary":""},{"Date":"Jan. 18, 2022 at 8:37 a.m. ET","Headline":"Fourth Covid Shot Is Not Enough to Stop Omicron, Study Finds","Summary":""},{"Date":"Jan. 18, 2022 at 2:03 a.m. ET","Headline":"Preliminary Israeli study shows fourth COVID booster doesn\u2019t stop omicron infections","Summary":""},{"Date":"Jan. 17, 2022 at 9:55 a.m. ET","Headline":"Unilever\u2019s Bid for Glaxo\u2019s Consumer Assets\u2014the Deal That No One Likes","Summary":""},{"Date":"Jan. 17, 2022 at 9:04 a.m. ET","Headline":"Moderna Targets Fall 2023 for Covid-Flu Combo Vaccine","Summary":""},{"Date":"Jan. 17, 2022 at 7:45 a.m. ET","Headline":"Pfizer Announces Fresh Investment to Tackle Covid in France","Summary":""},{"Date":"Jan. 17, 2022 at 4:09 a.m. ET","Headline":"GlaxoSmithKline shares soar \nafter Unilever bids for its consumer healthcare unit","Summary":""},{"Date":"Jan. 17, 2022 at 4:00 a.m. ET","Headline":"Sanofi CEO Says Vaccine Incumbents Will Win the Coming Showdown","Summary":""},{"Date":"Jan. 20, 2022 at 11:22 a.m. ET","Headline":"This is the next big test for the S&P 500 as a number of indicators flash \u2018oversold\u2019","Summary":"The National Institutes of Health on Wednesday updated its  for patients with mild to moderate forms of COVID-19 who are at high risk for disease progression. The new guidelines now include the recently authorized antivira..."},{"Date":"Jan. 20, 2022 at 8:42 a.m. ET","Headline":"NIH says Pfizer's Paxloid should be first treatment option for certain COVID-19 patients","Summary":"The National Institutes of Health on Wednesday updated its  for patients with mild to moderate forms of COVID-19 who are at high risk for disease progression. The new guidelines now include the recently authorized antivira..."},{"Date":"Jan. 20, 2022 at 6:35 a.m. ET","Headline":"Nasdaq Enters Correction Territory. Will Earnings Stop the Rot?","Summary":""},{"Date":"Jan. 19, 2022 at 11:13 a.m. ET","Headline":"GSK Loses R&D Chief Hal Barron Ahead of Historic Split","Summary":""},{"Date":"Jan. 19, 2022 at 8:05 a.m. ET","Headline":"Mergers Are Booming. U.S. Regulators Are Gearing Up to Crack Down on Them.","Summary":""},{"Date":"Jan. 19, 2022 at 7:57 a.m. ET","Headline":"Omicron cases seem to have peaked in northeastern states, but national case tally remains at record levels and hospitals are slammed","Summary":""},{"Date":"Jan. 19, 2022 at 6:48 a.m. ET","Headline":"The Microsoft-Activision Deal Is Far From Done. The Winners and Losers Are Already Emerging.","Summary":""},{"Date":"Jan. 19, 2022 at 6:36 a.m. ET","Headline":"Free N95 masks to be made available at U.S. pharmacies, White House says","Summary":""},{"Date":"Jan. 19, 2022 at 6:00 a.m. ET","Headline":"Stocks still look attractive even with the Fed tightening","Summary":""},{"Date":"Aug. 9, 2021 at 7:33 a.m. ET","Headline":"I traveled overseas as the delta variant of COVID-19 surged. Here\u2019s what I wish I knew before my trip","Summary":""},{"Date":"Jan. 21, 2022 at 7:24 p.m. ET","Headline":"Winter Chill and Geopolitical Uncertainties Makes This a World Fit for LNG","Summary":""},{"Date":"Jan. 21, 2022 at 12:54 p.m. ET","Headline":"Booster Doses Reduce Hospitalizations From Omicron, CDC Says","Summary":""},{"Date":"Jan. 21, 2022 at 6:19 a.m. ET","Headline":"South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing","Summary":""},{"Date":"Jan. 20, 2022 at 9:13 a.m. ET","Headline":"Unilever Stock Rises After $68 Billion Bid for Glaxo\u2019s Consumer Arm Is Abandoned","Summary":""},{"Date":"Jan. 24, 2022 at 6:32 p.m. ET","Headline":"We should double down on COVID-10 treatments for those at high risk instead of pushing boosters and tests for everyone","Summary":""},{"Date":"Jan. 24, 2022 at 6:04 p.m. ET","Headline":"FDA halts use of antibody drugs that don\u2019t work against omicron","Summary":""},{"Date":"Jan. 24, 2022 at 9:49 a.m. ET","Headline":"AbbVie to Face Humira Competition From Biosimilars. Here\u2019s What Could Happen.","Summary":""},{"Date":"Jan. 24, 2022 at 8:14 a.m. ET","Headline":"Pfizer, Opko Stock Fall After FDA Declines to Approve Somatrogon","Summary":""},{"Date":"Jan. 24, 2022 at 8:10 a.m. ET","Headline":"Johnson & Johnson\u2019s got a new CEO and a plan to split the company in two. Here\u2019s what else to expect out of J&J\u2019s earnings","Summary":""},{"Date":"Jan. 24, 2022 at 6:56 a.m. ET","Headline":"Bitcoin Slumps Again. It Isn\u2019t Just the Fed Putting Crypto Prices at Risk.","Summary":""},{"Date":"Jan. 24, 2022 at 4:00 a.m. ET","Headline":"Investors Can Change The Course of This Pandemic","Summary":""},{"Date":"Jan. 26, 2022 at 5:39 p.m. ET","Headline":"Moderna begins testing omicron-specific COVID-19 vaccine in adults","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Tuesday they are launching a trial to evaluate an omicron-based COVID-19 vaccine in healthy adults aged 18 to 55. \"While current research and real-world data show that boos..."},{"Date":"Jan. 26, 2022 at 5:05 p.m. ET","Headline":"Moderna Starts Testing Its Own Omicron-Specific Booster","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Tuesday they are launching a trial to evaluate an omicron-based COVID-19 vaccine in healthy adults aged 18 to 55. \"While current research and real-world data show that boos..."},{"Date":"Jan. 26, 2022 at 9:01 a.m. ET","Headline":"Covid-19 Deaths in U.S. Hit Highest Level in Nearly a Year","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Tuesday they are launching a trial to evaluate an omicron-based COVID-19 vaccine in healthy adults aged 18 to 55. \"While current research and real-world data show that boos..."},{"Date":"Jan. 25, 2022 at 2:54 p.m. ET","Headline":"Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Tuesday they are launching a trial to evaluate an omicron-based COVID-19 vaccine in healthy adults aged 18 to 55. \"While current research and real-world data show that boos..."},{"Date":"Jan. 25, 2022 at 10:10 a.m. ET","Headline":"How Omicron Is Changing Vaccine and Therapeutic Strategies","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Tuesday they are launching a trial to evaluate an omicron-based COVID-19 vaccine in healthy adults aged 18 to 55. \"While current research and real-world data show that boos..."},{"Date":"Jan. 25, 2022 at 9:37 a.m. ET","Headline":"These five signals will tell you when the Wall Street correction is over, says veteran strategist","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Tuesday they are launching a trial to evaluate an omicron-based COVID-19 vaccine in healthy adults aged 18 to 55. \"While current research and real-world data show that boos..."},{"Date":"Jan. 25, 2022 at 8:18 a.m. ET","Headline":"10 Cheap Stocks for Volatile Markets","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Tuesday they are launching a trial to evaluate an omicron-based COVID-19 vaccine in healthy adults aged 18 to 55. \"While current research and real-world data show that boos..."},{"Date":"Jan. 25, 2022 at 7:00 a.m. ET","Headline":"Pfizer and BioNTech launch study to evaluate omicron-based COVID-19 vaccine for adults 18 to 55 years old","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Tuesday they are launching a trial to evaluate an omicron-based COVID-19 vaccine in healthy adults aged 18 to 55. \"While current research and real-world data show that boos..."},{"Date":"Jan. 28, 2022 at 10:50 a.m. ET","Headline":"Moderna Faces Challenges Beyond the Covid Vaccine. Its Stock Is Still a Buy.","Summary":"Moderna  has begun testing an omicron-specific COVID-19 booster in healthy adults, following in the wake of a study announced earlier this week by Pfizer  and German partner BioNTech , The original vaccines still offer goo..."},{"Date":"Jan. 28, 2022 at 4:15 a.m. ET","Headline":"Wild in the Street: When Retail Investors Invade the Market","Summary":"Moderna  has begun testing an omicron-specific COVID-19 booster in healthy adults, following in the wake of a study announced earlier this week by Pfizer  and German partner BioNTech , The original vaccines still offer goo..."},{"Date":"Jan. 27, 2022 at 2:45 p.m. ET","Headline":"U.S. daily COVID case tally now falling and hospitalizations seem to be peaking, as Moderna launches trial of omicron-specific booster","Summary":"Moderna  has begun testing an omicron-specific COVID-19 booster in healthy adults, following in the wake of a study announced earlier this week by Pfizer  and German partner BioNTech , The original vaccines still offer goo..."},{"Date":"Jan. 27, 2022 at 10:48 a.m. ET","Headline":"Remember this important stock-market lesson: Oversold does not mean buy","Summary":"Moderna  has begun testing an omicron-specific COVID-19 booster in healthy adults, following in the wake of a study announced earlier this week by Pfizer  and German partner BioNTech , The original vaccines still offer goo..."},{"Date":"Jan. 27, 2022 at 7:01 a.m. ET","Headline":"Coronavirus tally: Moderna starts to test an omicron-specific COVID vaccine booster in health adults","Summary":"Moderna  has begun testing an omicron-specific COVID-19 booster in healthy adults, following in the wake of a study announced earlier this week by Pfizer  and German partner BioNTech , The original vaccines still offer goo..."},{"Date":"Jan. 26, 2022 at 6:33 a.m. ET","Headline":"Fed Day Is Here as Volatility Hits Fever Pitch. What to Watch.","Summary":""},{"Date":"Jan. 23, 2022 at 11:01 a.m. ET","Headline":"It\u2019s Time to Bargain Hunt. 27 Picks to Beat the Stock Market From Barron\u2019s Roundtable Experts.","Summary":""},{"Date":"Jan. 20, 2022 at 7:59 a.m. ET","Headline":"Citi Asks London Staff to Return to Office 3 Days a Week","Summary":""},{"Date":"Jan. 19, 2022 at 7:25 a.m. ET","Headline":"Biden to Give Away 400 Million N95 Masks Next Week","Summary":""},{"Date":"Jan. 30, 2022 at 7:29 p.m. ET","Headline":"How Low Can Bitcoin Go? The Views Vary.","Summary":""},{"Date":"Feb. 1, 2022 at 8:46 p.m. ET","Headline":"Gilead earnings slammed by legal settlement, stock falls","Summary":"Federal regulators are expected to be asked as soon as Tuesday to authorize Pfizer's  COVID-19 vaccine for children as young as 6 months old, and the first shots could come by the end of February, according to news reports..."},{"Date":"Feb. 1, 2022 at 4:59 p.m. ET","Headline":"Pfizer asks FDA to OK COVID vaccines for children under 5","Summary":"Federal regulators are expected to be asked as soon as Tuesday to authorize Pfizer's  COVID-19 vaccine for children as young as 6 months old, and the first shots could come by the end of February, according to news reports..."},{"Date":"Feb. 1, 2022 at 8:35 a.m. ET","Headline":"CDC data confirm boosters offer high level of protection against severe COVID, bolster case for unvaccinated to get their shots","Summary":"Federal regulators are expected to be asked as soon as Tuesday to authorize Pfizer's  COVID-19 vaccine for children as young as 6 months old, and the first shots could come by the end of February, according to news reports..."},{"Date":"Feb. 1, 2022 at 8:27 a.m. ET","Headline":"Pfizer Expected to Ask FDA to Approve Covid Vaccine for Kids Under 5","Summary":"Federal regulators are expected to be asked as soon as Tuesday to authorize Pfizer's  COVID-19 vaccine for children as young as 6 months old, and the first shots could come by the end of February, according to news reports..."},{"Date":"Feb. 1, 2022 at 7:37 a.m. ET","Headline":"Coronavirus tally: Pfizer and BioNTech expects to seek EUA for COVID vaccine in children as young as six months later Tuesday","Summary":"Federal regulators are expected to be asked as soon as Tuesday to authorize Pfizer's  COVID-19 vaccine for children as young as 6 months old, and the first shots could come by the end of February, according to news reports..."},{"Date":"Jan. 31, 2022 at 10:38 p.m. ET","Headline":"Pfizer may seek FDA\u2019s OK for COVID vaccine for kids under 5 as soon as Tuesday: reports","Summary":"Shares of Novavax Inc.  rallied 10.0% in trading on Monday after the company said it filed for authorization of its experimental COVID-19 shot in the U.S. Novavax's COVID-19 vaccine candidate is protein-based, meaning it's..."},{"Date":"Jan. 31, 2022 at 2:06 p.m. ET","Headline":"Novavax asks the FDA to authorize its COVID-19 vaccine candidate","Summary":"Shares of Novavax Inc.  rallied 10.0% in trading on Monday after the company said it filed for authorization of its experimental COVID-19 shot in the U.S. Novavax's COVID-19 vaccine candidate is protein-based, meaning it's..."},{"Date":"Jan. 31, 2022 at 11:59 a.m. ET","Headline":"FDA Approves Moderna\u2019s Covid-19 Vaccine","Summary":"Shares of Moderna Inc.  gained 3.4% in trading on Monday after the company said it received full approval from the Food and Drug Administration for its COVID-19 vaccine, which is now called Spikevax. The FDA has granted fu..."},{"Date":"Jan. 31, 2022 at 11:16 a.m. ET","Headline":"FDA grants full approval to Moderna's COVID-19 vaccine","Summary":"Shares of Moderna Inc.  gained 3.4% in trading on Monday after the company said it received full approval from the Food and Drug Administration for its COVID-19 vaccine, which is now called Spikevax. The FDA has granted fu..."},{"Date":"Jan. 31, 2022 at 8:00 a.m. ET","Headline":"Biotech stocks had a challenging year, but that doesn\u2019t mean they\u2019re \u2018necessarily on sale,\u2019 J&J exec tells investors","Summary":"Shares of Ionis Pharmaceuticals Inc.  fell 7.9% in premarket trading on Monday after the company and Pfizer Inc.  said they discontinued a program testing an experimental treatment for cardiovascular risk reduction and sev..."},{"Date":"Jan. 31, 2022 at 7:41 a.m. ET","Headline":"Ionis, Pfizer scrap plans for experimental cardiovascular drug","Summary":"Shares of Ionis Pharmaceuticals Inc.  fell 7.9% in premarket trading on Monday after the company and Pfizer Inc.  said they discontinued a program testing an experimental treatment for cardiovascular risk reduction and sev..."},{"Date":"Jan. 31, 2022 at 6:43 a.m. ET","Headline":"U.S. Stocks Had a Terrible January. History Offers Plenty of Comfort.","Summary":""},{"Date":"Feb. 3, 2022 at 11:05 a.m. ET","Headline":"Stay cautious about the S&P 500\u2019s \u2018monster oversold rally\u2019","Summary":""},{"Date":"Feb. 3, 2022 at 10:53 a.m. ET","Headline":"Merck\u2019s Earnings Guidance for 2022 Misses Estimates. The Stock Is Falling.","Summary":""},{"Date":"Feb. 2, 2022 at 2:22 p.m. ET","Headline":"U.S. COVID death toll tops fall peak and is higher than in other wealthy countries, as global deaths climb 9% in latest week","Summary":""},{"Date":"Feb. 2, 2022 at 10:56 a.m. ET","Headline":"How to Revive the Dow? Adding Nvidia, Berkshire, and Alphabet Would Help.","Summary":""},{"Date":"Feb. 2, 2022 at 6:46 a.m. ET","Headline":"Alphabet Stock Is Taking Off. The Tech Comeback Is On.","Summary":""},{"Date":"Feb. 2, 2022 at 6:18 a.m. ET","Headline":"Pfizer seeks FDA nod for vaccine for children as young as 6 months, and latest studies find omicron may not protect against future infection","Summary":""},{"Date":"Feb. 2, 2022 at 3:45 a.m. ET","Headline":"Why Anti-Vaxxers Could Help Boost Earnings for Pfizer","Summary":""},{"Date":"Feb. 1, 2022 at 5:32 p.m. ET","Headline":"Pfizer and BioNTech Seek Authorization of Covid Vaccine for Children Under 5","Summary":""},{"Date":"Feb. 4, 2022 at 8:37 p.m. ET","Headline":"Why Alphabet, Nvidia, and Others Belong in the Dow Jones Industrials","Summary":""},{"Date":"Feb. 7, 2022 at 5:46 p.m. ET","Headline":"Stocks Start Week Mixed. Tech Stocks Couldn\u2019t Hold On to Gains","Summary":""},{"Date":"Feb. 7, 2022 at 9:49 a.m. ET","Headline":"Crypto is like hydrogen, this JPMorgan strategist says, with valuations in both ahead of reality","Summary":""},{"Date":"Feb. 7, 2022 at 8:36 a.m. ET","Headline":"Time to Lift Covid Restrictions? Some Public Health Experts Call for a Pullback Soon.","Summary":""},{"Date":"Feb. 7, 2022 at 8:34 a.m. ET","Headline":"Disney, Chipotle, Pfizer, Twitter, and Other Stocks to Watch This Week","Summary":""},{"Date":"Feb. 7, 2022 at 8:25 a.m. ET","Headline":"With Omicron Waning, Americans Are Ready for the Reopening","Summary":""},{"Date":"Feb. 7, 2022 at 6:51 a.m. ET","Headline":"Four drug makers raked in $14 billion in sales of COVID-19 treatments in 2021. How will they do this year?","Summary":""},{"Date":"Feb. 7, 2022 at 6:50 a.m. ET","Headline":"The Big Tech Show May Be Over. But Volatility Is Not.","Summary":""},{"Date":"Feb. 6, 2022 at 11:11 a.m. ET","Headline":"Most parents say they won\u2019t get their children under 5 vaccinated against COVID-19 when it\u2019s available \u2014 here\u2019s why","Summary":""},{"Date":"Feb. 4, 2022 at 4:30 a.m. ET","Headline":"The FDA\u2019s Crisis Powers Need a Reset","Summary":""},{"Date":"Feb. 9, 2022 at 9:52 a.m. ET","Headline":"Pfizer Stock Is Falling. Did Investors Misunderstand the Revenue Guidance?","Summary":"U.S. stocks posted strong gains on Tuesday, with the Dow industrials clinching their best session in over a week,"},{"Date":"Feb. 9, 2022 at 8:39 a.m. ET","Headline":"Moderna and Novavax Stocks Rebound After Slumping on Pfizer\u2019s Outlook","Summary":"U.S. stocks posted strong gains on Tuesday, with the Dow industrials clinching their best session in over a week,"},{"Date":"Feb. 9, 2022 at 8:15 a.m. ET","Headline":"At least 5 states plan to ease face-mask mandates against advice of CDC, as U.S. daily death toll hovers close to 2,600","Summary":"U.S. stocks posted strong gains on Tuesday, with the Dow industrials clinching their best session in over a week,"},{"Date":"Feb. 9, 2022 at 8:14 a.m. ET","Headline":"Glaxo Expects Profit to Rise as Drugmaker Readies for Split","Summary":"U.S. stocks posted strong gains on Tuesday, with the Dow industrials clinching their best session in over a week,"},{"Date":"Feb. 9, 2022 at 6:49 a.m. ET","Headline":"Chipotle\u2019s Earnings May Be Too Hot for the Fed to Handle","Summary":"U.S. stocks posted strong gains on Tuesday, with the Dow industrials clinching their best session in over a week,"},{"Date":"Feb. 8, 2022 at 4:42 p.m. ET","Headline":"Stock market ends solidly higher as strong earnings support buying, despite rising Treasury yields","Summary":"U.S. stocks posted strong gains on Tuesday, with the Dow industrials clinching their best session in over a week,"},{"Date":"Feb. 8, 2022 at 4:16 p.m. ET","Headline":"Dow industrials post best day in over a week and broader stock market rallies despite 10-year\u2019s rise near 2%","Summary":"U.S. stocks posted strong gains on Tuesday, with the Dow industrials clinching their best session in over a week,"},{"Date":"Feb. 8, 2022 at 10:36 a.m. ET","Headline":"Novavax Stock Tumbles on Report That Vaccine Deliveries Are Lagging","Summary":"U.S. stocks trade Tuesday mixed, with the Dow industrials rising on the back of early moves in Amgen Inc. and Goldman Sachs."},{"Date":"Feb. 8, 2022 at 9:48 a.m. ET","Headline":"Dow climbs 110 points, but broader stock market wavers Tuesday as 10-year yield nears 2%","Summary":"U.S. stocks trade Tuesday mixed, with the Dow industrials rising on the back of early moves in Amgen Inc. and Goldman Sachs."},{"Date":"Feb. 8, 2022 at 9:27 a.m. ET","Headline":"Pregnant women who contract COVID-19 are more likely to develop serious complications","Summary":"Shares of Pfizer Inc.  sank 2.6% in premarket trading Tuesday, after the drug maker reported fourth-quarter profit that beat expectations, while revenue more than doubled but missed forecasts. The company also provided a f..."},{"Date":"Feb. 8, 2022 at 8:26 a.m. ET","Headline":"Pfizer Stock Drops After Earnings. Guidance Fell Short of Estimates.","Summary":"Shares of Pfizer Inc.  sank 2.6% in premarket trading Tuesday, after the drug maker reported fourth-quarter profit that beat expectations, while revenue more than doubled but missed forecasts. The company also provided a f..."},{"Date":"Feb. 8, 2022 at 7:02 a.m. ET","Headline":"Pfizer stock falls after profit beats but revenue misses, even as COVID-19 vaccine sales of $12.5 billion top forecasts","Summary":"Shares of Pfizer Inc.  sank 2.6% in premarket trading Tuesday, after the drug maker reported fourth-quarter profit that beat expectations, while revenue more than doubled but missed forecasts. The company also provided a f..."},{"Date":"Feb. 11, 2022 at 11:30 p.m. ET","Headline":"How Much Is Bitcoin Worth? The Challenges Modeling an Unruly Asset.","Summary":"Pfizer Inc.  and BioNTech SE  said Friday they are continuing to test their COVID-19 vaccine in children between the ages of 6 months old and 4 years old and will now wait until April when they believe they will have clini..."},{"Date":"Feb. 11, 2022 at 8:52 p.m. ET","Headline":"How Western Digital\u2019s Setback Actually Could Boost Its Shares","Summary":"Pfizer Inc.  and BioNTech SE  said Friday they are continuing to test their COVID-19 vaccine in children between the ages of 6 months old and 4 years old and will now wait until April when they believe they will have clini..."},{"Date":"Feb. 11, 2022 at 3:07 p.m. ET","Headline":"Covid Vaccines for Young Children Delayed at Least Two Months","Summary":"Pfizer Inc.  and BioNTech SE  said Friday they are continuing to test their COVID-19 vaccine in children between the ages of 6 months old and 4 years old and will now wait until April when they believe they will have clini..."},{"Date":"Feb. 11, 2022 at 1:56 p.m. ET","Headline":"Pfizer, BioNTech to delay seeking authorization of their COVID-19 shot in young children","Summary":"Pfizer Inc.  and BioNTech SE  said Friday they are continuing to test their COVID-19 vaccine in children between the ages of 6 months old and 4 years old and will now wait until April when they believe they will have clini..."},{"Date":"Feb. 11, 2022 at 12:53 p.m. ET","Headline":"Novavax Says Covid Vaccine Shows 80% Efficacy in Teens Aged 12 to 17","Summary":""},{"Date":"Feb. 11, 2022 at 9:52 a.m. ET","Headline":"Pfizer expects a record $100 billion in revenue this year, thanks to COVID-19 vaccines and treatments","Summary":""},{"Date":"Feb. 11, 2022 at 6:43 a.m. ET","Headline":"CDC directs vaccine makers to prep for shots for children below 5 by Feb. 21, as FDA advisory meeting looms","Summary":""},{"Date":"Feb. 10, 2022 at 11:00 a.m. ET","Headline":"These 2 stock-market trends need to reverse to disprove a bearish scenario","Summary":""},{"Date":"Feb. 10, 2022 at 6:53 a.m. ET","Headline":"Disney Tops Netflix for New Subscribers. The Streaming War Is Entering a New Phase.","Summary":""},{"Date":"Feb. 12, 2022 at 8:05 a.m. ET","Headline":"\u2018You will not believe what I\u2019ve just found.\u2019 Inside the ivermectin saga: a hacked password, mysterious websites and faulty data.","Summary":""},{"Date":"Feb. 15, 2022 at 4:47 p.m. ET","Headline":"New FDA program could boost drug development for rare diseases","Summary":""},{"Date":"Feb. 14, 2022 at 4:12 p.m. ET","Headline":"Dow Slides on Russia-Ukraine Tensions \u2014 and What Else Is Happening in the Stock Market Today","Summary":""},{"Date":"Feb. 14, 2022 at 1:20 p.m. ET","Headline":"Walmart ends mask requirement for vaccinated workers, paid COVID leave to follow","Summary":""},{"Date":"Feb. 14, 2022 at 7:44 a.m. ET","Headline":"Biden says it\u2019s \u2018probably premature\u2019 for states to drop face-mask requirements as Nevada \u2014 including its casinos \u2014 becomes latest to do so","Summary":""},{"Date":"Feb. 17, 2022 at 2:00 p.m. ET","Headline":"U.S. headed closer to point where pandemic is no longer a crisis, White House says, but sticks with face masks for now","Summary":"BioNTech SE  said Wednesday it is developing turkey mRNA manufacturing facilities based on a container solution in an effort to promote scalable vaccine production in Africa. The company is expecting to deliver the first B..."},{"Date":"Feb. 17, 2022 at 10:28 a.m. ET","Headline":"Stay bearish on the S&P 500","Summary":"BioNTech SE  said Wednesday it is developing turkey mRNA manufacturing facilities based on a container solution in an effort to promote scalable vaccine production in Africa. The company is expecting to deliver the first B..."},{"Date":"Feb. 17, 2022 at 8:20 a.m. ET","Headline":"U.S. excess death toll has climbed above 1 million during the pandemic: \u2018We\u2019ve never seen anything like it,\u2019 says CDC official","Summary":"BioNTech SE  said Wednesday it is developing turkey mRNA manufacturing facilities based on a container solution in an effort to promote scalable vaccine production in Africa. The company is expecting to deliver the first B..."},{"Date":"Feb. 16, 2022 at 6:19 a.m. ET","Headline":"BioNTech unveils plans to develop mRNA vaccine facilities in Africa","Summary":"BioNTech SE  said Wednesday it is developing turkey mRNA manufacturing facilities based on a container solution in an effort to promote scalable vaccine production in Africa. The company is expecting to deliver the first B..."},{"Date":"Feb. 18, 2022 at 12:54 p.m. ET","Headline":"Barron\u2019s Best Fund Families","Summary":""},{"Date":"Feb. 18, 2022 at 9:15 a.m. ET","Headline":"Sanofi and Glaxo Report Dual Disappointments. The Stocks Are Holding Up.","Summary":""},{"Date":"Feb. 21, 2022 at 11:08 a.m. ET","Headline":"FDA Mulling Approving Second Covid Booster Shot: Report","Summary":""},{"Date":"Feb. 23, 2022 at 10:14 a.m. ET","Headline":"Sanofi-Glaxo Vaccine May Threaten Pfizer, Moderna in Covid-19 Booster Market","Summary":""},{"Date":"Feb. 23, 2022 at 4:45 a.m. ET","Headline":"Why AstraZeneca Could Be a Sound Long-Term Bet","Summary":""},{"Date":"Feb. 22, 2022 at 6:54 a.m. ET","Headline":"Markets Are on a War Footing. Here\u2019s a Worst-Case Scenario.","Summary":""},{"Date":"Feb. 24, 2022 at 4:32 p.m. ET","Headline":"Moderna CEO Vows to Grow Vaccine Business as Competition Mounts","Summary":""},{"Date":"Feb. 24, 2022 at 7:54 a.m. ET","Headline":"WHO says omicron subvariant is not stopping global cases from falling, and U.S. nearing 940,000 COVID deaths","Summary":""},{"Date":"Feb. 24, 2022 at 6:39 a.m. ET","Headline":"Russia Has Attacked Ukraine. Markets Aren\u2019t Ready for the Fallout.","Summary":""},{"Date":"Feb. 24, 2022 at 5:00 a.m. ET","Headline":"4 Companies That Can Benefit From Buying Back More Stock","Summary":""},{"Date":"Mar. 1, 2022 at 1:22 p.m. ET","Headline":"Pfizer vaccine found to be less effective in preventing infection in very young children than older ones, as U.S. death toll tops 950,000","Summary":"The COVID-19 vaccine developed by Pfizer  and German partner BioNTech SE  is much less effective in preventing infection in children aged 5 to 11 than in older people, according to  from health officials in New York state,..."},{"Date":"Mar. 1, 2022 at 9:58 a.m. ET","Headline":"New Study Questions Lifting School Mask Mandates","Summary":"The COVID-19 vaccine developed by Pfizer  and German partner BioNTech SE  is much less effective in preventing infection in children aged 5 to 11 than in older people, according to  from health officials in New York state,..."},{"Date":"Mar. 1, 2022 at 8:55 a.m. ET","Headline":"Patent Ruling Is a Setback for Gene-Editing Firms Tied to Crispr Nobelists","Summary":"The COVID-19 vaccine developed by Pfizer  and German partner BioNTech SE  is much less effective in preventing infection in children aged 5 to 11 than in older people, according to  from health officials in New York state,..."},{"Date":"Mar. 1, 2022 at 8:07 a.m. ET","Headline":"Viatris stock slides 24% as analysts say sale of biosimilars to Indian partner removes key growth driver","Summary":"The COVID-19 vaccine developed by Pfizer  and German partner BioNTech SE  is much less effective in preventing infection in children aged 5 to 11 than in older people, according to  from health officials in New York state,..."},{"Date":"Mar. 1, 2022 at 6:25 a.m. ET","Headline":"Coronavirus tally: U.S. death toll tops 950,000 and Pfizer vaccine found less effective at preventing infection in young children","Summary":"The COVID-19 vaccine developed by Pfizer  and German partner BioNTech SE  is much less effective in preventing infection in children aged 5 to 11 than in older people, according to  from health officials in New York state,..."},{"Date":"Mar. 1, 2022 at 6:17 a.m. ET","Headline":"Pfizer\/BioNTech vaccine found to be much less affective in preventing infection in children aged 5 to 11: NYT","Summary":"The COVID-19 vaccine developed by Pfizer  and German partner BioNTech SE  is much less effective in preventing infection in children aged 5 to 11 than in older people, according to  from health officials in New York state,..."},{"Date":"Feb. 28, 2022 at 12:19 p.m. ET","Headline":"Viatris to Sell Biosimilars Business for $3 Billion. Shares Tumble.","Summary":"Viatris Inc. , the company formed by the merger of Mylan and Pfizer Inc.  unit Upjohn in 2020, said Monday it has reached an agreement to combine its biosimilars portfolio with Biocon Biologics Ltd. for up to $3.335 billio..."},{"Date":"Feb. 28, 2022 at 8:52 a.m. ET","Headline":"GlaxoSmithKline to Spin Off Haleon Consumer Business in July","Summary":"Viatris Inc. , the company formed by the merger of Mylan and Pfizer Inc.  unit Upjohn in 2020, said Monday it has reached an agreement to combine its biosimilars portfolio with Biocon Biologics Ltd. for up to $3.335 billio..."},{"Date":"Feb. 28, 2022 at 6:23 a.m. ET","Headline":"Viatris to contribute its biosimilars portfolio to Biocon Biologics for up to $3.335 billion, shares jump 4% premarket","Summary":"Viatris Inc. , the company formed by the merger of Mylan and Pfizer Inc.  unit Upjohn in 2020, said Monday it has reached an agreement to combine its biosimilars portfolio with Biocon Biologics Ltd. for up to $3.335 billio..."},{"Date":"Mar. 3, 2022 at 8:19 a.m. ET","Headline":"CVS, Walgreens, and Walmart part of Biden\u2019s test-to-treat COVID-19 program","Summary":"Shares of Pfizer Inc.  gained 0.6% in premarket trading on Wednesday after the company said its experimental respiratory syncytial virus (RSV) vaccine had received a breakthrough therapy designation from the Food and Drug ..."},{"Date":"Mar. 3, 2022 at 6:40 a.m. ET","Headline":"\u2018Uninvestable\u2019 Russian Stocks Are Officially Ostracized as Oil Surges to New Peak","Summary":"Shares of Pfizer Inc.  gained 0.6% in premarket trading on Wednesday after the company said its experimental respiratory syncytial virus (RSV) vaccine had received a breakthrough therapy designation from the Food and Drug ..."},{"Date":"Mar. 2, 2022 at 11:06 a.m. ET","Headline":"Pfizer Steps Ahead of Glaxo in Race for Maternal RSV Vaccine","Summary":"Shares of Pfizer Inc.  gained 0.6% in premarket trading on Wednesday after the company said its experimental respiratory syncytial virus (RSV) vaccine had received a breakthrough therapy designation from the Food and Drug ..."},{"Date":"Mar. 2, 2022 at 10:24 a.m. ET","Headline":"As Covid Cases Fall, Biden Says It\u2019s Time to Return to Normal Life","Summary":"Shares of Pfizer Inc.  gained 0.6% in premarket trading on Wednesday after the company said its experimental respiratory syncytial virus (RSV) vaccine had received a breakthrough therapy designation from the Food and Drug ..."},{"Date":"Mar. 2, 2022 at 8:06 a.m. ET","Headline":"FDA grants breakthrough therapy status to Pfizer's RSV vaccine candidate","Summary":"Shares of Pfizer Inc.  gained 0.6% in premarket trading on Wednesday after the company said its experimental respiratory syncytial virus (RSV) vaccine had received a breakthrough therapy designation from the Food and Drug ..."},{"Date":"Feb. 25, 2022 at 9:09 p.m. ET","Headline":"Competition Is Heating Up in Covid Boosters. Moderna and Pfizer, Take Heed.","Summary":""},{"Date":"Mar. 5, 2022 at 11:10 a.m. ET","Headline":"Haul away these 10 bargains in beaten-down quality stocks before it\u2019s too late","Summary":""},{"Date":"Mar. 7, 2022 at 7:01 p.m. ET","Headline":"Moderna Commits to Design and Test 15 Vaccines That Could Fight Next Pandemic","Summary":""},{"Date":"Mar. 7, 2022 at 11:47 a.m. ET","Headline":"Biotech AN2 Therapeutics Is Seeking a Traditional IPO","Summary":""},{"Date":"Mar. 7, 2022 at 8:55 a.m. ET","Headline":"Moderna Will Make Vaccines in Kenya","Summary":""},{"Date":"Mar. 9, 2022 at 9:59 a.m. ET","Headline":"Russia-Ukraine War Won\u2019t Affect Pharmaceutical Sales, but It Could Disrupt Trials, Companies Say","Summary":"Pfizer Inc.  said Wednesday it is starting a Phase 2\/3 trial of its COVID-19 antiviral in children below the age of 18 who are at high risk of developing severe illness. The aim of the study is to treat children outside of..."},{"Date":"Mar. 9, 2022 at 8:23 a.m. ET","Headline":"Pfizer Will Test Covid-19 Pill in Children","Summary":"Pfizer Inc.  said Wednesday it is starting a Phase 2\/3 trial of its COVID-19 antiviral in children below the age of 18 who are at high risk of developing severe illness. The aim of the study is to treat children outside of..."},{"Date":"Mar. 9, 2022 at 6:58 a.m. ET","Headline":"Pfizer to launch Phase 2\/3 study of COVID antiviral in pediatric patients","Summary":"Pfizer Inc.  said Wednesday it is starting a Phase 2\/3 trial of its COVID-19 antiviral in children below the age of 18 who are at high risk of developing severe illness. The aim of the study is to treat children outside of..."},{"Date":"Mar. 8, 2022 at 4:49 p.m. ET","Headline":"This \u2018all-weather\u2019 approach to quality stocks can help you sail through rough waters while staying ahead of inflation","Summary":""},{"Date":"Mar. 8, 2022 at 3:01 p.m. ET","Headline":"Why Fortune magazine\u2019s \u2018most admired\u2019 companies likely won\u2019t be among 2022\u2019s best-performing stocks","Summary":""},{"Date":"Mar. 11, 2022 at 8:24 p.m. ET","Headline":"Pharma Exposure to the Ukraine War? Clinical Trials","Summary":"Shares of Pfizer Inc.  were up 2.0% in trading on Friday after the company said it closed its $6.7 billion acquisition of Arena Pharmaceuticals Inc. Arena is developing treatments for immuno-inflammatory diseases like ulce..."},{"Date":"Mar. 11, 2022 at 11:04 a.m. ET","Headline":"Pfizer closes $6.7 billion acquisition of Arena Pharmaceuticals","Summary":"Shares of Pfizer Inc.  were up 2.0% in trading on Friday after the company said it closed its $6.7 billion acquisition of Arena Pharmaceuticals Inc. Arena is developing treatments for immuno-inflammatory diseases like ulce..."},{"Date":"Mar. 11, 2022 at 9:43 a.m. ET","Headline":"CEO St\u00e9phane Bancel Made $18.2M Last Year, Another Sign Moderna Is in the Big Leagues","Summary":""},{"Date":"Mar. 11, 2022 at 6:32 a.m. ET","Headline":"Yes, Inflation Could Get Even Worse, at a Bad Time for the Fed","Summary":""},{"Date":"Mar. 11, 2022 at 2:30 a.m. ET","Headline":"Two Years Ago Today, the WHO Declared Covid-19 a Pandemic","Summary":""},{"Date":"Mar. 10, 2022 at 4:15 p.m. ET","Headline":"Moderna and Other Vaccine Stocks Finally Rallied Wednesday. Buyers May Be Back.","Summary":""},{"Date":"Mar. 10, 2022 at 3:06 p.m. ET","Headline":"Amazon Is Splitting Its Stock. Why It Wants a Lower Share Price.","Summary":""},{"Date":"Mar. 10, 2022 at 7:58 a.m. ET","Headline":"Amazon to split stock for the first time since the dot-com boom, after gains of more than 4,500%","Summary":""},{"Date":"Mar. 12, 2022 at 1:39 p.m. ET","Headline":"Covid-19 Cases Climb in U.K. as BA.2 Spreads. What to Know.","Summary":""},{"Date":"Mar. 15, 2022 at 7:22 p.m. ET","Headline":"Pfizer, BioNTech Ask FDA to Approve Another Covid Shot for Older Americans","Summary":"AbbVie Inc.  said Tuesday that it will partner with Scripps Research to develop new COVID-19 antivirals. \"Our SARS-CoV-2 research program has the potential to impact significantly the ongoing gaps in patient needs to move ..."},{"Date":"Mar. 15, 2022 at 4:32 p.m. ET","Headline":"Pfizer expected to seek approval for fourth COVID vaccine dose for seniors","Summary":"AbbVie Inc.  said Tuesday that it will partner with Scripps Research to develop new COVID-19 antivirals. \"Our SARS-CoV-2 research program has the potential to impact significantly the ongoing gaps in patient needs to move ..."},{"Date":"Mar. 15, 2022 at 8:20 a.m. ET","Headline":"AbbVie, Scripps Research to develop COVID-19 antivirals","Summary":"AbbVie Inc.  said Tuesday that it will partner with Scripps Research to develop new COVID-19 antivirals. \"Our SARS-CoV-2 research program has the potential to impact significantly the ongoing gaps in patient needs to move ..."},{"Date":"Mar. 15, 2022 at 6:35 a.m. ET","Headline":"The Bond Market Has Shifted. A Hawkish Surprise May Be Coming.","Summary":"Pfizer Inc.  said Monday that it will continue to supply medicines to Russia but it plans to donate all profits to organizations that provide humanitarian support to Ukraine. The drug maker also said it will not start new ..."},{"Date":"Mar. 14, 2022 at 5:03 p.m. ET","Headline":"S&P 500 marks 1st death cross in 2 years as investors assess Russia-Ukraine ahead of Fed decision","Summary":"Pfizer Inc.  said Monday that it will continue to supply medicines to Russia but it plans to donate all profits to organizations that provide humanitarian support to Ukraine. The drug maker also said it will not start new ..."},{"Date":"Mar. 14, 2022 at 1:20 p.m. ET","Headline":"Pfizer to Continue to Supply Medicines to Russia, but Will End Planned Investments","Summary":"Pfizer Inc.  said Monday that it will continue to supply medicines to Russia but it plans to donate all profits to organizations that provide humanitarian support to Ukraine. The drug maker also said it will not start new ..."},{"Date":"Mar. 14, 2022 at 12:23 p.m. ET","Headline":"Booster Chatter and China Covid Surge Lead to Vaccine Stock Rally","Summary":"Pfizer Inc.  said Monday that it will continue to supply medicines to Russia but it plans to donate all profits to organizations that provide humanitarian support to Ukraine. The drug maker also said it will not start new ..."},{"Date":"Mar. 14, 2022 at 9:25 a.m. ET","Headline":"Two years of COVID-19: How the pandemic changed the way we shop, work, invest and get medical care","Summary":"Pfizer Inc.  said Monday that it will continue to supply medicines to Russia but it plans to donate all profits to organizations that provide humanitarian support to Ukraine. The drug maker also said it will not start new ..."},{"Date":"Mar. 14, 2022 at 9:01 a.m. ET","Headline":"Pfizer CEO Says Fourth Covid Vaccine Dose \u2018Necessary\u2019","Summary":"Pfizer Inc.  said Monday that it will continue to supply medicines to Russia but it plans to donate all profits to organizations that provide humanitarian support to Ukraine. The drug maker also said it will not start new ..."},{"Date":"Mar. 14, 2022 at 8:18 a.m. ET","Headline":"Pfizer to keep supplying medicine to Russia; will donate profits from drugs sold there to Ukrainian 'causes'","Summary":"Pfizer Inc.  said Monday that it will continue to supply medicines to Russia but it plans to donate all profits to organizations that provide humanitarian support to Ukraine. The drug maker also said it will not start new ..."},{"Date":"Mar. 14, 2022 at 7:49 a.m. ET","Headline":"Pfizer CEO says fourth COVID shot will be needed, shots for young kids could start in May","Summary":"The chief executive of Pfizer Inc.  said Sunday that COVID-19 is not going to just go away in the coming years, and that fully vaccinated people  In an interview with CBS News reporter Margaret Brennan on \"Face the Nation,..."},{"Date":"Mar. 14, 2022 at 7:43 a.m. ET","Headline":"Portfolio manager with 50 years of experience shares 1970s bear-market lesson, and three stocks to buy now","Summary":"The chief executive of Pfizer Inc.  said Sunday that COVID-19 is not going to just go away in the coming years, and that fully vaccinated people  In an interview with CBS News reporter Margaret Brennan on \"Face the Nation,..."},{"Date":"Mar. 14, 2022 at 6:18 a.m. ET","Headline":"Coronavirus tally: Pfizer CEO says fourth vaccine shot will be needed later this year as global tally nears 457 million","Summary":"The chief executive of Pfizer Inc.  said Sunday that COVID-19 is not going to just go away in the coming years, and that fully vaccinated people  In an interview with CBS News reporter Margaret Brennan on \"Face the Nation,..."},{"Date":"Mar. 17, 2022 at 9:51 p.m. ET","Headline":"Moderna seeks FDA approval for fourth dose of COVID vaccine for all adults","Summary":""},{"Date":"Mar. 17, 2022 at 10:50 a.m. ET","Headline":"The FDA Has a New Chief. Here Are 5 Key Decisions on Drugs to Watch.","Summary":""},{"Date":"Mar. 16, 2022 at 3:10 p.m. ET","Headline":"Global COVID case tally climbs in latest week, breaking streak of declines that began in January","Summary":""},{"Date":"Mar. 16, 2022 at 7:11 a.m. ET","Headline":"Sewage samples signal possible increase in U.S. COVID cases in some places, even though overall cases are falling","Summary":""},{"Date":"Mar. 19, 2022 at 8:50 a.m. ET","Headline":"Fully vaccinated will need fourth dose later this year, and new variant dubbed \u2018deltacron\u2019 detected in Europe","Summary":"Moderna  has asked the U.S.  Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults, The request is broader than rival pharmaceutical company Pfizer's  ..."},{"Date":"Mar. 18, 2022 at 1:57 p.m. ET","Headline":"What Moderna and Pfizer\u2019s Vaccine Moves Say About Covid\u2019s Next Phase","Summary":"Moderna  has asked the U.S.  Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults, The request is broader than rival pharmaceutical company Pfizer's  ..."},{"Date":"Mar. 18, 2022 at 1:30 p.m. ET","Headline":"Moderna wants to offer all adults a second booster, and HHS chief laments lack of funding for Biden \u2018test to treat\u2019 strategy","Summary":"Moderna  has asked the U.S.  Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults, The request is broader than rival pharmaceutical company Pfizer's  ..."},{"Date":"Mar. 18, 2022 at 10:16 a.m. ET","Headline":"New Patent Lawsuit Adds to Litigation Worries for Moderna Stock","Summary":"Moderna  has asked the U.S.  Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults, The request is broader than rival pharmaceutical company Pfizer's  ..."},{"Date":"Mar. 18, 2022 at 9:41 a.m. ET","Headline":"Moderna Seeks FDA Clearance for Second Covid-19 Booster Shot in All Adults","Summary":"Moderna  has asked the U.S.  Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults, The request is broader than rival pharmaceutical company Pfizer's  ..."},{"Date":"Mar. 18, 2022 at 6:46 a.m. ET","Headline":"Biden\u2019s Call With China\u2019s Xi Is a Diplomatic Duel With Seismic Ramifications","Summary":"Moderna  has asked the U.S.  Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults, The request is broader than rival pharmaceutical company Pfizer's  ..."},{"Date":"Mar. 18, 2022 at 6:29 a.m. ET","Headline":"Coronavirus tally: Moderna seeks FDA nod for fourth shot of its COVID booster for all adults, broader than Pfizer request","Summary":"Moderna  has asked the U.S.  Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults, The request is broader than rival pharmaceutical company Pfizer's  ..."},{"Date":"Mar. 21, 2022 at 5:16 p.m. ET","Headline":"AN2 Therapeutics Set for a March IPO","Summary":"A Food and Drug Administration advisory committee is scheduled  to discuss whether there is a need to authorize or approve COVID-19 booster doses in the future. The Vaccines and Related Biological Products Advisory Committ..."},{"Date":"Mar. 21, 2022 at 12:32 p.m. ET","Headline":"FDA Announces Meeting Focused on Booster Doses","Summary":"A Food and Drug Administration advisory committee is scheduled  to discuss whether there is a need to authorize or approve COVID-19 booster doses in the future. The Vaccines and Related Biological Products Advisory Committ..."},{"Date":"Mar. 21, 2022 at 10:53 a.m. ET","Headline":"FDA advisory committee to meet April 6 to discuss COVID-19 boosters","Summary":"A Food and Drug Administration advisory committee is scheduled  to discuss whether there is a need to authorize or approve COVID-19 booster doses in the future. The Vaccines and Related Biological Products Advisory Committ..."},{"Date":"Mar. 21, 2022 at 7:03 a.m. ET","Headline":"Warren Buffett Puts Some of His $144 Billion to Work With Alleghany Deal","Summary":""},{"Date":"Mar. 23, 2022 at 9:16 a.m. ET","Headline":"Moderna\u2019s stock, down 60% since the summer\u2019s delta wave, is rising again as COVID-19 cases increase","Summary":"Shares of Pfizer Inc.  gained 0.2% in premarket trading on Wednesday after the company said the experimental ulcerative colitis drug it bought through the recent Arena Pharmaceuticals deal improved clinical remission rates..."},{"Date":"Mar. 23, 2022 at 8:38 a.m. ET","Headline":"Moderna Announces Positive Data on Vaccine in Young Children, Will Ask FDA for Authorization","Summary":"Shares of Pfizer Inc.  gained 0.2% in premarket trading on Wednesday after the company said the experimental ulcerative colitis drug it bought through the recent Arena Pharmaceuticals deal improved clinical remission rates..."},{"Date":"Mar. 23, 2022 at 7:36 a.m. ET","Headline":"Pfizer's new ulcerative colitis drug improves clinical remission rates in Phase 3 study","Summary":"Shares of Pfizer Inc.  gained 0.2% in premarket trading on Wednesday after the company said the experimental ulcerative colitis drug it bought through the recent Arena Pharmaceuticals deal improved clinical remission rates..."},{"Date":"Mar. 23, 2022 at 7:36 a.m. ET","Headline":"European countries lifted COVID restrictions \u2018too brutally,\u2019 says WHO regional head, allowing BA.2 variant to spread","Summary":"Pfizer Inc.  said Tuesday it has entered an agreement with Unicef to supply it with up to 4 million doses of its COVID-19 antiviral for 95 low and middle-income countries. The deal will cover about 53% of the world's popul..."},{"Date":"Mar. 22, 2022 at 7:02 a.m. ET","Headline":"Pfizer to supply Unicef with up to 4 million courses of its COVID antiviral for low and middle-income countries","Summary":"Pfizer Inc.  said Tuesday it has entered an agreement with Unicef to supply it with up to 4 million doses of its COVID-19 antiviral for 95 low and middle-income countries. The deal will cover about 53% of the world's popul..."},{"Date":"Mar. 25, 2022 at 2:43 p.m. ET","Headline":"Airport-based study found first U.S. case of BA.2 subvariant of omicron in December","Summary":"Novavax Inc.  said Friday that its experimental COVID-19 booster is being tested in a Phase 1\/2 clinical trial sponsored by the National Institutes of Health. This study is evaluating Novavax's protein-based booster candid..."},{"Date":"Mar. 25, 2022 at 11:23 a.m. ET","Headline":"Political Stalemate Could Push Covid-19 Vaccines Onto the Private Markets","Summary":"Novavax Inc.  said Friday that its experimental COVID-19 booster is being tested in a Phase 1\/2 clinical trial sponsored by the National Institutes of Health. This study is evaluating Novavax's protein-based booster candid..."},{"Date":"Mar. 25, 2022 at 8:46 a.m. ET","Headline":"Novavax's COVID-19 booster to be evaluated in NIH study","Summary":"Novavax Inc.  said Friday that its experimental COVID-19 booster is being tested in a Phase 1\/2 clinical trial sponsored by the National Institutes of Health. This study is evaluating Novavax's protein-based booster candid..."},{"Date":"Mar. 24, 2022 at 6:58 a.m. ET","Headline":"Moderna seeks regulatory nod for COVID vaccine in very young children, and WHO reports second straight week with cases rising globally","Summary":""},{"Date":"Mar. 24, 2022 at 6:47 a.m. ET","Headline":"The Russian Stock Market Reopens to a Different Reality","Summary":""},{"Date":"Mar. 27, 2022 at 10:41 a.m. ET","Headline":"8 Stocks That Are Still Negative Since the Pandemic Lows\u2014and 1 That Finally Turned Positive","Summary":""},{"Date":"Mar. 26, 2022 at 12:02 p.m. ET","Headline":"The U.S. is talking about a second round of COVID-19 booster shots, and it\u2019s going to be even more complicated than last year","Summary":""},{"Date":"Mar. 29, 2022 at 5:20 p.m. ET","Headline":"FDA approves another Pfizer, Moderna COVID booster for those 50 and older","Summary":"The U.S. Food and Drug Administration said Tuesday it has authorized a second booster dose of either the Pfizer\/BioNTech  or Moderna  COVID-19 vaccines for people aged 50 and older. The agency has also authorized a second ..."},{"Date":"Mar. 29, 2022 at 11:06 a.m. ET","Headline":"U.S. FDA authorizes second COVID booster dose for people aged 50 and older","Summary":"The U.S. Food and Drug Administration said Tuesday it has authorized a second booster dose of either the Pfizer\/BioNTech  or Moderna  COVID-19 vaccines for people aged 50 and older. The agency has also authorized a second ..."},{"Date":"Mar. 29, 2022 at 11:00 a.m. ET","Headline":"FDA Authorizes Second Covid Booster for Adults Aged 50 and Up","Summary":""},{"Date":"Mar. 28, 2022 at 7:20 a.m. ET","Headline":"Netflix Losing Best Picture to Apple Is Just Another Bad Moment in a Rough 2022","Summary":""},{"Date":"Mar. 31, 2022 at 8:39 a.m. ET","Headline":"\u2018COVID-19 no longer controls our lives,\u2019 Biden says, while rolling out website for living with virus","Summary":"President Joe Biden said Wednesday the country is turning the page on the COVID-19 pandemic, as his administration took the wraps off a website that aims to help Americans deal with the pandemic. \"Because of the strategy w..."},{"Date":"Mar. 31, 2022 at 7:21 a.m. ET","Headline":"Novavax Asks EU Regulator to Clear Covid Vaccine for Adolescents","Summary":"President Joe Biden said Wednesday the country is turning the page on the COVID-19 pandemic, as his administration took the wraps off a website that aims to help Americans deal with the pandemic. \"Because of the strategy w..."},{"Date":"Mar. 31, 2022 at 6:30 a.m. ET","Headline":"Coronavirus tally: Biden says COVID 'no longer controls our lives,' as global case tally nears 490 million","Summary":"President Joe Biden said Wednesday the country is turning the page on the COVID-19 pandemic, as his administration took the wraps off a website that aims to help Americans deal with the pandemic. \"Because of the strategy w..."},{"Date":"Mar. 30, 2022 at 10:09 a.m. ET","Headline":"CureVac and Glaxo Begin Testing New \u2018Second Generation\u2019 Covid-19 Vaccine","Summary":""},{"Date":"Mar. 30, 2022 at 9:32 a.m. ET","Headline":"BioNTech\u2019s Earnings Top Estimates. It Plans a Buyback and Special Dividend.","Summary":""},{"Date":"Mar. 30, 2022 at 7:49 a.m. ET","Headline":"U.S. average daily deaths from COVID fall below 800 to lowest level since mid-August, and FDA allows second booster shot for people 50 and older","Summary":""},{"Date":"Mar. 30, 2022 at 6:38 a.m. ET","Headline":"The Bond Market Is Flashing a Recession Warning\u2014but Stocks Have Thrived After Inversion","Summary":""},{"Date":"Mar. 28, 2022 at 12:41 p.m. ET","Headline":"The BA.2 Covid Variant Is Already Changing the U.S. Response to the Pandemic","Summary":""},{"Date":"Apr. 1, 2022 at 2:33 p.m. ET","Headline":"U.S. lawmakers close to agreeing on $10 billion in funding for next phase of the COVID-19 battle, as death toll tops 980,000","Summary":"Merck  and privately held Ridgeback Biotherapeutics said Friday they will present data showing that treatment with their COVID-19 antiviral ended infectious illness more rapidly than placebo in a late-stage trial. Data on ..."},{"Date":"Apr. 1, 2022 at 7:00 a.m. ET","Headline":"Merck and Ridgeback to present data showing COVID antiviral ends infectious illness more quickly than placebo","Summary":"Merck  and privately held Ridgeback Biotherapeutics said Friday they will present data showing that treatment with their COVID-19 antiviral ended infectious illness more rapidly than placebo in a late-stage trial. Data on ..."},{"Date":"Apr. 1, 2022 at 6:38 a.m. ET","Headline":"Biden says U.S. turning corner on COVID, but experts are worried that BA.2 is pushing cases higher in 15 states","Summary":""},{"Date":"Apr. 4, 2022 at 10:26 a.m. ET","Headline":"Tesla is one of only 11 stocks in the S&P 500, excluding energy, that enjoys this critical support","Summary":""},{"Date":"Apr. 3, 2022 at 9:50 p.m. ET","Headline":"AbbVie, Exelon, and More Stocks for the Recession That May\u2014or May Not\u2014Be Coming","Summary":""},{"Date":"Apr. 2, 2022 at 9:31 a.m. ET","Headline":"AMC Battles the Streaming Trend. Its Biggest Weapon May Be the Meme Crowd.","Summary":""},{"Date":"Apr. 6, 2022 at 6:37 p.m. ET","Headline":"FDA Advisors Say Fall Booster Vaccine Will Be a Challenge","Summary":""},{"Date":"Apr. 5, 2022 at 4:43 p.m. ET","Headline":"FDA pulls GlaxoSmithKline\u2019s COVID-19 drug as omicron subvariant dominates U.S. cases","Summary":""},{"Date":"Apr. 5, 2022 at 12:38 p.m. ET","Headline":"Moderna Confirms Covax Turned Down More Covid-19 Vaccine Doses","Summary":""},{"Date":"Apr. 8, 2022 at 6:16 p.m. ET","Headline":"The Best Airline Bet Might Be the One That Owns an Oil Refinery","Summary":"Pfizer Inc.  said Thursday it has agreed to acquire ReViral Ltd., a privately held clinical-stage biotech focused on developing antiviral therapeutics that target respiratory synctial virus, or RSV. \"RSV is a respiratory p..."},{"Date":"Apr. 8, 2022 at 3:09 p.m. ET","Headline":"As COVID-19 cases decline in the U.S., White House officials face outbreak","Summary":"Pfizer Inc.  said Thursday it has agreed to acquire ReViral Ltd., a privately held clinical-stage biotech focused on developing antiviral therapeutics that target respiratory synctial virus, or RSV. \"RSV is a respiratory p..."},{"Date":"Apr. 7, 2022 at 2:37 p.m. ET","Headline":"A $10 billion funding package for next phase of COVID battle stalls in Senate, as cases start climbing again in 28 states","Summary":"Pfizer Inc.  said Thursday it has agreed to acquire ReViral Ltd., a privately held clinical-stage biotech focused on developing antiviral therapeutics that target respiratory synctial virus, or RSV. \"RSV is a respiratory p..."},{"Date":"Apr. 7, 2022 at 10:06 a.m. ET","Headline":"Novartis CEO Continues His Shake-Up, Says It Will Save More Than $1 Billion Annually","Summary":"Pfizer Inc.  said Thursday it has agreed to acquire ReViral Ltd., a privately held clinical-stage biotech focused on developing antiviral therapeutics that target respiratory synctial virus, or RSV. \"RSV is a respiratory p..."},{"Date":"Apr. 7, 2022 at 9:00 a.m. ET","Headline":"Pfizer Just Made a Small Acquisition. It May Be More Important Than It Looks.","Summary":"Pfizer Inc.  said Thursday it has agreed to acquire ReViral Ltd., a privately held clinical-stage biotech focused on developing antiviral therapeutics that target respiratory synctial virus, or RSV. \"RSV is a respiratory p..."},{"Date":"Apr. 7, 2022 at 7:57 a.m. ET","Headline":"BA.2 subvariant of omicron accounted for almost 94% of global cases in latest week, the latest sign of how dominant it has become","Summary":"Pfizer Inc.  said Thursday it has agreed to acquire ReViral Ltd., a privately held clinical-stage biotech focused on developing antiviral therapeutics that target respiratory synctial virus, or RSV. \"RSV is a respiratory p..."},{"Date":"Apr. 7, 2022 at 6:55 a.m. ET","Headline":"Pfizer to acquire privately held ReViral for up to $525 million","Summary":"Pfizer Inc.  said Thursday it has agreed to acquire ReViral Ltd., a privately held clinical-stage biotech focused on developing antiviral therapeutics that target respiratory synctial virus, or RSV. \"RSV is a respiratory p..."},{"Date":"Apr. 7, 2022 at 6:42 a.m. ET","Headline":"Fed Forges Boldly Ahead Into the Fog of Quantitative Tightening","Summary":""},{"Date":"Apr. 7, 2022 at 12:28 a.m. ET","Headline":"Shanghai reverses course and will allow some parents to remain with their coronavirus-infected children","Summary":""},{"Date":"Apr. 11, 2022 at 8:00 a.m. ET","Headline":"Lowe\u2019s CFO Exit Might Not Be as Bad as It Looks, According to This Analyst","Summary":"Pfizer Inc.  on Monday named David M. Denton as the company's new chief financial officer and executive vice president, effective May 2. He will succeed Frank D'Amelio, who has said he will leave the company after 15 years..."},{"Date":"Apr. 11, 2022 at 6:59 a.m. ET","Headline":"Pfizer names CFO from Lowe's to replace Frank D'Amelio","Summary":"Pfizer Inc.  on Monday named David M. Denton as the company's new chief financial officer and executive vice president, effective May 2. He will succeed Frank D'Amelio, who has said he will leave the company after 15 years..."},{"Date":"Apr. 11, 2022 at 6:46 a.m. ET","Headline":"Pfizer\u2019s New CFO Negotiated One of the Biggest Healthcare Deals in History. Is It a Sign of Things to Come?","Summary":""},{"Date":"Apr. 14, 2022 at 1:35 p.m. ET","Headline":"New York State\u2019s recent COVID case surge caused by two new versions of omicron that are even more infectious than BA.2","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a Phase 2\/3 trial of their COVID-19 vaccine booster showed a high immune response in children aged 5-to-11-years old. Data from a sub-analysis of 30 sera from the ..."},{"Date":"Apr. 14, 2022 at 10:10 a.m. ET","Headline":"Pfizer Said Its Booster Shot in Children Aged 5 to 11 Raises Antibodies","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a Phase 2\/3 trial of their COVID-19 vaccine booster showed a high immune response in children aged 5-to-11-years old. Data from a sub-analysis of 30 sera from the ..."},{"Date":"Apr. 14, 2022 at 6:56 a.m. ET","Headline":"Pfizer and BioNTech say data shows high immune response for COVID booster in children aged 5 to 11","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Thursday a Phase 2\/3 trial of their COVID-19 vaccine booster showed a high immune response in children aged 5-to-11-years old. Data from a sub-analysis of 30 sera from the ..."},{"Date":"Apr. 13, 2022 at 9:40 a.m. ET","Headline":"Sierra Oncology Stock Soars After $1.9 Billion Takeover by Glaxo","Summary":""},{"Date":"Apr. 13, 2022 at 3:00 a.m. ET","Headline":"An International Stock Fund Weathers the Storm","Summary":""},{"Date":"Apr. 16, 2022 at 12:01 p.m. ET","Headline":"How Covid-19 Could Pan Out From Here","Summary":""},{"Date":"Apr. 15, 2022 at 12:49 p.m. ET","Headline":"How well is the COVID-19 test-to-treat program working?","Summary":""},{"Date":"Apr. 17, 2022 at 7:00 a.m. ET","Headline":"Big Investor Halves Stake in AMC Stock and Trims Apple. It Bought PayPal and Pfizer.","Summary":""},{"Date":"Apr. 20, 2022 at 8:05 a.m. ET","Headline":"Moderna is developing a COVID-19 booster that protects against omicron and the original virus","Summary":""},{"Date":"Apr. 19, 2022 at 11:26 p.m. ET","Headline":"Japan approves Novavax as fourth COVID-19 vaccine amid new surge","Summary":""},{"Date":"Apr. 26, 2022 at 5:11 p.m. ET","Headline":"Pfizer, BioNTech Seek Emergency Authorization for Covid Booster in Children 5 to 11","Summary":"Pfizer Inc.  said Tuesday that an experimental Lyme disease vaccine it's developing with Valneva SE  will move into a Phase 3 clinical trial that includes children who are at least 5 years old, based on \"positive\" results ..."},{"Date":"Apr. 26, 2022 at 9:56 a.m. ET","Headline":"White House makes push for access to COVID antiviral, urges Congress to fund next leg of pandemic response","Summary":"Pfizer Inc.  said Tuesday that an experimental Lyme disease vaccine it's developing with Valneva SE  will move into a Phase 3 clinical trial that includes children who are at least 5 years old, based on \"positive\" results ..."},{"Date":"Apr. 26, 2022 at 7:59 a.m. ET","Headline":"Pfizer, Valneva plan to move Lyme disease vaccine candidate into Phase 3 trial","Summary":"Pfizer Inc.  said Tuesday that an experimental Lyme disease vaccine it's developing with Valneva SE  will move into a Phase 3 clinical trial that includes children who are at least 5 years old, based on \"positive\" results ..."},{"Date":"Apr. 26, 2022 at 6:56 a.m. ET","Headline":"Coronavirus tally: Biden administration pushes to expand access to antiviral Paxlovid as cases continue to rise","Summary":"President Joe Biden's administration is pushing to expand availability of COVID-19 antiviral treatment Paxlovid, developed by Pfizer Inc. , and is moving to raise awareness of the pill and taking steps to make it easier to..."},{"Date":"Apr. 26, 2022 at 5:46 a.m. ET","Headline":"White House expands availability of COVID antiviral pill","Summary":""},{"Date":"Apr. 25, 2022 at 11:02 a.m. ET","Headline":"Merck, Lilly, Bristol Earnings This Week Could Prove Big Pharma\u2019s Defensive Value","Summary":""},{"Date":"Oct. 28, 2021 at 1:46 p.m. ET","Headline":"Trump could have reduced COVID deaths by 30% or even 40%, Deborah Birx testifies","Summary":""},{"Date":"Apr. 28, 2022 at 4:26 p.m. ET","Headline":"The Pandemic\u2019s Impact on Merck Is Lessening, CFO Says","Summary":"Shares of Moderna Inc.  gained 2.1% in premarket trading on Thursday after the company said it filed for authorization of its COVID-19 vaccine in children between the ages of 6 months and 6 years old. The submission is set..."},{"Date":"Apr. 28, 2022 at 9:39 a.m. ET","Headline":"Dr. Fauci clarifies remarks, says \u2018pandemic is not over\u2019 yet \u2014 the U.S. is merely out of \u2018acute\u2019 phase","Summary":"Shares of Moderna Inc.  gained 2.1% in premarket trading on Thursday after the company said it filed for authorization of its COVID-19 vaccine in children between the ages of 6 months and 6 years old. The submission is set..."},{"Date":"Apr. 28, 2022 at 9:19 a.m. ET","Headline":"Merck Beats Earnings Estimates. The Stock Is Up.","Summary":"Shares of Moderna Inc.  gained 2.1% in premarket trading on Thursday after the company said it filed for authorization of its COVID-19 vaccine in children between the ages of 6 months and 6 years old. The submission is set..."},{"Date":"Apr. 28, 2022 at 9:02 a.m. ET","Headline":"How Gilead is positioning Veklury against COVID-19 antivirals like Paxlovid","Summary":"Shares of Moderna Inc.  gained 2.1% in premarket trading on Thursday after the company said it filed for authorization of its COVID-19 vaccine in children between the ages of 6 months and 6 years old. The submission is set..."},{"Date":"Apr. 28, 2022 at 9:00 a.m. ET","Headline":"Can a decades-old antidepressant keep COVID-19 patients out of the hospital?","Summary":"Shares of Moderna Inc.  gained 2.1% in premarket trading on Thursday after the company said it filed for authorization of its COVID-19 vaccine in children between the ages of 6 months and 6 years old. The submission is set..."},{"Date":"Apr. 28, 2022 at 7:43 a.m. ET","Headline":"Moderna asks the FDA to authorize its COVID-19 vaccine in young children","Summary":"Shares of Moderna Inc.  gained 2.1% in premarket trading on Thursday after the company said it filed for authorization of its COVID-19 vaccine in children between the ages of 6 months and 6 years old. The submission is set..."},{"Date":"Apr. 28, 2022 at 7:00 a.m. ET","Headline":"Moderna Seeks Approval for First Covid Vaccine in U.S. for Children Under 5","Summary":"BioNTech SE  and Pfizer Inc.  said Tuesday that they expect to share data from a clinical trial evaluating their COVID-19 vaccines in children between the ages of 6 months and 5 years old sometime before the end of June. T..."},{"Date":"Apr. 28, 2022 at 6:27 a.m. ET","Headline":"CDC study highlights speed with which omicron variant infected Americans, and WHO warns testing is still crucial","Summary":"BioNTech SE  and Pfizer Inc.  said Tuesday that they expect to share data from a clinical trial evaluating their COVID-19 vaccines in children between the ages of 6 months and 5 years old sometime before the end of June. T..."},{"Date":"Apr. 27, 2022 at 4:57 p.m. ET","Headline":"Dr. Fauci Says U.S. \u2018Out of the Pandemic Phase\u2019\u2014but Covid-19 Will Never Be Fully Eradicated","Summary":"BioNTech SE  and Pfizer Inc.  said Tuesday that they expect to share data from a clinical trial evaluating their COVID-19 vaccines in children between the ages of 6 months and 5 years old sometime before the end of June. T..."},{"Date":"Apr. 27, 2022 at 10:28 a.m. ET","Headline":"BioNTech, Pfizer say they expect to have COVID-19 vaccine data for young children this quarter","Summary":"BioNTech SE  and Pfizer Inc.  said Tuesday that they expect to share data from a clinical trial evaluating their COVID-19 vaccines in children between the ages of 6 months and 5 years old sometime before the end of June. T..."},{"Date":"Apr. 27, 2022 at 10:15 a.m. ET","Headline":"BioNTech, Pfizer seek FDA authorization of a COVID-19 booster for young children","Summary":"BioNTech SE  and Pfizer Inc.  said Tuesday that they asked the Food and Drug Administration to authorize a COVID-19 booster dose for children between the ages of 5 and 11 years old. Boosters are already authorized for teen..."},{"Date":"Apr. 27, 2022 at 8:48 a.m. ET","Headline":"GlaxoSmithKline Beats Expectations Boosted by  Covid-19 Treatment. The Stock Is Up.","Summary":""},{"Date":"Apr. 27, 2022 at 7:57 a.m. ET","Headline":"Many Americans feel the pandemic is over, but new, highly transmissible and immune-evasive variants are likely, says White House COVID response coordinator","Summary":""},{"Date":"Apr. 27, 2022 at 6:54 a.m. ET","Headline":"Tech Earnings Are a Reflection of the Postpandemic Economy. Facebook\u2019s Parent Is Next.","Summary":""},{"Date":"Apr. 29, 2022 at 3:15 p.m. ET","Headline":"The Next Move on Covid-19 Vaccines Is Up for Debate. The FDA Set a Key Date.","Summary":""},{"Date":"Apr. 29, 2022 at 7:25 a.m. ET","Headline":"Pandemic is not over yet, says Dr. Fauci, and WHO says omicron accounted for 99.7% of all cases sequenced in latest week","Summary":""},{"Date":"May. 2, 2022 at 11:32 p.m. ET","Headline":"Asian markets mixed in light \u2018Golden Week\u2019 trading","Summary":"Taking Pfizer Inc.'s  COVID-19 pill Paxlovid failed to reduce the risk of spreading the virus to household contacts, the company said Friday. The drug maker had been testing Paxlovid as a post-exposure prophylactic in Phas..."},{"Date":"May. 2, 2022 at 11:21 a.m. ET","Headline":"Pfizer\u2019s Paxlovid Stumbles as Covid Preventative. The Earnings Are Tuesday.","Summary":"Taking Pfizer Inc.'s  COVID-19 pill Paxlovid failed to reduce the risk of spreading the virus to household contacts, the company said Friday. The drug maker had been testing Paxlovid as a post-exposure prophylactic in Phas..."},{"Date":"May. 2, 2022 at 9:36 a.m. ET","Headline":"Storied VC says investors are unlearning the lessons of the last bull market. Jeff Bezos says you should listen.","Summary":"Taking Pfizer Inc.'s  COVID-19 pill Paxlovid failed to reduce the risk of spreading the virus to household contacts, the company said Friday. The drug maker had been testing Paxlovid as a post-exposure prophylactic in Phas..."},{"Date":"May. 2, 2022 at 8:20 a.m. ET","Headline":"Lilly\u2019s experimental obesity drug may be a \u2018multibillion-dollar opportunity\u2019","Summary":"Taking Pfizer Inc.'s  COVID-19 pill Paxlovid failed to reduce the risk of spreading the virus to household contacts, the company said Friday. The drug maker had been testing Paxlovid as a post-exposure prophylactic in Phas..."},{"Date":"May. 2, 2022 at 8:08 a.m. ET","Headline":"Pfizer says Paxlovid doesn't work as a post-exposure prophylactic","Summary":"Taking Pfizer Inc.'s  COVID-19 pill Paxlovid failed to reduce the risk of spreading the virus to household contacts, the company said Friday. The drug maker had been testing Paxlovid as a post-exposure prophylactic in Phas..."},{"Date":"May. 1, 2022 at 9:10 p.m. ET","Headline":"AMD, Uber, Starbucks, the Fed Decision and More to Watch This Week","Summary":""},{"Date":"May. 1, 2022 at 7:00 a.m. ET","Headline":"Giant Pension Bought Tesla, Pfizer, and Starbucks Stock. It Sold Nike.","Summary":""},{"Date":"Apr. 29, 2022 at 7:39 p.m. ET","Headline":"As Time Passes, and the Weather Warms, Putin\u2019s Power Play in Europe Loses Force","Summary":""},{"Date":"May. 4, 2022 at 3:56 p.m. ET","Headline":"Moderna CEO Says FDA Meeting Will Be Too Late to Switch Covid Strains for Fall Vaccine","Summary":"Pfizer Inc.  posted better-than-expected first-quarter earnings on Tuesday, boosted by sales of its COVID-19 vaccine and antiviral Paxlovid. The company posted net income of $7.864 billion, or $1.37 a share, for the quarte..."},{"Date":"May. 4, 2022 at 7:46 a.m. ET","Headline":"Omicron caused spike in deaths in vaccinated people, analysis finds, though unvaccinated remain most at risk","Summary":"Pfizer Inc.  posted better-than-expected first-quarter earnings on Tuesday, boosted by sales of its COVID-19 vaccine and antiviral Paxlovid. The company posted net income of $7.864 billion, or $1.37 a share, for the quarte..."},{"Date":"May. 3, 2022 at 4:27 p.m. ET","Headline":"U.S. stock benchmarks end higher after choppy trade on eve of expected half-point Fed interest rate hike","Summary":"Pfizer Inc.  posted better-than-expected first-quarter earnings on Tuesday, boosted by sales of its COVID-19 vaccine and antiviral Paxlovid. The company posted net income of $7.864 billion, or $1.37 a share, for the quarte..."},{"Date":"May. 3, 2022 at 9:50 a.m. ET","Headline":"Stocks may keep sliding until institutions join retail investors in capitulation, this firm says","Summary":"Pfizer Inc.  posted better-than-expected first-quarter earnings on Tuesday, boosted by sales of its COVID-19 vaccine and antiviral Paxlovid. The company posted net income of $7.864 billion, or $1.37 a share, for the quarte..."},{"Date":"May. 3, 2022 at 9:06 a.m. ET","Headline":"Pfizer Earnings and Revenue Soundly Beat Estimates, Though Paxlovid Sales Miss","Summary":"Pfizer Inc.  posted better-than-expected first-quarter earnings on Tuesday, boosted by sales of its COVID-19 vaccine and antiviral Paxlovid. The company posted net income of $7.864 billion, or $1.37 a share, for the quarte..."},{"Date":"May. 3, 2022 at 7:56 a.m. ET","Headline":"South Africa hit by new subvariants of omicron that have been detected in the U.S. in small numbers","Summary":"Pfizer Inc.  posted better-than-expected first-quarter earnings on Tuesday, boosted by sales of its COVID-19 vaccine and antiviral Paxlovid. The company posted net income of $7.864 billion, or $1.37 a share, for the quarte..."},{"Date":"May. 3, 2022 at 7:02 a.m. ET","Headline":"Pfizer beats Q1 estimates as COVID vaccine and antiviral boost revenue","Summary":"Pfizer Inc.  posted better-than-expected first-quarter earnings on Tuesday, boosted by sales of its COVID-19 vaccine and antiviral Paxlovid. The company posted net income of $7.864 billion, or $1.37 a share, for the quarte..."},{"Date":"May. 6, 2022 at 1:07 p.m. ET","Headline":"Drug companies are making an accounting change after the SEC cracked down on Biogen","Summary":"U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's  COVID-19 vaccine due to a rare but serious risk of blood clots,The Food and Drug Administration said the shot should only be given to adults..."},{"Date":"May. 6, 2022 at 9:40 a.m. ET","Headline":"Big Pharma Has Enough Cash to Buy All of Biotech. Why M&A Isn\u2019t Happening.","Summary":"U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's  COVID-19 vaccine due to a rare but serious risk of blood clots,The Food and Drug Administration said the shot should only be given to adults..."},{"Date":"May. 6, 2022 at 8:46 a.m. ET","Headline":"Pfizer is looking beyond the COVID-19 market, aiming to be the \u2018partner of choice for biotech\u2019","Summary":"U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's  COVID-19 vaccine due to a rare but serious risk of blood clots,The Food and Drug Administration said the shot should only be given to adults..."},{"Date":"May. 6, 2022 at 6:56 a.m. ET","Headline":"Coronavirus tally: FDA limits who can get J&J COVID vaccine over rare blood clot issue","Summary":"U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's  COVID-19 vaccine due to a rare but serious risk of blood clots,The Food and Drug Administration said the shot should only be given to adults..."},{"Date":"May. 6, 2022 at 5:17 a.m. ET","Headline":"J&J Stock Slips as Covid Vaccine Restricted by FDA Over Blood Clot Risk","Summary":""},{"Date":"May. 5, 2022 at 7:12 p.m. ET","Headline":"FDA restricts Johnson & Johnson\u2019s COVID-19 vaccine due to blood clot risk","Summary":""},{"Date":"May. 5, 2022 at 6:46 a.m. ET","Headline":"Powell\u2019s Balancing Act With the Punch Bowl Is Working Beautifully. For Now.","Summary":""},{"Date":"May. 6, 2022 at 9:13 p.m. ET","Headline":"One Amazing Stat That Captures Warren Buffett\u2019s Investing Career","Summary":""},{"Date":"May. 10, 2022 at 4:48 p.m. ET","Headline":"Dow books fourth straight day of losses as stocks end mixed","Summary":"Pfizer Inc.  said Tuesday it has entered a definitive agreement to acquire Biohaven Pharmaceutical Holding Company Ltd.  for $11.6 billion in cash. Biohaven is the maker of NURTEC ODT, a dual-acting migraine therapy approv..."},{"Date":"May. 10, 2022 at 2:26 p.m. ET","Headline":"Pfizer Is Spending $11.6 Billion on Biohaven. Its Plans Point to a Lot More M&A.","Summary":"Pfizer Inc.  said Tuesday it has entered a definitive agreement to acquire Biohaven Pharmaceutical Holding Company Ltd.  for $11.6 billion in cash. Biohaven is the maker of NURTEC ODT, a dual-acting migraine therapy approv..."},{"Date":"May. 10, 2022 at 1:50 p.m. ET","Headline":"What is Paxlovid, Pfizer\u2019s COVID antiviral drug, and how effective is it?","Summary":"Pfizer Inc.  said Tuesday it has entered a definitive agreement to acquire Biohaven Pharmaceutical Holding Company Ltd.  for $11.6 billion in cash. Biohaven is the maker of NURTEC ODT, a dual-acting migraine therapy approv..."},{"Date":"May. 10, 2022 at 10:06 a.m. ET","Headline":"Pfizer to Buy Biohaven Pharmaceuticals for $11.6 Billion","Summary":"Pfizer Inc.  said Tuesday it has entered a definitive agreement to acquire Biohaven Pharmaceutical Holding Company Ltd.  for $11.6 billion in cash. Biohaven is the maker of NURTEC ODT, a dual-acting migraine therapy approv..."},{"Date":"May. 10, 2022 at 9:27 a.m. ET","Headline":"Here\u2019s a list of 50 companies that are well-armed to beat back inflation","Summary":"Pfizer Inc.  said Tuesday it has entered a definitive agreement to acquire Biohaven Pharmaceutical Holding Company Ltd.  for $11.6 billion in cash. Biohaven is the maker of NURTEC ODT, a dual-acting migraine therapy approv..."},{"Date":"May. 10, 2022 at 7:47 a.m. ET","Headline":"New York Gov. Hochul tests positive for COVID, as two omicron subvariants spread across Empire State","Summary":"Pfizer Inc.  said Tuesday it has entered a definitive agreement to acquire Biohaven Pharmaceutical Holding Company Ltd.  for $11.6 billion in cash. Biohaven is the maker of NURTEC ODT, a dual-acting migraine therapy approv..."},{"Date":"May. 10, 2022 at 6:56 a.m. ET","Headline":"Pfizer to acquire Biohaven Pharma for $11.6 billion in cash sending Biohaven shares up 74% premarket","Summary":"Pfizer Inc.  said Tuesday it has entered a definitive agreement to acquire Biohaven Pharmaceutical Holding Company Ltd.  for $11.6 billion in cash. Biohaven is the maker of NURTEC ODT, a dual-acting migraine therapy approv..."},{"Date":"May. 9, 2022 at 8:16 a.m. ET","Headline":"New study finds omicron no less severe than earlier variants, and not just more transmissible","Summary":""},{"Date":"May. 9, 2022 at 8:02 a.m. ET","Headline":"A Strong Dollar Is the Latest Threat to the Stock Market","Summary":""},{"Date":"May. 12, 2022 at 10:25 a.m. ET","Headline":"A Healthcare Revolution Is Coming. How to Invest.","Summary":""},{"Date":"May. 14, 2022 at 3:45 p.m. ET","Headline":"12 stocks to consider for the next leg of the bull market","Summary":""},{"Date":"May. 13, 2022 at 7:39 p.m. ET","Headline":"How to Avoid the Biotech Bear Market: Get Some Products Approved","Summary":""},{"Date":"May. 13, 2022 at 12:39 p.m. ET","Headline":"Biotech Stocks Are Struggling. Relief Could Come Next Month.","Summary":""},{"Date":"May. 13, 2022 at 10:41 a.m. ET","Headline":"Some patients and physicians say it\u2019s hard to find Paxlovid, Pfizer\u2019s COVID-19 pill","Summary":""},{"Date":"May. 13, 2022 at 6:27 p.m. ET","Headline":"Don\u2019t Panic. It\u2019s Time to Be Bold and Buy Stocks.","Summary":""},{"Date":"May. 18, 2022 at 6:48 a.m. ET","Headline":"Retail Sales Data and Latest Earnings Suggest U.S. Isn\u2019t in Recession Just Yet","Summary":"The Food and Drug Administration said Tuesday that children between the ages of 5 and 11 years old can get a booster dose of BioNTech SE and Pfizer Inc.'s  COVID-19 vaccine. Children in this age group should wait at least ..."},{"Date":"May. 17, 2022 at 4:39 p.m. ET","Headline":"Dow climbs third straight day as stocks end sharply higher after retail sales, Fed Chair Powell\u2019s remarks","Summary":"The Food and Drug Administration said Tuesday that children between the ages of 5 and 11 years old can get a booster dose of BioNTech SE and Pfizer Inc.'s  COVID-19 vaccine. Children in this age group should wait at least ..."},{"Date":"May. 17, 2022 at 12:13 p.m. ET","Headline":"Pfizer\u2019s Covid-19 booster shot cleared for children ages 5 to 11","Summary":"The Food and Drug Administration said Tuesday that children between the ages of 5 and 11 years old can get a booster dose of BioNTech SE and Pfizer Inc.'s  COVID-19 vaccine. Children in this age group should wait at least ..."},{"Date":"May. 17, 2022 at 11:08 a.m. ET","Headline":"FDA authorizes a booster dose of BioNTech\/Pfizer's vaccine for 5 to 11 year olds","Summary":"The Food and Drug Administration said Tuesday that children between the ages of 5 and 11 years old can get a booster dose of BioNTech SE and Pfizer Inc.'s  COVID-19 vaccine. Children in this age group should wait at least ..."},{"Date":"May. 17, 2022 at 10:57 a.m. ET","Headline":"FDA Clears Pfizer Covid Booster for Kids Aged 5 to 11","Summary":""},{"Date":"May. 20, 2022 at 12:36 p.m. ET","Headline":"Rite Aid and its Bartell Drugs has COVID-19 boosters for 5-to-11 year olds available","Summary":"Rite Air Corp.  said Friday that the COVID-19 boosters for 5-to-11 year olds made by Pfizer Inc.  and BioNTech SE  are available at its drug stores and at Bartell Drugs, which it owns. The booster for that age group was au..."},{"Date":"May. 20, 2022 at 11:45 a.m. ET","Headline":"COVID-19 boosters for children to be rolled out","Summary":"The daily average for new COVID-19 cases topped the 100,000 mark of the third straight day and hospitalizations keep rising, but deaths fell to a 10-month low. Meanwhile, advisors to the Centers for Disease Control and Pre..."},{"Date":"May. 20, 2022 at 10:43 a.m. ET","Headline":"Novavax Gets First Sell Rating Since 2020. It\u2019s Got a Covid Vaccine Problem, Analyst Says.","Summary":"The daily average for new COVID-19 cases topped the 100,000 mark of the third straight day and hospitalizations keep rising, but deaths fell to a 10-month low. Meanwhile, advisors to the Centers for Disease Control and Pre..."},{"Date":"May. 20, 2022 at 9:44 a.m. ET","Headline":"U.S. government is offering free COVID tests again, as cases rise 57% from two weeks ago; FDA authorizes booster for children aged 5 to 11","Summary":"The daily average for new COVID-19 cases topped the 100,000 mark of the third straight day and hospitalizations keep rising, but deaths fell to a 10-month low. Meanwhile, advisors to the Centers for Disease Control and Pre..."},{"Date":"May. 20, 2022 at 6:54 a.m. ET","Headline":"Most Shoppers Have Never Seen This Inflation. The Results Haven\u2019t Been Pretty.","Summary":"The daily average for new COVID-19 cases topped the 100,000 mark of the third straight day and hospitalizations keep rising, but deaths fell to a 10-month low. Meanwhile, advisors to the Centers for Disease Control and Pre..."},{"Date":"May. 20, 2022 at 6:24 a.m. ET","Headline":"Coronavirus tally: Daily COVID-19 cases tops 100,000 again and hospitalizations rise, but deaths fall to 10-mo. low","Summary":"The daily average for new COVID-19 cases topped the 100,000 mark of the third straight day and hospitalizations keep rising, but deaths fell to a 10-month low. Meanwhile, advisors to the Centers for Disease Control and Pre..."},{"Date":"May. 20, 2022 at 5:23 a.m. ET","Headline":"Pfizer Covid Booster for Kids Aged 5 to 11 Cleared by CDC","Summary":"A team of advisers to the Centers for Disease Control and Prevention will meet Thursday to review a third dose of the vaccine developed by Pfizer  and BioNTech  for children aged 5 to 11, according to an The meeting comes ..."},{"Date":"May. 19, 2022 at 5:00 p.m. ET","Headline":"CDC Advisors Backs Pfizer Covid Booster for 5- to 11-Year-Olds","Summary":"A team of advisers to the Centers for Disease Control and Prevention will meet Thursday to review a third dose of the vaccine developed by Pfizer  and BioNTech  for children aged 5 to 11, according to an The meeting comes ..."},{"Date":"May. 19, 2022 at 4:25 p.m. ET","Headline":"CDC advisers recommend Pfizer COVID-19 booster shot for kids ages 5 to 11","Summary":"A team of advisers to the Centers for Disease Control and Prevention will meet Thursday to review a third dose of the vaccine developed by Pfizer  and BioNTech  for children aged 5 to 11, according to an The meeting comes ..."},{"Date":"May. 19, 2022 at 6:23 a.m. ET","Headline":"Coronavirus tally: CDC panel to meet to review boosters for children aged 5 to 11","Summary":"A team of advisers to the Centers for Disease Control and Prevention will meet Thursday to review a third dose of the vaccine developed by Pfizer  and BioNTech  for children aged 5 to 11, according to an The meeting comes ..."},{"Date":"May. 22, 2022 at 7:28 p.m. ET","Headline":"\u2018I chose to take a gamble\u2019: Husband-wife lab researchers admit taking Pfizer vaccine data to develop their own cancer treatment","Summary":""},{"Date":"May. 22, 2022 at 8:10 a.m. ET","Headline":"Biotech is in \u2018a Category 5 storm, the same as energy in 2020\u2019 \u2014 why contrarians say the sector is a buy","Summary":""},{"Date":"May. 21, 2022 at 10:15 a.m. ET","Headline":"Stocks Are Ready for a Bounce Higher After S&P 500 Rallies Out of Bear Market","Summary":""},{"Date":"May. 24, 2022 at 2:05 p.m. ET","Headline":"FDA panel to review Pfizer and Moderna vaccines for children aged six month to 4 years on June 15","Summary":"Pfizer Inc.  on Tuesday shared additional data in a news release from two Phase 3 clinical trials for its experimental ulcerative colitis drug, etrasimod. One study found clinical remission of 32.1% in patients taking etra..."},{"Date":"May. 24, 2022 at 11:13 a.m. ET","Headline":"Biogen Needs a New CEO. Here Are Some Options.","Summary":"Pfizer Inc.  on Tuesday shared additional data in a news release from two Phase 3 clinical trials for its experimental ulcerative colitis drug, etrasimod. One study found clinical remission of 32.1% in patients taking etra..."},{"Date":"May. 24, 2022 at 7:56 a.m. ET","Headline":"Philadelphia reinstates face-mask mandate for students and teachers, and WHO head warns pandemic is \u2018most certainly not over\u2019","Summary":"Pfizer Inc.  on Tuesday shared additional data in a news release from two Phase 3 clinical trials for its experimental ulcerative colitis drug, etrasimod. One study found clinical remission of 32.1% in patients taking etra..."},{"Date":"May. 24, 2022 at 7:22 a.m. ET","Headline":"Pfizer reports more positive clinical data for its investigational colitis drug","Summary":"Pfizer Inc.  on Tuesday shared additional data in a news release from two Phase 3 clinical trials for its experimental ulcerative colitis drug, etrasimod. One study found clinical remission of 32.1% in patients taking etra..."},{"Date":"May. 24, 2022 at 6:47 a.m. ET","Headline":"What Snap Tells Us About Consumers as Retailers Line Up More Earnings","Summary":"The Food and Drug Administration said Monday an advisory panel would meet June 15 to discuss use of the vaccines developed by Pfizer Inc.  and German partner BioNTech SE  as well as the one developed by Moderna Inc.  in ch..."},{"Date":"May. 24, 2022 at 6:45 a.m. ET","Headline":"Pfizer Gives Encouraging Treatment Data for New Drug from Arena Acquisition","Summary":"The Food and Drug Administration said Monday an advisory panel would meet June 15 to discuss use of the vaccines developed by Pfizer Inc.  and German partner BioNTech SE  as well as the one developed by Moderna Inc.  in ch..."},{"Date":"May. 24, 2022 at 6:27 a.m. ET","Headline":"Coronavirus tally: FDA advisory panel to meet June 15 to discuss Pfizer, BioNTech and Moderna vaccines for children aged 6 months to 4 years","Summary":"The Food and Drug Administration said Monday an advisory panel would meet June 15 to discuss use of the vaccines developed by Pfizer Inc.  and German partner BioNTech SE  as well as the one developed by Moderna Inc.  in ch..."},{"Date":"May. 24, 2022 at 6:03 a.m. ET","Headline":"\u2018If you wait for the right time to travel you may never do it\u2019 \u2014 seniors take stock of risks as COVID cases rise","Summary":"Shares of Pfizer Inc.  rose 0.3% and BioNTech SE  rallied 1.3% in premarket trading, after the drug makers said three doses of it COVID-19 vaccine for children aged six months to five years \"met all immunobridging criteria..."},{"Date":"May. 23, 2022 at 8:43 a.m. ET","Headline":"Pfizer\u2019s Three-Dose Covid Vaccine Is 80% Effective in Young Children, Data Show","Summary":"Shares of Pfizer Inc.  rose 0.3% and BioNTech SE  rallied 1.3% in premarket trading, after the drug makers said three doses of it COVID-19 vaccine for children aged six months to five years \"met all immunobridging criteria..."},{"Date":"May. 23, 2022 at 8:03 a.m. ET","Headline":"Pfizer, BioNTech COVID-19 vaccine for children aged 6 months to 5 years meets EUA criteria","Summary":"Shares of Pfizer Inc.  rose 0.3% and BioNTech SE  rallied 1.3% in premarket trading, after the drug makers said three doses of it COVID-19 vaccine for children aged six months to five years \"met all immunobridging criteria..."},{"Date":"May. 26, 2022 at 8:52 a.m. ET","Headline":"Exxon Mobil Stock Was Once Worth Less Than Zoom. That Seems Ridiculous Now.","Summary":""},{"Date":"May. 26, 2022 at 6:20 a.m. ET","Headline":"US moves to make antiviral drug more available against COVID","Summary":""},{"Date":"May. 25, 2022 at 1:48 p.m. ET","Headline":"Bill Gates and Pfizer\u2019s CEO Don\u2019t Want the World to Ignore Covid-19","Summary":""},{"Date":"May. 25, 2022 at 10:45 a.m. ET","Headline":"CDC: A Paxlovid rebound may be \u2018natural\u2019 part of a COVID-19 infection","Summary":""},{"Date":"May. 25, 2022 at 10:24 a.m. ET","Headline":"I wrongly expected COVID to fade last summer \u2014 here\u2019s what to expect this time","Summary":""},{"Date":"May. 25, 2022 at 10:07 a.m. ET","Headline":"Here\u2019s the signal for investors from the deep pessimism of Bill Ackman and George Soros","Summary":""},{"Date":"May. 25, 2022 at 8:43 a.m. ET","Headline":"An Unexpected Blue Wave Could Shake Up These Stocks","Summary":""},{"Date":"May. 25, 2022 at 5:25 a.m. ET","Headline":"Pfizer to Sell Medicines and Vaccines at Low Prices to Poorer Countries","Summary":""},{"Date":"May. 25, 2022 at 3:35 a.m. ET","Headline":"Pfizer to offer low-cost medicines, vaccines to poor nations","Summary":""},{"Date":"May. 24, 2022 at 8:32 a.m. ET","Headline":"The 10 Cheapest S&P 500 Stocks Include 3 Home Builders","Summary":""},{"Date":"May. 27, 2022 at 10:23 a.m. ET","Headline":"White House steps up effort to provide antiviral access to more Americans as cases start to stabilize in Northeast","Summary":""},{"Date":"May. 27, 2022 at 7:48 a.m. ET","Headline":"The FDA\u2019s decision on the Novavax COVID-19 vaccine could come in weeks","Summary":""},{"Date":"May. 29, 2022 at 8:58 a.m. ET","Headline":"A new generation of ulcerative colitis drugs is in development. Will they be blockbusters for Lilly and Pfizer?","Summary":""},{"Date":"Jun. 1, 2022 at 6:34 p.m. ET","Headline":"Pfizer asks FDA to authorize its 3-dose COVID vaccine for children under 5","Summary":""},{"Date":"Jun. 1, 2022 at 7:34 a.m. ET","Headline":"Pfizer to Exit GSK Consumer Health Venture After Spinoff","Summary":""},{"Date":"May. 31, 2022 at 10:10 a.m. ET","Headline":"Don\u2019t fall in love with stocks, they\u2019ll break your heart","Summary":""},{"Date":"May. 31, 2022 at 8:40 a.m. ET","Headline":"Buy This Pharma Stock. Its Rally Is Just Getting Started","Summary":""},{"Date":"May. 31, 2022 at 8:08 a.m. ET","Headline":"GSK to Buy U.S. Biotech Affinivax in $3.3 Billion Deal","Summary":""},{"Date":"Jun. 3, 2022 at 1:34 p.m. ET","Headline":"Novavax: There is 'insufficient evidence' tying its COVID-19 vaccine to heart inflammation","Summary":"Novavax Inc.  said Friday that the company believes \"there is insufficient evidence to establish a causal relationship\" between its COVID-19 vaccine candidate and instances of myocarditis and pericarditis. Novavax's stock ..."},{"Date":"Jun. 3, 2022 at 11:59 a.m. ET","Headline":"In boost for parents, Biden administration says COVID vaccine for kids under 5 could start June 21, and Prince Andrew misses Jubilee event after testing positive","Summary":"Shares of Novavax Inc.  tumbled 22.9% in trading on Friday after the Food and Drug Administration published a  that detailed the agency's assessment of the clinical data for the company's COVID-19 vaccine candidate. There ..."},{"Date":"Jun. 3, 2022 at 11:58 a.m. ET","Headline":"UPDATE: Novavax's stock slides 23% after FDA details myocarditis cases for COVID-19 vaccine candidate","Summary":"Shares of Novavax Inc.  tumbled 22.9% in trading on Friday after the Food and Drug Administration published a  that detailed the agency's assessment of the clinical data for the company's COVID-19 vaccine candidate. There ..."},{"Date":"Jun. 3, 2022 at 9:34 a.m. ET","Headline":"Turning Point Stock Doubles After Bristol Myers Announces Takeover. What It Means for Biotech M&A.","Summary":"Children under five years old could begin to receive vaccinations against COVID-19 as early as June 21, a top Biden administration official said Thursday. Dr. Ashish Jha, the White House's COVID response coordinator, told ..."},{"Date":"Jun. 3, 2022 at 6:27 a.m. ET","Headline":"Pfizer and BioNTech seek FDA authorization for 3-dose vaccine for children between 6 months and 5 years old, and WHO warns that fewer tests mean fewer cases detected","Summary":"Children under five years old could begin to receive vaccinations against COVID-19 as early as June 21, a top Biden administration official said Thursday. Dr. Ashish Jha, the White House's COVID response coordinator, told ..."},{"Date":"Jun. 3, 2022 at 6:15 a.m. ET","Headline":"Coronavirus tally: White House says vaccinations for children under 5 could start by June 21","Summary":"Children under five years old could begin to receive vaccinations against COVID-19 as early as June 21, a top Biden administration official said Thursday. Dr. Ashish Jha, the White House's COVID response coordinator, told ..."},{"Date":"Jun. 2, 2022 at 4:31 p.m. ET","Headline":"Dow, S&P 500, Nasdaq notch best session in nearly a week despite Microsoft warning citing U.S. dollar\u2019s strength","Summary":"Children under five years old could begin to receive vaccinations against COVID-19 as early as June 21, a top Biden administration official said Thursday. Dr. Ashish Jha, the White House's COVID response coordinator, told ..."},{"Date":"Jun. 2, 2022 at 3:35 p.m. ET","Headline":"COVID vaccinations for children under 5 could start as early as June 21, Biden official says","Summary":"Children under five years old could begin to receive vaccinations against COVID-19 as early as June 21, a top Biden administration official said Thursday. Dr. Ashish Jha, the White House's COVID response coordinator, told ..."},{"Date":"Jun. 2, 2022 at 8:25 a.m. ET","Headline":"Amazon Splits Its Stock Next Week. Who\u2019s Next, and Why It Matters.","Summary":"Pfizer Inc.  and partner BioNTech SE  have asked U.S. health regulators to authorize three doses of their vaccine for children under 5 years,  The move comes after the companies said last month that three doses of the shot..."},{"Date":"Jun. 2, 2022 at 7:16 a.m. ET","Headline":"Relief at the Pump Could Come Soon. Thank Saudi Arabia.","Summary":"Pfizer Inc.  and partner BioNTech SE  have asked U.S. health regulators to authorize three doses of their vaccine for children under 5 years,  The move comes after the companies said last month that three doses of the shot..."},{"Date":"Jun. 2, 2022 at 6:19 a.m. ET","Headline":"Coronavirus tally: Pfizer and BioNTech seek FDA authorization for 3-shot vaccine in children aged 6 months to five years","Summary":"Pfizer Inc.  and partner BioNTech SE  have asked U.S. health regulators to authorize three doses of their vaccine for children under 5 years,  The move comes after the companies said last month that three doses of the shot..."},{"Date":"Jun. 2, 2022 at 6:09 a.m. ET","Headline":"Pfizer Asks FDA to OK Covid Vaccine for Children Under 5","Summary":""},{"Date":"Jun. 5, 2022 at 4:35 p.m. ET","Headline":"AMD, Pfizer, NIO, DocuSign, Campbell Soup, and Other Stocks for Investors to Watch This Week","Summary":""},{"Date":"Jun. 3, 2022 at 7:01 p.m. ET","Headline":"Where GM Is Creating Its EV Future: Factory Zero","Summary":""},{"Date":"Jun. 7, 2022 at 1:19 p.m. ET","Headline":"FDA panel to review Novavax candidate as potential fourth vaccine for adult Americans, and Pete Buttigieg tests positive for COVID","Summary":"Shares of Pfizer Inc.  rose 0.8% in morning trading Monday, after the drug maker said it will make a $120 million investment at its facility in Kalamazoo, Mich. to support production of its oral COVID-19 treatment, Paxlovi..."},{"Date":"Jun. 7, 2022 at 6:36 a.m. ET","Headline":"Elon Musk\u2019s Fight About Twitter Bots Is Really a Fight Over Deal Price","Summary":"Shares of Pfizer Inc.  rose 0.8% in morning trading Monday, after the drug maker said it will make a $120 million investment at its facility in Kalamazoo, Mich. to support production of its oral COVID-19 treatment, Paxlovi..."},{"Date":"Jun. 6, 2022 at 5:10 p.m. ET","Headline":"Amazon\u2019s Split Shouldn\u2019t Mean Much. But It Helped the Stock Anyway.","Summary":"Shares of Pfizer Inc.  rose 0.8% in morning trading Monday, after the drug maker said it will make a $120 million investment at its facility in Kalamazoo, Mich. to support production of its oral COVID-19 treatment, Paxlovi..."},{"Date":"Jun. 6, 2022 at 12:04 p.m. ET","Headline":"A \u2018pinch\u2019 for the stock market but good news for the Fed: What investors need to know about a strong U.S. dollar","Summary":"Shares of Pfizer Inc.  rose 0.8% in morning trading Monday, after the drug maker said it will make a $120 million investment at its facility in Kalamazoo, Mich. to support production of its oral COVID-19 treatment, Paxlovi..."},{"Date":"Jun. 6, 2022 at 11:10 a.m. ET","Headline":"Pfizer to create 250 jobs with investment in Michigan facility producing COVID-19 pill","Summary":"Shares of Pfizer Inc.  rose 0.8% in morning trading Monday, after the drug maker said it will make a $120 million investment at its facility in Kalamazoo, Mich. to support production of its oral COVID-19 treatment, Paxlovi..."},{"Date":"Jun. 9, 2022 at 10:36 a.m. ET","Headline":"Novavax Covid Vaccine Won\u2019t Get Authorization Until the FDA Reviews Manufacturing Changes.","Summary":""},{"Date":"Jun. 9, 2022 at 7:25 a.m. ET","Headline":"Moderna\u2019s next-generation COVID-19 booster provides \u2018superior\u2019 protection against omicron","Summary":""},{"Date":"Jun. 9, 2022 at 6:48 a.m. ET","Headline":"On the ECB\u2019s Big Day, It Has Much a Tougher Job Than the Fed","Summary":""},{"Date":"Jun. 9, 2022 at 6:25 a.m. ET","Headline":"New omicron subvariants are rising in U.S., and FDA panel gives its backing to Novavax vaccine","Summary":""},{"Date":"Jun. 9, 2022 at 5:42 a.m. ET","Headline":"U.S. prepares to distribute Covid-19 shots to children under 5","Summary":""},{"Date":"Jun. 8, 2022 at 2:42 p.m. ET","Headline":"Why Novavax and Moderna Stocks May Not Get a Boost From Next Phase of Covid-19 Vaccines","Summary":""},{"Date":"Jun. 8, 2022 at 11:10 a.m. ET","Headline":"COVID patients with weak immune systems should get priority care to avoid new variants emerging, experts say","Summary":""},{"Date":"Jun. 8, 2022 at 9:05 a.m. ET","Headline":"Moderna Booster Targeting Omicron Shows Stronger Immune Response Than Original Vaccine","Summary":""},{"Date":"Jun. 8, 2022 at 6:22 a.m. ET","Headline":"FDA Advisors Back Novavax\u2019s Covid Vaccine, Clearing Way for Authorization. The Stock Surges.","Summary":""},{"Date":"Jun. 11, 2022 at 7:44 a.m. ET","Headline":"Energy stocks are this year\u2019s best performers \u2014 but they\u2019re not on the list of top investment newsletters","Summary":""},{"Date":"Jun. 10, 2022 at 9:18 a.m. ET","Headline":"GSK Reports a Win for Its RSV Vaccine and Plans to Ask for Approval This Year","Summary":""},{"Date":"Jun. 13, 2022 at 5:13 p.m. ET","Headline":"COVID-variant booster from Sanofi, GSK shows promising results","Summary":"Sanofi  said Monday that preliminary data shows that its experimental next-generation COVID-19 booster provided a 40-fold increase in antibody protection against BA.1, a subvariant of omicron, in adults who had been previo..."},{"Date":"Jun. 13, 2022 at 10:20 a.m. ET","Headline":"Sanofi and GSK\u2019s Beta-Specific Covid Booster Could Protect Against Multiple Variants","Summary":"Sanofi  said Monday that preliminary data shows that its experimental next-generation COVID-19 booster provided a 40-fold increase in antibody protection against BA.1, a subvariant of omicron, in adults who had been previo..."},{"Date":"Jun. 13, 2022 at 9:40 a.m. ET","Headline":"FDA and CDC Advisors Will Consider Covid Vaccines for Children Under 5 This Week","Summary":"Sanofi  said Monday that preliminary data shows that its experimental next-generation COVID-19 booster provided a 40-fold increase in antibody protection against BA.1, a subvariant of omicron, in adults who had been previo..."},{"Date":"Jun. 13, 2022 at 8:57 a.m. ET","Headline":"Sanofi's 'next-generation' COVID-19 booster outperformed traditional boosters","Summary":"Sanofi  said Monday that preliminary data shows that its experimental next-generation COVID-19 booster provided a 40-fold increase in antibody protection against BA.1, a subvariant of omicron, in adults who had been previo..."},{"Date":"Jun. 13, 2022 at 4:46 a.m. ET","Headline":"Pfizer\u2019s Covid Vaccine Safe and Effective in Children Under 5, FDA Says","Summary":""},{"Date":"Jun. 12, 2022 at 8:05 p.m. ET","Headline":"FDA says Pfizer\u2019s COVID-19 vaccine appears effective for kids under 5","Summary":""},{"Date":"Jun. 12, 2022 at 6:46 p.m. ET","Headline":"U.S. Stocks Poised to Open Lower on Monday Ahead of Fed Week","Summary":""},{"Date":"Jun. 12, 2022 at 3:58 p.m. ET","Headline":"Fed Meeting, Oracle and Adobe Earnings, May Inflation Data, and More to Watch This Week","Summary":""},{"Date":"Jun. 10, 2022 at 7:28 p.m. ET","Headline":"For Now, China\u2019s Crackdown on Tech Seems to Be Passing. But Will It Last?","Summary":""},{"Date":"Feb. 21, 2022 at 8:00 a.m. ET","Headline":"Go Ahead, Retire at 62 and Claim Social Security at 67. Your Benefit Will Climb.","Summary":""},{"Date":"Jun. 15, 2022 at 4:56 p.m. ET","Headline":"FDA Advisers Back Moderna and Pfizer Covid Vaccines for Young Children","Summary":"A panel of advisers to the Food and Drug Administration endorsed a second brand of COVID-19 vaccine for school-age children and teens, the Associated Press reported. The group voted unanimously that Moderna's  vaccine is s..."},{"Date":"Jun. 15, 2022 at 1:51 p.m. ET","Headline":"FDA panel reviews vaccines for children under 5, and WHO warns against pandemic complacency","Summary":"A panel of advisers to the Food and Drug Administration endorsed a second brand of COVID-19 vaccine for school-age children and teens, the Associated Press reported. The group voted unanimously that Moderna's  vaccine is s..."},{"Date":"Jun. 15, 2022 at 6:18 a.m. ET","Headline":"Coronavirus tally: FDA panel oks Moderna vaccine for children ages 6 to 17, to review Moderna and Pfizer shots for small children","Summary":"A panel of advisers to the Food and Drug Administration endorsed a second brand of COVID-19 vaccine for school-age children and teens, the Associated Press reported. The group voted unanimously that Moderna's  vaccine is s..."},{"Date":"Jun. 14, 2022 at 4:54 p.m. ET","Headline":"FDA Advisors Back Moderna Covid-19 Vaccine for 6- to 17-Year-Olds","Summary":"An independent panel of advisers to the Food and Drug Administration will meet later Tuesday to discuss the use of the Moderna  vaccine in children aged 6 to 17. If the panel offers a favorable opinion, the Moderna vaccine..."},{"Date":"Jun. 14, 2022 at 4:37 p.m. ET","Headline":"FDA panel backs Moderna\u2019s COVID-19 vaccine for kids ages 6-17","Summary":"An independent panel of advisers to the Food and Drug Administration will meet later Tuesday to discuss the use of the Moderna  vaccine in children aged 6 to 17. If the panel offers a favorable opinion, the Moderna vaccine..."},{"Date":"Jun. 14, 2022 at 1:36 p.m. ET","Headline":"FDA panel to review Moderna vaccine in children aged 6 to 17, and Rolling Stones front man Mick Jagger tests positive for COVID","Summary":"An independent panel of advisers to the Food and Drug Administration will meet later Tuesday to discuss the use of the Moderna  vaccine in children aged 6 to 17. If the panel offers a favorable opinion, the Moderna vaccine..."},{"Date":"Jun. 14, 2022 at 8:13 a.m. ET","Headline":"FDA says Pfizer three-shot vaccine is safe for children under 5, ahead of panel meeting that will also review Moderna\u2019s two-shot regimen","Summary":"An independent panel of advisers to the Food and Drug Administration will meet later Tuesday to discuss the use of the Moderna  vaccine in children aged 6 to 17. If the panel offers a favorable opinion, the Moderna vaccine..."},{"Date":"Jun. 14, 2022 at 6:22 a.m. ET","Headline":"Coronavirus tally: FDA panel to review Moderna vaccine for children aged 6 to 17","Summary":"An independent panel of advisers to the Food and Drug Administration will meet later Tuesday to discuss the use of the Moderna  vaccine in children aged 6 to 17. If the panel offers a favorable opinion, the Moderna vaccine..."},{"Date":"Jun. 17, 2022 at 3:43 p.m. ET","Headline":"FDA clears path for CDC to authorize mRNA vaccines in youngest children, but Florida officials say they do not recommend them","Summary":"The Food and Drug Administration announced Friday that it authorized the COVID-19 vaccines developed by BioNTech SE \/Pfizer Inc.  and Moderna Inc.  for children as young as six months old. The regulator said Moderna's two-..."},{"Date":"Jun. 17, 2022 at 9:54 a.m. ET","Headline":"It\u2019s time to let pharmacists prescribe COVID-fighting pills like Paxlovid","Summary":"The Food and Drug Administration announced Friday that it authorized the COVID-19 vaccines developed by BioNTech SE \/Pfizer Inc.  and Moderna Inc.  for children as young as six months old. The regulator said Moderna's two-..."},{"Date":"Jun. 17, 2022 at 9:25 a.m. ET","Headline":"FDA authorizes both mRNA vaccines for young children","Summary":"The Food and Drug Administration announced Friday that it authorized the COVID-19 vaccines developed by BioNTech SE \/Pfizer Inc.  and Moderna Inc.  for children as young as six months old. The regulator said Moderna's two-..."},{"Date":"Jun. 17, 2022 at 9:25 a.m. ET","Headline":"FDA Authorizes Covid-19 Vaccines for Young Children, Setting Stage for Call by CDC","Summary":"White House press secretary Karine Jean-Pierre on Thursday said the Biden administration is encouraging officials in Florida to pre-order COVID-19 vaccines for the youngest children, after a reporter asked about Florida be..."},{"Date":"Jun. 17, 2022 at 7:23 a.m. ET","Headline":"FDA panel gives go-ahead for children under 5 to be vaccinated, but experts fret that not all parents will get on board","Summary":"White House press secretary Karine Jean-Pierre on Thursday said the Biden administration is encouraging officials in Florida to pre-order COVID-19 vaccines for the youngest children, after a reporter asked about Florida be..."},{"Date":"Jun. 16, 2022 at 1:18 p.m. ET","Headline":"White House says it's encouraging Florida to pre-order COVID vaccines for youngest kids","Summary":"White House press secretary Karine Jean-Pierre on Thursday said the Biden administration is encouraging officials in Florida to pre-order COVID-19 vaccines for the youngest children, after a reporter asked about Florida be..."},{"Date":"Jun. 16, 2022 at 8:21 a.m. ET","Headline":"Pfizer says Paxlovid doesn\u2019t help COVID-19 patients unless they are high risk","Summary":"A panel of advisers to the Food and Drug Administration on Wednesdayto both the Moderna  and Pfizer  vaccines for children below the age of five, the last group to be added to the vaccine program. Advisers to the Centers f..."},{"Date":"Jun. 16, 2022 at 8:19 a.m. ET","Headline":"FDA committee recommends two COVID-19 vaccines for young children","Summary":"A panel of advisers to the Food and Drug Administration on Wednesdayto both the Moderna  and Pfizer  vaccines for children below the age of five, the last group to be added to the vaccine program. Advisers to the Centers f..."},{"Date":"Jun. 16, 2022 at 7:14 a.m. ET","Headline":"The Fed Will Keep Hiking, and the Market Outlook Won\u2019t Change Until It Stops","Summary":"A panel of advisers to the Food and Drug Administration on Wednesdayto both the Moderna  and Pfizer  vaccines for children below the age of five, the last group to be added to the vaccine program. Advisers to the Centers f..."},{"Date":"Jun. 16, 2022 at 6:30 a.m. ET","Headline":"Coronavirus tally: FDA panel oks Moderna and Pfizer vaccines for under-5s and Fauci tests positive for COVID","Summary":"A panel of advisers to the Food and Drug Administration on Wednesdayto both the Moderna  and Pfizer  vaccines for children below the age of five, the last group to be added to the vaccine program. Advisers to the Centers f..."},{"Date":"Jun. 19, 2022 at 11:05 p.m. ET","Headline":"U.S. opens COVID vaccine to little kids; shots begin this week","Summary":""},{"Date":"Jun. 18, 2022 at 2:38 p.m. ET","Headline":"CDC Advisors Recommend Moderna, Pfizer Covid-19 Vaccines for Young Children","Summary":""},{"Date":"Jun. 18, 2022 at 1:57 p.m. ET","Headline":"CDC advisers recommend COVID-19 shots for children under 5","Summary":""},{"Date":"Jun. 21, 2022 at 9:56 a.m. ET","Headline":"Valneva Shares Are Soaring. Pfizer Is Buying a Stake.","Summary":"U.S.-listed shares of Valneva  soared 81.9% in premarket trading on Tuesday, the day after Pfizer Inc.  announced a $95 million equity investment in Valneva as part of a previously established agreement aimed at developing..."},{"Date":"Jun. 21, 2022 at 7:42 a.m. ET","Headline":"Pfizer makes equity investment in Valneva as they prepare for Phase 3 trial of Lyme disease vaccine candidate","Summary":"U.S.-listed shares of Valneva  soared 81.9% in premarket trading on Tuesday, the day after Pfizer Inc.  announced a $95 million equity investment in Valneva as part of a previously established agreement aimed at developing..."},{"Date":"Jun. 21, 2022 at 6:28 a.m. ET","Headline":"Coronavirus tally: U.S. to start vaccinating children below the age of 5 this week","Summary":"The U.S. will start vaccinating children below the age of 5 starting this week, after regulatory agencies approved the shots developed by Moderna  and Pfizer  and BioNTech  over the weekend. Advisers to the Centers for Dis..."},{"Date":"Jun. 20, 2022 at 4:00 a.m. ET","Headline":"Pfizer to Buy 8.1% Stake in French Vaccines Company Valneva","Summary":""},{"Date":"Jun. 17, 2022 at 3:04 p.m. ET","Headline":"The Days of Big Pharma Are Over. What the Era of Big Biotech Means for Investors.","Summary":""},{"Date":"Jun. 23, 2022 at 4:14 p.m. ET","Headline":"Dr. Fauci\u2019s COVID case was \u2018mild\u2019 thanks to being vaccinated and double-boosted, he says","Summary":"The U.S. has delivered more than 4 million doses of the COVID-19 vaccines for young children to approximately 13,000 sites across the country, according to remarks made Thursday by White House COVID-19 Response Coordinator..."},{"Date":"Jun. 23, 2022 at 2:53 p.m. ET","Headline":"White House: 4 million doses of COVID-19 vaccines for young children have been distributed","Summary":"The U.S. has delivered more than 4 million doses of the COVID-19 vaccines for young children to approximately 13,000 sites across the country, according to remarks made Thursday by White House COVID-19 Response Coordinator..."},{"Date":"Jun. 23, 2022 at 9:46 a.m. ET","Headline":"Merck Clocks Wins Against Pfizer in Pneumococcal Vaccine Market","Summary":"BioNTech SE  said Thursday it has broken ground on the construction of the first mRNA manufacturing facility in Africa, a plant in Kigali, Rwanda that is expected to employ about 100 workers by 2024. The first of two BioNT..."},{"Date":"Jun. 23, 2022 at 7:46 a.m. ET","Headline":"Enanta Pharmaceuticals, which is developing its own COVID-19 antiviral, says Pfizer infringed on a patent with Paxlovid","Summary":"BioNTech SE  said Thursday it has broken ground on the construction of the first mRNA manufacturing facility in Africa, a plant in Kigali, Rwanda that is expected to employ about 100 workers by 2024. The first of two BioNT..."},{"Date":"Jun. 23, 2022 at 6:09 a.m. ET","Headline":"BioNTech breaks ground on first mRNA manufacturing facility in Africa in Kigali, Rwanda","Summary":"BioNTech SE  said Thursday it has broken ground on the construction of the first mRNA manufacturing facility in Africa, a plant in Kigali, Rwanda that is expected to employ about 100 workers by 2024. The first of two BioNT..."},{"Date":"Jun. 22, 2022 at 3:28 p.m. ET","Headline":"Moderna Says Its Latest Booster Offers Protection as Omicron Subvariants Spread","Summary":""},{"Date":"Jun. 22, 2022 at 12:01 p.m. ET","Headline":"Biden pushes back after Chevron CEO says oil industry has been vilified: \u2018He\u2019s mildly sensitive\u2019","Summary":""},{"Date":"Jun. 22, 2022 at 8:09 a.m. ET","Headline":"U.S. to start vaccinating very young children this week, and panel to recommend overhauling healthcare system","Summary":""},{"Date":"Jun. 25, 2022 at 4:09 p.m. ET","Headline":"COVID vaccines for kids under 5 \u2014 what parents need to know","Summary":"A panel of advisers to the Centers for Disease Control and Prevention voted unanimously Thursday to recommend Moderna's  COVID vaccine for children and adolescents aged 6 to 17. The move is expected to lead CDC head Dr. Ro..."},{"Date":"Jun. 25, 2022 at 11:02 a.m. ET","Headline":"Pfizer and BioNTech Say Their Updated Boosters Provide More Protection Against Omicron","Summary":"A panel of advisers to the Centers for Disease Control and Prevention voted unanimously Thursday to recommend Moderna's  COVID vaccine for children and adolescents aged 6 to 17. The move is expected to lead CDC head Dr. Ro..."},{"Date":"Jun. 25, 2022 at 4:00 a.m. ET","Headline":"Darden Restaurants and Kroger Raise Dividends in a Quiet Week for Payouts","Summary":"A panel of advisers to the Centers for Disease Control and Prevention voted unanimously Thursday to recommend Moderna's  COVID vaccine for children and adolescents aged 6 to 17. The move is expected to lead CDC head Dr. Ro..."},{"Date":"Jun. 24, 2022 at 4:30 p.m. ET","Headline":"How an Income Fund Makes Stocks Safer With High-Yield Bonds","Summary":"A panel of advisers to the Centers for Disease Control and Prevention voted unanimously Thursday to recommend Moderna's  COVID vaccine for children and adolescents aged 6 to 17. The move is expected to lead CDC head Dr. Ro..."},{"Date":"Jun. 24, 2022 at 1:38 p.m. ET","Headline":"CDC panel backs Moderna vaccine for children aged 6 to 17, and study finds vaccines saved about 20 million lives in their first year","Summary":"A panel of advisers to the Centers for Disease Control and Prevention voted unanimously Thursday to recommend Moderna's  COVID vaccine for children and adolescents aged 6 to 17. The move is expected to lead CDC head Dr. Ro..."},{"Date":"Jun. 24, 2022 at 9:50 a.m. ET","Headline":"New Data Suggest GSK and Sanofi\u2019s Covid Vaccine Could Pose a Challenge to Pfizer and Moderna","Summary":"A panel of advisers to the Centers for Disease Control and Prevention voted unanimously Thursday to recommend Moderna's  COVID vaccine for children and adolescents aged 6 to 17. The move is expected to lead CDC head Dr. Ro..."},{"Date":"Jun. 24, 2022 at 8:14 a.m. ET","Headline":"COVID cases surge again in Europe as Moderna says its booster candidate protects against BA.4 and BA.5 omicron subvariants","Summary":"A panel of advisers to the Centers for Disease Control and Prevention voted unanimously Thursday to recommend Moderna's  COVID vaccine for children and adolescents aged 6 to 17. The move is expected to lead CDC head Dr. Ro..."},{"Date":"Jun. 24, 2022 at 8:14 a.m. ET","Headline":"Cases climb in Southeast Asia and Europe in latest week as BA.4 and BA.5 subvariants take hold","Summary":"A panel of advisers to the Centers for Disease Control and Prevention voted unanimously Thursday to recommend Moderna's  COVID vaccine for children and adolescents aged 6 to 17. The move is expected to lead CDC head Dr. Ro..."},{"Date":"Jun. 24, 2022 at 6:29 a.m. ET","Headline":"Coronavirus tally: CDC panel backs Moderna vaccine for children aged 6 to 17 in move that could add second option for that group","Summary":"A panel of advisers to the Centers for Disease Control and Prevention voted unanimously Thursday to recommend Moderna's  COVID vaccine for children and adolescents aged 6 to 17. The move is expected to lead CDC head Dr. Ro..."},{"Date":"Jun. 27, 2022 at 12:03 p.m. ET","Headline":"Pfizer booster improved to fight omicron, as hospitalizations rise to 3-month high","Summary":"Pfizer Inc.  and BioNTech SE  said over the weekend that  that targets the omicron variant is both safe and effective. The announcement comes as the U.S. Food and Drug Administration considers this week if it should order ..."},{"Date":"Jun. 27, 2022 at 7:00 a.m. ET","Headline":"Pfizer says updated COVID-19 booster can provide more protection against super-contagious omicron","Summary":"Pfizer Inc.  and BioNTech SE  said over the weekend that  that targets the omicron variant is both safe and effective. The announcement comes as the U.S. Food and Drug Administration considers this week if it should order ..."},{"Date":"Jun. 27, 2022 at 6:33 a.m. ET","Headline":"The Russian Default Is Less Worrisome Than It Appears. Keep Watching Oil.","Summary":"Pfizer Inc.  and BioNTech SE  said over the weekend that  that targets the omicron variant is both safe and effective. The announcement comes as the U.S. Food and Drug Administration considers this week if it should order ..."},{"Date":"Jun. 27, 2022 at 6:17 a.m. ET","Headline":"Coronavirus tally: Pfizer says updated COVID-19 booster is better against omicron, as cases top 100,000 again","Summary":"Pfizer Inc.  and BioNTech SE  said over the weekend that  that targets the omicron variant is both safe and effective. The announcement comes as the U.S. Food and Drug Administration considers this week if it should order ..."},{"Date":"Jun. 27, 2022 at 3:00 a.m. ET","Headline":"FDA Panel Will Weigh In on Covid Boosters for This Fall. What\u2019s at Stake.","Summary":""},{"Date":"Jun. 29, 2022 at 5:03 p.m. ET","Headline":"U.S. to pay $3.2 billion to Pfizer, BioNTech for more COVID-19 vaccines for fall","Summary":"Pfizer Inc.  and BioNTech SE  said late Wednesday they have inked a new agreement with the U.S. government to supply 105 million doses of their COVID-19 vaccines, including a formulation adapted to target omicron variants,..."},{"Date":"Jun. 29, 2022 at 1:29 p.m. ET","Headline":"Elmo gets the COVID vaccine, and says \u2018there was a little pinch, but it was OK\u2019","Summary":"Johnson & Johnson  does not plan to update its COVID-19 vaccine, though other vaccine makers like Moderna Inc. , BioNTech SE  and Pfizer Inc. , and Novavax Inc.  are already working on new versions that aim to better prote..."},{"Date":"Jun. 29, 2022 at 8:23 a.m. ET","Headline":"FDA Advisers Recommend Updating Covid-19 Boosters for Omicron Component","Summary":"Johnson & Johnson  does not plan to update its COVID-19 vaccine, though other vaccine makers like Moderna Inc. , BioNTech SE  and Pfizer Inc. , and Novavax Inc.  are already working on new versions that aim to better prote..."},{"Date":"Jun. 29, 2022 at 7:51 a.m. ET","Headline":"FDA advisers say the U.S. needs updated COVID-19 boosters to fight omicron","Summary":"Johnson & Johnson  does not plan to update its COVID-19 vaccine, though other vaccine makers like Moderna Inc. , BioNTech SE  and Pfizer Inc. , and Novavax Inc.  are already working on new versions that aim to better prote..."},{"Date":"Jun. 29, 2022 at 6:48 a.m. ET","Headline":"Dividend Restraint Shows Banks Have Learned Some Lessons From the Last Crisis","Summary":"Johnson & Johnson  does not plan to update its COVID-19 vaccine, though other vaccine makers like Moderna Inc. , BioNTech SE  and Pfizer Inc. , and Novavax Inc.  are already working on new versions that aim to better prote..."},{"Date":"Jun. 28, 2022 at 3:39 p.m. ET","Headline":"Novartis Will Cut 8,000 Jobs Under CEO\u2019s Shake-Up Plan","Summary":"Johnson & Johnson  does not plan to update its COVID-19 vaccine, though other vaccine makers like Moderna Inc. , BioNTech SE  and Pfizer Inc. , and Novavax Inc.  are already working on new versions that aim to better prote..."},{"Date":"Jun. 28, 2022 at 1:33 p.m. ET","Headline":"J&J does not plan to update its COVID-19 vaccine","Summary":"Johnson & Johnson  does not plan to update its COVID-19 vaccine, though other vaccine makers like Moderna Inc. , BioNTech SE  and Pfizer Inc. , and Novavax Inc.  are already working on new versions that aim to better prote..."},{"Date":"Jun. 28, 2022 at 7:49 a.m. ET","Headline":"U.S. companies urged to invest in Ukraine as \u2018massive\u2019 reconstruction looms","Summary":"Shares of Roivant Sciences Ltd.  shot up 10.0% in premarket trading Tuesday, after the biopharmaceutical company and drug giant Pfizer Inc.  unveiled Priovant Therapeutics, a biotechnology company focused on developing nov..."},{"Date":"Jun. 28, 2022 at 6:27 a.m. ET","Headline":"Roivant, Pfizer unveil Priovant Therapeutics focused on autoimmune disease treatments, Roivant stock surges","Summary":"Shares of Roivant Sciences Ltd.  shot up 10.0% in premarket trading Tuesday, after the biopharmaceutical company and drug giant Pfizer Inc.  unveiled Priovant Therapeutics, a biotechnology company focused on developing nov..."},{"Date":"Jul. 1, 2022 at 3:14 p.m. ET","Headline":"The U.S. bets billions of dollars on better COVID-19 boosters as it prepares for a spike in COVID-19 cases in the coming months","Summary":"The Food and Drug Administration on Thursday told COVID-19 vaccine makers that plan to update their boosters to add a BA.4 and BA.5 spike protein component to the new shots that are in development. These \"bivalent\" booster..."},{"Date":"Jul. 1, 2022 at 7:02 a.m. ET","Headline":"Novavax is part of the FDA\u2019s COVID-19 booster debate, but its vaccine still hasn\u2019t been authorized","Summary":"The Food and Drug Administration on Thursday told COVID-19 vaccine makers that plan to update their boosters to add a BA.4 and BA.5 spike protein component to the new shots that are in development. These \"bivalent\" booster..."},{"Date":"Jun. 30, 2022 at 1:45 p.m. ET","Headline":"FDA Asks Vaccine Makers for Boosters to Target BA.5","Summary":"The Food and Drug Administration on Thursday told COVID-19 vaccine makers that plan to update their boosters to add a BA.4 and BA.5 spike protein component to the new shots that are in development. These \"bivalent\" booster..."},{"Date":"Jun. 30, 2022 at 10:49 a.m. ET","Headline":"FDA says COVID-19 boosters should be updated to combat two omicron subvariants","Summary":"The Food and Drug Administration on Thursday told COVID-19 vaccine makers that plan to update their boosters to add a BA.4 and BA.5 spike protein component to the new shots that are in development. These \"bivalent\" booster..."},{"Date":"Jun. 30, 2022 at 9:04 a.m. ET","Headline":"Pfizer Raises Covid Vaccine Price 27%. What It Means for the Stock.","Summary":"Pfizer Inc.  said Thursday that it has submitted a New Drug Application (NDA) for COVID-19 treatment pills PAXLOVID for patients at high risk for progression to severe illness. PAXLOVID has previously been granted Emergenc..."},{"Date":"Jun. 30, 2022 at 6:56 a.m. ET","Headline":"Pfizer submits a new NDA to FDA for COVID-19 pill PAXLOVID","Summary":"Pfizer Inc.  said Thursday that it has submitted a New Drug Application (NDA) for COVID-19 treatment pills PAXLOVID for patients at high risk for progression to severe illness. PAXLOVID has previously been granted Emergenc..."},{"Date":"Jul. 5, 2022 at 12:39 p.m. ET","Headline":"COVID hospitalizations dip for first time since mid-April, but daily deaths reach 2 1\/2-month high","Summary":""},{"Date":"Jul. 5, 2022 at 12:33 p.m. ET","Headline":"CureVac Sues BioNTech Over mRNA and Covid Vaccines. Pfizer Stock Isn\u2019t Spared.","Summary":""},{"Date":"Jul. 5, 2022 at 9:28 a.m. ET","Headline":"The BA.5 Omicron Wave Is Rising. What It Means for Your Next Booster.","Summary":""},{"Date":"Jul. 7, 2022 at 11:38 a.m. ET","Headline":"With BA.5 the dominant variant, hospitalizations rise to 4-month high","Summary":"The seven-day average of COVID-19-related hospitalizations in the U.S. jumped to 34,731 on July 6, up 13% from two-weeks ago and the most since March 7, according to . The daily average of those hospitalized in intensive-c..."},{"Date":"Jul. 7, 2022 at 10:45 a.m. ET","Headline":"Democrats\u2019 Latest Drug-Pricing Bill Has a Chance. What It Means for Pharma Stocks.","Summary":"The seven-day average of COVID-19-related hospitalizations in the U.S. jumped to 34,731 on July 6, up 13% from two-weeks ago and the most since March 7, according to . The daily average of those hospitalized in intensive-c..."},{"Date":"Jul. 7, 2022 at 6:48 a.m. ET","Headline":"Coronavirus tally: Hospitalizations jump to 4-month high, 2-week trend of new cases rise 11%","Summary":"The seven-day average of COVID-19-related hospitalizations in the U.S. jumped to 34,731 on July 6, up 13% from two-weeks ago and the most since March 7, according to . The daily average of those hospitalized in intensive-c..."},{"Date":"Jul. 6, 2022 at 4:04 p.m. ET","Headline":"FDA allows pharmacists to prescribe Pfizer\u2019s COVID-19 pill Paxlovid","Summary":""},{"Date":"Jul. 6, 2022 at 6:52 a.m. ET","Headline":"This Inflation Spike May Be Ending. That\u2019s Good for Cathie Wood.","Summary":""},{"Date":"Jul. 6, 2022 at 3:00 a.m. ET","Headline":"Sarepta Wants to Speed Up Approval of Its Gene Therapy. What It Means for the Stock.","Summary":""},{"Date":"Jun. 23, 2022 at 6:30 a.m. ET","Headline":"Powell\u2019s Rate Hikes Are a Sledgehammer. That\u2019s Good and Bad.","Summary":""},{"Date":"Jul. 9, 2022 at 9:40 a.m. ET","Headline":"Pfizer Brought Us a Covid Vaccine and Paxlovid. Here\u2019s What\u2019s Next.","Summary":""},{"Date":"Jul. 9, 2022 at 8:55 a.m. ET","Headline":"These are the dividend stocks most recommended by top-performing newsletters \u2014 and 6 yield above 4%","Summary":""},{"Date":"Jul. 11, 2022 at 1:58 p.m. ET","Headline":"New omicron variant worries experts as it spreads in India, and Moderna says new booster offers better protection against BA.4 and BA.5","Summary":""},{"Date":"Jul. 11, 2022 at 7:54 a.m. ET","Headline":"Here Are the Top CEOs of 2022","Summary":""},{"Date":"Jul. 2, 2022 at 12:34 p.m. ET","Headline":"FDA and drug makers deepen their commitment to clinical-trial diversity. Will it work?","Summary":""},{"Date":"Jul. 13, 2022 at 6:16 p.m. ET","Headline":"FDA Clears Novavax as a Covid-19 Vaccine","Summary":""},{"Date":"Jul. 13, 2022 at 6:49 a.m. ET","Headline":"Inflation Data Aren\u2019t the Fed\u2019s Biggest Problem Anymore","Summary":""},{"Date":"Jul. 15, 2022 at 6:27 a.m. ET","Headline":"Novavax\u2019s protein-based vaccine approval fails to boost stock as demand in U.S. for shots and boosters remains low","Summary":""},{"Date":"Jul. 14, 2022 at 5:19 p.m. ET","Headline":"Codexis stock drops as forecast comes in below Street estimate","Summary":""},{"Date":"Jul. 14, 2022 at 3:52 p.m. ET","Headline":"Investors piling into healthcare ETFs points to defensive bets, \u2018bottom-fishing\u2019 in biotech","Summary":""},{"Date":"Jul. 14, 2022 at 9:56 a.m. ET","Headline":"GSK\u2019s Big Spinoff Is on Monday. An Era Is Ending for Big Pharma.","Summary":""},{"Date":"Jul. 14, 2022 at 6:42 a.m. ET","Headline":"What\u2019s Next for the Fed After Inflation Shocks Again","Summary":""},{"Date":"Jul. 19, 2022 at 7:24 p.m. ET","Headline":"CDC gives final approval for more traditional Novavax COVID vaccine for adults","Summary":"An advisory panel to the Centers for Disease Control and Prevention will meet later Tuesday to discuss the Novavax [s:nvax] vaccine that recently won authorization from the Food and Drug Administration for use in adults ov..."},{"Date":"Jul. 19, 2022 at 6:46 a.m. ET","Headline":"If Apple Sees a Slowdown, What Does It Mean for Everyone Else?","Summary":"An advisory panel to the Centers for Disease Control and Prevention will meet later Tuesday to discuss the Novavax [s:nvax] vaccine that recently won authorization from the Food and Drug Administration for use in adults ov..."},{"Date":"Jul. 19, 2022 at 6:20 a.m. ET","Headline":"Coronavirus tally: CDC panel to discuss Novavax vaccine in move expected to remove final regulatory block to its use","Summary":"An advisory panel to the Centers for Disease Control and Prevention will meet later Tuesday to discuss the Novavax [s:nvax] vaccine that recently won authorization from the Food and Drug Administration for use in adults ov..."},{"Date":"Jul. 18, 2022 at 8:13 a.m. ET","Headline":"Hate Tesla? You Can Bet Against the EV Maker With a New Fund.","Summary":""},{"Date":"Jul. 18, 2022 at 1:00 a.m. ET","Headline":"Moderna\u2019s Stock Is on a Roll. Now It Has to Deliver a New Booster.","Summary":""},{"Date":"Jun. 13, 2022 at 6:36 a.m. ET","Headline":"Don\u2019t Just Blame the Fed. Crypto Assets Are Hard-Wired for Harsh Collapses.","Summary":""},{"Date":"Jun. 6, 2022 at 6:35 a.m. ET","Headline":"Apple Needs to Show Some Spark as Shoppers Favor Services Over Stuff","Summary":""},{"Date":"Jul. 21, 2022 at 2:48 p.m. ET","Headline":"Biden tests positive for COVID, has \u2018very mild symptoms,\u2019 White House says","Summary":"The Centers for Disease Control and Prevention authorized the Novavax [s:nvax] vaccine late Tuesday, lifting the final regulatory hurdle for the nation's fourth vaccine, which is based on more conventional technology than ..."},{"Date":"Jul. 21, 2022 at 11:06 a.m. ET","Headline":"President Biden Tests Positive for Covid-19, Has \u2018Mild Symptoms\u2019","Summary":"The Centers for Disease Control and Prevention authorized the Novavax [s:nvax] vaccine late Tuesday, lifting the final regulatory hurdle for the nation's fourth vaccine, which is based on more conventional technology than ..."},{"Date":"Jul. 21, 2022 at 7:41 a.m. ET","Headline":"CDC OK\u2019s Novavax vaccine to add fourth shot to U.S. program, and COVID cases triple in Europe in six-week span","Summary":"The Centers for Disease Control and Prevention authorized the Novavax [s:nvax] vaccine late Tuesday, lifting the final regulatory hurdle for the nation's fourth vaccine, which is based on more conventional technology than ..."},{"Date":"Jul. 20, 2022 at 6:12 a.m. ET","Headline":"Coronavirus tally: CDC OKs Novavax vaccine, adding fourth alternative -- and more conventional shot --  to U.S. program","Summary":"The Centers for Disease Control and Prevention authorized the Novavax [s:nvax] vaccine late Tuesday, lifting the final regulatory hurdle for the nation's fourth vaccine, which is based on more conventional technology than ..."},{"Date":"Jul. 23, 2022 at 1:30 p.m. ET","Headline":"Biden likely contracted highly contagious BA.5 coronavirus strain, his doctor says","Summary":""},{"Date":"Jul. 22, 2022 at 1:44 p.m. ET","Headline":"U.S. leads the world in new COVID cases as BA.5 continues to spread and illustrate that the pandemic is far from over","Summary":""},{"Date":"Jul. 22, 2022 at 9:23 a.m. ET","Headline":"Alphabet, Amazon Look Ready to Join the Dow After Stock Splits","Summary":""},{"Date":"Jul. 22, 2022 at 6:42 a.m. ET","Headline":"Jerome Powell Wants a Slowdown. Snap\u2019s Warning Shows That\u2019s Happening.","Summary":""},{"Date":"Jul. 25, 2022 at 9:47 a.m. ET","Headline":"Biden Wants Next-Generation Covid Vaccines That Prevent Infection: Report","Summary":""},{"Date":"Jul. 25, 2022 at 8:13 a.m. ET","Headline":"Apple, Visa, Microsoft, Exxon Mobil, Chipotle, and Other Stocks to Watch This Week","Summary":""},{"Date":"Jul. 25, 2022 at 6:39 a.m. ET","Headline":"Apple and the Federal Reserve: This Is a Crunch Week Unlike Any Other","Summary":""},{"Date":"Jul. 25, 2022 at 2:30 a.m. ET","Headline":"Giant Manager Buys Up Apple, Nvidia, Corning, and Pfizer Stock","Summary":""},{"Date":"Jul. 14, 2022 at 4:48 p.m. ET","Headline":"AXS Launches Single-Stock Leveraged ETFs. They Aren\u2019t for Long-Term Investors.","Summary":""},{"Date":"Jul. 27, 2022 at 7:23 p.m. ET","Headline":"Stock Futures Fall as Disappointing Meta Outlook Dampens Nasdaq\u2019s Massive Gain","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Wednesday they have started a Phase 2 study to evaluate an enhanced COVID-19 vaccine aimed at the original strain of the virus and the omicron variant that seeks to create ..."},{"Date":"Jul. 27, 2022 at 8:05 a.m. ET","Headline":"Pfizer loses court battle over drug copay assistance program with big implications for Medicare spending","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Wednesday they have started a Phase 2 study to evaluate an enhanced COVID-19 vaccine aimed at the original strain of the virus and the omicron variant that seeks to create ..."},{"Date":"Jul. 27, 2022 at 6:57 a.m. ET","Headline":"Pfizer and BioNTech launch study to evaluate COVID-19 vaccine targeting original virus strain plus omicron variant","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Wednesday they have started a Phase 2 study to evaluate an enhanced COVID-19 vaccine aimed at the original strain of the virus and the omicron variant that seeks to create ..."},{"Date":"Jul. 25, 2022 at 10:18 a.m. ET","Headline":"BA.5 named the variant that has likely infected President Biden and driven U.S. cases up 19% in a two-week period","Summary":""},{"Date":"Jul. 29, 2022 at 1:07 p.m. ET","Headline":"L.A. County dodges face-mask mandate as community transmission rates stabilize, and U.S. government orders 66 million doses of Moderna\u2019s pending booster","Summary":"The Biden administration has decided against offering COVID boosters to people under 50 for now, preferring to wait until retooled Pfizer  and Moderna  shots become available in September that could perform better against ..."},{"Date":"Jul. 29, 2022 at 12:01 p.m. ET","Headline":"Moderna Lands $1.7 Billion Deal with Government. Pfizer Is Getting More Per Dose.","Summary":"The Biden administration has decided against offering COVID boosters to people under 50 for now, preferring to wait until retooled Pfizer  and Moderna  shots become available in September that could perform better against ..."},{"Date":"Jul. 29, 2022 at 6:40 a.m. ET","Headline":"Apple and Amazon\u2019s Tech Strength Gets Bulls Buying Despite Recession on the Radar","Summary":"The Biden administration has decided against offering COVID boosters to people under 50 for now, preferring to wait until retooled Pfizer  and Moderna  shots become available in September that could perform better against ..."},{"Date":"Jul. 29, 2022 at 6:10 a.m. ET","Headline":"Coronavirus tally: Biden administration will halt boosters for under-50s until new ones are ready in September to attack omicron","Summary":"The Biden administration has decided against offering COVID boosters to people under 50 for now, preferring to wait until retooled Pfizer  and Moderna  shots become available in September that could perform better against ..."},{"Date":"Jul. 28, 2022 at 9:34 p.m. ET","Headline":"Retooled, omicron-specific COVID boosters expected in September: report","Summary":"Shares of Pfizer Inc.  gained 0.3% in premarket trading Thursday, after the pharmaceutical giant reported big second-quarter profit and revenue beats, driven primarily by \"strong contributions\" from its COVID drugs Comirna..."},{"Date":"Jul. 28, 2022 at 4:42 p.m. ET","Headline":"S&P 500, Dow book highest close in 7 weeks as investors shrug off weak GDP number","Summary":"Shares of Pfizer Inc.  gained 0.3% in premarket trading Thursday, after the pharmaceutical giant reported big second-quarter profit and revenue beats, driven primarily by \"strong contributions\" from its COVID drugs Comirna..."},{"Date":"Jul. 28, 2022 at 9:30 a.m. ET","Headline":"Pfizer Earnings Beat Expectations. Vaccine and Paxlovid Sales Were Higher Than Anticipated.","Summary":"Shares of Pfizer Inc.  gained 0.3% in premarket trading Thursday, after the pharmaceutical giant reported big second-quarter profit and revenue beats, driven primarily by \"strong contributions\" from its COVID drugs Comirna..."},{"Date":"Jul. 28, 2022 at 7:53 a.m. ET","Headline":"Meta, Ford, Spirit and More Thursday Morning Stock Movers","Summary":"Shares of Pfizer Inc.  gained 0.3% in premarket trading Thursday, after the pharmaceutical giant reported big second-quarter profit and revenue beats, driven primarily by \"strong contributions\" from its COVID drugs Comirna..."},{"Date":"Jul. 28, 2022 at 7:39 a.m. ET","Headline":"Research shows coronavirus pandemic originated in Wuhan wet market and did not escape from a Chinese lab","Summary":"Shares of Pfizer Inc.  gained 0.3% in premarket trading Thursday, after the pharmaceutical giant reported big second-quarter profit and revenue beats, driven primarily by \"strong contributions\" from its COVID drugs Comirna..."},{"Date":"Jul. 28, 2022 at 7:01 a.m. ET","Headline":"Pfizer reports big profit and revenue beats, as COVID drug sales increase by nearly $9 billion","Summary":"Shares of Pfizer Inc.  gained 0.3% in premarket trading Thursday, after the pharmaceutical giant reported big second-quarter profit and revenue beats, driven primarily by \"strong contributions\" from its COVID drugs Comirna..."},{"Date":"Jul. 28, 2022 at 3:31 a.m. ET","Headline":"Paxlovid has been given to Biden and millions of Americans infected with COVID-19. In the U.K., it sits on the shelf.","Summary":""},{"Date":"Jul. 28, 2022 at 3:56 p.m. ET","Headline":"Pfizer\u2019s Updated Covid-19 Booster Will \u2018Likely\u2019 Be Ready in Early Fall, CEO Says","Summary":""},{"Date":"Aug. 2, 2022 at 9:30 a.m. ET","Headline":"Pfizer, Cisco, and 5 Other Stocks With the Cash Flow to Raise Their Dividends","Summary":""},{"Date":"Aug. 2, 2022 at 8:07 a.m. ET","Headline":"Moderna\u2019s Earnings Are Coming. Market Share and 2 More Points to Watch.","Summary":""},{"Date":"Aug. 2, 2022 at 6:23 a.m. ET","Headline":"Biden\u2019s COVID \u2018rebound\u2019 after treatment with Paxlovid serves as a reminder that the antiviral can have that rare outcome","Summary":""},{"Date":"Aug. 1, 2022 at 8:26 a.m. ET","Headline":"Moderna and Pfizer to start clinical trials for COVID-19 boosters that target BA.5 \u2018in the near future\u2019","Summary":""},{"Date":"Aug. 1, 2022 at 6:56 a.m. ET","Headline":"Tech Stocks Are Hot on Wall Street. Main Street\u2019s Worries Are Elsewhere.","Summary":""},{"Date":"Jul. 30, 2022 at 9:50 a.m. ET","Headline":"World Hunger Is on the Rise. These Companies Have Solutions.","Summary":""},{"Date":"Jul. 29, 2022 at 10:40 a.m. ET","Headline":"Sarepta Will Seek Approval of Gene Therapy Before Completing Phase 3 Trial","Summary":""},{"Date":"Aug. 4, 2022 at 9:22 a.m. ET","Headline":"Moderna CEO:  No \u2018Crazy\u2019 Deals. We\u2019re Giving Cash to Shareholders.","Summary":""},{"Date":"Aug. 3, 2022 at 11:21 a.m. ET","Headline":"Alnylam Stock Rockets 50% as Trial Results Raise Hope for a Blockbuster","Summary":""},{"Date":"Aug. 6, 2022 at 10:17 a.m. ET","Headline":"Pharmaceutical CEOs use earnings calls to criticize drug-pricing proposal","Summary":"Shares of Global Blood Therapeutics Inc.  jumped 9.5% in trading on Friday after  that Pfizer Inc.  is considering buying the company for about $5 billion. There were media reports earlier this week that Global Blood Thera..."},{"Date":"Aug. 5, 2022 at 2:42 p.m. ET","Headline":"Official U.S. tally of new cases may be declining, but at-home testing obscures data; Novavax opens trial of vaccine for very young children","Summary":"Shares of Global Blood Therapeutics Inc.  jumped 9.5% in trading on Friday after  that Pfizer Inc.  is considering buying the company for about $5 billion. There were media reports earlier this week that Global Blood Thera..."},{"Date":"Aug. 5, 2022 at 12:08 p.m. ET","Headline":"Pfizer in Talks to Buy Global Blood Therapeutics for $5 Billion, Report Says","Summary":"Shares of Global Blood Therapeutics Inc.  jumped 9.5% in trading on Friday after  that Pfizer Inc.  is considering buying the company for about $5 billion. There were media reports earlier this week that Global Blood Thera..."},{"Date":"Aug. 5, 2022 at 12:05 p.m. ET","Headline":"A Recession Is Coming. These Are the Stocks to Hunker Down In.","Summary":"Shares of Global Blood Therapeutics Inc.  jumped 9.5% in trading on Friday after  that Pfizer Inc.  is considering buying the company for about $5 billion. There were media reports earlier this week that Global Blood Thera..."},{"Date":"Aug. 5, 2022 at 11:58 a.m. ET","Headline":"WSJ: Pfizer considering buying Global Blood Therapeutics for roughly $5 billion","Summary":"Shares of Global Blood Therapeutics Inc.  jumped 9.5% in trading on Friday after  that Pfizer Inc.  is considering buying the company for about $5 billion. There were media reports earlier this week that Global Blood Thera..."},{"Date":"Aug. 8, 2022 at 5:19 p.m. ET","Headline":"Pfizer, Valneva begin major test of first possible Lyme vaccine in 20 years","Summary":"Pfizer Inc.  has agreed to buy Global Blood Therapeutics Inc.  in a deal valued at $5.4 billion, the companies said Monday, confirming a report by the Wall Street Journal. Pfizer will pay $68.50 a share in cash for Global ..."},{"Date":"Aug. 8, 2022 at 4:09 p.m. ET","Headline":"Dow Wavered, Nvidia Slumped, Tesla Popped \u2014 and What Else Happened in the Stock Market Today","Summary":"Pfizer Inc.  has agreed to buy Global Blood Therapeutics Inc.  in a deal valued at $5.4 billion, the companies said Monday, confirming a report by the Wall Street Journal. Pfizer will pay $68.50 a share in cash for Global ..."},{"Date":"Aug. 8, 2022 at 12:58 p.m. ET","Headline":"Biden leaves White House after testing negative on two straight days, and China locks down 80,000 tourists on tropical island","Summary":"Pfizer Inc.  has agreed to buy Global Blood Therapeutics Inc.  in a deal valued at $5.4 billion, the companies said Monday, confirming a report by the Wall Street Journal. Pfizer will pay $68.50 a share in cash for Global ..."},{"Date":"Aug. 8, 2022 at 11:48 a.m. ET","Headline":"Karuna\u2019s Schizophrenia-Trial Data Are \u2018Best Case Scenario\u2019 for the Biotech Stock","Summary":"Pfizer Inc.  has agreed to buy Global Blood Therapeutics Inc.  in a deal valued at $5.4 billion, the companies said Monday, confirming a report by the Wall Street Journal. Pfizer will pay $68.50 a share in cash for Global ..."},{"Date":"Aug. 8, 2022 at 11:10 a.m. ET","Headline":"BioNTech Stock Falls. Earnings and Revenue Missed Expectations.","Summary":"Pfizer Inc.  has agreed to buy Global Blood Therapeutics Inc.  in a deal valued at $5.4 billion, the companies said Monday, confirming a report by the Wall Street Journal. Pfizer will pay $68.50 a share in cash for Global ..."},{"Date":"Aug. 8, 2022 at 9:01 a.m. ET","Headline":"Pfizer Buys Global Blood Therapeutics. How the Deal Could Solve Pipeline Worries.","Summary":"Pfizer Inc.  has agreed to buy Global Blood Therapeutics Inc.  in a deal valued at $5.4 billion, the companies said Monday, confirming a report by the Wall Street Journal. Pfizer will pay $68.50 a share in cash for Global ..."},{"Date":"Aug. 8, 2022 at 7:22 a.m. ET","Headline":"Tesla, Palantir, Berkshire Hathaway and More Stock Market Movers Monday","Summary":"Pfizer Inc.  has agreed to buy Global Blood Therapeutics Inc.  in a deal valued at $5.4 billion, the companies said Monday, confirming a report by the Wall Street Journal. Pfizer will pay $68.50 a share in cash for Global ..."},{"Date":"Aug. 8, 2022 at 6:56 a.m. ET","Headline":"Pfizer confirms to acquire Global Blood Therapeutics for $5.4 billion in deal that gives it access to sickle-cell disease treatment","Summary":"Pfizer Inc.  has agreed to buy Global Blood Therapeutics Inc.  in a deal valued at $5.4 billion, the companies said Monday, confirming a report by the Wall Street Journal. Pfizer will pay $68.50 a share in cash for Global ..."},{"Date":"Aug. 8, 2022 at 6:37 a.m. ET","Headline":"Pfizer agrees to buy Global Blood Therapeutics in deal valued at $5.4 billion: WSJ","Summary":"Pfizer Inc.  has reached an agreement to buy Global Blood Therapeutics Inc. [s :gbt] in a deal valued at $5.4 billion, the Wall Street Journal reported, citing people familiar with the matter. The news comes after the Jour..."},{"Date":"Aug. 8, 2022 at 6:17 a.m. ET","Headline":"BioNTech stock sinks more than 8% after profit, revenue fall below expectations","Summary":"The U.S.-listed shares of Germany-based BioNTech SE  sank 8.2% in premarket trading Monday, after the biotechnology company and Pfizer Inc.  partner in developing a COVID-19 vaccine reported second-quarter profit and reven..."},{"Date":"Aug. 9, 2022 at 3:59 p.m. ET","Headline":"As Covid Vaccine Boom Ends,  Pfizer and Moderna Pursue Opposite Strategies","Summary":""},{"Date":"Aug. 9, 2022 at 1:48 p.m. ET","Headline":"China closes Tibet\u2019s Potala Palace over COVID outbreak, and Novavax stock is slammed by weak earnings and halving of sales guidance","Summary":""},{"Date":"Aug. 9, 2022 at 8:28 a.m. ET","Headline":"Novavax slashes sales guidance in half, stock plunges 34%","Summary":""},{"Date":"Aug. 9, 2022 at 7:51 a.m. ET","Headline":"Bulls Ready Fresh Stampede as Markets Await Key Inflation Data","Summary":""},{"Date":"Aug. 12, 2022 at 3:24 p.m. ET","Headline":"GSK defends Zantac ahead of trials that have wiped off $44 billion from leading drugmakers","Summary":""},{"Date":"Aug. 12, 2022 at 1:50 p.m. ET","Headline":"GSK and Sanofi Push Back on Zantac Lawsuit Worries. Shares Rebounded.","Summary":""},{"Date":"Aug. 12, 2022 at 8:06 a.m. ET","Headline":"Get ready for more merger mania in the pharma sector for the rest of the year","Summary":""},{"Date":"Aug. 11, 2022 at 4:45 p.m. ET","Headline":"U.S. stocks end mixed as rally tied to cooler inflation \ndata takes breather","Summary":""},{"Date":"Aug. 11, 2022 at 1:10 p.m. ET","Headline":"3 Drug Companies Fall on Zantac Lawsuit Fears. It Shows the Power of Analysts.","Summary":""},{"Date":"Aug. 11, 2022 at 11:49 a.m. ET","Headline":"McDonald\u2019s set to reopen in some cities in Ukraine \u2014 report","Summary":""},{"Date":"Aug. 11, 2022 at 9:13 a.m. ET","Headline":"Single-Stock Funds Are Taking Off. What You Need to Know.","Summary":""},{"Date":"Aug. 13, 2022 at 9:34 a.m. ET","Headline":"10 defensive stocks that can also provide you with growth and dividends over the long term","Summary":""},{"Date":"Aug. 16, 2022 at 9:48 a.m. ET","Headline":"Merck Jumps Into a $3.7 Billion mRNA Collaboration","Summary":"First lady Jill Biden has tested positive for COVID-19, her spokeswoman said in a statement on Tuesday. She is experiencing mild symptoms and has been prescribed a course of Pfizer Inc.'s  Paxlovid. Following CDC guidance,..."},{"Date":"Aug. 16, 2022 at 9:40 a.m. ET","Headline":"First lady Jill Biden tests positive for COVID, has mild symptoms: spokeswoman","Summary":"First lady Jill Biden has tested positive for COVID-19, her spokeswoman said in a statement on Tuesday. She is experiencing mild symptoms and has been prescribed a course of Pfizer Inc.'s  Paxlovid. Following CDC guidance,..."},{"Date":"Aug. 16, 2022 at 7:22 a.m. ET","Headline":"U.K. regulator is first to authorize Moderna\u2019s bivalent COVID booster for 18-and-older population","Summary":"Pfizer Inc.  CEO Albert Bourla tested positive for COVID-19. He  Monday that he received four shots of the COVID-19 vaccine the company developed with BioNTech SE , is \"experiencing very mild symptoms\" and has started taki..."},{"Date":"Aug. 15, 2022 at 10:40 a.m. ET","Headline":"Biotech Keeps Staving Off the Bear, but for How Long?","Summary":"Pfizer Inc.  CEO Albert Bourla tested positive for COVID-19. He  Monday that he received four shots of the COVID-19 vaccine the company developed with BioNTech SE , is \"experiencing very mild symptoms\" and has started taki..."},{"Date":"Aug. 15, 2022 at 8:44 a.m. ET","Headline":"Pfizer CEO tests positive for COVID-19","Summary":"Pfizer Inc.  CEO Albert Bourla tested positive for COVID-19. He  Monday that he received four shots of the COVID-19 vaccine the company developed with BioNTech SE , is \"experiencing very mild symptoms\" and has started taki..."},{"Date":"Aug. 15, 2022 at 8:38 a.m. ET","Headline":"Pfizer CEO Bourla Has Mild Case of Covid-19","Summary":""},{"Date":"Aug. 15, 2022 at 8:29 a.m. ET","Headline":"U.K. Approves First Updated Covid-19 Booster, Ushering in New Era for mRNA Vaccines","Summary":""},{"Date":"Aug. 18, 2022 at 3:51 p.m. ET","Headline":"U.S. Plans Reduced Role in Distributing Covid Vaccines: Report","Summary":""},{"Date":"Aug. 18, 2022 at 8:48 a.m. ET","Headline":"Why Has Biotech Soared? These 10 Stocks Are the Biggest Reasons.","Summary":""},{"Date":"Aug. 17, 2022 at 8:46 a.m. ET","Headline":"Apple Urges Return to the Office as Tech CEOs Try to Boost Productivity","Summary":""},{"Date":"Aug. 17, 2022 at 7:09 a.m. ET","Headline":"Zantac lawsuit drop \u2018not as significant as it appears\u2019 for GSK stock, analysts say","Summary":""},{"Date":"Aug. 20, 2022 at 8:32 a.m. ET","Headline":"Large-scale study finds COVID patients at higher risk of brain fog and psychosis after two years compared with other respiratory illnesses","Summary":""},{"Date":"Aug. 19, 2022 at 7:55 a.m. ET","Headline":"Single-stock ETFs: \u2018We\u2019re going to see this entire ETF category absolutely explode\u2019","Summary":""},{"Date":"Aug. 19, 2022 at 7:42 a.m. ET","Headline":"The Dollar Will Stay Strong. That Spells More Pain for Companies.","Summary":""},{"Date":"Aug. 22, 2022 at 11:06 a.m. ET","Headline":"There\u2019s Progress, and Lots of Questions, on Fall Covid-19 Booster Shots","Summary":"Pfizer Inc.  and BioNTech SE  said Monday that they formally completed an application asking the Food and Drug Administration to authorize their experimental bivalent COVID-19 booster in those who are 12 years old or older..."},{"Date":"Aug. 22, 2022 at 10:45 a.m. ET","Headline":"Pfizer, BioNTech complete FDA submission for new COVID-19 booster","Summary":"Pfizer Inc.  and BioNTech SE  said Monday that they formally completed an application asking the Food and Drug Administration to authorize their experimental bivalent COVID-19 booster in those who are 12 years old or older..."},{"Date":"Aug. 21, 2022 at 10:15 a.m. ET","Headline":"What will insurance coverage of COVID-19 vaccines and treatments look like? The Biden administration is trying to figure that out","Summary":""},{"Date":"Aug. 21, 2022 at 10:10 a.m. ET","Headline":"Ivermectin among generic drugs that failed to help COVID-19 patients avoid hospitalization, large study shows","Summary":""},{"Date":"Aug. 24, 2022 at 2:35 p.m. ET","Headline":"The Fall Rollout of Covid-19 Boosters Looks Set to Start in Early September","Summary":"Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day, according to a new report. The New York Times reported Tuesday night that the Biden administration is eager to approve..."},{"Date":"Aug. 24, 2022 at 10:50 a.m. ET","Headline":"Moderna, Carnival, and Match Have a Lot to Do With S&P 500\u2019s Pullback From August Peak","Summary":"Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day, according to a new report. The New York Times reported Tuesday night that the Biden administration is eager to approve..."},{"Date":"Aug. 24, 2022 at 9:45 a.m. ET","Headline":"These 10 stocks matter the most to hedge funds right now","Summary":"Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day, according to a new report. The New York Times reported Tuesday night that the Biden administration is eager to approve..."},{"Date":"Aug. 24, 2022 at 7:29 a.m. ET","Headline":"Pfizer and BioNTech say data show COVID vaccine has more than 70% efficacy in small children, with cases now rising in just 7 states","Summary":"Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day, according to a new report. The New York Times reported Tuesday night that the Biden administration is eager to approve..."},{"Date":"Aug. 24, 2022 at 6:11 a.m. ET","Headline":"Coronavirus tally: Omicron boosters may be ready after Labor Day as Moderna submits EUA application","Summary":"Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day, according to a new report. The New York Times reported Tuesday night that the Biden administration is eager to approve..."},{"Date":"Aug. 23, 2022 at 8:46 p.m. ET","Headline":"Omicron-specific boosters could be rolled out after Labor Day: report","Summary":"Moderna Inc.  said late Tuesday it has completed its submission to the U.S. Food and Drug Administration for the emergency-use authorization for its experimental bivalent COVID-19 booster for those who are 18 years old or ..."},{"Date":"Aug. 23, 2022 at 4:42 p.m. ET","Headline":"Moderna completes FDA submission for new COVID-19 booster","Summary":"Moderna Inc.  said late Tuesday it has completed its submission to the U.S. Food and Drug Administration for the emergency-use authorization for its experimental bivalent COVID-19 booster for those who are 18 years old or ..."},{"Date":"Aug. 23, 2022 at 10:13 a.m. ET","Headline":"Pfizer Says 3-Dose Covid-19 Vaccine for Children is 73% Effective","Summary":"Pfizer Inc.  and German partner BioNTech SE  on Tuesday announced updated COVID vaccine data supporting efficacy in children aged 6 months through 4 years of age. The companies said updated analysis from 34 cases occurring..."},{"Date":"Aug. 23, 2022 at 7:15 a.m. ET","Headline":"Jill Biden leaves isolation after twice testing negative, and Novavax vaccine is now allowed for U.S. teens","Summary":"Pfizer Inc.  and German partner BioNTech SE  on Tuesday announced updated COVID vaccine data supporting efficacy in children aged 6 months through 4 years of age. The companies said updated analysis from 34 cases occurring..."},{"Date":"Aug. 23, 2022 at 6:54 a.m. ET","Headline":"Pfizer and BioNTech say COVID vaccine data showed 73.2% efficacy among children aged 6 month to 4 years","Summary":"Pfizer Inc.  and German partner BioNTech SE  on Tuesday announced updated COVID vaccine data supporting efficacy in children aged 6 months through 4 years of age. The companies said updated analysis from 34 cases occurring..."},{"Date":"Aug. 23, 2022 at 6:50 a.m. ET","Headline":"Wall Street Swings From Greed to Fear as the Fed\u2019s Message Sinks in","Summary":"Pfizer  and BioNTech have formally completed an application asking the Food and Drug Administration to authorize their experimental bivalent COVID-19 booster in those who are 12 years old or older. The new shot equally tar..."},{"Date":"Aug. 23, 2022 at 6:28 a.m. ET","Headline":"Coronavirus tally: Pfizer and BioNTech formally apply for FDA nod for bivalent COVID booster for people aged 12 and older","Summary":"Pfizer  and BioNTech have formally completed an application asking the Food and Drug Administration to authorize their experimental bivalent COVID-19 booster in those who are 12 years old or older. The new shot equally tar..."},{"Date":"Aug. 26, 2022 at 3:54 p.m. ET","Headline":"Moderna Is Suing Pfizer and BioNTech for Covid-19 Vaccine Patent Infringement. What to Know.","Summary":"Moderna Inc.  said Friday it is suing Pfizer Inc.  and German partner BioNTech SE  for infringing patents relating to its mRNA platform, the source of the COVID vaccines developed by the three parties. The suit is to be fi..."},{"Date":"Aug. 26, 2022 at 2:38 p.m. ET","Headline":"Report finds Americans with long COVID losing billions in wages, as Moderna sues Pfizer and BioNTech over mRNA patents","Summary":"Moderna Inc.  said Friday it is suing Pfizer Inc.  and German partner BioNTech SE  for infringing patents relating to its mRNA platform, the source of the COVID vaccines developed by the three parties. The suit is to be fi..."},{"Date":"Aug. 26, 2022 at 8:14 a.m. ET","Headline":"Moderna sues Pfizer and BioNTech for patent infringement relating to the mRNA platform used to develop COVID vaccines","Summary":"Moderna Inc.  said Friday it is suing Pfizer Inc.  and German partner BioNTech SE  for infringing patents relating to its mRNA platform, the source of the COVID vaccines developed by the three parties. The suit is to be fi..."},{"Date":"Aug. 26, 2022 at 6:54 a.m. ET","Headline":"Study finds Pfizer\u2019s antiviral has little or even zero benefit for younger adults, and WHO says BA.5 omicron subvariant accounted for 74% of cases in latest week","Summary":"Pfizer Inc.  said Thursday a Phase 3 trial of older adults testing its bivalent RSV vaccine candidate achieved 85.7% efficacy in participants with more severe disease. RSV, or Respiratory Syncytial Virus, is a contagious v..."},{"Date":"Aug. 25, 2022 at 10:07 a.m. ET","Headline":"Novartis Is Spinning Off Its Generics Unit, Joining Pack of Pure-Play Drugmakers","Summary":"Pfizer Inc.  said Thursday a Phase 3 trial of older adults testing its bivalent RSV vaccine candidate achieved 85.7% efficacy in participants with more severe disease. RSV, or Respiratory Syncytial Virus, is a contagious v..."},{"Date":"Aug. 25, 2022 at 7:42 a.m. ET","Headline":"Pfizer announces positive data from Phase 3 trial of older adults for bivalent RSV vaccine candidate","Summary":"Pfizer Inc.  said Thursday a Phase 3 trial of older adults testing its bivalent RSV vaccine candidate achieved 85.7% efficacy in participants with more severe disease. RSV, or Respiratory Syncytial Virus, is a contagious v..."},{"Date":"Aug. 25, 2022 at 6:45 a.m. ET","Headline":"Pfizer Jumps Ahead in Crowded Race for Lucrative RSV Vaccine","Summary":""},{"Date":"Aug. 25, 2022 at 6:40 a.m. ET","Headline":"Biden\u2019s Student Loan Stimulus Gives Powell Another Reason to Be Hawkish","Summary":""},{"Date":"Aug. 25, 2022 at 6:19 a.m. ET","Headline":"Study finds Pfizer COVID pill provides no benefit in younger adults","Summary":""},{"Date":"Aug. 25, 2022 at 12:30 a.m. ET","Headline":"This Income-Focused Money Manager Sees Bargains in Europe. \u2018Mass Fear Is an Opportunity.\u2019","Summary":""},{"Date":"Aug. 18, 2022 at 2:00 a.m. ET","Headline":"Buy This New Health Stock. It Offers Steady Growth and a Planned Dividend.","Summary":""},{"Date":"Aug. 27, 2022 at 4:49 p.m. ET","Headline":"House pandemic select committee zeroes in on Trump White House\u2019s hydroxychloroquine pressure campaign","Summary":""},{"Date":"Aug. 30, 2022 at 8:14 a.m. ET","Headline":"Omicron-targeting COVID boosters may be out after Labor Day, and Moderna has joined Pfizer and BioNTech in filing for authorization","Summary":""},{"Date":"Aug. 29, 2022 at 7:32 a.m. ET","Headline":"The Fed May Have Just Killed the Nasdaq Bull Market","Summary":""},{"Date":"Aug. 29, 2022 at 6:55 a.m. ET","Headline":"Moderna sets up clash with Pfizer and BioNTech with patent lawsuits in the U.S. and Germany","Summary":""},{"Date":"Sep. 1, 2022 at 7:43 p.m. ET","Headline":"CDC backs updated COVID-19 boosters to fight omicron; shots expected within days","Summary":""},{"Date":"Sep. 1, 2022 at 11:10 a.m. ET","Headline":"Has it been two months since your last COVID-19 shot? You may soon qualify for a newly designed booster","Summary":""},{"Date":"Sep. 1, 2022 at 7:46 a.m. ET","Headline":"U.S. life expectancy has seen its biggest two-year decline during COVID in almost a century, report finds","Summary":""},{"Date":"Sep. 1, 2022 at 7:44 a.m. ET","Headline":"Nvidia Ensnared in Geopolitical Spy Games With China Export Ban","Summary":""},{"Date":"Aug. 31, 2022 at 1:41 p.m. ET","Headline":"New Covid cases, deaths keep falling nearly everywhere, WHO says","Summary":""},{"Date":"Aug. 31, 2022 at 11:50 a.m. ET","Headline":"Moderna and Pfizer Omicron Booster Shots Cleared by FDA","Summary":""},{"Date":"Aug. 31, 2022 at 7:01 a.m. ET","Headline":"Jill Biden tests negative for COVID after rare rebound infection, and U.S. cases are rising in 12 states","Summary":""},{"Date":"Sep. 3, 2022 at 12:17 a.m. ET","Headline":"COVID boosters targeting omicron subvariants expected within days after CDC signs off","Summary":""},{"Date":"Sep. 7, 2022 at 12:03 p.m. ET","Headline":"Pfizer Gets FDA \u2018Breakthrough\u2019 Designation for Group B Strep Vaccine","Summary":""},{"Date":"Sep. 7, 2022 at 6:34 a.m. ET","Headline":"Fed Hammers Home Its Message This Week. Investors Are Looking Further Ahead.","Summary":""},{"Date":"Sep. 6, 2022 at 3:50 p.m. ET","Headline":"Fall Boosters Are Here. Your Questions, Answered.","Summary":""},{"Date":"Sep. 2, 2022 at 5:56 p.m. ET","Headline":"Stocks Could Have a Messy Fall. Time to Embrace the Risks.","Summary":""},{"Date":"Sep. 9, 2022 at 8:18 a.m. ET","Headline":"Big Tech Stocks Are Still Pricey. What That Means for the Market.","Summary":""},{"Date":"Sep. 8, 2022 at 8:40 a.m. ET","Headline":"Single-Stock ETFs Are Mushrooming. What to Know.","Summary":""},{"Date":"Sep. 13, 2022 at 2:15 a.m. ET","Headline":"China Is Stuck With Its Zero-Covid Policy Because of Weak Vaccines","Summary":""},{"Date":"Sep. 15, 2022 at 12:57 p.m. ET","Headline":"Humana Doesn\u2019t See a Covid-19 Headwind. One More Sign the Pandemic\u2019s End Is Near.","Summary":"Pfizer Inc.  on Thursday announced positive results from a late-stage trial of a meningococcal vaccine candidate called MenABCWY in adolescents and said it will submit an application for approval to the U.S. Food and Drug ..."},{"Date":"Sep. 15, 2022 at 7:02 a.m. ET","Headline":"PFizer announces positive results in late-stage trial of meningococcal vaccine candidate in adolescents","Summary":"Pfizer Inc.  on Thursday announced positive results from a late-stage trial of a meningococcal vaccine candidate called MenABCWY in adolescents and said it will submit an application for approval to the U.S. Food and Drug ..."},{"Date":"Sep. 14, 2022 at 7:36 a.m. ET","Headline":"U.S. known COVID cases hold at lowest level since May, but infections are rising again in New York","Summary":""},{"Date":"Sep. 16, 2022 at 4:37 p.m. ET","Headline":"Intellia Investors Are Dumping Stock on News of Crispr Gene-Editing Success","Summary":"Pfizer Inc.  and BioNTech SE  said Friday that the Committee for Medicinal Products for Human Use (CHMP) for the European Medicines Agency (EMA) has recommended the companies' COVID-19 vaccine Comirnaty be converted to sta..."},{"Date":"Sep. 16, 2022 at 10:22 a.m. ET","Headline":"Europe may give COVID vaccines full marketing authorization; WHO backs Gilead\u2019s Veklury for severe disease","Summary":"Pfizer Inc.  and BioNTech SE  said Friday that the Committee for Medicinal Products for Human Use (CHMP) for the European Medicines Agency (EMA) has recommended the companies' COVID-19 vaccine Comirnaty be converted to sta..."},{"Date":"Sep. 16, 2022 at 8:37 a.m. ET","Headline":"Pfizer, BioNTech COVID vaccine gets CHMP recommendation for 'full' MA for all indications","Summary":"Pfizer Inc.  and BioNTech SE  said Friday that the Committee for Medicinal Products for Human Use (CHMP) for the European Medicines Agency (EMA) has recommended the companies' COVID-19 vaccine Comirnaty be converted to sta..."},{"Date":"Sep. 16, 2022 at 8:18 a.m. ET","Headline":"Novavax says its COVID vaccine is now available in Israel for use in people aged 12 and older","Summary":"Novavax Inc.  said Friday that Israel has granted an import and use permit for the company's COVID vaccine for use in people aged 12 and older. The vaccine is protein based, using a more traditional technology than the mRN..."},{"Date":"Sep. 19, 2022 at 4:28 p.m. ET","Headline":"Stocks end choppy session with gains as investors await Fed decision","Summary":"Stocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said the pandemic is over, in an interview with \"60 Minutes\" that aired on Sunday. Moderna Inc.  fell 9.2%, Pfizer Inc.  was down 1.7% a..."},{"Date":"Sep. 19, 2022 at 3:26 p.m. ET","Headline":"Vaccine Stocks Sink as Biden Says Pandemic Is Over","Summary":"Stocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said the pandemic is over, in an interview with \"60 Minutes\" that aired on Sunday. Moderna Inc.  fell 9.2%, Pfizer Inc.  was down 1.7% a..."},{"Date":"Sep. 19, 2022 at 11:31 a.m. ET","Headline":"Vaccine stocks Pfizer, BioNTech, Moderna and Novavax slide after Biden says pandemic is over","Summary":"Stocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said the pandemic is over, in an interview with \"60 Minutes\" that aired on Sunday. Moderna Inc.  fell 9.2%, Pfizer Inc.  was down 1.7% a..."},{"Date":"Sep. 19, 2022 at 9:14 a.m. ET","Headline":"GE HealthCare\u2019s Spinoff Is Coming. Here\u2019s the Challenge for the Stock.","Summary":""},{"Date":"Sep. 20, 2022 at 11:08 a.m. ET","Headline":"Haleon Won\u2019t Indemnify Pfizer, GSK Over Zantac. Shares Are Up.","Summary":""},{"Date":"Sep. 20, 2022 at 8:36 a.m. ET","Headline":"Health experts dismayed by President Biden\u2019s view that the pandemic is over: \u2018Hell no \u2014 not even close\u2019","Summary":""},{"Date":"Sep. 23, 2022 at 7:20 a.m. ET","Headline":"Health official says updated COVID-19 boosters likely to be available in weeks for elementary school-age children","Summary":"Pfizer Inc.  said Thursday it has reached an agreement to supply up to six million treatment courses of its COVID antiviral Paxlovid to the Global Fund for low and middle-income countries. The company said it expects suppl..."},{"Date":"Sep. 22, 2022 at 8:57 p.m. ET","Headline":"Just 4.4 million Americans have gotten omicron-targeted boosters so far","Summary":"Pfizer Inc.  said Thursday it has reached an agreement to supply up to six million treatment courses of its COVID antiviral Paxlovid to the Global Fund for low and middle-income countries. The company said it expects suppl..."},{"Date":"Sep. 22, 2022 at 1:17 p.m. ET","Headline":"Novavax Stock Sinks. It Has \u2018Few Levers\u2019 for Covid Vaccine, Says New Bear.","Summary":"Pfizer Inc.  said Thursday it has reached an agreement to supply up to six million treatment courses of its COVID antiviral Paxlovid to the Global Fund for low and middle-income countries. The company said it expects suppl..."},{"Date":"Sep. 22, 2022 at 7:25 a.m. ET","Headline":"Moderna expects the shortage of its updated COVID-19 booster to soon be resolved","Summary":"Pfizer Inc.  said Thursday it has reached an agreement to supply up to six million treatment courses of its COVID antiviral Paxlovid to the Global Fund for low and middle-income countries. The company said it expects suppl..."},{"Date":"Sep. 22, 2022 at 6:51 a.m. ET","Headline":"Pfizer to supply Global Fund up to 6 million courses of its COVID antiviral Paxlovid for low-and-middle-income countries","Summary":"Pfizer Inc.  said Thursday it has reached an agreement to supply up to six million treatment courses of its COVID antiviral Paxlovid to the Global Fund for low and middle-income countries. The company said it expects suppl..."},{"Date":"Sep. 24, 2022 at 10:11 a.m. ET","Headline":"\u2018Reshoring\u2019 is poised to boost U.S. companies bringing business back home. Shares of these 17 companies will benefit.","Summary":""},{"Date":"Sep. 27, 2022 at 8:37 a.m. ET","Headline":"Novavax stock up 4.4% premarket after it says 1 million COVID vaccine doses now available in the U.K.","Summary":"Novavax Inc.  said Tuesday that one million doses of its protein-based COVID vaccine Nuvaxovid are now available in the U.K. \"With U.K. data showing that people infected with both COVID-19 and the flu are more than five ti..."},{"Date":"Sep. 27, 2022 at 6:26 a.m. ET","Headline":"Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Monday they have submitted an application to the U.S. Food and Drug Administration seeking an emergency use authorization for their bivalent vaccine booster for use in chil..."},{"Date":"Sep. 27, 2022 at 5:01 a.m. ET","Headline":"What are single-stock ETFs, and should you buy them? \u2018They\u2019re not for the faint of heart.\u2019","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Monday they have submitted an application to the U.S. Food and Drug Administration seeking an emergency use authorization for their bivalent vaccine booster for use in chil..."},{"Date":"Sep. 27, 2022 at 2:00 a.m. ET","Headline":"3 Large-Cap Blend Funds That Stood Out This Year","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Monday they have submitted an application to the U.S. Food and Drug Administration seeking an emergency use authorization for their bivalent vaccine booster for use in chil..."},{"Date":"Sep. 26, 2022 at 6:54 a.m. ET","Headline":"Pfizer and BioNTech seek FDA EUA for omicron-targeting booster for use in children aged 5 to 11","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Monday they have submitted an application to the U.S. Food and Drug Administration seeking an emergency use authorization for their bivalent vaccine booster for use in chil..."},{"Date":"Sep. 29, 2022 at 11:51 a.m. ET","Headline":"Novartis Can Outperform Wall Street Expectations, CEO Says","Summary":""},{"Date":"Sep. 28, 2022 at 8:04 a.m. ET","Headline":"Canada to scrap mask mandate on planes, joining Japan, Hong Kong and U.A.E. in lifting COVID restrictions","Summary":""},{"Date":"Sep. 30, 2022 at 12:52 p.m. ET","Headline":"1 in 5 of Americans don\u2019t know about new omicron-targeting COVID boosters, survey finds","Summary":""},{"Date":"Oct. 3, 2022 at 1:39 p.m. ET","Headline":"War over drug-cost assistance traps sickest patients in the middle","Summary":""},{"Date":"Oct. 3, 2022 at 8:26 a.m. ET","Headline":"Myovant Stock Leaps After Rejecting $2.5 Billion Sumitomo Bid","Summary":""},{"Date":"Oct. 10, 2022 at 8:07 a.m. ET","Headline":"Large number of U.S. COVID deaths could be prevented if patients would take Pfizer\u2019s Paxlovid, White House coordinator warns","Summary":""},{"Date":"Oct. 13, 2022 at 4:31 p.m. ET","Headline":"Dow ends over 800 points higher as stocks stage massive turnaround after hot inflation reading","Summary":""},{"Date":"Oct. 13, 2022 at 11:04 a.m. ET","Headline":"GSK, Pfizer Duel Over RSV Vaccine Is Heating Up","Summary":""},{"Date":"Oct. 13, 2022 at 6:56 a.m. ET","Headline":"Pfizer and BioNTech report positive data in trial of omicron-targeting bivalent booster in individuals aged 18 and older","Summary":""},{"Date":"Oct. 13, 2022 at 6:41 a.m. ET","Headline":"Avoiding Global Recession Is Tough Enough. A Disruptive OPEC Makes It Harder.","Summary":""},{"Date":"Oct. 12, 2022 at 5:28 p.m. ET","Headline":"Moderna Stock Takes Off on Cancer Vaccine News","Summary":""},{"Date":"Oct. 12, 2022 at 2:47 p.m. ET","Headline":"CDC officially recommends new boosters for young children","Summary":""},{"Date":"Oct. 12, 2022 at 12:17 p.m. ET","Headline":"Pfizer and Moderna Stocks Jump After FDA Grants Emergency Use of Boosters for Children","Summary":""},{"Date":"Oct. 12, 2022 at 10:47 a.m. ET","Headline":"FDA said children between 6 and 17 can get Moderna\u2019s new COVID-19 booster","Summary":""},{"Date":"Oct. 12, 2022 at 10:37 a.m. ET","Headline":"Pfizer, BioNTech stocks surge after FDA grants emergency use of BA.4, BA.5 adapted booster shots in children","Summary":""},{"Date":"Oct. 15, 2022 at 10:24 a.m. ET","Headline":"Study finds Paxlovid can interact badly with some heart medications, and White House renews COVID emergency through Jan. 11","Summary":""},{"Date":"Oct. 14, 2022 at 6:27 a.m. ET","Headline":"Fresh data supports updated boosters targeting omicron subvariants, raising hopes more Americans will get the shot","Summary":""},{"Date":"Oct. 18, 2022 at 10:07 a.m. ET","Headline":"Johnson & Johnson Earnings Top Estimates. Its CFO Explains What Went Right.","Summary":""},{"Date":"Oct. 18, 2022 at 7:08 a.m. ET","Headline":"CDC identifies new COVID variants that accounted for 11.4% of new cases in week ending Oct. 15","Summary":""},{"Date":"Oct. 21, 2022 at 1:56 p.m. ET","Headline":"Pfizer\u2019s Covid Vaccine Is Going to Cost a Lot More. That\u2019s Good News for Moderna.","Summary":""},{"Date":"Oct. 21, 2022 at 7:57 a.m. ET","Headline":"WHO says another omicron subvariant, which may be more resistant to antibodies,  spread to 26 countries in latest week","Summary":""},{"Date":"Oct. 20, 2022 at 6:58 a.m. ET","Headline":"Tesla Bigger Than Apple and Saudi Aramco Combined? Dream On, Investors Tell Musk.","Summary":""},{"Date":"Oct. 22, 2022 at 10:01 a.m. ET","Headline":"Pfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per dose","Summary":""},{"Date":"Oct. 24, 2022 at 7:14 a.m. ET","Headline":"CDC shoots down false claims it will mandate COVID-19 vaccines for schoolchildren, saying states make that decision","Summary":""},{"Date":"Oct. 29, 2022 at 8:21 a.m. ET","Headline":"Buffett\u2019s Berkshire Chases Musk\u2019s Tesla on Market Value","Summary":""},{"Date":"Oct. 27, 2022 at 2:20 p.m. ET","Headline":"Merck\u2019s CFO Says Biotech Deals are Getting Done","Summary":""},{"Date":"Oct. 31, 2022 at 10:00 a.m. ET","Headline":"The S&P 500 can get to 4,150 before \u2018reality sets in,\u2019 says Morgan Stanley\u2019s normally bearish top strategist","Summary":""},{"Date":"Oct. 31, 2022 at 7:58 a.m. ET","Headline":"Wall Street is being nicer on earnings as vaccine makers, fintech reports near","Summary":""},{"Date":"Oct. 30, 2022 at 6:09 p.m. ET","Headline":"Fed Meeting, Jobs Data, Uber and PayPal Earnings, and More to Watch this Week","Summary":""},{"Date":"Nov. 2, 2022 at 6:40 a.m. ET","Headline":"Recession Is the Dark Cloud Hanging Over Powell\u2019s Inflation-Busting Fed","Summary":"Pfizer Inc.'s  COVID-19 antiviral Paxlovid brought in $7.5 billion in sales in the , against a FactSet consensus of $7.6 billion. The drug company also reiterated guidance for Paxlovid revenues in 2022, saying it still exp..."},{"Date":"Nov. 2, 2022 at 6:01 a.m. ET","Headline":"GSK Raises Guidance as Earnings Beat Helps Shore Up Position of CEO","Summary":"Pfizer Inc.'s  COVID-19 antiviral Paxlovid brought in $7.5 billion in sales in the , against a FactSet consensus of $7.6 billion. The drug company also reiterated guidance for Paxlovid revenues in 2022, saying it still exp..."},{"Date":"Nov. 1, 2022 at 4:30 p.m. ET","Headline":"U.S. stocks end lower as investors weigh economic data, brace for Fed decision on interest rates","Summary":"Pfizer Inc.'s  COVID-19 antiviral Paxlovid brought in $7.5 billion in sales in the , against a FactSet consensus of $7.6 billion. The drug company also reiterated guidance for Paxlovid revenues in 2022, saying it still exp..."},{"Date":"Nov. 1, 2022 at 2:40 p.m. ET","Headline":"Pfizer Will Dominate RSV Vaccine Market, CEO Says","Summary":"Pfizer Inc.'s  COVID-19 antiviral Paxlovid brought in $7.5 billion in sales in the , against a FactSet consensus of $7.6 billion. The drug company also reiterated guidance for Paxlovid revenues in 2022, saying it still exp..."},{"Date":"Nov. 1, 2022 at 10:37 a.m. ET","Headline":"Hospitalizations on the rise in New York City as new COVID strains spread rapidly","Summary":"Pfizer Inc.'s  COVID-19 antiviral Paxlovid brought in $7.5 billion in sales in the , against a FactSet consensus of $7.6 billion. The drug company also reiterated guidance for Paxlovid revenues in 2022, saying it still exp..."},{"Date":"Nov. 1, 2022 at 9:48 a.m. ET","Headline":"Pfizer climbs on strong Q3 results, raised outlook","Summary":"Pfizer Inc.'s  COVID-19 antiviral Paxlovid brought in $7.5 billion in sales in the , against a FactSet consensus of $7.6 billion. The drug company also reiterated guidance for Paxlovid revenues in 2022, saying it still exp..."},{"Date":"Nov. 1, 2022 at 8:30 a.m. ET","Headline":"Pfizer Stock Gains After Earnings, Strong Data on RSV Vaccine","Summary":"Pfizer Inc.'s  COVID-19 antiviral Paxlovid brought in $7.5 billion in sales in the , against a FactSet consensus of $7.6 billion. The drug company also reiterated guidance for Paxlovid revenues in 2022, saying it still exp..."},{"Date":"Nov. 1, 2022 at 7:47 a.m. ET","Headline":"Pfizer's COVID-19 antiviral Paxlovid brought in $7.5 billion in sales in Q3","Summary":"Pfizer Inc.'s  COVID-19 antiviral Paxlovid brought in $7.5 billion in sales in the , against a FactSet consensus of $7.6 billion. The drug company also reiterated guidance for Paxlovid revenues in 2022, saying it still exp..."},{"Date":"Nov. 1, 2022 at 7:38 a.m. ET","Headline":"New omicron subvariants accounted for more cases in New York region in latest week than BA.5, CDC data shows","Summary":"Pfizer Inc.'s  stock rose 3.4% before market open on Tuesday, lifted by the pharmaceutical giant's third-quarter earnings. The company earned $1.51 a share on net income of $8.608 billion, compared with earnings of $1.42 a..."},{"Date":"Nov. 1, 2022 at 7:15 a.m. ET","Headline":"Pfizer stock climbs on Q3 top and bottom line beat, raised outlook","Summary":"Pfizer Inc.'s  stock rose 3.4% before market open on Tuesday, lifted by the pharmaceutical giant's third-quarter earnings. The company earned $1.51 a share on net income of $8.608 billion, compared with earnings of $1.42 a..."},{"Date":"Nov. 1, 2022 at 6:48 a.m. ET","Headline":"Pfizer says late-stage trial of RSV vaccine proved effective in reducing risk in very young children","Summary":"Pfizer Inc.  said Tuesday a late-stage trial of its Respiratory Syncytial Virus, or RSV, vaccine proved highly effective in reducing the risk of severe disease for infants against a virus that causes hundreds of deaths a y..."},{"Date":"Nov. 1, 2022 at 1:15 a.m. ET","Headline":"3 Things to Watch When Pfizer Announces Earnings","Summary":""},{"Date":"Nov. 4, 2022 at 6:35 p.m. ET","Headline":"Pfizer Stock\u2019s Post-Covid Future Looks Healthy","Summary":"Pfizer Inc.  and Germany-based partner BioNTech SE  said new data from a Phase 2\/3 trial showed that the booster for companies' omicron BA.4\/BA.5-adapted bivalent COVID-19 vaccine demonstrated a \"robust neutralizing immune..."},{"Date":"Nov. 4, 2022 at 3:25 p.m. ET","Headline":"Twitter Is Now Filled With Tweets From the Company\u2019s Laid Off Staff","Summary":"Pfizer Inc.  and Germany-based partner BioNTech SE  said new data from a Phase 2\/3 trial showed that the booster for companies' omicron BA.4\/BA.5-adapted bivalent COVID-19 vaccine demonstrated a \"robust neutralizing immune..."},{"Date":"Nov. 4, 2022 at 2:36 p.m. ET","Headline":"Elon Musk Cites a \u2018Massive Drop\u2019 in Twitter Revenue as Questions About Business Mount","Summary":"Pfizer Inc.  and Germany-based partner BioNTech SE  said new data from a Phase 2\/3 trial showed that the booster for companies' omicron BA.4\/BA.5-adapted bivalent COVID-19 vaccine demonstrated a \"robust neutralizing immune..."},{"Date":"Nov. 4, 2022 at 11:21 a.m. ET","Headline":"Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day","Summary":"Pfizer Inc.  and Germany-based partner BioNTech SE  said new data from a Phase 2\/3 trial showed that the booster for companies' omicron BA.4\/BA.5-adapted bivalent COVID-19 vaccine demonstrated a \"robust neutralizing immune..."},{"Date":"Nov. 4, 2022 at 10:41 a.m. ET","Headline":"General Mills, Audi Latest to Pull Twitter Ads After Musk Takeover","Summary":"Pfizer Inc.  and Germany-based partner BioNTech SE  said new data from a Phase 2\/3 trial showed that the booster for companies' omicron BA.4\/BA.5-adapted bivalent COVID-19 vaccine demonstrated a \"robust neutralizing immune..."},{"Date":"Nov. 4, 2022 at 7:03 a.m. ET","Headline":"Pfizer, BioNTech stocks rally after announcing positive trial data on BA.4\/BA.5 bivalent booster shot","Summary":"Pfizer Inc.  and Germany-based partner BioNTech SE  said new data from a Phase 2\/3 trial showed that the booster for companies' omicron BA.4\/BA.5-adapted bivalent COVID-19 vaccine demonstrated a \"robust neutralizing immune..."},{"Date":"Nov. 4, 2022 at 6:39 a.m. ET","Headline":"Elon Musk Looks Set to Put His Own Twist on Jobs Friday","Summary":"Shares of Germany-based BioNTech SE  surged 5.1% toward a three-month high in premarket trading Friday, after  that China agreed to approve the biotechnology company's COVID-19 vaccines for foreign residents in China. Pfiz..."},{"Date":"Nov. 4, 2022 at 6:23 a.m. ET","Headline":"BioNTech stock surges toward 3-month high after report China agrees to approve its COVID vaccine for foreigners","Summary":"Shares of Germany-based BioNTech SE  surged 5.1% toward a three-month high in premarket trading Friday, after  that China agreed to approve the biotechnology company's COVID-19 vaccines for foreign residents in China. Pfiz..."},{"Date":"Nov. 4, 2022 at 2:00 a.m. ET","Headline":"Want to Find Winning Stocks? Take a Look at This Group of Losers.","Summary":""},{"Date":"Nov. 3, 2022 at 9:25 a.m. ET","Headline":"Moderna Stock Tumbles on Earnings Miss, Guidance Cut. Blame Covid-19 Vaccine Sales.","Summary":""},{"Date":"Nov. 5, 2022 at 1:59 p.m. ET","Headline":"\u2018I own the responsibility for why everyone is in this situation\u2019: Twitter founder Jack Dorsey apologizes for layoffs","Summary":""},{"Date":"Nov. 5, 2022 at 1:14 p.m. ET","Headline":"Activist groups urge advertisers to pause Twitter buys after Elon Musk blames them for \u2018massive drop in revenue\u2019","Summary":""},{"Date":"Nov. 7, 2022 at 1:58 p.m. ET","Headline":"All eyes on China as Apple and Foxconn outline zero-COVID issues. Meanwhile, cases are rising again in the U.S.","Summary":""},{"Date":"Nov. 7, 2022 at 10:31 a.m. ET","Headline":"Twitter Begins Second Week Under Elon Musk. Here\u2019s What Has Happened so Far.","Summary":""},{"Date":"Nov. 7, 2022 at 10:16 a.m. ET","Headline":"Alibaba and Other Chinese Stocks Are Rallying Again. It Doesn\u2019t Make Sense.","Summary":""},{"Date":"Nov. 7, 2022 at 7:43 a.m. ET","Headline":"BioNTech Issues Bright Revenue Outlook. But The Stock Sinks After Profit Drop.","Summary":""},{"Date":"Nov. 10, 2022 at 10:11 a.m. ET","Headline":"Pfizer, BioNTech BA.4\/BA.5-adapted booster gets CHMP recommendation for 5-11 year olds in EU","Summary":"Pfizer Inc.  and Germany-based partner BioNTech SE  said Thursday that their booster dose of the omicron BA.4\/BA.5-adapted bivalent COVID vaccine for 5-to-11 year olds was recommended for marketing authorization in the the..."},{"Date":"Nov. 9, 2022 at 8:09 a.m. ET","Headline":"Novavax stock rallies, even as company offers a dimmer sales forecast for vaccines","Summary":""},{"Date":"Nov. 12, 2022 at 12:14 p.m. ET","Headline":"Twitter\u2019s advertiser exodus benefits TikTok, Reddit and Snapchat, data suggest","Summary":""},{"Date":"Nov. 11, 2022 at 8:24 a.m. ET","Headline":"WHO says 90% decline in COVID deaths since Feb. is \u2019cause for optimism,\u2019 while urging vigilance against new variants","Summary":""},{"Date":"Nov. 14, 2022 at 1:55 p.m. ET","Headline":"Moderna Stock Climbs. Its New Covid Booster Works Against Variants.","Summary":""},{"Date":"Nov. 14, 2022 at 8:22 a.m. ET","Headline":"Elon Musk Complains of High Workload After Twitter Takeover","Summary":""},{"Date":"Nov. 18, 2022 at 1:19 p.m. ET","Headline":"Pfizer and BioNTech booster shows strong results in fresh analysis of data","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday a new analysis of data reviewing the immune response created by the omicron BA.4\/BA.5 adapted bivalent COVID vaccine showed strong results against newer omicron subl..."},{"Date":"Nov. 18, 2022 at 6:59 a.m. ET","Headline":"Pfizer and BioNTech say bivalent booster increases neutralizing antibodies against new omicron variants","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday a new analysis of data reviewing the immune response created by the omicron BA.4\/BA.5 adapted bivalent COVID vaccine showed strong results against newer omicron subl..."},{"Date":"Nov. 22, 2022 at 10:59 a.m. ET","Headline":"GSK Pulls Cancer Drug After Trial Failure","Summary":""},{"Date":"Nov. 23, 2022 at 8:31 a.m. ET","Headline":"China\u2019s three-week COVID case tally tops 253,000 and daily average is rising, government says","Summary":""},{"Date":"Nov. 23, 2022 at 7:59 a.m. ET","Headline":"The FTX Fallout Is Laying Crypto Bare. It\u2019s Now Sink or Swim for the Industry.","Summary":""},{"Date":"Nov. 25, 2022 at 7:50 p.m. ET","Headline":"Alphabet and Pfizer Stock Look Like Buys, Says This Longtime Market Maven","Summary":""},{"Date":"Nov. 25, 2022 at 9:30 a.m. ET","Headline":"As COVID cases rise, China locks down despite criticism","Summary":""},{"Date":"Nov. 25, 2022 at 7:32 a.m. ET","Headline":"Confused about COVID boosters? Here\u2019s what the science and the experts say about the new generation of shots.","Summary":""},{"Date":"Nov. 28, 2022 at 10:40 a.m. ET","Headline":"Sarepta\u2019s Gene Therapy Set for Quick FDA Review","Summary":"Widespread protests across China over the government's zero-COVID policy dominated headlines on Monday, with Dr. Anthony Fauci, President Joe Biden's chief medical adviser, weighing in with the view that the strategy  Chin..."},{"Date":"Nov. 28, 2022 at 6:22 a.m. ET","Headline":"Coronavirus tally: China protests in focus as Dr. Fauci says zero-COVID strategy -- and China-made vaccines -- are not working","Summary":"Widespread protests across China over the government's zero-COVID policy dominated headlines on Monday, with Dr. Anthony Fauci, President Joe Biden's chief medical adviser, weighing in with the view that the strategy  Chin..."},{"Date":"Nov. 30, 2022 at 7:23 a.m. ET","Headline":"IMF head joins chorus calling on China to adapt COVID strategy as officials pledge to boost vaccinations among elderly","Summary":""},{"Date":"Nov. 29, 2022 at 6:49 a.m. ET","Headline":"China\u2019s zero-COVID strategy makes no sense and its homegrown vaccines are not \u2018particularly effective,\u2019 says  Fauci","Summary":""},{"Date":"Nov. 28, 2022 at 4:13 a.m. ET","Headline":"China\u2019s zero COVID strategy \u2018doesn\u2019t make public health sense,\u2019 says Fauci","Summary":""},{"Date":"Dec. 2, 2022 at 8:04 a.m. ET","Headline":"Elon Musk Has a Plan to Bring Advertisers Back to Twitter.  Suspending Kanye West Might Help.","Summary":"Roivant Sciences  and Pfizer Inc.  said Thursday that they created a new company focused on developing and commercializing an ulcerative colitis treatment currently in a Phase 2b clinical study. Roivant's stock was up 7.1%..."},{"Date":"Dec. 1, 2022 at 11:36 a.m. ET","Headline":"China Could Face a \u2018Tsunami\u2019 of Covid Deaths. What the Options Are if Lockdowns Are Lifted.","Summary":"Roivant Sciences  and Pfizer Inc.  said Thursday that they created a new company focused on developing and commercializing an ulcerative colitis treatment currently in a Phase 2b clinical study. Roivant's stock was up 7.1%..."},{"Date":"Dec. 1, 2022 at 8:37 a.m. ET","Headline":"The Stock Market Keeps Going Up. How to Protect Yourself From Another Drop.","Summary":"Roivant Sciences  and Pfizer Inc.  said Thursday that they created a new company focused on developing and commercializing an ulcerative colitis treatment currently in a Phase 2b clinical study. Roivant's stock was up 7.1%..."},{"Date":"Dec. 1, 2022 at 8:20 a.m. ET","Headline":"Roivant, Pfizer form company to develop ulcerative colitis treatment","Summary":"Roivant Sciences  and Pfizer Inc.  said Thursday that they created a new company focused on developing and commercializing an ulcerative colitis treatment currently in a Phase 2b clinical study. Roivant's stock was up 7.1%..."},{"Date":"Dec. 6, 2022 at 5:09 p.m. ET","Headline":"Zantac Lawsuits Get Tossed. GSK, Sanofi, and Haleon Stock Soars.","Summary":"Pfizer Inc.  and BioNTech SE  said Monday that they asked the Food and Drug Administration to authorize their updated COVID-19 vaccine as the third dose for children between the ages of 6 months and 5 years old. Children i..."},{"Date":"Dec. 6, 2022 at 6:37 a.m. ET","Headline":"Investors Desperately Want to See the Market Bottom Out. It\u2019s Not Happening Yet.","Summary":"Pfizer Inc.  and BioNTech SE  said Monday that they asked the Food and Drug Administration to authorize their updated COVID-19 vaccine as the third dose for children between the ages of 6 months and 5 years old. Children i..."},{"Date":"Dec. 5, 2022 at 5:23 p.m. ET","Headline":"Covid Cases Are Rising. L.A. Could Bring Back Masks.","Summary":"Pfizer Inc.  and BioNTech SE  said Monday that they asked the Food and Drug Administration to authorize their updated COVID-19 vaccine as the third dose for children between the ages of 6 months and 5 years old. Children i..."},{"Date":"Dec. 5, 2022 at 11:31 a.m. ET","Headline":"China begins to loosen COVID rules","Summary":"Pfizer Inc.  and BioNTech SE  said Monday that they asked the Food and Drug Administration to authorize their updated COVID-19 vaccine as the third dose for children between the ages of 6 months and 5 years old. Children i..."},{"Date":"Dec. 5, 2022 at 11:10 a.m. ET","Headline":"Pfizer, BioNTech ask FDA to authorize bivalent COVID vaccine in young children","Summary":"Pfizer Inc.  and BioNTech SE  said Monday that they asked the Food and Drug Administration to authorize their updated COVID-19 vaccine as the third dose for children between the ages of 6 months and 5 years old. Children i..."},{"Date":"Dec. 8, 2022 at 11:47 a.m. ET","Headline":"FDA Just Authorized Moderna, Pfizer Bivalent Vaccines for Kids Under 5. The Pandemic Is Not Yet Over.","Summary":"The Food and Drug Administration on Thursday authorized the bivalent COVID-19 boosters made by Moderna Inc.  and BioNTech SE \/Pfizer Inc.  for children as young as 6 months old. The regulator said children between the ages..."},{"Date":"Dec. 8, 2022 at 10:02 a.m. ET","Headline":"FDA to allow bivalent COVID boosters for some infants and young children","Summary":"The Food and Drug Administration on Thursday authorized the bivalent COVID-19 boosters made by Moderna Inc.  and BioNTech SE \/Pfizer Inc.  for children as young as 6 months old. The regulator said children between the ages..."},{"Date":"Dec. 7, 2022 at 7:44 a.m. ET","Headline":"FDA set to decide on Pfizer's RSV vaccine by May","Summary":"Pfizer Inc.  said Wednesday that its experimental respiratory syncytial virus vaccine received Priority Review from the Food and Drug Administration. The drug maker is seeking FDA approval of the vaccine in adults who are ..."},{"Date":"Dec. 7, 2022 at 6:06 a.m. ET","Headline":"GSK and Sanofi shares surge after Florida ruling dismisses Zantac lawsuits in what one analyst describes as \u2018best-case scenario\u2019","Summary":""},{"Date":"Dec. 10, 2022 at 12:39 p.m. ET","Headline":"This fund beats the S&P 500 by using just 75 of its components. Here\u2019s how it works.","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday they have received fast track designation from the U.S. Food and Drug Administration for a single-dose-mRNA-based vaccine candidate targeting both COVID and flu. The..."},{"Date":"Dec. 10, 2022 at 11:46 a.m. ET","Headline":"Value stocks keep leading the market, and these are the 16 best picks from top investment newsletters","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday they have received fast track designation from the U.S. Food and Drug Administration for a single-dose-mRNA-based vaccine candidate targeting both COVID and flu. The..."},{"Date":"Dec. 9, 2022 at 10:22 a.m. ET","Headline":"Omicron subvariants are now dominant in the U.S. as COVID cases tick up and New York City becomes a hot spot","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday they have received fast track designation from the U.S. Food and Drug Administration for a single-dose-mRNA-based vaccine candidate targeting both COVID and flu. The..."},{"Date":"Dec. 9, 2022 at 8:50 a.m. ET","Headline":"Pfizer, BioNTech Announce FDA Fast Track for Covid, Flu Vaccine","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday they have received fast track designation from the U.S. Food and Drug Administration for a single-dose-mRNA-based vaccine candidate targeting both COVID and flu. The..."},{"Date":"Dec. 9, 2022 at 7:14 a.m. ET","Headline":"Get ready for a \u2018confusing\u2019 respiratory illness season","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday they have received fast track designation from the U.S. Food and Drug Administration for a single-dose-mRNA-based vaccine candidate targeting both COVID and flu. The..."},{"Date":"Dec. 9, 2022 at 7:04 a.m. ET","Headline":"Foxconn, which makes iPhones, reportedly urged Chinese government to loosen COVID restrictions","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday they have received fast track designation from the U.S. Food and Drug Administration for a single-dose-mRNA-based vaccine candidate targeting both COVID and flu. The..."},{"Date":"Dec. 9, 2022 at 6:54 a.m. ET","Headline":"Pfizer and BioNTech get FDA fast track designation for single-dose COVID and flu vaccine candidate","Summary":"Pfizer Inc.  and German partner BioNTech SE  said Friday they have received fast track designation from the U.S. Food and Drug Administration for a single-dose-mRNA-based vaccine candidate targeting both COVID and flu. The..."},{"Date":"Dec. 9, 2022 at 1:20 a.m. ET","Headline":"Shares rise in Asia after upbeat day on Wall Street","Summary":""},{"Date":"Dec. 14, 2022 at 7:40 a.m. ET","Headline":"With COVID cases rising fast, critics question why there\u2019s no push for face masks in indoor settings","Summary":""},{"Date":"Dec. 14, 2022 at 6:46 a.m. ET","Headline":"Falling Inflation Is Good News for the Fed. Just Don\u2019t Get Too Excited.","Summary":""},{"Date":"Dec. 13, 2022 at 5:04 p.m. ET","Headline":"Pfizer Lays Out Plan to Grow Revenue Ahead of $17 Billion Hit","Summary":""},{"Date":"Dec. 13, 2022 at 7:43 a.m. ET","Headline":"COVID cases continue upward march as new, more infectious variants emerge and flu, RSV and other respiratory illnesses spread","Summary":""},{"Date":"Dec. 15, 2022 at 10:55 a.m. ET","Headline":"Covid-19 Hospitalizations Keep Climbing as New Variants Take Over","Summary":""},{"Date":"Dec. 15, 2022 at 7:26 a.m. ET","Headline":"China to stop reporting asymptomatic COVID cases, which are \u2018impossible\u2019 to track without mass testing","Summary":""},{"Date":"Dec. 17, 2022 at 7:41 a.m. ET","Headline":"This momentum-stock strategy can be a winner regardless of whether the Federal Reserve pivots","Summary":""},{"Date":"Dec. 19, 2022 at 10:52 a.m. ET","Headline":"Pfizer gains rights to experimental RSV treatment in China, Hong Kong, Macau and Singapore","Summary":"Pfizer Inc.  said Monday that it will help develop and commercialize sisunatovir, LianBio's  experimental respiratory syncytial virus (RSV) treatment candidate, in mainland China, Hong Kong, Macau and Singapore. Sisunatovi..."},{"Date":"Dec. 22, 2022 at 8:38 a.m. ET","Headline":"Oric's stock rallies on multiple myeloma deal with Pfizer","Summary":"Shares of Oric Pharmaceuticals Inc.  soared about 56% in premarket trading on Thursday, the day after the company said it will collaborate with Pfizer Inc.  to develop a multiple myeloma therapeutic candidate. Pfizer will ..."},{"Date":"Dec. 21, 2022 at 1:03 p.m. ET","Headline":"Covid Cases Are Surging. Cities Advise Masks.","Summary":"Pfizer Inc.  said Wednesday that the  Food and Drug Administration and the European Medicines Agency accepted the new drug application for its ulcerative colitis treatment candidate. The FDA is expected to make a decision ..."},{"Date":"Dec. 21, 2022 at 11:31 a.m. ET","Headline":"Federal spending bill\u2019s pandemic provisions: more public health data, no investigation into COVID\u2019s origin","Summary":"Pfizer Inc.  said Wednesday that the  Food and Drug Administration and the European Medicines Agency accepted the new drug application for its ulcerative colitis treatment candidate. The FDA is expected to make a decision ..."},{"Date":"Dec. 21, 2022 at 7:45 a.m. ET","Headline":"Pfizer submits colitis drug application to FDA, EMA","Summary":"Pfizer Inc.  said Wednesday that the  Food and Drug Administration and the European Medicines Agency accepted the new drug application for its ulcerative colitis treatment candidate. The FDA is expected to make a decision ..."},{"Date":"Dec. 23, 2022 at 11:37 a.m. ET","Headline":"Why 2023 Will Be a Huge Year for Vaccines","Summary":""},{"Date":"Dec. 23, 2022 at 10:18 a.m. ET","Headline":"6 Defensive Healthcare Stocks for 2023","Summary":""},{"Date":"Dec. 27, 2022 at 10:59 a.m. ET","Headline":"China turns a corner on COVID as it lifts quarantines for foreigners","Summary":""},{"Date":"Dec. 30, 2022 at 1:47 p.m. ET","Headline":"COVID-related ICU patients rise to 5-month high above 5,000\u2014are new cases really falling?","Summary":""},{"Date":"Dec. 30, 2022 at 9:12 a.m. ET","Headline":"China COVID cases could double next month, as Merck antiviral gets approval","Summary":""},{"Date":"Dec. 29, 2022 at 7:20 a.m. ET","Headline":"Pfizer\u2019s hemophilia B treatment meets primary endpoint in Phase 3 study","Summary":""},{"Date":"Dec. 28, 2022 at 2:30 p.m. ET","Headline":"What\u2019s Ahead\u2014and 3 Stocks to Watch\u2014for Every S&P 500 Sector","Summary":""},{"Date":"Jan. 4, 2023 at 3:15 p.m. ET","Headline":"As EU works to coordinate response to China\u2019s COVID wave, Beijing and airlines are unhappy","Summary":""},{"Date":"Jan. 4, 2023 at 10:01 a.m. ET","Headline":"Moderna Bolsters Its Vaccine Pipeline With $85 Million Deal for Biotech Firm OriCiro","Summary":""},{"Date":"Jan. 4, 2023 at 7:51 a.m. ET","Headline":"Tesla stock wipes out three-day bounce, falls to lowest price in more than 2 years","Summary":""},{"Date":"Jan. 7, 2023 at 9:12 a.m. ET","Headline":"XBB.1.5, which makes up 28% of new COVID cases in the U.S., fuels worries about a winter wave","Summary":""},{"Date":"Jan. 6, 2023 at 3:46 p.m. ET","Headline":"A Highly Contagious Covid-19 Variant Is Spreading in the U.S. What to Know.","Summary":""},{"Date":"Jan. 6, 2023 at 12:24 p.m. ET","Headline":"China\u2019s latest COVID challenge: Lunar New Year holiday travel surge","Summary":""},{"Date":"Jan. 6, 2023 at 8:57 a.m. ET","Headline":"As COVID vaccine and Paxlovid sales decline, analysts want to know what\u2019s next for Pfizer","Summary":""},{"Date":"Jan. 6, 2023 at 8:06 a.m. ET","Headline":"Pfizer could sell some assets, convert others into new companies amid broader refocus","Summary":""},{"Date":"Jan. 6, 2023 at 7:00 a.m. ET","Headline":"Why Pfizer Is Pulling Back on Early-Stage Rare Disease Research, Selling Some Major Assets","Summary":""},{"Date":"Jan. 9, 2023 at 10:34 p.m. ET","Headline":"Pfizer\u2019s Paxlovid will not be included in China\u2019s national insurance","Summary":""},{"Date":"Jan. 9, 2023 at 2:52 p.m. ET","Headline":"WSJ: Moderna may charge up to $130 per dose of its COVID shot","Summary":""},{"Date":"Jan. 9, 2023 at 8:44 a.m. ET","Headline":"The Year\u2019s Biggest Healthcare Conference Starts Monday. What to Expect.","Summary":""},{"Date":"Jan. 9, 2023 at 6:47 a.m. ET","Headline":"Fed Wants Weaker Markets, Investors Want a Bargain. Brace for Earnings Season.","Summary":""},{"Date":"Jan. 8, 2023 at 6:32 p.m. ET","Headline":"It\u2019s Pharma Time: Why Merck and Lilly Are Buys, but Not Pfizer.","Summary":""},{"Date":"Jan. 11, 2023 at 6:52 a.m. ET","Headline":"China takes first steps to punish countries that imposed testing mandates for Chinese travelers","Summary":"Hewlett Packard Enterprise Co.  on Tuesday appointed Frank D'Amelio, former chief financial officer of Pfizer Inc. , to HPE's board of directors. D'Amelio has more than 40 years of leadership experience in finance, operati..."},{"Date":"Jan. 10, 2023 at 4:26 p.m. ET","Headline":"HPE appoints former Pfizer CFO D'Amelio to board","Summary":"Hewlett Packard Enterprise Co.  on Tuesday appointed Frank D'Amelio, former chief financial officer of Pfizer Inc. , to HPE's board of directors. D'Amelio has more than 40 years of leadership experience in finance, operati..."},{"Date":"Jan. 10, 2023 at 2:21 p.m. ET","Headline":"CureVac Stock Has Nearly Doubled in 3 Days","Summary":""},{"Date":"Jan. 10, 2023 at 8:48 a.m. ET","Headline":"Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government\u2019s pandemic response","Summary":""},{"Date":"Jan. 10, 2023 at 6:40 a.m. ET","Headline":"Powell\u2019s in Sweden. Rates Will Likely Go Higher Still Despite Companies\u2019 Pain.","Summary":""},{"Date":"Jan. 13, 2023 at 12:55 p.m. ET","Headline":"New COVID subvariant is now dominant across the U.S., accounting for 43% of all new cases in latest week, CDC says","Summary":""},{"Date":"Jan. 13, 2023 at 1:30 a.m. ET","Headline":"How Novavax Could Shake Up the Market for Covid-19 Vaccines","Summary":""},{"Date":"Jan. 14, 2023 at 1:40 p.m. ET","Headline":"Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns than research","Summary":""},{"Date":"Jan. 14, 2023 at 2:00 a.m. ET","Headline":"Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.","Summary":""},{"Date":"Jan. 17, 2023 at 6:54 a.m. ET","Headline":"Pfizer expands commitment to \u2018An Accord for a Healthier World\u2019 to meet unmet medical needs in 45 lower-income countries","Summary":""},{"Date":"Jan. 18, 2023 at 12:23 p.m. ET","Headline":"Moderna is the latest company to produce a promising RSV vaccine","Summary":""},{"Date":"Jan. 18, 2023 at 10:05 a.m. ET","Headline":"Moderna Says Its RSV Vaccine Trial Was a Success. A Clash With Pfizer and GSK Looms.","Summary":""},{"Date":"Jan. 18, 2023 at 9:00 a.m. ET","Headline":"Covid Isn\u2019t Going Away. New Drugs Are Coming.","Summary":""},{"Date":"Jan. 18, 2023 at 8:53 a.m. ET","Headline":"Costco and 6 Other Stocks to Buy for a \u2018Hard Landing\u2019 Scenario","Summary":""},{"Date":"Jan. 18, 2023 at 7:50 a.m. ET","Headline":"WHO calls on China to release more information on its COVID case surge to learn more about which variants are circulating","Summary":""},{"Date":"Jan. 18, 2023 at 7:42 a.m. ET","Headline":"CDC to investigate \u2018safety signal\u2019 for Pfizer\u2019s updated COVID booster","Summary":""},{"Date":"Jan. 18, 2023 at 6:38 a.m. ET","Headline":"Japan\u2019s Surprise Decision Matters for Markets. The Dollar\u2019s Set for a Bumpy Ride.","Summary":""},{"Date":"Jan. 23, 2023 at 3:40 p.m. ET","Headline":"An Annual Covid Booster Could Be Coming. What It Would Mean for Pfizer and Moderna.","Summary":""},{"Date":"Jan. 25, 2023 at 2:56 a.m. ET","Headline":"Eli Lilly, Novo Nordisk Get a Share-Price Pop From Weight-Loss Drugs","Summary":""},{"Date":"Jan. 24, 2023 at 6:31 a.m. ET","Headline":"Job Cuts Today, What Tomorrow? Big Tech Faces Some Big Tests.","Summary":""},{"Date":"Jan. 27, 2023 at 1:52 p.m. ET","Headline":"FDA panel backs plan for annual COVID-19 booster, as new omicron subvariant continues to dominate in new cases","Summary":""},{"Date":"Jan. 27, 2023 at 7:36 a.m. ET","Headline":"What investors need to know about Pfizer\u2019s latest downgrade","Summary":""},{"Date":"Jan. 26, 2023 at 5:28 p.m. ET","Headline":"FDA Advisers Recommend Replacing All Covid Vaccines With Bivalent Version","Summary":""},{"Date":"Jan. 28, 2023 at 11:04 a.m. ET","Headline":"Gas Prices Are Rising. Refiner Stocks Are Riding the Wave\u2014for Now.","Summary":""},{"Date":"Jan. 31, 2023 at 4:48 p.m. ET","Headline":"The Worst-Performing S&P 500 Stocks in January","Summary":""},{"Date":"Jan. 31, 2023 at 4:40 p.m. ET","Headline":"Nasdaq books best January since 2001 as U.S. stocks post strong monthly gains ahead of Fed decision","Summary":""},{"Date":"Jan. 31, 2023 at 1:52 p.m. ET","Headline":"Moderna\u2019s stock is down as Pfizer lowers revenue estimates for its COVID vaccine for 2023","Summary":""},{"Date":"Jan. 31, 2023 at 9:44 a.m. ET","Headline":"This newsletter editor has been recommending stocks and bonds this year and says the rally has room to run","Summary":""},{"Date":"Jan. 31, 2023 at 7:50 a.m. ET","Headline":"Pfizer Stock Falls on Downbeat Guidance as Company Braces for Covid Vaccine Drop-Off","Summary":""},{"Date":"Jan. 31, 2023 at 7:05 a.m. ET","Headline":"Pfizer tops profit expectations but gives downbeat outlook, as COVID product sales set to tumble","Summary":""},{"Date":"Jan. 30, 2023 at 8:28 p.m. ET","Headline":"Biden to end COVID-19 emergency declarations on May 11","Summary":""},{"Date":"Jan. 30, 2023 at 4:31 p.m. ET","Headline":"Could Big Tech layoffs grow? Apple, Amazon, Facebook and Google may give hints in biggest week of holiday earnings.","Summary":""},{"Date":"Feb. 1, 2023 at 10:24 a.m. ET","Headline":"Pfizer CEO: Covid Infections Will Rise. So Will Paxlovid and Vaccine Sales.","Summary":""},{"Date":"Feb. 1, 2023 at 8:43 a.m. ET","Headline":"Biden to end U.S. COVID emergencies on May 11, but more than 500 people are still dying every day","Summary":""},{"Date":"Feb. 1, 2023 at 8:29 a.m. ET","Headline":"Pfizer\u2019s COVID revenues have dropped off along with attention to the pandemic","Summary":""},{"Date":"Feb. 4, 2023 at 12:12 p.m. ET","Headline":"Retirees: Don\u2019t fall for a popularity contest when it comes to your investments","Summary":""},{"Date":"Feb. 3, 2023 at 8:22 a.m. ET","Headline":"Alphabet and Other Stocks That Are Solid Bets in a Wild Market","Summary":""},{"Date":"Feb. 3, 2023 at 8:15 a.m. ET","Headline":"Regeneron\u2019s Earnings Beat Forecasts, With No Sales of Covid-19 Treatment","Summary":""},{"Date":"Jan. 30, 2023 at 8:43 a.m. ET","Headline":"Apple and Amazon Earnings, a Fed Decision, Jobs Data, and More to Watch This Week","Summary":""},{"Date":"Feb. 6, 2023 at 6:31 a.m. ET","Headline":"Fed Cuts Look Like a Dream, Not Reality. What It Means for Stocks.","Summary":""},{"Date":"Feb. 16, 2023 at 7:26 a.m. ET","Headline":"After IPO, Bausch + Lomb turns to an industry favorite to run the company","Summary":""},{"Date":"Feb. 15, 2023 at 5:58 p.m. ET","Headline":"Moderna promises to keep COVID vaccine free","Summary":""},{"Date":"Feb. 5, 2023 at 9:53 a.m. ET","Headline":"Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy.","Summary":""},{"Date":"Dec. 2, 2022 at 12:01 a.m. ET","Headline":"A Big Chill Is Here for the Housing Market. Next Year Could Bring More Trouble.","Summary":""},{"Date":"Feb. 18, 2023 at 9:20 a.m. ET","Headline":"10 dividend stocks with yields as high as 6.5% from a value manager with a strong track record","Summary":""},{"Date":"Feb. 18, 2023 at 1:00 a.m. ET","Headline":"The Commercialization of Covid Vaccines Is Coming. Here\u2019s What It Means.","Summary":""},{"Date":"Feb. 17, 2023 at 2:44 p.m. ET","Headline":"Pfizer Shuts Trial Sites for Lyme Disease Jab After Standards Breaches","Summary":""},{"Date":"Feb. 17, 2023 at 9:13 a.m. ET","Headline":"Pfizer and Other Stocks That Haven\u2019t Been Able to Snap Their Losing Streak","Summary":""},{"Date":"Feb. 17, 2023 at 8:24 a.m. ET","Headline":"Moderna\u2019s COVID vaccine will remain free for all Americans in coup for Bernie Sanders","Summary":""},{"Date":"Feb. 21, 2023 at 2:29 p.m. ET","Headline":"Mal Makin\u2019s Underrated\u2014and Understated\u2014Ways to Gain Clients","Summary":""},{"Date":"Feb. 24, 2023 at 3:59 p.m. ET","Headline":"\u2018Ukraine is open for business\u2019: Western companies urged to be part of country\u2019s recovery","Summary":""},{"Date":"Feb. 26, 2023 at 10:26 p.m. ET","Headline":"Pfizer eyes takeover of biotech Seagen, at value of more than $30 billion","Summary":""},{"Date":"Feb. 28, 2023 at 5:55 p.m. ET","Headline":"FDA panel narrowly backs Pfizer\u2019s RSV vaccine for older adults","Summary":""},{"Date":"Feb. 28, 2023 at 4:33 p.m. ET","Headline":"FDA Panel Says Pfizer\u2019s RSV Vaccine Is Safe and Effective","Summary":""},{"Date":"Feb. 28, 2023 at 4:02 p.m. ET","Headline":"Novavax Says There Is \u2018Substantial Doubt\u2019 Around Its Ability to Continue Operating This Year","Summary":""},{"Date":"Feb. 28, 2023 at 9:03 a.m. ET","Headline":"Moderna\u2019s Covid Boom Is Ending. Why the Outlook Isn\u2019t All Grim.","Summary":""},{"Date":"Feb. 27, 2023 at 4:37 p.m. ET","Headline":"U.S. stocks finish slightly higher, gaining back some ground after worst week of 2023","Summary":""},{"Date":"Feb. 27, 2023 at 4:16 p.m. ET","Headline":"These Stocks Are Moving the Most Today: Fisker, Tegna, FuboTV, Seagen, and More","Summary":""},{"Date":"Feb. 27, 2023 at 10:30 a.m. ET","Headline":"Tesla, Seagen, Fisker and Union Pacific shares pop \u2014 and more stock-market movers","Summary":""},{"Date":"Feb. 27, 2023 at 10:21 a.m. ET","Headline":"Pfizer in Talks to Buy Seagen for $30 Billion or More","Summary":""},{"Date":"Feb. 27, 2023 at 9:58 a.m. ET","Headline":"This is what Warren Buffett, a self-described \u2018so-so investor,\u2019 says is his \u2018secret sauce\u2019","Summary":""},{"Date":"Mar. 2, 2023 at 12:09 p.m. ET","Headline":"FDA Advisers Had Questions on Pfizer\u2019s RSV Vaccine. GSK Could Be First to Market.","Summary":""},{"Date":"Mar. 1, 2023 at 6:11 a.m. ET","Headline":"Retail Earnings Indicate Unclear Outlook. Why the Fed Needs Consumers to Cut Back.","Summary":""},{"Date":"Mar. 3, 2023 at 8:28 p.m. ET","Headline":"Housing Stages a Comeback. That\u2019s a Problem.","Summary":""},{"Date":"Mar. 4, 2023 at 9:08 a.m. ET","Headline":"Bears control the stock market for now, but these takeover plays can keep the bulls satisfied","Summary":""},{"Date":"Mar. 10, 2023 at 6:54 a.m. ET","Headline":"Pfizer wins FDA approval for its migraine nasal spray","Summary":""},{"Date":"Mar. 10, 2023 at 1:15 a.m. ET","Headline":"Johnson & Johnson, Kellogg, and 2 Other Spinoffs to Watch in 2023","Summary":""},{"Date":"Mar. 11, 2023 at 9:24 a.m. ET","Headline":"This is your brain on AI: Powerful billionaires are pouring money into life-extending technology \u2014 and they just might succeed.","Summary":""},{"Date":"Mar. 14, 2023 at 6:47 a.m. ET","Headline":"SVB May Be a Failure of Supervision. What It Means for Other Banks.","Summary":""},{"Date":"Mar. 13, 2023 at 4:28 p.m. ET","Headline":"Dow finishes down for fifth straight session as investors weigh regional-bank fallout","Summary":""},{"Date":"Mar. 13, 2023 at 4:16 p.m. ET","Headline":"These Stocks Are Moving the Most Today: First Republic, Schwab, Seagen, Provention Bio, Illumina, and More","Summary":""},{"Date":"Mar. 13, 2023 at 3:22 p.m. ET","Headline":"Regional banks pace decliners after bank failures, as biotech deals lift Seagen and Provention Bio","Summary":""},{"Date":"Mar. 13, 2023 at 2:36 p.m. ET","Headline":"Pfizer\u2019s $43 billion bid for Seagen aims to broaden  company\u2019s cancer portfolio","Summary":""},{"Date":"Mar. 13, 2023 at 10:23 a.m. ET","Headline":"SVB\u2019s rescue means the Fed won\u2019t hike rates in March, says Goldman Sachs","Summary":""},{"Date":"Mar. 13, 2023 at 10:07 a.m. ET","Headline":"Pfizer Rolls the Dice on Seagen in $43 Billion Deal. The Risks It Faces.","Summary":""},{"Date":"Mar. 16, 2023 at 3:16 p.m. ET","Headline":"FDA committee says benefits outweigh risks for Pfizer\u2019s Paxlovid","Summary":""},{"Date":"Mar. 16, 2023 at 8:35 a.m. ET","Headline":"FDA panel to meet Thursday to discuss full approval of Paxlovid","Summary":""},{"Date":"Mar. 15, 2023 at 8:39 a.m. ET","Headline":"FDA updates authorization of BioNTech, Pfizer\u2019s bivalent booster for young children","Summary":""},{"Date":"Mar. 17, 2023 at 9:10 p.m. ET","Headline":"Stocks for Market Turmoil: Consumer Staples","Summary":""},{"Date":"Mar. 17, 2023 at 4:41 p.m. ET","Headline":"Seagen and Newell Brands Stock See Action From Activist Investors","Summary":""},{"Date":"Mar. 17, 2023 at 1:48 p.m. ET","Headline":"WHO expects to declare end to pandemic sometime in 2023 as virus becomes more like seasonal flu","Summary":""},{"Date":"Mar. 17, 2023 at 8:31 a.m. ET","Headline":"How a nasal vaccine could reduce the risk of COVID infections \u2014 and new variants","Summary":""},{"Date":"Mar. 22, 2023 at 3:40 p.m. ET","Headline":"Moderna CEO defends price increase for COVID vaccine to Congress","Summary":""},{"Date":"Mar. 22, 2023 at 9:25 a.m. ET","Headline":"CDC Rings Alarm About Deadly Fungus. 6 Things to Know.","Summary":""},{"Date":"Mar. 22, 2023 at 7:10 a.m. ET","Headline":"China grants emergency use for first homegrown mRNA COVID vaccine: WSJ","Summary":""},{"Date":"Mar. 24, 2023 at 11:23 a.m. ET","Headline":"GSK, Haleon Shares Drop After Setback on Zantac Cancer Litigation","Summary":""},{"Date":"Mar. 27, 2023 at 8:27 a.m. ET","Headline":"BioNTech Stock Is Falling. Blame the Covid Vaccine Outlook.","Summary":""},{"Date":"Mar. 27, 2023 at 7:02 a.m. ET","Headline":"BioNTech stock falls as earnings beat expectations, but show falling demand for COVID-19 vaccines","Summary":""},{"Date":"Mar. 29, 2023 at 12:08 p.m. ET","Headline":"What WHO\u2019s New Covid-19 Vaccine Guidance Means for Pfizer and Moderna Stock","Summary":""},{"Date":"Mar. 29, 2023 at 9:36 a.m. ET","Headline":"Zoetis Stock Could Rise 30% as People Spend More on Pets","Summary":""},{"Date":"Apr. 6, 2023 at 2:45 a.m. ET","Headline":"The Stock Market\u2019s Rally Is Being Driven by a Few Big Stocks","Summary":""},{"Date":"Apr. 11, 2023 at 3:51 p.m. ET","Headline":"Antivaccine Groups See Hope in Abortion-Pill Ruling. What It Means for Pharma.","Summary":""},{"Date":"Apr. 11, 2023 at 6:32 a.m. ET","Headline":"The Inflation Wave May Be Cresting. What\u2019s Next for Fed Rates.","Summary":""},{"Date":"Apr. 17, 2023 at 3:02 p.m. ET","Headline":"Moderna Cancer-Therapy Sees More Upbeat Data","Summary":""},{"Date":"Apr. 17, 2023 at 2:45 p.m. ET","Headline":"Healthcare Is Back. But Is It Here to Stay?","Summary":""},{"Date":"Apr. 19, 2023 at 3:32 p.m. ET","Headline":"Supreme Court Extends Decision on Abortion Pills to Friday","Summary":""},{"Date":"Apr. 19, 2023 at 11:13 a.m. ET","Headline":"8 Defensive Plays as Healthcare Stocks Stumble","Summary":""},{"Date":"Apr. 19, 2023 at 6:35 a.m. ET","Headline":"FDA approves single booster dose of bivalent COVID vaccine for people aged 65 and older or those with immunocompromise","Summary":""},{"Date":"Apr. 18, 2023 at 9:55 a.m. ET","Headline":"China Turns On the Charm, but Economist Stephen Roach Isn\u2019t Buying It","Summary":""},{"Date":"Apr. 18, 2023 at 9:33 a.m. ET","Headline":"IPO for J&J\u2019s Consumer Health Division is Coming Soon, CFO Says","Summary":""},{"Date":"Apr. 18, 2023 at 9:04 a.m. ET","Headline":"Merck\u2019s $10.8 billion takeover of Prometheus is a good strategic move that gives it a foothold in immunology","Summary":""},{"Date":"Apr. 18, 2023 at 1:31 a.m. ET","Headline":"Stocks Paying Big Dividends Should Outperform Those Doing Big Buybacks","Summary":""},{"Date":"Apr. 13, 2023 at 12:48 p.m. ET","Headline":"Ukraine\u2019s prime minister urges U.S. companies to join $411 billion reconstruction effort","Summary":""},{"Date":"Apr. 21, 2023 at 2:00 a.m. ET","Headline":"Biopharma Deals Are Hot. There\u2019s More to Come\u2014and These Stocks Can Benefit.","Summary":""},{"Date":"Apr. 23, 2023 at 2:13 p.m. ET","Headline":"\u2018The inflation genie is not going back in the bottle anytime soon.\u2019 Why this veteran trader likes oil and retail stocks now.","Summary":""},{"Date":"Apr. 26, 2023 at 9:32 a.m. ET","Headline":"GSK Earnings Beat Expectations, Updates on Pipeline","Summary":""},{"Date":"Apr. 29, 2023 at 8:40 a.m. ET","Headline":"8 value stocks that look like bargains for long-term investors","Summary":""},{"Date":"Apr. 28, 2023 at 4:38 p.m. ET","Headline":"FDA authorizes Pfizer-BioNTech booster for young kids with compromised immune systems","Summary":""},{"Date":"May. 1, 2023 at 9:09 a.m. ET","Headline":"Watch for a Fed pause, a debt-ceiling battle and a volatile summer. Shelter in these stocks, says strategist.","Summary":""},{"Date":"May. 1, 2023 at 7:59 a.m. ET","Headline":"Amazon made earnings look better \u2014 can Apple continue the momentum?","Summary":""},{"Date":"Apr. 28, 2023 at 8:11 p.m. ET","Headline":"TJX Was Already a Retail Winner. Bed Bath & Beyond\u2019s Bankruptcy Now Plays to Its Strengths.","Summary":""},{"Date":"May. 3, 2023 at 6:25 a.m. ET","Headline":"Fed Holds an Ace to Calm Banking Turmoil. Why It\u2019s Not Playing It.","Summary":""},{"Date":"May. 2, 2023 at 5:06 p.m. ET","Headline":"Dow ends 370 points lower as Fed decision looms and debt ceiling draws focus","Summary":""},{"Date":"May. 2, 2023 at 4:14 p.m. ET","Headline":"Pfizer Will Shift Focus to Dividends and Share Buybacks, Execs Say","Summary":""},{"Date":"May. 2, 2023 at 2:37 p.m. ET","Headline":"Apple and 10 other stocks tied to China supply chains are at risk, but 7 others may benefit, says Morgan Stanley","Summary":""},{"Date":"May. 2, 2023 at 1:51 p.m. ET","Headline":"Pfizer first-quarter results beat expectations despite COVID-19 vaccine sales plunge","Summary":""},{"Date":"May. 2, 2023 at 9:35 a.m. ET","Headline":"Pfizer Stock Jumps After Sales Beat. There\u2019s More Good News From Earnings.","Summary":""},{"Date":"May. 2, 2023 at 7:55 a.m. ET","Headline":"Chegg\u2019s stock tumbles on ChatGPT student usage, Pfizer and Burger King parent shares rise on results and other stocks on the move","Summary":""},{"Date":"Apr. 28, 2023 at 7:19 p.m. ET","Headline":"Many Stocks Look Attractive. The Stock Market Doesn\u2019t.","Summary":""},{"Date":"May. 4, 2023 at 1:20 p.m. ET","Headline":"Kenvue Stock Jumps in IPO of Former J&J Consumer-Health Business","Summary":""},{"Date":"May. 4, 2023 at 9:16 a.m. ET","Headline":"Moderna Posts Earnings Beat. There\u2019s Good News on Covid Vaccines Too.","Summary":""},{"Date":"May. 4, 2023 at 8:42 a.m. ET","Headline":"Weight-Loss Drugs Will Be Blockbusters. Here\u2019s the Stock to Buy.","Summary":""},{"Date":"May. 4, 2023 at 6:39 a.m. ET","Headline":"Powell Says Banking System \u2018Sound and Resilient.\u2019 Try Telling That to PacWest Investors.","Summary":""},{"Date":"Apr. 30, 2023 at 3:00 p.m. ET","Headline":"Apple, AB InBev, and Uber Earnings, a Fed Decision, April Jobs Data, and More to Watch This Week","Summary":""},{"Date":"Apr. 28, 2023 at 5:13 p.m. ET","Headline":"Why J&J\u2019s Kenvue Spinoff Is Just What the IPO Doctor Ordered","Summary":""},{"Date":"May. 9, 2023 at 12:11 p.m. ET","Headline":"Birth-control pills with no prescription? 4 things you need to know as FDA weighs over-the-counter approval.","Summary":""},{"Date":"May. 8, 2023 at 12:32 p.m. ET","Headline":"PacWest leads regional bank rally. Berkshire Hathaway, Dish, AMC, Tyson and other stocks on the move.","Summary":""},{"Date":"May. 8, 2023 at 9:02 a.m. ET","Headline":"You Can Have Dividends and Growth. Here\u2019s How.","Summary":""},{"Date":"May. 8, 2023 at 7:09 a.m. ET","Headline":"BioNTech\u2019s stock jumps 4.3% premarket after earnings fall but top estimates","Summary":""},{"Date":"May. 10, 2023 at 2:30 p.m. ET","Headline":"As COVID public health emergency ends, \u2018whack-a-mole\u2019 virus won\u2019t be easy to track","Summary":""},{"Date":"May. 10, 2023 at 6:50 a.m. ET","Headline":"Novavax\u2019s stock soars after positive COVID and flu trial data and news of plan to lay off 25% of workforce","Summary":""},{"Date":"May. 9, 2023 at 10:43 a.m. ET","Headline":"Novavax Plans to Cut 25% of Staff. Here\u2019s Why the Stock Is Soaring.","Summary":""},{"Date":"May. 12, 2023 at 10:22 a.m. ET","Headline":"Healthcare Stocks Are on Sale. Pfizer and Stryker Have Strong Growth Prospects.","Summary":""},{"Date":"May. 17, 2023 at 3:46 p.m. ET","Headline":"Western Alliance Bancorp deposit growth and debt ceiling optimism sparks rally in bank stocks","Summary":""},{"Date":"May. 17, 2023 at 12:38 p.m. ET","Headline":"Pfizer, Amgen, and 7 More Cheap Healthcare Stocks for Investors to Consider","Summary":""},{"Date":"May. 17, 2023 at 8:29 a.m. ET","Headline":"FTC sues to block Amgen\u2019s acquisition of Horizon Therapeutics","Summary":""},{"Date":"May. 17, 2023 at 8:12 a.m. ET","Headline":"XPO to offer $830 million of five-year bonds and $450 million of eight-year bonds","Summary":""},{"Date":"May. 17, 2023 at 7:42 a.m. ET","Headline":"Megabank stocks rise in premarket as Pfizer deal boosts underwriting","Summary":""},{"Date":"May. 17, 2023 at 7:34 a.m. ET","Headline":"Pfizer borrows $31 billion in mega bond deal as debt issuance picks up ahead of debt-ceiling deadline","Summary":""},{"Date":"May. 17, 2023 at 6:47 a.m. ET","Headline":"Pfizer Prices $31 Billion Debt Offering to Fund Seagen Acquisition","Summary":""},{"Date":"May. 17, 2023 at 6:29 a.m. ET","Headline":"Debt Ceiling Negotiations Turn a Corner. Why The Risk Isn\u2019t Over Yet.","Summary":""},{"Date":"May. 16, 2023 at 12:41 p.m. ET","Headline":"FTC Sues to Block Amgen\u2019s $27.8 Billion Acquisition of Horizon Therapeutics","Summary":""},{"Date":"May. 16, 2023 at 11:23 a.m. ET","Headline":"Abortion pill case heads back to federal appeals court: What\u2019s at stake","Summary":""},{"Date":"May. 18, 2023 at 6:10 p.m. ET","Headline":"FDA advisers vote in favor of Pfizer\u2019s maternal RSV vaccine","Summary":""},{"Date":"May. 18, 2023 at 2:57 p.m. ET","Headline":"Charles Schwab raises $2.5 billion in bond offering amid surge in corporate-bond deals","Summary":""},{"Date":"May. 18, 2023 at 11:38 a.m. ET","Headline":"CEOs and other top execs are saving billions with \u2018top hat\u2019 retirement plans, study says","Summary":""},{"Date":"May. 19, 2023 at 1:56 p.m. ET","Headline":"Washington Is Coming Down Hard on Deal Making. What It Means for Stocks.","Summary":""},{"Date":"May. 23, 2023 at 3:05 p.m. ET","Headline":"New Weight-Loss Pills Are Coming. What to Know.","Summary":""},{"Date":"May. 23, 2023 at 7:40 a.m. ET","Headline":"Seagate joins flurry of bond issuance with plans to issue up to $1 billion of high-yield bonds","Summary":""},{"Date":"May. 22, 2023 at 2:19 p.m. ET","Headline":"Micron, Meta and Nike stocks fall and Nio, DraftKings shares rally, and other stocks on the move","Summary":""},{"Date":"May. 22, 2023 at 1:36 p.m. ET","Headline":"Pfizer shares jump 4% after diabetes drug shows weight-loss results","Summary":""},{"Date":"May. 25, 2023 at 11:31 a.m. ET","Headline":"Pfizer wins full FDA approval for oral COVID therapy Paxlovid for adults at high risk of developing severe illness","Summary":""},{"Date":"May. 27, 2023 at 11:02 a.m. ET","Headline":"The dark side of the weight-loss-drug craze: eating disorders, medication shortages, dangerous knockoffs","Summary":""},{"Date":"May. 26, 2023 at 11:42 a.m. ET","Headline":"Drugmakers Released a Ton of New Cancer Treatment Data. The Biggest Developments.","Summary":""},{"Date":"May. 25, 2023 at 2:59 a.m. ET","Headline":"Hedge Funds Are Bullish on Their Stocks but Bearish on the Market","Summary":""},{"Date":"May. 26, 2023 at 10:54 a.m. ET","Headline":"Greece\u2019s Economy Is on the Mend. What the U.S. Can Learn From Its Revival.","Summary":""},{"Date":"May. 30, 2023 at 12:48 p.m. ET","Headline":"Vitamins can make your brain 3 years younger, study says","Summary":""},{"Date":"Jun. 1, 2023 at 11:46 a.m. ET","Headline":"RSV vaccine competition heats up as Pfizer\u2019s shot for older adults gets FDA approval","Summary":""},{"Date":"Jun. 2, 2023 at 6:42 p.m. ET","Headline":"Regulators Have Cracked Down on Big Deals. Why Investors Might Try Some Merger Arb.","Summary":""},{"Date":"Jun. 12, 2023 at 8:34 a.m. ET","Headline":"A Stock\u2019s Dividend Yield Isn\u2019t Enough. Pay Attention to \u2018Shareholder Yield.\u2019","Summary":""},{"Date":"Jun. 12, 2023 at 3:00 a.m. ET","Headline":"The First Vaccines for RSV Are Coming Soon. What to Know.","Summary":""},{"Date":"Jun. 16, 2023 at 6:27 a.m. ET","Headline":"The Market Thinks the Fed Is Wrong. Why That\u2019s Dangerous.","Summary":""},{"Date":"Jun. 15, 2023 at 4:49 p.m. ET","Headline":"FDA advisers endorse updating COVID vaccines to target latest omicron strain","Summary":""},{"Date":"Jun. 15, 2023 at 4:46 p.m. ET","Headline":"The FDA Is Prepping for Fall Covid Boosters. The Next Step Is Today.","Summary":""},{"Date":"Jun. 17, 2023 at 8:20 a.m. ET","Headline":"Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays.","Summary":""},{"Date":"Jun. 20, 2023 at 3:50 p.m. ET","Headline":"Most Ukrainian businesses are fully operational, says Kyiv-based American Chamber of Commerce","Summary":""},{"Date":"Jun. 19, 2023 at 8:48 a.m. ET","Headline":"Why Peter Hotez says he won\u2019t debate RFK Jr. after weekend of Rogan, Musk taunts","Summary":""},{"Date":"Jun. 22, 2023 at 8:09 a.m. ET","Headline":"Roivant Sciences shares gain after ulcerative colitis treatment shows longer-term results","Summary":""},{"Date":"Jun. 21, 2023 at 2:38 p.m. ET","Headline":"GSK\u2019s RSV Vaccine Could Be Effective for Longer. What That Means.","Summary":""},{"Date":"Jun. 21, 2023 at 8:39 a.m. ET","Headline":"15 Biotech Stocks Wall Street Analysts Say Are Too Cheap","Summary":""},{"Date":"Jun. 23, 2023 at 6:02 p.m. ET","Headline":"Pfizer\u2019s alopecia drug for teens and adults approved by FDA","Summary":""},{"Date":"Jun. 23, 2023 at 9:09 a.m. ET","Headline":"CDC Advisors Offer Lukewarm Endorsement of GSK, Pfizer RSV Vaccines. What to Know.","Summary":""},{"Date":"Jun. 23, 2023 at 7:55 a.m. ET","Headline":"GSK Stock Climbs on Zantac Settlement. Drug Maker Avoids a California Trial.","Summary":""},{"Date":"Jun. 26, 2023 at 4:33 p.m. ET","Headline":"These Stocks Are Moving the Most Today: Carnival, Lucid, PacWest, Tesla, Pfizer, and More","Summary":""},{"Date":"Jun. 26, 2023 at 7:22 a.m. ET","Headline":"No more needles? A daily pill may work as well as Wegovy shots to treat obesity.","Summary":""},{"Date":"Jun. 26, 2023 at 6:58 a.m. ET","Headline":"Pfizer to advance oral candidate danuglipron as treatment for obesity and diabetes toward late-stage trial and discontinue lotiglipron","Summary":""},{"Date":"Jun. 28, 2023 at 3:50 p.m. ET","Headline":"After \u2018transformative\u2019 year, Roivant aims to challenge bigger rivals in inflammation and immunology","Summary":""},{"Date":"Jun. 28, 2023 at 6:56 a.m. ET","Headline":"Pfizer wins FDA approval for once-weekly human growth hormone treatment for children aged three and older","Summary":""},{"Date":"Jun. 27, 2023 at 8:52 a.m. ET","Headline":"Eli Lilly Stock Jumps. Its  Weight-Loss Shot Melts More Pounds Than Its Pill.","Summary":""},{"Date":"Jun. 27, 2023 at 8:12 a.m. ET","Headline":"Pfizer Makes a Call on Obesity Pill. Investors Aren\u2019t Happy.","Summary":""},{"Date":"Jun. 27, 2023 at 8:10 a.m. ET","Headline":"Weight-loss drugs in development aim to replace injections with pills","Summary":""},{"Date":"Jun. 27, 2023 at 6:27 a.m. ET","Headline":"Fed Will Pay High Price to Bring Down Inflation. Investors Should Take Note.","Summary":""},{"Date":"Jun. 27, 2023 at 2:00 a.m. ET","Headline":"Mergers Are Down, but These 2 Sectors Are Booming","Summary":""},{"Date":"Jun. 30, 2023 at 6:56 a.m. ET","Headline":"Ozempic and other weight-loss drugs boost pharmacy sales at Rite Aid","Summary":""},{"Date":"Jun. 29, 2023 at 9:27 a.m. ET","Headline":"A Drug for Itchy Dogs Costs $1,200. Why Is the Human Equivalent $43,000?","Summary":""},{"Date":"Jul. 1, 2023 at 3:56 p.m. ET","Headline":"Bad boys: Four dumb ways people just got caught allegedly engaging in insider trading","Summary":""},{"Date":"Jun. 30, 2023 at 2:02 p.m. ET","Headline":"The 10 Best Income Plays for the Second Half of 2023","Summary":""},{"Date":"Jul. 4, 2023 at 7:20 a.m. ET","Headline":"Pfizer Taps Samsung Biologics in $900 Million Manufacturing Deal","Summary":""},{"Date":"Jul. 4, 2023 at 6:48 a.m. ET","Headline":"Americans still say Disney is among the most patriotic brands in the U.S., despite DeSantis feud","Summary":""},{"Date":"Jul. 6, 2023 at 7:12 p.m. ET","Headline":"Pfizer Bets on Caribou\u2019s Gene-Edited Cancer Treatment","Summary":""},{"Date":"Jul. 8, 2023 at 8:26 a.m. ET","Headline":"Top investment newsletters are down on tech, Tesla and Meta Platforms. Here\u2019s what they like.","Summary":""},{"Date":"Jul. 7, 2023 at 7:50 p.m. ET","Headline":"Why Studios May Need to Rethink Summer Movie Blockbusters","Summary":""},{"Date":"Jul. 6, 2023 at 10:53 a.m. ET","Headline":"4 Big Pharma Stocks On Sale Right Now","Summary":""},{"Date":"Jul. 12, 2023 at 7:23 a.m. ET","Headline":"EU regulator is reviewing weight-loss drugs Ozempic and Wegovy for risk of suicidal thoughts and self-harm","Summary":""},{"Date":"Jul. 14, 2023 at 6:50 a.m. ET","Headline":"Crypto Is Back From the Dead After Court Ruling. Why It\u2019s a Big Moment.","Summary":""},{"Date":"Jul. 13, 2023 at 6:24 p.m. ET","Headline":"Roivant stock rallies on report of pending drug sale: WSJ","Summary":""},{"Date":"Jul. 12, 2023 at 3:59 p.m. ET","Headline":"Drug manufacturers\u2019 deal making will plow ahead despite antitrust scrutiny, according to analysts","Summary":""},{"Date":"Jul. 12, 2023 at 10:23 a.m. ET","Headline":"Microsoft\u2019s Win in the Activision Case Could Spur a Merger Revival","Summary":""},{"Date":"Jul. 18, 2023 at 7:18 a.m. ET","Headline":"Pfizer, Flagship Pioneering in Drug-Development Pact >PFE","Summary":""},{"Date":"Jul. 18, 2023 at 7:10 a.m. ET","Headline":"Pfizer and Flagship Pioneering to invest $100 million to develop treatments for unmet medical needs","Summary":""},{"Date":"Jul. 20, 2023 at 1:53 p.m. ET","Headline":"Johnson & Johnson Stock Jumps on Earnings Beat. But Talc Worries Loom.","Summary":""},{"Date":"Jul. 20, 2023 at 10:32 a.m. ET","Headline":"Don\u2019t Give Up on Dividend Stocks After AT&T\u2019s Drop","Summary":""},{"Date":"Jul. 20, 2023 at 8:39 a.m. ET","Headline":"It\u2019s a dash for trash right now, and these lotto stocks have rocketed 86% on average","Summary":""},{"Date":"Jul. 19, 2023 at 8:19 p.m. ET","Headline":"Pfizer pharmaceutical plant in North Carolina damaged by tornado, no serious injuries","Summary":""},{"Date":"Jul. 19, 2023 at 3:31 a.m. ET","Headline":"5 Beaten-Down Healthcare Stocks With Potential for a Rebound","Summary":""},{"Date":"Jul. 22, 2023 at 11:38 a.m. ET","Headline":"FDA Moves to Soothe Fears of Drug Shortages After Tornado Hits Pfizer Plant","Summary":""},{"Date":"Jul. 22, 2023 at 11:37 a.m. ET","Headline":"Tornado damage at Pfizer facility threatens to make critical drug-supply shortages even worse, experts say","Summary":""},{"Date":"Jul. 21, 2023 at 5:05 a.m. ET","Headline":"As Ozempic\/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion","Summary":""},{"Date":"Jul. 24, 2023 at 8:16 a.m. ET","Headline":"Pfizer says tornado greatly damaged warehouse; FDA downplays injection supply impact","Summary":""},{"Date":"Jul. 28, 2023 at 8:02 p.m. ET","Headline":"With Hurricane Season Looming, Florida Faces an Insurance Meltdown","Summary":""},{"Date":"Jul. 28, 2023 at 11:00 a.m. ET","Headline":"AstraZeneca strikes $1 billion deal for Pfizer rare-disease gene therapies","Summary":""},{"Date":"Jul. 29, 2023 at 1:13 p.m. ET","Headline":"As syphilis cases rise and supply of a key treatment runs short, federal health officials are forming a task force to address the threat","Summary":""},{"Date":"Jul. 29, 2023 at 10:34 a.m. ET","Headline":"These 7 momentum stocks ignited the market. Look out when they start to fall.","Summary":""},{"Date":"Aug. 1, 2023 at 4:46 p.m. ET","Headline":"Tornado Damage at Pfizer Plant Could Lead to Hospital Medicine Shortages, CEO Says","Summary":""},{"Date":"Aug. 1, 2023 at 4:31 p.m. ET","Headline":"S&P 500, Nasdaq start August lower while Apple, Amazon earnings and jobs data loom this week","Summary":""},{"Date":"Aug. 1, 2023 at 9:19 a.m. ET","Headline":"Pfizer Stock Wavers Despite Earnings Beat. Revenue and Outlook Aren\u2019t So Good.","Summary":""},{"Date":"Aug. 1, 2023 at 7:45 a.m. ET","Headline":"Manufacturing stalled in the first half. But now the stage is set for a recovery, says JPMorgan.","Summary":""},{"Date":"Jul. 31, 2023 at 12:30 p.m. ET","Headline":"Drugmakers Want to Crush Medicare\u2019s Pricing Power. They\u2019ll Probably Succeed.","Summary":""},{"Date":"Jul. 31, 2023 at 8:10 a.m. ET","Headline":"Amazon and Apple to headline Q2 earnings this week","Summary":""},{"Date":"Jun. 27, 2023 at 2:10 p.m. ET","Headline":"Eli Lilly, Pfizer, and Others Are Working on Weight-Loss Pills. What to Know.","Summary":""},{"Date":"Aug. 3, 2023 at 4:43 p.m. ET","Headline":"Gilead Sciences Cuts Profit Forecast on Legal Settlement","Summary":""},{"Date":"Aug. 3, 2023 at 10:37 a.m. ET","Headline":"Moderna Raises Hope, Concern, With Update on Sales of Covid-19 Vaccine","Summary":""},{"Date":"Aug. 2, 2023 at 7:43 a.m. ET","Headline":"Merck swings to loss as it books charge on $10.8 billion acquisition of Prometheus Biosciences","Summary":""},{"Date":"Aug. 2, 2023 at 7:41 a.m. ET","Headline":"Pfizer\u2019s stock drops as earnings fall sharply amid lower sales for its COVID products","Summary":""},{"Date":"Aug. 2, 2023 at 6:33 a.m. ET","Headline":"Fitch\u2019s U.S. Credit Downgrade Is a Bad Look. Why It\u2019s Not a Disaster.","Summary":""},{"Date":"Aug. 4, 2023 at 9:59 a.m. ET","Headline":"CDC Recommends New Sanofi, AstraZeneca Shot to Prevent RSV in Babies","Summary":""},{"Date":"Jul. 31, 2023 at 9:25 a.m. ET","Headline":"Apple, Amazon, Starbucks, Uber, AMD, and More Stocks to Watch This Week","Summary":""},{"Date":"Aug. 7, 2023 at 4:31 p.m. ET","Headline":"BioNTech Stock Was a Covid Darling. Now It\u2019s Paying the Price.","Summary":""},{"Date":"Aug. 7, 2023 at 1:33 p.m. ET","Headline":"These Stocks Moved the Most Today: Tesla, Sage, Sovos, Veritiv, Tyson, BioNTech, Moderna, and More","Summary":""},{"Date":"Aug. 7, 2023 at 6:17 a.m. ET","Headline":"BioNTech stock drops after revenue falls well short of expectations, but affirms 2023 COVID vaccine revenue view","Summary":""},{"Date":"Aug. 9, 2023 at 7:47 a.m. ET","Headline":"Novo Nordisk\u2019s Wegovy shows positive results in reducing risk of cardio events, not just weight loss","Summary":""},{"Date":"Aug. 9, 2023 at 2:00 a.m. ET","Headline":"For Dieters, Obesity Drugs Are a Magic Pill. Snack Makers Might Be the Real Losers.","Summary":""},{"Date":"Aug. 8, 2023 at 12:05 p.m. ET","Headline":"Eli Lilly\u2019s stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook","Summary":""},{"Date":"Aug. 8, 2023 at 10:25 a.m. ET","Headline":"New Data May Push Insurers to Cover Novo, Lilly Obesity Drugs","Summary":""},{"Date":"Aug. 8, 2023 at 7:24 a.m. ET","Headline":"Just When You Think Banks Are Safe Again, Moody\u2019s Sounds the Alarm","Summary":""},{"Date":"Aug. 11, 2023 at 9:09 a.m. ET","Headline":"Covid Vaccine Revenues Are Caving. New Boosters May Not Help.","Summary":""},{"Date":"Aug. 8, 2023 at 4:02 p.m. ET","Headline":"J&J\u2019s $40 Billion Kenvue Stock Swap:\u00a0What You Need to Know","Summary":""},{"Date":"Aug. 14, 2023 at 2:40 p.m. ET","Headline":"Pfizer gets FDA accelerated approval for multiple myeloma treatment","Summary":""},{"Date":"Aug. 14, 2023 at 8:22 a.m. ET","Headline":"New Covid Strain Arrives as Vaccine Makers Gear Up","Summary":""},{"Date":"Aug. 14, 2023 at 8:05 a.m. ET","Headline":"WHO names Eris a coronavirus variant of interest. Here\u2019s what you need to know.","Summary":""},{"Date":"Aug. 14, 2023 at 6:28 a.m. ET","Headline":"Goldman Starts Talking About Fed Cuts. What It Means for Stocks.","Summary":""},{"Date":"Jul. 29, 2023 at 10:41 a.m. ET","Headline":"Here\u2019s how many Diet Cokes you\u2019d have to drink daily to get too much aspartame","Summary":""},{"Date":"Aug. 16, 2023 at 12:30 a.m. ET","Headline":"6 Pharma and Life Sciences Stocks That Are Actually Up This Year","Summary":""},{"Date":"Aug. 19, 2023 at 2:53 p.m. ET","Headline":"As COVID hospitalizations rise, Pfizer and Moderna say updated shots show promise against Eris variant","Summary":""},{"Date":"Aug. 18, 2023 at 5:02 p.m. ET","Headline":"Buy Moderna and BioNTech Stock. Both Pharmas Have Strong Drug Pipelines and Plenty of Cash.","Summary":""},{"Date":"Aug. 21, 2023 at 5:32 p.m. ET","Headline":"Pfizer Gets FDA OK for Maternal Use of Abrysvo RSV Vaccine >PFE","Summary":""},{"Date":"Aug. 21, 2023 at 11:07 a.m. ET","Headline":"Palo Alto Networks shares surge after earnings, Tesla climbs and more stocks on the move","Summary":""},{"Date":"Aug. 22, 2023 at 4:46 p.m. ET","Headline":"Covid-19 Hospitalizations Jump. So Could Vaccine Demand.","Summary":""},{"Date":"Aug. 22, 2023 at 7:57 a.m. ET","Headline":"Novavax says updated COVID vaccine effective against Eris, other new variants","Summary":""},{"Date":"Aug. 22, 2023 at 7:54 a.m. ET","Headline":"Pfizer maternal RSV vaccine gets FDA approval","Summary":""},{"Date":"Aug. 25, 2023 at 12:31 p.m. ET","Headline":"Novo Nordisk\u2019s Wegovy Helped Heart-Failure Patients. What\u2019s Next?","Summary":""},{"Date":"Aug. 25, 2023 at 6:45 a.m. ET","Headline":"The Nvidia Distraction Is Over. Jackson Hole, Powell, Bonds Take Center Stage.","Summary":""},{"Date":"Aug. 24, 2023 at 1:48 p.m. ET","Headline":"Covid Boosters Will Come Later Than Last Year, Despite Rising Hospitalizations","Summary":""},{"Date":"Aug. 26, 2023 at 1:07 p.m. ET","Headline":"As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit \u2014 even if their drugs aren\u2019t on the list","Summary":""},{"Date":"Aug. 26, 2023 at 9:44 a.m. ET","Headline":"Stock buybacks spur wealth inequality and stifle innovation. Should they be banned?","Summary":""},{"Date":"Aug. 26, 2023 at 8:53 a.m. ET","Headline":"\u2018The sharks are still there.\u2019 Stock market\u2019s decline is just beginning, this top fund manager says","Summary":""},{"Date":"Aug. 26, 2023 at 8:42 a.m. ET","Headline":"Bullish on Nvidia? This single-stock ETF could offer 1.5 times leverage on the popular chip stock \u2014 but be careful what you wish for.","Summary":""},{"Date":"Aug. 29, 2023 at 3:26 p.m. ET","Headline":"Eli Lilly and Other Pharma Stocks Are Ignoring Medicare\u2019s 10 Drug List","Summary":""},{"Date":"Aug. 29, 2023 at 3:03 p.m. ET","Headline":"5 Things to Know About the New \u2018Pirola\u2019 Variant of Covid","Summary":""},{"Date":"Aug. 28, 2023 at 11:53 a.m. ET","Headline":"COVID is evolving quickly in white-tailed deer, study finds","Summary":""},{"Date":"Aug. 28, 2023 at 3:00 a.m. ET","Headline":"Biden Administration to Reveal Which Pharma Blockbusters Medicare Will Pay Less For","Summary":""},{"Date":"Aug. 30, 2023 at 3:56 p.m. ET","Headline":"Medicare\u2019s Plan to Negotiate Drug Discounts Won\u2019t Hit Pharma Hard, Analysts say","Summary":""},{"Date":"Aug. 30, 2023 at 10:15 a.m. ET","Headline":"Pfizer, BioNTech updated COVID vaccine to treat new variants gets CHMP recommendation use in Europe","Summary":""},{"Date":"Aug. 30, 2023 at 6:46 a.m. ET","Headline":"Crypto Scores Big Win Over the SEC. Why the Battle\u2019s Far From Over.","Summary":""},{"Date":"Sep. 1, 2023 at 2:54 p.m. ET","Headline":"Amgen, FTC Settle Over $27.8 Billion Horizon Deal. Stocks Rise.","Summary":""},{"Date":"Sep. 1, 2023 at 12:19 p.m. ET","Headline":"Drug Developer Stocks Are Risky. Why a Picks-and-Shovels Approach Makes Sense.","Summary":""},{"Date":"Sep. 6, 2023 at 8:12 a.m. ET","Headline":"Moderna says updated COVID vaccine effective against BA.2.86 Pirola variant","Summary":""},{"Date":"Sep. 5, 2023 at 4:30 p.m. ET","Headline":"New Covid-19 Variant Might Not Be That Bad. More Boosters Are Coming Soon.","Summary":""},{"Date":"Sep. 7, 2023 at 6:41 a.m. ET","Headline":"Apple Stock Is Under Pressure. How China Is Killing the iPhone 15 Hype.","Summary":""},{"Date":"Sep. 12, 2023 at 7:25 p.m. ET","Headline":"CDC recommends updated COVID shots for people 6 months of age and older","Summary":""},{"Date":"Sep. 12, 2023 at 6:30 a.m. ET","Headline":"Tesla Is an AI Stock, Apple Isn\u2019t. Who\u2019s Next to Join the Club?","Summary":""},{"Date":"Sep. 11, 2023 at 3:04 p.m. ET","Headline":"Pfizer and Moderna Covid Vaccines Approved by FDA. When They Could Become Available.","Summary":""},{"Date":"Sep. 11, 2023 at 3:01 p.m. ET","Headline":"New Pfizer and Moderna COVID shots approved by FDA","Summary":""},{"Date":"Sep. 11, 2023 at 1:53 p.m. ET","Headline":"Pfizer, BioNTech Get FDA OK for Updated Covid-19 Vaccine >PFE BNTX","Summary":""},{"Date":"Sep. 14, 2023 at 8:15 a.m. ET","Headline":"Alnylam Pharmaceuticals shares fall after FDA advisers weigh in on heart-disease drug","Summary":""},{"Date":"Sep. 13, 2023 at 4:37 p.m. ET","Headline":"U.S. stocks close mostly higher despite inflation edging up in August","Summary":""},{"Date":"Sep. 13, 2023 at 6:32 a.m. ET","Headline":"Moderna aims to prove it\u2019s \u2018more than a COVID company\u2019","Summary":""},{"Date":"Sep. 16, 2023 at 10:35 a.m. ET","Headline":"Why large-cap stocks are a better bet for the rest of 2023 \u2014 and 10 you want to own","Summary":""},{"Date":"Sep. 17, 2023 at 2:26 p.m. ET","Headline":"New Cancer Drugs Are Changing the Odds. The Latest on Treatments.","Summary":""},{"Date":"Sep. 19, 2023 at 12:32 p.m. ET","Headline":"Most Ukrainian companies are fully operational after 18 months of war, Kyiv-based American Chamber of Commerce says","Summary":""},{"Date":"Sep. 14, 2023 at 12:30 a.m. ET","Headline":"\u2018This Is Not a Covid Vaccine Company,\u2019 Moderna CEO Says","Summary":""},{"Date":"Sep. 22, 2023 at 5:24 p.m. ET","Headline":"Pfizer maternal RSV vaccine recommended by CDC","Summary":""},{"Date":"Sep. 24, 2023 at 6:28 p.m. ET","Headline":"Have you gotten your shot? 5 things to know about the new COVID-19 vaccine.","Summary":""},{"Date":"Sep. 22, 2023 at 12:00 p.m. ET","Headline":"The Covid Booster Rollout Is a Mess. That\u2019s Good News for Pfizer and Moderna.","Summary":""},{"Date":"Sep. 26, 2023 at 7:50 a.m. ET","Headline":"Pfizer restarts production at tornado-damaged facility, but some supply is still affected","Summary":""},{"Date":"Sep. 25, 2023 at 8:46 a.m. ET","Headline":"Free Covid Tests Are Coming. Here\u2019s How to Get Yours.","Summary":""},{"Date":"Sep. 25, 2023 at 6:29 a.m. ET","Headline":"Shutdown, Strikes, Sticky Inflation, and More\u2026 Brace for a Bumpy Fourth Quarter","Summary":""},{"Date":"Sep. 28, 2023 at 11:23 a.m. ET","Headline":"Covid-19 Vaccine Uptake Could Beat Expectations, Poll Indicates","Summary":""}]